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Abstract 
 The stereochemical stability of bromonium and chloronium ions has been investigated in 
the context of asymmetric catalysis. Bromonium ions have been found to racemize in the 
presence of olefins by an olefin to olefin transfer process. Chloronium ions do not racemize 
under the same conditions. The applicability of Lewis base catalysis to bromo- and iodo- 
cyclization has been investigated. A variety of Lewis bases with sulfur and selenium donors 
atoms were found to be effective catalysts. Some of these Lewis bases altered the observed ratio 
of product isomers, implying that they were present in the stereodetermining transition state and 
therefore had the capacity to produce asymmetric induction despite racemization of the halonium 
intermediate. Efforts to develop an enantioselective catalyst system based on this principle were 
unsuccessful, however the combination of an achiral Lewis base and a chiral phosphoric acid 
enabled a catalytic enantioselective bromoetherification of aryl-pentenols to be developed. 
 Highly enantioselective additions of silyl ketene imines to aromatic aldehydes under 
SiCl4/chiral Lewis base catalysis were demonstrated. Additions of silyl ketene imines to aliphatic 
aldehydes were demonstrated with moderate to high enantioselectivity.   
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'Well, in OUR country,' said Alice, still panting a little, 'you'd generally get to somewhere 
else—if you ran very fast for a long time, as we've been doing.'  
'A slow sort of country!' said the Queen. 'Now, HERE, you see, it takes all the running 
YOU can do, to keep in the same place. If you want to get somewhere else, you must run at least 
twice as fast as that!'  
-Through the Looking-Glass, Lewis Carroll  
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Chapter 1:  Introduction to Lewis Base Catalysis 
1.1. The Nature of Lewis Base/Lewis Acid Adducts. 
“It seems to me that with complete generality we may say that a basic substance is one which 
has a lone pair of electrons which may be used to complete the stable group of another atom and 
that an acid substance is one which can employ a lone pair from another molecule in completing 
the stable group of one of its own atoms. In other words, the basic substance furnishes a pair of 
electrons for a chemical bond: the acid substance accepts such a pair.” G. N. Lewis, 19231 
 The Lewis definition of acid-base interactions provides an elegant and general model for 
a broad class of interactions. Its validity extends even beyond the original statement, as there is 
no requirement that the donated electrons be from a non-bonded lone pair. The breadth of this 
definition makes it useful to divide these interactions in to subclasses. One such classification 
scheme based on the orbitals involved has been proposed by Jensen (Table 1). 
2
 
Table 1. Jensen’s Classification Scheme for Lewis Acid-Base Interactions. 
Donor Acceptor 
 n* * π* 
n n-n* n-* n- π* 
 -n* -* - π* 
π π-n* π -* π- π* 
 
 Although all nine types of interaction in Jensen’s classification scheme can lead to 
productive complex formation, only three have significant applications in catalysis: the 
interaction of non-bonding lone pairs with: anti-bonding orbitals of π character (n-π*), anti-
bonding orbitals of -character (n-*), and non-bonding orbitals (n-n*).  
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1.1.1.  Consequences of complex formation: Gutmann’s rules. 
The structural consequences of complex formation have been analyzed by Gutmann
3
 who 
has proposed the following empirical rules for the changes in bond length and charge distribution 
as a result of complex formation: (1) the smaller the intramolecular distance between the donor 
(D) and the acceptor (A), the greater the induced lengthening of the peripheral bonds (A-X), (2) 
the longer the bond between D and A, the greater the degree of polarization of electron density 
across that bond, (3) as the coordination number of an atom increases, so do the lengths of all the 
bonds originating from that coordination center, and (4) the bonds adjacent to D and A will 
either contract or elongate to compensate for the changes in electron density at D and A. 
Additionally, he described a phenomenon critical for Lewis base catalysis: that complex 
formation leads to a net increase of electron density at the donor atom and a net decrease of 
electron density at the acceptor atom. This polarization phenomenon results in a rather counter-
intuitive increase in the Lewis acidity of the acceptor, provided that it is able to coordinate 
additional ligands. The lengthening of the A-X bonds is accompanied by further localization of 
negative charge on the X ligands. This phenomenon exists on a continuum with complete 
displacement and ionization of an X ligand, resulting in a much stronger coordinatively 
unsaturated cationic Lewis acid (Scheme 1). In the case of coordinatively saturated Lewis acids 
of first row elements, such as alkyl halides, the neutral complex is a transition state rather than an 
intermediate and the process is an Sn2 displacement.  
Scheme 1. 
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The effects on bond lengths can be clearly seen in the case of the complex Ph3PS·I2.
4
 The 
largest change is the lengthening of the I-I bond by 0.156 Å. Significant lengthening of the S-P 
bond (+0.048 Å) and contraction of the P-C bonds (- 0.011 Å) can also be seen, reflecting the 
redistribution of charge in the phosphine sulfide as predicted by Gutmann’s fourth rule. 
 
Figure 1. Bond lengths in Ph3PS·I2 and changes on complexation. 
 
1.1.2.  Molecular orbital analysis: Hypervalency and the 3 center-4 electron bond. 
The above empirical rules can be rationalized in terms of the formation of hypervalent 
complexes with 3 center-4 electron (3c-4e) bonds formed from unhybridized p orbitals.
5
 In a 3c-
4e bond, one of the electron pairs is localized on  the ligands, giving them a formal charge of -0.5 
each, and giving the acceptor a charge of +1.0 (Figure 2). The observed lengthening of bonds is 
explained by the fact that the 3c-4e bond has only one occupied bonding orbital distributed 
between three atoms.  
 
Figure 2. Molecular orbital diagram of the 3 center-4 electron bond. 
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Atoms form a mixture of 3c-4e and ordinary 2c-2e bonds as necessary to accommodate 
the number of ligands present. Because the 3c-4e bonds are formed from unhybridized p orbitals, 
the number of p orbitals available for forming hybrids drops as the number of ligands increases. 
For example, pentacoordinate complexes of group 14 elements such as Si and Ge form three sp
2
 
hybrids and one 3c-4e bond (Figure 3). The 3c-4e bond (dashed lines) is located at the apical 
positions of the trigonal bipyramid. Similarly, a hexacoordinate complex must form two 3c-4e 
bonds, leaving only one p orbital to form a pair of sp hybrids. The increased s character of the 
hybrid orbitals lowers their energy levels, stabilizing the complex despite the reduced number of 
occupied bonding orbitals. 
 
Figure 3. Changes in hybridization with formation of additional 3c-4e bonds. 
 
Earlier theories of hypervalency invoked the participation of d orbitals to form hybrids 
such as dsp
3
 and d
2
sp
3
.
6
 It is now generally recognized that d orbitals are too high in energy to 
play a primary role in bonding in main group elements, although small fractional occupancies 
may contribute noticeably to the overall stability in some cases by altering polarization of the 
orbitals or by contributing a small amount of bonding character to the non-bonding orbital.
7
 The 
existence of a very small number of stable hypervalent compounds of the first row elements
8
 
shows that hypervalency can exist without any d orbital contribution.  
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1.2.  Types of Lewis Base Catalysis. 
1.2.1.  Catalysis by n–π* interaction. 
 The most common type of Lewis base catalysis features an n-π* interaction, wherein the 
Lewis base interacts with the π* orbital of a carbonyl, olefin or other functional group. This type 
of catalysis is frequently referred to as nucleophilic catalysis; however it can result in the 
enhancement of electrophilic or nucleophilic character at the reaction site. This type of catalysis 
can proceed without the formation of a hypervalent intermediate, making it particularly 
applicable to first row main group elements. The most familiar example of enhanced 
electrophilicity by n-* Lewis base catalysis is the catalysis of acylations by pyridine (eq 1, 
Scheme 2.).
9
 Condensation of pyridine with an electrophilic acyl equivalent such as an acid 
chloride or anhydride produces a highly electrophilic acyl pyridinium ion, which is then captured 
by a nucleophile.
10
 The Morita-Baylis-Hillman reaction
11
 is a representative example of an n-* 
interaction leading to enhanced nucleophilicity (eq 2, Scheme 2.). In this case, conjugate addition 
of the Lewis base to the  system produces a zwitterionic enolate, which reacts with an aldehyde 
followed by regeneration of the catalyst by elimination.   
Scheme 2.  
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1.2.2. Catalysis by n-* interaction. 
Main group elements of the second row and beyond can participate in Lewis base 
catalyzed reactions through n-* interactions, forming a polarized or ionized hypervalent 
intermediate (Section 1.1). Analogous to n-π* interactions, n-* interactions can lead to either 
enhanced electrophilicity of the acceptor atom or enhanced nucleophilicity of its ligands. For 
example, the addition of silyl enol ethers into aldehydes may be catalyzed by sources of 
nucleophilic fluoride or oxyanion equivalents which generate a highly reactive enolate by 
desilylation
12
 (eq 1 in Scheme 3.) or by the generation of a highly Lewis acidic trichlorosilyl 
cation from complexation of SiCl4 with a chiral bis-phosphoramide ligand (eq 2 in Scheme 3.).
13
 
Scheme 3.  
 
  
The research in this thesis will focus on using Lewis base catalysis through n-* 
interactions to develop new enantioselective reactions to solve challenging, unsolved problems in 
organic synthesis. The first six chapters will focus on efforts towards the development of 
enantioselective halocylization reactions using chlorine, bromine and iodine. This includes 
mechanistic and feasibility studies (Chapters 1-4), the successful development of an 
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enantioselective bromocycloetherification reaction using Lewis base/Brønsted acid cooperative 
catalysis (Chapter 5). The final chapter will detail the development of chiral Lewis base 
catalyzed, SiCl4 promoted additions of silyl ketene imines to a variety of carbonyl electrophiles.  
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Chapter 2:  Halonium Ion Configuration and Exchange 
2.1.  Introduction 
Electrophilic halofunctionalizations of olefins, in which halonium ions are generated 
from olefins and opened by nucleophiles,
14
 are among the oldest and simplest organic 
transformations. Despite the versatility of these reactions, at the time that this research was 
initiated only a few practical enantioselective variants had been reported, even fewer of which 
required substoichiometric amounts of chiral promoter.
15
 The last several years have seen an 
explosion of new and innovative approaches to enantioselective catalysis of 
halofunctionalization,
16
 however many desirable transformations still lack enantioselective 
variants. The development of enantioselective halofunctionalization reactions is particularly 
challenging due in part to the propensity of the halonium ions to racemize by olefin-to-olefin 
transfer. (Scheme 4) 
Scheme 4. 
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2.2. Background 
2.2.1.  The halonium ion mechanism of halofunctionalization. 
The intermediacy of a cyclic halonium ion in the halofunctionalization of olefins was first 
proposed by Roberts and Kimball
14
 to explain the relative stereospecificity observed in the 
bromination and chlorination of disubstituted olefins. A series of studies by Lucas and 
Winstein
17
 showed that ionization and displacement of bromohydrins and bromohydrin acetates 
in aqueous HBr proceeds with the relative stereochemistry expected from the intermediacy of a 
bromonium ion. Furthermore, was shown that when optically active bromobutanols were 
subjected to the same conditions (1a-b, Scheme 5.), optically inactive products were obtained. 
This excludes the possibility of an open cation that is captured faster than a bond rotation, 
because the open cation derived from 1b would be chiral and would be expected to lead to chiral 
products.  
Scheme 5. 
 
 
Many halonium ions can be spectroscopically observed following treatment with SbF5 in 
SO2 at low temperature. In a series of studies by Olah
18
  and co-workers all of the iodonium and 
bromonium ions examined gave NMR spectra consistent with cyclic structures. (Scheme 6) 
Contrarily, no evidence for the existence of cyclic fluoronium ions could be obtained, only β-
10 
 
fluorocarbonium ions. Chloronium ions displayed intermediate properties; a tetramethyl 
substituted chloronium ion was found to be cyclic, while the 1,1-dimethyl analog was acyclic. 
Attempts to prepare a 1,2-dimethyl chloronium ion resulted in rearranged products. 
Scheme 6. 
 
 
Halonium ions formed from the extremely hindered olefin adamantylidene adamantane 
are unable to be captured by nucleophiles or eliminate, allowing them to be isolated and 
studied.
19
 X-ray crystallographic studies show clear essentially symmetrical bridging of both 
bromonium and iodonium ions (Figure 4, 4a-b). The degree of rehybridization of the olefin 
carbons was rather small (average C-C-C angle 118.8
o
). 
 
Figure 4. X-ray crystal structures of halonium ions derived from adamantylidene adamantane 
(Counterions and water molecules omitted for clarity). 
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2.2.2.  Absolute configurational stability of halonium ions. 
The aforementioned results establish the generally cyclic nature of halonium ions
*
, as 
well as their relative configurational stability. The absolute configurational stability of these ions 
however was in doubt. Several potential processes can be envisioned which would result in 
racemization of halonium ions without epimerization; these include olefin-to-olefin transfer, 
dissociation to a solvated X
+
 ion, and reversible formation of the halonium ion.  
Solvolysis and crossover studies conducted by Brown
21
 showed that solvolysis of a 
bromohydrin triflate in the presence of cyclopentene resulted in no crossover (Scheme 7.). 
However, when LiBr was introduced, substantial amounts of crossover were observed. These 
observations are consistent with abstraction of Br
+
 by Br
- 
to form Br2, at a rate competitive with 
that of capture by solvent. They also show that olefin-to-olefin transfer is slow in comparison to 
capture by solvent under these conditions.  
Scheme 7. 
 
 
The unique qualities of the halonium ions 4a and 4b allowed the direct observation and 
quantification of olefin-to-olefin transfer (Scheme 8).
19b,19c
 Low temperature dynamic NMR 
studies showed this process to be extremely rapid; for 4a and 4b 2
nd
 order rate constants of 
7.6x10
6
 and 2.0x10
6
 M
-1
s
-1
 were observed at -80 
o
C in CD2Cl2. The activation parameters for the 
exchange of 4b were found to be H‡ = 1.8 ± 0.2 kcal/mol and S‡ = -21 ± 1 cal K-1 mol-1. On 
                                                 
*
 In very polar solvents, strong cation stabilizing substituents can favor acyclic cations
20
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the whole, it would appear that this process is essentially encounter rate and entropy limited. An 
associative mechanism (Scheme 8) was proposed based on the above data in combination with 
ab-initio calculations. 
Scheme 8. 
 
 
Braddock
22
 has demonstrated that a series of enantiopure unsymmetrically substituted 
bromosulfonate precursors can produce enantiopure substitution products on treatment with 
TiCl4, presumably through the intermediacy of a bromonium ion. This is the first demonstration 
of the stereochemical stability of bromonium ions, however no attempt was made to examine the 
effects of added olefins. 
Analogous olefin-to-olefin transfer processes have been demonstrated for thiiranium and 
seleniranium ions.
23
 In these cases, it was shown the transfer of seleniranium ions was faster than 
that of thiiranium ions. Careful modification of the electrophile structure was required to obtain 
enantioenriched selenocycloetherification products.
23c
 
2.2.3.  Objectives 
The previous work in the field left several unanswered questions. Is the extremely high 
rate of olefin-to-olefin transfer somehow unique to 4a-b? Can less than solvent quantities of 
13 
 
nucleophiles outcompete olefin-to-olefin transfer? Could there be a periodic trend that leads to 
reduced transfer rates for chloronium ions?  
The objectives of this study were (1) to demonstrate the generation of enantiopure 
bromonium and chloronium ions and their trapping by representative nucleophiles (2) to 
demonstrate the trapping of enantiopure bromonium and chloronium ions under conditions 
where racemization by degenerate olefin-to-olefin transfer could be competitive with capture by 
nucleophiles. 
2.3.  Results 
2.3.1. Bromonium Ions 
Enantioenriched bromotosylate (4R,5S)-5 was prepared from known diol (3R,4R)-6 by 
modification of the known procedure for synthesizing (1R,2R)-dipropyloxirane;
24
 the 
intermediate bromoformate (4R,5S)-7 was hydrolyzed to (4R,5S)-8 then tosylated (Scheme 9).  
Scheme 9. 
 
 
Solvolysis of (4R,5S)-5 in buffered formic acid provided (4R,5S)-7 in good yield with 
complete preservation of enantiomeric purity, even in the presence of a large excess of olefin 9 
(Scheme 10). However, the thermodynamics of bromine transfer to 9 are unknown and could be 
unfavorable. Additionally the solubility of unfunctionalized olefins in formic acid is limited, so a 
strongly ionizing non-nucleophilic solvent capable of dissolving both (E)-4-octene and a range of 
non-solvent nucleophiles was desired. 
14 
 
Scheme 10. 
 
 
Trifluoroethanol (TFE) and hexafluoroisopropanol (HFIP) are both strongly ionizing 
solvents of low nucleophilicity, capable of dissolving significant amounts of both hydrocarbons 
and nucleophilic salts.
†
 When treated with TFE containing NaOAc at 40 
o
C, (4R,5S)-5 provided 
a mixture of the desired acetolysis product (4R,5S)-10a and the solvolysis product. Gratifyingly, 
treatment of (4R,5S)-5 with HFIP containing a variety of nucleophiles provided good yields of 
10a-c with high to total enantiospecificity. (Table 2)  
Table 2. Substitution with (4R,5S)-5. 
 
Nu R product yield (%) er
b 
e. s. (%) 
NaOAc
c 
OAc 10a 79 97:3 100 
CH3OH
d 
OCH3 10b 80 97:3 100 
Bu4NN3
c 
N3 10c 80 95:5 96 
a All reactions were run at 0.1 M substrate concentration. b  Determined by CSP-GC  
analysis. c 2.0 equiv. d 10.0 equiv. 
 
When olefin 11 was introduced in to the acetolysis of (4R,5S)-5, (4R,5S)-10a was 
produced with reduced enantiospecificity (Figure 5). The attenuation of enantiospecificity 
                                                 
†
 Interestingly, sodium salts of poorly nucleophilic anions, such as TsO
-
 and even TfO
-
 and BPh4
-
 are insoluble in 
HFIP. This made certain control experiments impossible. 
15 
 
increased with increasing concentration of 11 (red diamonds). Contrary to expectations, the 
attenuation of enantiospecificity was not reduced with increasing concentration of NaOAc. (blue 
diamonds). Altering the nucleophile to nBu4NOAc afforded increased enantiospecificity of 
acetolysis in the presence of 11, and increasing the concentration of n-Bu4NOAc increased this 
enhancement still further.  
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Figure 5. Effects of counterion identity, acetate concentration and added olefin on the 
enantiospecificity of acetolysis. 
 
A crossover experiment was performed in an attempt to demonstrate the associative 
nature of olefin-to-olefin transfer. Acetolysis of bromotosylate 12c was carried out in the 
presence of 11, resulting in a mixture of acetolysis products (Scheme 11).
‡
 Regrettably, the 
crossover product 10a was essentially racemic.  
                                                 
‡
 Acetolysis of (4R, 5S)-5 in the presence of dibenzylethylene did not result in formation of 13 
16 
 
Scheme 11. 
 
2.3.2.  Chloronium Ions. 
Previous efforts
25
 identified the chloro triflate (4R,5S)-14 as a useful chloronium ion 
precursor and demonstrated that it undergoes solvolysis in buffered formic acid without 
racemization, even in the presence of an excess of 9. Subjecting (4R,5S)-14 to acetolysis with 
NaOAc in HFIP resulted in a complex mixture of products; however modest yields of 
substitution products could be obtained using n-Bu4NOAc as the nucleophile in HFIP/CH2Cl2 
(Scheme 10). Presumably the low chemical stability of 1,2-dialkyl chloronium ions
18c
 requires 
the use of a more reactive nucleophile to trap them before low energy decomposition pathways 
intervene. Most gratifyingly, no erosion of enantiospecificity was observed in the presence of 
added 11.  
Table 3. Substitution with (4R,5S)-14 
 
product  Nu R 11(equiv) yield (%) er
b 
e.s. (%) 
15a n-Bu4NOAc
c 
Ac 0.0 32 98:2 100 
15a n-Bu4NOAc
c 
Ac 0.25 39 98:2 100 
15a n-Bu4NOAc
c 
Ac 1.0 43 98:2 100 
15b MeOH
d 
Me 0.0 42 98:2 100 
a All reactions were run at 0.1 M substrate concentration.  b Determined by CSP-GC analysis. c 2.0 equiv d 10.0 equiv 
 
17 
 
2.4.  Discussion 
2.4.1.  Configurational stability in the absence of olefins. 
Both the bromonium ion derived from (4R,5S)-5 and the chloronium ion derived from 
(4R,5S)-14 were found to be configurationally stable in the absence of olefins with one 
exception: a small amount of racemization was observed when treating (4R,5S)-5 with n-
Bu4NN3/HFIP (Table 2). The slight erosion enantiomeric purity observed when trapping with 
azide indicates the intervention of a minor racemization pathway, possibly due to nucleophilic 
attack at bromine to generate BrN3, analogously to what has been observed in the presence of Br
-
.
21b
  
2.4.2.  Configurational stability in the presence of olefins. 
The lower chemical stability of chloronium ions, as well as their complete 
configurational stability in the presence of olefins can be rationalized in terms of the localization 
of positive charge. (Figure 6). The greater electronegativity of chlorine compared to bromine 
leads to a greater degree of positive charge localization on carbon and less on chlorine. The 
increased carbocationic character leads to an increased propensity towards processes 
characteristic of carbocations such as elimination and Wagner-Meerwein rearrangements,
18c
 
while the reduced charge on chlorine reduces its susceptibility towards olefin-to-olefin transfer 
by an associative mechanism. Increased carbocationic character may also increase the rate of 
capture by nucleophiles. 
18 
 
 
Figure 6. The relationship between charge localization, racemization rate, and chemical stability. 
 
2.4.3.  Mechanism of olefin-to-olefin transfer. 
The associative mechanism of olefin-to-olefin transfer proposed by Brown
19d
 proceeds 
via nucleophilic attack by the olefin at bromine, following formation of a preassociation olefin  
complex.
19c
 If the crossover experiment detailed previously (Scheme 11) had resulted in 
enantioenriched crossover product, it would have conclusively proven that the crossover was 
associative.
23a
 Unfortunately, the absence of observable chirality transfer is an ambiguous result 
which cannot distinguish the possible pathways. 
The best evidence that olefin-to-olefin transfer proceeds through an associative 
mechanism is the observed dependence of enantiospecificity, and hence exchange rate, on olefin 
concentration. If a dissociative mechanism were operative, regardless of whether it was mediated 
by solvent or nucleophile, no dependence of enantiospecificity on olefin concentration should be 
observed, as the chirality is destroyed at the moment of dissociation. The only way that a 
dissociative exchange could lead to such a dependence would be if the dissociated Br
+ 
equivalent 
was somehow unproductively consumed at low olefin concentration. However, if this were the 
case low yields of 10a-c would have been obtained in the absence of added olefin. 
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2.5. Conclusions 
In conclusion, the enantiospecific generation and trapping of bromonium ions has been 
demonstrated. In addition, it has been shown that the racemization of bromonium ions by olefin-
to-olefin transfer is competitive with intermolecular capture by anionic nucleophiles. It has also 
been shown that chloronium ions do not racemize under comparable conditions.
26
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Chapter 3:  Lewis Base Catalysis of Bromo and 
Iodocyclization 
3.1.  Introduction 
Electrophilic halocyclization reactions of olefins, in which halonium ions are generated 
from olefins and opened intramolecularly by nucleophilic functional groups (Scheme 12), are 
versatile synthetic transformations with proven applications to the synthesis of biologically 
relevant molecules.
27
 The development of catalytic enantioselective halocyclization methods is a 
topic of increasing interest in synthetic organic chemistry,
16
 one that presents unique challenges 
and opportunities for various paradigms of catalysis in addition to the obvious importance and 
utility of this transformation.  
Scheme 12. 
 
 
3.2.  Background 
3.2.1.  Lewis base catalysis of halocyclization and the Lewis base chemistry of halogens. 
Lewis base catalysis of halogenation, in which an n-* interaction between a Lewis base 
and a Lewis acidic halogen reagent leads to a reactive cationic halogen species, has been 
reported in a variety of contexts, using a variety of achiral Lewis bases.
28
 Although these studies 
suggest several competent structural types, they provide little basis on which to make 
comparisons between them. 
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 Many structural and spectroscopic studies have been carried out on Lewis base-dihalogen 
adducts.
4,29
  These complexes exhibit a variety of structural motifs depending the structure of the 
Lewis base and the choice of dihalogen. The phosphine chalcogenides, R3P=E (E = S, Se)
4,29a-
c,29f,29i,29j
 and the thio- and selenoureas
29e,29g,29i,29k
 frequently exist as either simple n-* adducts, 
containing a hypervalent halogen atom or T-shaped adducts containing a hypervalent chalcogen 
atom (Figure 7). The latter result from oxidative addition of the dihalogen to the donor atom and 
are more frequently observed with lighter halogens and heavier chalcogens, presumably for 
reasons of relative oxidation potentials. 
 
Figure 7. Common structural motifs of phosphine chalcogenide-dihalogen complexes. 
 
One structure of particular interest to Lewis base catalysis is the ionized cationic Lewis 
base-X
+
 complex. Recently, such a complex has been reported (Figure 8) in the course of a study 
on the halogenation of Au(I)-phosphine sulfide complexes.
30
  An interesting feature of this 
structure is the 101.3 
o
 P-S-Br angle, which is intermediate between the values typically observed 
in n-* adducts and T-shaped adducts (see Figure 1, Figure 7.).   
22 
 
 
Figure 8. X-ray Crystal Structure of Ph3P=S-Br
+
 AuBr4
-
 
 
Ishihara has demonstrated that stoichiometric quantities of chiral phosphoramidites 
promote highly enantioselective iodopolycyclization of polyprenoids.
15c
 On the basis of  the data 
presented, it is not clear whether the use of a stoichiometric amount of chiral phosphoramidite is 
required to obtain useful reaction rates or whether it is necessary for enantioselectivity.  
Multiple studies have been carried out using superstoichiometric quantities of amine 
ligands
31
 or preformed 2:1 amine/X
+
 complexes in enantioselective halocyclizations.
15a,32
 Only 
low enantioselectivities have been observed.  
An interesting system for enantioselective, conjugate bromolactonization of ene-ynes has 
been developed by Tang
33
 using a quinine-derived sulfonyl urea catalyst (Scheme 13.). This 
system is of particular mechanistic interest because the intermediate bromonium ion is achiral. 
This catalyst must be associated with bromonium intermediate during the stereodetermining 
capture event, although due to the polyfunctional nature of the catalyst it is not clear how this is 
accomplished. An anion binding interaction similar to that proposed for Jacobsen’s amino-urea34 
catalyst may be possible.  
Scheme 13. 
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Since the initiation of this research program, several new methods for Lewis base 
catalyzed enantioselective bromo- and iodocyclization have been developed. Yeung has 
developed Cinchona-alkaloid derived amino-thiocarbamate catalysts for bromolactonization
35
 
and bromoaminocyclization.
36
 Fujioka
37
 has developed a novel C3-symmetric trisimidazoline 
catalyst for bromolactonization. 
An enantioselective system for iodolactonization has been developed by Jacobsen,
34
 
based on a tertiary amino-urea catalyst. It is proposed that this catalyst operates via anion binding 
through hydrogen bonding to the thiourea and delivery of I
+
 by the Lewis basic tertiary amine.  
3.2.2.  Approaches to enantioselective halogenation other than Lewis base catalysis. 
Several enantioselective halogenation methods have been developed which are not based 
on Lewis base catalysis. Kang has reported enantioselective iodocycloetherification reactions 
catalyzed by Ti(IV)-BINOL
38
 and Cr(III)-salen
15b
  complexes. The latter system cyclizes 
unconjugated (Z) alkenols with good enantioselectivity. 
Modified Wacker oxidations provide a very different approach to enantioselective 
halogenation, one that does not proceed through a halonium ion intermediate. At high X
- 
 and 
CuX2 concentrations (typically >2M), in the presence of chiral phosphine ligands, 1,2-
dibromides
39
 and 1,2-chlorohydrins
15d,15e,15g,15h
 can be produced from terminal olefins with high 
enantioselectivity. 
An enantioselective iodolactonization reaction has been reported using chiral phase 
transfer catalysis,
40
 however only low enantioselectivities were observed (≤ 60:40 er).  
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3.2.3.  Hypothesis and research objectives. 
The studies described and referenced in Chapter 2 identified a serious obstacle to the 
development of catalytic, enantioselective iodination and bromination methods, namely the 
propensity of iodonium and bromonium ions (but not chloronium ions) to undergo degenerate 
halogen exchange with olefins. This process racemizes the halonium ions at rates that can 
compete with nucleophilic capture. Chiral Lewis base catalysts have the potential to prevent this 
or other racemization processes, if they remain bound to the halonium ion until the newly created 
stereocenters are irreversibly set, thus maintaining a chiral environment regardless of exchange 
(Scheme 14.). Although it may appear that dissociation of a Lewis basic ligand from a cationic, 
and hence highly Lewis acidic, halonium ion should be thermodynamically unfavorable, under 
catalytic conditions, other Lewis acidic species are present that could compete for binding the 
chiral Lewis base, provided that the halonium ion has a lifetime long enough for an equilibrium 
to be established. The most straightforward possibility is competitive binding of the catalyst to 
the unreacted halogen source. Although the halogen source should be a much weaker Lewis acid, 
it is present much higher concentrations than the bromonium ion. Competitive binding to the 
highly Lewis acidic activated halogen source may also be possible.  
  At the time that this study was initiated a variety of achiral Lewis bases were known to 
catalyze halocyclization as discussed above, as were several enantioselective halocyclization 
reactions promoted by stoichiometric amounts of chiral Lewis bases. However, the paucity of 
catalytic, enantioselective Lewis base catalyzed halogenations suggested that some of the 
aforementioned systems did not preserve the stereochemical integrity of intermediates as 
described here. Given the significant effort required for the preparation of new chiral Lewis 
bases, and the structural and functional diversity of the reported achiral Lewis base catalysts, a 
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systematic means of inferring the properties of chiral Lewis base catalysts from those of readily 
available achiral analogs is highly desirable. 
Scheme 14. 
 
 
Halolactonization and cycloetherification reactions can produce either of two 
constitutional isomers, arising from cyclization in an exo or endo fashion. The ratio of the two 
isomers is influenced largely by the substrate, the identity of the halogen, and the choice of 
reaction conditions. Under conditions wherein the halonium ion is undergoing rapid exchange, 
the product-determining step must also be the stereochemistry-determining step. Therefore, the 
ratio of constitutional isomers produced in the presence of an achiral Lewis base catalyst serves 
as an indicator of the presence of the catalyst in the stereo-determining transition structure. This 
knowledge would allow the search for an enantioselective catalyst to focus on classes of 
compound whose presence in and capacity to influence the relevant transition state structure has 
been demonstrated. 
The objectives of this study are: (1) to determine the catalytic competencies of a wide 
range of catalysts via in-situ IR monitoring of bromo- and iodolactonization (2) to infer from the 
observed endo/exo isomer ratios whether or not the screened catalysts are present in the 
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stereodetermining transition structure and (3) to apply this knowledge to bromo- and 
iodocycloetherification. 
3.3.  Results 
The program to evaluate the feasibility of Lewis base catalysis of halofunctionalization of 
isolated double bonds would involve electrophilic bromine and iodine sources 
(halosuccinimides) in conjunction with unsaturated carboxylic acids and alcohols. For the initial 
survey of Lewis bases, 5-phenyl-4-pentenoic acid (16) was chosen as the test substrate and a 
standard experimental procedure was adopted. All reactions were run in dichloromethane at 
0.15 M in substrate with 1.2 equivalent (equiv) of electrophile and 0.05 equiv of Lewis base. The 
temperature was adjusted such that the background (uncatalyzed) reaction was negligible. A 
broad selection of Lewis bases was evaluated for kinetic competence. The optimal catalyst was 
then employed in a brief survey of olefinic substrates with varying double bond geometries and 
substituents. 
3.3.1.  Achiral Lewis base catalysis with bromine. 
The influence of Lewis bases on the rate and cyclization selectivity in the 
bromolactonization of 16a with N-bromosuccinimide (NBS) was evaluated first. Reaction 
progress was measured by the disappearance of the IR band at 967 cm
-1
, corresponding to a 
C=C-H out of plane bending mode.
§
 The yields and ratios of cyclization products 17aa and 18aa 
were assayed by 
1
H NMR integration against an internal standard. 
The results from the Lewis base survey are compiled in Table 4 and are organized by 
donor heteroatom. Under the standard reaction protocol, the mixture was homogenous and the 
rate of the background reaction in the absence of catalyst was insignificant (entry 1). The oxygen 
                                                 
§
 The carbonyl region was unsuitable for monitoring due to multiple overlapping signals  
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donors (Me2N)2C=O, n-Bu3P=O, and (Me2N)3P=O (entries 2–4) were only marginally faster than 
the background rate and were still incomplete after 3 h. On the other hand DMSO (entry 5), 
which could function as either an oxygen or sulfur donor, led to complete reaction after only 1 h. 
Gratifyingly, very high rate acceleration was observed with many Lewis bases bearing sulfur, 
selenium, and phosphorus donor atoms. The thiono containing bases (thiourea, phosphine 
sulfides, or a thiophosphoramide, entries 6–10) were all indistinguishably rapid (t1/2 < 35 sec) 
and provided good yields of the cyclization products. Interestingly, other divalent sulfur donors 
behaved quite differently. Whereas tetrahydrothiophene (entry 11) was equipotent with the 
thiono bases, reaction using dimethyl sulfide (entry 12) was somewhat slower and diphenyl 
disulfide (entry 13) was completely ineffective. All of the selenium- (entries 14–16) and 
phosphorus- (entries 17 and 18) based donors were powerful catalysts and within the resolution 
of this measurement, indistinguishable. In a final control experiment, bromine, a common 
impurity in NBS, was shown to be an effective catalyst (entry 19), most likely due to formation 
of HBr by rapid uncatalyzed bromolactonization. 
 In addition to dramatic differences in the rates of the catalyzed reactions, the steric course 
of the reaction was also significantly influenced by the action of the different catalysts.  
Although substrate 16a is intrinsically biased toward endocyclic closure (entry 1), the endo/exo 
selectivity in the catalyzed reactions ranged from 7.3:1 to 94:1. Highly reactive catalysts that also 
lead to increases in the already high endo/exo selectivity included Ph3P=S (entry 7), n-Bu3P=S 
(entry 8), n-Bu3P=Se (entry 14), (PhSe)2 (entry 16), and n-Bu3P (entry 17). Of the Lewis base 
catalysts surveyed the highest endo selectivity was observed in the presence of Ph3P=S and 
(PhSe)2, but the highest overall endo selectivity was observed in the control experiment with a 
catalytic quantity of Br2 (entry 19). Substantial reductions in the ratio of 17aa to 18aa were 
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observed in the presence of (Me2N)2C=S, (Me2N)3P=S, (Me2N)3P=Se, and (Me2N)3P, and 
(entries 6, 10, 15, 18, resp.). Among the thiono donors an apparent correlation of increasing 
steric bulk with decreasing endo/exo selectivity was noted (entries 6-10).  
Table 4. Catalyst Survey for Bromolactonization. 
 
entry catalyst t1/2 (min)
a 
reaction time 
(min)
b 
yield (%)
c 
17aa:18aa
d 
1 None >180 180 13 25:1 
2 (Me2N)2C=O >180 180 36 23:1 
3 n-Bu3P=O >180 180 47 51:1 
4 (Me2N)3P=O >180 180 15 50:1 
5 Me2S=O 25 60 93 23:1 
6 (Me2N)2C=S <0.5 8 71 7.3:1 
7 Ph3P=S <0.5 8 82 91:1 
8 n-Bu3P=S <0.5 8 89 75:1 
9 Cy3P=S <0.5 8 78 25:1 
10 (Me2N)3P=S <0.5 8 87 3.4:1 
11 (CH2)4S <0.5 8 89 27:1 
12 Me2S 6 20 94 19:1 
13 (PhS)2 >180 180 8 N/D 
14 n-Bu3P=Se <0.5 8 78 85:1 
15 (Me2N)3P=Se <0.5 8 88 8.1:1 
16 (PhSe)2 0.5-1 8 84 94:1 
17 n-Bu3P <0.5 5 75 38:1 
18 (Me2N)3P <0.5 8 86 6.7:1 
19 Br2 <0.5 8 64 400:1 
a Determined by React-IR monitoring, reactions performed on 0.2 mmol of 16a, in 1.5 mL of CH2Cl2 
b Time elapsed before 
quenching c Determined by integration of 1H NMR signals for H-6 against 1,2,4,5-C6H2Cl4 internal standard 
d Determined by 
integration of 1H NMR signals for H-6 
 
To evaluate the preparative utility of this bromolactonization, the reaction of test 
substrate 16a was run on a 1.0 mmol scale and the cyclization products were isolated in 81% 
yield and a 90:1 ratio of isomers favoring 17aa (Scheme 15.). Next, unsaturated acids 16b and 
16c, representing the effects of olefin geometry and conjugation, were examined. Under the 
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optimized reaction conditions, both 16b and 16c afforded mixtures of constitutional isomers now 
weakly favoring exo-cyclization product 18. Interestingly, the use of (MeN)3P=S, which 
previously displayed the lowest endo selectivity (Table 4, entry 6), produced 18ba with high exo 
selectivity. In the cyclization of 16c, the exo selectivity increased with the use of (Me2N)3P=S, 
but only marginally. 
Scheme 15. 
 
 
The preparative utility of the catalytic bromofunctionalization was next extended to 
include Lewis base catalyzed bromocycloetherification. Unsaturated alcohols 19a–c were chosen 
to demonstrate the effects of conjugation and alkene geometry. In situ FTIR monitoring of the 
cyclization of 19a under the previously optimized reaction conditions (5 mol % of Ph3P=S), 
revealed that only ca. 50% of 19a was consumed before the reaction stalled. A previous report 
from these laboratories on selenocyclization revealed a similar trend for unsaturated acids and 
alcohols which could be ameliorated by the addition of a weak Brønsted acid. Accordingly, 
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bromocycloetherification of 19a was carried out in the presence of 1.0 equiv of AcOH with the 
intention of producing a level of acidity similar to that present during bromolactonization. 
Gratifyingly, this simple remedy rescued the reactivity of 19a and allowed the reaction to 
proceed rapidly to completion in good yield and with good endo selectivity (Scheme 16). This 
simple observation would later prove to be the key to developing a catalytic enantioselective 
bromoetherification reaction (Chapter 5). Bromocycloetherification of 19b in the presence of 
Ph3P=S and AcOH afforded the product of exo cyclization, 21ba in high yield and with good 
selectivity. In the hope of obtaining even higher exo selectivity, this reaction was attempted in 
the presence of (Me2N)3P=S, however no alteration in the isomer ratio was observed. Similarly, 
the (Z)-alkenol 19c produced 21ca in good yield and with high exo selectivity.  
Scheme 16. 
 
 
3.3.2.  Achiral Lewis base catalysis with iodine. 
Iodolactonization is an extensively studied cyclofunctionalization process and often 
provides different, sometimes complementary selectivity compared to bromolactonization, 
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typically producing a greater proportion of 5-exo cyclization.
41
 Given the successful application 
of Lewis base catalysis to bromolactonization and the range of selectivities observed, catalysis of 
iodolactonization presented an attractive target. As before, 16a was selected as a representative 
substrate and was subjected to the action of N-iodosuccinimide (NIS) in the presence of a wide 
variety of Lewis bases (Table 5). As above, the reaction progress was monitored by in situ FTIR 
analysis and the yield and product ratios were obtained from 
1
H NMR spectra. 
Table 5. Catalyst Survey for Iodolactonization. 
 
 
entry catalyst T1/2 (min)
a 
reaction time (h)
b 
yield (%)
c 
17ab:18ab
d
 
1 None >180 2 4 9.5:1 
2 (Me2N)2C=O >180 3 10 20:1 
3 n-Bu3P=O >180 3 14 16:1 
4 (Me2N)3P=O >180 3 33 20:1 
5 Me2SO >180 3 4 N/D 
6 (Me2N)2C=S 4 1 91 4.7:1 
7 Ph3P=S 35 1 92 5.5:1 
8 n-Bu3P=S 7 1 72 6.1:1 
9 Cy3P=S 8 1 93 1.7:1 
10 (Me2N)3P=S 4 1 97 2.5:1 
11 (CH2)4S 10 1 97 5.8:1 
12 Me2S >180 3 45 5.8:1 
13 (PhS)2 >180 3 2 N/D 
14 n-Bu3P=Se 9 1 77 8.5:1 
15 (Me2N)3P=Se 4 1 95 4.6:1 
16 (PhSe)2 15 1 82 10:1 
17 n-Bu3P 52 2 94 5.1:1 
18 (Me2N)3P 40 2 53 1.4:1 
19 I2 >180 3 10 24:1 
20 TFA >180 3 0 N/D 
a Determined by React-IR monitoring, all reactions run on 0.2 mmol of 16a b Time elapsed before quenching b Determined by 
integration of 1H NMR signals for H-6 against PhMe6 internal standard 
c Determined by integration of 1H NMR signals for H-6 
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Unsurprisingly, iodolactonization is much faster than bromolactonization such that 
suppressing the uncatalyzed reaction of 16a with NIS in dichloromethane required executing the 
experiments at -40 °C (Table 5, entry 1). Consequently, the solubility of NIS in dichloromethane, 
which is only modest at room temperature, was quite low. 
The results from the survey of Lewis bases are compiled in Table 5  in the same order as 
was presented in Table 4. Here as well, the oxygen-based donors (Me2N)C=O, n-Bu3P=O, and 
(Me2N)3P=O, (entries 2–4)) provided at best only modest rate acceleration. However, the 
complete lack of reactivity of DMSO (entry 5) diverged markedly from its behavior in 
bromolactonization. As was the case in bromolactonization, the highest rates were observed in 
the presence of thiono- ((Me2N)2C=S, n-Bu3P=S, Cy3P=S, (Me2N)3P=S, entries 6, 8–10) and 
seleno-based donors (n-Bu3P=S and (Me2N)3P=Se (entries 14, 15), though Ph3P=S was less 
effective (entry 7). Similarly, the divalent chalcogen donors tetrahydrothiophene (entry 11) and 
(PhSe)2 (entry 16) also gave rise to high reaction rates. On the other hand, dimethyl sulfide (entry 
12) was ca. 20 times less reactive than tetrahydrothiophene, the pnictogens (Me2N)3P and n-
Bu3P (entries 17, 18) were substantially less reactive, and (Ph2S)2 (entries 13) was completely 
ineffective. In contrast to bromolactonization, the addition of 5 mol% of I2 had a negligible 
impact on the rate of iodolactonization, although the endo/exo ratio increased (entry 19). 
The intrinsic preference for endocyclization of 16a persisted, but with attenuated 
magnitude ranging from 1.4:1–20:1 ratios for 17ab/18ab. In fact, only the oxygen-based donors 
(entries 2–4) afforded improved selectivities compared to background reaction. Moreover, 
substantial reductions in the endo/exo selectivity were observed in the presence of Cy3P=S, 
(Me2N)3P=S, and (Me2N)3P (entries 9, 10, 18). Diphenyl diselenide had no effect on the product 
ratio (entry 16), and the other Lewis bases tested reduced the exo selectivity modestly. 
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These results were both disappointing and also perplexing. In preliminary experiments, n-
Bu3P=S displayed a greatly increased endo selectivity compared to the result shown in entry 8. 
After several unsuccessful attempts to reproduce the original, more promising result, it was 
hypothesized that some component of the original reaction mixture had been contaminated in 
some way. Among several potential contaminants examined, a trace amount of TFA, in 
combination with n-Bu3P=S resulted in the almost exclusive formation of 17ab (Scheme 17). To 
exclude the possibility that this outcome was the result of thermodynamic control of the product 
ratio, 17ab and 18ab, the latter produced under established conditions of thermodynamic control 
42
 were submitted to the reaction conditions as single purified isomers (Scheme 18). Almost no 
isomerization was observed, thus demonstrating that the product ratio was the result of 
kinetically controlled selectivity. 
Scheme 17. 
 
Substrates 16b and 16c were again chosen to explore the scope of this iodolactonization 
and to demonstrate the effects of olefin geometry and conjugation. Iodolactonization of 16b in 
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the presence of (Me2N)3P=S afforded 18bb in good yield and exo selectivity (Scheme 17). The 
iodolactonization of 16c was attempted in the presence of Ph3P=S and Cy3P=S separately. As 
was seen previously, one of the least endo selective catalysts, Cy3P=S, provided slightly higher 
exo selectivity, allowing 18cb to be isolated in good yield. 
 
Scheme 18. 
 
 
To further explore the scope of Lewis base catalysis of iodocyclization, the insights 
gained from the development of iodolactonization were applied to the development of 
iodocycloetherification. As was done for bromocycloetherification, the conjugated (E)-alkenol 
19a and the unconjugated (E)- and (Z)-alkenols 19b and 19c were chosen to represent the effects 
of conjugation and olefin geometry. The conditions that were previously optimized for the 
iodolactonization of 16a were applied to the iodocycloetherification of 19a (5 mol % of n-
Bu3P=S, 5 mol% TFA, -45 °C), and afforded the product of endo cyclization, 20ab, in a good 
yield and high selectivity (Scheme 19). Aside from extending the reaction time, no further 
changes to the reaction conditions were required in this case. The aliphatic alkenols 19b and 19c 
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were both cyclized in good yield and high 5-exo selectivity. No measurable effect on the 
endo/exo ratio was observed for the more exo selective catalyst (Me2N)3P=S. 
Scheme 19. 
 
 
3.4.  Discussion  
The development of Lewis base catalyzed bromo- and iodolactonization described above 
has led to insights into the effects of catalyst structure on the rate and selectivity of cyclization, 
highlighted the effects of substrate structure and the identity of the halogen on cyclization 
selectivity, and produced synthetically useful improvements in cyclization selectivity which will 
be discussed along with their implications for the development of enantioselective catalysts. 
3.4.1.  Rates of iodolactonization and bromolactonization. 
The first readily apparent trend in the rates of catalyzed iodolactonization is that the 
donor atom has a significant influence as follows: R2C=S ≈ R3P=S ≈ R3P=Se > R3P=O (Table 5). 
The ordering of the chalcogen derivatives parallels the differences in softness between the 
isolated atoms (ionization potentials (IP): Se, 9.75 eV; S, 10.36 eV; P, 10.49 eV; O, 13.61 eV) as 
well as the differences in ionization potentials for the (Me2N)3P=X chalcogenides which Bruno 
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et. al. have estimated from the charge transfer band of their I2 complexes (IP (Me2N)3P=O -
 (Me2N)3P=S = 1.5 eV; (Me2N)3P=S - (Me2N)3P=Se = 0.18 eV).
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The trend in rate with variation in the substituents on the P(III) and P(V) donors also follows the 
order (Me2N)3P=Y > alkyl3P=Y > Ph3P=Y . This order is the same as that of their enthalpies of 
I2 complexation.
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The most readily apparent trend in the rates of catalyzed bromolactonization parallels that 
of iodolactonization, namely: (Me2N)2C=S ≈ R3P=Se ≈ R3P=S ≈ R3P≫R3P=O, wit h any rate 
difference between the sulfur and selenium homologs and their parent phosphines obscured by 
the rates of the data acquisition (Table 5). Although this ordering is similar to the trend that was 
observed in iodolactonization, there are discernible differences in the relative reactivities of some 
Lewis bases. Diphenyldiselenide is slightly slower than the phosphine sulfide and selenide 
donors, where as in iodolactonization it was faster than Ph3PS. In iodolactonization the reactivity 
of (Me2N)3P=O is greater than n-Bu3P=O and (Me2N)2C=O while in bromolactonization it is the 
least active of the three (Table 4, entries 16–18; Table 5, entries 15–17). 
3.4.2. Substrate effects on selectivity in halocyclizations. 
The preference for 5-exo cyclization over 6-endo cyclization observed with substrates 
16c and 19b–c, which lack a conjugating substituent on the alkene is typical for a variety of 
halocyclization reactions.
27b-d
 Substrates 16a and 19a favor 6-endo cyclization as a result of the 
greater stability of positive charge localized on benzylic carbons. The greater proportion of 6-
endo cyclization observed in bromolactonization and bromocycloetherification compared to their 
iodine counterparts has ample precedent and appears to be a general phenomenon, although a 
satisfactory explanation has yet to be proposed.
41
 The superposition of these factors frequently 
leads to modest selectivity in bromolactonizations, such as was observed in the case of 16c. 
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The alkene geometry can have a strong influence on site selectivity as well; the 
preference of 16b for 5-exo cyclization despite the directing effect of the phenyl group has been 
observed previously,
45
 and a less dramatic effect was seen in bromocycloetherification of 19c. 
The preference of Z olefins for exo cyclization may be attributed to the avoidance of an 
unfavorable 1,3-diaxial interaction in the transition state for endo cyclization of 16b (II, Scheme 
20.) which is not present in the transition state structures leading to endo cyclization of 16a (I) or 
exo cyclization 16b (III). 
Scheme 20. 
 
3.4.3. Catalyst effects on selectivity.  
The least endo selective catalysts for 16a and most exo selective catalysts for 16b and 
16c share two important structural features: (i) they possess points of branching, either 
dimethylamino groups or cyclohexyl groups, and (ii) donate a nonbonding pair from an element 
softer than oxygen. Tetramethylthiourea and (Me2N)3P, as well as (Me2N)3P=S and 
(Me2N)3P=Se, are exo selective in both iodo- and bromolactonization. In contrast, Cy3P=S, 
which lacks electron donating dimethylamino groups, is less electron rich but still very sterically 
demanding, promotes exo iodolactonization but not exo bromolactonization of 16b and 16c. Such 
exceptional behavior of Cy3P=S may be a result of the differences in reaction conditions rather 
than differences in the halogen. The iodolactonizations were conducted at lower temperatures, 
which should entropically favor ligand association and under conditions of low NIS solubility, 
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which should limit competitive binding of the catalyst to free NIS. These factors should allow 
somewhat weaker binding ligands to have noticeable effects on the outcome of the reaction. 
Comparing the catalyst effects on bromo- and iodo- lactonization of 16c, which lacks a 
conjugating substituent, illuminates the roles played by the steric and electronic properties of the 
Lewis bases. In the bromolactonization of 16c the magnitude of the catalyst effect on cyclization 
selectivity is small (Scheme 15.) although the reduction in endo/exo ratio using (Me2N)3P=S is 
consistent with the direction of the effect observed in the bromolactonization of 16a (Table 4). 
Similarly, the endo/exo ratio observed in the iodolactonization of 16c (Scheme 17.) was only 
modestly reduced by the use of Cy3P=S as the catalyst, although the greater preference for exo 
cyclization is in the same direction as that observed in the iodolactonization of 16a. In contrast 
the endo/exo ratios in the bromolactonizations of 16a–b, which possess conjugating substituents, 
were both greatly reduced by the use of (Me2N)3P=S compared to Ph3P=S (Table 4, Scheme 15.) 
despite the inversion of overall selectivity. This selectivity suggests that the effect of 
(Me2N)3P=S on the bromolactonizations of 16a–b predominately arises from modulation of the 
directing ability of the phenyl group, possibly by reducing the positive charge localized on the 
electrophilic carbons. 
The stability of the isomers 17ab and 18ab to the reaction conditions under which 17ab 
was formed (n-Bu3P=S/TFA, 1:1; 5 mol %, NIS, -40 °C, Scheme 18.) demonstrates that the 
inclusion of a cocatalytic amount of TFA does not result in thermodynamic control of the 
endo/exo ratio. Therefore, because the ratio is under kinetic control, the same consideration 
applies to TFA as applies to Lewis bases, namely that to affect the endo/exo ratio the agent must 
be present in the product-determining transition state structure. The acidity of TFA naturally 
leads to the hypothesis that this is due to proton transfer from TFA, perhaps by causing a change 
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in the counter ion, protonation state, or the timing of proton transfer. This hypothesis is 
reinforced by the extremely high endo selectivity observed in the bromolactonization of 1a in the 
presence of Br2, which likely produces HBr through uncatalyzed bromolactonization. Two 
plausible mechanisms of halolactonization can be envisioned that differ by the rate and timing of 
proton transfer (Scheme 21.), one in which the nucleophile is deprotonated prior to (or during) 
irreversible cyclization (Scheme 21., Path A), and one in which the nucleophile is deprotonated 
after cyclization (Path B). The former path should be favored by the presence of base, such as the 
succinimidate anion generated during the reaction, while the latter should be favored under 
conditions with added TFA. Proton transfer from any of the intermediates depicted in Scheme 21 
to succinimidate anion (pKa of succinimide 9.6
46
; pKa of TFA 0.26; pKa of acetic acid 4.76
47
; 
pKBH
+ 
of
 
MeOAc -3.9
48
 is thermodynamically favorable, whereas transfer to trifluoroacetate is 
only favorable from the protonated lactones. 
Scheme 21. 
 
In path A, closure is the microscopic reverse of C-O bond heterolysis. Such a reaction of a 
charged nucleophile-electrophile pair held in close proximity should have a very low barrier. It is 
hypothesized that such a low barrier leads to low selectivities, analogously to the erosion of 
stereoselectivity that has been observed by Woerpel in diffusion controlled glycosylations. 
49
 An 
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analogy can be made between path A and biphasic iodolactonization conditions wherein the 
substrate is premixed with excess aq. NaHCO3 solution. It is safe to assume that the substrate 
exists and reacts as a sodium carboxylate. Under such conditions (I2, saturated aqueous NaHCO3 
solution/dichloromethane, 0 °C) a 4:1 mixture of 2ab and 3ab has been reported from 
lactonization of 1a, suggesting that reactions dominated by path A should display modest endo 
selectivity.  This is consistent with a substantial contribution of path A to the iodolactonization of 
1a under the conditions of the experiments shown in Table 5. In halocycloetherification, path A 
is much less likely to operate due to the higher pKa of alcohols (pKa of H3COH 16). This is 
consistent with the absence of catalyst influence on endo/exo ratio observed in 
bromocyloetherification (Scheme 16.). It is also consistent with the absence of catalyst influence 
on endo/exo ratio observed in iodocyloetherification, (Scheme 18.) although this could be the 
result of the inclusion of TFA. 
The most critical conclusion from all of these experiments is that those catalysts that 
influenced the endo/exo ratio in halolactonization must have been present in the product-
determining transition structure. This conclusion implies that chiral analogs of these catalysts 
have the potential to catalyze enantioselective halocyclization reactions. This conclusion does 
not mean that catalysts that did not measurably influence the endo/exo ratio must not have been 
present in the product-determining transition structure, simply that the experiments described in 
this paper do not provide evidence that they were. Similarly, the absence of an observable 
catalyst effect on the endo/exo ratios of halocycloetherification does not prove that the catalysts 
are not present in this product-determining transition structure either. It is possible that the 
conditions or substrates chosen were simply not conducive to observing such an effect. 
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3.5. Conclusions 
A systematic examination of the affect of a wide range of Lewis bases on the rate and 
constitutional site selectivity in halofunctionalization reactions has been conducted. Cyclization 
reactions of unsaturated acids and alcohols with NBS and NIS are dramatically accelerated by 
Lewis bases that contain sulfur, selenium, and phosphorus donor atoms. The mode of cyclization 
(exo vs. endo) is primarily controlled by the structure of the substrate such that conjugated (E)-
alkenes undergo highly endo selective cyclization whereas conjugated (Z)-alkene and alkenes of 
either geometry bearing aliphatic substituents undergo exo selective cyclization. In both cases the 
cyclization diastereoselectivities are perfect. Lewis bases significantly influence the 
constitutional site selectivity in all halolactonizations indicating that the Lewis base must be 
present in the stereochemistry-determining transition structure. This observation implies that 
chiral derivatives of these catalysts have the potential to provide enantioenriched products 
regardless of the rates or mechanisms of halonium ion racemization. 
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Chapter 4:  Lewis Base Catalysis of Chlorocyclization and 
Chlorofunctionalization 
4.1. Introduction 
Chlorocyclization and chlorofunctionalization reactions are in the literature than the 
corresponding transformations with bromine and iodine. This deficiency is particularly striking 
when one considers the greater abundance of chlorine.
50
 Several important reasons for this 
discrepancy exist; the low stability of the intermediate chloronium ions often leads to lower 
yielding reactions,
18,26
 and chlorides are less useful for further manipulation than are bromides or 
iodides for example. Of these, the latter is balanced by the need to prepare chlorinated 
products.
51
  Recent interest in the synthesis of chlorinated natural products has further 
highlighted the need for additional methods for the stereoselective installation of chlorine into 
complex molecules.
51
 Furthermore, since chloronium ions do not undergo racemization by 
olefin-to-olefin transfer,  chlorofunctionalization reactions may be more amenable to 
enantioselective catalysis.
26
 
4.2. Background 
As discussed in Chapter 2, chloronium ions are much less chemically stable than 
bromonium or iodonium ions and are prone to rearrangement and elimination processes. For this 
reason it is necessary to devise methods in which they are captured rapidly by nucleophiles.   
 Previous work in the Denmark group
52
 aimed at Lewis base catalysis of the 
chlorocycloetherification of 19a found that 1-chlorobenzotriazole (1-CBT) could be activated by 
thiourea and thiophosphoramide Lewis bases, however complex mixtures of products were 
obtained and 20ac could only be isolated in 25% yield.  
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Shortly after the publication of the research described in Chapter 2 of this thesis, Borhan 
and co-workers published the first catalytic enantioselective chlorolactonization reaction, using 
(DHQD2)PHAL as a catalyst and dichlorodiphenylhydantoin (DCDPH) as an electrophile to 
effect 5-exo chlorolactonization of 1,1-disubstituted olefins. (Scheme 22.).
53
 This system has 
since been adapted to enantioselective chlorocyclization of unsaturated amides.
54
 The 
mechanism of this transformation is uncertain, however NMR observations of the complex 
formed from dichlorohydantoin, benzoic acid and (DHQD2)PHAL demonstrate that the 
hydantoin is complexed in a chiral environment. It is speculated that this complex is the result of  
either by hydrogen bonding to a protonated quinuclidine or by ion pairing with a N-
chloroquinuclidinium ion. 
Scheme 22. 
 
More recently, a catalytic enantioselective dichlorination of allylic alcohols has been 
developed by Nicolaou, using p-Ph-C6H4ICl2 and (DHQ)2PHAL (Scheme 23.).
55
 Dichlorination 
is potentially a more challenging reaction than chlorolactonization to perform enantioselectively, 
because both the facial selectivity of chloronium ion formation and the site of nucleophilic attack 
must be controlled. No enantioselectivity was observed when allylic alcohol was protected as a 
trialkylsilyl ether. This absence of selectivity, along with the poor performance of (DHQ)2AQN, 
led the authors to postulate that a hydrogen bond between the alcohol and one of the phthalazine 
nitrogens was key for enantioselectivity.  
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Scheme 23. 
 
4.3. Results 
4.3.1. Chlorolactionization 
 An initial survey of chlorolactonization conditions using 16a as a representative substrate 
was carried out at room temperature in CDCl3 and monitored by 
1
H NMR spectroscopy. The key 
results are summarized in Table 6. N-Chlorosuccinimide (NCS) was found to be insufficiently 
reactive with all tested Lewis bases (entries 2-6). N-Chlorophthalimide (NCP) was slightly less 
reactive than NCS in the presence of (Me2N)3P=S (entry 7) and moderately more reactive than 
NCS in the presence of quinuclidine (entry 9). 1-Chlorobenzotriazole (1-CBT) was substantially 
more reactive than NCS (entries 10-14), however the rate of the uncatalyzed reaction was higher 
(entry 10). Trichloroisocyanuric acid (TCICA) was highly reactive in the absence of a catalyst, 
completely consuming 16a within 15 min (entry 17). The sulfur and selenium donors (Me2-
N)3P=S, (Me2N)3P=Se, and (Me2N)2C=S were moderately active catalysts, however they were 
more active in catalyzing unproductive consumption of 16a than in catalyzing the formation of 
17ac, particularly at higher catalyst loadings (entries 2-5, 8, 11-13). Under the conditions of 
entry 13, 
31
P NMR taken after two hours showed signals at δ 59.8, 38.5, and 27.9 ppm, in a 
1:2.6:3.4 ratio. The signal at 27.9 ppm is inconsistent with the major catalyst species remaining 
as a P(V) sulfide or P(V) sulfide complex and is most likely (Me2N)3P=O. Quinuclidine proved 
to be a more competent catalyst, particularly in combination with 1-CBT (entries 6, 9, 14-15). 
Unlike (Me2N)2C=S (entries 4-5, 11-12) increasing the loading of quinuclidine led to rapid, 
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complete conversion (entries 14-15). Even the very sterically hindered i-Pr2NEt showed catalytic 
activity (entry 16), although the much less basic PhNMe2 was inactive (entry 17). 
Table 6. Optimization of Chlorolactonization Conditions. 
 
    Yield
a
 after   
entry Lewis base electrophile ca. 15 min 2 h 24 h 
1 None NCS - 0 0 (48 h) 
2 (Me2N)3P=S NCS - 4 12 
3 (Me2N)3P=Se NCS - 2 12 
4 (Me2N)2C=S NCS - 7 11 
5 (Me2N)2C=S (30%) NCS - 8 35 
6 quinuclidine NCS - 7 25 
7 None NCP - 0 0 
8 (Me2N)3P=S NCP - 1  7 
9 quinuclidine NCP - 13 42 
10 None 1-CBT 1.5 - 19 
11 (Me2N)2C=S 1-CBT 20 26 32 
12 (Me2N)2C=S (30%) 1-CBT 35 35 - 
13 (Me2N)3P=S 1-CBT 17 29 41 
14 quinuclidine 1-CBT 32 91 - 
15 quinuclidine (30%) 1-CBT 91 99 - 
16 i-Pr2NEt 1-CBT 17 88 (3h) - 
17 PhNMe2 1-CBT 1 3 - 
18 None TCICA Rapid consumption of olefin
c 
a All reactions conducted on 0.065 mmol of 16a in 0.65 mL of CDCl3 in a 5mm NMR tube 
dDetermined by integration of 1H 
NMR signals for H-6 against 1,2,4,5-PhCl4 internal standard 
c Precipitation of cyanuric acid prevented accurate NMR integration. 
 
 Encouraged by these results, a survey of chiral tertiary amines was carried out (Table 7). 
Disappointingly, the best catalyst, (DHQD)2PHAL, provided 17ac in only 45:55 er. Previously, 
(DHQD2)PHAL had been shown to catalyze the chlorolactonization of 16d with high 
enantioselectivity using dichlorodiphenylhydantoin as a chlorine source(Scheme 22.).
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However, using commercially available dichlorodimethylhydantoin (DCDMH) as a chlorine 
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source in the chlorolactonization of 16a, in combination with (DHQD)2PHAL, resulted in the 
isolation of racemic 17ac in reduced yield.  
Table 7. Chiral Catalyst Screen for Chlorolactonization. 
 
 
 For the sake of comparison, the 1,1-disubstituted substrate 16d was subjected to the 
optimized reaction conditions, producing 18dc in moderate yield and enantioselectivity. (Scheme 
24.) This demonstrates that enantioselective cyclizations are possible using 1-CBT as a chlorine 
source. 
Scheme 24. 
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4.3.2.  Chlorocycloetherification 
 Because no catalytic enantioselective chlorocycloetherification reaction has been 
reported, a survey of substrates and reaction conditions was undertaken to determine the 
feasibility of developing such a reaction based on Lewis base catalysis. Initial experiments 
showed that the quinuclidine catalyzed cyclization of 19a occurred more slowly than that of 16a 
and in only modest yield, even in the presence of AcOH (Table 8). The remainder of 19a 
appeared to have been converted into complex mixtures of side products. 
Table 8. Screening of Conditions for Chlorocycloetherification of 19a. 
 
   conversion (%)
b
  yield
c
 after 
entry Lewis base additive Ca. 15 min 2 h 24 h 
1 none AcOH 0 5 24 
2 quinuclidine - 4 45 43 
3 quinuclidine AcOH 9 54 36 
a All reactions conducted on 0.065 mmol of 19a in 0.65 mL of CDCl3 in a 5mm NMR tube 
bSignal for internal standard 
overlapped other signals at these time points, determined by integration of 1H NMR signals for H-6 against H-5 of 19a  
cDetermined by integration of 1H NMR signals for H-6 against 1,2,4,5-PhCl4 internal standard  
 
On the basis of previous results it was hypothesized that 19a might be an especially poor 
substrate for chlorocycloetherification. The 1,1-disubstituted substrate 19d was chosen for 
further optimization based on its similarity to 16d which was already known to be a suitable 
substrate for enantioselective chlorolactonization. The effects of Lewis base, chlorine source and 
Brønsted acid additives were explored and key results are given in Table 9. In general, yields 
were low (<50%) and limited by the formation of elimination products. Chlorostyrene 22 was 
isolated from one reaction mixture (entry 1) and appeared to represent the major side product in 
most cases. It was found that although the formation of 22 was suppressed in the presence of 
48 
 
Cl3CCOOH, however additional unidentified side products were formed such that the yield did 
not increase. Cooling the reactions to -20 
o
C did not increase product yields or reduce 
unproductive consumption of starting material.  
Table 9. Attempted Optimization of the Chlorocycloetherification of 19d. 
 
   yield (%)
b 
after  olefin remaining 
entry Lewis base electrophile ca. 15 min 3.5 h at 3.5 h (%) 
1 None 1-CBT 3 44 18 
2 (Me2N)3P=S 1-CBT 17 29 6 
3 (Me2N)2C=S 1-CBT 18 33 7 
4 quinuclidine 1-CBT 36 50 5 
5 None DCDMH 5 27 23 
6 (Me2N)3P=S DCDMH 22 33 0 
7 (Me2N)2C=S DCDMH 34 34 0 
8 quinuclidine DCDMH 22 41 22 
a All reactions conducted on 0.065 mmol of 16a in 0.65 mL of CDCl3 in a 5mm NMR tube 
bDetermined by integration of 1H 
NMR signals for H-6 against 1,2,4,5-PhCl4 internal standard 
 
4.3.3.  Acyclic Chlorofunctionalization. 
Considering the hypothesis that strong anionic nucleophiles might be able to trap the 
chloronium ion intermediate efficiently, conditions were surveyed for the acyclic 
chlorofunctionalization of 11. In the absence of added nucleophile, quinuclidine exhibited 
modest catalytic activity, promoting the chlorobenzotriazolation of 11 in moderate yield, albeit 
as a 5:1 mixture of benzotriazol-2-yl and benzotriazol-1-yl isomers (Table 10). This 
transformation has been previously reported,
56
 and is of regrettably limited synthetic utility. 
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Table 10. Catalysis of Chlorobenzotriazolation. 
 
   yield (%)
b
 after   
entry Lewis base ca.15 min 2 h 24 h 
1 None 0.5 12 60 
2 quinuclidine 13
c 
47 61 
a All reactions conducted on 0.065 mmol of 16a in 0.65 mL of CDCl3 in a 5mm NMR tube 
bDetermined by integration of 1H NMR signals for H-6 against 1,2,4,5-PhCl4 internal 
standard. c Partial overlap of 1,2,4,5-PhCl4 signals with 1-CBT signals. Conversion was 8%. 
See Figure 9 for spectrum. 
 
None of the catalysts tested showed activity in the presence of n-Bu4NOAc, with (Table 
11, entries 5–7) or without (entries 1-4) added acetic acid. In the presence of only acetic acid, 
little if any catalysis was observed, and a mixture of the desired chloro acetate 15a and the 
chlorobenzotriazolation product 23 was produced (entries 8-9).  
When DCDMH was used as a chlorine source, quinuclidine exhibited minimal catalytic 
activity in chloroacetoxylation in the presence of AcOH (entries 10-11). Under these conditions, 
the major product was 4,5-dichlorooctane. No catalysis was observed in the presence of n-
Bu4NOAc (entries 12-13). Unsurprisingly, n-Bu4NCN and n-Bu4NN3 appeared to react directly 
with 1-CBT on contact. 1-Cyanobenzotriazole, the known product
57
 from the reaction of NaCN 
and 1-CBT was not observed. The combination of n-Bu4NN3 and 1-CBT immediately generated 
a gas presumed to be N2. 
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Table 11. Attempted Optimization of Chloroacetoxylation. 
 
   AcOH  n-Bu4NOAc  yield (%)
b
 at  
entry Lewis base electrophile (equiv) (equiv)  ca.15 min 2 h 
1 none 1-CBT 0 1.5 4 8 
2 quinuclidine 1-CBT 0 1.5 4 5 
3 (Me2N)3P=S 1-CBT 0 1.5 1 2 
4 (Me2N)2C=S 1-CBT 0 1.5 1 1 
5 none 1-CBT 2.0 1.5 12
c 
27
 c
 
6 quinuclidine 1-CBT 2.0 1.5 12
 c
 26
 c
 
7 (Me2N)3P=S 1-CBT 2.0 1.5 12
 c
 19
 c
 
8 none 1-CBT 2.0 0 6 37 
9 quinuclidine 1-CBT 2.0 0 13 36 
10 none DCDMH 1.5 0 1 9 
11 quinuclidine DCDMH 1.5 0 8 16 
12 none DCDMH 2.0 1.5 6 14 
13 quinuclidine DCDMH 2.0 1.5 8 14 
a All reactions conducted on 0.065 mmol of 16a in 0.65 mL of CDCl3 in a 5mm NMR tube 
bDetermined by integration 
of 1H NMR signals for H-4 against 1,2,4,5-PhCl4 internal standard 
c Determined by integration of 1H NMR signals for 
H-4 against PhMe6 internal standard 
 
Attempts to develop an acyclic chloroetherification reaction (Scheme 25.) led to only 
mixtures of 4,5-dichlorooctane, oxidized nucleophile, and chlorobenzotriazolation product 23.  
Scheme 25. 
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4.4. Discussion 
4.4.1. Stability of catalysts to the reaction conditions. 
Under some of the reaction conditions examined, certain catalysts showed signs of 
instability. For example, (Me2N)3P=S in the presence of 1-CBT (Table 6, entry 13) showed clear 
signs of desulfurization in 
31
P NMR (signals at 38.5 (unknown) and 27.9 ppm (HMPA)). 
No evidence of decomposition of quinuclidine was ever observed. However, N-methyl 
amines showed possible signs of decomposition under the reaction conditions, based on the 
observation of multiple sets of methyl signals, the intensities of which varied over time. Smith 
has shown that while quinuclidine can be recovered intact after treatment with 1-CBT and 
quenching, other amines undergo oxidative fragmentation likely due to single electron transfer 
reactions.
58
 Even structurally similar 1,4-diaza[2,2,2]bicyclooctane (DABCO) undergoes 
oxidative fragmentation. In this case, an ESR spectrum of the intermediate aminium radical was 
obtained. This problem might be ameliorated by the use of an electrophile that is less prone to 
single electron transfer. Smith also reported the isolation of small amounts 4- and 5-
chlorobenzotriazole, which he hypothesized to arise from the chlorination of benzotriazolate by 
chloroquinuclidinium ion. Smith was unable to observe the chloroquinuclidinum ion in this 
reaction, which he attributes to rapid Cl
+
exchange with free quinuclidine. He reports that Cl
+
 
exchange between quinuclidine and authentic chloroquinuclidinium chloride is rapid at -100 
o
C 
by NMR (field strength unspecified).
58
 
The protonation state of amine catalysts is potentially a significant factor in any 
discussion of their reactivity. In particular, the much higher rates and yields observed in 
quinuclidine catalyzed lactonization compared to all of the other chlorofunctionalization 
reactions explored in this chapter raises the possibility that quinuclidine is acting as Brønsted 
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base. A Brønsted base could hypothetically promote chlorolactonization by accelerating the 
formation of an acyl hypochlorite species, which could undergo intramolecular cyclization. This 
assumes that tertiary amines in general and quinuclidine in particular are competent Brønsted 
bases towards carboxylic acids. If one considers only aqueous pKa data, it would seem that a 
carboxylic acid (pKa ca 4.8)
47
 should completely protonate quinuclidine (pKa of conjugate acid 
11.29).
59
 However in organic solvents this is not necessarily the case. For example in DMSO the 
conjugate acid of quinuclidine has a pKa of 9.8, while acetic acid has a pKa
 
of 12.3.
60
 pKa data for 
quinuclidine is not available in other solvents, however in MeCN the pKa of Et3NH
+
 is 18.82,
61
 
while that of AcOH is 23.51.
62
 The gas phase acidity of acetic acid is 341.1 kcal/mol, while the 
gas phase basicity of Et3N is 227.7 kcal/mol.
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If the role of tertiary amine catalysts was to promote acyl hypochlorite formation there 
would be little or no opportunity for a chiral catalyst to control the stereochemical outcome of 
the cyclization. This argues that acyl hypochlorite formation is not the mechanism by which 
enantioselective (DHQD)2PHAL catalyzed chlorolactonizations operate. It is not possible to 
completely rule out this possibility in the cases of catalysis by of achiral amines or chiral amines 
which yield racemic products.  
Quinuclidine-catalyzed chlorobenzotrazolation of olefins is a useful test case. The lack of 
other functionality on the substrate or in solution greatly simplifies analysis of the mechanism. 
Hypochlorite formation is impossible since there is no nucleophilic functional group other than 
the olefin. Quinuclidine cannot be protonated because there is no acid. It is known that 
uncatalyzed chlorobenzotrazolation typically proceeds stereospecifically with Markovnikov site 
selectivity, suggesting the intermediacy of a chloronium ion, and gives predominately the 
benzotriazol-2-yl isomers as a products. Under UV irradiation, site selectivity is eroded, 
53 
 
presumably due to a radical mechanism, and mostly benzotriazol-1-yl isomers are observed.
56
 In 
Table 10, the ratio of benzotriazol-2-yl to benzotriazol-1-yl isomers was ca. 5:1 regardless of the 
presence of quinuclidine, suggesting that quinuclidine promotes the formation of a chloronium 
ion intermediate, rather than a radical.  
While the initial 
1
H NMR spectrum of the chlorobenzotrazolation reaction in the absence 
of quinuclidine (Table 10, entry 1) shows only olefin 11, 1,2,4,5-PhCl4 internal standard, and 
unaltered 1-CBT, that of the reaction in the presence of quinuclidine (Table 10, entry 2) shows 
several interesting features (Figure 9). First, the aromatic protons of 1-CBT form two broadened 
multiplets (δ 7.87 and 7.51 ppm, black triangles) rather than the three signals seen in pure 1-CBT 
(inset). This change indicates that Cl
+
 site exchange is taking place on the NMR time scale. 
Additionally, the amino-methylene protons of quinuclidine can be seen δ 3.99 ppm (black 
arrow), rather 2.86 ppm where they are found in the pure compound. The chemical shift of the 
corresponding protons in chloroquinuclidinium perchlorate is reported to be δ 4.20 ppm in 
TFA.
64
 This observation is consistent with the formation of chloroquinuclidinium benzotriazolate 
which is in rapid equilibrium with a small amount of complex between quinuclidine and 1-CBT. 
The quinuclidine – 1-CBT complex is then in equilibrium with an undetectable amount of free 
quinuclidine and the excess 1-CBT, which results in the time averaging of the 1-CBT signals. 
Variable temperature NMR experiments would be required to observe the unaveraged signals 
and determine the equilibrium positions. The signals for olefin 11 (δ 5.38 ppm), 1,2,4,5-C6H2Cl4 
internal standard (7.55 ppm), the product 23 and its minor isomer (4.87 and 4.94 ppm) are also 
visible. The other minor signals are unidentified side products. 
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Figure 9.  In Situ 
1
H NMR Spectrum from the Quinuclidine Catalyzed Chlorobenzotriazolation 
of  11 at 8% Conversion Showing the  Formation of a Complex Between  Quinuclidine (arrow) 
and 1-CBT (triangles). Inset: Spectrum of Pure 1-CBT  
 Given this data, the most reasonable hypothesis is that that the complex  of quinuclidine 
and 1-CBT is in rapid equilibrium with chloroquinuclidinium benzotriazolate, which then reacts 
with 11 to form 23 through the intermediacy of a chloronium ion (Scheme 26.). If the 
chloroquinuclidinium ion is the major equilibrium component, then further increases in 
electrophile strength or concentration should produce minimal increases in the rate of the 
catalyzed reaction.                                                                                                                                                                                                                                                                                                                                                    
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Scheme 26. 
 
4.4.2. Effects of substrates 
The results in Sections 4.3.1. and 4.3.2. show that chlorolactonization reactions proceed 
much more rapidly and with fewer side products than analogous chlorocycloetherification 
reactions. This difference could be explained if the closure onto the chloronium ion occurs faster 
in lactonization reactions than in etherification reactions. In Chapter 2, it was found that a highly 
reactive nucleophile was necessary to trap a chloronium ion before it was able to undergo side 
reactions. As discussed in Section 3.4.3. the lower pKa of the carboxylic acid may allow it to be 
deprotonated by the counter anion of the chloronium ion, such as benzotriazolate. The resulting 
zwitterion could then undergo a more rapid closure, reducing the lifetime of the chloronium ion 
and thus its opportunity to participate in side reactions (Scheme 27.).  
Scheme 27. 
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The oxidation of alcohols to aldehydes that was encountered during attempts to develop 
an acyclic chloroetherification reaction are not surprising, the first report of the preparation of 
1-CBT detailed its use in the oxidation of alcohols to carbonyl compounds, albeit at elevated 
temperatures.
65
 This was hypothesized to be a radical process based on the induction period 
observed. No aldehydes were observed in chlorocycloetherification experiments. This may be 
because the substrates in chlorocycloetherification experiments were always present at lower 
concentration than the alcohols in acyclic chloroetherification experiments. It is also possible 
that the resulting aldehydes were unstable under the reaction conditions and therefore not 
observed.  
4.5. Conclusions 
Quinuclidine is an effective Lewis base catalyst for chlorolactonization and 
chlorobenzotriazolation of isolated olefins. Other chlorofunctionalization reactions are limited by 
a variety of side reactions, including elimination and reactions of the nucleophile with the 
electrophile. The greatest challenge is capturing the chloronium ion faster than it can decompose. 
The second greatest challenge is avoiding unproductive side reactions between the chlorine 
electrophile and other functionality in the substrate. Addressing these side reactions will require 
further optimization, possibly including the preparation of different electrophiles and the 
exploration of different substrate classes. Good nucleophiles which do not react irreversibly with 
electrophilic chlorine sources must be found. Amides or sulfonamides may be suitable. 
Alternatively, it may be possible to incorporate electrofugal groups into the substrate to quench 
the chloronium ion, or to design substrates that rearrange more efficiently to provide desirable 
products. 
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Chapter 5:  Development of an Enantioselective 
Bromocycloetherification Reaction. 
5.1. Introduction 
The research described in Chapter 3 of this thesis deals with one potential strategy to 
effect stereocontrol in halocyclization reactions despite the racemization of halonium ion 
intermediates, namely continued association of the intermediate halonium ion with a chiral 
Lewis base catalyst. Ion pairing with a chiral counterion should in principle provide the same 
opportunity for stereocontrol that an associated chiral Lewis base does, except with the added 
advantage that the association of the halonium ion with its counter ion is guaranteed in nonpolar 
media by the principle of electroneutrality
66
 and the force of Coulombic attraction.
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Consequently, a chiral counterion should have the opportunity to influence the stereochemical 
course of every step of the reaction, regardless of any known or unknown racemization 
pathways. Such a chiral ion pair should arise as a natural consequence of catalysis by a 
sufficiently strong, chiral Brønsted acid or the combination of a chiral Brønsted acid and a Lewis 
base because the acid should protonate and replace the succinimide counterion (Scheme 28.). 
Scheme 28. 
 
Related studies in these laboratories had demonstrated that Lewis base catalyzed 
seleno-,
23c
 thio-
68
 and bromocycloetherification
69
 (Chapter 3) are greatly accelerated by the 
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addition of a stoichiometric amount of an achiral Brønsted acid.  The pKa and general 
applicability of chiral phosphoric acids made them attractive candidates for the development of 
an enantioselective bromocycloetherification process using a catalytic amount of a chiral 
Bronsted acid, potentially in conjunction with a Lewis base co-catalyst.
70
 
5.2. Background 
5.2.1. Chiral phosphoric acid catalysis. 
BINOL-derived chiral phosphoric acids and phosphoric acid derivatives are among the 
strongest and most broadly applicable chiral Brønsted acids used in enantioselective catalysis. 
The development of this catalyst class began with concurrent efforts by Akiyama
71
 and Terada
72
 
toward the development of enantioselective Mannich reactions (Scheme 29., eq 1 and 2 
respectively). In addition to the obvious potential for phosphoric acids to protonate imines, both 
groups were attracted to the structural rigidity provided by the tetracoordinate P(V) center, as 
well as the potential for the Lewis basic phosphoryl oxygen to engage in secondary binding 
interactions such as hydrogen bonding.  
Scheme 29. 
 
Akiyama’s use of 2-hydroxyphenyl imines takes particular advantage of this capacity to 
provide a two point binding interaction between the catalyst and imine. (Figure 10) DFT 
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calculations support this proposed interaction and suggest that transition state structure leading to 
the minor product enantiomer is disfavored by unfavorable steric interactions between the 3,3’-
aryl group and the TMS group of the nucleophile as well as with the N-aryl group of the imine.
73
 
The hydroxyl group also serves to abstract the TMS group from the ester functionality following 
C-C bond formation, thus allowing the catalyst to turn over. 
 
 
Figure 10. Two-point hydrogen bonding interaction between 2-hydroxyphenylbenzaldimine and 
a chiral phosphoric acid catalyst; Favored transition state for Mannich addition at the 
BHandHLYP/631-G
*
 level of theory
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Subsequently, BINOL-derived phosphoric acids and phosphoric acid derivatives have 
been applied to a wide range of problems in enantioselective catalysis.
70a-e,74
 Their principle 
limitations in Brønsted acid catalyzed reactions seem to be the accessible pKa range (ca 2.4 to 
4.2)
70f
 and performance in polar solvents, which is frequently poor. BINOL-derived phosphoric 
acids are not limited to acting as Brønsted acids however, they are finding an increasing number 
of applications as anionic ligands in transition metal catalysis.
70c
   
One interesting application is the enantioselective Bayer-Villager reaction developed by 
Ding (Scheme 30.).
75
 Extensive kinetic and computational studies
76
 suggest that the active 
species is a hydrogen bonded complex of the phosphoric acid and H2O2. The mechanism of 
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enantioselection appears to be dominated by entropy and solvation energy, rather than steric or 
electronic factors. 
Scheme 30. 
 
Despite widespread use of chiral BINOL-derived phosphoric acids, a key property of 
these catalysts was not widely recognized for nearly six years. Purifying chiral phosphoric acids 
by chromatography on silica gel results in irreproducible mixtures of the free acid and its salts 
with group 1 and 2 metals due to proton exchange with metal silanolate groups on the silica. The 
extent of exchange presumably depends on the chromatography conditions and the cation content 
of the silica used. The free phosphoric acid can be regenerated by extraction with aqueous HCl, 
however in many early examples this was not done.
72
 Ishihara has found that much of the 
activity of these mixed salts may be the result of calcium salts acting as chiral Lewis acids.
77
 
Depending on the application, such salts can display enantioselectivity opposite to that of the 
free acid.
**
 In other applications they are simply inert.
78
  
The wide applicability of BINOL-derived phosphoric acids and phosphoric acid 
derivatives is in a large part due to their tunable nature. The shape and accessibility of the chiral 
environment provided by these catalysts is determined by the substituents at the 3,3’ positions. 
Depending on the reaction in question the optimal substituents range from simple 4-substituted 
phenyl groups to polycyclic aromatics, multiply substituted biaryls, and bulky silyl groups. 
Which 3,3’ substituents are best suited for a particular application cannot be predicted a priori, 
                                                 
**
 All phosphoric acids used in this thesis were acid washed or purified without recourse to chromatography. See 
supporting information for details. 
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although the 2,4,6-triisopropylphenyl substituted phosphoric acid catalyst 24a (commonly 
known as TRIP
78
) and its derivatives have proven remarkably versatile. Altering the 3,3’ 
substituents also alters the pKa of the catalyst somewhat.
70f
 Derivatization of the phosphoric acid 
group, replacing one or more oxygen atoms with S, Se, or N substituents allows the acidity of the 
catalyst to be varied along with the Lewis basicity, softness, coordination geometry, and other 
properties.
70e,79
  
Chart 1. 
 
5.2.2. Use of chiral phosphoric acids in halogenation. 
In the related bromolactonization and bromosulfonamidocylization reactions, several 
chiral catalysts containing Lewis basic nitrogen functional groups are able to provide high 
enantioselectivity.
35-37
 These successes, as discussed in previous chapters,  have been ascribed in 
part to the formation of strong hydrogen bonds or tight ion pairs between the carboxylate and 
sulfonamide groups. However, these catalyst systems are not effective in enantioselective 
bromoetherification reactions. During the development of the methods described in this chapter, 
several similar methods employing chiral phosphoric acids and their salts were published to 
address this deficiency. 
Hennecke
80
 showed that the sodium salt 25a catalyzes enantioselective bromo and iodo 
cycloetherification by desymmetrization of  meso halonium ions (Scheme 31.). It is proposed 
that 25a is acting as an anionic Lewis base in this reaction. Since the halonium ion is meso, 
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enantioselectivity can only arise from controlling the site of nucleophilic attack, but olefin-to-
olefin transfer is irrelevant. This outcome provides an unambiguous demonstration of the ability 
of a chiral counterion to effect the stereochemical outcome of halocyclization reactions. 
Scheme 31. 
 
An enantioselective bromocycloetherification method very similar to that described in 
this chapter was developed simultaneously by Shi and co-workers.
81
 These authors showed that 
acid 24a (TRIP) catalyzes enantioselective bromocycloetherification and bromoaminocyclization 
(Scheme 32.). In contrast to the final conditions described in this chapter, no Lewis base co-
catalyst was used. A wide range of substrates were demonstrated with a heavy emphasis on 
unconjugated olefins. Moderate levels of enantioselectivity were observed in etherification 
reactions, likely due in part to the concentration at which the reactions were run (compare 
Scheme 32. eq 1 with Table 14, entries 1, 4-5). High enantioselectivity was observed in many 
bromoaminocyclization reactions (Scheme 32., eq 2), particularly those of (Z) olefins. 
Scheme 32. 
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 Toste has developed an enantioselective fluoro cyclization reaction using the phosphate 
salt  25b as an enantioselective solid/liquid phase transfer catalyst to solubilize the otherwise 
highly insoluble dicationic Selectfluor reagent (Scheme 33.).
82
 
Scheme 33. 
 
5.3. Results 
5.3.1. Initial efforts with chiral Lewis bases. 
Efforts to apply the findings of the studies described in Chapter 3 to enantioselective 
bromolactonization began shortly after their completion and continued periodically thereafter. 
These results will be discussed here for the sake of narrative coherence. Previously, thioureas, 
phosphine sulfides, thiophosphoramides, and selenophosphoramides showed a promising ability 
to effect the ratio of endo to exo cyclization in the bromolactonization of 16a. Catalysts 26a-d 
were tested under the conditions established in Chapter 3 (Table 12). Although catalysts 26a and 
26c-d were able to alter the ratio of 17aa to 18aa, no enantioselectivity was observed. Catalysts 
26c-d were previously optimized for analogous thio-
68
 and seleno-
23c
 cyclizations, so their failure 
in this transformation was particularly disappointing.  
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Table 12. Attempted Enantioselective Bromolactonization of 16a. 
 
entry catalyst 17aa:18aa er (17aa)
b 
er (18aa)
b 
yield (%)
a 
1 26a 7.3:1 50:50 51:49 78 
2 26b 20:1 50:50 53:47 73 
3 26c 4.9:1 50:50 50:50 82 
4 26d 7.5:1 51:49 53:47 66 
a Yield of chromatographically homogenous material b Determined by CSP-HPLC 
 
Inspired by Yeung’s35-36 work on bromolactonization, catalysts 26e-f were prepared and 
tested in a series of bromolactonization reactions (Table 13). No significant enantioselectivity 
was observed in any case. The absence of enantioselectivity observed with these catalysts 
suggested that a different approach would be required.  
Table 13. Attempted Enantioselective Bromolactonization of 16d. 
 
entry catalyst mol % solvent T (
o
 C) yield (%)
a 
er
b 
1 26e 5 CH2Cl2 23 98 50:50 
2 26e 10 PhMe/CHCl3 2:1 -75 4 50:50 
3 26f 5 CH2Cl2 23 88 51:49 
4 26f 10 PhMe/CHCl3 2:1 -75 91 54:46 
a Yield of chromatographically homogenous material b Determined by CSP-HPLC 
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5.3.2. Chiral phosphoric acid catalysis. 
On the basis of the broad applicability of 24a, the potential of 24b to act as a Lewis base, 
and general knowledge of the chiral Brønsted acid catalysis literature, catalysts 24a-c seemed to 
provide the best chances for inducing enantioselectivity. Gratifyingly, 24a-c (Table 14, entries 1-
3) catalyzed the enantioselective bromocycloetherification of 19a providing the exo cyclization 
product 21aa with moderate to high enantioselectivity and the endo cyclization product 20aa 
with low enantioselectivity. Ordinarily, 21aa is a minor product in the cyclization of 19a 
(Scheme 16.). It is therefore fortunate that 24a-b substantially increase the proportion of 21aa 
formed, albeit to only ca. 1:1 mixtures. Contrary to what had been hypothesized based on its 
potential to provide an internal Lewis base to assist in activation of the NBS, 24a (entry 1) 
catalyzed the cyclization in higher yield and selectivity than the thio analog 24c (entry 2). 
Triflimide 24c (entry 3) catalyzed the cyclization in higher conversion, however the site and 
enantioselectivity was again lower and the absolute sense of enantioselectivity was inverted 
(entry 3). Lower enantio- and site selectivities were also observed when the reaction was run at 
higher concentrations (entries 4 -5). Lower enantio- and site selectivities were also observed 
when the cyclizations were run in CHCl3 (entry 6), PhCF3 (entry 7), Et2O (entry 8), hexane 
(entry 9), or MeCN (entry 10). From this initial survey, it appeared that a Lewis base was not 
required for this transformation. 
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Table 14. Optimization of Chiral Phosphoric Acid Catalyzed Bromocycloetherification. 
 
entry catalyst solvent conc. (M) time (h) 20aa:21aa
a 
er (20aa)
b 
er (21aa)
b 
yield
c 
1 24a PhMe 0.025 24 48:52 62:38 95:5 64 
2 24b PhMe 0.025 24 56:44 59:41 94:6 40 
3 24c PhMe 0.025 13 87:13 48:52 28:72 78 
4 24a PhMe 0.05 24 61:39 58:42 92:8 39 
5 24a PhMe 0.1 24 72:28 55:45 88:12 48 
6 24a CHCl3 0.025 24 89:11 51:49 86:14 59 
7 24a PhCF3 0.025 24 73:27 52:48 74:26 82 
8 24a Hexane 0.025 24 80:20 51:49 81:19 37 
9 24a Et2O 0.025 25 98:2 50:50 51:49 57 
10 24a MeCN 0.025 1 98:2 50:50 51:49 75 
a
 Determined by integration of 1H NMR signals for H-6 b Determined by CSP-SFC c Yield of chromatographically homogenous 
material 
 
5.3.3. Chiral Brønsted acid/achiral Lewis base cooperative catalysis. 
Unfortunately, a serious problem was encountered while attempting to extend the results 
described above. Subsequent batches of 24a catalyzed the cyclization of 19a in substantially 
lower conversion and site selectivity and slightly lower enantioselectivity. The cause of this 
discrepancy was not firmly established because unfortunately the original batch had been 
expended before the problem was noticed. Multiple batches of 24a prepared from different 
batches of the diol precursor exhibited similar behavior, so the new, inferior result appeared to be 
the reproducible one. It was hypothesized that the original material contained some co-catalytic 
impurity, possibly some sort of Lewis base. It was found that the addition of catalytic amounts of 
Ph3P=S restored catalyst activity and site selectivity (Table 15). The optimal conditions (entry 1) 
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gave higher conversion than the original conditions in shorter reaction times using only half as 
much 24a. 
Table 15. Optimization of Chiral Bronsted Acid/Achiral Lewis Base Cooperatively Catalyzed  
Bromocyloetherification. 
 
entry cat. solvent conc.,  M t, h 20aa:21aa er (21a) er (20a) yield, %b 
1 24a PhMe 0.025 9 48:52 93:7 57:43 83 
2 24b PhMe 0.025 12 13:87 72:28 50:50 65 
3 24c PhMe 0.025 12 12:88 75:25 49:51 85 
4 24d PhMe 0.025 12 15:85 63:37 50:50 95 
5 24e PhMe 0.025 35 26:74 77:23 49:51 31 
6 24f PhMe 0.025 12 19:81 68:31 48:52 86 
7 24a PhMe 0.1 12 39:61 90:10 54:46 84 
8 24a Et2O 0.025 12 17:83 88:12 50:50 87 
9 24a CHCl3 0.025 12 3:97 56:44 51:49 90 
a Determined by 1H NMR integration of signals for H-6 of 3a against H-2 of 4a b Yield 
after chromatography, all reactions run on 0.1 mmol substrate 
 
 
Several additional catalysts were prepared, and the effects of solvent, concentration and 
catalyst were evaluated under the new conditions (Table 15).In all cases, furan 21aa was formed 
with higher enantioselectivity than pyran 20aa. Phosphoric acid 24a continued to be the optimal 
catalyst (entry 1). Substantially lower enantio- and site selectivities were observed when 
catalysts with alternative acidic groups (entries 2-3), alternative 3,3’-aryl groups (entries 4-5) and 
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an alternative chiral scaffold (entry 6) were used. Curiously, the absolute sense of 
enantioselectivity induced by 24c was inverted compared to the previous result (entry 3 vs Table 
14 entry 3), making it the same as that observed with 24a-b and 24d-f. Increasing the reaction 
concentration (entry 7) or using solvents other than toluene (entries 8-9) gave inferior 
enantioselectivity.  
To better understand the selectivity of this cyclization and determine its potential utility, a 
series of substrates were chosen to evaluate the effects of sterically and electronically diverse 
aryl groups, as well as olefin configuration (Table 16). The effect of electronic perturbations was 
strong, particularly among the E-configured substrates. A moderately more electron-rich aryl 
group unsurprisingly reduced the proportion of 5-exo cyclization (entry 2), although 
enantioselectivity increased. Conversely, substitution with an electron-withdrawing group 
favored the formation of exo cyclized product 21fa but with reduced enantioselectivity (entry 3).  
Table 16. Scope of Bromocycloetherification. 
 
entry R products 20:21b
 
er (21)
c yield (21) %d
 
er (20) yield (20), % 
1 (E)-C6H5 21aa, 20aa 45:55 93:7 77
f 58:42  
2 (E)-4-CH3C6H4 21ea, 20ea 37:63 97:3 28 65:35 67 
3 (E)-4-CF3C6H4 21fa, 20fa 86:14 85:15 43 65:35 12
e 
4 (Z)-C6H5 21ga >95:5 91:9 77 n/d  
5 (Z)-2-naphthyl 21ha, 20ha 95:5 92:8 73 n/d  
6 (Z)-2-CH3C6H4 21ia, 20ia 94:6 94:6 86
f 89:11  
7 (Z)-3-CH3C6H4 21ja >95:5 92:8 86 n/d  
8 (Z)-4-CH3C6H4 21ka, 20ka 90:10 94:6 64 65:35 9 
9 (Z)-4-FC6H4 21la, 20la 95:5 90:10 78
f 60:40  
10 (Z)-4-CF3OC6H4 21ma, 20ma 98:2 84:16 77
f,g n/d  
a All reactions run at 0.025 M on 1.0 mmol substrate b Determined by 1H NMR integration of signals for H-6 of 21 against H-2 
of 20 c Determined by CSP-SFC d Yields of analytically pure material e Run at 23 oC for full conversion, selectivity at 0 oC was 
unchanged. f Yield of both isomers g Yield of chromatographically homogenous material 
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More encouragingly, the cyclization of (Z)-configured double bonds occurred with uniformly 
high exo selectivity (entries 4–10). The enantioselectivity in these cases was only slightly 
reduced compared to E-configured alkenes (entries 1 and 4, 2 and 8), and varying the steric 
demands of the substrate (entries 5–8) had no clearly discernible effect. Electron-withdrawing 
groups again reduced the enantioselectivity (entries 9–10). 
The enantioselectivity observed in the cyclization of unconjugated olefins 19b-c was 
substantially lower (Table 17, entry 1). This is partially due to the higher intrinsic reactivity of 
19b-c, which leads to a substantial rate of cyclization in the absence of acid. When Ph3P=S was 
omitted, enantioselectivity improved (entries 2-3), although not to the level observed with 
conjugated olefins. This modification came at the cost of greatly extended reaction times and, in 
the case of 19c, low conversion. Several additional catalysts were prepared and tested in the 
cyclization of 19b-c. Cyclization of 19c proceeded in modestly higher enantioselectivity when 
catalyzed by 24g than when catalyzed by 24a (entry 5), however no difference was observed in 
the cyclization of 19b (entry 4).  
The absolute configuration of the Z-double bond derived products was established by 
single crystal X-ray diffraction analysis of 21ha and was then correlated with that of the E-olefin 
derived products by reductive dehalogenation of 21aa and 21ga. The resulting samples of 2-
benzyltetrahydropyran were of identical configuration judged by optical rotation ([α]D
24
 -1.9 and 
-5.5 ) and CSP-SFC analysis (tR 3.707 and 3.714 min) (Scheme 34.). The configurations of 20aa–
ma are assumed based on this information. 
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Table 17.  Catalyst Survey for Bromocycloetherification of Unconjugated Olefins. 
 
entry cat. R Lewis base substrate t, h er a
 
yield, %
b 
1 24a 2,4,6-iPr3(C6H2) Ph3P=S 19b 12 65:35 n/d 
2 24a 2,4,6-iPr3(C6H2) - 19b 39 85:15 89 
3 24a 2,4,6-iPr3(C6H2) - 19c 40 82:18 50 
4 24g 2,4,6-Cy3(C6H2) - 19b 40 85:15 83 
5 24g 2,4,6-Cy3(C6H2) - 19c 40 86:14 79 
6 24h 2,4,6-Ph3(C6H2) - 19b 40 53:47 30 
7 24h 2,4,6-Ph3(C6H2) - 19c 15 56:44 75 
8 24i 2,4,6-Me3(C6H2) - 19b 40 68:32 65 
9 24i 2,4,6-Me3(C6H2) - 19c 40 80:20 76 
10 24j 4-CF3C6H4 - 19b 40 61:39 59 
11 24j 4-CF3C6H4 - 19c 40 70:30 64 
12 24k 3,5-(CF3)2C6H4 - 19b 40 63:37 82 
13 24k 3,5-(CF3)2C6H4 - 19c 40 64:36 75 
14 24l 9-anthryl - 19b 12 72:28 87 
15 24l 9-anthryl - 19c 40 72:28 74 
a Determined by CSP-SFC b Yield after chromatography, all reactions run on 0.1 mmol 
substrate 
 
Scheme 34. 
 
5.4. Discussion 
5.4.1. Site selectivity. 
 The production of constitutional isomers of different composition provides a few 
intriguing clues about the reaction mechanism. First, the effect of electron-donating and 
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withdrawing groups on site selectivity (Table 16, entries 2–3) shows the dependence expected 
from altering the degree of charge stabilization at the benzylic carbon of a bromonium ion 
intermediate. The increased amount of the tetrahydrofuran isomer observed in the presence of 
24a (Table 15, entry 1) shows that the chiral acid is present in the final cyclization step and is not 
merely controlling the initial bromine delivery. 
 The differences in enantioselectivity between 20aa and 21aa are striking and are visible 
to varying degrees in all of the catalysts surveyed. A number of explanations are possible given 
the limited data; however it should be noted that the presence of the chiral counterion means that 
all four product-generating transition state structures are unequal in energy and therefore a priori 
the enantiomeric composition of 20 and 21 need not be equal (Scheme 35.). For example if kRe–
endo/kRe–exo > kSi–endo/kSi–exo then kinetic resolution would occur, increasing the er of 21aa at the 
expense of lower er of 20aa and a lower ratio of 21aa:20aa.
††
 In other words, the minor 
enantiomer of the bromonium ion undergoes mostly endo cyclization, while the major 
enantiomer undergoes both cyclization modes. Any background reaction would also produce 
mostly racemic 20aa.  
The greater proportion of exo cyclization of Z alkenes compared to E alkenes is a 
property of the substrate, independent of the selectivity of the catalyst system. This phenomenon 
was discussed in Section 3.4.2. 
The racemization of bromonium ions by olefin-to-olefin transfer is not very important in 
the current catalyst system. A four-fold increase in reaction concentration led to a negligible 
decrease in the enantiomeric composition of 21aa (93:7 to 90:10). This drop suggests that olefin-
to-olefin transfer may be occurring to some extent, but either it is substantially slower than 
                                                 
††
 This is analogous to the divergence of enantioselectivity for cis and trans epoxides seen in the Jacobsen 
epoxidation of (Z) alkenes.
83
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cyclization at 0.1 M or the equilibrium ratio of bromonium ions is favorably high. All other 
experiments were conducted at 0.025 M, where associative transfer should be 16 times slower, 
and the erosion of enantioselectivity should be negligible. 
 
Scheme 35. 
 
5.4.2. Origin of enantioselectivity. 
Comparing the absolute configurations of the E- and Z-derived products offers a clue 
about the origin of enantioselection. The two trigonal carbons that constitute the Z olefin faces 
are (Si, Si) and (Re, Re) whereas the E olefin faces are (Si, Re) and (Re, Si). The cyclization of E 
and Z isomers can be said to have the same (or opposite) sense of enantioselection only if one 
focuses on one trigonal carbon. This catalyst system consistently delivers Br
+
 to the C(4)-Si face, 
regardless of whether that face is also C(5)-Si or C(5)-Re (Figure 11). I hypothesize that this 
outcome reflects which substituent on the double bond dominates the chiral recognition and that 
since the configuration of the tetrahydrofuran is conserved (Scheme 34., C(4) of 19, C(2) of 21), 
the dominant recognition feature is the tethered hydroxyl group. This sense of recognition is 
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tentatively hypothesized to result from hydrogen bonding to the phosphate group, analogous to 
what is proposed in certain Mannich reactions (Figure 11, Figure 10).
71-72
  
 
Figure 11. Observed sense of enantioselectivity and postulated substrate-catalyst interaction. 
Preliminary calculations aimed at validating this model were carried out using the PM6 
semi-empirical method
84
 as implemented in Spartan 10
85
 in vacuo. The hypothesized hydrogen 
bonded intermediates were located for delivery of Br
+
 to the favored and disfavored faces of 
substrates 19a and 19g. Similar structures which lack the hydrogen bond were found to be 2 – 3 
kcal/mol higher in energy. After systematic conformational searches were carried out, the correct 
facial selectivity was predicted for the E configured substrate 19a. The facial selectivity 
predicted for the Z configured substrate 19g was opposite to that observed experimentally. The 
inclusion of continuum solvation and the use of the PM6-DH+
86
 dispersion and hydrogen 
bonding correction method or the PM6-DH2X
87
 dispersion, hydrogen and halogen bonding 
correction method as implemented in MOPAC-2009
88
 had minimal effects (<0.1kcal/mol) on the 
results with substrate 19g. Attempts to locate transition states leading to or from the 
intermediates were unsuccessful. The mean error in energies between pairs of conformers for the 
PM6 method is 2.3 kcal/mol, larger than the energy differences observed here. Any quantitative 
interpretation of this model will require the use of more accurate computational methods. 
5.5. Conclusions 
In conclusion, an enantioselective bromocycloetherification of 5-arylpentenols has been 
developed using a chiral Brønsted acid and an achiral Lewis base to provide good yield and 
enantiomeric induction. High site selectivity was achieved by a combination of substrate and 
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catalyst control. Further studies aimed at understanding the mechanism of this transformation are 
described in Appendix 2. 
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Chapter 6:  Addition of Silyl Ketene Imines to Carbonyl 
Electrophiles 
6.1. Introduction 
The catalytic symmetric construction of quaternary stereogenic centers is an ongoing 
challenge in organic synthesis.
89
 The methods for constructing such stereocenters are markedly 
more limited than for secondary and tertiary centers. To a great extent, this is because steric 
repulsion increasingly disfavors many reactions as the degree of substitution increases. A classic 
example of this is the virtual impossibility of SN
2
 displacement of a tertiary electrophile, which 
prevents the construction of quaternary stereogenic centers by simple stereospecific alkylation of 
primary carbon nucleophiles. More to the point, the aldol reactions of silyl ketene acetals such as 
those developed in this laboratory are greatly retarded by the steric interactions inherent in the 
formation of quaternary stereocenters.
90
 The enantioselective addition of silyl ketene imines to 
carbonyl electrophiles provides a method of constructing quaternary stereogenic centers while 
simultaneously setting an adjacent secondary or tertiary stereogenic center in an aldol-type 
reaction. This chapter will deal with the addition of silyl ketene imines to aldehydes and ketones 
using Lewis base/SiCl4 activation.  
6.2. Background 
6.2.1. Lewis base catalysis with SiCl4. 
Lewis acidic silicon reagents can undergo Lewis base activation through n-* 
interactions with neutral or anionic Lewis bases. In accordance with Gutmann’s rules3 these n-* 
interactions enhance the electrophilicity of the Si center and increase the nucleophilicity of the 
ligands. In the case of SiCl4, the enhancement of Lewis acidity induced by binding to a Lewis 
basic phosphoramide strongly favors binding of a second phosphoramide to form octahedral 
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complexes (26), which exist in equilibrium with highly Lewis acidic ionized complexes (27). 
(Scheme 36.).
91
 The weakly Lewis acidic nature of unactivated SiCl4 allows it to be used in 
stoichiometric quantities without inducing an uncatalyzed background reaction. The ability to 
use a stoichiometric amount of Lewis acid is particularly advantageous in reactions in which 
achieving turnover of a catalytic Lewis acid is troublesome, such as the aldol reaction (Scheme 
37.). 
Scheme 36. 
 
The aldol reaction has great utility in the construction of biologically interesting natural 
products, and the development of catalytic enantioselective variants has attracted widespread 
interest in the synthetic community.
92
 Many efforts in this area have focused on the use of chiral 
Lewis acids to catalyze Mukaiyama-type aldol reactions between carbonyl anion equivalents, 
such as silyl enol ethers, and a range of carbonyl electrophiles, typically aldehydes (Scheme 37., 
eqn 1).
92
 For the catalyst to turn over, the intermediate 29a must be converted into 29b. The 
product is a stronger binding ligand than the substrate, thus product inhibition can limit catalyst 
turnover.
92b
  
The need to achieve turnover of the Lewis acid can be avoided entirely by using a 
stoichiometric amount of a weak Lewis acid, such as SiCl4, activated by a substoichiometric 
amount of a chiral Lewis base. In such a system, it is the ligand, not the Lewis acid, which must 
turn over. This is a simpler task, as 29a is a weaker Lewis acid than M
+
X
- 
(Scheme 37., eqn 2). 
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Scheme 37. 
 
Another successful approach to promoting catalyst turnover is exemplified by Carreira’s 
titanium Schiff base complex 31, which catalyzes highly enantioselective Mukaiyama-type 
acetate aldol reactions of silyl ketene acetals (Scheme 38.).
93
 The salicylate ligand of 22 is 
proposed to accelerate catalyst turnover by acting as a silyl group shuttle. When it is replaced by 
isopropoxide yield and enantioselectivity are substantially lower. 
Scheme 38. 
 
The activation of SiCl4 and trichlorosilyl reagents with chiral Lewis basic catalysts has 
been the subject of extensive research in the Denmark group. A series of catalyst systems have 
been developed allowing productive addition of a wide range of nucleophiles including silyl 
ketene acetals,
90b,94
 isocyanides,
95
 N,O-silyl ketene acetals,
96
 silyl enol ethers,
97
 and silyl dienol 
ethers,
98
 to aldehydes and, in some cases, ketones.
94a
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Aromatic aldehydes are suitable substrates for all of these transformations, however even 
in such favorable cases disubstitution of the nucleophilic center to yield quaternary stereogenic 
centers leads to a reduction or loss of reactivity, presumably due to steric repulsion in the aldol 
transition structure. The reaction of acetate silyl ketene acetal 32a with benzaldehyde 33a and 
silicon tetrachloride, catalyzed by (R,R)-34 is complete in less than 30 seconds, whereas the α-
disubstituted isobutyrate silyl ketene acetal 35 requires >12 hours (Scheme 39.).
90b
 To form a 
quaternary stereogenic center, rather than the nonstereogenic quaternary center in 36 one of the 
substituents on the nucleophile must be larger than a methyl group, which results in a complete 
loss of reactivity.
90a
 
Scheme 39. 
 
The reactions of aliphatic aldehydes with enoxysilane nucleophiles under Lewis 
base/silicon tetrachloride activation poses a special problem. The active complex I rearranges to 
form trichlorosilyl chlorohydrin II rapidly even at -78 °C. This adduct is thermodynamically 
favored in the case of aliphatic aldehydes, but not with aromatic aldehydes whose carbonyl form 
is stabilized by conjugation. (Scheme 40.) 
90b 
The stability of this adduct results in a very low 
equilibrium concentration of the active complex I in the reaction mixture, which in turn produces 
a drastic reduction in reaction rate. As a result, aliphatic aldehydes can require long reaction 
times, higher temperatures or other more forcing conditions than their aromatic counterparts.
90b,99
 
Depending on the reactivity of the nucleophile, aliphatic aldehydes may not react at all.   
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Scheme 40. 
 
Highly reactive nucleophiles such as acetate derived silyl ketene acetals
90b
 (Scheme 41., 
eq 1) and conjugated silyl ketene aminals
96
 (Scheme 41., eq 2) will react productively with the 
small equilibrium concentration of activated aliphatic aldehyde present in these reaction 
conditions. More hindered, hence less reactive,  propionate derived silyl ketene acetals react with 
aliphatic aldehydes in moderate yield in the presence of i-Pr2NEt or TBAI (Scheme 41., eq 3).
90b
 
High yields and enantioselectivities are observed in many of these cases. 
Scheme 41. 
 
Relative to aldol additions to aldehydes, few systems exist that can perform catalytic 
enantioselective aldol additions to ketones. Previous work in the Denmark group has 
demonstrated the enantioselective addition of the highly reactive trichlorosilyl ketene acetal 32b 
to ketones in the presence of the chiral bis-N-oxide catalyst 37 (Scheme 42.).
94a
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Scheme 42. 
 
Another such system, developed by the Shibasaki group, is catalyzed by a chiral 
copper(I) fluoride-phosphine complex (Scheme 43.).
100
 It is proposed that the active nucleophile 
in this reaction is a copper(I) enolate formed by transmetalation of the silyl ketene acetal.  
Scheme 43. 
 
6.2.2. Structural and synthetic aspects of silyl ketene imines. 
Silyl ketene imines are cumulenes and as such they can potentially exhibit a chiral axis 
when unsymmetrically substituted. Inversion of the nitrogen center may be sufficiently rapid to 
render them effectively achiral. This inversion is analogous to the E/Z isomerization of other 
imines.
101
 Although detailed studies of the stereochemical lability of the silyl ketene imine chiral 
axis are not available, the inversion process in N-aryl ketene imines has been the object of 
several studies. The barrier to inversion is typically ~7 to 15 kcal/mol, depending on substitution, 
and inversion at room temperature is accordingly rapid.
102
 Theoretical calculations support the 
hypothesis that this process proceeds through a transition state structure with a C=N-aryl angle of 
ca. 180
o
. The inversion barrier of aryl ketene imines is typically measured by observing the 
coalescence of diastereotopic signals by variable temperature NMR. This cannot be done with 
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silyl ketene imines because separate signals for diastereotopic nuclei are not observable even at 
low temperature.
90a
 Ketene imine 40a demonstrates the structural parameters typical of an aryl 
ketene imine, including an N-aryl group nearly perpendicular to the plane as drawn (dihedral 
84
o
) and a C=N-C angle of 124.6
o
, only slightly wider than the theoretical sp2 angle of 120
o
. The 
only silyl ketene imine for which crystallographic data is available is 40b, which exhibits a C=N-
Si angle of 158.8
o
. Steric interactions between the N-silyl and C-silyl groups are likely 
responsible for some enlargement of the C-N-Si angle in 40b. 
Chart 2. 
 
Silyl ketene imines are nitrile anion equivalents. They are easily prepared by treating a 
lithiated secondary nitrile
‡‡
 with a bulky chlorosilane (Scheme 44.).
104
  Silylation occurs at 
nitrogen due to steric interactions between the substituents of the nitrile and those of the 
chlorosilane. Reducing the size of the silane and / or nitrile substituents can lead to partial or 
exclusive silylation at the α carbon of the nitrile. Choosing an appropriately sized chlorosilane 
typically allows either product to be produced exclusively. In some cases, isomerization of silyl 
ketene imines to the C-silylated product can occur on heating strongly suggesting that C-
silylation is thermodynamically favored. 
Silyl ketene imines possess several potential advantages over silyl ketene acetals. First, 
silyl ketene imines do not exist as E/Z isomers and therefore do not need to be produced in 
geometrically pure form. Second, sterically bulky silyl group of silyl ketene imines is located 
                                                 
‡‡
 Secondary nitriles are accessible by monoalkylation of lithiated primary nitriles.
103
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further from the site of reaction than that of silyl ketene acetals. This reduction in steric 
hindrance should lead to increased reactivity. Third, reactions of silyl ketene imines may benefit 
from the same low intrinsic barriers to reactions with electrophiles that are characteristic of 
nitrile anions,
105
 a factor which would further increase their reactivity. 
Scheme 44. 
 
Early work on the use of silyl ketene imines as nitrile anion equivalents includes that of 
Frainnet, who reported that 41 reacts with benzaldehyde when mixed neat, and with 
acetophenone in the presence of trace amounts of mercuric iodide (Scheme 45.).
106
 
 
Scheme 45. 
 
Watt
104
 has demonstrated an oxidative process for converting secondary nitriles into 
ketones, enabling their use as acyl anion equivalents (Scheme 46.). This process involves 
formation of the silyl ketene imine, iodination with I2 in THF to form an α-iodonitrile which is 
then decyanated with Ag2O to yield the ketone 38a.  
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Scheme 46. 
 
Matsuda
107
 has demonstrated the addition of a tris(trimethylsilyl) ketene imine to 
aldehydes in the presence of BF3·OEt2, TiCl4 or MgBr2. (Scheme 47.) The initial aldol product 
undergoes in-situ Peterson elimination to give a trisubstituted vinyl silane which can be 
desilylated with KF in MeOH/H2O to provide a Z alkene nitrile. 
Scheme 47. 
 
The first, catalytic, enantioselective transformation of silyl ketene imines was reported by 
Fu and co-workers, whose planar chiral DMAP analog 42 catalyzes the acylation of a variety of 
silyl ketene imines with propionic anhydride (Scheme 37.).
108
 This reaction is proposed to occur 
(by analogy to previous studies with this catalyst)
109
 by acylation of 42 to form a strongly 
electrophilic acylpyridinium ion 43.  The resulting propionate anion then is proposed to 
nucleophilically desilylate the ketene imine to generate a free nitrile anion (44) as the active 
nucleophile. This work culminated in the catalytic asymmetric synthesis of the anti-hypertensive 
drug Verapamil (45). 
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Scheme 48. 
 
Chart 3. 
 
 
Leighton and co-workers have demonstrated enantioselective Mannich-type addition of 
silyl ketene imines and α-monosubstituted silyl ketene acetals to acyl hydrazones promoted by a 
chiral silicon Lewis acid (Scheme 49.).
110
 It is significant that they were unable to obtain 
addition of α-disubstituted ketene acetals, requiring them to use the more reactive silyl ketene 
imines. When an allyl substituted silyl ketene imine is used, the products can undergo a thermal 
Beuchamin hydroamination to produce highly substituted pyrrolidines.
110
 
Scheme 49. 
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6.3. Results 
6.3.1. Addition of silyl ketene imines to aromatic aldehydes. 
Preliminary investigations by co-authors J. R. Heemstra and T. W. Wilson
111
 
demonstrated that silyl ketene imine 46a reacts rapidly with benzaldehyde at low temperature in 
the presence of silicon tetrachloride and chiral Lewis base catalyst (R,R)-34 to provide adduct 
47aa in high yield and enantioselectivity (Scheme 50.).   
Scheme 50. 
 
In order to expand on the results of the initial study and to further examine the scope of 
addition of silyl ketene imines to aldehydes, a series of aromatic aldehydes were subjected to the 
previously determined reaction conditions (Table 18). For entries 1 through 6, the products 
47ba-47ga were obtained in 76 to 92% yields. In these cases, no differences in rate and only 
small differences in selectivity were observed even with hindered (entries 4 and 5), electron rich 
(entry 2) and electron poor (entry 1 and 3) aldehydes. A heteroaromatic aldehyde (entry 6) 
reacted at an indistinguishable rate with only a small decrease in enantioselectivity. The furan 
moiety (entry 6) is a synthetic equivalent to unsaturated dicarbonyl compounds. This furan, as 
well as the methyl ester (entry 3), provide valuable handles for further synthetic manipulation. 
Unsurprisingly, isonicotinaldehyde (entry 7) reacted slowly (~20 % conversion in 4 h) in 
low yield and selectivity. This low reactivity may be attributed to competitive binding of the 
strongly Lewis basic pyridyl nitrogen to silicon tetrachloride.  
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Table 18. Scope in Aromatic Aldehyde. 
 
entry product aryl yield (%)
a
 dr
b
 er
b
 
1 47ba 4-CF3C6H4 88 99.4:0.6
d
 99.3:0.7 
2 47ca 4-CH3OC6H4 78 96.4:3.6 96.6:3.4 
3 47da 4-CH3O2C6H4 93 99.2:0.8 98.6:1.4 
4 47ea 2-CH3C6H4 84 99.1:0.9 99.2:0.8 
5 47fa 1-naphthyl 76 99.4:0.6 98.4:1.6 
6 47ga 2-furanyl 92 99.0:1.0 94.9:5.1 
7 47ha 4-pyridyl 10
d
 2:1 N/D 
a Yield of analytically pure material b Determined by CSP-SFC  c Determined by 1H NMR analysis   d Yield of 
chromatographically homogenous material.  
 
A further study was carried out to determine the influence of differently substituted silyl 
ketene imine aryl groups on the course of the reaction. A series of analogs were prepared, 
containing electron rich, electron poor, and sterically encumbered aryl groups. These were then 
combined with benzaldehyde under the same conditions as the previous series (Table 19).  
Table 19. Scope in Silyl Ketene Imine 
 
entry aryl R SKI product yield (%)
a
 dr
b
 er
b
 
1 4-CF3C6H4 Et 46b 47ab 73 97:3
c
 99.5:0.5 
2 4-CH3OC6H4 Me 46c 47ac 90 98.7:1.3 99.1:0.9 
3 2-CH3C6H4 Me 46d 47ad 74 87:13
c
 94.2:5.8
d
 
a Yield of analytically pure material  b Determined by CSP-SFC c Determined by 1H NMR analysis d Determined by 
CSP-HPLC after derivatization with 3,5-dinitrobenzoyl chloride 
 
All members of this series reacted at indistinguishably rapid rates, and provided the 
products in good yields. Electron withdrawing (entry 1) and electron donating (entry 2) 
substituents in the para position had no significant effects on the stereoselectivity of the 
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reactions, while adding steric encumbrance at the ortho position (entry 3) resulted in a small 
reduction in enantioselectivity and a moderate reduction in diastereoselectivity. 
6.3.2. Addition of silyl ketene imines to ketones. 
As mentioned previously, Frainnet and co-workers reported that silyl ketene imine 41 
reacts with acetophenone when mixed neat in the presence of HgI2 (Scheme 45.).
106
 No further 
examples were reported, however this result raised the possibility that previous work on addition 
of silyl ketene imines to aromatic aldehydes could be extended to include addition to ketones. 
This process would create a quaternary stereocenter adjacent to a tertiary alcohol, bringing 
together a bulky electrophile with a bulky nucleophile. It was felt that this would be an excellent 
demonstration of the power of silyl ketene imines compared to other aldol-type processes. 
Although the reductions in steric bulk and intrinsic barriers facilitated by the use of silyl 
ketene imines was sufficient to allow very rapid reaction with aldehydes, it was not surprising 
that no reaction was observed for ketones under the standard reaction conditions. In the additions 
to acetophenone, silyl ketene imine 46a was unreactive in the desired pathway, leading instead to 
self-condensation of the ketone, presumably via trichlorosilyl enol ether 48 (Scheme 51.). This 
outcome was not altered by changes in Lewis base, or the use of added tetrabutylammonium 
salts, previously shown to increase the yield of related reactions.
90b,112
 
Scheme 51. 
 
 Because the lower acidity of an aliphatic ketone might reduce enolization and self-
condensation, 2-heptanone was selected for further study. Combining 2-heptanone 38b with 46a 
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at room temperature in the presence of n-Bu4NI and trioctylphosphine oxide as a Lewis base 
catalyst produced 49ba in a low but promising 28% isolated yield.  
A survey of achiral Lewis bases was undertaken in an attempt to improve the yield of this 
reaction, using No-D NMR monitoring (Table 20).
113
 Phosphoramide 50 was markedly superior 
to all others tested, providing a good yield of 49ba in 18h, albeit at relatively high catalyst 
loading (0.5 equiv., entry 6). Other oxygen and sulfur Lewis bases, including Me2SO (entry 1), 
(Me2N)2C=O (entry 2), (Me2N)2C=S (entry 3), n-Bu3P=S (entry 4), n-Oct3P=O (entry 5) and 
(EtO)3P=O (entry 8) showed lower activity. Pyridine N-oxide (entry 7) and Ph3P=Se (entry 9) 
were completely inactive as catalysts.  
Encouraged by the initial results, a series of experiments were carred out with the aim of 
optimizing the reaction conditions using readily available phosphoramide 50 before committing 
more valuable chiral catalysts (Table 21). Reducing the amount of n-Bu4NI used to 0.5 equiv 
increased the yield of 49ba slightly (entry 1), however the use of less than 0.5 equiv of n-Bu4NI 
was detrimental (entries 2-3) Further optimization was carried out with 0.2 equiv of 50 in hope 
of reducing the amount of chiral catalyst that would be required in later work (entries 4-6). 
Interestingly, the activity of n-Bu4NOTf (entry 5) was similar to or slightly lower than that of n-
Bu4NI. This observation is in contrast to related chemistry
14
 where n-Bu4NOTf was superior, and 
was used at much lower loading. Increasing the loading of ketene imine 46a to 2.0 equiv (entry 
6) resulted in increased yield consistent with the observation that 46a was being consumed at a 
rate greater than ketone 38b. This non-productive consumption of reagent continued throughout 
later developments of this process.  
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Table 20. Survey of Lewis Bases for Silyl Ketene Imine Addition to 2-Heptanone. 
 
entry Lewis base yield
a
 (%) time (h) 
1 Me2SO 23 25 
2 (Me2N)2C=O 54 25 
3 (Me2N)2C=S 52 25 
4 n-Bu3P=S 40 25 
5 n-Oct3P=O 20 2 
6 50 55 
70 
2 
18 
7 Pyridine N-oxide 0% 2 
8 (EtO)3P=O 8% 2 
9 Ph3P=Se 0% 2 
a Yields by NMR integration relative to PhMe6 internal standard 
   
Under the reaction conditions optimized for catalyst 50 (Table 4, entry 6), a series of 
chiral phosphoramides were surveyed (Table 22). Catalyst (R,R)-34 (5 mol%) provided 49ba in a 
promising 87:13 er (entry 1), however the rate and isolated yield was low. Increasing the catalyst 
loading to 15 mol% gave no improvement in yield or selectivity (entry 2). Reducing the tether 
length to 3 or 4 methylene units (entries 4 and 5) resulted in increased yield, at the cost of 
reduced selectivity. This is consistent with previous research in these laboratories that showed 
increased rates with shorter tether lengths.
91
 The survey was continued with ketone 38c, as the 
unusually weak chromophore of 49ba exacerbated difficulties that were encountered obtaining 
baseline resolution of stereoisomers by chiral stationary phase SFC, and hence accurate 
determination of enantio- and diastereoselectivity. However, it should be noted that under 
identical conditions 49ca (entry 3) was produced in lower enantio- and diastereoselectivity than 
49ba (entry 1). 
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Table 21. Optimization of Conditions for Silyl Ketene Imine Addition to 2-Heptanone. 
 
entry 50 (equiv) 46a (equiv) X n-Bu4NX, equiv yield (%)
a
 time (h) 
1 0.5 1.2 I 0.5 80 8 
2 0.5 1.2 I 0.2 40 8 
3 0.5 1.2 -- 0.0 23 8 
4 0.2 1.2 I 0.5 27 
57 
70 
1 
6 
29 
5 0.2 1.2 OTf 0.5 21 
53 
1 
18 
6 0.2 2.0 I 0.5 47 
81 
1 
18 
aYield by NMR integration relative to PhMe6 internal standard 
 
Curiously, isolated yields of 49ca were typically lower, sometimes much lower (entries 3, 
9) than NMR yields, whereas with product 49ba isolated and NMR yields tracked closely. The 
cause of this was not conclusively determined prior to termination of the project, however it was 
hypothesized that 49ca has a lower barrier to reversion to ketone and nitrile, a process that  is 
expected to be thermodynamically favored in all cases and might in this case be occurring during 
the quench or subsequent workup. The only catalyst that offered higher enantioselectivity than 
(R,R)-34 was the bispyrrolidine catalyst 51h (entry 12 vs. entry 3). However, this came at the 
price of very poor diastereoselectivity, clearly an unacceptable tradeoff. Uniquely among the 
catalysts tested, the major diastereomer formed was not the same as was observed with catalyst 
(R,R)-34. 
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Table 22. Survey of Chiral Phosphoramide Catalysts for the Addition of Silyl Ketene Imines to 
Ketones. 
 
entry catalyst cat (mol %) ketone yield (%) 
a
 dr
d 
er of major diast.
c 
er of minor diast.
c 
1 34 5 38b 45 72:28 87:13 67:33 
2 34 15 38b 47 71:29 86:14 67:33 
3 34 5 38c 14
a
, (65
b
) 66:33 80:20 64:36 
4 51a 5 38b 58 66:34 74:26 68:32 
5 51b 5 38b 73 66:34 70:30 64:36 
6 51c 5 38b 46 52:48 68:32 64:36 
7 51d 5 38b 68 53:47 80:20 78:28 
8 51e 5 38b 63 51:49 40:60 61:39 
9 51f 5 38c 22
a
, (69
b
) 52:48 56:44 53:47 
10 51f 10 38c 51
a
, (68
b
) 53:47 70:30 63:37 
11 51g 5 38c 17
a
, (42
b
) 57:43 66:34 61:39 
12 51h 5 38c 30
a
, (41
b
) 45:55 74:26 83:17 
13 51i 10 38c 37 51:49 39:61 39:61 
a Combined yield of both isomers after chromatography b Combined yield of both isomers measured by NMR integration against 
PhMe6 internal std. 
c Determined by CSP-SFC d Determined by 1H NMR analysis  
 
Chart 4. 
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Investigation of the role of the tetrabutylammonium salt revealed several noteworthy 
effects (Table 23). Whereas ketone 38b reacted slowly in the presence of n-Bu4NOTf and 
phosphoramide 50 (Table 21, entry 5), no reaction of 38c was observed in the presence of (R,R)-
34 and n-Bu4NOTf (Table 23, entry 1). Instead, a portion of ketene imine 46a was degraded with 
concomitant formation of TBSCl, and what was tentatively assigned as α-trichlorosilyl nitrile 52 
(Scheme 52.). This process was far slower in the absence of any additive. 
Scheme 52. 
 
Although a small increase in rate was observed using n-Bu4NBr rather than n-Bu4NI the 
yield did not increase accordingly (entry 3). When run in the presence of n-Bu4NCl the reaction 
reached completion in 1 h, however yield still did not increase, and the remainder of the ketone 
was converted into numerous side products (entry 4). Reducing the reaction temperature to 0 - 10 
°C led to no product formation. Reaction in the presence of n-Bu4NOAc produced a 43% yield of 
49ca in 1 h, with no further reaction after this time (entry 5). The remainder of the ketone was 
unreacted, and a large amount of nitrile was observed. The use of 1 equiv of dry n-Bu4NOAc 
produced a rapid, exothermic desilylation and no product formation (entry 6). The use of external 
cooling allowed some product formation, however never more than 25%. The observation of a 
signal for the α proton of the nitrile following desilylation unambiguously demonstrates that this 
process involves abstraction of a proton by the ketene imine. The ketone is one potential proton 
donor, however partial desilylation is observed even in its absence (Scheme 53.). Other 
unassigned signals account for the remainder of the material. 
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Scheme 53. 
 
Table 23. Investigation of the Effects of Tetraalkylammonium Salts on the Addition of Silyl 
Ketene Imines to Ketones. 
 
entry X (equiv) yield (%)
a
 time (h) 
1 OTf, 0.5 0 3-72 
2 I, 0.5 6 
65 
2 
30 
3 Br, 0.5 7 
48 
1 
39 
4 Cl, 0.5 46 1
c
 
5 OAc, 0.5 43 1 
6 OAc, 1.0 0 1
d
 
a Yield by NMR integration relative to PhMe6 internal standard 
c All reagents consumed at 1 h  d Rapid,  exothermic desilylation observed. 
 
 By this point, it was becoming clear that the challenges posed by enantioselective 
addition of silyl ketene imines to ketones were simply too numerous. Yields were too low; 
enantioselectivity was too low; diastereoselectivity was too low. The products easily 
decomposed during isolation. The reagents were consumed unproductively by a variety of 
pathways. Any single one of these problems should have been solvable in isolation, but solving 
all of them simultaneously appeared increasingly unlikely. 
6.3.3. Addition of silyl ketene imines to aliphatic aldehydes. 
The reactions of aliphatic aldehydes with enoxysilane nucleophiles under Lewis 
base/silicon tetrachloride activation poses a challenge due to the formation of a parasitic 
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trichlorosilyl chlorohydrin species II (Scheme 40.). This difficulty can be overcome with a 
sufficiently reactive nucleophile as discussed in Section 6.2.1. The high reactivity of silyl ketene 
imines and the knowledge obtained from the previous study of silyl ketene imine addition to 
ketones, in particular the knowledge of halide activation, could be applied to address the problem 
of addition to aliphatic aldehydes. In terms of substrate choice, aliphatic aldehydes appeared to 
have several advantages over ketones. First, differentiating the prochiral faces of ketones is 
frequently difficult due to similar bulk of the substituents. The efficient and selective binding of 
ketones places substantially different demands on ligand design, and can require major redesign 
efforts.
 94a,114
 Furthermore, a great deal of effort had already been put in to the optimization of 
the steric environment of catalysts to differentiate the prochiral faces of aldehydes.
115
 Choosing 
aldehydes as substrates allowed this project to stand on the tallest, steadiest shoulders available. 
Furthermore, the products are less sterically crowded, which greatly reduced problems of 
retroaddition during isolation that were sometimes observed in ketone-derived adducts. 
The reaction conditions previously optimized for the addition of silyl ketene imines to 
ketones were used as a starting point for optimizing the addition to aliphatic aldehydes (Table 
24). The course of the reaction was conveniently accomplished by in-situ FT-IR monitoring, 
observing the very strong silyl ketene imine stretch (2030 cm
-1
). Cooling to 0 °C or below was 
required to control side reactions (entries 1-3), and -20 
°
C provided optimal selectivity (entry 5). 
Once again, n-Bu4NI proved superior to other halides, whereas n-Bu4NOTf was unreactive (entry 
8) and n-Bu4NCl (entry 6) induced rapid desilylation of the ketene imine. Use of TIPS-protected 
ketene imine 54a at 0 °C in place of 46a (entry 9) improved selectivity to a level comparable to 
that obtained with 46a at -20 °C (entry 5), with a rate similar to that observed at -10 °C (entry 4). 
Further increases in the size of the silyl group reduced enantioselectivity and yield (entry 10). 
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The omission of n-Bu4NI led to lower enantio- and diastereoselectivity as well as decreased rate, 
which suggested that an increased loading of this reagent might be beneficial (entry 11). 
Gratifyingly, a small increase in enantioselectivity was observed when a full equivalent of n-Bu4-
NI was used (entry 12). Interestingly, there was no corresponding increase in rate or yield. 
Finally, by combining previous positive results, a set of optimal conditions was estimated (entry 
13). Under these conditions, high yield as well as enantio- and diastereoselectivities were 
achieved.  
Several additional phosphoramide catalysts (55a-c) were prepared to explore the 
suitability of dimethylbiphenyldiamine as an alternative to 1,1’-binapthyl-2,2’-diamine, as well 
as the effects of substitution at the 3,3’ and 4,4’ positions. Substantially lower enantioselectivity 
was observed with biphenyl catalyst (S,S)-55a compared to (R,R)-34 (entry 14) however the 
diastereoselectivity was unchanged. The 5,5’ substituted catalyst (R,R)-55b provided the same 
selectivity as (S,S)-55a, albeit in opposite absolute configuration (entry 15). Disappointingly, 
catalyst (S,S)-55c, which is substituted at the 3,3’ position, (entry 16) produced only racemic 
product with low diastereoselectivity.  
Chart 5. 
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Table 24.  Optimization of Silyl Ketene Imine Addition to Aliphatic Aldehydes. 
 
entry catalyst (equiv) SiR3 additive (equiv) temp (°C) time (h) yield
a
 (%) er
b 
dr
c 
1 50 (0.2) TBS n-Bu4NI (0.5) 23 17 0 -- -- 
2 50 (0.2 ) TBS n-Bu4NI (0.5) 0 – 14 17 33 -- -- 
3 34 (0.05) TBS n-Bu4NI (0.5) 0 24 66 88:12 90:10 
4 34 (0.05) TBS n-Bu4NI (0.5) -10 18 74 90:10 90:10 
5 34 (0.05) TBS n-Bu4NI (0.5) -20 17 66 93:7 91:9 
6 34 (0.05) TBS n-Bu4NCl (0.5) 0 1 Trace --- -- 
7 34 (0.05) TBS n-Bu4NBr (0.5) 0 17 56 87:13 82:18 
8 34 (0.05) TBS n-Bu4NOTf (0.5) 0 17 Trace -- -- 
9 34 (0.05) TIPS (54a) n-Bu4NI (0.5) 0 17 63 92:8 93:7 
10 34 (0.05) TBDPS (54b) n-Bu4NI (0.5) 0 17 20 78:22 93:7 
11 34 (0.05) TBS -- 0 17 34 71:29 80:20 
12 34 (0.05) TBS n-Bu4NI (1.0) 0 17 67 90:10 90:10 
13 34 (0.05) TIPS (54a) n-Bu4NI (1.0) -20 22 84 94.5:5.5 98.5:1.5 
14 55a (0.05) TIPS (54a) n-Bu4NI (1.0) -20 24 95 24:76 98.5:1.5 
15 55b (0.05) TIPS (54a) n-Bu4NI (1.0) -20 24 69 76:24 98.8:1.2 
16 55c (0.05) TIPS (54a) n-Bu4NI (1.0) -20 24 84 50:50 75:25 
aYield after chromatography b Determined by CSP-SFC c Determined by 1H NMR analysis 
 
Next, a survey of simple aliphatic aldehydes was undertaken to explore the scope of this 
reaction. Five aliphatic aldehydes were selected to explore the effects of substitution patterns on 
reactivity and selectivity (Table 25). The reactions of silyl ketene imine 54a with 30b, which 
bears an n-pentyl chain, (entry 1) and benzyloxy functionalized aldehyde 30c (entry 2) proceeded 
in good yields although the enantioselectivities were somewhat lower than was observed with 
30a. The reaction with β-branched aldehyde 30d also proceeded in good yield, however the 
enantioselectivity was still lower. The silyl ketene imine addition was found to be completely 
intolerant of α-branching at the aldehyde (entry 4), which lead to no reaction, as well as α-aryl 
substitution (entry 5), which lead to a complex mixture. The latter is likely due to the increased 
acidity of the aldehyde and consequent increased self-condensation.  
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Table 25. Substrate Scope in the Addition of a Silyl Ketene Imine to Aliphatic Aldehydes. 
 
entry product R yield
a
 (%) er
b 
dr
c 
1 53ba CH3(CH2)4 94 ~91:9
d
 n/d 
2 53ca BnO(CH2)5 83 90:10 98.5:1.5 
3 53da i-Bu 85 <85:15
d
 n/d 
4 53ea i-Pr 0 -- -- 
5 53fa PhCH2 0 -- -- 
a 
Yield after chromatography b Determined by CSP-SFC c Determined by 1H NMR analysis
 d
 Incomplete separation of 
stereoisomers 
 
6.4. Discussion 
6.4.1. Effects of the nucleophile. 
Disubstituted silyl ketene imines are more reactive than the corresponding disubstituted 
silyl ketene acetals, which only react slowly with aromatic aldehydes at -78 
o
C, although less 
reactive than unsubstituted and monosubstituted silyl ketene acetals which react with aliphatic 
aldehydes at -78 
o
C.
90b
 This behavior may be partially due to the location of the bulky silyl 
group, which is further from the site of reaction in silyl ketene imines than in silyl ketene acetals. 
Since silyl ketene imines are silylated equivalents of nitrile anions it is likely that some of their 
high reactivity arises from the same factors that cause the exceptionally high reactivity of nitrile 
anions. The anion of phenyl propionitrile has a Mayr nucleophilicity of 28.95, making it one of 
the most reactive nucleophiles incorporated into the Mayr scale.
105
 This number is 
disproportionately high for a carbon nucleophile with a pKa of 23.0 in DMSO, and indicates that 
the intrinsic barrier for nucleophilic reactivity is lower for nitrile anions than anions of other 
carbon acids.
105
 Similarly low intrinsic barriers have been observed for proton-transfer reactions 
of nitriles.
116
 Intrinsic barriers for proton transfer to and from carbon acids have been explained 
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by application of the Principle of Non-perfect Synchronization as arising from the loss of 
resonance stabilization early in the reaction coordinate, prior to the development of factors that 
stabilize the product.
116-117
 This effect is much less pronounced in the reactions of nitrile anions 
compared with those of enolates because their stability resides more in the electrostatic effect of 
the CN bond dipole than in the effects of resonance. 
6.4.2. Effects of the substrate. 
Excellent selectivities were observed in the additions of silyl ketene imines to aromatic 
aldehydes. This outcome can be attributed largely to the extensive catalyst optimization studies 
that had previously been performed on Lewis base catalyzed, SiCl4 promoted aldol and allylation 
reactions, culminating in the development of phosphoramide catalyst 34.
115b
  
Lower enantio- and diastereoselectivities were observed in additions to ketones. Much of 
this reduction in selectivity is likely due to the much higher reaction temperatures necessitated by 
the inherently lower reactivity of ketones. Additionally, the two carbon substituents of the ketone 
carbonyl are more sterically similar to one another than the corresponding carbon and hydrogen 
substituents of an aldehyde. This factor should make it inherently more difficult to differentiate 
the prochiral faces of ketones than those of aldehydes by reducing the energetic penalty for 
binding a Lewis acid syn to the larger substituent rather than anti.  
Silyl ketene imine additions to aliphatic aldehydes were achieved at temperatures 
intermediate between those of ketones and aromatic aldehydes. The levels of enantioselectivity 
observed in these reactions were more variable than those observed in additions to aromatic 
aldehydes, ranging from 94.5:5.5 to <85:15. Once again, some of this reduction in selectivity 
may be the result of the reaction temperature. Aliphatic aldehydes are more conformationally 
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flexible and structurally diverse than aromatic aldehydes, either of which may contribute to 
increased variability in substrate catalyst interactions.  
6.4.3. Rationalization of diastereoselectivity in silyl ketene imine additions. 
The diastereoselectivity of silyl ketene imine additions to aldehydes poses several 
interesting questions. The assumption of an open transition structure is justified by the difficulty 
of coordinating a nucleophile to an already hexacoordinate silicon complex. This assumption 
leads to two enantiomeric sets of six possible transition structures (56a-f), of which three (56a-c) 
are consistent with the observed diastereoselectivity (Figure 12). Which of these dominates 
depends on several issues that cannot be answered from a simple diagram. First, by analogy to 
the chemistry of silyl ketene acetals, an electronic preference may operate in the anti transition 
state structures. Second, the magnitude of steric interactions of the silyl group will depend on the 
degree of rehybridization occurring in the transition state. Although the silyl groups in Figure 12 
are drawn as pointing out of the page, away from major interactions with anything, this is merely 
one set of limiting, ground-state like structures. Later in the reaction coordinate, the Si-N-C 
angles should approach 180° as the nitrogen of ketene imine 46a becomes sp hybridized, 
potentially bringing the silyl group into close interaction with sections of the transition structure 
some distance away from the forming bond.  
In order to better understand the factors effecting diastereoselectivity in silyl ketene imine 
additions, semiempirical calculations (PM6, MOPAC2007 and MOPAC 2009)
84,118
 were 
performed to locate transition structures of the reaction of 46a, SiCl4, catalyst (R,R)-34, and 
benzaldehyde (Scheme 54., Figure 12, Figure 13). The lowest energy transition structure (56b,-
scanti) corresponds to the major diastereomer obtained experimentally.  
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Several aspects of these transition structures are of particular interest. Most notably, the 
two lowest energy transition structures are open synclinal (56b -scanti and 56f +scsyn
, 
Figure 13). 
The unfavorable dipole – dipole interactions which disfavor open synclinal transition states in 
aldol reactions of non chelating alkali metal enolates and naked enolates
119
 are only modestly 
strong in the more closely analogous Mukyama type aldol reactions
120
 and may be outweighed 
by steric factors in the case of silyl ketene imine additions. 
In the lowest energy structure, 56b -scanti, the ketene imine axis faces the bulky silicon 
Lewis acid; indicating that the ketene imine is effectively the smallest substituent, despite the 
possibility of steric interactions with the TBS group (Figure 13). The next smallest substituent, 
the methyl group, is positioned to the right as drawn, in a pocket formed by one of the naphthyl 
groups of the catalyst. This interaction may be how the catalyst reinforces the inherent 
diastereoselectivity of the reaction, as the far wall of the pocket is positioned to encounter the 
TBS group. This interaction may be seen in structure 56f +scsyn, where the O-C-C-C dihedral 
angle of the forming bond is distorted to 92°, compared to the ideal 60°, to avoid this interaction 
(Figure 13). The largest substituent, the phenyl group, points downward, a direction which 
appears essentially open. No attempt was made to locate the six additional transition structures 
which are epimeric at the ketene imine chiral axis, however the C=N-Si angles in the six 
evaluated transition structures are 172 - 174
o
 which suggests that this omission is of little or no 
consequence since the chiral axis has essentially been lost in the transition state. 
Scheme 54. 
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Figure 12. Calculated transition structure energies for addition of 46a to benzaldehyde. 
 
 
56b -scanti (0.0 kcal/mol)   56f +scsyn (+ 3.1 kcal/mol) 
Figure 13. Calculated transition structures for silyl ketene imine addition to benzaldehyde. 
 
6.4.4. Mechanism of the halide effect. 
The addition of silyl ketene imines to aliphatic aldehydes and ketones was made possible 
by a rate-accelerating effect observed in the presence of tetrabutylammonium salts. In particular, 
iodide was much more effective than triflate, and reactions run in the presence of acetate were 
fast, but low yielding and difficult to reproduce. The use of chloride led to rapid, low yielding 
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reactions and the formation of many side products. Previous investigations in to the effect of 
tetrabutylammonium salts on Lewis base catalyzed reactions of trichlorosilyl nucleophiles and 
SiCl4 have typically found that iodide and triflate increase reaction yield and that triflate is the 
more effective of the two.
112 
This effect has been attributed to the increased ionic strength of the 
medium favoring ionized intermediates and disfavoring the addition of chloride to the carbonyl 
group.  
The inefficacy of triflate in promoting the silyl ketene imine additions discussed here, 
together with the high, albeit partially unproductive, reactivity observed in the presence of more 
nucleophilic anions such as bromide and acetate, suggest that a different or additional 
mechanism is operative under such conditions. It is hypothesized that nucleophilic halides and 
carboxylates form an anionic pentacoordinate silicate intermediate IIa or a free nitrile anion IIb, 
either of which is a more reactive nucleophile than I (Figure 14). The formation of free anion IIb 
is more likely in the presence of more nucleophilic anions such as acetate. Such a free anion 
should react with carbonyls readily without Lewis acid activation. It is therefore unlikely that a 
free nitrile anion is generated in the presence of n-Bu4NI, since the intermediacy of such a 
reactive species should lead to greatly reduced enantioselectivity. This hypothesis explains the 
trend for higher reactivity of strongly coordinating anions (OAc > Cl > Br > I). Considering that 
IIa may be, and IIb undoubtedly will be, a more kinetically competent Brønsted base, this 
hypothesis can also explain the observation of complex mixtures of side products observed in the 
presence of n-Bu4NCl, as well as the strong tendency of the ketene imine to protonate in the 
presence of n-Bu4NOAc. Activation by chloride would occur in the presence of additional free 
chloride, which would suppress the formation of IV. This action will reduce the rate at which 
IIa/b can participate in the desired pathway, allowing side reactions to predominate.  
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Nucleophilic activation of trimethylsilyl ketene acetals by n-Bu4NOAc and other 
carboxylates and similar anions has been demonstrated extensively by Mukaiyama and co-
workers.
121
 Fluoride activation of silicon enolate equivalents has also been explored in multiple 
contexts, including aldol additions to aldehydes
12
 (Scheme 3., eq 1) and ketones
100
 (Scheme 43.). 
The proposed mechanism of activation by acetate is similar to that proposed by Fu for activation 
by propionate in the acylation of  silyl ketene imines (Scheme 48.).
108
  
 
Figure 14. Proposed mechanism of the effect of tetraalkylammonium salts on the addition of 
silyl ketene imines to carbonyls. 
 
6.5. Conclusions 
The addition of silyl ketene imines to aromatic aldehydes is an efficient process for the 
enantioselective construction of quaternary stereocenters. The addition is tolerant of a variety of 
substituents on both the aldehyde and the ketene imine, and products are generally isolated in 
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high yields, as well as excellent enantiomeric and diastereomeric ratios. The major stereoisomer 
is proposed to arise from a synclinal transition structure, and is reinforced by the catalyst 
structure. 
The addition of silyl ketene imines to ketones occurs at room temperature. High yields 
can be achieved in the presence of high loadings of achiral catalyst 50 and n-Bu4NI, however 
only moderate enantioselectivity and moderate to low yield could be achieved with chiral 
catalysts. Efforts to find a catalyst more selective than (R,R)-34 were unsuccessful. After 
providing promising initial results, this system was unresponsive to further optimization efforts. 
The addition of silyl ketene imines to aliphatic aldehydes was achieved in high yield in 
favorable cases, also aided by the presence of n-Bu4NI. The enantioselectivity of this process 
was strongly dependant on aldehyde structure, varying from moderate to excellent. Efforts to 
find a catalyst more selective than (R,R)-34 were again unsuccessful. This catalyst structure 
appears to represent at least a local optimum as all accessible modifications produced less 
selective catalysts. Therefore, while a more general or more selective catalyst may be possible, 
the chances of locating it in a reasonable amount of time are low. 
The primary effect of n-Bu4NI on the addition reactions of silyl ketene imines is 
hypothesized to be the generation of a small equilibrium amount of a strongly nucleophilic 
anionic pentavalent silicate by nucleophilic addition to the silyl group of the silyl ketene imine. 
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Appendix A:  Reductive Crossed Aldol via Germanium 
Enolates 
A.1.  Introduction 
Extended polypropionate and polyacetate chains are frequently occurring motifs in 
biologically relevant natural products, and common synthetic targets.
122
 A variety of synthetic 
methods are available, frequently based on sequential aldol and allylation reactions.
122-123
 
Typically, these require an oxidation state change in addition to installation of a protecting group 
at each iteration. An aldol reaction between two aldehydes generates the desired oxidation state 
directly, saving synthetic steps and improving the redox economy
124
 of the process. Aldehyde – 
aldehyde crossed aldol reaction pose significant challenges. The root of these is that both starting 
materials as well as the product are aldehydes. The use of preformed enolates allows the 
nucleophile to be differentiated from the electrophile, however some means of preventing the 
nucleophile from reacting with the product to form uncontrolled oligomers is still required. As a 
result, methods for crossed aldehyde-aldehyde aldols, especially enantioselective ones, are far 
fewer in number than other types of aldol reactions. 
A.2. Background 
A.2.1. Existing methods for crossed aldehyde-aldehyde aldols. 
Several methods have been developed for enantioselective crossed aldehyde/aldehyde 
aldol reactions using chiral amine catalysts. The first of these was introduced by MacMillan 
using proline (Scheme 55.).
125
 This method takes advantage of the lower stability and reactivity 
of enamines derived from α- and β- branched aldehydes to differentiate the nucleophilic partner 
from the electrophilic partner and carefully tuned syringe pump addition of an excess of the 
nucleophilic partner to prevent oligomerization. 
106 
 
Scheme 55. 
 
Maruoka has demonstrated proline will catalyze crossed aldol reactions using α-chloro 
aldehydes as electrophiles (Scheme 56.).
126
 The halogen substituent disfavors enamine formation 
and increases the electrophilicity of the acceptor aldehyde. The alkyl chloride can be used in 
further synthetic manipulations, or removed by reduction with LiAlH4. Reduction also negates 
the redox economy
124
 associated with aldehyde-aldehyde crossed aldol reactions. 
Scheme 56. 
 
Primary amines, unlike secondary amines such as proline, form enamines with α-
branched aldehydes. Mahrwaldhas demonstrated that histidine is an effective catalyst for the 
enantioselective addition of electron rich α-branched aldehydes to electron poor aldehydes 
(Scheme 57.).
127
 This method also allows access to quaternary stereocenters, although 
diastereoselectivity is typically modest in such cases. 
Scheme 57. 
 
The Denmark group has demonstrated the enantioselective addition of aldehyde-derived 
trichlorosilyl enol ethers to aldehydes (Scheme 58.).
128
 This method takes advantage of the 
formation of a cyclic dichlorosilyl chlorohydrin 57 to reduce the reactivity of the product and 
prevent oligomerization. This clever application of Lewis base catalysis turns silyl chlorohydrin 
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formation from an undesirable scope-limiting process (see Section 6.2.1. ) into a key scope-
expanding process. 
Scheme 58. 
 
An intriguing non-enantioselective Lewis base catalyzed method reported by Baba
129
 
operates by reductive formation of a trihalogermanium (IV) enolate (58a) from an α-
bromoaldehyde (59a) and the stable, commercially available germanium (II) chloride dioxane 
complex in the presence of PPh3 or n-Bu4NBr. (Scheme 59.) The formation of oligomers 
reported to be minor or non-existent; likely because of the low Lewis acidity of germanium(IV), 
which prevents internal coordination and activation of the product (60ia), as well as the 
increased steric hindrance produced by the presence of the bulky trihalogermyl group. No cyclic 
halohydrin intermediate analogous to 57 is observed.The addition is syn selective and the scope 
includes branched and unbranched aliphatic aldehydes as well as diastereoselective formation of 
all carbon quaternary stereogenic centers.  
Scheme 59. 
 
 In most cases the trihalogermyl enolates are too reactive to observe, but α-disubstuted 
enolates such as 58b are an exception. 58b undergoes facile ligand exchange at germanium and 
therefore exists as a mixture of at least seven compounds by 
1
H and 
13
C NMR analysis. An X-ray 
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crystal structure has been obtained of 58b coordinated to 4-tert-butylpyridine (Scheme 60.). 
Regrettably, the refinement was too poor to discuss the structural parameters beyond noting that 
the complex is hexacoordinate and has two enolates per germanium. 
Scheme 60. 
 
A.2.2. Known Lewis base chemistry of germanium. 
Germanium lies between silicon and tin on the periodic table. Accordingly, some of its 
properties are similar to or intermediate between those of silicon and tin. Although the chemistry 
of germanium has been less thoroughly explored than that of silicon or tin, some important 
results have been disclosed that are directly relevant to the Lewis base activation of germanium 
enolates. The most encouraging of these observations is the isolation and crystallization of a 
series of ionized Ge(IV) phosphine oxide complexes (Chart 6.).
130
 Cationic complex 62 is 
analogous to the silyl cations that are central to Lewis base activation chemistry of silicon 
tetrachloride and trichlorosilyl enolates, strongly suggesting that Lewis base activation of 
germanium reagents should be possible. Dicationic complex 63 has no known parallel in the 
Lewis base activation of SiCl4 with phosphoramides, although a few analogous examples are 
known with nitrogen ligands.
131
 Simple consideration of charge density suggests that such 
dicationic complexes should be very strong Lewis acids, assuming that dissociation of one of the 
phosphine oxide ligands is still facile.  
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Chart 6. 
 
Trialkylphosphines react with GeCl4 to produce chlorophosphonium salts ([R3PCl]
+
 
[GeCl3]
-
) analogous to the formation of halophosphonium ions in the Appel reaction.
132
 
Triphenylphosphine is inert under these conditions and does not form an observable complex.
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Germanium dichloride has an empty p orbital to which Lewis bases can donate electrons. 
The effect of Lewis base coordination on the reduction potentials of GeCl2 has been studied by 
cyclic voltammetry. The coordination of PPh3, AsPh3 or pyridine to GeCl2 results in a stronger 
reducing agent than the dioxane complex.
134
  
Given the analogies between silicon and germanium, the Lewis base catalyzed reductive 
crossed aldehyde aldehyde aldol appeared to be an attractive target for catalysis by chiral Lewis 
bases.   
 
A.3. Results 
The first question that had to be answered upon beginning the project was whether the 
catalysts reported for this reaction did in fact increase the rate of aldolization, particularly in light 
of the studies discussed above. In situ 
1
H NMR monitoring of the PPh3 catalyzed and 
uncatalyzed background reactions raised serious doubts. (Figure 15)  
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Figure 15. Observation of phosphine catalysis in the generation of a Ge (IV) enolate. 
This experiment demonstrated that although no product was produced in the absence of 
triphenylphosphine, this was clearly due to a lack of enolate formation. In the presence of 
triphenylphosphine, no buildup of an enolate was observed. This experiment suggests that the 
rate of aldolization is comparable to or faster than the formation of the enolate, and therefore no 
conclusion regarding catalysis of the stereochemically determining step can be drawn from the 
presence or absence of product or the rate of its formation. Clearly further investigation was 
required before firm conclusions could be drawn.  
A.3.1. Studies on preformed Ge(IV) enolates. 
Two approaches were considered, the first and simplest was to add enantiopure chiral 
catalysts to the reaction and try to detect asymmetric induction. The second was to prepare a 
sample of trihalogermyl enolate free of any contaminating Lewis bases, and monitor its reaction 
with an aldehyde. The first possibility could be run immediately and produce conclusive positive 
results, however it could never produce conclusive negative results. The second would require 
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developing a preparation of trihalogermyl enolates, something which was not known, with the 
exception of Baba’s mechanistic studies which resulted in a highly stabilized enolate reported to 
be unreactive with aldehydes regardless of added catalyst.
31c
 Therefore, several readily available 
enantiopure chiral Lewis bases were tested. DuPhos, BINAP, and bis-phosphoramide 34 were 
screened and the products were found to be racemic.  
Thus, a study was initiated into the generation and possible isolation of trihalogermyl 
enolates. By analogy, trichlorosilyl enolates of aldehydes can be prepared by several methods 
including direct enolization with an amine base in the presence of SiCl4 and catalytic Lewis base, 
and metathesis from trimethylsilyl enol ethers or enol stannanes catalyzed by Pd(OAc)2 or 
Hg(OAc)2.
135
 (Scheme 61.) Both deprotonation and metathesis from trimethylsilyl enol ethers 
were explored, however only deprotonation is preparatively useful in the case of germanium, 
apparently due to an unfavorable equilibrium position for metathesis from silicon. 
Scheme 61. 
 
Attempts to prepare enolate 58a from hydrocinnamaldehyde (30a) were unsuccessful due 
to rapid addition of the enolate to unreacted 30a. Gratifyingly, the replacement of 
hydrocinnamaldehyde with isobutyraldehyde 30e added sufficient steric hindrance to eliminate 
self-addition almost entirely, allowing the preparation of 58e (Scheme 62.). Attempts to purify 
the enolate 58e beyond simple cannula filtration to remove Et3NHCl were unsuccessful, 
therefore subsequent experiments were run with NMR titrated solutions diluted to a standard 
concentration. Simply concentrating these solutions in vacuo resulted in an irreversible 
transformation into a new unidentified species. Attempts to store 58e solutions overnight were 
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unsuccessful, requiring daily preparation of fresh solutions. Solution of 58e had to be kept at or 
below 0 
o
C to prevent them from decomposing before they could be used. Clearly, preformed 
58e is not and will never be a practical synthetic reagent. As a mechanistic tool however, 
preformed 58e enabled the effects of Lewis bases on the stereodetermining aldolization to be 
explored without the complications of reductive enolate formation. 
Scheme 62. 
 
1
H NMR spectra of the 58e solutions exhibit two sets of signals for each proton and 
carbon. Both appeared to be active in the aldolization. It is hypothesized that this represents a 
mixture of compounds with one and two enolates per germanium center. Therefore, there must 
have been free GeCl4 in solution despite the strict 1:1 stoichiometry employed. Baba’s success in 
crystallizing the less reactive diphenyl analog 58b with two enolates per germanium center 
following reductive enolate formation indicates that both species are potentially relevant to the 
synthetic reaction conditions and are likely in equilibrium. 
The use of a 2% excess of Et3N in the enolate preparation is necessary to guard against 
the effects of HCl due to trace hydrolysis during handling. Trace HCl catalyzes the addition of 
58e to aldehydes, resulting in an inconsistent background rate. This was not initially appreciated, 
and as a result, an early, broad survey of achiral Lewis bases erroneously identified DMPU as the 
most competent catalyst. Later results showed DMPU to completely ineffective as a catalyst. The 
catalysts with the highest activity in the initial screen were rescreened in the presence of 2% 
excess of Et3N, and n-Bu3P=O was found to be the most active (Table 26, entry 3), followed by 
phosphoramide 50 (entry 4). The rate of aldolization in the presence of Ph3P was found to be at 
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most, slightly higher than background (entry 2). This result was judged to be within the error of 
the experiment, although some effect is possible. The deliberate addition of a small amount of 
H2O in a control experiment had a minimal effect on the reaction rate (entry 5). Further 
experiments were carried out with benzaldehyde 33a as the acceptor aldehyde because self-
condensation of the acceptor appeared to be contributing to reproducibility problems. This 
reduction in side reactions allowed the rates to be quantified more precisely by fitting to the 
second order rate law. The highest ratio of catalyzed reaction to background reaction was 
observed in CH2Cl2/PhMe (entries 6-7). Neat CH2Cl2 was not evaluated because the solubility of 
trialkylammonium salts in CH2Cl2 precluded filtration of the Et3NHCl produced in the enolate 
preparation. Coordinating ethereal solvents had a negative effect on the stability of the enolate, 
as judged by slow, steady formation of a white precipitate.  
Table 26. Catalyst Survey for Aldolization Step. 
 
entry LB solvent R yield (%)  
after 5 min
a 
kobs  
(L mol
-1
 s
-1
)
d 
1 none toluene C6H5(CH2)2 10-14 - 
2 Ph3P toluene C6H5(CH2)2 23 - 
3 n-Bu3P=O toluene C6H5(CH2)2 45-50 - 
4 50 toluene C6H5(CH2)2 44
c
 - 
5 none
b 
toluene C6H5(CH2)2 18 - 
6 none toluene /CH2Cl2 
28:72 
C6H5 21 0.0048 
7 n-Bu3P=O  
(10 mol%) 
toluene /CH2Cl2
 
28:72 
C6H5 71 0.23 
a Obtained by NMR integration of signals for 60 relative to anisole internal standard. All reactions run at 0.147 M b 0.05 equiv of 
H2O added 
c Reaction stalled at 44% cObtained by non-linear fitting to 2nd order rate law. 
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Several chiral phosphine oxides were surveyed with the intention of locating a catalyst 
with the potential to give significant enantioselectivity so that the feasibility of transferring the 
findings made with preformed 58e to the reductive aldol reaction could be evaluated. The highest 
enantioselectivity observed was 75:25 er in the presence of DUPHOS(O2) (64) (Scheme 63.). 
Lower levels of enantioselectivity were observed in replicate experiments, again highlighting the 
impracticality of isolated 58e as a synthetic reagent. 
Scheme 63. 
 
A series of experiments were carried out to determine the effects of phosphine oxides on 
the reductive aldol reaction (Table 27). Consistent with the observations made by Baba
129a
, 
unlike bromoaldehyde 59a, 59e is slowly and productively reduced by GeCl2·dioxane in ethereal 
solvents in the absence of a catalyst other than n-Bu3P=O. In CH2Cl2 (entry 1), 59e reacts 
quickly with GeCl2·dioxane to generate a new species 65e which does not react further. The 
1
H 
NMR spectrum of 65e is consistent with tentative assignment as a mixture of 
α-trihalogermylisobutyraldehydes, which could arise from a direct insertion into the C-Br bond 
of 59e. The addition of PPh3 as a co-catalyst restored some of the desired reactivity, although 
yields were poor (entries 2-3). Several other additives were examined however none led to any 
detectable product formation. The absence of observable product formation in the presence of n-
Bu4NBr and pyridine (entries 4 - 5) was particularly disheartening as the former had previously 
been shown by Baba et. al.
129
 to be of comparable efficacy to PPh3, while the latter has been 
shown to form a GeCl2 complex with an oxidation potential (E1/2 (ox) = +1.12 V vs. Ag/AgCl) 
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almost identical to GeCl2·PPh3 (E1/2 (ox) = +1.14 V vs. Ag/AgCl).
134
 Interestingly, both n-
Bu4NBr and pyridine appeared to inhibit the production of 65e. 
 
Table 27 Effect of Lewis Bases on Reductive Enolate Formation in CH2Cl2 
 
entry additive (equiv) result yield
a
 of 60ae (%) 
1 none 65e - 
2 Ph3P (0.1) 65e + 60ae 24 
3 Ph3P (1.0) 65e + 60ae 31 
4 n-Bu4NBr (1.0) N/R - 
5 pyridine (1.0) N/R - 
a Obtained by NMR integration of signals for 60ae relative to PhMe6 internal standard after quench and workup  
 
Next, it was it was necessary to determine whether 64 could be used to induce 
enantioselectivity under any reductive aldol conditions (Table 28). Reductive aldol reactions run 
in the presence of 64 in dioxane gave racemic product (entry 1) unless a stoichiometric amount 
of 64 was used (entry 2), as did reactions run in CH2Cl2 with a co-catalytic amount of PPh3 (entry 
3). The observation of some enantioselectivity when a stoichiometric amount of 64 was 
employed, suggested that the problem lay in the relative affinities of 64 for GeCl2 and the 
intermediate Ge(IV) enolate (entry 2). The combination of catalytic 64 and stoichiometric or 
superstoichiometric Ph3P (entries 4 – 5) also allowed some enantioselectivity to be observed, 
however it was substantially lower than was observed in the presence of a stoichiometric amount 
of 64. This suggested that the affinity of PPh3 for GeCl2 was inadequate to fully prevent 
sequestration of 64.  
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Table 28. Attempts to Develop an Enantioselective Aldol Reaction Under Reductive Conditions 
 
entry additive (equiv) 64 (mol %) solvent yield (%) er 
1 none 10 dioxane 54 51:49 
2 none 100 dioxane <25 65:35 
3 Ph3P (0.1) 10 CH2Cl2 42 50:50 
4 Ph3P (1.0) 10 CH2Cl2 57 54:46 
5 Ph3P (1.5) 10 CH2Cl2 60 56:44 
a Obtained by NMR integration of signals for 61ae relative to PhMe6 internal standard after quench and workup  
 
A.4. Discussion 
A.4.1. Effects of catalysts on the rate of aldolization. 
Of the catalysts surveyed under preformed enolate conditions, n-Bu3P=O provided the 
greatest rate acceleration. No rate acceleration was visible with PPh3. The highest catalyzed rates 
were observed in toluene/CH2Cl2.  
A.4.2. Relative ligand affinities of Ge(IV)  and Ge(II) : the chief obstacle to developing a 
practical enantioselective reductive aldol reaction. 
The reductive formation of Ge(IV) enolates from α-bromoaldehydes and GeCl2·dioxane 
is very sensitive to the nature of the ligands on GeCl2. A competing process is hypothesized to be 
a direct insertion of GeCl2 in to the C-Br bond of 59e to produce 65e. This process is inhibited by 
coordination to a variety of Lewis bases including dioxane, PPh3, and pyridine. It is hypothesized 
that this inhibition is simply the result of occupying the empty Lewis acidic site required for the 
insertion process to occur. Only a limited number of ligands are effective at promoting the 
formation of 58e. Triphenylphosphine is by far the most effective ligand, although it does not 
significantly promote the subsequent aldolization.  Unfortunately, the affinity of GeCl2 for 64 
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appears to be higher than the affinity of the germanium enolate for 64. Since GeCl2 is present in 
large excess under the catalytic conditions, it is able to sequester the chiral catalyst resulting in 
racemic product. Unfortunately, the affinity of GeCl2 for PPh3 is not high enough to fully 
outcompete the sequestration.  
 
A.5. Conclusions 
The affinity of GeCl2 for phosphine oxides is too high and results in sequestration of the 
chiral catalyst DUPHOS(O2) (64). The affinity of PPh3 for GeCl2 is not high enough to fully 
displace the phosphine oxide. The semi-isolated germanium enolates are too unstable to be 
practical reagents.  
  
118 
 
Appendix B:  Kinetic Studies on the Chiral Brønsted 
Acid/Achiral Lewis Base Cooperatively Catalyzed 
Enantioselective Bromocycloetherification 
 
B.1. Introduction 
The mechanism of the chiral Brønsted acid/achiral Lewis base cooperatively catalyzed 
enantioselective bromocycloetherification reaction developed in Chapter 5 is an interesting topic. 
The role of the Lewis base, Ph3P=S, is of particular interest given that Lewis base catalysis is the 
central theme of this thesis. The early results obtained in the absence of Ph3P=S (Section 5.3.2. ), 
the reactivity of unconjugated olefins in the absence of Ph3P=S and the independent results from 
the Shi laboratory
81
 raise questions about the true role of Ph3P=S in this system. Therefore, after 
having demonstrated the scope of the cooperatively catalyzed bromocycloetherification reaction 
it was deemed necessary to explore the mechanism of the reaction. The determination of the 
kinetic equation for the reaction was judged to be an appropriate means of doing so. 
B.2. Results 
B.2.1. Choice of method. 
The kinetics of the cooperatively catalyzed bromocycloetherification reaction were 
studied using the initial rate method. In situ monitoring of the bromocycloetherification of 21l 
using 
19
F NMR was chosen because this method provides good sensitivity, and a high sample 
rate. This method is also applicable to a substrate (21l) that was known to react productively and 
selectively. The solubility of NBS in toluene required that the reactions be carried out at 23 
o
C
§§
 
                                                 
§§
 Tetramethyl NBS was explored as an alternative more soluble reagent, however the reaction rate was much lower 
and there was a long induction period of ca 8.5 min. The use of this reagent was judged to be a substantial alteration 
that was likely to affect the outcome of the study and was therefore not pursued further. 
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and the concentrations of Ph3P=S and 24a were reduced by a factor of 4 to 0.31 mM (1.25 mol% 
at 25 mM 21l) to allow a sufficient number of data points to be collected. Otherwise the 
conditions developed in Chapter 5 were used. To determine the partial order of the reaction in 
each readily soluble component (acid 24a, Ph3P=S, and olefin 21l) five concentrations per 
component were chosen such that the data points spanned an order of magnitude, were evenly 
spaced on a logarithmic scale, and were centered around the baseline conditions (25 mM 21l, 30 
mM NBS, 0.31 mM Ph3P=S, 0.31 mM 24a). Due to the limited solubility of NBS in PhMe, five 
concentrations were chosen such that they were evenly spaced on a logarithmic scale and 
spanned an order of magnitude from the baseline concentration (30 mM NBS) to 1/10
th
 of the 
baseline concentration (3 mM NBS). Triplicate experiments were run for each concentration. 
Additional replicates were run as needed. 
On the basis of initial rate data (Figure 16)., the rate of reaction was found to be;  
                             
     
B.3. Discussion 
The presence of fractional partial orders greatly complicates analysis of the reaction 
mechanism. The observed order of 0.82 in substrate could arise from a systematic error, partial 
(ca. 40% at 25mM 21l) contribution of a mechanism with an order of ½ or the beginning of a 
slow transition to a saturation kinetic regime. Attempts to determine whether saturation could be 
reached were stymied by the onset of interfering side reactions at high olefin concentration.  
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Figure 16. Determination of partial orders in reaction components. 
The origin of the fractional order in Ph3P=S is unclear however it may be due to 
experimental error. At the lowest concentration of Ph3P=S, 0.0988 mM, the reactions stalled 
before reaching 10% conversion, making it impossible to process the data in a manner consistent 
with the rest of the study. To construct the plot in Figure 16 the initial rate for that point was 
calculated from the first 5% conversion. There is still some curvature of the time/concentration 
plots for the low [Ph3P=S] that is not present in the other data series which should increase the 
-9 -8 -7
-12
-11
ln
(K
in
it
ia
l)
ln([24a])
Intercept Slope Slope Slope Slope Statistics
Value Value Standard Err 99% LCL 99% UCL Adj. R-Squa
N -3.28161 1.02106 0.00491 0.99237 1.04975 0.99991
-5 -4
-14
-13
-12
ln
(K
in
it
)
ln([NBS])
Intercept Slope Slope Slope Slope Statistics Statistics
Value Value Standard Err 99% LCL 99% UCL R-Square(CO Adj. R-Squar
O -7.68248 1.06501 0.0843 0.57264 1.55738 0.98155 0.9754
-5 -4 -3
-12.5
-12.0
-11.5
-11.0
-10.5
ln
(K
in
it
ia
l) 
ln([21l])
Intercept Slope Slope Slope Slope Statistics Statistics
Value Value Standard Error 99% LCL 99% UCL R-Square(CO Adj. R-Square
-8.56944 0.81627 0.03245 0.62674 1.0058 0.99528 0.99371
-9 -8 -7
-13
-12
-11
-10
ln
(K
in
it
ia
l)
ln([Ph
3
P=S])
Intercept Slope Slope Slope Slope Statistics
Value Value Standard Error 99% LCL 99% UCL Adj. R-Square
L 0.21017 1.47248 0.05189 1.16938 1.77558 0.99505
121 
 
apparent order. At the highest concentration of Ph3P=S examined (0.988 mM) only two data 
points could be acquired below 10% conversion.  
Several noteworthy phenomena were encountered in the analysis of this data. The first is 
that the reaction exhibits a transient phase or induction period. The length of this period depends 
on the reagent concentrations and is therefore unlikely to be due to incomplete mixing or other 
experimental artifacts. The most likely explanation is that it takes time for the concentrations of 
reactive intermediates to reach a steady state. The transient phase has been removed from the 
plotted data by basing the initial rate on the interval from 1 to 10% conversion, or in the case of 
the order in 21l, by removing the first acquired time point. Acquiring data with higher time 
resolution may allow mechanistic information to be extracted from this phase of the reaction. 
Under the conditions of this study, all reactions stalled at low conversion (typically ca. 
30%) due to catalyst deactivation. As discussed above, at low Ph3P=S concentration the reactions 
stalled before reaching 10% conversion. It is likely that Ph3P=S is the component of the catalyst 
system that is consumed in the catalyst deactivation. The severity of catalyst deactivation is 
unfortunate because it makes numerical modeling of the reaction time course to resolve the 
origin of the observed fractional orders quite difficult.  
B.4. Conclusions 
The results of this study are inconclusive. Nevertheless, the intimate involvement of 
Ph3P=S in the catalytic cycle has been clearly demonstrated. Furthermore, no step prior to the 
entry of olefin 21l into the catalytic cycle can be rate determining.  
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Appendix C:  Experimental 
C.1. General Experimental 
Dichloromethane, toluene, Et2O, CH2Cl2 and THF (Fisher, HPLC grade) were dried by 
percolation through neutral alumina in a solvent dispensing system. 1,1,1,3,3,3-Hexafluoro-2-
propanol (Oakwood) was dried over 3Å molecular sieves. Chloroform was dried over 4Å 
molecular sieves and passed through activated basic alumina immediately before use. ACS 
reagent grade diethyl ether, ethyl acetate, methyl tert-butyl ether, CH2Cl2, pentane and hexanes 
used for chromatography and recrystallization were purchased from Fisher. Column 
chromatography was performed using Merck grade 9385, 60 Å silica gel. Visualization was 
accomplished by UV light and/or ceric ammonium molybdate solution, iodine vapor, or p-
anisaldehyde solution. Analytical and preparative thin-layer chromatography was performed on 
Merck silica gel plates with F-254 indicator. N-Bromosuccinimide was recrystallized from hot 
H2O either once (Chapter 3) or twice (Chapters 5 – 6),
136
 dried under vacuum at room 
temperature, stored at -20 °C, and protected from light. N-Iodosuccinimide was recrystallized 
from dioxane/CCl4, dried under vacuum at room temperature, ground in a mortar and pestle, 
stored at -20 °C and protected from light. Benzaldehyde (33a), 4-methoxybenzaldehyde (33c), 2-
tolualdehyde (33e), 4-trifluoromethylbenzaldehyde (33b), 1-naphthaldehyde (33f) and 2-
furaldehyde (33g) were distilled under reduced pressure before use. Methyl 4-formylbenzoate 
(33d), 4-bromobenzaldehyde (33i), and 2-naphthaldehyde were sublimed under high vacuum and 
stored in a glove box. 3-Phenylpropionaldehyde (30a), hexanal (30b) and 3-methylbutanal (30d) 
were distilled and stored at -20 °C. Diisopropylamine, diisopropylethylamine, and triethylamine, 
pyridine, nicotine, anisole and 2,6-lutidine were distilled from CaH2. Triflic anhydride was 
distilled from P2O5. Isobutyraldehyde was distilled from MgSO4. Dioxane and acetonitrile were 
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distilled from Na freshly before use. p-Toluenesulfonyl chloride was recrystallized from hexane. 
(E)- and (Z)-4-octene were purchased from Alfa Aesar and used as received. meta-
Chloroperoxybenzoic acid (77%), 4-dimethylaminopyridine, trimethyl orthoformate, pyridinium 
p-toluenesulfonate, tetrabutylammonium azide, sodium acetate, formic acid, sodium formate, 
CCl4, TFA, AcOH, (CH2)4S, Me2S, (Me2N)2C=O, (Me2N)2C=S, (PhSe)2, (PhS)2, (Me2N)3P=O, 
I2, Br2, lithium aluminum hydride, C6Me6 and KHMDS were purchased from Aldrich and used 
as received. n-Bu3P=O was purchased from Aldrich and sublimed in vacuo before use. Silicon 
tetrachloride was purchased from Gelest and used as received for epoxide openings (Chapter 2) 
or was heated at reflux for >24 h and was distilled prior to use. Ph3P=S and n-Bu3P were 
purchased from Strem and used as received. Me2SO was purchased from Fischer and used as 
received. (Me2N)3P and GeCl4 were distilled and stored in a sealed tube under argon. N-Bu4NI 
was dried azeotropically with PhMe. Sodium thiosulfate solution refers to 1 volume of saturated 
aqueous Na2S2O3 solution diluted to 2.5 volumes with H2O. 
1
H NMR, 
13
C NMR and 
19
F NMR spectra were acquired in CDCl3 at 400 or 500 MHz. 
Spectra were referenced to residual CHCl3 (7.26 ppm 
1
H; 77.00 ppm 
13
C). Assignments were 
obtained by reference to COSY and HMQC correlations. Chemical shifts are reported in ppm, 
multiplicities are indicated by s(singlet), d (doublet), t (triplet), q (quartet), p (pentet), h (hextet), 
hep (heptet), m (multiplet) and br (broad). Coupling constants, J, are reported in Hertz. Mass 
spectrometry was performed by the University of Illinois Mass Spectrometer Center. EI mass 
spectra were performed on a 70-VSE instrument. ESI mass spectra were performed on a Waters 
Q-Tof Ultima instrument. Data are reported in the form of (M/Z) versus intensity. Infrared 
spectra (IR) were recorded in KBr pellets or on NaCl plates. Peaks are reported in cm
-1
 with 
indicated relative intensities: s (strong, 67-100%); m(medium, 34-66%); w (weak, 0-33%). 
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Melting points (mp) were determined in sealed tubes and are corrected. Analytical supercritical 
fluid chromatography was performed on a Berger Instruments SFC with spectrophotometric 
detector (220 nm) using Daicel Chiralpak OD and AS columns. Analytical gas chromatography 
was performed on a Hewlett-Packard 5980 or 5890 Series II instrument using 30-m Astec G-TA 
or B-PH (Chiraldex
TM
) columns. Optical rotations were measured in Fischer ACS reagent grade 
CHCl3, CH3OH, or absolute ethanol and are reported as follows: concentration (c = g/dL), and 
solvent. Kugelrohr distillation temperatures reported are air bath temperatures (ABT). 
Enantioselective bromocycloetherification reactions were monitored by 
1
H NMR of 0.2 mL 
aliquots quenched into 1 mL of a rapidly stirred 1:1 mixture of sat. NaHCO3 and Na2S2O3 
solutions. 
C.2. Literature Procedures 
The preparation of (4R,5R)-octane-4,5-diol and (2R,3R)-2,3-dipropyloxirane by 
dihydroxylation of (E)-4-octene was based  on the syntheses of their enantiomers by Nelson and 
Warren,
24
 following the procedure reported by Denmark and Vogler.
23a
 (2R,3R)-1,4-
Diphenylbutane-2,3-diol and (2R,3R)-2,3-dibenzyloxirane were prepared by dihydroxylation of 
(E)-1,4-diphenyl-2-butene by the method of Tanner and coworkers,
137
 using the procedure 
reported by Denmark and Vogler.
23a
 (E)-1,4-Diphenyl-2-butene was prepared by reduction of 
(E,E)-1,4-diphenyl-1,3-butadiene with sodium in ethanol according to the procedure of Tanner 
and coworkers.
137
 (E,E)-1,4-diphenyl-1,3-butadiene was prepared from cinnamaldehyde and 
benzyltriphenyphosphonium chloride according to the procedure of Friedrich and Henning.
138
 
Tetrabutylammonium acetate was prepared by neutralizing a solution of tetrabutylammonium 
hydroxide in methanol with acetic acid. (Z)-1,4-Dibenzyloxy-2-butene was prepared by the 
method of Charette and co-workers.
139
 Acetic formic anhydride was prepared by the method of 
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Krimen.
140
 (E)-6-Methyl-4-heptenoic acid 16c was prepared by Claisen rearrangement according 
to the procedure of Orito and coworkers.
141
 (Z)-4-Phenyl-4-pentenoic acid 16b was prepared by 
Wittig reaction according to the procedure of Borhan and co-workers.
142
 (E)-4-Phenyl-4-
pentenoic acid 16a and (4E)-5-(4-methylphenyl)-4-pentenoic acid 16d were prepared by Claisen 
rearrangement according to the procedure of Gao and co-workers.
40
 (E)-7-Phenyl-hept-4-en-1-ol 
4b was prepared according to the procedure of Breidt.
143
 (Z)-7-Phenyl-hept-4-en-1-ol 4c was 
prepared according to the procedure of Kang.
15b
  Cy3P=S,
144
 Bu3P=S,
145
 (Me2N)3P=S
146
, 
Bu3P=Se
146
, (Me2N)3P=Se
146
) were prepared by reaction of their parent phosphines with 
elemental S or Se according to the procedures specified. (4Z)-5-(4-Fluorophenyl)-4-pentenoic 
acid (16k) was prepared according to a literature procedure,
147
 and was recrystallized until >99:1 
Z/E. Ethyl (4E)-5-(4-trifluoromethylphenyl)-4-pentenoate,
148
 (4Z)-5-phenyl-4-penten-1-ol 
(19f),
142
, 4-phenyl-4-penten-1-ol,
149
 4-phenyl-4-pentenoic acid
149
 and (3-
cyanopropyl)triphenylphosphonium chloride
150
 were prepared according to literature procedures.  
24a used in Chapter 5 was prepared according to the procedure of Gong,
151
 and 
recrystallized from MeCN according to the procedure of List.
78
 24a used in Appendix 2 was 
prepared by the procedure of List.
78
 24b
152
 and 24c
79
 were prepared according to literature 
procedures. 24d
153
 and 24e
154
 were prepared according to literature methods, and acid-washed 
according to the procedure of Ishihara.
77
 24f was prepared according to the procedure of 
Antilla,
155
 omitting chromatography. 24g was prepared according to the method of Toste
156
 
omitting chromatography. 24i-k were prepared according to the method of Akiyama.
157
 24l was 
prepared according to the procedure of Borman.
158
 As detailed above, all chiral acids were either 
acid washed after chromatography (24a – 24e) or else clean compound was obtained without 
chromatography (24f, 24g-l). See Ishihara
77
 for an examination of the contamination of chiral 
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phosphoric acids by formation of salts with Group 1 and 2 metals which can occur during 
chromatography. List
78
 discusses this issue as it relates to the preparation of 24a. 
 2-Phenylpropanenitrile,
159
 2-(4-methoxyphenyl)-propanenitrile,
159
 2-(2-
methylphenyl)propanenitrile,
104
 and 2-(4-(trifluoromethyl)phenyl)-butanenitrile
108
 were prepared 
according to the general procedure of Watt except di-isopropylamine was used in place of N-
isopropylcyclohexaneylamine.
159
 1-(1,1-dimethylethyl)-1,1-dimethyl-N-(2-phenyl-1-propen-1-
ylidene)silanamine (46a),
108
  was prepared according to the general procedure of Fu and 
coworkers except cannula filtration was substituted for filtration in a glove box.
108
   1-(1,1-
Dimethylethyl)-1,1-dimethyl-N-[2-[4-(trifluoromethyl)phenyl]-1-butenylidene]silanamine 
(46b)
108
 
 
was prepared according to the modified procedure of Fu and coworkers except cannula 
filtration was substituted for filtration in a glove box, and the reaction was run at -98°C in a 
MeOH/N2(l) bath.
108
 GeCl2·dioxane
160
and 59a
161
were prepared according to literature 
procedures.  
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C.3. Experimental Procedures. 
C.3.1. Preparation and Solvolysis of Halosulfonates. 
Preparation and Solvolysis of (4R,5S)-5-Bromo-4-octyl 4-Methylbenzenesulfonate (5). 
Preparation of (4R,5S)-5-Bromo-4-octanol (8) 
 
To a 500-mL, round-bottomed flask open to air were added potassium ferricyanide (9.88 
g, 30.0 mmol, 3.00 equiv), K2CO3 (4.15 g, 30.0 mmol, 3.00 equiv) and H2O (50.0 mL).  The 
mixture was stirred until a homogenous solution was obtained. (DHQD)2PHAL (78 mg, 0.1 
mmol, 0.01 equiv), potassium osmate dihydrate (7.4 mg, 0.02 mmol, 0.002 equiv), 
methanesulfonamide (950 mg, 10.0 mmol, 1.00 equiv) and t-BuOH (50 mL) were added and the 
mixture was cooled in an ice bath. (E)-4-Octene (1.57 mL, 10.0 mmol) was added by syringe and 
the slurry was allowed to warm to room temperature and was stirred for 11 h. Solid sodium 
sulfite (12 g) was added and the mixture was stirred for 40 min. Dichloromethane (100 mL) was 
added, the mixture was transferred to a 500-mL separatory funnel and the layers were separated. 
The aqueous phase was extracted with CH2Cl2 (3 x 75 mL), and the combined organic layers 
were washed with aq. NaOH solution (10 % w/v, 40 mL) and brine (40 mL). The combined 
organic layers were dried over MgSO4, filtered and concentrated in vacuo (40 
o
C, 10 mmHg) to 
128 
 
provide a colorless oil that was used without further purification. 
 To an oven-dried, 50-mL Schlenk flask fitted with a septum and a magnetic stir bar were 
added a solution of 6 
23a
(10.0 mmol assumed) in dry CH2Cl2 (20 mL), trimethyl orthoformate 
(1.32 mL, 12.0 mmol, 1.20 equiv), and pyridinium p-toluenesulfonate (23 mg, 0.09 mmol, 0.009 
equiv) under Ar. The mixture was stirred at room temperature for 21 h, and then the stir bar was 
removed. The mixture was concentrated in vacuo (40
 o
C, 10 mmHg). 
 The flask was fitted with a magnetic stir bar and a septum and then was evacuated and 
filled with Ar. Dichloromethane (20 mL) was added, and the solution was cooled in an ice bath. 
Acetyl bromide (1.0 mL, 13.5 mmol, 1.35 equiv) was added dropwise by syringe. The solution 
was allowed to slowly warm to room temperature and stir for 20 h, after which the stir bar was 
removed. The mixture was concentrated in vacuo (40
 o
C, 10 mmHg) to provide a yellow oil 
containing 2. A small sample was removed for CSP-GC analysis (97:3 er).  
The reaction mixture was pipetted into a 250-mL, round-bottomed flask containing a 
magnetic stir bar. Methanol (100 mL) was added followed by conc. aq. HCl solution (10 mL) 
and the mixture was allowed to stir for 24 h, then was concentrated in vacuo (40
 o
C, 10 mmHg) 
to a total mass of ~20 g. The residue was poured into a 250-mL separatory funnel then was 
diluted with brine (10 mL) and H2O (30 mL), and then washed with Et2O (3 x 30 mL). The 
combined organic extracts were washed with brine (30 mL) and sat. aq. NaHCO3 solution (30 
mL), then were dried over MgSO4, filtered and concentrated in vacuo (23
 o
C, 10 mmHg). The 
residue was purified by column chromatography (silica gel (21 g), 2 cm diam, pentane/Et2O, 
gradient from 95:5 to 93:7) to yield 1.69 g (81%) of (4R,5S)-8 as a colorless oil. The 
spectroscopic data are in accordance with those described in the literature.
162
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Data for (4R,5S)-8: 
1
H NMR:  (500 MHz, CDCl3) 
δ 4.20 (dt, J = 10.5, 3.3, 1 H, HC(5)), 3.75 – 3.66 (m, 1 H, HC(4)), 1.94 (br d, J = 
5.5, 1 H, OH), 1.90 – 1.78 (m, 1 H, H2C(2, 3, 7, 6)), 1.73 (m, 1 H, H2C(2, 3, 7, 6)), 
1.69 – 1.61 (m, 1 H, H2C(2, 3, 7, 6)), 1.61 – 1.46 (m, 3 H, H2C(2, 3, 7, 6)), 1.46 – 
1.32 (m, 2 H, H2C(2, 3, 7, 6)), 0.95 (t, J = 7.0, 3 H, H3C(1, 8)), 0.94 (t, J = 7.3, 3 H, 
H3C(1, 8)). 
13
C NMR: (125 MHz, CDCl3) 
δ 74.6 (C(4)), 65.1 (C(5)), 35.3 (C(3, 6)), 35.1 (C(3, 6)), 21.2 (C(2, 7)), 19.2 (C(2, 
7)), 14.0 (C(1, 8)), 13.4 (C(1, 8)). 
Opt. Rot: [α]D
24
 –13.2 (c=0.44, CHCl3)  
TLC: Rf  0.22 (hexanes/EtOAc, 9:1) [I2/CAM] 
Data for (4R,5S)-7: 
GC: (4S,5R)-7, tR 19.81 (2.7%); (4R,5S)-7, tR 20.68 (97.3%) (Chiraldex B-PH, 90 
o
C, 5 
psi) 
 
Preparation of (4R,5S)-5-Bromo-4-octyl 4-Methylbenzenesulfonate (5)  
 
To a flame-dried, 10-mL Schlenk flask equipped with a magnetic stir bar and a septum, 
was added by syringe (4R,5S)-8 (0.209 g, 1.00 mmol, 97:3 er) followed by dry CH2Cl2 (4.0 mL) 
under Ar.  The solution was cooled in an ice bath and 4-dimethylaminopyridine (244 mg, 2.00 
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mmol, 2.00 equiv) was added followed by p-toluenesulfonyl chloride (285 mg, 1.5 mmol, 1.5 
equiv). The mixture was allowed to slowly warm to room temperature and was stirred for 21 h 
then was quenched by the addition of brine (5 mL) and was allowed to stir for 20 min. The 
resulting biphasic mixture was transferred to a 60-mL separatory funnel then was diluted with 
brine (5 mL) and extracted with TBME (3 x 10 mL). The combined organic extracts were 
washed with brine (10 mL) and sat. aq. NaHCO3 solution (10 mL) then were dried over MgSO4. 
The solution was filtered and concentrated in vacuo (23 
o
C, 10 mmHg) and the residue was 
purified by column chromatography (silica gel (23 g), 2 cm diam, hexanes/EtOAc, 19:1) to 
provide 321 mg (91%) of (4R,5S)-5 as a colorless oil. 
Data for (4R,5S)-5: 
1
H NMR:  (500 MHz, CDCl3) 
δ 7.82 (d, J = 8.3, 2 H, HC(10)), 7.34 (d, J = 8.0, 2 H, HC(10)), 4.58 (dt, J = 8.7, 3.6, 
1 H, HC(4)), 4.12 (dt, J = 9.0, 4.3, 1 H, HC(5)), 2.45 (s, 3 H, H3C(13)), 1.89 (dddd, J 
= 13.5, 10.1, 8.6, 4.8, 1 H, H2C(3)), 1.76 – 1.63 (m, 2 H, H2C(6)), 1.63 – 1.50 (m, 2 
H, H2C(3, 7)), 1.45 – 1.29 (m, 2 H, H2C(2, 7)), 1.28 – 1.14 (m, 1 H, H2C(2)), 0.88 (t, 
J = 7.4, H3C(1, 8)), 0.85 (t, J = 7.3, H3C(1, 8)). 
13
C NMR: (125 MHz, CDCl3) 
δ 144.8 (C(9)), 134.1 (C(12)), 129.7 (C(11)), 127.7 (C(10)), 83.8 (C(4)), 56.5 (C(5)), 
36.6 (C(6)), 32.9 (C(3)), 21.6 (C(13)), 20.8 (C(7)), 17.9 (C(2)), 13.6(C(1, 8)), 13.2 
(C(1, 8)). 
IR: (neat) 
2962 (s), 2875 (s), 1921 (w), 1599 (s), 1495 (m), 1463 (s), 1368 (s), 1273 (m), 1177 
(s), 1096 (s), 926 (s), 885 (s), 815 (s), 732 (s), 666 (s), 609 (w), 555 (s).  
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MS: (EI, 70 eV) 
362.1 (1), 227.1 (67), 156.0 (13), 155.0 (100), 111.1 (40), 91.1 (56), 81.1 (16), 69.1 
(63), 67.1 (13), 65.0 (14), 54.9 (40). 
HRMS: calcd for C15 H23O3BrS
+
: 362.0551, found: 362.0551 
Opt. Rot: [α]D
24
 + 18.9 (c=0.60, EtOH) 
TLC: Rf  0.38 (hexanes/EtOAc, 9:1) [UV/I2/CAM] 
Analysis: C15 H23O3BrS (363.3) 
 Calcd: C, 49.59; H, 6.38%;  
 Found: C, 49.67; H, 6.50%; 
 
Formic Acid Solvolysis of (4R,5S)-5. Preparation of (4R,5S)-5-Bromo-4-octyl Formate (7). 
 
A 250-mL, round-bottomed flask, fitted with a magnetic stir bar, an inert gas inlet, and a 
septum was charged with (4R,5S)-5 (363 mg, 1.00 mmol, 97:3 er) under argon. A solution of 
sodium formate (884 mg, 13.0 mmol, 13.0 equiv) in formic acid (100 mL) was added by 
cannula. The resulting solution was allowed to stir for 6 h and then was transferred to a 250-mL 
separatory funnel where it was washed with pentane (3 x 25 mL). The combined pentane extracts 
were washed with brine (3 x 25 mL), dried over MgSO4, filtered and concentrated at atmospheric 
pressure (45 
o
C). The residue was purified by column chromatography (silica gel (19 g), 2 cm 
diam, pentane/Et2O, 98:2) followed by bulb-to-bulb distillation (125 
o
C, 10 mmHg)
 
to provide 
160 mg (68%) of (4R,5S)-7 as a colorless oil. 
132 
 
Data for (4R,5S)-7: 
1
H NMR:  (500 MHz, CDCl3) 
δ 8.13 (s, 1 H, HC(9)), 5.10 (dt, J = 9.4, 3.8, 1 H, HC(5)), 4.14 – 4.09 (m, 1 H, 
HC(4)), 1.87 – 1.73 (m, 3 H, H2C(3, 6)), 1.72 - 1.61 (m, 2 H, H2C(6’, 7)), 1.50 – 
1.37 (m, 2 H, H2C(2, 7’)), 1.31 (ddt, J = 13.7, 9.5, 7.0, 1 H, H2C(2’)), 0.94 (t, J = 
7.3, 6 H, H3C(1, 8)). 
13
C NMR: (125 MHz, CDCl3) 
δ 160.4 (C(9)), 75.4 (C(5)), 57.1 (C(4)), 36.2 (C(3)), 32.9 (C(6)), 20.9 (C(7)), 18.5 
(C(2)), 13.8 (C(8, 1)), 13.3 (C(8, 1)). 
IR: (neat) 
2962 (s), 2935 (s), 2876 (s), 2359 (w), 1731 (s), 1465 (m), 1381 (m), 1249 (w), 1172 
(s), 1117 (s), 1059 (w), 968 (w), 924 (w), 876 (w), 827 (w), 749 (w), 640 (w), 556 
(w). 
MS: (CI, CH4) 
237.0 (1), 193.0 (68). 192.0 (11), 157.1 (25), 129.1 (26), 112.1 (23), 111.1 (100), 
109.1 (16), 69.1 (42). 
HRMS: calcd for C9H18O2Br: 237.0490, found: 237.0480 
Opt. Rot: [α]D
24
 + 15.2 (c=0.51, EtOH) 
TLC: Rf  0.51 (hexanes/EtOAc, 9:1) [UV/I2/CAM] 
GC: (4S,5R)-7, tR 19.81 (2.6%); (4R,5S)-7, tR 20.62 (97.4%) (Chiraldex B-PH, 90 
o
C, 5 
psi) 
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Analysis: C9H17O2 Br (227.1) 
 Calcd: C, 45.58; H, 7.23%;  
 Found: C, 45.41; H, 7.24%; 
 
Formic Acid Solvolysis of (4R,5S)-5 in the Presence of 3. 
 
 A 50-mL recovery flask was charged with (4R,5S)-5 (66 mg, 0.18 mmol, 97:3 er), 
followed by a solution of 9 (488 mg, 1.82 mmol, 10.0 equiv) and sodium formate (162 mg, 2.38 
mmol, 13.0 equiv) in formic acid (18 mL). The resulting solution was allowed to stir for 6 h and 
then was transferred to a 60-mL separatory funnel where it was washed with pentane (3 x 5 mL). 
The combined pentane extracts were washed with brine (3 x 5 mL), dried over MgSO4, filtered 
and concentrated in vacuo (23 
o
C, 10 mmHg). The residue was purified by column 
chromatography (silica gel (4.5 g), 1 cm diam, pentane/Et2O, 98:2) to yield 35 mg (81%) of 
(4R,5S)-7 as a colorless oil. 
Data for (4R,5S)-7: 
GC: (4S,5R)-7, tR 19.75 (2.9%); (4R,5S)-7, tR 20.60 (97.1%) (Chiraldex B-PH, 90 
o
C, 5 
psi) 
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Acetolysis of (4R,5S)-5 in the Presence of 2.0 equiv of NaOAc.  Preparation of (4R,5S)-5-
Bromo-4-octyl Acetate (10a) 
 
To an oven-dried, 5-mL Schlenk flask equipped with a magnetic stir bar and a septum 
was added (4R,5S)-5 (73 mg, 0.2 mmol, 98:2 er) under Ar. A solution of NaOAc (33 mg, 0.4 
mmol, 2.0 equiv) in HFIP (2 mL) was added rapidly via cannula and the solution was allowed to 
stir at room temperature for 1 h. Pentane (2 mL), sat. aq. NaHCO3 solution (2 mL), and H2O (2 
mL) were added and the solution was stirred for ca. 15 min. The resulting biphasic mixture was 
transferred to a 60-mL separatory funnel where it was diluted with H2O (10 mL) and was washed 
with pentane/Et2O, 9:1 (3 x 10 mL). The combined organic extracts were dried over MgSO4, 
filtered, and concentrated in vacuo (23 
o
C, 10 mmHg). The residue was purified by column 
chromatography (silica gel (4.5 g), 1 cm diam, pentane/Et2O, 95:5) to provide 40 mg (79%) of 
(4R,5S)-10a as a colorless oil. The spectroscopic data are in accordance with those described in 
the literature.
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Data for (4R,5S)-10a: 
 
1
H NMR:  (500 MHz, CDCl3) 
δ 4.95 (dt, J = 9.5, 3.6, 1 H, HC(4)), 4.12 (ddd, J = 8.6, 6.9, 4.2, 1 H, HC(5)), 2.10 (s, 
3 H, H3C(10)), 1.80 – 1.70 (m, 2 H, H2C(2, 3, 6, 7)), 1.70 – 1.57 (m, 2 H, H2C(2, 3, 
6, 7)), 1.47 – 1.35 (m, 2 H, H2C(2, 3, 6, 7)), 1.34 – 1.23 (m, 2 H, H2C(2, 3, 6, 7)), 
0.94 (t, J = 7.3, 3 H, H3C(1, 8)), 0.93 (t, J = 7.4, 3 H, H3C(1, 8)). 
13
C NMR: (125 MHz, CDCl3) 
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δ 170.6 (C(10), 75.5 (C(4)), 57.9 (C(5)), 36.3 (C(6)), 32.9 (C(5)), 21.0 (C(2, 7, 10)), 
20.9 (C(2, 7, 10)), 18.6 (C(2, 7)), 13.9 (C(1, 8)), 13.3 (C(1, 8)). 
TLC: Rf  0.44 (hexanes/EtOAc, 9:1) [UV/I2/CAM] 
GC: (4S,5R)-10a, tR 23.11 min (2.6%); (4R,5S)-10a, tR 18.74 min (97.4%) (Chiraldex 
G-TA, 90 °C for 5 min, 1 °C / min ramp to 120 °C ) 
Opt. Rot: [α]D
24
 +14.1 (c=0.53, CHCl3) 
 
General Procedure 5. Acetolysis of (4R,5S)-5 in the Presence of 1.0 equiv of 11 and 2.0 
equiv of NaOAc.  Preparation of (4R,5S)-5-Bromo-4-octyl Acetate (10a) 
 
To an oven-dried, 5-mL Schlenk flask equipped with a magnetic stir bar and a septum 
was added (4R,5S)-5 (73 mg, 0.2 mmol, 98:2 er) followed by 11 (31 μL, 0.2 mmol, 1.0 equiv) 
under Ar. A solution of NaOAc (33 mg, 0.4 mmol, 2.0 equiv) in HFIP (2 mL) was added rapidly 
by syringe and the solution was allowed to stir at room temperature for 1 h. Pentane (2 mL), sat. 
aq. NaHCO3 solution (2 mL), and H2O (2 mL) were added and the solution was stirred for ca. 15 
min. The resulting biphasic mixture was transferred to a 60-mL separatory funnel where it was 
diluted with H2O (10 mL) and was washed with pentane/Et2O, 9:1 (3 x 10 mL). The combined 
organic extracts were dried over MgSO4, filtered, and concentrated in vacuo (23 
o
C, 10 mmHg). 
The residue was purified by column chromatography (silica gel (4.5 g), 1 cm diam, 
pentane/Et2O, 95:5) to provide 38 mg (75%) of (4R,5S)-10a as a colorless oil. The spectroscopic 
data are in accordance with those described in the literature.
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Data for (4R,5S)-10a: 
GC: (4S,5R)-10a, tR 23.27 min (37.6%); (4R,5S)-10a, tR 23.75 min (62.4%) (Chiraldex 
G-TA, 90 °C for 5 min, 1 °C / min ramp to 120 °C) 
 
Acetolysis of (4R,5S)-5 in the Presence of 2.0 equiv of 11 and 2.0 equiv NaOAc. 
 Following General Procedure 1, a 5-mL Schlenk flask was charged with (4R,5S)-5 (73 
mg, 0.2 mmol, 98:2 er) and 11 (62 μL, 0.4 mmol, 2.0 equiv), followed by a solution of NaOAc 
(33 mg, 0.4 mmol, 2.0 equiv) in HFIP (2 mL) to yield after column chromatography (silica gel 
(4.5 g), 1 cm diam, pentane/Et2O, 95:5) 36 mg (71%) of (4R,5S)-10a as a colorless oil. 
Data for (4R,5S)-10a: 
GC: (4S,5R)-10a, tR 23.17 min (41.7%); (4R,5S)-10a, tR 23.65 min (58.3%) (Chiraldex 
G-TA, 90 °C for 5 min, 1 °C / min ramp to 120 °C ) 
 
Acetolysis of (4R,5S)-5 in the Presence of 0.75 equiv of 11 and 2.0 equiv NaOAc. 
 Following General Procedure 1, a 5-mL Schlenk flask was charged with (4R,5S)-5 (73 
mg, 0.2 mmol, 98:2 er) and 11 (23 μL, 0.15 mmol, 0.75 equiv), followed by a solution of NaOAc 
(33 mg, 0.4 mmol, 2.0 equiv) in HFIP (2 mL) to yield after column chromatography (silica gel 
(4.5 g), 1 cm diam, pentane/Et2O, 95:5) 40 mg (79%) of (4R,5S)-10a as a colorless oil. 
Data for (4R,5S)-10a: 
GC: (4S,5R)-10a, tR 23.16 min (33.9%); (4R,5S)-10a, tR 23.62 min (66.1%) (Chiraldex 
G-TA, 90 °C for 5 min, 1 °C / min ramp to 120 °C ) 
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Acetolysis of (4R,5S)-5 in the Presence of 0.5 equiv of 11 and 2.0 equiv NaOAc. 
 Following General Procedure 1, a 5-mL Schlenk flask was charged with (4R,5S)-5 (73 
mg, 0.2 mmol, 98:2 er) and 11 (16 μL, 0.1 mmol, 0.5 equiv), followed by a solution of NaOAc 
(33 mg, 0.4 mmol, 2.0 equiv) in HFIP (2 mL) to yield after column chromatography (silica gel 
(4.5 g), 1 cm diam, pentane/Et2O, 95:5) 36 mg (71%) of (4R,5S)-10a as a colorless oil. 
Data for (4R,5S)-10a: 
GC: (4S,5R)-10a, tR 23.23 min (28.3%); (4R,5S)-10a, tR 23.71 min (71.7%) (Chiraldex 
G-TA, 90 °C for 5 min, 1 °C / min ramp to 120 °C ) 
 
Acetolysis of (4R,5S)-5 in the Presence of 0.25 equiv of 11 and 2.0 equiv NaOAc. 
 Following General Procedure 1, a 5-mL Schlenk flask was charged with (4R,5S)-5 (73 
mg, 0.2 mmol, 98:2 er) and 11 (8 μL, 0.05 mmol, 0.25 equiv), followed by a solution of NaOAc 
(33 mg, 0.4 mmol, 2.0 equiv) in HFIP (2 mL) to yield after column chromatography (silica gel 
(4.5 g), 1 cm diam, pentane/Et2O, 95:5) 40 mg (79%) of (4R,5S)-10a as a colorless oil. 
Data for (4R,5S)-10a: 
GC: (4S,5R)-10a, tR 23.13 min (20.2%); (4R,5S)-10a, tR 23.62 min (79.8%) (Chiraldex 
G-TA, 90 °C for 5 min, 1 °C / min ramp to 120 °C ) 
 
Acetolysis of (4R,5S)-5 in the Presence of 0.1 equiv of 11 and 2.0 equiv NaOAc. 
 Following General Procedure 1, a 5-mL Schlenk flask was charged with (4R,5S)-5 (73 
mg, 0.2 mmol, 98:2 er) and 11 (3 μL, 0.02 mmol, 0.1 equiv), followed by a solution of NaOAc 
(33 mg, 0.4 mmol, 2.0 equiv) in HFIP (2 mL) to yield after column chromatography (silica gel 
(4.5 g), 1 cm diam, pentane/Et2O, 95:5) 41 mg (81%) of (4R,5S)-10a as a colorless oil. 
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Data for (4R,5S)-10a: 
GC: (4S,5R)-10a, tR 23.11 min (9.2%); (4R,5S)-10a, tR 23.59 min (90.8%) (Chiraldex 
G-TA, 90 °C for 5 min, 1 °C / min ramp to 120 °C ) 
 
Acetolysis of (4R,5S)-5 in the Presence of 1.0 equiv of 11 and 5.0 equiv NaOAc. 
 Following General Procedure 1, a 5-mL Schlenk flask was charged with (4R,5S)-5 (73 
mg, 0.2 mmol, 98:2 er) and 11 (31 μL, 0.2 mmol, 1.0 equiv), followed by a solution of NaOAc 
(82 mg, 1 mmol, 5.0 equiv) in HFIP (2 mL) to yield after column chromatography (silica gel (4.5 
g), 1 cm diam, pentane/Et2O, 95:5) 38 mg (75%) of (4R,5S)-10a as a colorless oil. 
Data for (4R,5S)-10a: 
GC: (4S,5R)-10a, tR 23.16 min (33.7%); (4R,5S)-10a, tR 23.66 min (66.3%) (Chiraldex 
G-TA, 90 °C for 5 min, 1 °C / min ramp to 120 °C ) 
 
Acetolysis of (4R,5S)-5 in the Presence of 0.75 equiv of 11 and 5.0 equiv NaOAc. 
 Following General Procedure 1, a 5-mL Schlenk flask was charged with (4R,5S)-5 (73 
mg, 0.2 mmol, 98:2 er) and 11 (23 μL, 0.15 mmol, 0.75 equiv), followed by a solution of NaOAc 
(82 mg, 1 mmol, 5.0 equiv) in HFIP (2 mL) to yield after column chromatography (silica gel (4.5 
g), 1 cm diam, pentane/Et2O, 95:5) 36 mg (71%) of (4R,5S)-10a as a colorless oil. 
Data for (4R,5S)-10a: 
GC: (4S,5R)-10a, tR 23.10 min (31.6%); (4R,5S)-10a, tR 23.62 min (68.4%) (Chiraldex 
G-TA, 90 °C for 5 min, 1 °C / min ramp to 120 °C ) 
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Acetolysis of (4R,5S)-5 in the Presence of 0.5 equiv of 4 and 5.0 equiv NaOAc. 
 Following General Procedure 1, a 5-mL Schlenk flask was charged with (4R,5S)-5 (73 
mg, 0.2 mmol, 98:2 er) and 11 (16 μL, 0.1 mmol, 0.5 equiv), followed by a solution of NaOAc 
(82 mg, 1 mmol, 5.0 equiv) in HFIP (2 mL) to yield after column chromatography (silica gel (4.5 
g), 1 cm diam, pentane/Et2O, 95:5) 42 mg (83%) of (4R,5S)-10a as a colorless oil. 
Data for (4R,5S)-10a: 
GC: (4S,5R)-10a, tR 23.27 min (26.1%); (4R,5S)-10a, tR 23.76 min (73.9%) (Chiraldex 
G-TA, 90 °C for 5 min, 1 °C / min ramp to 120 °C ) 
 
Acetolysis of (4R,5S)-5 in the Presence of 0.25 equiv of 11 and 5.0 equiv NaOAc. 
 Following General Procedure 1, a 5-mL Schlenk flask was charged with (4R,5S)-5 (73 
mg, 0.2 mmol, 98:2 er) and 11 (8 μL, 0.05 mmol, 0.25 equiv), followed by a solution of NaOAc 
(82 mg, 1 mmol, 5.0 equiv) in HFIP (2 mL) to yield after column chromatography (silica gel (4.5 
g), 1 cm diam, pentane/Et2O, 95:5) 42 mg (83%) of (4R,5S)-10a as a colorless oil. 
Data for (4R,5S)-10a: 
GC: (4S,5R)-10a, tR 23.13 min (19.8%); (4R,5S)-10a, tR 23.62 min (80.2%) (Chiraldex 
G-TA, 90 °C for 5 min, 1 °C / min ramp to 120 °C ) 
 
Acetolysis of (4R,5S)-5 in the Presence of 0.1 equiv of 11 and 5.0 equiv NaOAc. 
 Following General Procedure 1, a 5-mL Schlenk flask was charged with (4R,5S)-5 (73 
mg, 0.2 mmol, 98:2 er) and 11 (3 μL, 0.02 mmol, 0.1 equiv), followed by a solution of NaOAc 
(82 mg, 1 mmol, 5.0 equiv) in HFIP (2 mL) to yield after column chromatography (silica gel (4.5 
g), 1 cm diam, pentane/Et2O, 95:5) 39 mg (77%) of (4R,5S)-10a as a colorless oil. 
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Data for (4R,5S)-10a: 
GC: (4S,5R)-10a, tR 23.07 min (11.9%); (4R,5S)-10a, tR 23.62 min (88.1%) (Chiraldex 
G-TA, 90 °C for 5 min, 1 °C / min ramp to 120 °C ) 
 
Acetolysis of (4R,5S)-5 in the Presence of 5.0 equiv NaOAc. 
 Following General Procedure 1, a 5-mL Schlenk flask was charged with (4R,5S)-5 (73 
mg, 0.2 mmol, 98:2 er), followed by a solution of NaOAc (82 mg, 1 mmol, 5.0 equiv) in HFIP (2 
mL) to yield after column chromatography (silica gel (4.5 g), 1 cm diam, pentane/Et2O, 95:5) 40 
mg (79%) of (4R,5S)-10a as a colorless oil. 
Data for (4R,5S)-10a: 
GC: (4S,5R)-10a, tR 23.03 min (2.2%); (4R,5S)-10a, tR 23.62 min (97.8%) (Chiraldex 
G-TA, 90 °C for 5 min, 1 °C / min ramp to 120 °C ) 
 
Acetolysis of (4R,5S)-5 in the Presence of 2.0 equiv of n-Bu4NOAc. 
 Following General Procedure 1, a 5-mL Schlenk flask was charged with (4R,5S)-5 (73 
mg, 0.2 mmol, 98:2 er), followed by a solution of n-Bu4NOAc (121 mg, 0.4 mmol, 2.0 equiv) in 
HFIP (2 mL) to yield after column chromatography (silica gel (4.5 g), 1 cm diam, pentane/Et2O, 
95:5) 39 mg (77%) of (4R,5S)-10a as a colorless oil. 
Data for (4R,5S)-10a: 
GC: (4S,5R)-10a, tR 18.36 min (2.2%); (4R,5S)-10a, tR 18.74 min (97.8%) (Chiraldex 
B-PH, 90 
o
C 5 psi) 
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Acetolysis of (4R,5S)-5 in the Presence of 0.5 equiv of 11 and 2.0 equiv of n-Bu4NOAc. 
 Following General Procedure 1, a 5-mL Schlenk flask was charged with (4R,5S)-5 (73 
mg, 0.2 mmol, 98:2 er) and 11 (16 μL, 0.1 mmol, 0.5 equiv) followed by a solution of n-
Bu4NOAc (121 mg, 0.4 mmol, 2.0 equiv) in HFIP (2 mL) to yield after column chromatography 
(silica gel (4.5 g), 1 cm diam, pentane/Et2O, 95:5) 43 mg (85%) of (4R,5S)-10a as a colorless oil. 
Data for (4R,5S)-10a: 
GC: (4S,5R)-10a, tR 18.27 min (6.5%); (4R,5S)-10a, tR 18.62 min (93.5%) (Chiraldex 
B-PH, 90 
o
C, 5 psi) 
 
 
Acetolysis of (4R,5S)-5 in the Presence of 1.0 equiv of 11 and 2.0 equiv of n-Bu4NOAc. 
 Following General Procedure 1, a 5-mL Schlenk flask was charged with (4R,5S)-5 (73 
mg, 0.2 mmol, 98:2 er) and 11 (31 μL, 0.2 mmol, 1.0 equiv), followed by a solution of n-
Bu4NOAc (121 mg, 0.4 mmol, 2.0 equiv) in HFIP (2 mL) to yield after column chromatography 
(silica gel (4.5 g), 1 cm diam, pentane/Et2O, 95:5) 37 mg (73%) of (4R,5S)-10a as a colorless oil. 
Data for (4R,5S)-10a: 
GC: (4S,5R)-10a, tR 18.67 min (11.5%); (4R,5S)-10a, tR 19.02 min (88.5%) (Chiraldex 
B-PH, 90 
o
C, 5 psi) 
 
Acetolysis of (4R,5S)-5 in the Presence of 5.0 equiv of n-Bu4NOAc. 
 Following General Procedure 1, a 5-mL Schlenk flask was charged with (4R,5S)-5 (73 
mg, 0.2 mmol, 98:2 er), followed by a solution of n-Bu4NOAc (301 mg, 1.0 mmol, 5.0 equiv) in 
HFIP (2 mL) to yield after column chromatography (silica gel (4.5 g), 1 cm diam, pentane/Et2O, 
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95:5) 38 mg (75%) of (4R,5S)-10a as a colorless oil. 
Data for (4R,5S)-10a: 
GC:  (4S,5R)-10a, tR 16.89 min (1.9%); (4R,5S)-10a, tR 17.20 min (98.1%) (Chiraldex 
B-PH, 90 
o
C, 5 psi)  
 
Acetolysis of (4R,5S)-5 in the Presence of 1.0 equiv of 11 and 5.0 equiv of n-Bu4NOAc. 
 Following General Procedure 1, a 5-mL Schlenk flask was charged with (4R,5S)-5 (73 
mg, 0.2 mmol, 98:2 er) and 11 (31 μL, 0.2 mmol, 1.0 equiv), followed by a solution of n-
Bu4NOAc (301 mg, 1.0 mmol, 5.0 equiv) in HFIP (2 mL) to yield after column chromatography 
(silica gel (4.5 g), 1 cm diam, pentane/Et2O, 95:5) 41 mg (81%) of (4R,5S)-10a as a colorless oil. 
Data for (4R,5S)-10a: 
GC:  (4S,5R)-10a, tR 18.43 min (5.2%); (4R,5S)-10a, tR 18.80 min (94.8%) (Chiraldex 
B-PH, 90 
o
C, 5 psi)  
 
Preparation of (4S,5R)-4-Bromo-5-methoxyoctane (10b) 
 
To a flame-dried, 50-mL Schlenk flask equipped with a magnetic stir bar and a septum 
was added (4R,5S)-5 (363 mg, 1.00 mmol, 97:3 er) under Ar. Methanol (0.405 mL, 10.0 mmol, 
10.0 equiv) was added by syringe followed by HFIP (10 mL). The solution was stirred at room 
temperature for 22.5 h, after which pentane (10 mL), sat. aq. NaHCO3 solution (5 mL), and H2O 
(10 mL) were added. The resulting biphasic mixture was stirred for ca. 15 min, then was 
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transferred to a 125-mL separatory funnel where it was diluted with H2O (30 mL) and was 
washed with pentane (3 x 30 mL). The combined organic extracts were dried over MgSO4, 
filtered and concentrated in vacuo (23 
o
C, 10 mmHg). The residue was purified by column 
chromatography (silica gel (19 g), 2 cm diam, pentane/Et2O, 49:1) to provide 179 mg (80%) of 
(4S,5R)-10b as a colorless oil. 
Data for (4S,5R)-10b: 
1
H NMR:  (500 MHz, CDCl3) 
δ 4.13 (dt, J = 5.6, 4.3, 1 H, HC(4)), 3.43 (s, 3 H, H3C(9)), 3.23 – 3.18 (m, 1 H, 
HC(5)), 1.84 – 1.71 (m, 2 H, H2C(2, 3, 6, 7)), 1.64 (m, 2 H,H2C(2, 3, 6, 7)), 1.58 – 
1.45 (m, 2 H, H2C(2, 3, 6, 7)), 1.45 – 1.27 (m, 2 H, H2C(2, 3, 6, 7)), 0.94 (t, J = 7.3, 
3 H, H3C(1, 8)), 0.93 (t, J = 7.1, 3 H, H3C(1, 8)). 
13
C NMR: (125 MHz, CDCl3) 
δ 84.0 (C(5)), 58.6 (C(4, 9)), 58.2 (C(4, 9)), 36.2 (C(3)), 33.7 (C(6)), 21.2 (C(2)), 
18.8 (C(7)), 14.1 (C(1, 8)), 13.4 (C(1, 8). 
IR: (neat) 
2960 (s), 2934 (s), 2823 (m), 1464 (m), 1379 (m), 1258 (w), 1194 (m), 1170 (m), 
1145 (m), 1197 (s), 964 (w), 875 (w), 827 (w), 748 (w), 649 (w), 558 (w), 513 (w). 
MS: (EI, 70 eV) 
223.0 (1), 221.0 (1), 181.0 (21), 179.0 (21), 99.1 (54), 88.1 (40), 87.1 (100), 86.1 
(15), 71.0 (39), 69.1 (24), 67.0 (29), 56.9 (18), 54.9 (62). 
Opt. Rot: [α]D
24
 –2.3 (c=0.48, EtOH) 
TLC: Rf  0.53 (hexanes/EtOAc, 9:1) [UV/I2/CAM] 
GC: (4R,5S)-10b, tR 14.57 min (3.2%); (4S,5R)-10b, tR 15.14 min (96.8%) (Chiraldex 
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G-TA, 90 °C for 5 min, 1 °C / min ramp to 120 °C ) 
 
Preparation of (4R,5S)-4-Azido-5-bromooctane (10c) 
 
To a flame-dried, 50-mL Schlenk flask equipped with a magnetic stir bar and a septum 
was added (4R,5S)-5 (363 mg, 1.00 mmol, 97:3 er) under Ar. A solution of tetrabutylammonium 
azide (569 mg, 2.00 mmol, 2.0 equiv) in HFIP (10 mL) was added by syringe. The solution was 
stirred at room temperature for 3 h, after which Et2O (50 mL) was added. The resulting solution 
was filtered through a plug of silica gel (2.5 cm x 4 cm diam) and the plug was washed with 
Et2O (2 x 25 mL). The eluate was concentrated in vacuo (23 
o
C, 10 mmHg) and the residue was 
purified by column chromatography (silica gel (15 g), 2 cm diam, pentane) to provide 187 mg 
(80%) of (4R,5S)-10c as a colorless oil. The spectroscopic data are in accordance with those 
described in the literature.
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Data for (4R,5S)-10c: 
1
H NMR:  (500 MHz, CDCl3) 
δ 4.05 (ddd, J = 9.8, 4.8, 3.5, 1 H, HC(5)), 3.51 (ddd, J = 12.2, 8.2, 3.8, 1 H, HC(4)), 
1.88 – 1.73 (m, 2 H, H2C(2, 3, 6, 7), 1.72 – 1.63 (m, 3 H, H2C(2, 3, 6, 7)), 1.63 – 
1.55 (m, 1 H, H2C(2, 3, 6, 7)), 1.47 – 1.35 (m, 2 H, H2C(2, 3, 6, 7)), 0.97 (t, J = 7.3, 
3 H, H3C(1, 8)) 0.95 (t, J = 7.4, 3 H, H3C(1, 8)). 
13
C NMR: (125 MHz, CDCl3) 
δ 67.2 (C(4)), 59.1 (C(5)), 36.3 (C(6)), 33.9 (C(3)), 20.9 (C(2, 7), 19.6 (C(2, 7)), 
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13.8 (C(1, 8)), 13.3 (C(1, 8)). 
IR: (neat) 
1296 (s), 2936 (s), 2875 (m), 2106 (s), 1466 (m), 1382 (w), 1369 (w), 1271 (m), 
1193 (w), 1119 (w), 1052 (w), 967 (w), 875 (w), 827 (w), 749 (w), 624 (w). 
Opt. Rot: [α]D
24
 –0.96 (c=0.97, CHCl3)  
TLC: Rf  0.59 (hexanes/EtOAc, 9:1) [I2] 
GC: (4S,5R)-10c, tR 14.14 min (4.8%); (4R,5S)-10c, tR 23.62 min (95.2%) (Chiraldex 
G-TA, 6 psi, 110 °C for 5 min, 1 °C / min ramp to 120 °C) 
Preparation and Solvolysis of (2R,3S)-2-Bromo-1,4-diphenyl-2-butyl 4-Methylbenzene-
sulfonate (12c). 
Preparation of (2R,3S)-3-Bromo-1,4-diphenyl-2-butanol (12b).  
 
To a flame-dried, 50-mL Schlenk flask equipped with a magnetic stir bar and a septum, 
was added (2R,3R)-12a (242 mg, 1.00 mmol) under Ar. Dichloromethane (6 mL) was added by 
syringe followed by trimethyl orthoformate (106 mg, 1.20 equiv, 1.20 mmol) and pyridinium p-
toluenesulfonate (3 mg, 0.01 equiv, 0.01 mmol). The reaction mixture was allowed to stir at rt 
for 18 h then the stir bar was removed. Next, the mixture was concentrated in vacuo (40 
o
C, 10 
mmHg). The flask was fitted with a magnetic stir bar and a septum, and then was filled with Ar. 
Dichloromethane (12 mL) was added, the solution was cooled in an ice bath and acetyl bromide 
(0.104 mL, 1.40 equiv, 1.40 mmol) was added dropwise by syringe. The mixture was allowed to 
stir for 3 h after which the bath was removed and stirring was continued for another 15 h. The 
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magnetic stir bar was removed and the reaction mixture was concentrated in vacuo (40 
o
C, 10 
mmHg) and then fitted with a magnetic stir bar and a septum. Methanol (10 mL) and 
concentrated aq. HCl solution (1 mL) were added. The solution was allowed to stir for 24 h, then 
was concentrated in vacuo (40 
o
C, 10 mmHg) and transferred into a 125-mL separatory funnel 
where it was diluted with H2O (5 mL) and washed with TBME (3 x 10 mL). The combined 
organic extracts were washed with brine (5 mL) and sat. aq. NaHCO3 solution (5 mL) then were 
dried over MgSO4, filtered, and concentrated in vacuo (40 
o
C, 10 mmHg). The residue was 
purified by column chromatography (silica gel (20 g), 2 cm diam, hexanes/EtOAc, 9:1) to 
provide 221 mg (72%) of (2R,3S)-12b as a colorless oil.  
Data for (2R,3S)-12b: 
1
H NMR:  (500 MHz, CDCl3) 
7.37 – 7.30 (m, 4 H, HC(6, 10)), 7.30 – 7.21 (m, 6 H, HC(7, 8, 11, 12)), 4.33 (dt, J = 
9.2, 4.5, 1 H, HC(2)), 4.03 (dt, J = 8.6, 4.2, 1 H, HC(3)), 3.40 (dd, J = 14.7, 4.6, 1 H, 
HC(1)), 3.17 (dd, J = 14.7, 9.5, 1 H, HC(1’)), 3.11 (dd, J = 13.9, 4.2, 1 H, HC(4)), 
2.93 (dd, J = 13.9, 8.8, 1 H, HC(4’)), 2.06 (br. s, 1 H, OH). 
13
C NMR: (125 MHz, CDCl3) 
138.1 (C(9, 5)), 137.3 (C(9, 5)), 129.3 (C(6, 7, 10, 11), 129.12 (C(6, 7, 10, 11), 
128.72 (C(6, 7, 10, 11), 128.44 (C(6, 7, 10, 11), 126.86 (C(8, 12), 126.83 (C(8, 12)), 
74.9 (C(2), 62.0 (C(3), 39.96 (C(1, 4)), 39.82 (C(1, 4).  
IR: (neat) 
3444 (m), 3086 (m), 3062 (m), 3028 (m), 2921 (w), 1949 (w), 1880 (w), 1808 (w), 
1603 (m), 1584 (w), 1495 (m), 1454 (m), 1386 (w), 1261 (w), 1031 (m), 965 (w), 
927 (w), 854 (w), 744 (m), 699 (m), 610 (w). 
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MS: (EI, 70 eV) 
304.0 (1), 207.1 (32), 134.1 (11), 133.1 (37), 117.1 (13), 105.1 (25), 103.1 (11), 92.1 
(82), 91.1 (100), 77.1 (11), 65.1 (11). 
Opt. Rot: [α]D
24
 + 15.0 (c=0.56, EtOH) 
TLC: Rf  0.23 (hexanes/EtOAc, 9:1) [UV/I2/CAM] 
Analysis: C16 H17O Br (305.2) 
 Calcd: C, 62.96; H, 5.61%;  
 Found: C, 62.81; H, 5.49%; 
 
Preparation of (2R,3S)-2-Bromo-1,4-diphenyl-2-butyl 4-Methylbenzenesulfonate (12c). 
 
To a flame-dried, 10-mL Schlenk flask equipped with a magnetic stir bar and a septum 
were added by syringe (2R,3S)-12b (305 mg, 1.00 mmol), and dry CH2Cl2 (4.0 mL) under Ar. 
The solution was cooled in an ice bath and 4-dimethylaminopyridine (244 mg, 2.00 mmol, 2.00 
equiv) was added followed by p-toluenesulfonyl chloride (285 mg, 1.50 mmol, 1.50 equiv). The 
mixture was allowed to slowly warm to room temperature and was stirred for 21 h then was 
quenched by addition of brine (4 mL) and was allowed to stir for 20 min. The resulting biphasic 
mixture was poured into a 125-mL separatory funnel and was diluted with brine (5 mL), and 
TBME (10 mL). The organic layer was separated and the aqueous layer was extracted with 
TBME (2 x 10 mL). The combined organic extracts were washed with brine (10 mL) and sat. aq. 
NaHCO3 solution (10 mL) then were dried over MgSO4. The solution was filtered and then was 
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concentrated in vacuo (23 
o
C, 10 mmHg). The residue was purified by column chromatography 
(silica gel (20 g), 2 cm diam, hexanes/EtOAc/CH2Cl2, 85:10:5) to provide 447 mg of a white 
solid that was recrystallized from hot EtOAc (ca. 1 mL) and hexanes (ca. 2 mL) to provide 438 
mg (95%) of (2R,3S)-12c as white needles. 
Data for (2R,3S)- 12c: 
mp:  105-106 
o
C 
1
H NMR:  (500 MHz, CDCl3) 
δ 7.38 – 7.27 (m, 5 H, HC(aryl)) , 7.20 – 7.10 (m, 5 H, HC(aryl)), 7.08 (d, J = 8.1, 2 
H, HC(14)), 6.97 (d, J = 8.2, 2 H, HC(15)), 4.60 (dt, J = 7.9, 4.1, 1 H, HC(2)), 4.54 
(ddd, J = 8.7, 6.9, 3.7, 1 H, HC(3)), 3.25 – 3.09 (m, 3 H H2C(1, 4)), 3.04 (dd, J = 
14.6, 4.4, 1 H, H2C(1’)), 2.38 (s, 3 H, H3C(17)). 
13
C NMR: (125 MHz, CDCl3) 
δ 144.5 (C(13), 137.2 (C(16)), 135.2 (C(5, 9), 132.64 (C(5, 9), 129.54(C(14, 15)), 
129.49(C(14, 15)), 129.0 (C(aryl)), 128.7 (C(aryl)), 128.5 (C(aryl)), 127.7 (C(aryl)), 
127.2 (C(8, 12), 126.7 (C(8, 12), 83.3 (C(2)), 55.4 (C(3)), 41.3 (C(4)), 37.2 (C(1)), 
21.6 (C(17)). 
IR: (KBr pellet) 
3064 (m), 3031 (m), 2936 (m), 1952 (w), 1890 (w), 1815 (w), 1598 (m), 1496 (m), 
1455 (s), 1361 (s), 1303 (m), 1176 (s), 1095 (m), 976 (s), 914 (s), 885 (s), 809 (s), 
776 (s), 756 (s), 701 (s), 528 (m), 553 (s). 
MS: (ESI) 
484.0 (25), 483.0 (100), 481.0 (98), 478.0 (42), 392.9 (17), 390.9 (27), 372.0 (28), 
207.1 (35), 195.0 (49). 
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HRMS:   calcd for C23H23O3BrSNa: 481.0449, found: 481.0459 
Opt. Rot: [α]D
24
 + 49.3 (c=0.56, CHCl3) 
TLC: Rf  0.20 (hexanes/EtOAc, 9:1) [UV/I2/CAM] 
SFC: (2R,3S)-12c, tR 6.94 (95.8%); (2S,3R)-12c, tR 7.54 (4.2 %) (Chiralpak AS, 125 bar, 
40 
o
C, 10% MeOH in CO2, 2.5 mL/min, 220 nm) 
Analysis: C23 H23O3BrS (459.4) 
 Calcd: C, 60.13; H, 5.05%;  
 Found: C, 59.96; H, 5.07%;   
 
Acetoylsis of (2R,3S)-2-Bromo-1,4-diphenyl-2-butyl 4-Methylbenzenesulfonate (12c). 
Preparation of (2R,3S)-2-Bromo-1,4-diphenyl-2-butyl Acetate (13). 
 
To a flame-dried, 50-mL Schlenk flask equipped with a magnetic stir bar and a septum 
was added (2R,3S)-12c (459 mg, 1.00 mmol, 96:4 er) as a solid under Ar. A solution of NaOAc 
(164 mg, 2.00 mmol, 2.00 equiv) in HFIP (10 mL) was added rapidly by syringe with stirring. 
After ca. 47 min a cloudy white precipitate began to form. The solution was stirred at room 
temperature for another 51 h after which pentane (10 mL), sat. aq. NaHCO3 solution (5 mL), and 
H2O (10 mL) were added. The resulting biphasic mixture was stirred for ca. 15 min, then was 
transferred to a 125-mL separatory funnel where it was diluted with H2O (30 mL) and was 
washed with pentane (3 x 30 mL) and 10:1 pentane/Et2O (33 mL). The combined organic 
extracts were dried over MgSO4, filtered and concentrated in vacuo (23 
o
C, 10 mmHg). The 
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residue was purified by column chromatography (silica gel (38 g), 3 cm diam, hexanes/EtOAc, 
96:4) to provide 231 mg of a colorless oil that was partially decomposed upon bulb-to-bulb 
distillation (6x10
-5
 mmHg, 110-120 
o
C). Further purification by column chromatography (silica 
gel (19 g), 2 cm diam, hexanes/EtOAc, 96:4) followed by reverse-phase column chromatography 
(C18 RP silica gel, 1.5 cm diam, 21.5 cm length, MeOH/H2O, 85:15) followed by normal-phase 
column chromatography (silica gel (19 g), CH2Cl2/pentane, 4:6) yielded 150 mg (43%) of 
(2R,3S)-13 as a colorless oil. 
Data for (2R,3S)-13: 
1
H NMR:  (500 MHz, CDCl3) 
δ 7.59 – 7.00 (m, 10 H, HC(aryl)), 5.29 (ddd, J = 7.3, 5.7, 4.7, 1 H, HC(2)), 4.36 (dt, 
J = 9.5, 4.7, 1 H, HC(3)), 3.35 (dd, J = 14.6, 4.7, 1 H, H2C(4)), 3.26 – 3.06 (m, 3 H, 
H2C(1, 4)), 2.03 (s, J = 2.9, 3 H, H3C(14)). 
13
C NMR: (125 MHz, CDCl3) 
δ 170.0 (C(13)), 137.7 (C(9, 5)), 136.5 (C(9, 5)), 129.4 (C(aryl)), 129.0 (C(aryl)), 
128.5 (C(aryl)), 127.0 (C(aryl)), 126.8  (C(aryl)), 76.1 (C(2)), 56.6 (C(3)), 40.7 
(C(4)), 37.2 (C(1)), 20.9 (C(14)). 
IR: (neat) 
3088 (w), 3064 (m), 3029 (m), 1950 (w), 1874 (w), 1807 (w), 1738 (s), 1604 (m), 
1586 (w), 1496 (m), 1456 (m), 1372 (m), 1233 (s), 1074 (m), 938 (m), 742 (s), 699 
(s), 784 (m), 699 (s), 666 (m), 532 (w). 
MS: (CI, CH4 70 eV) 
347.1 (1), 208.2 (19), 207.2 (100), 129.1 (21), 91.1 (27) 
 HRMS:   calcd for C18H20O2Br: 347.06466, found: 347.06523 
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Opt. Rot: [α]D
24
 + 30.4 (c=1.4, EtOH) 
TLC: Rf  0.32 (hexanes/EtOAc, 9:1) [UV/I2/CAM] 
SFC: (2S,3R)-13, tR 5.44 (6.9%); (2R,3S)-13, tR 5.75 (93.1 %) (Chiralpak OD, 125 bar, 40 
o
C, 3% MeOH in CO2, 3 mL/min, 220 nm) 
Analysis: C18H19O2 Br (347.2) 
 Calcd: C, 62.26; H, 5.52%;  
 Found: C, 62.43; H, 5.50%; 
 
Crossover Experiment. Acetolysis of (2R,3S)-12c in the Presence of 0.25 equiv of 11. 
 
To a oven-dried, 5-mL Schlenk flask equipped with a magnetic stir bar and a septum was 
added (2R,3S)-12c (64 mg, 0.14 mmol, 96:4 er) as a solid, followed by 11 (5.5 μL, 0.035 mmol, 
0.25 equiv) by syringe under Ar.  A solution of NaOAc (23 mg, 2.0 mmol, 2.0 equiv) in HFIP 
(1.4 mL) was added rapidly by syringe with stirring. After ca. 40 min a cloudy white precipitate 
began to form. The solution was stirred at room temperature for another 50 h, after which 
pentane (2 mL), sat. aq. NaHCO3 solution (1 mL), and H2O (1 mL) were added. The resulting 
biphasic mixture was stirred for ca. 15 min then was transferred to a 60-mL separatory funnel 
where it was diluted with H2O (5 mL) and was washed with pentane (3 x 5 mL). The combined 
organic extracts were dried over MgSO4, filtered and concentrated in vacuo (23 
o
C, 10 mmHg). 
The residue was purified by column chromatography (silica gel (4.5 g), 1 cm diam, 
pentane/Et2O, gradient from 98:2 through 95:5 to 90:10) to provide 5 mg (14%) of (4R,5S)-10a 
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and 19 mg (40%) of  (2R,3S)-13 as colorless oils. 
Data for rel-(4R,5S)-10a:  
 GC: (4S,5R)-10a tR 18.09 min (49.0%); (4R,5S)-10a, tR 18.41 min (51.0%) (Chiraldex 
B-PH, 5 psi, 90 °C) 
Data for (2R,3S)-7: 
SFC: (2S,3R)-13, tR 5.47 (8.2%); (2R,3S)-13, tR 5.79 (91.8 %) (Chiralpak OD, 125 bar, 40 
o
C, 3% MeOH in CO2, 3 mL/min, 220 nm) 
 
Acetolysis of (4R,5S)-14. Preparation of (4R,5S)-5-Chloro-4-octyl Acetate ((4R,5S)-15a) 
 
To a flame-dried, 50-mL Schlenk flask equipped with a magnetic stir bar and a septum 
was added neat (4R,5S)-14 (296 mg, 1.00 mmol, 98:2 er) by syringe under Ar.
***
  
Dichloromethane (5 mL) was added by syringe, followed immediately by a solution of n-
Bu4NOAc (603 mg, 2.00 mmol, 2.00 equiv) in HFIP (5 mL). The solution was stirred at room 
temperature for 14 min after which pentane (10 mL), sat. aq. NaHCO3 solution (5 mL) and H2O 
(10 mL) were added. The resulting biphasic mixture was stirred for ca. 15 min then was 
transferred to a 125-mL separatory funnel where it was diluted with H2O (50 mL) and extracted 
with CH2Cl2 (30 mL) and pentane (2 x 30 mL). The combined organic extracts were washed 
with H2O (3 x 30 mL) and brine (30 mL), dried over MgSO4, filtered and concentrated at 
atmospheric pressure (45 
o
C). The residue was purified by column chromatography (silica gel 
                                                 
***
 Neat 8 may be handled at room temperature for short periods of time, if care is taken to minimize exposure to 
moisture. 
153 
 
(65 g), 3 cm diam, Et2O/pentane, 2:98) to provide a colorless oil, that was further purified by 
bulb-to-bulb distillation (95 
o
C, 10 mmHg) to provide 66 mg (32%) of (4R,5S)-15a as a colorless 
oil. 
Data for (4R,5S)-15a: 
1
H NMR:  (500 MHz, CDCl3) 
δ 5.00 (ddd, J = 9.6, 4.2, 3.3, 1 H, HC(4)), 4.00 (dt, J = 9.3, 4.2, 1 H, HC(5)), 2.09 (s, 
3 H, H3C(10)), 1.80 – 1.53 (m, 5 H, H2C(2, 3, 6)), 1.48 – 1.34 (m, 2 H, H2C(7)), 1.34 
– 1.21 (m, 1 H, H2C(2)), 0.94 (t, J = 7.1, 3 H, H3C(1, 8)), 0.93 (t, J = 7.4, 3 H, H3-
C(1, 8)). 
13
C NMR: (125 MHz, CDCl3) 
δ 170.6 (C(9)), 75.6 (C(4)), 63.9 (C(5)), 35.8 (C(3)), 31.8 (C(6)), 21.0 (C(10)), 19.8 
(C(2)), 18.6 (C(7)), 13.8 (C(1, 8)), 13.5 (C(1, 8)). 
IR: (neat) 
2962 (s), 2876 (s), 1747 (s), 1467 (m), 1435 (m), 1372 (s), 1235 (s), 1120 (m), 1120 
(m), 1061 (m), 1023 (s), 945 (w), 921 (w), 858 (w), 832 (w), 755 (m), 673 (w), 621 
(w). 
MS: (EI, 70 eV) 
207.1 (3), 147.1 (13), 128.2 (33), 116.1 (23), 115.1 (100), 111.2 (41),  103.1 (11), 
99.1 (23), 81.1 (14), 69.2 (37), 67.1 (12), 55.0 (59). 
HRMS: calcd for C10H20O2Cl
+
: 207.11518, found: 207.11476 
Opt. Rot: [α]D
24
 +15.3 (c=0.51, CHCl3) 
TLC: Rf  0.42 (hexanes/EtOAc, 9:1) [UV/I2/CAM] 
GC: (4S,5R)-15a, tR 16.72 min (1.8%); (4R,5S)-15a, tR 17.04 min (98.2%) (Chiraldex 
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B-PH, 5 psi, 80 °C) 
Analysis: C10H19O2Cl (206.7) 
 Calcd: C, 58.10; H, 9.26%;  
 Found: C, 58.25; H, 9.41%; 
 
General Procedure 3. Acetolysis of (4R,5S)-14 in the Presence of 0.25 equiv of 11.  
Preparation of (4R, 5S)-5-Bromo-4-octyl Acetate (15a) 
 
To a flame-dried, 5-mL Schlenk flask equipped with a magnetic stir bar and a septum 
was added neat (4R,5S)-14 (59 mg, 0.20 mmol, 98:2 er) by syringe under Ar. Dichloromethane 
(1 mL) and 11 (8 μL, 0.05 mmol, 0.3 equiv) were added by syringe followed immediately by a 
solution of n-Bu4NOAc (121 mg, 0.4 mmol, 2.0 equiv) in HFIP (1 mL). The solution was stirred 
at room temperature overnight after which pentane (2 mL), sat. aq. NaHCO3 solution (2 mL) and 
H2O (2 mL) were added. The resulting biphasic mixture was stirred for ca. 15 min then was 
transferred to a 125-mL separatory funnel where it was diluted with H2O (30 mL) and extracted 
with pentane (3 x 10 mL) and CH2Cl2 (4 mL). The combined organic extracts were washed with 
H2O (1 x 10 mL), dried over MgSO4, filtered and concentrated in vacuo. The residue was 
purified by column chromatography (silica gel (19 g), 2 cm diam, pentane/Et2O, 98:2) to yield 16 
mg (39%) of (4R,5S)-15a as a colorless oil. 
Data for (4R,5S)-10a: 
GC: (4S,5R)-15a, tR 17.98 min (1.9%); (4R,5S)-15a, tR 18.31 min (98.1%) (Chiraldex 
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B-PH, 5 psi, 80 °C) 
 
Acetolysis of (4R,5S)-14 in the Presence of 1.0 equiv of 11. 
 Following General Procedure 3, a 5-mL Schlenk flask was charged with (4R,5S)-14 (59 
mg, 0.2 mmol, 98:2 er), CH2Cl2 (1 mL) and 11 (31 μL, 0.2 mmol, 1.0 equiv), followed by a 
solution of n-Bu4NOAc (121 mg, 0.4 mmol, 2.0 equiv) in HFIP (1 mL) to yield after 
chromatography (silica gel (19 g), 2 cm diam, pentane/Et2O, 98:2) 18 mg (44%) of (4R,5S)-10a. 
Data for (4R,5S)-15a: 
GC: (4S,5R)-15a, tR 17.97 min (1.9%); (4R,5S)-15a, tR 18.32 min (98.1%) (Chiraldex 
B-PH, 5 psi, 80 °C) 
 
Preparation of (4S,5R)-4-Chloro-5-methoxyoctane ((4S,5R)-15b) 
 
To a flame-dried, 50-mL Schlenk flask equipped with a magnetic stir bar and a septum 
was added CH2Cl2 (5 mL), HFIP (5 mL), and MeOH (405 μL, 10.0 mmol, 10.0 equiv) under Ar. 
Neat (4R,5S)-14 (296 mg, 1.0 mmol, 98:2 er) was added dropwise by syringe. The bright yellow 
solution was stirred at room temperature for 40 min after which pentane (10 mL), sat. aq. 
NaHCO3 solution (5 mL) and H2O (10 mL) were added. The resulting biphasic mixture was 
stirred for ca. 15 min then was transferred to a 125-mL separatory funnel where it was diluted 
with H2O (50 mL) and extracted with pentane (3 x 30 mL). The combined organic extracts were 
dried over MgSO4, filtered and concentrated at atmospheric pressure (50 
o
C). The residue was 
purified by column chromatography (silica gel (65 g), 3 cm diam, pentane/Et2O, gradient from 
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1:0 to 98:2) to yield 75 mg (42%) of (4S,5R)-15b. The spectroscopic data are in accordance with 
those described in the literature.
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Data for (4S,5R)-15b: 
1
H NMR:  (500 MHz, CDCl3) 
δ 3.99 (dt, J = 9.6, 4.0, 1 H, HC(4)), 3.43 (s, J = 4.0, 3 H, H3C(9)), 3.25 (ddd, J = 
8.0, 4.4, 3.3, 1 H, HC(5)), 1.79 – 1.22 (m, 8H, H2C(2, 3, 6, 7)), 0.94 (t, J = 7.3, 3 H, 
H3C(1, 8)), 0.94 (t, J = 7.2, H3C(1, 8)). 
13
C NMR: (125 MHz, CDCl3) 
δ 84.2 (C(5)), 64.1 (C(4)), 58.4 (C(9)), 35.7 (C(3)), 32.9 (C(6)), 20.1 (C(2, 7)), 18.7 
(C(2, 7)), 14.1 (C(1, 8)), 13.5 (C(1, 8)). 
Opt. Rot: [α]D
24
 –4.7 (c=0.77, EtOH)  
TLC: Rf  0.53 (hexanes/EtOAc, 9:1) [I2/CAM] 
GC: (4S,5R)-15b, tR 8.68 (97.7%); (4R,5S)-15b, tR 8.92 (2.3%) (Chiraldex B-PH, 5 psi, 
60 °C) 
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C.3.2. Bromo and Iodocyclizations Catalyzed by Achiral Lewis Bases (Chapter 3) 
Lewis Base Catalyzed Bromolactonizations 
General Procedure 4. Bromolactonization of 16a. Preparation of rel-(5R,6S)-5-
Bromotetrahydro-6-phenyl-2H-pyran-2-one (17aa)
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A 20-mL, flame-dried Schlenk flask, fitted with a septum and a magnetic stir bar, was 
charged with N-bromosuccinimide (213 mg, 1.2 mmol, 1.2 equiv). The flask was wrapped in Al-
foil and then was evacuated and filled with argon. Dichloromethane (5.0 mL) was added via 
syringe, followed by a solution of 16a (176.1 mg, 1.0 mmol, 1.0 equiv) in CH2Cl2 (2.0 mL) via 
cannula. A solution of Ph3P=S in CH2Cl2 (500 μL, 0.1 M, 0.05 equiv, 0.05 mmol) was added 
rapidly via syringe, and the resulting solution was stirred for at room temperature for 5 min after 
which a yellow color was observed. Saturated aq. Na2S2O3 solution (5 mL) was added, and the 
resulting biphasic mixture was transferred to a 125-mL separatory funnel where it was diluted 
with H2O (10 mL) and was extracted with CH2Cl2 (4 x 10 mL). The combined organic extracts 
were dried over MgSO4, filtered and concentrated in vacuo (23 °C, 10 mmHg). The ratio of 17aa 
to 18aa was determined to be 90:1 by 
1
H NMR spectroscopy. The residue was purified by 
column chromatography (silica gel (18 g), 2 cm diam., CH2Cl2) to provide 207 mg (81%) of 
17aa as a white solid. 
Data for 17aa: 
mp: 104 - 106 °C 
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1
H NMR: (500 MHz, CDCl3) 
δ 7.45 – 7.35 (m, 1H, HC(Aryl)), 7.35 – 7.29 (m, 1H, HC(Aryl)), 5.57 (d, J = 6.3 Hz, 
1H, HC(6)), 4.39 (td, J = 6.5, 4.3 Hz, 1H, HC(5)), 2.96 (dt, J = 18.2, 7.8 Hz, 1H, 
HC(3)), 2.72 (dt, J = 18.2, 6.2 Hz, 1H, HC(3’)), 2.42 (dddd, J = 14.8, 8.4, 6.6, 4.3 
Hz, 1H, HC(4)), 2.27 (ddd, J = 14.3, 13.0, 6.7 Hz, 1H, HC(4’)). 
13
C NMR: (125 MHz, CDCl3) 
δ 169.0 (C(2)), 137.3 (C(7)), 129.1 (C(10)), 128.8 (C(8/9), 126.4 (C(8/9), 85.6 (C(6), 
47.2 (C(5)), 28.4 (C(3/4)), 27.6 (C(3/4)). 
 
General Procedure 5. In-situ IR Monitoring of the Bromolactonization of 16a in the 
Presence of (Me2N)2C=O (Table 4, entry 2)  
 
 
 An oven-dried, 3-necked React-IR cell was fitted with a magnetic stir bar, a septum and a 
stopper. The cell was fitted to the React-IR probe (DiComp), and purged with argon through an 
oil bubbler. Dichloromethane (0.8 mL) was added via syringe, and a background spectrum was 
acquired (2 cm
-1
 resolution, 700 – 1900 cm-1, 256 scans). The apparatus was wrapped in Al foil, 
and N-bromosuccinimide (43 mg, 0.24 mmol, 1.2 equiv.) was added under positive argon flow. 
Dichloromethane (0.2 mL) was added. Data acquisition was begun (2 cm
-1
 resolution, 32 scans, 
35 seconds/spectrum). A solution of 16a (35.5 mg, 0.2 mmol, 1.0 equiv) and 1,2,4,5-C6H2Cl4 
(12.6 mg) in CH2Cl2 (0.4 mL) was added via short cannula. After a delay to verify the stability of 
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data acquisition and the homogeneity of the reaction mixture, a solution of (Me2N)2C=O in 
CH2Cl2 (0.1 mL, 0.1 M, 0.01 mmol, 0.05 equiv) was added rapidly via syringe. The reaction 
mixture was allowed to stir for 3 h while the disappearance of 16a was monitored by its 
absorption at 967 cm
-1
. The half-life of the reaction was observed to be > 180 min. The reaction 
mixture was quenched with saturated aq. Na2S2O3 solution (1 mL), diluted with CH2Cl2 (4 mL) 
and allowed to stir for 20 min. An aliquot (ca. 4 mL) was taken from the organic phase, 
concentrated in vacuo, and analyzed by 
1
H NMR spectroscopy (4 scans, d1= 40 sec). A yield of 
36% was calculated by comparing the integrated area of the signal of 1,2,4,5-C6H2Cl4 (δ 7.5 (s, 
2H)) with the combined areas of the signals for H-6 of 17aa (δ 5.56 (d, J = 6.4 Hz, 1H)) and 
18aa (δ 5.01(d, J = 7.0 Hz, 1H)). The ratio of integrals for H-6 of 17aa and 18aa was 23:1. 
 
Bromolactonization of 16a in the Absence of a Catalyst (Table 4, entry 1) 
 Following General Procedure 5, a React-IR cell was charged with CH2Cl2 (0.8 mL) and 
N-bromosuccinimide (43 mg, 0.24 equiv), followed by CH2Cl2 (0.2 mL) and a solution of 16a 
(35.3 mg, 0.2 mmol, 1.0 equiv) and 1,2,4,5-C6H2Cl4 (13.1 mg) in CH2Cl2 (0.5 mL). The half-life 
of the reaction was observed to be > 180 min. After stirring for 3 h and quenching, 13% yield 
and a 25:1 ratio of 17aa:18aa were observed by 
1
H NMR spectroscopy. 
 
Bromolactonization of 16a in the Presence of n-Bu3P=O (Table 4, entry 3) 
 Following General Procedure 5, a React-IR cell was charged with CH2Cl2 (0.8 mL) and 
N-bromosuccinimide (43 mg, 0.24 equiv), followed by CH2Cl2 (0.2 mL), a solution of 16a (35.1 
mg, 0.2 mmol, 1.0 equiv) and 1,2,4,5-C6H2Cl4 (15.5 mg) in CH2Cl2 (0.4 mL) and a solution of n-
Bu3P=O in CH2Cl2 (0.1 mL, 0.1 M, 0.01 mmol, 0.05 equiv). The half-life of the reaction was 
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observed to be > 180 min. After stirring for 3 h and quenching, 47% yield and a 51:1 ratio of 
17aa:18aa were observed by 
1
H NMR spectroscopy. 
 
Bromolactonization of 16a in the Presence of (Me2N)3P=O (Table 4, entry 4) 
 Following General Procedure 5, a React-IR cell was charged with CH2Cl2 (0.8 mL) and 
N-bromosuccinimide (43 mg, 0.24 equiv), followed by CH2Cl2 (0.2 mL), a solution of 16a (35.5 
mg, 0.2 mmol, 1.0 equiv) and 1,2,4,5-C6H2Cl4 (11.5 mg) in CH2Cl2 (0.4 mL), and a solution of 
(Me2N)3P=O in CH2Cl2 (0.1 mL, 0.1 M, 0.01 mmol, 0.05 equiv). The half-life of the reaction 
was observed to be > 180 min. After stirring for 3 h and quenching, 15% yield and a 50:1 ratio of 
17aa:18aa were observed by 
1
H NMR spectroscopy. 
 
Bromolactonization of 16a in the Presence of Me2SO (Table 4, entry 5) 
 Following General Procedure 5, a React-IR cell was charged with CH2Cl2 (0.8 mL) and 
N-bromosuccinimide (43 mg, 0.24 equiv), followed by CH2Cl2 (0.2 mL), a solution of 16a (34.9 
mg, 0.2 mmol, 1.0 equiv) and 1,2,4,5-C6H2Cl4 (12.1 mg) in CH2Cl2 (0.4 mL) and a solution of 
Me2SO in CH2Cl2 (0.1 mL, 0.1 M, 0.01 mmol, 0.05 equiv). The half-life was observed to be 25 
min. After stirring for 1 h and quenching, 93% yield and a 23:1 ratio of 17aa:18aa were 
observed by 
1
H NMR spectroscopy. 
 
Bromolactonization of 16a in the Presence of (Me2N)2C=S (Table 4, entry 6) 
 Following General Procedure 5, a React-IR cell was charged with CH2Cl2 (0.8 mL) and 
N-bromosuccinimide (43 mg, 0.24 equiv), followed by CH2Cl2 (0.2 mL), a solution of 16a (35.6 
mg, 0.2 mmol, 1.0 equiv) and 1,2,4,5-C6H2Cl4 (11.6 mg) in CH2Cl2 (0.4 mL) and a solution of 
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(Me2N)2C=S in CH2Cl2 (0.1 mL, 0.1 M, 0.01 mmol, 0.05 equiv). The half-life was observed to 
be < 35 sec. After stirring for 8 min and quenching, 71% yield and a 7.3:1 ratio of 17aa:18aa 
were observed by 
1
H NMR spectroscopy. 
 
Bromolactonization of 16a in the Presence of Ph3P=S (Table 4, entry 7) 
 Following General Procedure 5, a React-IR cell was charged with CH2Cl2 (0.8 mL) and 
N-bromosuccinimide (43 mg, 0.24 equiv), followed by CH2Cl2 (0.2 mL), a solution of 16a (35.5 
mg, 0.2 mmol, 1.0 equiv) and 1,2,4,5-C6H2Cl4 (15.6 mg) in CH2Cl2 (0.4 mL) and a solution of 
Ph3P=S in CH2Cl2 (0.1 mL, 0.1 M, 0.01 mmol, 0.05 equiv). The half-life was observed to be < 
35 sec. After stirring for 8 min and quenching, 82% yield and a 91:1 ratio of 17aa:18aa were 
observed by 
1
H NMR spectroscopy. 
 
Bromolactonization of 16a in the Presence of n-Bu3P=S (Table 4, entry 8) 
 Following General Procedure 5, a React-IR cell was charged with CH2Cl2 (0.8 mL) and 
N-bromosuccinimide (43 mg, 0.24 equiv), followed by CH2Cl2 (0.2 mL), a solution of 16a (35.5 
mg, 0.2 mmol, 1.0 equiv) and 1,2,4,5-C6H2Cl4 (10.5 mg) in CH2Cl2 (0.4 mL) and a solution of n-
Bu3P=S in CH2Cl2 (0.1 mL, 0.1 M, 0.01 mmol, 0.05 equiv). The half-life was observed to be < 
35 sec. After stirring for 8 min and quenching, 89% yield and a 75:1 ratio of 17aa:18aa were 
observed by 
1
H NMR spectroscopy. 
 
Bromolactonization of 16a in the Presence of Cy3P=S (Table 4, entry 9) 
 Following General Procedure 5, a React-IR cell was charged with CH2Cl2 (0.8 mL) and 
N-bromosuccinimide (43 mg, 0.24 equiv), followed by CH2Cl2 (0.2 mL), a solution of 16a (34.7 
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mg, 0.2 mmol, 1.0 equiv) and 1,2,4,5-C6H2Cl4 (12.9 mg) in CH2Cl2 (0.4 mL) and a solution of 
Cy3P=S in CH2Cl2 (0.1 mL, 0.1 M, 0.01 mmol, 0.05 equiv). The half-life was observed to be < 
35 sec. After stirring for 8 min and quenching, 78% yield and a 25:1 ratio of 17aa:18aa were 
observed by 
1
H NMR spectroscopy. 
 
Bromolactonization of 16a in the Presence of ( Me2N)3P=S (Table 4, entry 10) 
 Following General Procedure 5, a React-IR cell was charged with CH2Cl2 (0.8 mL) and 
N-bromosuccinimide (43 mg, 0.24 equiv), followed by CH2Cl2 (0.2 mL), a solution of 16a (35.4 
mg, 0.2 mmol, 1.0 equiv) and 1,2,4,5-C6H2Cl4 (10.1 mg) in CH2Cl2 (0.4 mL) and a solution of 
(Me2N)3P=S in CH2Cl2 (0.1 mL, 0.1 M, 0.01 mmol, 0.05 equiv). The half-life was observed to 
be < 35 sec. After stirring for 8 min and quenching, 87% yield and a 3.4:1 ratio of 17aa:18aa 
were observed by 
1
H NMR spectroscopy. All material was combined and transferred to a 60-mL 
separatory funnel, where it was extracted with CH2Cl2 (3 x 3 mL). The combined organic 
extracts were dried over MgSO4, filtered and concentrated in vacuo. The residue was purified by 
column chromatography (silica gel (4.5 g), 1 cm diam., hexane/EtOAc 4:1) to provide 22.6 mg 
(44%) of 17aa as a white solid, and 21.3 mg (42 %) of a 1.3:1 mixture of 17aa and 18aa as a 
white solid. 
Data for 18aa: 
1
H NMR:  (500 MHz, CDCl3)  
δ 5.01 (d, J = 6.9 Hz, 1H, HC(6)), 4.97 – 4.86 (m, 1H, HC(5)), 2.57 – 2.46 (m, 3H, 
H2C(3, 4)), 2.32-2.20 (m, 1H, H2C(3, 4)) . 
13
C NMR: (125 MHz, CDCl3) 
δ 175.9 (C(2)), 137.1 (C(7)), 128.8 (C(8/9/10)), 128.2 (C(8/9/10)), 126.4(C(8/9/10)), 
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81.6 (C(5)), 55.4 (C(6)), 28.5 (C(3/4)), 26.4 C(3/4)). 
IR: (neat) 
 1779 (s, 17aa), 1747 (s, 18aa). 
 
Bromolactonization of 16a in the Presence of (CH2)4S (Table 4, entry 11) 
 Following General Procedure 5, a React-IR cell was charged with CH2Cl2 (0.8 mL) and 
N-bromosuccinimide (43 mg, 0.24 equiv), followed by CH2Cl2 (0.2 mL), a solution of 16a (35.2 
mg, 0.2 mmol, 1.0 equiv) and 1,2,4,5-C6H2Cl4 (11.8 mg) in CH2Cl2 (0.4 mL) and a solution of 
(CH2)4S in CH2Cl2 (0.1 mL, 0.1 M, 0.01 mmol, 0.05 equiv). The half-life was observed to be < 
35 sec. After stirring for 8 min and quenching, 89% yield and a 27:1 ratio of 17aa:18aa were 
observed by 
1
H NMR spectroscopy. 
 
Bromolactonization of 16a in the Presence of Me2S (Table 4, entry 12) 
 Following General Procedure 5, a React-IR cell was charged with CH2Cl2 (0.8 mL) and 
N-bromosuccinimide (43 mg, 0.24 equiv), followed by CH2Cl2 (0.2 mL), a solution of 16a (35.1 
mg, 0.2 mmol, 1.0 equiv) and 1,2,4,5-C6H2Cl4 (11.3 mg) in CH2Cl2 (0.4 mL) and a solution of 
Me2S in CH2Cl2 (0.1 mL, 0.1 M, 0.01 mmol, 0.05 equiv). The half-life was observed to be 6 min. 
After stirring for 20 min and quenching, 94% yield and a 19:1 ratio of 17aa:18aa were observed 
by 
1
H NMR spectroscopy. 
 
Bromolactonization of 16a in the Presence of (PhS)2 (Table 4, entry 13) 
 Following General Procedure 5, a React-IR cell was charged with CH2Cl2 (0.8 mL) and 
N-bromosuccinimide (43 mg, 0.24 equiv), followed by CH2Cl2 (0.2 mL), a solution of 16a (35.5 
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mg, 0.2 mmol, 1.0 equiv) and 1,2,4,5-C6H2Cl4 (12.0 mg) in CH2Cl2 (0.4 mL) and a solution of 
(PhS)2 in CH2Cl2 (0.1 mL, 0.1 M, 0.01 mmol, 0.05 equiv). The half-life was observed to be >180 
min. After stirring for 3 h and quenching, 8% yield was observed by 
1
H NMR spectroscopy. 
 
Bromolactonization of 16a in the Presence of n-Bu3P=Se (Table 4, entry 14) 
 Following General Procedure 5, a React-IR cell was charged with CH2Cl2 (0.8 mL) and 
N-bromosuccinimide (43 mg, 0.24 equiv), followed by CH2Cl2 (0.2 mL), a solution of 16a (34.9 
mg, 0.2 mmol, 1.0 equiv) and 1,2,4,5-C6H2Cl4 (10.9 mg) in CH2Cl2 (0.4 mL) and a solution of n-
Bu3P=Se in CH2Cl2 (0.1 mL, 0.1 M, 0.01 mmol, 0.05 equiv). The half-life was observed to be < 
30 sec. After stirring for 8 min and quenching, 78% yield and an 85:1 ratio of 17aa:18aa were 
observed by 
1
H NMR spectroscopy. 
 
Bromolactonization of 16a in the Presence of (Me2N)3P=Se (Table 4, entry 15) 
 Following General Procedure 5, a React-IR cell was charged with CH2Cl2 (0.8 mL) and 
N-bromosuccinimide (43 mg, 0.24 equiv), followed by CH2Cl2 (0.2 mL), a solution of 16a (35.0 
mg, 0.2 mmol, 1.0 equiv) and 1,2,4,5-C6H2Cl4 (11.5 mg) in CH2Cl2 (0.4 mL) and a solution of 
(Me2N)3P=Se in CH2Cl2 (0.1 mL, 0.1 M, 0.01 mmol, 0.05 equiv). The half-life was observed to 
be < 35 sec. After stirring for 8 min and quenching, 88% yield and an 8.1:1 ratio of 17aa:18aa 
were observed by 
1
H NMR spectroscopy. 
 
Bromolactonization of 16a in the Presence of (PhSe)2 (Table 4, entry 16) 
 Following General Procedure 5, a React-IR cell was charged with CH2Cl2 (0.8 mL) and 
N-bromosuccinimide (43 mg, 0.24 equiv), followed by CH2Cl2 (0.2 mL), a solution of 16a (35.3 
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mg, 0.2 mmol, 1.0 equiv) and 1,2,4,5-C6H2Cl4 (11.7 mg) in CH2Cl2 (0.4 mL) and a solution of 
(PhSe)2 in CH2Cl2 (0.1 mL, 0.1 M, 0.01 mmol, 0.05 equiv). The half-life was observed to be 
between 35 sec and 70 sec. After stirring for 8 min and quenching, 84% yield and a 94:1 ratio of 
17aa:18aa were observed by 
1
H NMR spectroscopy.  
 
Bromolactonization of 16a in the Presence of n-Bu3P (Table 4, entry 17) 
 Following General Procedure 5, a React-IR cell was charged with CH2Cl2 (0.8 mL) and 
N-bromosuccinimide (43 mg, 0.24 equiv), followed by CH2Cl2 (0.2 mL), a solution of 16a (35.4 
mg, 0.2 mmol, 1.0 equiv) and 1,2,4,5-C6H2Cl4 (12.0 mg) in CH2Cl2 (0.4 mL) and a solution of n-
Bu3P in CH2Cl2 (0.1 mL, 0.1 M, 0.01 mmol, 0.05 equiv). The half-life was observed to be < 35 
sec. After stirring for 5 min and quenching, 75% yield and a 38:1 ratio of 17aa:18aa were 
observed by 
1
H NMR spectroscopy.  
 
Bromolactonization of 16a in the Presence of (Me2N)3P (Table 4, entry 18) 
 Following General Procedure 5, a React-IR cell was charged with CH2Cl2 (0.8 mL) and 
N-bromosuccinimide (43 mg, 0.24 equiv), followed by CH2Cl2 (0.2 mL), a solution of 16a (35.5 
mg, 0.2 mmol, 1.0 equiv) and 1,2,4,5-C6H2Cl4 (11.8 mg) in CH2Cl2 (0.4 mL) and a solution of 
(Me2N)3P in CH2Cl2 (0.1 mL, 0.1 M, 0.01 mmol, 0.05 equiv). The half-life was observed to be < 
35 sec. After stirring for 8 min and quenching, 86% yield and a 6.7:1 ratio of 17aa:18aa were 
observed by 
1
H NMR spectroscopy.  
 
Bromolactonization of 16a in the Presence of Br2 (Table 4, entry 19) 
 Following General Procedure 5, a React-IR cell was charged with CH2Cl2 (0.8 mL) and 
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N-bromosuccinimide (43 mg, 0.24 equiv), followed by CH2Cl2 (0.2 mL), a solution of 16a (35.3 
mg, 0.2 mmol, 1.0 equiv) and 1,2,4,5-C6H2Cl4 (11.3 mg) in CH2Cl2 (0.4 mL) and a solution of 
Br2 in CH2Cl2 (0.1 mL, 0.1 M, 0.01 mmol, 0.05 equiv). The half-life was observed to be < 35 
sec. After stirring for 8 min and quenching, 64% yield and a 400:1 ratio of 17aa:18aa were 
observed by 
1
H NMR spectroscopy.  
 
Bromolactonization of 16b. Preparation of rel-(5R)-Dihydro-5-[(R)-bromophenylmethyl]-
2(3H)-furanone (18ba) 
 
A 20-mL, flame-dried Schlenk flask, fitted with a septum and a magnetic stir bar, was 
charged with N-bromosuccinimide (213 mg, 1.2 mmol, 1.2 equiv). The flask was wrapped in Al-
foil and then was evacuated and filled with argon. Dichloromethane (5.0 mL) was added via 
syringe, followed by a solution of 16b (176.1 mg, 1.0 mmol, 1.0 equiv) in CH2Cl2 (2.0 mL) via 
cannula. A solution of (Me2N)3P=S in CH2Cl2 (500 μL, 0.1 M, 0.05 equiv, 0.05 mmol) was 
added rapidly via syringe, and the resulting solution was stirred for at room temperature for 5 
min after which a yellow color was observed. Saturated aq. Na2S2O3 solution (5 mL) was added, 
and the resulting biphasic mixture was transferred to a 125-mL separatory funnel where it was 
diluted with H2O (25 mL) and was extracted with CH2Cl2 (3 x 25 mL). The combined organic 
extracts were dried over MgSO4, filtered and concentrated in vacuo (23 °C, 10 mmHg). The ratio 
of 17ba to 18ba was determined to be 1:40 by 
1
H NMR spectroscopy. The residue was purified 
by column chromatography (silica gel (19 g), 2 cm diam., CH2Cl2), to provide 211 mg (83%) of 
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18ba as a white solid, which was recrystallized from hot EtOAc/hexanes (ca. 0.3 mL/ 5 mL) to 
provide 206 mg (81%) of 18ba as colorless plates. 
Data for 18ba: 
mp: 126 – 129 °C  
1
H NMR: (500 MHz, CDCl3) 
 δ 7.62 – 7.41 (m, 2H, HC(Aryl)), 7.41 – 7.24 (m, 3H, HC(Aryl)), 4.99 (d, J = 5.5 
Hz, 1H, HC(6)), 4.91 (td, J = 7.0, 5.6 Hz, 1H, HC(5)), 2.55 – 2.33 (m, 2H, H2C(3)), 
2.31 – 2.17 (m, 1H, HC(4)), 2.05 (dddd, J = 13.4, 10.0, 8.4, 6.8 Hz, 1H, HC(4)). 
13
C NMR: (125 MHz, CDCl3) 
 δ 175.9 (C(2)), 136.8 (C(7)), 129.1 (C(10)), 128.8 (C(8/9)), 128.4 (C(8/9)), 81.9 
(C(5)), 55.1 (C(6)), 28.3 (C(3)), 25.6 (C(4)). 
IR: (KBr pellet) 
3064 (w), 2936 (w), 1777 (s), 1458 (w), 1419 (w), 1335 (w), 1175 (s), 1146 (m), 
1052 (m), 1030 (m), 918 (m), 870 (w), 783 (w), 706 (s), 664 (m), 597 (w).  
MS: (EI, 70 eV) 
85 (100), 91 (25), 175 (47), 254 (1, M
79
Br
+
), 256 (1, M
81
Br
+
). 
TLC: Rf 0.11 (hexanes/EtOAc, 4:1) [UV] 
Analysis: C11H11O2Br (255.1) 
 Calcd: C, 51.79; H, 4.35;  
Found: C, 51.52; H, 4.24;  
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Bromolactonization of 16b in the Presence of Ph3P=S.  
 
 A 5-mL, flame-dried Schlenk flask, fitted with a septum and a magnetic stir bar, was 
charged with N-bromosuccinimide (21 mg, 0.12 mmol, 1.2 equiv). The flask was wrapped in Al-
foil and then was evacuated and filled with argon. Dichloromethane (0.5 mL) was added via 
syringe. Neat 16b (17.2 mg, 0.1 mmol, 1.0 equiv) was added via syringe, followed by CH2Cl2 
(0.2 mL). A solution of Ph3P=S in CH2Cl2 (50 μL, 0.1 M, 0.05 equiv, 0.005 mmol) was added 
rapidly via syringe, and the resulting solution was stirred for at room temperature for 5 min. Sat. 
aq. Na2S2O3 solution (1 mL) was added, and the resulting biphasic mixture was transferred to a 
60-mL separatory funnel where it was diluted with brine (4 mL) and H2O (1 mL) and was 
extracted with CH2Cl2 (3 x 5 mL). The combined organic extracts were dried over MgSO4, 
filtered and concentrated in vacuo (23 °C, 10 mmHg). A 1.4:1 mixture of 18ba and 17ba was 
observed by 
1
H NMR spectroscopy. The residue was purified by column chromatography (silica 
gel (4.5 g), 1 cm diam., gradient from hexane/CH2Cl2 1:1 to 0:1), to provide 9.8 mg (39%) of a 
7.7:1 mixture of 18ba and 17ba, and 5.9 mg (24%) of a 0.02:1 mixture of 18ba and 17ba. 
Data for 17ba: 
1
H NMR:  (500 MHz, CDCl3)  
 δ 7.45 – 7.32 (m, 5H, HC(Aryl)), 5.49 (d, J = 1.5 Hz, 1H, HC(6)), 4.58 (m, 1H, 
HC(5)), 3.05 (ddd, J = 18.7, 10.9, 8.0 Hz, 1H, HC(3)), 2.79 (ddd, J = 18.6, 7.3, 1.9 
Hz, 1H, HC(3’)), 2.63 (dddd, J = 14.4, 10.8, 7.3, 3.3 Hz, 1H, HC(4)), 2.49 (dddd, J = 
14.5, 7.9, 3.3, 2.2 Hz, 1H, HC(4’)).  
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Bromolactonization of 16c. Preparation of rel-(5R)-5-[(1’S)-1’-Bromo-2’-
methylpropyl]dihydro-2(3H)-furanone (18ca) 
 
A 50-mL, flame-dried Schlenk flask, fitted with a septum and a magnetic stir bar, was 
charged with N-bromosuccinimide (213 mg, 1.2 mmol, 1.2 equiv). The flask was wrapped in Al-
foil and then was evacuated and filled with argon. Dichloromethane (5.0 mL) was added via 
syringe, followed by 16c (141.8 mg, 1.0 mmol, 1.0 equiv) via syringe and CH2Cl2 (2.0 mL) via 
syringe. A solution of (Me2N)3P=S in CH2Cl2 (500 μL, 0.1 M, 0.05 equiv, 0.05 mmol) was 
added rapidly via syringe, and the resulting solution was stirred for at room temperature for 5 
min after which a yellow color was observed. Sat. aq. Na2S2O3 solution (5 mL) was added, and 
the resulting biphasic mixture was transferred to a 250-mL separatory funnel where it was 
diluted with H2O (25 mL) and was extracted with EtOAc (3 x 25 mL). The combined organic 
extracts were washed with sat. aq. NaHCO3 (25 mL), dried over MgSO4, filtered, and 
concentrated in vacuo (23 °C, 10 mmHg). The residue was purified by column chromatography 
(silica gel (37 g), 3 cm diam., hexane/EtOAc, 80:20), followed by bulb-to-bulb distillation (100 – 
110 °C, 0.46 mmHg) to provide 193.1 mg (88%) of a 6:1 mixture of 18ca and 17ca as a colorless 
oil. 
Data for 18ca: 
bp: 100 – 110 °C (0.46 mmHg, ABT) 
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1
H NMR:  (500 MHz, CDCl3)  
δ 4.66 – 4.55 (m, 1H, HC(5)), 3.94 (dd, J = 9.0, 3.3 Hz, 1H, HC(6)), 2.59 – 2.46 (m, 
3H, HC(4, 3, 3’)), 2.16 (dtt, J = 13.3, 6.6, 3.4 Hz, 1H, HC(7)), 2.13 – 2.04 (m, 1H, 
HC(4’)), 1.02 (d, J = 6.7 Hz, 3H, H3C(8)), 0.98 (d, J = 6.5 Hz, 3H, H3C(9)). 
13
C NMR: (125 MHz, CDCl3) 
δ 176.3 (C(2)), 79.5 (C(5)), 65.8 (C(6)), 30.0 (C(7)), 28.4 (C(3)), 27.5 (C(4)), 21.3 
(C(8)), 16.8 (C(9)). 
IR: (neat) 
2968 (s), 2879 (m), 1790 (s), 1464 (m), 1421 (m), 1370 (m), 1334 (m), 1174 (s), 
1116 (m), 1023 (s), 991 (m), 912 (m), 871 (m), 823 (m), 803 (m), 705 (w), 666 (m), 
529 (w). 
MS: (EI, 70 eV) 
55 (12), 85 (100), 99 (6), 141 (6), 219 (M
79
Br – H-, 2), 221 (M81Br – H-, 2). 
TLC: Rf 0.29 (hexanes/EtOAc, 4:1) [UV/I2/CAM] 
Analysis: C8H13O2 Br (221.1) 
 Calcd: C, 43.46; H, 5.93;  
 Found: C, 43.68; H, 5.90;  
Data for 17ca: 
1
H NMR:  (500 MHz, CDCl3)  
δ 4.31 (dd, J = 8.2, 3.7 Hz, 1H, HC(6)), 4.19 (td, J = 8.0, 5.0 Hz, 1H, HC(5)), 2.79 
(tt, J = 15.7, 7.8 Hz, 1H, HC(3)), 2.60-2.52 (m, 1H, HC(3’)), 2.50 – 2.40 (m, 1H, 
HC(4)), 2.33 (dt, J = 14.3, 6.7 Hz, 1H, HC(4’)), 2.29-2.24 (m, 1H, HC(7)) 1.10 (d, J 
= 7.0 Hz, 3H, (H3C(8)), 1.00 (d, J = 6.8 Hz, 3H, H3C(9)). 
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13
C NMR: (125 MHz, CDCl3) 
δ 87.6 (C(6)), 44.0 (C(5)), 30.3, 29.5, 28.94, 19.3 (C(8)), 15.1 (C(9)). 
IR: (KBr pellet) 
1748 (s). 
 
Lewis Base Catalyzed Bromocycloetherifications 
Bromocycloetherification of 19a. Preparation of rel-(2R,3S)-3-Bromotetrahydro-2-phenyl-
2H-pyran, (20aa)
166
 
 
 A 20-mL, flame-dried Schlenk flask, fitted with a septum and a magnetic stir bar, was 
charged with N-bromosuccinimide (213 mg, 1.2 mmol, 1.2 equiv). The flask was wrapped in Al-
foil and then was evacuated and filled with argon. Dichloromethane (5.0 mL) was added via 
syringe, followed by a solution of 19a (162.0 mg, 1.0 mmol, 1.0 equiv) and AcOH (57 μL, 1.0 
mmol, 1.0 equiv) in CH2Cl2 (2.0 mL) via cannula. A solution of Ph3P=S in CH2Cl2 (500 μL, 0.1 
M, 0.05 equiv, 0.05 mmol) was added rapidly via syringe, and the resulting solution was stirred 
for at room temperature for 5 min after which a yellow color was observed. Saturated aq. 
Na2S2O3 solution (5 mL) and sat. aq. NaHCO3 solution (5 mL) were added, and the resulting 
biphasic mixture was transferred to a 125-mL separatory funnel where it was diluted with H2O 
(20 mL) and was extracted with EtOAc (3 x 25 mL). The combined organic extracts were dried 
over MgSO4, filtered and concentrated in vacuo (23 °C, 10 mmHg). The ratio of 20aa to 21aa 
was determined to be 11:1 by 
1
H NMR spectroscopy. The residue was purified by column 
172 
 
chromatography (silica gel (35 g), 3 cm diam., hexane/EtOAc, 95:5) to provide 166.5 mg (69%) 
of 20aa as colorless needles. 
Data for 20aa: 
mp: 41 – 42 °C 
1
H NMR: (500 MHz, CDCl3) 
δ 7.42 – 7.29 (m, 5H, HC(Aryl)), 4.32 (d, J = 10.0 Hz, 1H, HC(2)), 4.14 (ddt, J = 
11.4, 4.5, 1.6 Hz, 1H, HC(6)), 4.06 (ddd, J = 11.7, 10.1, 4.4 Hz, 1H, HC(3)), 3.65 
(td, J = 12.0, 2.2 Hz, 1H, HC(6’)), 2.65 – 2.54 (m, 1H, HC(4/5), 2.13 (tdd, J = 13.0, 
11.6, 4.2 Hz, 1H, HC(4’)), 1.95 (ddddd, J = 13.8, 13.1, 12.3, 4.7, 3.8 Hz, 1H, 
HC(5’)), 1.83 – 1.70 (m, 1H, HC(4/5)) 
  
Bromocycloetherification of 19b. Preparation of rel-(2R)-Tetrahydro-2-[(1’S)-1’-bromo-3-
phenylpropyl]furan (21ba) 
 
A 50-mL, flame-dried Schlenk flask, fitted with a septum and a magnetic stir bar, was 
charged with N-bromosuccinimide (213 mg, 1.2 mmol, 1.2 equiv). The flask was wrapped in Al-
foil and then was evacuated and filled with argon. Dichloromethane (5.0 mL) was added via 
syringe, followed by 19c (189.7 mg, 1.0 mmol, 1.0 equiv), AcOH (57 μL, 1.0 mmol, 1.0 equiv), 
and CH2Cl2 (2.0 mL). A solution of Ph3P=S in CH2Cl2 (500 μL, 0.1 M, 0.05 equiv, 0.05 mmol) 
was added rapidly via syringe, and the resulting solution was stirred for at room temperature for 
5 min after which a yellow color was observed. Sat. aq. Na2S2O3 solution (5 mL) and sat. aq. 
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NaHCO3 solution (5 mL) were added. The resulting biphasic mixture was transferred to a 250-
mL separatory funnel where it was diluted with H2O (25 mL) and was extracted with EtOAc (3 x 
25 mL). The combined organic extracts were washed with sat. aq. NaHCO3 solution (25 mL) and 
brine (25 mL). The organic extracts were dried over MgSO4, filtered and concentrated in vacuo 
(23 °C, 10 mmHg). The ratio of 21ba to 20ba was determined to be 12:1 by 
1
H NMR 
spectroscopy. The residue was purified by column chromatography (silica gel (36 g), 3 cm diam., 
hexane/EtOAc, 95:5), to provide a light straw-colored oil, which was further purified by bulb-to-
bulb distillation (55 - 65 °C, 3.4 x 10
-5
 mmHg) to provide 223.1 mg (83%) of 21ba as a colorless 
oil. 
Data for 21ba: 
bp: 55 – 65 °C (ABT, 3.4 x 10-5 mmHg) 
1
H NMR: (500 MHz, CDCl3) 
δ 7.33 – 7.27 (m, 2H, HC(argon)), 7.25 – 7.18 (m, 3H, HC(argon)), 3.99 (q, J = 6.7 
Hz, 1H, HC(2)), 3.93 (ddd, J = 9.9, 7.0, 2.8 Hz, 1H, HC(6)), 3.89 (dt, J = 14.3, 6.8 
Hz, 1H, H2C(5/5’)), 3.85 – 3.79 (m, 1H, H2C(5/5’)), 2.98 (ddd, J = 13.9, 9.3, 4.7 Hz, 
1H, H2C(8/8’)), 2.75 (ddd, J = 13.8, 9.1, 7.4 Hz, 1H, H2C(8/8’)), 2.37 – 2.25 (m, 1H, 
H2C(7/7’)), 2.16 – 2.07 (m, 1H, H2C(3/3’)), 2.07 – 1.98 (m, 1H, H2C(7/7’)), 1.98 – 
1.75 (m, 3H, H2C(3/3’, 4, 4’)). 
13
C NMR: (125 MHz, CDCl3) 
δ 140.9 (C(9)), 128.5 (C(10/11)), 128.4 (C(10/11)), 126.0 (C(12)), 81.8 (C(2)), 68.9 
(C(5)), 59.3 (C(6)), 36.9 (C(7)), 33.4 (C(8)), 30.2 (C(3)), 25.9 (C(4)). 
IR: (neat) 
3062 (w), 3027 (m), 2950 (s), 2865 (s), 1603 (m), 1497 (m), 1454 (s), 1357 (w), 
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1283 (w), 1192 (m), 1061 (s), 926 (m), 750 (s), 700 (s), 626 (w). 
MS: (EI, 70 eV) 
55 (18), 65 (13), 71 (13), 87 (20), 91 (100), 92 (15), 97 (31), 104 (36), 105 (21), 115 
(18), 117 (32), 129 (13), 141 (13), 143 (23), 145 (12), 162 (11), 164 (10), 169 (45), 
187 (72), 188 (14), 205 (13), 267 (37, M 
79
Br - H
-
), 269 (34, M 
81
Br - H
-
). 
TLC: Rf 0.22 (hexanes/EtOAc, 19:1) [UV] 
Analysis: C13H17O Br (269.2) 
 Calcd: C, 58.01; H, 6.37;  
 Found: C, 58.10; H, 6.28;  
 
Bromocycloetherification of 19c. Preparation of rel-(2R)-Tetrahydro-2-[(1’R)-1’-bromo-3-
phenylpropyl]furan (21ca) 
 
A 50-mL, flame-dried Schlenk flask, fitted with a septum and a magnetic stir bar, was 
charged with N-bromosuccinimide (213 mg, 1.2 mmol, 1.2 equiv). The flask was wrapped in Al-
foil and then was evacuated and filled with argon. Dichloromethane (5.0 mL) was added via 
syringe, followed by 19c (189.7 mg, 1.0 mmol, 1.0 equiv), AcOH (57 μL, 1.0 mmol, 1.0 equiv), 
and CH2Cl2 (2.0 mL). A solution of Ph3P=S in CH2Cl2 (500 μL, 0.1 M, 0.05 equiv, 0.05 mmol) 
was added rapidly via syringe, and the resulting solution was stirred for at room temperature for 
5 min after which a yellow color was observed. Saturated aq. Na2S2O3 solution (5 mL) and sat. 
aq. NaHCO3 solution (5 mL) were added, and the resulting biphasic mixture was transferred to a 
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250-mL separatory funnel where it was diluted with H2O (25 mL) and was extracted with EtOAc 
(3 x 25 mL). The combined organic extracts were washed with sat. aq. NaHCO3 solution (25 
mL) and brine (25 mL). The organic extracts were dried over MgSO4, filtered and concentrated 
in vacuo (23 °C, 10 mmHg). The ratio of 21ca to 20ca was determined to be >19:1 by 
1
H NMR 
spectroscopy. The residue was purified by column chromatography (silica gel (35 g), 3 cm diam., 
hexane/EtOAc, 95:5), to provide 205.5 mg of a light straw-colored oil, which was further 
purified by bulb-to-bulb distillation (60 - 75 °C, 3.4 x 10
-5
 mmHg) to provide 201.5 mg (75%) of 
21ca as a colorless oil. 
Data for 21ca: 
bp: 60 – 75 °C (ABT, 3.4 x 10-5 mmHg) 
1
H NMR: (500 MHz, CDCl3) 
δ 7.34 – 7.27 (m, 2H, HC(argon)), 7.25 – 7.16 (m, 3H, HC(argon)), 4.05 – 3.98 (m, 
1H, HC(2)), 3.98 – 3.90 (m, 2H, HC(6, 5/5’)), 3.82 (td, J = 7.7, 5.7 Hz, 1H, 
H2C(5/5’)), 2.98 (ddd, J = 13.7, 8.2, 5.5 Hz, 1H, HC(8/8’)), 2.77 (dt, J = 13.8, 8.2 
Hz, 1H, HC(8/8’)), 2.21 – 2.11 (m, 2H, HC(7,7’)), 2.06 – 1.94 (m, 3H, HC(3, 4, 4’)), 
1.82 – 1.72 (m, 1H, HC(3’)). 
13
C NMR: (125 MHz, CDCl3) 
δ 140.8 (C(9)), 128.5 (C(10/11)), 128.4 (C(10/11)), 126.1 (C(12)), 81.7 (C(2)), 68.9 
(C(5)), 58.9 (C(6)), 36.5 (C(7)), 33.7 (C(8)), 29.5 (C(3)), 26.1 (C(4)). 
IR: (neat) 
3062 (m), 3026 (m), 2951 (s), 2865 (s), 1603 (m), 1496 (s), 1454 (s), 1358 (m), 1289 
(w), 1239 (m), 1058 (s), 1030 (m), 925 (m), 750 (s), 700 (s), 621 (w). 
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MS: (EI, 70 eV) 
55 (16), 65 (18), 74 (84), 77 (10), 87 (14), 91 (100), 92 (14), 97 (38), 104 (29), 105 
(16), 115 (13), 117 (21), 129 (11), 267 (M 
79
Br - H
-
, 6), 269 (M 
81
Br - H
-
, 5). 
TLC: Rf 0.19 (hexanes/EtOAc, 19:1) [UV] 
Analysis: C13H17O Br (269.2) 
 Calcd: C, 58.01; H, 6.37;  
 Found: C, 57.88; H, 6.35;  
 
Lewis Base Catalyzed Iodolactonizations 
Iodolactonization of 16a. Preparation of rel-(5R,6S)-5-iodotetrahydro-6-phenyl-2H-pyran-
2-one (17ab)
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A 20-mL, flame-dried Schlenk flask, fitted with a septum and a magnetic stir bar and 
wrapped in foil, was charged with N-iodosuccinimide (270 mg, 1.2 mmol, 1.2 equiv). The flask 
was evacuated and filled with argon. Dichloromethane (5.0 mL) was added via syringe and then 
a thermocouple was fitted and the flask was cooled to -45 °C (CO2/MeCN bath, internal temp). 
A solution of 16a (176.0 mg, 1.0 mmol, 1.0 equiv) and TFA (3.8 μL, 0.05 mmol, 0.05 equiv) in 
CH2Cl2 (2.0 mL) was added via cannula. Next, a solution of nBu3P=S in CH2Cl2 (500 μL, 0.1 M, 
0.05 equiv, 0.05 mmol) was added rapidly via syringe. The reaction mixture was stirred at -45 °C 
for 2 h, and then a solution of butyl vinyl ether in EtOH (2.5 mL, 1.2 M, 3.0 equiv) was added. 
After 5 min, sat. aq. Na2S2O3 solution (5 mL) was added and the resulting biphasic mixture was 
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allowed to warm to room temperature. Saturated aq. NaHCO3 solution (5 mL) was added and the 
reaction mixture was transferred to a 250-mL separatory funnel where it was diluted with H2O 
(20 mL) and was extracted with EtOAc (3 x 25 mL). The ratio of 17ab to 18ab was determined 
to be 32:1 by 
1
H NMR spectroscopy. The combined organic extracts were dried over MgSO4, 
filtered and concentrated in vacuo (23 °C, 10 mmHg). The residue was purified by column 
chromatography (silica gel (35 g), 3 cm diam., hexane/EtOAc, 80:20) to provide 183.4 mg (61%) 
of 17ab as a white solid.  
Data for 17ab: 
mp: 68 – 76 °C (dec.) 
1
H NMR: (500 MHz, CDCl3) 
δ 7.44 – 7.36 (m, 3H, HC(Aryl)), 7.36 – 7.29 (m, 2H, HC(Aryl), 5.56 (d, J = 7.8 Hz, 1H, 
HC(6)), 4.42 (td, J = 8.0, 4.6 Hz, 1H, HC(5)), 2.86 (dt, J = 18.1, 6.9 Hz, 1H, HC(3)), 2.72 
(dt, J = 18.2, 6.9 Hz, 1H, HC(3’)), 2.51 – 2.33 (m, 2H, H2C(4)). 
 
General Procedure 6. In-situ IR Monitoring of the Iodolactonization of 16a in the Presence 
of (Me2N)2C=O. 
 
 An oven-dried, 3-necked React-IR cell was fitted with a magnetic stir bar, a septum, a 
thermometer adapter and a thermocouple. The cell was fitted to the React-IR probe (DiComp), 
and was wrapped in Al foil. N-iodosuccinimide (54 mg, 0.24 mmol, 1.2 equiv) was added and 
the cell was purged with argon through an oil bubbler. Dichloromethane (1.0 mL) was added via 
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syringe, the cell was cooled to -45 °C and a background spectrum was acquired (2 cm
-1
 
resolution, 700 – 1900 cm-1, 256 scans). Data acquisition was begun (2 cm-1 resolution, 32 scans, 
35 seconds/spectrum). A solution of 16a (35.3 mg, 0.2 mmol, 1.0 equiv) and C6Me6 (12.6 mg) in 
CH2Cl2 (0.4 mL) was added via a short cannula. After a delay to verify the stability of data 
acquisition and the efficient stirring of the reaction mixture, a solution of (Me2N)2C=O in 
CH2Cl2 (0.1 mL, 0.1 M, 0.01 mmol, 0.05 equiv) was added rapidly via syringe. The reaction 
mixture was allowed to stir for 3 h while the disappearance of 16a was monitored by its 
absorption at 967 cm
-1
. The half-life was observed to be >180 min. The reaction mixture was 
quenched with a solution of butyl vinyl ether in EtOH (0.5 mL, 1.2 M, 3.0 equiv) and was 
allowed to stir at -45 
°
C for 15 min. Saturated aq. Na2S2O3 solution (1 mL) was added and the 
resulting biphasic mixture was allowed to warm to room temperature, then was diluted with 
CH2Cl2 (4 mL) and was allowed to stir for 20 min. An aliquot (ca. 4 mL) was taken from the 
organic phase, concentrated in vacuo, and analyzed by 
1
H NMR spectroscopy (4 scans, d1= 40 
sec). A yield of 10% was calculated by comparing the integrated area of the signal of C6Me6 (δ 
2.24 (s, 18H)) with the combined areas of the signals for H-6 of 17ab (δ 5.56 (d, J = 7.9 Hz, 1H)) 
and 18ab (δ 5.13 (d, J = 7.9 Hz, 1H)). The ratio of integrals for H-6 of 17ab and 18ab was 20:1.  
 
Iodolactonization of 16a in the Absence of a Catalyst (Table 5, entry 1) 
 Following General Procedure 6, a React-IR cell was charged with CH2Cl2 (1.0 mL), N-
iodosuccinimide (54 mg, 0.24 equiv), and a solution of 16a (35.3 mg, 0.2 mmol, 1.0 equiv) and 
C6Me6 (11.1 mg) in CH2Cl2 (0.5 mL). The half-life was observed to be >180 min. After stirring 
for 3 h and quenching, 4% yield and a 9.5:1 ratio of 17ab:18ab were observed by 
1
H NMR 
spectroscopy. 
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Iodolactonization of 16a in the Presence of n-Bu3P=O (Table 5, entry 3) 
 Following General Procedure 6, a React-IR cell was charged with CH2Cl2 (1.0 mL), N-
iodosuccinimide (54 mg, 0.24 equiv), a solution of 16a (35.5 mg, 0.2 mmol, 1.0 equiv) and 
C6Me6 (11.6 mg) in CH2Cl2 (0.4 mL), and a solution of n-Bu3P=O in CH2Cl2 (0.1 mL, 0.1 M, 
0.01 mmol, 0.05 equiv). The half-life was observed to be >180 min. After stirring for 3 h and 
quenching, 14% yield and a 16:1 ratio of 17ab:18ab were observed by 
1
H NMR spectroscopy. 
 
Iodolactonization of 16a in the Presence of ( Me2N)3P=O (Table 5, entry 4) 
 Following General Procedure 6, a React-IR cell was charged with CH2Cl2 (1.0 mL), N-
iodosuccinimide (54 mg, 0.24 equiv), a solution of 16a (35.4 mg, 0.2 mmol, 1.0 equiv) and 
C6Me6 (10.4 mg) in CH2Cl2 (0.4 mL), and a solution of (Me2N)3P=O in CH2Cl2 (0.1 mL, 0.1 M, 
0.01 mmol, 0.05 equiv). The half-life was observed to be >180 min. After stirring for 3 h and 
quenching, 33% yield and a 20:1 ratio of 17ab:18ab were observed by 
1
H NMR spectroscopy. 
 
Iodolactonization of 16a in the Presence of Me2SO (Table 5, entry 5) 
 Following General Procedure 6, a React-IR cell was charged with CH2Cl2 (1.0 mL), N-
iodosuccinimide (54 mg, 0.24 equiv), a solution of 16a (35.2 mg, 0.2 mmol, 1.0 equiv) and 
C6Me6 (10.3 mg) in CH2Cl2 (0.4 mL), and a solution of Me2SO in CH2Cl2 (0.1 mL, 0.1 M, 0.01 
mmol, 0.05 equiv). The half-life was observed to be >180 min. After stirring for 3 h and 
quenching, 4% yield was observed by 
1
H NMR spectroscopy. 
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Iodolactonization of 16a in the Presence of ( Me2N)2C=S (Table 5, entry 6) 
 Following General Procedure 6, a React-IR cell was charged with CH2Cl2 (1.0 mL), N-
iodosuccinimide (54 mg, 0.24 equiv), a solution of 16a (35.4 mg, 0.2 mmol, 1.0 equiv) and 
C6Me6 (10.6 mg) in CH2Cl2 (0.4 mL), and a solution of (Me2N)2C=S in CH2Cl2 (0.1 mL, 0.1 M, 
0.01 mmol, 0.05 equiv). The half-life was observed to be 4 min. After stirring for 1 h and 
quenching, 91% yield and a 4.7:1 ratio of 17ab:18ab were observed by 
1
H NMR spectroscopy. 
 
Iodolactonization of 16a in the Presence of Ph3P=S (Table 5, entry 7) 
 Following General Procedure 6, a React-IR cell was charged with CH2Cl2 (1.0 mL), N-
iodosuccinimide (54 mg, 0.24 equiv), a solution of 16a (35.2 mg, 0.2 mmol, 1.0 equiv) and 
C6Me6 (10.2 mg) in CH2Cl2 (0.4 mL), and a solution of Ph3P=S in CH2Cl2 (0.1 mL, 0.1 M, 0.01 
mmol, 0.05 equiv). The half-life was observed to be 35 min. After stirring for 1 h and quenching, 
92% yield and a 5.5:1 ratio of 17ab:18ab were observed by 
1
H NMR spectroscopy. 
 
Iodolactonization of 16a in the Presence of n-Bu3P=S (Table 5, entry 8) 
 Following General Procedure 6, a React-IR cell was charged with CH2Cl2 (1.0 mL), N-
iodosuccinimide (54 mg, 0.24 equiv), a solution of 16a (35.4 mg, 0.2 mmol, 1.0 equiv) and 
C6Me6 (11.8 mg) in CH2Cl2 (0.4 mL), and a solution of n-Bu3P=S in CH2Cl2 (0.1 mL, 0.1 M, 
0.01 mmol, 0.05 equiv). The half-life was observed to be 7 min. After stirring for 1 h and 
quenching, 72% yield and a 6.1:1 ratio of 17ab:18ab were observed by 
1
H NMR spectroscopy. 
 
Iodolactonization of 16a in the Presence of Cy3P=S (Table 5, entry 9) 
 Following General Procedure 6, a React-IR cell was charged with CH2Cl2 (1.0 mL), N-
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iodosuccinimide (54 mg, 0.24 equiv), a solution of 16a (35.3 mg, 0.2 mmol, 1.0 equiv) and 
C6Me6 (10.5 mg) in CH2Cl2 (0.4 mL), and a solution of Cy3P=S in CH2Cl2 (0.1 mL, 0.1 M, 0.01 
mmol, 0.05 equiv). The half-life was observed to be 8 min. After stirring for 1 h and quenching, 
93% yield and a 1.7:1 ratio of 17ab:18ab were observed by 
1
H NMR spectroscopy. 
  
Iodolactonization of 16a in the Presence of ( Me2N)3P=S (Table 5, entry 10) 
 Following General Procedure 6, a React-IR cell was charged with CH2Cl2 (1.0 mL), N-
iodosuccinimide (54 mg, 0.24 equiv), a solution of 16a (35.4 mg, 0.2 mmol, 1.0 equiv) and 
C6Me6 (10.1 mg) in CH2Cl2 (0.4 mL), and a solution of (Me2N)3P=S in CH2Cl2 (0.1 mL, 0.1 M, 
0.01 mmol, 0.05 equiv). The half-life was observed to be 4 min. After stirring for 1 h and 
quenching, 97% yield and a 2.5:1 ratio of 17ab:18ab were observed by 
1
H NMR spectroscopy.  
 
Iodolactonization of 16a in the Presence of (CH2)4S (Table 5, entry 11) 
Following General Procedure 6, a React-IR cell was charged with CH2Cl2 (1.0 mL), N-
iodosuccinimide (54 mg, 0.24 equiv), a solution of 16a (35.1 mg, 0.2 mmol, 1.0 equiv) and 
C6Me6 (13.1 mg) in CH2Cl2 (0.4 mL), and a solution of (CH2)4S in CH2Cl2 (0.1 mL, 0.1 M, 0.01 
mmol, 0.05 equiv). The half-life was observed to be 10 min. After stirring for 1 h and quenching, 
97% yield and a 5.8:1 ratio of 17ab:18ab were observed by 
1
H NMR spectroscopy.  
 
Iodolactonization of 16a in the Presence of Me2S (Table 5, entry 12) 
Following General Procedure 6, a React-IR cell was charged with CH2Cl2 (1.0 mL), N-
iodosuccinimide (54 mg, 0.24 equiv), a solution of 16a (35.4 mg, 0.2 mmol, 1.0 equiv) and 
C6Me6 (10.2 mg) in CH2Cl2 (0.4 mL), and a solution of Me2S in CH2Cl2 (0.1 mL, 0.1 M, 0.01 
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mmol, 0.05 equiv). The half-life was observed to be >180 min. After stirring for 3 h and 
quenching, 45% yield and a 5.8:1 ratio of 17ab:18ab were observed by 
1
H NMR spectroscopy.  
 
Iodolactonization of 16a in the Presence of (PhS)2 (Table 5, entry 13) 
Following General Procedure 6, a React-IR cell was charged with CH2Cl2 (1.0 mL), N-
iodosuccinimide (54 mg, 0.24 equiv), a solution of 16a (35.5 mg, 0.2 mmol, 1.0 equiv) and 
C6Me6 (11.9 mg) in CH2Cl2 (0.4 mL), and a solution of (PhS)2 in CH2Cl2 (0.1 mL, 0.1 M, 0.01 
mmol, 0.05 equiv). The half-life was observed to be >180 min. After stirring for 3 h and 
quenching, 2% yield was observed by 
1
H NMR spectroscopy.  
 
Iodolactonization of 16a in the Presence of n-Bu3P=Se (Table 5, entry 14) 
Following General Procedure 6, a React-IR cell was charged with CH2Cl2 (1.0 mL), N-
iodosuccinimide (54 mg, 0.24 equiv), a solution of 16a (35.0 mg, 0.2 mmol, 1.0 equiv) and 
C6Me6 (11.8 mg) in CH2Cl2 (0.4 mL), and a solution of n-Bu3P=Se in CH2Cl2 (0.1 mL, 0.1 M, 
0.01 mmol, 0.05 equiv). The half-life was observed to be 9 min. After stirring for 1 h and 
quenching, 77% yield and an 8.5:1 ratio of 17ab:18ab were observed by 
1
H NMR spectroscopy.  
 
Iodolactonization of 16a in the Presence of ( Me2N)3P=Se (Table 5, entry 15) 
Following General Procedure 6, a React-IR cell was charged with CH2Cl2 (1.0 mL), N-
iodosuccinimide (54 mg, 0.24 equiv), a solution of 16a (34.9 mg, 0.2 mmol, 1.0 equiv) and 
C6Me6 (10.7 mg) in CH2Cl2 (0.4 mL), and a solution of (Me2N)3P=Se in CH2Cl2 (0.1 mL, 0.1 M, 
0.01 mmol, 0.05 equiv). The half-life was observed to be 4 min. After stirring for 1 h and 
quenching, 95% yield and a 4.6:1 ratio of 17ab:18ab were observed by 
1
H NMR spectroscopy.  
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Iodolactonization of 16a in the Presence of (PhSe)2 (Table 5, entry 16) 
Following General Procedure 6, a React-IR cell was charged with CH2Cl2 (1.0 mL), N-
iodosuccinimide (54 mg, 0.24 equiv), a solution of 16a (35.0 mg, 0.2 mmol, 1.0 equiv) and 
C6Me6 (10.4 mg) in CH2Cl2 (0.4 mL), and a solution of (PhSe)2 in CH2Cl2 (0.1 mL, 0.1 M, 0.01 
mmol, 0.05 equiv). The half-life was observed to be 15 min. After stirring for 1 h and quenching, 
82% yield and a 10:1 ratio of 17ab:18ab were observed by 
1
H NMR spectroscopy.  
 
Iodolactonization of 16a in the Presence of n-Bu3P (Table 5, entry 17) 
Following General Procedure 6, a React-IR cell was charged with CH2Cl2 (1.0 mL), N-
iodosuccinimide (54 mg, 0.24 equiv), a solution of 16a (35.4 mg, 0.2 mmol, 1.0 equiv) and 
C6Me6 (12.2 mg) in CH2Cl2 (0.4 mL), and a solution of n-Bu3P in CH2Cl2 (0.1 mL, 0.1 M, 0.01 
mmol, 0.05 equiv). The half-life was observed to be 52 min. After stirring for 2 h and quenching, 
94% yield and a 5.1:1 ratio of 17ab:18ab were observed by 
1
H NMR spectroscopy.  
 
Iodolactonization of 16a in the Presence of ( Me2N)3P (Table 5, entry 18) 
Following General Procedure 6, a React-IR cell was charged with CH2Cl2 (1.0 mL), N-
iodosuccinimide (54 mg, 0.24 equiv), a solution of 16a (35.3 mg, 0.2 mmol, 1.0 equiv) and 
C6Me6 (10.2 mg) in CH2Cl2 (0.4 mL), and a solution of (Me2N)3P in CH2Cl2 (0.1 mL, 0.1 M, 
0.01 mmol, 0.05 equiv). The half-life was observed to be 40 min. After stirring for 2 h and 
quenching, 53% yield and a 1.4:1 ratio of 17ab:18ab were observed by 
1
H NMR spectroscopy.  
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Iodolactonization of 16a in the Presence of I2 (Table 5, entry 19) 
Following General Procedure 6, a React-IR cell was charged with CH2Cl2 (1.0 mL), N-
iodosuccinimide (54 mg, 0.24 equiv), a solution of 16a (34.8 mg, 0.2 mmol, 1.0 equiv) and 
C6Me6 (10.4 mg) in CH2Cl2 (0.4 mL), and a solution of I2 in CH2Cl2 (0.1 mL, 0.1 M, 0.01 mmol, 
0.05 equiv). The half-life was observed to be >180 min. After stirring for 3 h and quenching, 
10% yield and a 24:1 ratio of 17ab:18ab were observed by 
1
H NMR spectroscopy.  
 
Iodolactonization of 16a in the Presence of TFA (Table 5, entry 20) 
Following General Procedure 6, a React-IR cell was charged with CH2Cl2 (1.0 mL), N-
iodosuccinimide (54 mg, 0.24 equiv), a solution of 16a (35.0 mg, 0.2 mmol, 1.0 equiv) and 
C6Me6 (11.1 mg) in CH2Cl2 (0.4 mL), and a solution of TFA in CH2Cl2 (0.1 mL, 0.1 M, 0.01 
mmol, 0.05 equiv). The half-life was observed to be >180 min. After stirring for 3 h and 
quenching, 17ab and 18ab could not be observed by 
1
H NMR spectroscopy.  
 
Iodolactonization of 16b. Preparation of rel-(5R)-Dihydro-5-[(R)-iodophenylmethyl]-2(3H)-
furanone (18bb)
167
 
 
A 20-mL, flame-dried Schlenk flask, fitted with a septum and a magnetic stir bar and 
wrapped in foil, was charged with N-iodosuccinimide (270 mg, 1.2 mmol, 1.2 equiv). The flask 
was evacuated and filled with argon. Dichloromethane (5.0 mL) was added via syringe and then 
a thermocouple was fitted and the flask was cooled to -45 °C (CO2/MeCN bath, internal temp). 
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A solution of 16b (176.5 mg, 1.0 mmol, 1.0 equiv) in CH2Cl2 (2.0 mL) was added via cannula. 
Next, a solution of (Me2N)3P=S in CH2Cl2 (500 μL, 0.1 M, 0.05 equiv, 0.05 mmol) was added 
rapidly via syringe. The reaction mixture was stirred at -45 °C for 1 h, and then a solution of 
butyl vinyl ether in EtOH (2.5 mL, 1.2 M, 3.0 equiv) was added. After 5 min, sat. aq. Na2S2O3 
solution (5 mL) was added and the resulting biphasic mixture was allowed to warm to room 
temperature. The reaction mixture was transferred to a 250-mL separatory funnel where it was 
diluted with H2O (25 mL) and was extracted with EtOAc (3 x 25 mL). The combined organic 
extracts were washed with sat. aq. NaHCO3 solution (20 mL) then were dried over MgSO4, 
filtered, and concentrated in vacuo (23 °C, 10 mmHg). The ratio of 18bb to 17bb was 
determined to be 24:1 by 
1
H NMR spectroscopy. The residue was purified by column 
chromatography (silica gel (37 g), 3 cm diam., hexane/EtOAc, 80:20) to provide a yellow light-
sensitive solid, which was recrystallized from EtOAc/hexane (ca. 5 mL EtOAc at 23 °C, conc. in 
vacuo to ca. 3.5 mL, added 8 mL of hexane slowly, then cooled to -20 °C for 16 h) to provide 
238.5 mg (79%) of 18bb as very light yellow plates. 
Data for 18bb: 
mp: 90 - 94 °C (dec.) 
1
H NMR: (500 MHz, CDCl3) 
δ 7.52 – 7.40 (m, 2H, HC(Aryl)), 7.37 – 7.21 (m, 3H, HC(Aryl)), 5.12 (d, J = 5.7 Hz, 
1H, HC(6)), 4.66 (td, J = 7.3, 5.5 Hz, 1H, HC(5)), 2.55 – 2.46 (m, 2H, H2C(3)), 2.33 
– 2.22 (m, 1H, HC(4)), 1.97 (dtd, J = 13.3, 9.4, 7.3 Hz, 1H, HC(4’)). 
13
C NMR: (125 MHz, CDCl3) 
δ 175.6 (C(2)), 139.1 (C(7)), 128.9 (C(9/8)), 128.7 (C(10)), 128.4 (C9/8)), 82.8 
(C(5)), 34.2 (C(6)), 28.7 (C(3)), 26.9 (C(4)). 
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IR: (neat) 
3064 (w), 2936 (m), 1778 (s), 1498 (m), 1456 (s), 1415 (m), 1332 (m), 1296 (m), 
1278 (m), 1176 (s), 1071 (m), 1049 (s), 1027 (s), 915 (s), 866 (m), 828 (m), 808 (m), 
780 (s), 704 (s), 640 (s), 614 (m), 594 (m), 528 (w). 
MS: (ESI) 
129 (31), 157 (19), 175 (75), 303 (M + H
+
, 100), 304 (15), 325 (55). 
HRMS: Calculated: C11H12IO2 (M + H
+
, 302.9882; Found: 302.9879. 
TLC: Rf 0.13 (hexanes/EtOAc, 4:1) [UV] 
Analysis: C11H11O2 I (302.1) 
 Calcd: C, 43.73; H, 3.67;  
 Found: C, 43.53; H, 3.56;  
 
Iodolactonization of 16c. Preparation of rel-(5R)-5-[(1’S)-1’-Iodo-2-methylpropyl]dihydro-
2(3H)-furanone (18cb) 
 
 A 20-mL, flame-dried Schlenk flask, fitted with a septum and a magnetic stir bar and 
wrapped in foil, was charged with N-iodosuccinimide (270 mg, 1.2 mmol, 1.2 equiv). The flask 
was evacuated and filled with argon. Dichloromethane (5.0 mL) was added via syringe and then 
a thermocouple was fitted and the flask was cooled to -45 °C (CO2/MeCN bath, internal temp). 
A solution of 16c (142.0 mg, 1.0 mmol, 1.0 equiv) in CH2Cl2 (2.0 mL) was added via cannula. 
Next, a solution of Cy3P=S in CH2Cl2 (500 μL, 0.1 M, 0.05 equiv, 0.05 mmol) was added rapidly 
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via syringe. The reaction mixture was stirred at -45 °C for 2 h, and then a solution of butyl vinyl 
ether in EtOH (2.5 mL, 1.2 M, 3.0 equiv) was added. After 10 min, sat. aq. Na2S2O3 solution (5 
mL) was added and the resulting biphasic mixture was allowed to warm to room temperature. 
The reaction mixture was transferred to a 250-mL separatory funnel where it was diluted with 
H2O (25 mL) and was extracted with EtOAc (3 x 25 mL). The combined organic extracts were 
washed with sat. aq. NaHCO3 (25 mL), and then with brine (25 mL). The combined organic 
extracts were dried over MgSO4, filtered and concentrated in vacuo (23 °C, 10 mmHg). The ratio 
of 18cb to 17cb was determined to be 34:1 by 
1
H NMR spectroscopy. The residue was purified 
by column chromatography (silica gel (37 g), 3 cm diam., hexane/EtOAc, 80:20) to provide a 
colorless oil, which was diluted with hexane (ca. 0.5 mL) and seeded to provide 240.1 mg (90%) 
of 18cb as colorless needles.  
Data for 18cb: 
mp: 49 – 51 °C  
1
H NMR: (500 MHz, CDCl3) 
 δ 4.61 (ddd, J = 9.9, 8.2, 6.3 Hz, 1H, HC(5)), 4.08 (dd, J = 10.0, 3.0 Hz, 1H, 
HC(6)), 2.67 – 2.48 (m, 3H, HC(3, 3’, 4), 2.07 – 1.94 (m, 1H, HC(4’)), 1.51 (heptd, 
J = 6.5, 3.1 Hz, 1H, HC(7)), 0.97 (d, J = 6.6 Hz, 3H, H3C(9)), 0.92 (d, J = 6.4 Hz, 
3H, H3C(8)). 
13
C NMR: (125 MHz, CDCl3) 
δ 176.5 (C(2), 80.6 (C(5)), 51.4 (C(6)), 30.0 (C(4)), 29.9 (C(7)), 29.0 (C(3)), 23.6 
(C(9), 19.0 (C(8)). 
IR: (KBr pellet) 
2959 (s), 1768 (s), 1459 (s), 1427 (w), 1370 (m), 1339 (m), 1315 (m), 1302 (m), 
188 
 
1222 (m), 1167 (s), 1049 (m), 1017 (s), 990 (s), 912 (s), 870 (m), 822 (w), 802 (m), 
691 (w), 636 (s), 539 (w), 529 (w). 
MS: (ESI) 
95 (30), 123 (30), 141 (100), 261 (12), 269 (15), 282 (52), 291 (M+ Na
+
, 100), 322.9 
(15), 338.9 (17). 
HRMS: Calculated: C8H13IO2Na (M + Na
+
) (290.9858); Found: 290.9859. 
TLC: Rf 0.28 (hexanes/EtOAc, 4:1) [UV/I2/CAM] 
Analysis: C8H13O2 I (268.1) 
 Calcd: C, 35.84; H, 4.89;  
 Found: C, 35.58; H, 4.78;  
 
Stability of Iodolactones to Iodolactonization Conditions. 
Iodolactonization of 16a under Thermodynamic Conditions.
42a
 Preparation of rel-(5R)-
Dihydro-5-[(S)-iodophenylmethyl]-2(3H)-furanone (18ab).
167
 
 
 To a 10-mL, flame-dried Schlenk flask, fitted with a septum and a magnetic stir bar was 
added 16a (44 mg, 0.25 mmol, 1.0 equiv) and dry MeCN (2 mL) under argon. The flask was 
cooled in an ice bath, charged with I2 (190 mg, 0.75 mmol, 3.0 equiv) and wrapped in Al foil. 
The reaction mixture was allowed to stir in the ice bath for 5.2 h, and then was quenched with 
saturated aq. Na2S2O3 solution (10 mL). The resulting biphasic mixture was transferred to a 60-
mL separatory funnel, where it was diluted with H2O (10 mL) and extracted with CH2Cl2 (3 x 5 
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mL). The combined organic extracts were washed with sat. aq. NaHCO3 solution (5 mL), dried 
over MgSO4, and concentrated in vacuo (23 °C, 10 mmHg) to provide a yellow solid. The 
residue was purified by column chromatography (silica gel (4 g), 1 cm diam., CH2Cl2 ) to 
provide 25.8 mg (34%) of 18ab. The spectroscopic data were in accordance with those described 
in the literature,
167
 and 17ab was not observable by 
1
H NMR spectroscopy. 
 
Stability of 18ab to Iodolactonization Conditions.  
 
 To a flame-dried, 0.75-mL Schlenk flask, fitted with a septum and a magnetic stir bar, 
was added N-iodosuccinimide (9 mg, 0.04 mmol, 1.2 equiv). The flask was wrapped in Al foil, 
then was evacuated and filled with argon. The flask was cooled in a MeCN/CO2, then was 
charged with 18ab (10.0 mg, 0.033 mmol, 1.0 equiv, >19:1 exo:endo) and the sides of the flask 
were rinsed with CH2Cl2 (0.1 mL). A solution of TFA in CH2Cl2 (0.025 mL, 0.066 M, 0.05 
equiv), followed by a solution of n-Bu3P=S in CH2Cl2 (0.025 mL, 0.066 M, 0.05 equiv). The 
reaction mixture was allowed to stir in the MeCN/CO2 bath for 2 h, then was quenched with 
butyl vinyl ether in EtOH (0.081 mL, 1.2 M, 3.0 equiv), followed by sat. aq. Na2S2O3 solution 
(0.5 mL). The resulting biphasic mixture was allowed to warm to room temperature, and was 
transferred to a 60-mL separatory funnel where it was diluted with brine (5 mL) and was 
extracted with CH2Cl2 (3 x 5 mL). The combined organic extracts were dried over MgSO4, 
filtered and concentrated in vacuo (23 °C, 10 mmHg). 
1
H NMR analysis showed a 40:1 ratio of 
18ab to 17ab.  
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Stability of 17ab to Iodolactonization Conditions.  
 
 To a flame-dried, 0.75-mL Schlenk flask, fitted with a septum and a magnetic stir bar, 
was added N-iodosuccinimide (9 mg, 0.04 mmol, 1.2 equiv). The flask was wrapped in Al foil, 
then was evacuated and filled with argon. The flask was cooled in a MeCN/CO2, then was 
charged with 17ab (10.0 mg, 0.033 mmol, 1.0 equiv, >19:1 endo:exo) and the sides of the flask 
were rinsed with CH2Cl2 (0.1 mL). A solution of TFA in CH2Cl2 (0.025 mL, 0.066 M, 0.05 
equiv), followed by a solution of n-Bu3P=S in CH2Cl2 (0.025 mL, 0.066 M, 0.05 equiv). The 
reaction mixture was allowed to stir in the MeCN/CO2 bath for 2 h, then was quenched with 
butyl vinyl ether in EtOH (0.081 mL, 1.2 M, 3.0 equiv), followed by sat. aq. Na2S2O3 solution 
(0.5 mL). The resulting biphasic mixture was allowed to warm to room temperature, and was 
transferred to a 60-mL separatory funnel where it was diluted with brine (5 mL) and was 
extracted with CH2Cl2 (3 x 5 mL). The combined organic extracts were dried over MgSO4, 
filtered and concentrated in vacuo (23 °C, 10 mmHg). 
1
H NMR analysis showed a >19:1 ratio of 
17ab to 18ab. 
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Lewis Base Catalyzed Iodocycloetherifications 
Iodocycloetherification of 19a. Preparation of rel-(2R,3S)-3-Iodotetrahydro-2-phenyl-2H-
pyran (20ab) 
 
A 50-mL, flame-dried Schlenk flask, fitted with a septum and a magnetic stir bar and 
wrapped in foil, was charged with N-iodosuccinimide (270 mg, 1.2 mmol, 1.2 equiv). The flask 
was evacuated and filled with argon. Dichloromethane (5.0 mL) was added via syringe and then 
a thermocouple was fitted and the flask was cooled to -45 °C (CO2/MeCN bath, internal temp). 
A solution of 19a (162.2 mg, 1.0 mmol, 1.0 equiv) and TFA (3.8 μL, 0.05 mmol, 0.05 equiv) in 
CH2Cl2 (2.0 mL) was added via cannula. Next, a solution of n-Bu3P=S in CH2Cl2 (500 μL, 0.1 
M, 0.05 equiv, 0.05 mmol) was added rapidly via syringe. The reaction mixture was stirred at -
45 °C for 2 h, and then a solution of butyl vinyl ether in EtOH (2.5 mL, 1.2 M, 3.0 equiv) was 
added. After 15 min, sat. aq. Na2S2O3 solution (5 mL) and sat. aq. NaHCO3 solution (5 mL) were 
added and the resulting biphasic mixture was allowed to warm to room temperature. The reaction 
mixture was transferred to a 250-mL separatory funnel where it was diluted with H2O (25 mL) 
and was extracted with EtOAc (3 x 25 mL). The combined organic extracts were washed with 
sat. aq. NaHCO3 solution (25 mL) and brine (25 mL) then were dried over MgSO4, filtered and 
concentrated in vacuo (23 °C, 10 mmHg). The ratio of 20ab to 21ab was determined to be 23:1 
by 
1
H NMR spectroscopy. The residue was purified by column chromatography (silica gel (36 
g), 3 cm diam., hexane/EtOAc, 95:5) to provide 250.2 mg of 20ab as a light straw-colored oil. 
Further purification by column chromatography (silica gel (19 g), 2 cm diam., hexane/EtOAc, 
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95:5) provided 215.7 mg (75%) of 20ab as a colorless oil. 
Data for 20ab: 
1
H NMR: (500 MHz, CDCl3) 
δ 7.42 – 7.29 (m, 5H), 4.44 (d, J = 10.4 Hz, 1H, HC(2)), 4.28 – 4.16 (m, 2H, 
HC(3,6)), 3.70 (td, J = 12.1, 2.1 Hz, 1H, HC(6’)), 2.79 – 2.64 (m, 1H, HC(4)), 2.35 
(m, 1H, HC(4’)), 1.96 (m, 1H, HC(5)), 1.59 (dd, J = 13.8, 2.2 Hz, 1H, HC(5’)). 
13
C NMR: (125 MHz, CDCl3) 
δ 140.4 (C(7)), 128.5 (C(10)), 128.2 (C(8/9)), 127.5 (C(8/9), 86.3 (C(2)), 69.0 
(C(6)), 38.5 (C(4)), 32.8 (C(3)), 29.7 (C(5)). 
IR: (neat) 
3064 (m), 3033 (s), 2943 (s), 2849 (s), 1494 (s), 1454 (s), 1372 (s), 1327 (m), 1308 
(m), 1258 (s), 1214 (m), 1181 (m), 1140 (s), 1140 (s), 1100 (s), 1020 (s), 960 (s), 
933 (s), 906 (m), 880 (m), 846 (w), 820 (m), 755 (s), 697 (s), 636 (m), 533 (s), 519 
(m). 
MS: (EI, 70 eV) 
51 (12), 55 (51), 56 (16), 57 (90), 60 (11), 61 (16), 67 (14), 69.0 (12), 69.1 (32), 70 
(16), 71 (30), 73 (16), 77 (25), 78 (11), 79 (12), 81 (17), 82 (12), 83 (29), 85 (20.4), 
90 (11), 91 (77), 92 (11), 95 (16), 96 (11), 97 (22), 105 (52), 107 (12), 109 (14), 111 
(14), 115 (13), 129 (17), 134 (13), 149 (19), 154 (13), 161 (100), 162 (14), 176 (16), 
177 (61), 234 (18), 259 (11), 260 (28), 281 (10), 288 (M
+
, 4). 
HRMS: Calculated: C11H13IO (M
 +
) (288.00115); Found: 287.99999. 
TLC: Rf 0.19 (hexanes/EtOAc, 19:1) [UV] 
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Analysis: C11H12O I (288.1) 
 Calcd: C, 45.85; H, 4.55;  
 Found: C, 46.09; H, 4.28;  
 
Iodocycloetherification of 19b. Preparation of rel-(2S)-Tetrahydro-2-[(1’R)-1’-iodo-3-
phenylpropyl]furan (21bb) 
 
A 50-mL, flame-dried Schlenk flask, fitted with a septum and a magnetic stir bar and 
wrapped in foil, was charged with N-iodosuccinimide (270 mg, 1.2 mmol, 1.2 equiv). The flask 
was evacuated and filled with argon. Dichloromethane (5.0 mL) was added via syringe and then 
a thermocouple was fitted and the flask was cooled to -45 °C (CO2/MeCN bath, internal temp). 
A solution of 19b (190.3 mg, 1.0 mmol, 1.0 equiv) and TFA (3.8 μL, 0.05 mmol, 0.05 equiv) in 
CH2Cl2 (2.0 mL) was added via cannula. Next, a solution of n-Bu3P=S in CH2Cl2 (500 μL, 0.1 
M, 0.05 equiv, 0.05 mmol) was added rapidly via syringe. The reaction mixture was stirred at 
-45 °C for 2 h, and then a solution of butyl vinyl ether in EtOH (2.5 mL, 1.2 M, 3.0 equiv) was 
added. After 15 min, sat. aq. Na2S2O3 solution (5 mL) and sat. aq. NaHCO3 solution (5 mL) were 
added and the resulting biphasic mixture was allowed to warm to room temperature. The reaction 
mixture was transferred to a 250-mL separatory funnel where it was diluted with Hs2O (25 mL) 
and was extracted with EtOAc (3 x 25 mL). The combined organic extracts were washed with 
sat. aq. NaHCO3 (25 mL) and brine (25 mL) then were dried over MgSO4, filtered and 
concentrated in vacuo (23 °C, 10 mmHg). The ratio of 21bb to 20bb was determined to be 35:1 
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by 
1
H NMR spectroscopy. The residue was purified by column chromatography (silica gel (36 
g), 3 cm diam., hexane/EtOAc, 95:5) to provide 268.1 mg of a colorless oil, which was 
crystallized from cold hexane (ca. 0.3 mL) to provide 253.8 mg of 21bb as colorless tabular 
crystals. 
Data for 21bb: 
mp: 28– 30 °C  
1
H NMR: (500 MHz, CDCl3) 
δ 7.28 (m, 2H, HC(10/11)), 7.21 (m, 3H, HC(12, 10/11), 4.07 (ddd, J = 10.2, 7.1, 3.2 
Hz, 1H, HC(6)), 3.92 (dd, J = 15.0, 7.2 Hz, 1H, HC(5)), 3.84 (td, J = 7.8, 5.5 Hz, 
1H, HC(5’)), 3.76 (q, J = 7.1 Hz, 1H, HC(2)), 2.97 (ddd, J = 13.8, 9.1, 4.8 Hz, 1H, 
HC(8)), 2.71 (ddd, J = 13.8, 9.0, 7.4 Hz, 1H, HC(8’)), 2.22 – 2.10 (m, 2H, HC(3, 7)), 
2.05 (dtd, J = 14.7, 9.6, 4.8 Hz, 1H, HC(7’)), 1.99 – 1.82 (m, 2H, H2C(4)), 1.73 (ddd, 
J = 16.2, 12.4, 8.1 Hz, 1H, HC(3’)). 
13
C NMR: (125 MHz, CDCl3) 
δ 140.8 (C(9)), 128.5 (C(10/11)), 128.4 (C(10/11)), 126.0 (C(12)), 82.3 (C(2)), 68.9 
(C(5)), 42.6 (C(6)), 38.0 (C(7)), 35.4 (C(8)), 32.2 (C(3)), 25.9 (C(4)). 
IR: (neat) 
3026 (m), 2945 (s), 2863 (m), 1603 (m), 1497 (m), 1454 (s), 1353 (m), 1182 (m), 
1055 (s), 924 (m), 747 (s), 699 (s), 528 (m).  
MS: (ESI) 
199 (100), 200 (11), 287 (22), 317 (M + H
+
, 2). 
TLC: Rf 0.20 (hexanes/EtOAc, 19:1) [UV] 
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Analysis: C13H17OI (316.2) 
 Calcd: C, 49.38; H, 5.42;  
 Found: C, 49.11; H, 5.38;  
 
Iodocycloetherification of 19c. Preparation of rel-(2R)-Tetrahydro-2-[(1’R)-1’-iodo-3-
phenylpropyl]furan (21cb)  
 
A 50-mL, flame-dried Schlenk flask, fitted with a septum and a magnetic stir bar and 
wrapped in foil, was charged with N-iodosuccinimide (270 mg, 1.2 mmol, 1.2 equiv). The flask 
was evacuated and filled with argon. Dichloromethane (5.0 mL) was added via syringe and then 
a thermocouple was fitted and the flask was cooled to -45 °C (CO2/MeCN bath, internal temp). 
A solution of 19c (190.7 mg, 1.0 mmol, 1.0 equiv) and TFA (3.8 μL, 0.05 mmol, 0.05 equiv) in 
CH2Cl2 (2.0 mL) was added via cannula. Next, a solution of n-Bu3P=S in CH2Cl2 (500 μL, 0.1 
M, 0.05 equiv, 0.05 mmol) was added rapidly via syringe. The reaction mixture was stirred at 
-45 °C for 2 h, and then a solution of butyl vinyl ether in EtOH (2.5 mL, 1.2 M, 3.0 equiv) was 
added. After 20 min, sat. aq. Na2S2O3 solution (5 mL) and sat. aq. NaHCO3 solution (5 mL) were 
added and the resulting biphasic mixture was allowed to warm to room temperature. The reaction 
mixture was transferred to a 250-mL separatory funnel where it was diluted with H2O (25 mL) 
and was extracted with EtOAc (3 x 25 mL). The combined organic extracts were washed with 
sat. aq. NaHCO3 (25 mL) and brine (25 mL) then were dried over MgSO4, filtered, and 
concentrated in vacuo (23 °C, 10 mmHg). The residue was purified by column chromatography 
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(silica gel (29 g), 3 cm diam., hexane/EtOAc, 95:5) to provide 255.1 mg (80%) of 21cb as a 
colorless oil.  
Data for 21cb: 
1
H NMR: (500 MHz, CDCl3) 
 δ 7.34 – 7.25 (m, 2H, HC(Aryl)), 7.21 (m, 3H, HC(Aryl)), 4.04 (ddd, J = 10.6, 4.5, 
3.4 Hz, 1H, HC(6)), 3.96 (dt, J = 8.1, 6.8 Hz, 1H, HC(5)), 3.83 (td, J = 7.9, 5.8 Hz, 
1H, HC(5’)), 3.74 (ddd, J = 8.0, 6.7, 4.7 Hz, 1H, HC(2)), 2.97 (ddd, J = 13.7, 8.9, 
4.7 Hz, 1H, HC(8)), 2.73 (ddd, J = 13.8, 8.7, 7.7 Hz, 1H, HC(8’)), 2.20 (dddd, J = 
15.1, 10.6, 8.9, 4.8 Hz, 1H, HC(7)), 2.11 – 1.85 (m, 4H, HC(4, 4’, 7’, 3)), 1.68 (dq, J 
= 11.9, 8.0 Hz, 1H, HC(3’)). 
13
C NMR: (125 MHz, CDCl3) 
δ 140.8 (C(9)), 128.6 (C(10/11)), 128.5 (C(10/11), 126.1 (C(12)), 82.4 (C(2)), 69.0 
(C(5)), 41.6 (C(6)), 37.9 (C(3/7/8)), 35.6 (C(3/7/8)), 30.9 (C(3/7/8)), 26.2 (C(4)). 
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C.4. Lewis Base Catalyzed Chlorofunctionalizations.  
C.4.1. Chlorolactonizations 
General Procedure 7. Chlorolactonization of 16a with NCS in the presence of (Me2N)3P=S. 
(Table 6, entry 2) [MTB-XI-085] 
 
 An 5-mm, oven-dried NMR tube equipped with a septum was charged with NCS (10 mg, 
0.078 mmol, 1.2 equiv) and 1,2,4,5-C6H2Cl4 (10.2 mg). The tube was then purged with Ar 
through a needle. Deuterochloroform (600 μL) was added via syringe and then the tube was 
agitated with a vortex mixer. 16a (11.7 mg, 0.066 mmol) was added as a solid and then the tube 
was agitated with a vortex mixer. A solution of (Me2N)3P=S (0.6 mg in 50 μL of CDCl3, 0.0032 
mmol, 0.05 equiv) was added and then the tube was agitated with a vortex mixer. The reaction 
mixture was analyzed by 
1
H NMR spectroscopy after 2h and 24 h. Yields of 4% and 12% 
respectively were calculated by comparing the integrated area of the signal of 1,2,4,5-C6H2Cl4 (δ 
7.5 (s, 2H)) with the signal for H-6 of 17ac (δ 5.49 (d, J = 5.9 Hz, 1H)).  
 
Chlorolactonization of 16a with NCS in the absence of catalyst. (Table 6, entry 1) [MTB-
XI-084] 
 According to General Procedure 7, an NMR tube was charged with NCS (10  mg, 0.078 
mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (10.5 mg), CDCl3 (600 μL) and 16a (11.5 mg, 0.066 mmol). 
0% yield was observed by 
1
H NMR spectroscopy after ca 15 min, 2h, and 48 h. 
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Chlorolactonization of 16a with NCS in the presence of (Me2N)3P=Se. (Table 6, entry 3) 
[MTB-XI-086] 
 According to General Procedure 7, an NMR tube was charged with NCS (10  mg, 0.078 
mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (11.6 mg), CDCl3 (600 μL), 16a (11.7 mg, 0.066 mmol), and 
a solution of (Me2N)3P=Se (0.8 mg in 50 μL of CDCl3, 0.0032 mmol, 0.05 equiv). Yields of 2% 
and 12% were observed by 
1
H NMR spectroscopy after 2h and 24 h. 
 
Chlorolactonization of 16a with NCS in the presence of (Me2N)2C=S. (Table 6, entry 4) 
[MTB-XI-087] 
 According to General Procedure 7, an NMR tube was charged with NCS (10  mg, 0.078 
mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (11.0 mg), CDCl3 (600 μL), 16a (11.3 mg, 0.066 mmol), and 
a solution of (Me2N)2C=S (0.4 mg in 50 μL of CDCl3, 0.0032 mmol, 0.05 equiv). Yields of 7% 
and 11% were observed by 
1
H NMR spectroscopy after 2h and 24 h. 
 
Chlorolactonization of 16a with NCS in the presence of (Me2N)2C=S (30 mol%). (Table 6, 
entry 5) [MTB-XII-018] 
 According to General Procedure 7, an NMR tube was charged with NCS (10  mg, 0.078 
mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (11.0 mg), CDCl3 (600 μL), 16a (11.3 mg, 0.066 mmol), and 
a solution of (Me2N)2C=S (2.6 mg in 50 μL of CDCl3, 0.019 mmol, 0.3 equiv). Yields of 8% and 
35% were observed by 
1
H NMR spectroscopy after 2h and 24 h. 
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Chlorolactonization of 16a with NCS in the presence of quinuclidine. (Table 6, entry 6) 
[MTB-XI-088] 
 According to General Procedure 7, an NMR tube was charged with NCS (10  mg, 0.078 
mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (12.0 mg), CDCl3 (600 μL), 16a (11.4 mg, 0.066 mmol), and 
a solution of (Me2N)2C=S (2.6 mg in 50 μL of CDCl3, 0.0032 mmol, 0.05 equiv). Yields of 7% 
and 25% were observed by 
1
H NMR spectroscopy after 2h and 24 h. 
 
Chlorolactonization of 16a with NCP in the absence of a catalyst. (Table 6, entry 7) [MTB-
XI-096] 
 According to General Procedure 7, an NMR tube was charged with NCP (14  mg, 0.078 
mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (12.0 mg), CDCl3 (600 μL), and 16a (11.4 mg, 0.066 mmol). 
0% yield was observed by 
1
H NMR spectroscopy after ca 15 min, 2h, and 48 h. 
 
Chlorolactonization of 16a with NCP in the presence of (Me2N)3P=S. (Table 6, entry 8) 
[MTB-XI-099] 
 According to General Procedure 7, an NMR tube was charged with NCP (10  mg, 0.078 
mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (11.4 mg), CDCl3 (600 μL), 16a (11.5 mg, 0.066 mmol), and 
a solution of (Me2N)3P=S (0.6 mg in 50 μL of CDCl3, 0.0032 mmol, 0.05 equiv). Yields of 1% 
and 7% were observed by 
1
H NMR spectroscopy after 2h and 24 h. 
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Chlorolactonization of 16a with NCP in the presence of quinuclidine. (Table 6, entry 9) 
[MTB-XI-099] 
 According to General Procedure 7, an NMR tube was charged with NCP (10  mg, 0.078 
mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (11.7 mg), CDCl3 (600 μL), 16a (11.3 mg, 0.066 mmol), and 
a solution of quinuclidine (0.4 mg in 50 μL of CDCl3, 0.0032 mmol, 0.05 equiv). Yields of 13% 
and 42% were observed by 
1
H NMR spectroscopy after 2h and 24 h. 
Chlorolactonization of 16a with 1-CBT in the absence of a catalyst. (Table 6, entry 10) 
[MTB-XII-011] 
 According to General Procedure 7, an NMR tube was charged with 1-CBT (12  mg, 
0.078 mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (10.7 mg), CDCl3 (600 μL), 16a (11.6 mg, 0.066 
mmol). Yields of 1.5% and 19% were observed by 
1
H NMR spectroscopy after 25 min and 24 h. 
 
Chlorolactonization of 16a with 1-CBT in the presence of (Me2N)2C=S. (Table 6, entry 11) 
[MTB-XII-015] 
 According to General Procedure 7, an NMR tube was charged with 1-CBT (12  mg, 
0.078 mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (9.9 mg), CDCl3 (600 μL), 16a (11.1 mg, 0.066 
mmol), and a solution of  (Me2N)2C=S (0.4 mg in 50 μL of CDCl3, 0.0032 mmol, 0.05 equiv). 
Yields of 20%, 26% and 32% were observed by 
1
H NMR spectroscopy after ca. 15 min, 2h and 
24 h. 
201 
 
Chlorolactonization of 16a with 1-CBT in the presence of (Me2N)2C=S (30 mol%). (Table 6, 
entry 12) [MTB-XII-021] 
 According to General Procedure 7, an NMR tube was charged with 1-CBT (12  mg, 
0.078 mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (10.1 mg), CDCl3 (600 μL), 16a (11.4 mg, 0.066 
mmol), and a solution of  (Me2N)2C=S (2.6 mg in 50 μL of CDCl3, 0.019 mmol, 0.3 equiv). 
Yields of 35% and 35% were observed by 
1
H NMR spectroscopy after ca. 15 min and 2h. 
 
Chlorolactonization of 16a with 1-CBT in the presence of (Me2N)3P=S. (Table 6, entry 13) 
[MTB-XII-014] 
 According to General Procedure 7, an NMR tube was charged with 1-CBT (12  mg, 
0.078 mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (11.5 mg), CDCl3 (600 μL), 16a (11.6 mg, 0.066 
mmol), and a solution of  (Me2N)3P=S (0.6 mg in 50 μL of CDCl3, 0.0032 mmol, 0.05 equiv). 
Yields of 17%, 29%, and 41% were observed by 
1
H NMR spectroscopy after ca. 15 min, 2h and 
24 h. 
 
Chlorolactonization of 16a with 1-CBT in the presence of quinuclidine. (Table 6, entry 14) 
[MTB-XII-022] 
 According to General Procedure 7, an NMR tube was charged with 1-CBT (12  mg, 
0.078 mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (10.7 mg), CDCl3 (600 μL), 16a (11.4 mg, 0.066 
mmol), and a solution of  quinuclidine (0.4 mg in 50 μL of CDCl3, 0.0032 mmol, 0.05 equiv). 
Yields of 32% and 91% were observed by 
1
H NMR spectroscopy after ca. 15 min and 2h. 
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Chlorolactonization of 16a with 1-CBT in the presence of quinuclidine (30 mol%). (Table 6, 
entry 15) [MTB-XII-022] 
 According to General Procedure 7, an NMR tube was charged with 1-CBT (12  mg, 
0.078 mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (10.2 mg), CDCl3 (600 μL), 16a (11.3 mg, 0.066 
mmol), and a solution of  quinuclidine (0.4 mg in 50 μL of CDCl3, 0.0032 mmol, 0.05 equiv). 
Yields of 91% and 99% were observed by 
1
H NMR spectroscopy after ca. 15 min and 2h. 
 
Chlorolactonization of 16a with 1-CBT in the presence of i-Pr2NEt. (Table 6, entry 16) 
[MTB-XII-052] 
 According to General Procedure 7, an NMR tube was charged with 1-CBT (12  mg, 
0.078 mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (10.2 mg), CDCl3 (650 μL), 16a (11.3 mg, 0.066 
mmol), and i-Pr2NEt (0.6 μL, 0.0032 mmol, 0.05 equiv). Yields of 17% and 88% were observed 
by 
1
H NMR spectroscopy after ca. 15 min and 3h. 
 
Chlorolactonization of 16a with 1-CBT in the presence of PhNMe2. (Table 6, entry 17) 
[MTB-XII-033] 
 According to General Procedure 7, an NMR tube was charged with 1-CBT (12  mg, 
0.078 mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (11.1 mg), CDCl3 (650 μL), 16a (11.3 mg, 0.066 
mmol), and PhNMe2 (0.6 μL, 0.0032 mmol, 0.05 equiv). Yields of 1% and 3% were observed by 
1
H NMR spectroscopy after ca. 15 min and 3h. 
 
203 
 
Chlorolactonization of 16a with TCICA in the absence of a catalyst. (Table 6, entry 18) 
[MTB-XI-94] 
 According to General Procedure 7, an NMR tube was charged with TCICA (6  mg, 0.078 
mmol , 0.4 equiv, 1.2 equiv of active Cl), 1,2,4,5-C6H2Cl4 (11.1 mg), CDCl3 (650 μL) and 16a 
(11.4 mg, 0.066 mmol). A thick white precipitate formed rapidly and prevented proper shimming 
and integration, however 16a was completely consumed within 15 min.  
 
General Procedure 8. Chlorolactonization of 16a with 1-CBT in the presence of Nicotine. 
(Table 7) Preparation of rel-(5R,6S)-5-Chlorotetrahydro-6-phenyl-2H-pyran-2-one. (17ac) 
[MTB-XII-31] 
 
An 5-mm, oven-dried NMR tube equipped with a septum was charged with 1-CBT (10 
mg, 0.078 mmol, 1.2 equiv) and 1,2,4,5-C6H2Cl4 (10.2 mg). The tube was then purged with Ar 
through a needle. Deuterochloroform (650 μL) was added via syringe and then the tube was 
agitated with a vortex mixer. 16a (12.1 mg, 0.066 mmol) was added as a solid and then the tube 
was agitated with a vortex mixer. Nicotine (1.0 μL 0.0065 mmol, 0.1 equiv) was added via 
syringe and then the tube was agitated with a vortex mixer. The reaction mixture was analyzed 
by 
1
H NMR spectroscopy after ca 15 min, 2h and 24 h. Yields of 30%, 41% and 39% 
respectively were calculated by comparing the integrated area of the signal of 1,2,4,5-C6H2Cl4 (δ 
7.5 (s, 2H)) with the signal for H-6 of 17ac (5.49 (d, J = 5.9 Hz, 1H)).  After 24 h, a  solution of 
butyl vinyl ether in ethanol (15 vol%, 100 μL) was added to quench the reaction. The resulting 
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solution was concentrated in vacuo (23 
o
C, 6 mmHg). The residue was purified by column 
chromatography ( silica gel (1 g), 1 cm diam, hexane/CH2Cl2, 20:80) to afford 6.5 mg (45%) of 
17ac as a colorless oil. 
  Data for 17ac: 
1
H NMR: (500 MHz, CDCl3) 
δ 7.46 – 7.35 (m, 3H, HC(Aryl)), 7.35 – 7.28 (m, 2H, HC(Aryl)), 5.49 (d, J = 5.9 Hz, 
1H, HC(6)), 4.32 (td, J = 6.2, 4.3 Hz, 1H, HC(5)), 2.96 (ddd, J = 18.2, 8.9, 7.2 Hz, 
1H, HC(3)), 2.71 (dt, J = 18.2, 6.0 Hz, 1H, HC(3’)), 2.40 – 2.29 (m, 1H, HC(4)), 
2.23 – 2.12 (m, 1H, HC(4’)). 
SFC: (5R,6S)/(5S,6R)-17ac, tR 7.0 min (49.6%); (5S,6R)/(5R,6S)-17ac, tR 11.5 min 
(50.4%); (Chirapak AD, 125 bar, 3 mL/min, 5% MeOH in CO2) 
 
Chlorolactonization of 16a with 1-CBT in the presence of (DHQD)2PHAL. Preparation of 
rel-(5R,6S)-5-Chlorotetrahydro-6-phenyl-2H-pyran-2-one. (17ac) [MTB-XII-24] 
According to General Procedure 8, an NMR tube was charged with 1-CBT (12  mg, 
0.078 mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (11.1 mg), CDCl3 (600 μL), 16a (11.2 mg, 0.066 
mmol), and a solution of  (DHQD)2PHAL (5.0 mg in 50 μL of CDCl3, 0.0065 mmol, 0.1 equiv). 
After 1h and 24 h, broad signals interfered with yield determination by 
1
H NMR. The reaction 
was quenched after 25 h to afford after chromatography (silica gel (1 g), CH2Cl2) 8.8 mg (66%) 
of 17ac. 
  Data for 17ac: 
SFC: (5R,6S)/(5S,6R)-17ac, tR 6.8 min (45.0%); (5S,6R)/(5R,6S)-17ac, tR 11.4 min 
(55.0%); (Chirapak AD, 125 bar, 3 mL/min, 5% MeOH in CO2). 
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Chlorolactonization of 16a with 1-CBT in the presence of Dihydrocinchonidine. 
Preparation of rel-(5R,6S)-5-Chlorotetrahydro-6-phenyl-2H-pyran-2-one. (17ac) [MTB-
XII-25] 
According to General Procedure 8, an NMR tube was charged with 1-CBT (12  mg, 
0.078 mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (11.3 mg), CDCl3 (600 μL), 16a (11.3 mg, 0.066 
mmol), and a suspension of  dihydrocinchonidine (1.9 mg in 150 μL of CDCl3, 0.0065 mmol, 0.1 
equiv). A yield of 93% was observed by 
1
H NMR spectroscopy after 26 h. The reaction was 
quenched after 26 h to afford after chromatography (silica gel (1 g), CH2Cl2) 11.9 mg (89%) of 
17ac. 
  Data for 17ac: 
SFC: (5R,6S)/(5S,6R)-17ac, tR 6.6 min (48.0%); (5S,6R)/(5R,6S)-17ac, tR 11.4 min 
(52.0%); (Chirapak AD, 125 bar, 3 mL/min, 5% MeOH in CO2). 
 
Chlorolactonization of 16a with 1-CBT in the presence of Quinidine. Preparation of rel-
(5R,6S)-5-Chlorotetrahydro-6-phenyl-2H-pyran-2-one. (17ac) [MTB-XII-26] 
According to General Procedure 8, an NMR tube was charged with 1-CBT (12  mg, 
0.078 mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (12.5 mg), CDCl3 (600 μL), 16a (11.4 mg, 0.066 
mmol), and a solution of  quinidine (1.9 mg in 50 μL of CDCl3, 0.0065 mmol, 0.1 equiv). A yield 
of 87% was observed by 
1
H NMR spectroscopy after 2 h. The reaction was quenched after 3 h to 
afford after chromatography (silica gel (1 g), CH2Cl2) 1.5 mg (77%) of 17ac. 
  Data for 17ac: 
SFC: (5R,6S)/(5S,6R)-17ac, tR 6.6 min (48.8%); (5S,6R)/(5R,6S)-17ac, tR 11.1 min 
(51.2%); (Chirapak AD, 125 bar, 3 mL/min, 5% MeOH in CO2). 
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Chlorolactonization of 16a with 1-CBT in the presence of Cinchonine. Preparation of rel-
(5R,6S)-5-Chlorotetrahydro-6-phenyl-2H-pyran-2-one. (17ac) [MTB-XII-27] 
According to General Procedure 8, an NMR tube was charged with 1-CBT (12  mg, 
0.078 mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (11.3 mg), CDCl3 (350 μL), 16a (11.4 mg, 0.066 
mmol), and a suspension of  cinchonine (1.9 mg in 300 μL of CDCl3, 0.0065 mmol, 0.1 equiv). A 
yield of ca 95% was observed by 
1
H NMR spectroscopy after 0.8 h. The reaction was quenched 
after 3 h to afford after chromatography (silica gel (1 g), CH2Cl2) 9.3 mg (67%) of 17ac. 
  Data for 17ac: 
SFC: (5R,6S)/(5S,6R)-17ac, tR 6.2 min (49.4%); (5S,6R)/(5R,6S)-17ac, tR 6.9 min (50.6%); 
(Chirapak OJ, 125 bar, 3 mL/min, 3% MeOH in CO2). 
 
Chlorolactonization of 16a with 1-CBT in the presence of Quinine. Preparation of rel-
(5R,6S)-5-Chlorotetrahydro-6-phenyl-2H-pyran-2-one. (17ac) [MTB-XII-28] 
According to General Procedure 8, an NMR tube was charged with 1-CBT (12  mg, 
0.078 mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (12.5 mg), CDCl3 (600 μL), 16a (10.5 mg, 0.066 
mmol), and a solution of  quinine (2.1 mg in 50 μL of CDCl3, 0.0065 mmol, 0.1 equiv). A yield 
of 82% was observed by 
1
H NMR spectroscopy after 2 h. The reaction was quenched after 2 h to 
afford after chromatography (silica gel (1 g), CH2Cl2) 10.4 mg (76%) of 17ac. 
  Data for 17ac: 
SFC: (5R,6S)/(5S,6R)-17ac, tR 5.9 min (50.6%); (5S,6R)/(5R,6S)-17ac, tR 6.6 min (49.4%); 
(Chirapak OJ, 125 bar, 3 mL/min, 3% MeOH in CO2) 
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Chlorolactonization of 16a with 1-CBT in the presence of Cinchonidine. Preparation of rel-
(5R,6S)-5-Chlorotetrahydro-6-phenyl-2H-pyran-2-one. (17ac) [MTB-XII-34] 
According to General Procedure 8, an NMR tube was charged with 1-CBT (12  mg, 
0.078 mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (10.4 mg), CDCl3 (650 μL), 16a (11.9 mg, 0.066 
mmol), and cinchonidine (1.9 mg, 0.0065 mmol, 0.1 equiv). A yield of 81% was observed by 
1
H 
NMR spectroscopy after 2.2 h. The reaction was quenched after 3 h to afford after 
chromatography (silica gel (1 g), CH2Cl2) 8.0 mg (56%) of 17ac. 
  Data for 17ac: 
SFC: (5R,6S)/(5S,6R)-17ac, tR 7.7 min (48.4%); (5S,6R)/(5R,6S)-17ac, tR 12.7 min 
(51.6%); (Chirapak AD, 125 bar, 3 mL/min, 5% MeOH in CO2). 
 
Chlorolactonization of 16a with 1-CBT in the presence of O-Methylcinchonidine. 
Preparation of rel-(5R,6S)-5-Chlorotetrahydro-6-phenyl-2H-pyran-2-one. (17ac) [MTB-
XII-35] 
According to General Procedure 8, an NMR tube was charged with 1-CBT (12  mg, 
0.078 mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (10.3 mg), CDCl3 (550 μL), 16a (11.2 mg, 0.066 
mmol), and a solution of  O-methylcinchonidine (2.0 mg in 100 μL of CDCl3, 0.0065 mmol, 0.1 
equiv). A yield of 83% was observed by 
1
H NMR spectroscopy after 2 h. The reaction was 
quenched after 3 h to afford after chromatography (silica gel (1 g), CH2Cl2) 8.1 mg (60%) of 
17ac. 
  Data for 17ac: 
SFC: (5R,6S)/(5S,6R)-17ac, tR 7.8 min (49.5%); (5S,6R)/(5R,6S)-17ac, tR 13.0 min 
(50.5%); (Chirapak AD, 125 bar, 3 mL/min, 5% MeOH in CO2). 
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Chlorolactonization of 16a with 1-CBT in the presence of (1R,3S,5aS,7aS,7bR)-Octahydro-
1-benzyloxy-1-phenyl-7b-methyl-2H-cyclopenta[gh]pyrrolizine. Preparation of rel-(5R,6S)-
5-Chlorotetrahydro-6-phenyl-2H-pyran-2-one. (17ac) [MTB-XII-36] 
According to General Procedure 8, an NMR tube was charged with 1-CBT (12  mg, 
0.078 mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (10.3 mg), CDCl3 (600 μL), 16a (11.2 mg, 0.066 
mmol), and a solution of  catalyst (2.1 mg in 50 μL of CDCl3, 0.0065 mmol, 0.1 equiv). A yield 
of 96% was observed by 
1
H NMR spectroscopy after 2 h. The reaction was quenched after 3 h to 
afford after chromatography (silica gel (1 g), CH2Cl2) 8.5 mg (62%) of 17ac. 
  Data for 17ac: 
SFC: (5R,6S)/(5S,6R)-17ac, tR 7.8 min (51.1%); (5S,6R)/(5R,6S)-17ac, tR 13.0 min 
(48.9%); (Chirapak AD, 125 bar, 3 mL/min, 5% MeOH in CO2). 
 
Chlorolactonization of 16a with 1-CBT in the presence of (R,R)-N,N,N’,N’-
Tetramethylcyclohexanediamine. Preparation of of rel-(5R,6S)-5-Chlorotetrahydro-6-
phenyl-2H-pyran-2-one. (17ac) [MTB-XII-38] 
According to General Procedure 8, an NMR tube was charged with 1-CBT (12  mg, 
0.078 mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (11.3 mg), CDCl3 (600 μL), 16a (11.6 mg, 0.066 
mmol), and a solution of  catalyst (2.1 mg in 50 μL of CDCl3, 0.0065 mmol, 0.1 equiv). A yield 
of 73% was observed by 
1
H NMR spectroscopy after 22.5 h. The reaction was quenched after 24 
h to afford after chromatography (silica gel (1 g), CH2Cl2) 17ac. 
  Data for 17ac: 
SFC: (5R,6S)/(5S,6R)-17ac, tR 8.4 min (52.0%); (5S,6R)/(5R,6S)-17ac, tR 13.02 min 
(48.0%); (Chirapak AD, 125 bar, 3 mL/min, 5% MeOH in CO2). 
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Chlorolactonization of 16a with 1-CBT in the presence of (-)-Sparteine. Preparation of  rel-
(5R,6S)-5-Chlorotetrahydro-6-phenyl-2H-pyran-2-one. (17ac) [MTB-XII-39] 
According to General Procedure 8, an NMR tube was charged with 1-CBT (12  mg, 
0.078 mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (10.2 mg), CDCl3 (600 μL), 16a (11.6 mg, 0.066 
mmol), and a solution of  catalyst (2.1 mg in 50 μL of CDCl3, 0.0065 mmol, 0.1 equiv). A yield 
of 47% was observed by 
1
H NMR spectroscopy after 22.5 h. The reaction was quenched after 24 
h to afford after chromatography (silica gel (1 g), CH2Cl2) 17ac. 
  Data for 17ac: 
SFC: (5R,6S)/(5S,6R)-17ac, tR 8.2 min (50.7%); (5S,6R)/(5R,6S)-17ac, tR 13.4 min 
(49.3%); (Chirapak AD, 125 bar, 3 mL/min, 5% MeOH in CO2). 
 
C.4.2. Chlorocycloetherifications 
General Procedure 9. Chloroetherification of 19a with 1-CBT in the presence of 
Quinuclidine. (Table 8, entry 2) [MTB-XII-041] 
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 An 5-mm, oven-dried NMR tube equipped with a septum was charged with 1-CBT 
(12mg, 0.078 mmol, 1.2 equiv) and 1,2,4,5-C6H2Cl4 (11.3 mg). The tube was then purged with 
Ar through a needle. Deuterochloroform (600 μL) was added via syringe and then the tube was 
agitated with a vortex mixer. 19a (10.8 mg, 0.066 mmol) was added via syringe and then the 
tube was agitated with a vortex mixer. A solution of quinuclidine (0.4 mg in 50 μL of CDCl3, 
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0.0032 mmol, 0.05 equiv) was added and then the tube was agitated with a vortex mixer. The 
reaction mixture was analyzed by 
1
H NMR spectroscopy after 15 min, 2h and 24 h. Conversions 
of 4 and 14% at 15 min and 2 h were calculated by comparing the signals for H-6 of 20ac (δ 4.20 
(d, J = 9.8 Hz, 1H)) 
168
 with signals for 19a because the signal of 1,2,4,5-C6H2Cl4 was obscured. 
After 24h, a yield of 42% was calculated by comparing the integrated area of the signal of 
1,2,4,5-C6H2Cl4 (δ 7.5 (s, 2H)) with the signal for H-6 of 20ac. 
 
Chloroetherification of 19a with 1-CBT in the presence of Quinuclidine and AcOH. (Table 
8, entry 3) [MTB-XII-042] 
According to General Procedure 9, an NMR tube was charged with 1-CBT (12  mg, 
0.078 mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (10.9 mg), CDCl3 (600 μL), 19a (10.9 mg, 0.066 
mmol), AcOH (3.5 μL, 0.065 mmol, 1.0 equiv) and a solution of quinuclidine (0.4 mg in 50 μL 
of CDCl3, 0.0032 mmol, 0.05 equiv). Conversions of 9% and 44% were measured by  
1
H NMR 
spectroscopy at 15 min and 2 h. A yield of 34% was observed by  
1
H NMR spectroscopy after 24 
h.  
 
Chloroetherification of 19a with 1-CBT in the presence of \AcOH. (Table 8, entry 3) [MTB-
XII-043] 
According to General Procedure 9, an NMR tube was charged with 1-CBT (12  mg, 
0.078 mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (10.9 mg), CDCl3 (650 μL), 19a (10.2 mg, 0.066 
mmol), and AcOH (3.5 μL, 0.065 mmol, 1.0 equiv). Conversions of 0% and 5% were measured 
by 
1
H NMR spectroscopy at 15 min and 2 h. A yield of 24% was observed by  
1
H NMR 
spectroscopy after 24 h.  
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General Procedure 10. Attempted Optimization of the Chlorocyclization of 19d. 
Chloroetherification of 19d with 1-CBT. Preparation of 2-Chloromethyl-2-phenyl-
tetrahydrofuran (21dc). (Table 9, entry 1) [MTB-XII-071] 
 
 An 5-mm, oven-dried NMR tube equipped with a septum was charged with 1-
CBT (12 mg, 0.078 mmol, 1.2 equiv) and 1,2,4,5-C6H2Cl4 (11.9 mg). The tube was then purged 
with Ar through a needle. Deuterochloroform (650 μL) was added via syringe and then the tube 
was agitated with a vortex mixer. 19d (10.7 mg, 0.066 mmol) was added via syringe and then the 
tube was agitated with a vortex mixer. The reaction mixture was analyzed by 
1
H NMR 
spectroscopy after 15 min and 3.5 h. Yields of 2.5% and 44% respectively were calculated by 
comparing the integrated area of the signal of 1,2,4,5-C6H2Cl4 (δ 7.5 (s, 2H)) with the signal for 
H-6 of 21dc. After 24 h, a  solution of butyl vinyl ether in ethanol (15 vol%, 100 μL) was added 
to quench the reaction. The resulting solution was concentrated in vacuo (23 
o
C, 6 mmHg). The 
residue was combined with the residues from Table 9 entries 2-4 and was purified by column 
chromatography (silica gel (4.5 g), 1 cm diam, gradient from hexane/EtOAc, 9:1 to 
hexane/EtOAc, 4:1) to afford 60.7 mg of 21dc as a colorless oil containing a small amount of 
1,2,4,5-C6H2Cl4,
 
13.5 mg of 22 as a colorless oil, and 8.8 mg of a complex mixture of olefins. 
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Data for 21dc: 
1
H NMR:  (500 MHz, CDCl3)  
δ 7.46 – 7.39 (m, 2H, HC(Aryl)), 7.39 – 7.32 (m, 2H, HC(Aryl)), 7.28 (dt, J = 8.0, 
1.6 Hz, 1H, HC(10)), 4.15 – 4.05 (m, 1H, HC(5)), 3.94 (td, J = 7.8, 6.2 Hz, 1H, 
HC(5’)), 3.73 (A of AB, J = 11.5 Hz, 1H, HC(6)), 3.71 (B of AB, J = 11.5 Hz, 1H, 
HC(6’)), 2.43 (dt, J = 12.4, 8.0 Hz, 1H, HC(3)), 2.22 (ddd, J = 12.7, 7.9, 5.5 Hz, 1H, 
HC(3’)), 2.09 – 2.00 (m, 1H, HC(4)), 1.90 – 1.80 (m, 1H, HC(4’)).  
13
C NMR: (125 MHz, CDCl3) 
δ 143.9 (C(10)), 128.2 (C(Aryl)), 127.3 (C(Aryl)), 125.6 (C(Aryl)), 85.9 (C(2)), 68.7 
(C(5)), 52.3 (C(6)), 35.5 (C(3)), 26.1 (C(4)). 
TLC: Rf 0.54 (hexanes/EtOAc, 4:1) [UV/I2/CAM] 
 
Data for 22: 
1
H NMR:  (500 MHz, CDCl3)  
δ 7.38 – 7.27 (m, 5H, HC(Aryl)), 6.27 (s, 1H, HC(5)), 3.63 (t, J = 6.4 Hz, 2H, 
H2C(1)), 2.83 – 2.75 (m, 2H, H2C(3)), 1.68 (dt, J = 15.3, 6.4 Hz, 2H, H2C(2)), 1.40 
(br s, 1H, OH).  
13
C NMR: (125 MHz, CDCl3) 
δ 142.8 (C(4/6), 139.1 (C(4/6), 128.6 (C(Aryl)), 127.9 (C(Aryl)), 126.5 (C(Aryl)), 
115.9 (C(5)), 62.1 (C(1)), 30.2 (C(2/3)), 26.8, (C(2/3)). 
TLC: Rf 0.18 (hexanes/EtOAc, 4:1) [UV/I2/CAM] 
 
213 
 
Attempted Optimization of the Chlorocyclization of 19d. Chloroetherification of 19d with 
1-CBT in the Presence of (Me2N)3P=S. (Table 9, entry 2) [MTB-XII-073] 
According to General Procedure 10, an NMR tube was charged with 1-CBT (12  mg, 
0.078 mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (12.9 mg), (Me2N)3P=S (0.6 mg), CDCl3 (650 μL), and 
19d (10.3 mg, 0.066 mmol). Yields of 17% and 29% were measured by 
1
H NMR spectroscopy at 
15 min and 3.5 h.  
 
Attempted Optimization of the Chlorocyclization of 19d. Chloroetherification of 19d with 
1-CBT in the Presence of (Me2N)2C=S. (Table 9, entry 3) [MTB-XII-072] 
According to General Procedure 10, an NMR tube was charged with 1-CBT (12  mg, 
0.078 mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (11.5 mg), (Me2N)2C=S (0.4 mg), CDCl3 (650 μL), 
and 19d (10.2 mg, 0.066 mmol). Yields of 18% and 33% were measured by 
1
H NMR 
spectroscopy at 15 min and 3.5 h.  
 
Attempted Optimization of the Chlorocyclization of 19d. Chloroetherification of 19d with 
1-CBT in the Presence of Quinuclidine. (Table 9, entry 3) [MTB-XII-074] 
According to General Procedure 10, an NMR tube was charged with 1-CBT (12  mg, 
0.078 mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (11.3 mg), quinuclidine (0.4 mg), CDCl3 (650 μL), and 
19d (10.5 mg, 0.066 mmol). Yields of 36% and 50% were measured by 
1
H NMR spectroscopy at 
15 min and 3.5 h.  
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Attempted Optimization of the Chlorocyclization of 19d. Chloroetherification of 19d with 
DCDMH. (Table 9, entry 5) [MTB-XII-076] 
According to General Procedure 10, an NMR tube was charged with DCDMH (15.3  mg, 
0.078 mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (12.1 mg), CDCl3 (650 μL), and 19d (10.1 mg, 0.066 
mmol). Yields of 5% and 27% were measured by 
1
H NMR spectroscopy at 15 min and 3.5 h.  
 
Attempted Optimization of the Chlorocyclization of 19d. Chloroetherification of 19d with 
DCDMH in the Presence of (Me2N)3P=S. (Table 9, entry 6) [MTB-XII-078] 
According to General Procedure 10, an NMR tube was charged with DCDMH (15  mg, 
0.078 mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (12.3 mg), (Me2N)3P=S (0.6 mg), CDCl3 (650 μL), and 
19d (10.7 mg, 0.066 mmol). Yields of 22% and 33% were measured by 
1
H NMR spectroscopy at 
15 min and 3.5 h.  
 
Attempted Optimization of the Chlorocyclization of 19d. Chloroetherification of 19d with 
DCDMH in the Presence of (Me2N)2C=S. (Table 9, entry 7) [MTB-XII-077] 
According to General Procedure 10, an NMR tube was charged with DCDMH (15  mg, 
0.078 mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (12.9 mg), (Me2N)2C=S (0.4 mg), CDCl3 (650 μL), 
and 19d (10.8 mg, 0.066 mmol). Yields of 34% and 34% were measured by 
1
H NMR 
spectroscopy at 15 min and 3.5 h.  
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Attempted Optimization of the Chlorocyclization of 19d. Chloroetherification of 19d with 
DCDMH in the Presence of Quinuclidine. (Table 9, entry 7) [MTB-XII-079] 
According to General Procedure 10, an NMR tube was charged with DCDMH (15  mg, 
0.078 mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (12.9 mg), quinuclidine (0.4 mg), CDCl3 (650 μL), and 
19d (10.8 mg, 0.066 mmol). Yields of 22% and 41% were measured by 
1
H NMR spectroscopy at 
15 min and 3.5 h.  
C.4.3. Acyclic Chlorofunctionalizations 
General Proceedure 11. Attempted Optimization of Acyclic Chlorofunctionalization. 
Chloroacetoxylation of 11 with 1-CBT in the Presence of Quinuclidine and 1.5 equiv of n-
Bu4NOAc. (Table 10, entry 2)[MTB-XII-90] 
 
An 5-mm, oven-dried NMR tube equipped with a septum was charged with 1-CBT (12 
mg, 0.078 mmol, 1.2 equiv) and 1,2,4,5-C6H2Cl4 (12.2 mg). The septum was then removed and 
the tube was then brought in through the antechamber of an Ar filled glove box where it was 
charged with dry n-Bu4NOAc (29 mg, 0.097 mmol, 1.5 equiv). The septum was then refitted and 
the tube was removed from the glove box. Deuterochloroform (600 μL) was added via syringe 
and then the tube was agitated with a vortex mixer. 11 (10 μL, 0.065 mmol) was added via 
syringe and then the tube was agitated with a vortex mixer. A solution of quinuclidine (0.4 mg in 
50 μL, 0.003 mmol, 0.05 equiv) was added via syringe and then the tube was agitated with a 
vortex mixer. The reaction mixture was analyzed by 
1
H NMR spectroscopy after 15 min and 2 h. 
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Yields of 4% and 5% respectively were calculated by comparing the integrated area of the signal 
of 1,2,4,5-C6H2Cl4 (δ 7.5 (s, 2H)) with the signals for H-4 and H-5 of 15a.  
 
Attempted Optimization of Acyclic Chlorofunctionalization. Chloroacetoxylation of 11 
with 1-CBT in the Presence of  1.5 equiv of n-Bu4NOAc. (Table 10, entry 1)[MTB-XII-91] 
According to General Procedure 11, an NMR tube was charged with 1-CBT (12  mg, 
0.078 mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (11.9 mg), n-Bu4NOAc (29 mg, 0.097 mmol, 1.5 
equiv), CDCl3 (650 μL), and 11 (10 μL, 0.065 mmol). Yields of 4% and 8% were measured by 
1
H NMR spectroscopy at 15 min and 2 h.  
 
Attempted Optimization of Acyclic Chlorofunctionalization. Chloroacetoxylation of 11 
with 1-CBT in the Presence of (Me2N)3P=S and 1.5 equiv of n-Bu4NOAc. (Table 10, entry 
3)[MTB-XIII-10] 
According to General Procedure 11, an NMR tube was charged with 1-CBT (12  mg, 
0.078 mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (11.9 mg), n-Bu4NOAc (29 mg, 0.097 mmol, 1.5 
equiv), CDCl3 (600 μL), 11 (10 μL, 0.065 mmol) and a solution of (Me2N)3P=S (0.6 mg, 0.0032 
mmol, 0.05 equiv in 50 μL of CDCl3). Yields of 1% and 2% were measured by 
1
H NMR 
spectroscopy at 15 min and 2 h.  
Attempted Optimization of Acyclic Chlorofunctionalization. Chloroacetoxylation of 11 
with 1-CBT in the Presence of (Me2N)2C=S and 1.5 equiv of n-Bu4NOAc. (Table 10, entry 
4)[MTB-XIII-08] 
According to General Procedure 11, an NMR tube was charged with 1-CBT (12  mg, 
0.078 mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (11.4 mg), n-Bu4NOAc (29 mg, 0.097 mmol, 1.5 
217 
 
equiv), CDCl3 (600 μL), 11 (10 μL, 0.065 mmol) and a solution of (Me2N)2C=S (0.6 mg, 0.0032 
mmol, 0.05 equiv in 50 μL of CDCl3). Yields of 1% and 1% were measured by 
1
H NMR 
spectroscopy at 15 min and 2 h.  
Attempted Optimization of Acyclic Chlorofunctionalization. Chloroacetoxylation of 11 
with 1-CBT in the Presence of 2.0 equiv of AcOH and 1.5 equiv of n-Bu4NOAc. (Table 10, 
entry 5)[MTB-XIII-06] 
According to General Procedure 11, an NMR tube was charged with 1-CBT (12  mg, 
0.078 mmol , 1.2 equiv), PhMe6 (5.9 mg), n-Bu4NOAc (29 mg, 0.097 mmol, 1.5 equiv), CDCl3 
(650 μL), AcOH (7.5 μL, 0.13 mmol. 2.0 equiv) and 11 (10 μL, 0.065 mmol). Yields of 12% and 
27% were measured by 
1
H NMR spectroscopy at 15 min and 2 h.  
 
Attempted Optimization of Acyclic Chlorofunctionalization. Chloroacetoxylation of 11 
with 1-CBT in the Presence of Quinuclidine, 2.0 equiv of AcOH and 1.5 equiv of n-
Bu4NOAc. (Table 10, entry 6)[MTB-XII-95] 
According to General Procedure 11, an NMR tube was charged with 1-CBT (12  mg, 
0.078 mmol , 1.2 equiv), PhMe6 (9.5 mg), n-Bu4NOAc (29 mg, 0.097 mmol, 1.5 equiv), CDCl3 
(600 μL), AcOH (7.5 μL, 0.13 mmol. 2.0 equiv) and 11 (10 μL, 0.065 mmol) a solution of 
quinuclidine (0.4 mg, 0.0032 mmol, 0.05 equiv in 50 μL of CDCl3). Yields of 12% and 26% 
were measured by 
1
H NMR spectroscopy at 15 min and 2 h.  
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Attempted Optimization of Acyclic Chlorofunctionalization. Chloroacetoxylation of 11 
with 1-CBT in the Presence of (Me2N)3P=S, 2.0 equiv of AcOH and 1.5 equiv of n-
Bu4NOAc. (Table 10, entry 7)[MTB-XIII-11] 
According to General Procedure 11, an NMR tube was charged with 1-CBT (12  mg, 
0.078 mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (12.0 mg), n-Bu4NOAc (29 mg, 0.097 mmol, 1.5 
equiv), CDCl3 (600 μL), AcOH (7.5 μL, 0.13 mmol. 2.0 equiv), 11 (10 μL, 0.065 mmol) and a 
solution of (Me2N)3P=S (0.6 mg, 0.0032 mmol, 0.05 equiv in 50 μL of CDCl3). Yields of 12% 
and 19% were measured by 
1
H NMR spectroscopy at 15 min and 2 h. 
 
Attempted Optimization of Acyclic Chlorofunctionalization. Chloroacetoxylation of 11 
with 1-CBT in the Presence of 2.0 equiv of AcOH. (Table 10, entry 8)[MTB-XIII-16] 
According to General Procedure 11, an NMR tube was charged with 1-CBT (12  mg, 
0.078 mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (11.2 mg), CDCl3 (600 μL), AcOH (7.5 μL, 0.13 
mmol. 2.0 equiv), and 11 (10 μL, 0.065 mmol). Yields of 6% and 37% were measured by 1H 
NMR spectroscopy at 15 min and 2 h.  
 
Attempted Optimization of Acyclic Chlorofunctionalization. Chloroacetoxylation of 11 
with 1-CBT in the Presence of Quinuclidine and 2.0 equiv of AcOH. (Table 10, entry 
9)[MTB-XIII-17] 
According to General Procedure 11, an NMR tube was charged with 1-CBT (12  mg, 
0.078 mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (12.5 mg), CDCl3 (600 μL), AcOH (7.5 μL, 0.13 
mmol. 2.0 equiv), 11 (10 μL, 0.065 mmol) and a solution of quinuclidine (0.4 mg, 0.0032 mmol, 
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0.05 equiv in 50 μL of CDCl3). Yields of 13% and 36% were measured by 
1
H NMR 
spectroscopy at 15 min and 2 h.  
 
Attempted Optimization of Acyclic Chlorofunctionalization. Chloroacetoxylation of 11 
with DCDMH in the Presence of 1.5 equiv of AcOH. (Table 10, entry 10)[MTB-XIII-28] 
According to General Procedure 11, an NMR tube was charged with DCDMH (15  mg, 
0.078 mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (12.3 mg), CDCl3 (650 μL), AcOH (7.5 μL, 0.13 
mmol. 2.0 equiv), and 11 (10 μL, 0.065 mmol). Yields of 1.5% and 9% were measured by 1H 
NMR spectroscopy at 15 min and 2 h.  
 
Attempted Optimization of Acyclic Chlorofunctionalization. Chloroacetoxylation of 11 
with DCDMH in the Presence of Quinuclidine and 1.5 equiv of AcOH. (Table 10, entry 
11)[MTB-XIII-29] 
According to General Procedure 11, an NMR tube was charged with DCDMH (15  mg, 
0.078 mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (14.3 mg), CDCl3 (600 μL), AcOH (7.5 μL, 0.13 
mmol. 2.0 equiv), 11 (10 μL, 0.065 mmol) and a solution of quinuclidine (0.4 mg, 0.0032 mmol, 
0.05 equiv in 50 μL of CDCl3) Yields of 8% and 16% were measured by 
1
H NMR spectroscopy 
at 15 min and 2 h. Additionally, 16% of 4,5-dichlorooctane was observed after 2 h. 
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Attempted Optimization of Acyclic Chlorofunctionalization. Chloroacetoxylation of 11 
with DCDMH in the Presence of 1.5 equiv of n-Bu4NOAc and 2.0 equiv of AcOH. (Table 
10, entry 12)[MTB-XII-99] 
According to General Procedure 11, an NMR tube was charged with DCDMH (15  mg, 
0.078 mmol , 1.2 equiv), PhMe6 (7.0 mg), n-Bu4NOAc (29 mg, 0.097 mmol, 1.5 equiv),  CDCl3 
(650 μL), AcOH (7.5 μL, 0.13 mmol. 2.0 equiv), and 11 (10 μL, 0.065 mmol). Yields of 6% and 
14% were measured by 
1
H NMR spectroscopy at 15 min and 2 h.  
 
Attempted Optimization of Acyclic Chlorofunctionalization. Chloroacetoxylation of 11 
with DCDMH in the Presence of Quinuclidine, 1.5 equiv of n-Bu4NOAc and 2.0 equiv of 
AcOH. (Table 10, entry 12)[MTB-XII-100] 
According to General Procedure 11, an NMR tube was charged with DCDMH (15  mg, 
0.078 mmol , 1.2 equiv), PhMe6 (8.0 mg), n-Bu4NOAc (29 mg, 0.097 mmol, 1.5 equiv),  CDCl3 
(600 μL), AcOH (7.5 μL, 0.13 mmol. 2.0 equiv), and 11 (10 μL, 0.065 mmol). Yields of 8% and 
14% were measured by 
1
H NMR spectroscopy at 15 min and 2 h.  
Attempted Optimization of Acyclic Chlorofunctionalization. Chlorobenzotriazolation of 11 
with 1-CBT. (Table 10, entry 11)[MTB-XII-92] 
 
According to General Procedure 11, an NMR tube was charged with 1-CBT (15  mg, 
0.078 mmol , 1.2 equiv), 1,2,4,5-C6H2Cl4 (12.5 mg), CDCl3 (650 μL) and 11 (10 μL, 0.065 
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mmol). Combined yields of 23a-b of 0.5%, 12% and 60% were measured by 
1
H NMR 
spectroscopy at 15 min, 2 h and 24 h. This compound was not isolated. 
Partial for data for 23a: 
1
H NMR:  (500 MHz, CDCl3)  
δ 7.92 – 7.87 (m, 2H, HC(Aryl)), 7.44 – 7.37 (m, 2H, HC(Aryl)), 4.95 (ddd, J = 
10.1, 8.4, 4.1 Hz, 1H), 4.40 (ddd, J = 9.8, 8.4, 2.8 Hz, 1H).  
Partial for data for 23b: 
1
H NMR:  (500 MHz, CDCl3)  
δ 8.10 (d, J = 8.4 Hz, 1H, HC(Aryl)), 4.88 (ddd, J = 11.0, 7.4, 3.6 Hz, 1H), 4.46 
(ddd, J = 10.3, 7.4, 3.0 Hz, 1H).  
Attempted Optimization of Acyclic Chlorofunctionalization. Chlorobenzotriazolation of 11 
with 1-CBT in the Presence of Quinuclidine. (Table 10, entry 11)[MTB-XII-92] 
According to General Procedure 11, an NMR tube was charged with 1-CBT (15  mg, 
0.078 mmol , 1.2 equive), 1,2,4,5-C6H2Cl4 (12.4 mg), CDCl3 (600 μL), 11 (10 μL, 0.065 mmol) 
and a solution of quinuclidine (0.4 mg, 0.0032 mmol, 0.05 equiv in 50 μL of CDCl3). Combined 
yields of 23a-b of 13%, 47% and 61% were measured by 
1
H NMR spectroscopy at 15 min, 2 h 
and 24 h. The signal for 1,2,4,5-C6H2Cl4 was not well resolved at the 15 min time point, see 
Figure 9 for spectrum. 
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C.5. Enantioselective Bromocyclizations 
C.5.1. Chiral Lewis Base Catalyzed Bromocyclizations 
Bromolactonization of 16a in the Presence of 26a. Preparation of rel-(5R,6S)-5-
Bromotetrahydro-6-phenyl-2H-pyran-2-one (17aa) (Table 12, Entry 1) [MTB-XVI-80] 
 
A 5-mL, flame-dried Schlenk flask, fitted with a septum and a magnetic stir bar, was 
charged with N-bromosuccinimide (21 mg, 0.12 mmol, 1.2 equiv). The flask was wrapped in Al-
foil and then was evacuated and filled with argon. Dichloromethane (0.3 mL) was added via 
syringe. A solution of  16a (17.6 mg in 0.4 mL, 0.1 mmol, 1.0 equiv) was added via a short 
cannula. A solution of 26a in CH2Cl2 (0.9 mg in 50 μL, 0.1 M, 0.05 equiv, 0.005 mmol) was 
added rapidly via syringe, and the resulting solution was stirred for at room temperature for 5 
min. Aq. Na2S2O3 solution (1 mL) was added, and the resulting biphasic mixture was transferred 
to a 60-mL separatory funnel where it was diluted with sat. aq. NaHCO3 solution (5 mL) and was 
extracted with EtOAc (5 mL, 2 x 2.5 mL). The combined organic extracts were dried over 
Na2SO4, decanted and concentrated in vacuo (23 °C, 10 mmHg). A 7.3:1 mixture of 17aa and 
18aa was observed by 
1
H NMR spectroscopy. The residue was purified by column 
chromatography (silica gel (1 g), Pasteur pipet., CH2Cl2), to provide 19.9 mg (78%) of a mixture 
of 17aa  and 18aa.  
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Data for 17aa/18aa: 
SFC: (5R,6S)/(5S,6R)-17aa, tR 5.0 min (38.1%); (5S,6R)/(5R,6S)-17aa, tR 5.5 min (38.7%); 
(5R,6S)/(5S,6R)-18aa, tR 6.3 min (11.7%); (5S,6R)/(5R,6S)-17aa, tR 7.2 min (11.4%) 
(Chirapak OJ, 125 bar, 3 mL/min, 5% MeOH in CO2). 
 
Bromolactonization of 16a in the Presence of 26b. Preparation of rel-(5R,6S)-5-
Bromotetrahydro-6-phenyl-2H-pyran-2-one (17aa) (Table 12, Entry 2) [MTB-XI-81] 
 
A 5-mL, flame-dried Schlenk flask, fitted with a septum and a magnetic stir bar, was 
charged with N-bromosuccinimide (21 mg, 0.12 mmol, 1.2 equiv). The flask was wrapped in Al-
foil and then was evacuated and filled with argon. Dichloromethane (0.3 mL) was added via 
syringe. A solution of  16a (17.6 mg in 0.4 mL, 0.1 mmol, 1.0 equiv) was added via a short 
cannula. A solution of 26b in CH2Cl2 (1.9 mg in 50 μL, 0.1 M, 0.05 equiv, 0.005 mmol) was 
added rapidly via syringe, and the resulting solution was stirred for at room temperature for 5 
min. Aq. Na2S2O3 solution (1 mL) was added, and the resulting biphasic mixture was transferred 
to a 60-mL separatory funnel where it was diluted with sat. aq. NaHCO3 solution (5 mL) and was 
extracted with EtOAc (5 mL, 2 x 2.5 mL). The combined organic extracts were dried over 
Na2SO4, decanted and concentrated in vacuo (23 °C, 10 mmHg). A 20:1 mixture of 17aa and 
18aa was observed by 
1
H NMR spectroscopy. The residue was purified by column 
chromatography (silica gel (1 g), Pasteur pipet., CH2Cl2), to provide 18.7 mg (73%) of a mixture 
of 17aa  and 18aa.  
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Data for 17aa/18aa: 
SFC: (5R,6S)/(5S,6R)-17aa, tR 5.8 min (45.8%); (5S,6R)/(5R,6S)-17aa, tR 6.3 min (46.3%); 
(5R,6S)/(5S,6R)-18aa, tR 7.3 min (4.1%); (5S,6R)/(5R,6S)-17aa, tR 8.1 min (3.7%) 
(Chirapak OJ, 125 bar, 3 mL/min, 5% MeOH in CO2). 
 
Bromolactonization of 16a in the Presence of 26c. Preparation of rel-(5R,6S)-5-
Bromotetrahydro-6-phenyl-2H-pyran-2-one (17aa) (Table 12, Entry 3) [MTB-XI-82] 
 
A 5-mL, flame-dried Schlenk flask, fitted with a septum and a magnetic stir bar, was 
charged with N-bromosuccinimide (21 mg, 0.12 mmol, 1.2 equiv). The flask was wrapped in Al-
foil and then was evacuated and filled with argon. Dichloromethane (0.3 mL) was added via 
syringe. A solution of  16a (17.6 mg in 0.4 mL, 0.1 mmol, 1.0 equiv) was added via a short 
cannula. A solution of 26c in CH2Cl2 (2.3 mg in 50 μL, 0.1 M, 0.05 equiv, 0.005 mmol) was 
added rapidly via syringe, and the resulting solution was stirred for at room temperature for 5 
min. Aq. Na2S2O3 solution (1 mL) was added, and the resulting biphasic mixture was transferred 
to a 60-mL separatory funnel where it was diluted with sat. aq. NaHCO3 solution (5 mL) and was 
extracted with EtOAc (5 mL, 2 x 2.5 mL). The combined organic extracts were dried over 
Na2SO4, decanted and concentrated in vacuo (23 °C, 10 mmHg). A 4.9:1 mixture of 17aa and 
18aa was observed by 
1
H NMR spectroscopy. The residue was purified by column 
chromatography (silica gel (1 g), Pasteur pipet., CH2Cl2), to provide 18.7 mg (73%) of a mixture 
of 17aa  and 18aa.  
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Data for 17aa/18aa: 
SFC: (5R,6S)/(5S,6R)-17aa, tR 6.9 min (36.3%); (5S,6R)/(5R,6S)-17aa, tR 7.5 min (35.7%); 
(5R,6S)/(5S,6R)-18aa, tR 8.4 min (14.0%); (5S,6R)/(5R,6S)-17aa, tR 9.3 min (13.9%) 
(Chirapak OJ, 125 bar, 3 mL/min, 5% MeOH in CO2). 
 
Bromolactonization of 16a in the Presence of 26d. Preparation of rel-(5R,6S)-5-
Bromotetrahydro-6-phenyl-2H-pyran-2-one. (17aa) (Table 12, Entry 3) [MTB-XI-83] 
 
A 5-mL, flame-dried Schlenk flask, fitted with a septum and a magnetic stir bar, was 
charged with N-bromosuccinimide (21 mg, 0.12 mmol, 1.2 equiv). The flask was wrapped in Al-
foil and then was evacuated and filled with argon. Dichloromethane (0.3 mL) was added via 
syringe. A solution of 16a (17.6 mg in 0.4 mL, 0.1 mmol, 1.0 equiv) was added via a short 
cannula. A solution of 26d in CH2Cl2 (2.6 mg in 50 μL, 0.1 M, 0.05 equiv, 0.005 mmol) was 
added rapidly via syringe, and the resulting solution was stirred for at room temperature for 5 
min. Aq. Na2S2O3 solution (1 mL) was added, and the resulting biphasic mixture was transferred 
to a 60-mL separatory funnel where it was diluted with sat. aq. NaHCO3 solution (5 mL) and was 
extracted with EtOAc (5 mL, 2 x 2.5 mL). The combined organic extracts were dried over 
Na2SO4, decanted and concentrated in vacuo (23 °C, 10 mmHg). A 7.5:1 mixture of 17aa and 
18aa was observed by 
1
H NMR spectroscopy. The residue was purified by column 
chromatography (silica gel (1 g), Pasteur pipet., CH2Cl2), to provide 18.7 mg (66%) of a mixture 
of 17aa  and 18aa.  
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Data for 17aa/18aa: 
SFC: (5R,6S)/(5S,6R)-17aa, tR 5.8 min (41.0%); (5S,6R)/(5R,6S)-17aa, tR 6.4 min (41.5%); 
(5R,6S)/(5S,6R)-18aa, tR 7.3 min (8.3%); (5S,6R)/(5R,6S)-17aa, tR 8.2 min (9.2%) 
(Chirapak OJ, 125 bar, 3 mL/min, 5% MeOH in CO2). 
 
Bromolactonization of 16d in the Presence of 26e. Preparation of 5-(Bromomethyl)dihydro-
5-phenyl-2(3H)-furanone. (Table 13, Entry 1) [MTB-XII-61] 
35a
 
 
A 5-mL, flame-dried Schlenk flask, fitted with a septum and a magnetic stir bar, was 
charged with N-bromosuccinimide (21 mg, 0.12 mmol, 1.2 equiv). The flask was wrapped in Al-
foil and then was evacuated and filled with argon. Dichloromethane (3 mL) was added via 
syringe. A solution of 16d  (17.7 mg, 0.1 mmol, 1.0 equiv) and 26e (2.5 mg, 0.05 equiv, 0.005 
mmol) in CH2Cl2
 
(1.0 mL)
 
was added via a short cannula, and the resulting solution was stirred 
for at room temperature for 5 min. Aq. Na2S2O3 solution (2 mL) was added, and the resulting 
biphasic mixture was transferred to a 60-mL separatory funnel where it was extracted with 
CH2Cl2 (2 x 2 mL). The combined organic extracts were washed with NaHCO3 (2 x 2 mL), dried 
over MgSO4, filtered and concentrated in vacuo (23 °C, 10 mmHg). The residue was purified by 
column chromatography (silica gel (1 g), Pasteur pipet, hexane/EtOAc, 4:1), to provide 26 mg 
(99%) of 18da.  The spectroscopic data were in accordance with those described in the 
literature.
35a
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Data for 18da: 
SFC: (S)/(R)-18da, tR 4.38 min (49.9%); (S)/(R)-18da, tR 4.90 min (50.1%); (Chirapak AD, 
125 bar, 3 mL/min, 5% MeOH in CO2). 
 
Bromolactonization of 16d in the Presence of 26e at -75 
o
C. Preparation of 5-
(Bromomethyl)dihydro-5-phenyl-2(3H)-furanone. (Table 13, Entry 2) [MTB-XII-63] 
35a
 
 
A 5-mL, flame-dried Schlenk flask, fitted with a septum and a magnetic stir bar, was 
charged with N-bromosuccinimide (21 mg, 0.12 mmol, 1.2 equiv). The flask was wrapped in Al-
foil and then was evacuated and filled with argon. Toluene/CHCl3 (2:1, 3 mL) was added via 
syringe. The flask was cooled to -75 
o
C (thermostated IPA bath). A solution of 16d  (17.7 mg, 
0.1 mmol, 1.0 equiv) and 26e (2.5 mg, 0.05 equiv, 0.005 mmol) in PhMe/CHCl3
 
(1.0 mL)
 
was 
added was added via a short cannula, and the resulting solution was stirred for 40 h at -75 
o
C. A 
solution of butyl-vinyl ether in EtOH (0.1 mL, 1.2 M, 1.2 equiv), and the resulting solution was 
stirred for 0.5 h at -75 
o
C. Aq. Na2S2O3 solution (2 mL) was added, and the mixture was allowed 
to warm to room temperature. The resulting biphasic mixture was transferred to a 60-mL 
separatory funnel where it was extracted with EtOAc (2 x 2 mL). The combined organic extracts 
were washed with NaHCO3 (2 x 2 mL), dried over MgSO4, filtered and concentrated in vacuo 
(23 °C, 10 mmHg). The residue was purified by column chromatography (silica gel (1 g), 
Pasteur pipet, hexane/EtOAc, 4:1), to provide 1.1 mg (4%) of 18da. 
Data for 18da:  
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SFC: (S)/(R)-18da, tR 6.1 min (50.7%); (S)/(R)-18da, tR 6.6 min (49.3%); (Chirapak AD, 
125 bar, 3 mL/min, 5% MeOH in CO2). 
 
Bromolactonization of 16e in the Presence of 26f. Preparation of 5-(Bromomethyl)dihydro-
5-phenyl-2(3H)-furanone. (Table 13, Entry 3) [MTB-XII-62] 
35a
 
 
A 5-mL, flame-dried Schlenk flask, fitted with a septum and a magnetic stir bar, was 
charged with N-bromosuccinimide (21 mg, 0.12 mmol, 1.2 equiv). The flask was wrapped in Al-
foil and then was evacuated and filled with argon. Dichloromethane (3 mL) was added via 
syringe. A solution of 16d  (17.6 mg, 0.1 mmol, 1.0 equiv) and 26f (2.2 mg, 0.05 equiv, 0.005 
mmol) in CH2Cl2
 
(1.0 mL)
 
was added via a short cannula, and the resulting solution was stirred 
for at room temperature for 5 min. Aq. Na2S2O3 solution (2 mL) was added, and the resulting 
biphasic mixture was transferred to a 60-mL separatory funnel where it was extracted with 
CH2Cl2 (2 x 2 mL). The combined organic extracts were washed with NaHCO3 (2 x 2 mL), dried 
over MgSO4, filtered and concentrated in vacuo (23 °C, 10 mmHg). The residue was purified by 
column chromatography (silica gel (1 g), Pasteur pipet, hexane/EtOAc, 4:1), to provide 22.5 mg 
(88%) of 18da. 
Data for 18da: 
SFC: (S)/(R)-18da, tR 4.2 min (50.6%); (S)/(R)-18da, tR 4.69 min (49.4%); (Chirapak AD, 
125 bar, 3 mL/min, 5% MeOH in CO2). 
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Bromolactonization of 16d in the Presence of 26f at -75 
o
C. Preparation of 5-
(Bromomethyl)dihydro-5-phenyl-2(3H)-furanone. (Table 13, Entry 4) [MTB-XII-64] 
35a
 
 
A 5-mL, flame-dried Schlenk flask, fitted with a septum and a magnetic stir bar, was 
charged with N-bromosuccinimide (21 mg, 0.12 mmol, 1.2 equiv). The flask was wrapped in Al-
foil and then was evacuated and filled with argon. Toluene/CHCl3 (2:1, 3 mL) was added via 
syringe. The flask was cooled to -75 
o
C (thermostated IPA bath). A solution of 16d  (17.7 mg, 
0.1 mmol, 1.0 equiv) and 26f (2.5 mg, 0.05 equiv, 0.005 mmol) in PhMe/CHCl3
 
(1.0 mL)
 
was 
added was added via a short cannula, and the resulting solution was stirred for 40 h at -75 
o
C. A 
solution of butyl-vinyl ether in EtOH (0.1 mL, 1.2 M, 1.2 equiv), and the resulting solution was 
stirred for 0.5 h at -75 
o
C. Aq. Na2S2O3 solution (2 mL) was added, and the mixture was allowed 
to warm to room temperature. The resulting biphasic mixture was transferred to a 60-mL 
separatory funnel where it was extracted with EtOAc (2 x 2 mL). The combined organic extracts 
were washed with NaHCO3 (2 x 2 mL), dried over MgSO4, filtered and concentrated in vacuo 
(23 °C, 10 mmHg). The residue was purified by column chromatography (silica gel (1 g), 
Pasteur pipet, hexane/EtOAc, 4:1), to provide 23.3 mg (91%) of 18da. 
Data for 18da:  
SFC: (S)/(R)-18da, tR 6.5 min (53.8%); (S)/(R)-18da, tR 6.6 min (46.2%); (Chirapak AD, 
125 bar, 3 mL/min, 5% MeOH in CO2). 
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Preparation of O-Diphenylthiophosphinoyl-cinchonidine. (26e) [MTB-XVII-55] 
 
A 10-mL, oven-dried Schlenk flask, fitted with a septum and a magnetic stir bar, under Ar, was 
charged with cinchonidine (294 mg, 1.0 mmol, 1.0 equiv) and was heated to 100 
o
C in vacuo (0.1 
mmHg) for 1h. The flask was allowed to cool, and was filled with Ar. Dichloromethane (4.0 mL) 
and Et3N (0.28 mL, 2.0 mmol, 2.0 equiv) were added and the resulting white suspension was 
cooled in an ice bath. Chlorodiphenylphosphine (0.222 mL, 1.2 mmol, 1.2 equiv) was added via 
syringe over 4 min. The suspension was stirred for 0.5 h, and then was allowed to warm to room 
temperature and stir for 1.5 h. The mixture was concentrated in vacuo (0.1 mmHg) and then a 
condenser was fitted to the flask. The flask was charged with PhMe (5 mL) and S8 (41.7 mg, 
0.15 mmol, 0.15 equiv of S8, 1.2 equiv of S) and was heated to reflux for 2.5 h. The mixture was 
allowed to cool to room temperature and stir overnight. The mixture was poured into a 60-mL 
separatory funnel containing sat. aq. NaHCO3 solution (10 mL) and was extracted with EtOAc 
(10 mL). Saturated aq. Na2CO3 solution (2 mL) was added and the mixture was extracted with 
EtOAc (2 x 10 mL).  The combined organic extracts were dried over MgSO4, filtered, and 
concentrated in vacuo (23 
o
C, 6 mmHg). The residue was purified by column chromatography 
(silica gel (17 g), 2 cm diam., 9 cm length, hexane/EtOAc/Et3N, 40:56:4) to provide 446 mg 
(87%) of 26e as a yellow solid. The solid was dissolved in CH2Cl2 (20 mL) and washed with 
10% aq. NaOH (10 mL), and sat. aq. Na2PO4 solution (2 x 5 mL). The aqueous washes were 
back extracted with CH2Cl2 (5 mL). The combined organic phases were dried over K2CO3, 
filtered and concentrated in vacuo  (23 
o
C, 6 mmHg) to provide a yellow solid (435.1 mg) which 
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was recrystallized from EtOAc/hexane to provide 372 mg (73%) of 26e as pale yellow/white 
plates. The spectra show broadening from restricted rotation, and fully coalesce in 
31
P NMR at 
65 
o
C. 
Data for 26e:  
1
H NMR: (500 MHz, CDCl3
, 
23 
o
C) 
δ 8.67 (br s, 1H), 8.16 (br s, 1H), 7.93 (br s, 1H), 7.89 – 7.76 (m, 2H), 7.60 (br m, 
1H), 7.56 – 7.40 (m, 4H), 7.35 – 7.16 (m, 3H), 6.98 (br s, 1H), 6.75 (br m, 2H), 6.04 
– 5.79 (m, 1H), 5.16 – 4.87 (m, 2H), 4.20-3.40 (br m, 1H), 3.11 (br s, 1H), 2.96 (dd, 
J = 13.7, 10.1 Hz, 1H), 2.53 (br m, 2H), 2.26 (br s, 1H), 2.07 (br m), 1.94 (br s, 1H), 
1.91 – 1.85 (br m, 1H), 1.85 – 1.74 (m, 1H), 1.52 (br s, 1H). 
31
P NMR: (202 MHz, CDCl3, 23 
o
C)  
δ 86.5-85.1 (br). 
1
H NMR: (400 MHz, PhMe-d8, 65 
o
C) 
δ 8.57 (d, J = 3.4 Hz, 1H), 8.40 (d, J = 8.0 Hz, 1H), 8.07 (d, J = 8.4 Hz, 1H), 8.00 – 
7.91 (m, 2H), 7.40 (dd, J = 13.8, 8.3 Hz, 2H), 7.25 (dt, J = 27.9, 6.9 Hz, 2H), 6.62 (t, 
J = 7.4 Hz, 2H), 6.53 – 6.44 (m, 2H), 5.76 (ddd, J = 17.3, 10.4, 7.4 Hz, 1H), 4.96 – 
4.84 (m, 2H), 3.70 – 3.56 (m, 1H), 3.16 – 2.97 (m, 1H), 2.63 (dd, J = 13.7, 10.1 Hz, 
1H), 2.36 (d, J = 13.5 Hz, 1H), 2.32 – 2.20 (m, 1H), 1.93 (s, 1H), 1.69 – 1.61 (m, 
2H), 1.22 (d, J = 13.4 Hz, 1H). 
31
P NMR: (162 MHz, PhMe-d8, 65 
o
C)  
δ 85.4. 
TLC: Rf 0.18 (hexane/EtOAc/Et3N, 40:56:4) [UV] 
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Preparation of O-(Bis(dimethylamino)thiophosphinoyl)-cinchonidine. (26e) [MTB-XVII-
55] 
 
A 10-mL, oven-dried Schlenk flask, fitted with a septum and a magnetic stir bar, under Ar, was 
charged with cinchonidine (294 mg, 1.0 mmol, 1.0 equiv) and was heated to 100 
o
C in vacuo (0.1 
mmHg) for 1h. The flask was allowed to cool, and was filled with Ar. Dichloromethane (2.0 mL) 
and Et3N (0.28 mL, 2.0 mmol, 2.0 equiv) were added and the resulting white suspension was 
cooled in an ice bath. A solution of Bis(dimethylamino)chlorophosphine (1.2 mmol, 1.2 equiv) 
in CH2Cl2 (2 mL) was added dropwise via cannula. The suspension was stirred for 0.5 h, and 
then was allowed to warm to room temperature and stir for 1.5 h. The mixture was concentrated 
in vacuo (0.1 mmHg) and then a condenser was fitted to the flask. The flask was charged with 
PhMe (5 mL) and S8 (41.7 mg, 0.15 mmol, 0.15 equiv of S8, 1.2 equiv of S) and was heated to 
reflux for 2.5 h. The mixture was allowed to cool to room temperature and stir overnight. The 
mixture was poured into a 60-mL separatory funnel containing sat. aq. NaHCO3 solution (10 
mL) and was extracted with EtOAc (10 mL). Saturated aq. Na2CO3 solution (2 mL) was added 
and the mixture was extracted with EtOAc (2 x 10 mL).  The combined organic extracts were 
dried over MgSO4, filtered, and concentrated in vacuo (23 
o
C, 6 mmHg). The residue was 
purified by column chromatography (silica gel (17 g), 2 cm diam., 10 cm length, 
hexane/EtOAc/Et3N, 40:56:4) to provide 319 mg (72%) of 26e as a white solid foam. The solid 
was dissolved in CH2Cl2 (20 mL) and washed with 10% aq. NaOH (10 mL), and sat. aq. Na2PO4 
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solution (2 x 5 mL). The aqueous washes were back extracted with CH2Cl2 (5 mL). The 
combined organic phases were dried over K2CO3, filtered and concentrated in vacuo  (23 
o
C, 6 
mmHg) to provide a white solid (308.9 mg) which was recrystallized from EtOAc/hexane to 
provide 228.4 mg of 26e as colorless needles. The spectra show a 2:1 mixture of rotamers which 
become dynamically broad at 45 
o
C. Attempts to acquire a 
13
C spectrum were unsuccessful due 
to dynamic broadening.  
Data for 26e:  
1
H NMR: (500 MHz, CDCl3, major rotamer) 
δ 8.96 (d, J = 3.8 Hz, 1H), 8.44 (d, J = 8.5 Hz, 1H), 8.12 (d, J = 8.3 Hz, 2H), 7.70 (t, 
J = 7.1 Hz, 2H), 7.62 (t, J = 7.5 Hz, 1H), 7.55 (d, J = 4.2 Hz, 2H), 7.34 (s, 1H), 6.43 
(t, J = 11.5 Hz, 1H), 5.93 (d, J = 8.6 Hz, 2H), 5.05 (d, J = 10.8 Hz, 3H), 3.93 – 3.67 
(m, 1H), 3.42 (q, J = 8.7 Hz, 1H), 3.10 – 2.84 (m, 3H), 2.49 (s, 3H), 2.46 (s, 3H), 
2.30 – 2.19 (m, 2H), 2.14 – 2.00 (m, 2H), 1.81 (s, 3H), 1.78 (s, 3H). 
31
P NMR: (202 MHz, CDCl3)  
δ 85.7 (minor rotamer), 85.4 (major rotamer). 
TLC: Rf 0.2 (hexane/EtOAc/Et3N, 40:56:4) [UV] 
 
C.5.2. Chiral Brønsted Acid Catalyzed Bromocycloetherifications 
Optimization of the Bromocycloetherification of 19a in the Absence of Ph3=S. General 
Procedure 12. Bromocycloetherification of 19a in the Presence of 24a (Table 14, Entry 1) 
[MTB-XIII-68] 
A 10-mL, oven-dried Schlenk flask, fitted with a septum and a magnetic stir bar, wrapped 
in Al-foil, under Ar, was charged with N-bromosuccinimide (22 mg, 0.12 mmol, 1.2 equiv). The 
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flask was then evacuated and filled with argon. Toluene (3.4 mL) was added via syringe and then 
the flask was cooled to 0 
o
C (thermostated H2O/ethylene glycol bath). A solution of 19a (16.0 
mg, 0.1 mmol, 1.0 equiv) in toluene (0.4 mL) was added via short cannula. A solution of 24a 
(7.5 mg, 0.01 mmol, 0.1 equiv) in toluene (0.2 mL) was added via syringe. The reaction mixture 
was stirred at 0 
o
C for 24 h. Chilled (ca. 0 
o
C) aq. Na2S2O3 solution (1 mL) was added, by chilled 
sat. aq. NaHCO3 solution (1 mL). The resulting biphasic mixture was stirred at 0 
o
C for 10 min, 
after which it was allowed to warm to room temperature while stirring vigorously. The colorless 
biphasic mixture was transferred to a 60-mL separatory funnel where it was diluted with H2O (3 
mL) and was extracted with Et2O (3 x 5 mL). The combined organic extracts were dried over 
Na2SO4, filtered, and concentrated in vacuo (23 
o
C, 6 mmHg). The ratio of 21aa to 20aa was 
determined to be 48:52 by NMR spectroscopy. The residue was purified by column 
chromatography (silica gel (4.5g), 1 cm diam., 10 cm length, hexane/EtOAc, 19:1) to provide 
15.3 mg (65%) of a mixture of 21aa and 20aa. 
Data for 21aa and 20aa: 
SFC: (2S,6R)-21aa, tR 8.3 min (4.3%); (2R,6S)-21aa, tR 8.5 min (87.0%); (2R,3S)-20aa, tR 
9.8 min (5.3%); (2S,3R)-20aa, tR 12.9 min (3.3%) (Chiralcel OD, 200 bar, 2.0 
mL/min, gradient from 0% MeOH in CO2 to 3% MeOH in CO2 over 10 min, then 
gradient to 4.5% MeOH in CO2 at 15 min) 
 
Optimization of the Bromocycloetherification of 19a in the Absence of Ph3=S. 
Bromocycloetherification of 19a in the Presence of 24b (Table 14, Entry 2) [MTB-XIII-67] 
Following General Procedure 12, a 10-mL Schlenk flask was charged with N-
bromosuccinimide (21 mg, 0.12 mmol, 1.2 equiv), followed by toluene (3.4 mL), a solution of 
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19a (16.4 mg, 1.0 equiv, 0.1 mmol) in toluene (0.4 mL), and a solution of 24c (7.7 mg, 0.1 equiv, 
0.01 mmol) in toluene (0.2 mL). After stirring for 24 h and quenching an 44:56 mixture of 21aa 
and 20aa was observed by 
1
H NMR. Column chromatography (SiO2, 1 cm diam, 10 cm length, 
hexane/EtOAc 19:1) provided 3.4 mg (14 %) of 20aa and 6.2 mg (26%) of a mixture of 21aa 
and 20aa.  
Data for 21aa and 20aa: 
SFC: (2S,6R)-21aa, tR 8.5 min (5.3%); (2R,6S)-21aa, tR 8.6 min (90.8%); (2R,3S)-20aa, tR 
9.9 min (2.06%); (2S,3R)-20aa, tR 13.0 min (1.79%) (Chiralcel OD, 200 bar, 2.0 
mL/min, gradient from 0% MeOH in CO2 to 3% MeOH in CO2 over 10 min, then 
gradient to 4.5% MeOH in CO2 at 15 min) 
 
Optimization of the Bromocycloetherification of 19a in the Absence of Ph3=S. 
Bromocycloetherification of 19a in the Presence of 24c (Table 14, Entry 3) [MTB-XIII-74] 
Following General Procedure 12, a 10-mL Schlenk flask was charged with N-
bromosuccinimide (21 mg, 0.12 mmol, 1.2 equiv), followed by toluene (2.9 mL), a solution of 
19a (16.7 mg, 1.0 equiv, 0.1 mmol) in toluene (0.4 mL), and a solution of 24c (8.8 mg, 0.1 equiv, 
0.01 mmol) in toluene (0.2 mL). After stirring for 13 h and quenching an 13:87 mixture of 21aa 
and 20aa was observed by 
1
H NMR. Column chromatography (SiO2, 1 cm diam, 10 cm length, 
hexane/EtOAc 19:1) provided 19.3 mg (78%) of a mixture of 21aa and 20aa.  
Data for 21aa and 20aa: 
SFC: (2S,6R)-21aa, tR 8.3 min (42.5%); (2R,6S)-21aa, tR 8.7 min (16.7%); (2R,3S)-20aa, 
tR 10.0 min (19.1%); (2S,3R)-20aa, tR 13.0 min (21.7%) (Chiralcel OD, 200 bar, 2.0 
mL/min, gradient from 0% MeOH in CO2 to 3% MeOH in CO2 over 10 min, then 
236 
 
gradient to 4.5% MeOH in CO2 at 15 min) 
 
Optimization of the Bromocycloetherification of 19a in the Absence of Ph3=S. 
Bromocycloetherification of 19a in the Presence of 24a at 0.05 M (Table 14, Entry 4) 
[MTB-XIII-76] 
Following General Procedure 12, a 10-mL Schlenk flask was charged with N-
bromosuccinimide (21 mg, 0.12 mmol, 1.2 equiv), followed by toluene (1.4 mL), a solution of 
19a (16.7 mg, 1.0 equiv, 0.1 mmol) in toluene (0.4 mL), and a solution of 24a (7.5 mg, 0.1 
equiv, 0.01 mmol) in toluene (0.2 mL). After stirring for 24 h and quenching an 42:58 mixture of 
21aa and 20aa was observed by 
1
H NMR. Column chromatography (SiO2, 1 cm diam, 10 cm 
length, hexane/EtOAc 19:1) provided 9.3 mg (39%) of a mixture of 21aa and 20aa.  
Data for 21aa and 20aa: 
SFC: (2S,6R)-21aa, tR 8.1 min (6.8%); (2R,6S)-21aa, tR 8.4 min (78.7%); (2R,3S)-20aa, tR 
9.5 min (8.3%); (2S,3R)-20aa, tR 12.7 min (6.0%) (Chiralcel OD, 200 bar, 2.0 
mL/min, gradient from 0% MeOH in CO2 to 3% MeOH in CO2 over 10 min, then 
gradient to 4.5% MeOH in CO2 at 15 min) 
 
Optimization of the Bromocycloetherification of 19a in the Absence of Ph3=S. 
Bromocycloetherification of 19a in the Presence of 24a at 0.1 M (Table 14, Entry 5) [MTB-
XIII-77] 
Following General Procedure 12, a 10-mL Schlenk flask was charged with N-
bromosuccinimide (21 mg, 0.12 mmol, 1.2 equiv), followed by toluene (0.4 mL), a solution of 
19a (16.3 mg, 1.0 equiv, 0.1 mmol) in toluene (0.4 mL), and a solution of 24a (7.5 mg, 0.1 
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equiv, 0.01 mmol) in toluene (0.2 mL). After stirring for 24 h and quenching a 28:72 mixture of 
21aa and 20aa was observed by 
1
H NMR. Column chromatography (SiO2, 1 cm diam, 10 cm 
length, hexane/EtOAc 19:1) provided 11.5 mg (48%) of a mixture of 21aa and 20aa.  
Data for 21aa and 20aa: 
SFC: (2S,6R)-21aa, tR 8.1 min (9.5%); (2R,6S)-21aa, tR 8.4 min (69.1%); (2R,3S)-20aa, tR 
9.5 min (11.8%); (2S,3R)-20aa, tR 12.7 min (9.5%) (Chiralcel OD, 200 bar, 2.0 
mL/min, gradient from 0% MeOH in CO2 to 3% MeOH in CO2 over 10 min, then 
gradient to 4.5% MeOH in CO2 at 15 min) 
 
Optimization of the Bromocycloetherification of 19a in the Absence of Ph3=S. 
Bromocycloetherification of 19a in the Presence of 24a in CHCl3 (Table 14, Entry 6) [MTB-
XIII-69] 
Following General Procedure 12, a 10-mL Schlenk flask was charged with N-
bromosuccinimide (21 mg, 0.12 mmol, 1.2 equiv), followed by CHCl3 (3.4 mL), a solution of 
19a (16.3 mg, 1.0 equiv, 0.1 mmol) in CHCl3 (0.4 mL), and a solution of 24a (7.5 mg, 0.1 equiv, 
0.01 mmol) in CHCl3 (0.2 mL). After stirring for 24 h and quenching a 9:91 mixture of 21aa and 
20aa was observed by 
1
H NMR. Column chromatography (SiO2, 1 cm diam, 10 cm length, 
hexane/EtOAc 19:1) provided 14.0 mg (59%) of a mixture of 21aa and 20aa.  
Data for 21aa and 20aa: 
SFC: (2S,6R)-21aa, tR 8.1 min (7.4%); (2R,6S)-21aa, tR 8.4 min (46.8%); (2R,3S)-20aa, tR 
9.5 min (23.1%); (2S,3R)-20aa, tR 12.7 min (22.6%) (Chiralcel OD, 200 bar, 2.0 
mL/min, gradient from 0% MeOH in CO2 to 3% MeOH in CO2 over 10 min, then 
gradient to 4.5% MeOH in CO2 at 15 min) 
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Optimization of the Bromocycloetherification of 19a in the Absence of Ph3=S. 
Bromocycloetherification of 19a in the Presence of 24a in PhCF3 (Table 14, Entry 7) [MTB-
XIII-71] 
Following General Procedure 12, a 10-mL Schlenk flask was charged with N-
bromosuccinimide (21 mg, 0.12 mmol, 1.2 equiv), followed by PhCF3 (3.4 mL), a solution of 
19a (16.3 mg, 1.0 equiv, 0.1 mmol) in PhCF3 (0.4 mL), and a solution of 24a (7.5 mg, 0.1 equiv, 
0.01 mmol) in PhCF3 (0.2 mL). After stirring for 24 h and quenching a 27:73 mixture of 21aa 
and 20aa was observed by 
1
H NMR. Column chromatography (SiO2, 1 cm diam, 10 cm length, 
hexane/EtOAc 19:1) provided 19.8 mg (82%) of a mixture of 21aa and 20aa.  
Data for 21aa and 20aa: 
SFC: (2S,6R)-21aa, tR 8.1 min (19.4%); (2R,6S)-21aa, tR 8.4 min (56.3%); (2R,3S)-20aa, 
tR 9.5 min (11.4%); (2S,3R)-20aa, tR 12.7 min (12.8%) (Chiralcel OD, 200 bar, 2.0 
mL/min, gradient from 0% MeOH in CO2 to 3% MeOH in CO2 over 10 min, then 
gradient to 4.5% MeOH in CO2 at 15 min) 
 
 
Optimization of the Bromocycloetherification of 19a in the Absence of Ph3=S. General 
Procedure 12. Bromocycloetherification of 19a in the Presence of 24a in Hexane (Table 14, 
Entry 8) [MTB-XIII-71] 
Following General Procedure 12, a 10-mL Schlenk flask was charged with N-
bromosuccinimide (21 mg, 0.12 mmol, 1.2 equiv), followed by hexane (1.8 mL), a solution of 
19a (16.3 mg, 1.0 equiv, 0.1 mmol) in hexane (0.6 mL), and a suspension of 24a (7.5 mg, 0.1 
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equiv, 0.01 mmol) in hexane (1.2 mL). After stirring for 24 h and quenching a 20:80 mixture of 
21aa and 20aa was observed by 
1
H NMR. Column chromatography (SiO2, 1 cm diam, 10 cm 
length, hexane/EtOAc 19:1) provided 8.9 mg (37%) of a mixture of 21aa and 20aa.  
Data for 21aa and 20aa: 
SFC: (2S,6R)-21aa, tR 8.1 min (13.6%); (2R,6S)-21aa, tR 8.4 min (58.3%); (2R,3S)-20aa, 
tR 9.5 min (13.9%); (2S,3R)-20aa, tR 12.7 min (13.8%) (Chiralcel OD, 200 bar, 2.0 
mL/min, gradient from 0% MeOH in CO2 to 3% MeOH in CO2 over 10 min, then 
gradient to 4.5% MeOH in CO2 at 15 min) 
 
Optimization of the Bromocycloetherification of 19a in the Absence of Ph3=S. General 
Procedure 12. Bromocycloetherification of 19a in the Presence of 24a in Et2O (Table 14, 
Entry 9) [MTB-XIII-73] 
Following General Procedure 12, a 10-mL Schlenk flask was charged with N-
bromosuccinimide (21 mg, 0.12 mmol, 1.2 equiv), followed by Et2O (3.4 mL), a solution of 19a 
(16.8 mg, 1.0 equiv, 0.1 mmol) in Et2O (0.4 mL), and a solution of 24a (7.5 mg, 0.1 equiv, 0.01 
mmol) in Et2O (0.4 mL). After stirring for 24 h and quenching a 2:98 mixture of 21aa and 20aa 
was observed by 
1
H NMR. Column chromatography (SiO2, 1 cm diam, 10 cm length, 
hexane/EtOAc 19:1) provided 14.2 mg (57%) of a mixture of 21aa and 20aa.  
Data for 21aa and 20aa: 
SFC: (2S,6R)-21aa, tR 8.1 min (7.4%); (2R,6S)-21aa, tR 8.4 min (7.8%); (2R,3S)-20aa, tR 
9.5 min (41.1%); (2S,3R)-20aa, tR 12.7 min (43.7%) (Chiralcel OD, 200 bar, 2.0 
mL/min, gradient from 0% MeOH in CO2 to 3% MeOH in CO2 over 10 min, then 
gradient to 4.5% MeOH in CO2 at 15 min) 
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Optimization of the Bromocycloetherification of 19a in the Absence of Ph3=S. General 
Procedure 12. Bromocycloetherification of 19a in the Presence of 24a in MeCN (Table 14, 
Entry 10) [MTB-XIII-75] 
Following General Procedure 12, a 10-mL Schlenk flask was charged with N-
bromosuccinimide (21 mg, 0.12 mmol, 1.2 equiv), followed by MeCN (3.0 mL), a solution of 
19a (16.8 mg, 1.0 equiv, 0.1 mmol) in MeCN (0.4 mL), and a suspension of 24a (7.5 mg, 0.1 
equiv, 0.01 mmol) in MeCN (0.6 mL). After stirring for 24 h and quenching a 2:98 mixture of 
21aa and 20aa was observed by 
1
H NMR. Column chromatography (SiO2, 1 cm diam, 10 cm 
length, hexane/EtOAc 19:1) provided 18.3 mg (75%) of a mixture of 21aa and 20aa.  
Data for 21aa and 20aa: 
SFC: (2S,6R)-21aa, tR 8.1 min (8.4%); (2R,6S)-21aa, tR 8.4 min (8.8%); (2R,3S)-20aa, tR 
9.5 min (41.2%); (2S,3R)-20aa, tR 12.7 min (41.6%) (Chiralcel OD, 200 bar, 2.0 
mL/min, gradient from 0% MeOH in CO2 to 3% MeOH in CO2 over 10 min, then 
gradient to 4.5% MeOH in CO2 at 15 min) 
 
C.5.3. Chiral Brønsted Acid/Achiral Lewis Base Cooperatively Catalyzed 
Bromocycloetherifications. 
Optimization of the Bromocycloetherification of 19a. General Procedure 13. 
Bromocycloetherification of 19a in the Presence of 24a (Table 15, Entry 1)  
A 10-mL, oven-dried Schlenk flask, fitted with a septum and a magnetic stir bar, wrapped 
in Al-foil, under Ar, was charged with N-bromosuccinimide (22 mg, 0.12 mmol, 1.2 equiv). The 
flask was then evacuated and filled with argon. Toluene (2.9 mL) was added via syringe and then 
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the flask was cooled to 0 
o
C (thermostated H2O/ethylene glycol bath). A solution of 19a (16.5 
mg, 0.1 mmol, 1.0 equiv) in toluene (0.4 mL) was added via short cannula. A solution of 24a 
(3.8 mg, 0.005 mmol, 0.05 equiv) in toluene (0.2 mL) was added via syringe, followed by a 0.01 
M solution of Ph3P=S in toluene (0.50 mL, 0.005 mmol, 0.05 equiv) The reaction mixture was 
stirred at 0 
o
C for 9 h. Aqueous Na2S2O3 solution (1 mL) was added, followed by sat. aq. 
NaHCO3 solution (1 mL). The resulting biphasic mixture was stirred at 0 
o
C for 10 min, after 
which it was allowed to warm to room temperature while stirring vigorously. The colorless 
biphasic mixture was transferred to a 60-mL separatory funnel where it was diluted with H2O (5 
mL) and was extracted with Et2O (3 x 5 mL). The combined organic extracts were dried over 
Na2SO4, filtered, and concentrated in vacuo (23 
o
C, 6 mmHg). The ratio of 21aa to 20aa was 
determined to be 52:48 by NMR spectroscopy. The residue was purified by column 
chromatography (silica gel, 0.5 cm diam., 5 cm length, hexane/EtOAc, 19:1) to provide 20.3 mg 
(83%) of a mixture of 21aa and 20aa. 
Note: This reaction was run descriptively (1.0 mmol) and the products were fully 
characterized by Dr. Dipannita Kalyani, who refused authorship on the publication.
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Data for 21aa and 20aa: 
SFC: (2S,6R)-21aa, tR 9.4 min (6.11%); (2R,6S)-21aa, tR 9.7 min (88.1%); (2R,3S)-20aa, 
tR 11.0 min (3.32%); (2S,3R)-20aa, tR 13.9 min (2.50%) (Chiralcel OD, 200 bar, 2.0 
mL/min, gradient from 0% MeOH in CO2 to 3% MeOH in CO2 over 10 min, then 
gradient to 4.5% MeOH in CO2 at 15 min) 
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Optimization of the Bromocycloetherification of 19a. Bromocycloetherification of 19a in 
the Presence of 24b. (Table 15, Entry 2) 
Following General Procedure 13, a 10-mL Schlenk flask was charged with N-
bromosuccinimide (21 mg, 0.12 mmol, 1.2 equiv), followed by toluene (2.9 mL), a solution of 
19a (16.4 mg, 1.0 equiv, 0.1 mmol) in toluene (0.4 mL), a solution of 24b (3.8 mg, 0.05 equiv, 
0.005 mmol) in toluene (0.2 mL), and a 0.01 M solution of Ph3P=S in toluene (0.5 mL, 0.05 
equiv, 0.005 mmol). After stirring for 12 h and quenching an 87:13 mixture of 21aa and 20aa 
was observed by 
1
H NMR. Column chromatography (SiO2, 1 cm diam, 10 cm length, 
hexane/EtOAc 19:1) provided 15.9 mg (65 %) of a mixture of 21aa and 20aa.  
Data for 21aa and 20aa: 
SFC: (2S,6R)-21aa, tR 8.9 min (17.7%); (2R,6S)-21aa, tR 9.2 min (46.6%); (2R,3S)-20aa, 
tR 10.5 min (18.0%); (2S,3R)-20aa, tR 13.7 min (17.7%) (Chiralcel OD, 200 bar, 2.0 
mL/min, gradient from 0% MeOH in CO2 to 3% MeOH in CO2 over 10 min, then 
gradient to 4.5% MeOH in CO2 at 15 min) 
 
Optimization of the Bromocycloetherification of 19a. Bromocycloetherification of 19a in 
the Presence of 24b. (Table 15, Entry 2) 
Following General Procedure 13, a 10-mL Schlenk flask was charged with N-
bromosuccinimide (21 mg, 0.12 mmol, 1.2 equiv), followed by toluene (2.9 mL), a solution of 
19a (16.4 mg, 1.0 equiv, 0.1 mmol) in toluene (0.4 mL), a solution of 24b (3.8 mg, 0.05 equiv, 
0.005 mmol) in toluene (0.2 mL), and a 0.01 M solution of Ph3P=S in toluene (0.5 mL, 0.05 
equiv, 0.005 mmol). After stirring for 12 h and quenching an 87:13 mixture of 21aa and 20aa 
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was observed by 
1
H NMR. Column chromatography (SiO2, 1 cm diam, 10 cm length, 
hexane/EtOAc 19:1) provided 15.9 mg (65 %) of a mixture of 21aa and 20aa.  
Data for 21aa and 20aa: 
SFC: (2S,6R)-21aa, tR 8.9 min (17.7%); (2R,6S)-21aa, tR 9.2 min (46.6%); (2R,3S)-20aa, 
tR 10.5 min (18.0%); (2S,3R)-20aa, tR 13.7 min (17.7%) (Chiralcel OD, 200 bar, 2.0 
mL/min, gradient from 0% MeOH in CO2 to 3% MeOH in CO2 over 10 min, then 
gradient to 4.5% MeOH in CO2 at 15 min) 
 
Optimization of the Bromocycloetherification of 19a. Bromocycloetherification of 19a in 
the Presence of 24c (Table 15, Entry 3) 
Following General Procedure 13, a 10-mL Schlenk flask was charged with N-
bromosuccinimide (21 mg, 0.12 mmol, 1.2 equiv), followed by toluene (2.9 mL), a solution of 
19a (16.4 mg, 1.0 equiv, 0.1 mmol) in toluene (0.4 mL), a solution of 24c (4.4 mg, 0.05 equiv, 
0.005 mmol) in toluene (0.2 mL), and a 0.01 M solution of Ph3P=S in toluene (0.5 mL, 0.05 
equiv, 0.005 mmol). After stirring for 12 h and quenching a 12:88 mixture of 21aa and 20aa was 
observed by 
1
H NMR. Column chromatography (SiO2, 1 cm diam, 10 cm length, hexane/EtOAc 
19:1) provided 20.8 mg (85 %) of a mixture of 21aa and 20aa. 
Data for 21aa and 20aa: 
SFC: (2S,6R)-21aa, tR 9.0 min (14.3%); (2R,6S)-21aa, tR 9.4 min (44.1%); (2R,3S)-20aa, 
tR 10.7 min (20.5%); (2S,3R)-20aa, tR 13.9 min (21.1%) (Chiralcel OD, 200 bar, 2.0 
mL/min, gradient from 0% MeOH in CO2 to 3% MeOH in CO2 over 10 min, then 
gradient to 4.5% MeOH in CO2 at 15 min) 
 
244 
 
Optimization of the Bromocycloetherification of 19a. Bromocycloetherification of 19a in 
the Presence of 24d (Table 15, Entry 4) 
Following General Procedure 13, a 10-mL Schlenk flask was charged with N-
bromosuccinimide (21 mg, 0.12 mmol, 1.2 equiv), followed by toluene (2.9 mL), a solution of 
19a (16.2 mg, 1.0 equiv, 0.1 mmol) in toluene (0.4 mL), a solution of 24d (3.8 mg, 0.05 equiv, 
0.005 mmol) in toluene (0.2 mL), and a 0.01 M solution of Ph3P=S in toluene (0.5 mL, 0.05 
equiv, 0.005 mmol). After stirring for 12 h and quenching a 15:85 mixture of 21aa and 20aa was 
observed by 
1
H NMR. Column chromatography (SiO2, 1 cm diam, 10 cm length, hexane/EtOAc 
19:1) provided 22.9 mg (95 %) of a mixture of 21aa and 20aa. 
Data for 21aa and 20aa: 
SFC: (2S,6R)-21aa, tR 9.3 min (23.4%); (2R,6S)-21aa, tR 9.6 min (39.5%); (2R,3S)-20aa, 
tR 10.8 min (18.5%); (2S,3R)-20aa, tR 13.9 min (18.5%) (Chiralcel OD, 200 bar, 2.0 
mL/min, gradient from 0% MeOH in CO2 to 3% MeOH in CO2 over 10 min, then 
gradient to 4.5% MeOH in CO2 at 15 min) 
 
Optimization of the Bromocycloetherification of 19a. Bromocycloetherification of 19a in 
the Presence of 24e (Table 15, Entry 5) 
Following General Procedure 13, a 10-mL Schlenk flask was charged with N-
bromosuccinimide (21 mg, 0.12 mmol, 1.2 equiv), followed by toluene (2.9 mL), a solution of 
19a (16.2 mg, 1.0 equiv, 0.1 mmol) in toluene (0.4 mL), a solution of 24e (5.1 mg, 0.05 equiv, 
0.005 mmol) in toluene (0.2 mL), and a 0.01 M solution of Ph3P=S in toluene (0.5 mL, 0.05 
equiv, 0.005 mmol). After stirring for 35 h and quenching a 15:85 mixture of 21aa and 20aa in 
57% conversion was observed by 
1
H NMR. Column chromatography (SiO2, 1 cm diam, 10 cm 
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length, hexane/EtOAc 19:1) provided 7.0 mg (31 %) of a mixture of 21aa and 20aa. 
Data for 21aa and 20aa: 
SFC: (2S,6R)-21aa, tR 10.8 min (16.3%); (2R,6S)-21aa, tR 11.1 min (55.5%); (2R,3S)-
20aa, tR 12.4 min (13.8%); (2S,3R)-20aa, tR 13.9 min (14.4%)  
 
Optimization of the Bromocycloetherification of 19a. Bromocycloetherification of 19a in 
the Presence of 2f (Table 15, Entry 6) 
Following General Procedure 13, a 10-mL Schlenk flask was charged with N-
bromosuccinimide (21 mg, 0.12 mmol, 1.2 equiv), followed by toluene (2.7 mL), a solution of 
19a (16.4 mg, 1.0 equiv, 0.1 mmol) in toluene (0.4 mL), a solution of 2f (3.0 mg, 0.05 equiv, 
0.005 mmol) in toluene (0.4 mL), and a 0.02 M solution of Ph3P=S in toluene (0.25 mL, 0.05 
equiv, 0.005 mmol). After stirring for 12 h and quenching a 19:81 mixture of 21aa and 20aa was 
observed by 
1
H NMR. Column chromatography (SiO2, 1 cm diam, 10 cm length, hexane/EtOAc 
19:1) provided 21.1 mg (86 %) of a mixture of 21aa and 20aa. 
Data for 21aa and 20aa: 
SFC: (2S,6R)-21aa, tR 9.0 min (22.0%); (2R,6S)-21aa, tR 9.4 min (47.9%); (2R,3S)-20aa, 
tR 10.5 min (14.3%); (2S,3R)-20aa, tR 13.9 min (15.7%) (Chiralcel OD, 200 bar, 2.0 
mL/min, gradient from 0% MeOH in CO2 to 3% MeOH in CO2 over 10 min, then 
gradient to 4.5% MeOH in CO2 at 15 min) 
 
Optimization of the Bromocycloetherification of 19a. Bromocycloetherification of 19a at 0.1 
M (Table 15, Entry 7) 
Following General Procedure 13, a 10-mL Schlenk flask was charged with N-
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bromosuccinimide (21 mg, 0.12 mmol, 1.2 equiv), followed by toluene (0.15 mL), a solution of 
19a (16.2 mg, 1.0 equiv, 0.1 mmol) in toluene (0.4 mL), a solution of 24a (3.8 mg, 0.05 equiv, 
0.005 mmol) in toluene (0.2 mL), and a 0.02 M solution of Ph3P=S in toluene (0.25 mL, 0.05 
equiv, 0.005 mmol). After stirring for 12 h and quenching a 39:61 mixture of 21aa and 20aa was 
observed by 
1
H NMR. Column chromatography (SiO2, 1 cm diam, 10 cm length, hexane/EtOAc 
19:1) provided 20.2 mg (84 %) of a mixture of 21aa and 20aa. 
Data for 21aa and 20aa: 
SFC: (2S,6R)-21aa, tR 8.8 min (8.45%); (2R,6S)-21aa, tR 9.1 min (77.7%); (2R,3S)-20aa, 
tR 10.4 min (7.51%); (2S,3R)-20aa, tR 13.6 min (6.36%) (Chiralcel OD, 200 bar, 2.0 
mL/min, gradient from 0% MeOH in CO2 to 3% MeOH in CO2 over 10 min, then 
gradient to 4.5% MeOH in CO2 at 15 min) 
 
Optimization of the Bromocycloetherification of 19a. Bromocycloetherification of 19a in 
Et2O (Table 15, Entry 8) 
Following General Procedure 13, a 10-mL Schlenk flask was charged with N-
bromosuccinimide (21 mg, 0.12 mmol, 1.2 equiv), followed by Et2O (2.9 mL), a solution of 19a 
(16.2 mg, 1.0 equiv, 0.1 mmol) in Et2O (0.4 mL), a solution of 24a (3.0 mg, 0.05 equiv, 0.005 
mmol) in Et2O (0.2 mL), and a 0.01 M solution of Ph3P=S in Et2O (0.50 mL, 0.05 equiv, 0.005 
mmol). After stirring for 12 h and quenching a 17:83 mixture of 21aa and 20aa was observed by 
1
H NMR. Column chromatography (SiO2, 1 cm diam, 10 cm length, hexane/EtOAc 19:1) 
provided 21.0 mg (87 %) of a mixture of 21aa and 20aa. 
 
Data for 21aa and 20aa: 
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SFC: (2S,6R)-21aa, tR 8.8 min (7.94%); (2R,6S)-21aa, tR 9.4 min (57.8%); (2R,3S)-20aa, 
tR 10.5 min (17.2%); (2S,3R)-20aa, tR 13.9 min (16.9%) (Chiralcel OD, 200 bar, 2.0 
mL/min, gradient from 0% MeOH in CO2 to 3% MeOH in CO2 over 10 min, then 
gradient to 4.5% MeOH in CO2 at 15 min) 
 
Optimization of the Bromocycloetherification of 19a. Bromocycloetherification of 19a in 
CHCl3 (Table 15, Entry 9) 
Following General Procedure 13, a 10-mL Schlenk flask was charged with N-
bromosuccinimide (21 mg, 0.12 mmol, 1.2 equiv), followed by CHCl3 (2.9 mL), a solution of 
19a (16.2 mg, 1.0 equiv, 0.1 mmol) in CHCl3 (0.4 mL), a solution of 24a (3.0 mg, 0.05 equiv, 
0.005 mmol) in CHCl3 (0.2 mL), and a 0.01 M solution of Ph3P=S in CHCl3 (0.50 mL, 0.05 
equiv, 0.005 mmol). After stirring for 12 h and quenching a 3:97 mixture of 21aa and 20aa was 
observed by 
1
H NMR. Column chromatography (SiO2, 1 cm diam, 10 cm length, hexane/EtOAc 
19:1) provided 21.7 mg (90 %) of a mixture of 21aa and 20aa. 
Data for 21aa and 20aa: 
SFC: (2S,6R)-21aa, tR 9.1 min (10.9%); (2R,6S)-21aa, tR 9.5 min (13.7%); (2R,3S)-20aa, 
tR 10.6 min (37.0%); (2S,3R)-20aa, tR 13.6 min (38.3%) (Chiralcel OD, 200 bar, 2.0 
mL/min, gradient from 0% MeOH in CO2 to 3% MeOH in CO2 over 10 min, then 
gradient to 4.5% MeOH in CO2 at 15 min) 
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Bromocycloetherifications 
General Procedure 14. Bromocycloetherification of 19h. Preparation of (2R)-Tetrahydro-2-
[(R)-bromo(2-naphthyl)methyl]furan (21ha) 
 
A 100-mL, oven-dried Schlenk flask, fitted with a septum and a magnetic stir bar, 
wrapped in Al-foil, under Ar, was charged with N-bromosuccinimide (214 mg, 1.2 mmol, 1.2 
equiv). The flask was then evacuated and filled with argon. Toluene (29 mL) was added via 
syringe and then a thermocouple was fitted and the flask was cooled to 0 
o
C (thermostated 
H2O/ethylene glycol bath, internal temp ±2 
o
C). Solutions of 19h (212.6 mg, 1.0 mmol, 1.0 
equiv) in toluene (4.0 mL), 24a (38 mg, 0.05 mmol, 0.05 equiv) in toluene (2.0 mL) and Ph3P=S 
(14.8 mg, 0.05 mmol, 0.05 equiv) in toluene (5.0 mL) were added via syringe. The reaction 
mixture was stirred at 0 
o
C for 12 h. Aqueous Na2S2O3 solution (10 mL) was added, followed by 
sat. aq. NaHCO3 solution (10 mL). The resulting biphasic mixture was stirred at 0 
o
C for 10 min, 
after which it was allowed to warm to room temperature while stirring vigorously. The colorless 
biphasic mixture was transferred to a 250-mL separatory funnel where it was diluted with H2O 
(50 mL) and was extracted with Et2O (3 x 50 mL). The combined organic extracts were dried 
over Na2SO4, filtered, and concentrated in vacuo (23 
o
C, 6 mmHg). The ratio of 21ha to 20ha 
was determined to be 95:5 by NMR spectroscopy. The residue was purified by column 
chromatography (silica gel (19g), 2 cm diam, 10 cm length, hexane/EtOAc, 19:1), and 
recrystallization from hexane (twice via partial concentration in vacuo (6 mmHg, 23 
o
C) to ca. 1 
mL volume) to yield 213.8 mg (73%) of 21ha as white needles. Crystals suitable for x-ray 
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crystallography were obtained from EtOAc/hexane (via partial concentration in vacuo).  
Data for 21ha: 
mp: 70 – 73 oC 
1
H NMR: (500 MHz, CDCl3) 
δ 7.90 – 7.78 (m, 4H, HC(aryl)), 7.59 (dd, J = 8.5, 1.8 Hz, 1H, HC(8)), 7.55 – 7.45 
(m, 2H, HC(12, 13)), 5.05 (d, J = 7.6 Hz, 1H, HC(6)), 4.52 (td, J = 7.6, 6.6 Hz, 1H, 
HC(2)), 4.04 – 3.87 (m, 2H, H2C(5)), 1.99 – 1.87 (m, 2H, H2C(4)), 1.87 – 1.77 (m, 
1H, HC(3)), 1.59 (ddt, J = 12.8, 8.2, 7.8 Hz, 1H, HC(3’)). 
13
C NMR: (125 MHz, CDCl3) 
δ 136.8 (C(7)), 133.1 (C(10/15)), 133.0 (C(10/15)), 128.6 (C(aryl)), 128.0 (C(aryl)), 
127.6 (C(aryl)), 127.0 (C(aryl)), 126.5 (C(12/13)), 126.4 (C(12/13)), 125.7 (C(8)), 
82.6 (C(2)), 68.8 (C(5)), 58.48 (C(6)), 30.3 (C(3)), 26.2 (C(4)). 
IR: (KBr pellet) 
2976 (w), 2948 (w), 2870 (w), 1599 (w), 1507 (w), 1367 (w), 1340 (w), 1174 (w), 
1085 (m), 1011 (w), 946 (w), 905 (w), 866 (w), 823 (w), 753 (m), 688 (w). 
MS: (ESI) 
233 (100), 265 (51), 308 (53), 310 (57), 313 (M
79
Br+Na
+
), 315 (M
81
Br+Na
+
) 
TLC: Rf 0.13 (hexanes/EtOAc, 19:1) [UV] 
SFC: (2S,6S)-21ha, tR 8.9 min (8.03%); (2R,6R)-21ha, tR 9.6 min (92.0%); (Chirapak OD, 
200 bar, 2.5 mL/min, gradient from 1% MeOH in CO2 to 5% MeOH in CO2 over 10 
min) 
Opt. Rot.: []D
24
 -96.6 (c = 1.01, EtOH) 
Analysis: C15H15OBr (291.2) 
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 Calcd: C, 61.87; H, 5.19 
 Found: C, 61.96; H, 5.34 
 
Bromocycloetherification of 19g. Preparation of (2R)-Tetrahydro-2-[(R)-
bromophenylmethyl]furan (21ga) 
 
Note: This preliminary reaction was run descriptively (1.0 mmol) and the products were 
fully characterized by Dr. Dipannita Kalyani, who refused authorship on the publication.
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Following General Procedure 13, a 100-mL Schlenk flask was charged with N-
bromosuccinimide (21.6 mg, 0.12 mmol, 1.2 equiv), toluene (2.9 mL), a solution of 19a in 
toluene (16.5 mg in 4.0 mL, 1.0 equiv, 1.0 mmol), a solution of 24a in toluene (3.76 mg in 0.2 
mL, 0.05 mmol, 0.05 equiv), a solution of Ph3P=S in toluene (147 mg in 5.0 mL, 0.05 mmol, 
0.05 equiv), and stirred for 14 h at 0 
o
C to yield after filtration through a plug of silica gel (19:1 
hex/EtOAc) an oil containing 21ga.  
Data for 21ga: 
1
H NMR: (500 MHz, CDCl3) 
δ 7.42 (d, J = 7.5 Hz, 2H, HC(8)), 7.35-7.26 (m, 3H, HC(aryl)), 4.86 (d, J = 7.5 Hz, 
1H, HC(6)), 4.41 (td, J = 7.7, 6.6 Hz, 1H, HC(2)), 3.95 (m, 1H, H2C(5)), 3.89 (m, 
1H, H2C(5’)), 1.93-1.86 (m, 2H, H2C(4)), 1.81 (ddt, J = 12.8, 6.9, 6.5 Hz, 1H, 
H2C(3)), 1.54 (dq, J = 12.1, 8.1 Hz, 1H, H2C(3’)). 
SFC: (2R,6R)-21ga, tR 6.1 min (88%); (2S,6S)-21ga, tR 6.7 min (12%); (Chirapak OJ, 200 
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bar, 2.5 mL/min, gradient from 1% MeOH in CO2 to 5% MeOH in CO2 over 10 
min) 
 
Bromocycloetherification of 19e. Preparation of (2R)-Tetrahydro-2-[(S)-bromo(4-
methylphenyl)methyl]furan (21ea) and (2R,3S)-3- Bromotetrahydro-2-(4-methylphenyl)-
2H-pyran (20ea) 
 
Following General Procedure 14, a 100-mL Schlenk flask was charged with N-
bromosuccinimide (214 mg, 1.2 mmol, 1.2 equiv), toluene (29 mL), a solution of 19e in toluene 
(175.9 mg in 4.0 mL, 1.0 equiv, 1.0 mmol), a solution of 24a in toluene (38 mg in 2.0 mL, 0.05 
mmol, 0.05 equiv), a solution of Ph3P=S in toluene (15 mg in 5.0 mL, 0.05 mmol, 0.05 equiv), 
and stirred for 14 h at 0 
o
C to yield after column chromatography (silica gel (25 g), 2 cm diam, 
14 cm length, hexane/TBME, 19:1, cold H2O jacketed, 200 μL Et3N included in column 
packing), further purification of the mixed fractions by column chromatography (silica gel (25 
g), 2 cm diam, 14 cm length, hexane/TBME, 19:1, cold H2O jacketed, 200 μL Et3N included in 
column packing), followed by column chromatography of the mixed fractions (silica gel, 1 cm 
diam, 15 cm length, hexane/TBME, 19:1) and further purification of the 21ea containing 
fractions by column chromatography (silica gel, 2 cm diam, 10 cm length, hexane/CH2Cl2, 
70:30) 111.8 mg (67%) of 20ea as a low melting solid, and 71.3 mg (28%) of 21ea as a low 
melting solid. The ratio of 21ea to 20ea was determined to be 37:63 by NMR spectroscopy prior 
to chromatography. 
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Data for 21ea: 
1
H NMR: (500 MHz, CDCl3) 
δ 7.38 – 7.30 (m, 2H, HC(aryl)), 7.16 (d, J = 7.8 Hz, 2H, HC(aryl)), 4.85 (d, J = 7.9 
Hz, 1H, HC(6)), 4.46 (dt, J = 7.9, 6.6 Hz, 1H, HC(2)), 3.96 – 3.72 (m, 2H, H2C(5)), 
2.34 (s, 3H, H3C(11)), 2.31 – 2.18 (m, 1H, HC(3)), 2.05 – 1.81 (m, 3H, HC(3’, 4, 
4’). 
13
C NMR: (125 MHz, CDCl3) 
δ 138.3 (C(7/10)), 136.7 (C(7/10), 129.3 (C(8/9)), 128.0 (C(8/9)), 82.0 (C(2)), 69.3 
(C(5)), 57.4 (C(6)), 31.1 (C(3)), 25.9 (C(4)), 21.2 (C(11)). 
IR: (NaCl plates, CH2Cl2) 
3028 (w), 2947 (w), 1616 (w), 1515 (w), 1448 (w), 1373 (w), 1330 (w), 1309 (w), 
1259 (w), 1219 (w), 1164 (w), 1100 (m), 1075 (m), 1024 (m), 966 (w), 949 (w), 934 
(m), 885 (w), 808 (m), 770 (w), 720 (m), 534 (w). 
MS: (CI) 
61 (30), 81 (20), 81 (25), 83 (19), 89 (19), 105 (29), 107 (23), 173 (17), 174 (54), 
175 (100), 176 (13), 255 (3, M
79
Br+H
+
), 257 (3, M
81
Br+H
+
). 
TLC: Rf 0.20 (hexanes/EtOAc, 19:1) [UV] 
SFC: (2S,6R)-21ea, tR 8.6 min (3.28%); (2R,6S)-21ea, tR 9.8 min (96.7%) (Chiralcel OD, 
200 bar, 2.0 mL/min, gradient from 0% MeOH in CO2 to 3% MeOH in CO2 over 10 
min, then gradient to 4.5% MeOH in CO2 at 15 min) 
Opt. Rot.: [α]D
24 
72.6 (c = 1.00, EtOH) 
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Data for 20ea:  
1
H NMR: (500 MHz, CDCl3) 
δ 7.35 – 7.24 (m, 2H, HC(aryl)), 7.17 (d, J = 7.9 Hz, 2H, HC(aryl)), 4.29 (d, J = 10.0 
Hz, 1H, HC(2)), 4.13 (ddt, J = 11.5, 4.7, 1.7 Hz, 1H, HC(3)), 4.07 (ddd, J = 11.8, 
10.0, 4.4 Hz, 1H, HC(6)), 3.64 (ddd, J = 12.3, 11.4, 2.2 Hz, 1H, HC(6’)), 2.64 – 2.54 
(m, 1H, HC(4)), 2.35 (s, 3H, H3C(11)), 2.13 (tdd, J = 13.1, 11.7, 4.2 Hz, 1H, 
HC(4’)), 2.01 – 1.87 (m, 1H, HC(5)), 1.74 (dtd, J = 13.8, 4.1, 2.0 Hz, 1H, HC(5’)). 
13
C NMR: (125 MHz, CDCl3) 
δ 138.2 (C(7/10), 136.7 (C(7/10)), 128.9 (C(8/9)), 127.4 (C(8/9)), 85.3 (C(2)), 68.7 
(C(6)), 52.5 (C(3)), 36.2 (C(4)), 28.4 (C(5)), 21.2 (C(11)). 
IR: (NaCl plates, CH2Cl2) 
2976 (w), 2868 (w), 1613 (w), 1513 (w), 1455 (w), 1183 (w), 1183 (w), 1063 (m), 
926 (w), 816 (w), 760 (w), 723 (w), 659 (w), 635 (w), 533 (w). 
MS: (EI, 70 eV) 
55 (17), 91 (26), 105 (41), 119 (100), 120 (52), 121 (12), 131 (37), 174 (39), 175 
(50), 254 (16), 256 (16). 
HRMS: calcd for C12H14OBr: 253.02280, found: 253.02344 
TLC: Rf 0.20 (hexanes/EtOAc, 19:1) [UV] 
SFC: (2R,3S)-20ea, tR 10.2 min (65.3%); (2S,3R)-20ea, tR 11.2 min (34.7%) (Chiralcel 
OD, 200 bar, 2.0 mL/min, gradient from 0% MeOH in CO2 to 3% MeOH in CO2 
over 10 min, then gradient to 4.5% MeOH in CO2 at 15 min) 
Opt. Rot.: [α]D
24
 12.7(c = 1.03, EtOH) 
Analysis: C12H15OBr (255.1) 
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 Calcd: C, 56.49; H, 5.93 
Found: C, 56.18; H, 5.92 
 
Bromocycloetherification of 19f. Preparation of (2R)-Tetrahydro-2-[(S)-bromo(4-
trifluoromethylphenyl)methyl]furan (21fa) and (2R,3S)-3-Bromotetrahydro-2-(4-
trifluoromethylphenyl)-2H-pyran (20fa) 
  
Following General Procedure 14, a 100-mL Schlenk flask was charged with N-
bromosuccinimide (214 mg, 1.2 mmol, 1.2 equiv), toluene (29 mL), a solution of 19f in toluene 
(230.0 mg in 4.0 mL, 1.0 equiv, 1.0 mmol), a solution of 24a in toluene (38 mg in 2.0 mL, 0.05 
mmol, 0.05 equiv), a solution of Ph3P=S in toluene (15 mg in 5.0 mL, 0.05 mmol, 0.05 equiv), 
and stirred for 12 h at 0 
o
C to yield after column chromatography (silica gel, 3 cm diam, 13 cm 
length, hexane/TBME, 19:1), followed by further column chromatography of the mixed fractions 
(silica gel, 3 cm diam, 13 cm length, hexane/TBME, 19:1), followed by further column 
chromatography (silica gel, 3 cm diam, 13 cm length, hexane/CH2Cl2, 7:3) and plug filtration to 
remove color (SiO2, 0.5 cm diam., 1.5 cm length, pentane) 134.2 mg (43%) of 21fa as a colorless 
oil which darkens readily at ambient temperature and 37.7 mg (12%) of 20fa as a white solid. 
The ratio of 21fa to 20fa was determined to be 86:14 by NMR spectroscopy prior to 
chromatography. 
Data for 21fa: 
1
H NMR: (500 MHz, CDCl3) 
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δ 7.60 (d, J = 8.1 Hz, 2H, HC(9)), 7.55 (d, J = 8.1 Hz, 2H, HC(8)), 4.81 (d, J = 8.2 
Hz, 1H, HC(6)), 4.47 (ddd, J = 8.2, 6.7, 5.6 Hz, 1H, HC(2)), 3.93 – 3.78 (m, 2H, 
H2C(5)), 2.36 – 2.25 (m, 1H, HC(3)), 2.01 – 1.88 (m, 3H, HC(3’, 4, 4’)). 
13
C NMR: (125 MHz, CDCl3) 
δ 143.6 (q, J = 1.4 Hz, C(7)), 130.4 (q, J = 32.5 Hz, C(10)), 128.6 (C(8)) 125.6 (q, J 
= 3.8 Hz, C(9)), 123.9 (q, J = 272.2 Hz, C(11)), 81.9 (C(2)), 69.5 (C(5)), 55.3 (C(6)), 
31.2 (C(2)), 25.9 (C(4)). 
19
F NMR: (470 MHz, CDCl3) 
δ -63.13. 
IR: (neat) 
2980 (m), 2874 (m), 1921 (w), 1776 (w), 1725 (w), 1619 (m), 1418 (m), 1325 (s), 
1165 (s), 1124 (s), 1067 (s), 1019 (s), 955 (w), 926 (w), 844 (m), 758 (m), 668 (m), 
623 (w). 
MS: (ESI) 
229 (100, M-Br), 307 (11, M
79
Br-H), 309 (10, M
81
Br-H) 
TLC: Rf 0.12 (hexanes/EtOAc, 19:1) [UV] 
SFC: (2S,6R)-21fa, tR 2.7 min (15.2%); (2R,6S)-21fa, tR 5.2 min (85.2%); (Chirapak OJ, 
200 bar, 2.0 mL/min, 1% MeOH in CO2) 
Opt. Rot.: [α]D
24 
55.7 (c = 1.06, EtOH) 
Analysis: C12H12OF3Br (309.12) 
 Calcd: C, 46.63; H, 3.91 
 Found: C, 46.90; H, 3.89 
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Data for 20fa:  
mp: 44 – 46 oC 
1
H NMR: (500 MHz, CDCl3) 
δ 7.62 (d, J = 8.1 Hz, 2H, HC(9)), 7.52 (d, J = 8.0 Hz, 2H, HC(8)), 4.38 (d, J = 10.0 
Hz, 1H, HC(2)), 4.15 (ddt, J = 11.5, 4.7, 1.6 Hz, 1H, HC(6)), 3.98 (ddd, J = 11.8, 
10.0, 4.4 Hz, 1H, HC(3)), 3.65 (td, J = 12.1, 2.3 Hz, 1H, HC(6’)), 2.65 – 2.54 (m, 
1H, HC(4)), 2.13 (tdd, J = 13.2, 11.7, 4.2 Hz, 1H, HC(4’)), 1.96 (qt, J = 13.0, 4.3 Hz, 
1H, HC(5)), 1.84 – 1.71 (m, 1H, HC(5’)). 
13
C NMR: (125 MHz, CDCl3) 
δ 143.6 (C(7)), 130.8 (q, J = 32.4 Hz, C(10)), 128.2 (C(8)), 125.4 (q, J = 3.8 Hz, 
C(9)), 124.3 (q, J = 272.0 Hz, C(11)), 85.0 (C(2)), 68.9 (C(6)), 52.1 (C(3)), 36.2 
(C(4)), 28.5 (C(5)). 
19
F NMR: (470 MHz, CDCl3) 
δ -62.99. 
IR: (NaCl plates, CH2Cl2) 
2959 (m), 2856 (m), 1622 (w), 1464 (w), 1450 (w), 1437 (w), 1422 (m), 1324 (s), 
1260 (w), 1166 (s), 1125 (s), 1099 (s), 1068 (s), 1027 (m), 1018 (m), 969 (w), 936 
(m), 886 (w), 825 (m), 763 (w), 723 (m), 665 (w), 604 (w), 534 (w), 523 (w). 
MS: (EI, 70 eV) 
50 (11), 53 (11), 55 (77), 69 (11), 106 (20), 108 (19), 127 (22), 128 (12), 129 (13), 
145 (35), 159 (44), 173 (100), 174 (18), 175 (11), 185 (10), 199 (18), 201 (25), 228 
(71), 229 (42), 308 (10, M
79
Br
+
), 310 (10, M
81
Br
+
). 
HRMS: calcd for C12H12OBrF3: 308.00236, found: 308.00297 
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TLC: Rf 0.23 (hexanes/EtOAc, 19:1) [UV] 
SFC: (2R,3S)-20fa, tR 5.23 min (65.5%); (2S,3R)-20fa, tR 5.88 min (34.5%) (Chirapak OJ, 
200 bar, 2.0 mL/min, 1% MeOH in CO2) 
Opt. Rot.: [α]D
24 
17.77 (c = 0.48, EtOH) 
 
Bromocycloetherification of 19i. Preparation of (2R)-Tetrahydro-2-[(R)-bromo(2-
methylphenyl)methyl]furan (21ia) and (2S,3S)-3-Bromotetrahydro-2-(2-methylphenyl)-2H-
pyran (20ia) 
  
Following General Procedure 14, a 100-mL Schlenk flask was charged with N-
bromosuccinimide (214 mg, 1.2 mmol, 1.2 equiv), toluene (29 mL), a solution of 19i in toluene 
(176.0 mg in 4.0 mL, 1.0 equiv, 1.0 mmol), a solution of 24a in toluene (38 mg in 2.0 mL, 0.05 
mmol, 0.05 equiv), a solution of Ph3P=S in toluene (15 mg in 5.0 mL, 0.05 mmol, 0.05 equiv), 
and stirred for 12 h at 0 
o
C to yield after column chromatography (silica gel, 2 cm diam, 10 cm 
length, hexane/EtOAc, 19:1), 219.3 mg (86%) of 21ia as a colorless oil. The ratio of 21ia to 20ia 
was determined to be 94:6 by NMR spectroscopy prior to chromatography. 
Data for 21ia:  
1
H NMR: (500 MHz, CDCl3) 
δ 7.54 (dd, J = 7.4, 1.8 Hz, 1H, HC(12)), 7.24-7.17 (m, 2H, HC(10, 11)), 7.16 – 7.12 
(m, 1H, HC(9)), 5.14 (d, J = 7.9 Hz, 1H, HC(6)), 4.54 (td, J = 8.0, 6.2 Hz, 1H, 
HC(2)), 4.04 – 3.97 (m, 1H, HC(5)), 3.98 – 3.86 (m, 1H, HC(5’)), 2.40 (s, 3H, 
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H3C(13)), 2.02 – 1.83 (m, 3H, H2C(4, 4’, 3)), 1.56 – 1.38 (m, 1H, HC(3’)). 
13
C NMR: (125 MHz, CDCl3) 
δ 138.0 (C(7)), 135.4 (C(8)), 130.7 (C(9)), 128.3 (C(10/11)), 128.0 (C(12)), 126.7 
(10/11)), 82.4 (C(2)), 68.7 (C(5)), 54.1 (C(6)), 30.5 (C(3)), 26.2 (C(4)), 19.4 (C(13)). 
IR: (neat) 
3023 (w), 2975 (m), 2869 (w), 1604 (w), 1409 (w), 1462 (w), 1381 (w), 1292 (w), 
1060 (w), 1064 (m), 1013 (w), 943 (w), 839 (w), 770 (w), 727 (m), 656 (m), 610 
(w), 531 (w). 
MS: (ESI) 
229 (89), 272 (30), 274 (42), 277 (100, M
79
Br+Na
+
), 279 (78, M
81
Br+Na
+
), 287 (83), 
289 (55). 
TLC: Rf 0.22 (hexanes/EtOAc, 19:1) [UV] 
SFC: (2R,6R)-21ia, tR 15.0 min (90.4%); (2S,6S)-21ia, tR 17.0 min (5.47%); (2R,3R)-20ia, 
tR 20.2 min (0.444%); (2S,3S)-20ia, tR 22.0 min (3.68%) (Chirapak OB, 200 bar, 
0.75 mL/min, 5% of 95:5 hexane/IPA in CO2) 
Opt. Rot.: [α]D
24
 -20.3(c = 1.03, EtOH) 
Analysis: C12H15OBr (255.1) 
 Calcd: C, 56.49; H, 5.93 
 Found: C, 56.66; H, 5.68 
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Bromocycloetherification of 19j. Preparation of (2R)-Tetrahydro-2-[(R)-bromo(3-
methylphenyl)methyl]furan (21ja) 
  
Following General Procedure 14, a 100-mL Schlenk flask was charged with N-
bromosuccinimide (214 mg, 1.2 mmol, 1.2 equiv), toluene (29 mL), a solution of 19j in toluene 
(176.2 mg in 4.0 mL, 1.0 equiv, 1.0 mmol), a solution of 24a in toluene (38 mg in 2.0 mL, 0.05 
mmol, 0.05 equiv), a solution of Ph3P=S in toluene (15 mg in 5.0 mL, 0.05 mmol, 0.05 equiv), 
and stirred for 12 h at 0 
o
C to yield after column chromatography (silica gel (19g), 2 cm diam, 10 
cm length, hexane/CH2Cl2, 19:1, run twice), and further purification by column chromatography 
(silica gel (27 g), 2 cm diam, 15 cm length, hexane/EtOAc, 19:1) 219.3 mg (86%) of 21ja as a 
colorless oil. The ratio of 21ja to 20ja was determined to be >95:5 by NMR spectroscopy prior 
to chromatography. 
Data for 21ja: 
1
H NMR: (500 MHz, CDCl3) 
δ 7.29 – 7.17 (m, 3H, HC(aryl)), 7.17 – 7.05 (m, 1H, HC(aryl)), 4.83 (d, J = 7.8 Hz, 
1H, HC(6)), 4.40 (td, J = 7.7, 6.6 Hz, 1H, HC(2)), 4.01 – 3.84 (m, 2H, H2C(5)), 2.35 
(s, 3H, H3C(13)), 1.96 – 1.85 (m, 2H, H2C(4)), 1.81 (dtd, J = 12.5, 7.1, 5.7 Hz, 1H, 
HC(3)), 1.53 (ddd, J = 16.1, 12.5, 7.9 Hz, 1H, HC(3’)). 
13
C NMR: (125 MHz, CDCl3) 
δ 139.4 (C(7/9)), 138.3 (C(7/9)), 129.3 (C(aryl)), 128.7 (C(aryl)), 128.5 (C(aryl)), 
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125.1 (C(aryl)), 82.7 (C(2)), 68.7 (C(5)), 58.2 (C(6)), 30.3 (C(3)), 26.1 (C(4)), 21.3 
(C(13)). 
IR: (neat) 
2975 (m), 2869 (m), 1605 (w), 1488 (w), 1456 (w), 1378 (w), 1263 (w), 1176 (w), 
1068 (m), 1014 (w), 921 (m), 788 (w), 752 (w), 706 (m), 665 (w), 611 (w), 534 (w). 
MS: (EI, 70 eV) 
71 (100), 77 (11), 103 (11), 104 (13), 105 (27), 115 (11), 132 (12), 174 (22), 254 (2, 
M
79
Br
+
), 256 (2, M
81
Br
+
). 
TLC: Rf 0.21 (hexanes/EtOAc, 19:1) [UV] 
SFC: (2R,6R)-21ja, tR 4.5 min (92.1%); (2S,6S)-21ja, tR 4.8 min (7.87%); (Chirapak OD, 
200 bar, 2.5 mL/min, gradient from 1% MeOH in CO2 to 5% MeOH in CO2 over 10 
min) 
Opt. Rot.: [α]D
24
 -123.9 (c = 0.95, EtOH) 
Analysis: C12H15OBr (255.1) 
 Calcd: C, 56.49; H, 5.93 
 Found: C, 56.64; H, 6.02 
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Bromocycloetherification of 19k. Preparation of (2R)-Tetrahydro-2-[(R)-bromo(4-
methylphenyl)methyl]furan (21ka) and (2S,3S)-3-Bromotetrahydro-2-(4-methylphenyl)-
2H-pyran (20ka) 
  
Following General Procedure 14, a 100-mL Schlenk flask was charged with N-
bromosuccinimide (214 mg, 1.2 mmol, 1.2 equiv), toluene (29 mL), a solution of 19k in toluene 
(165.9 mg in 4.0 mL, 1.0 equiv, 1.0 mmol), a solution of 24a in toluene (38 mg in 2.0 mL, 0.05 
mmol, 0.05 equiv), a solution of Ph3P=S in toluene (15 mg in 5.0 mL, 0.05 mmol, 0.05 equiv), 
and stirred for 12 h at 0 
o
C to yield after column chromatography (silica gel (45 g), 3 cm diam, 
hex/TBME, 19:1), 164.3 mg (64%) of 21ka as a pale solid and 22.8 mg (9%) of 20ka as a white 
solid. 20ka was contaminated with ca 10% of 21ea and 9% of 20ea from trace (ca 1%) of 19e in 
the starting material. Sacrificial chromatography (silica gel, 0.5 cm diam, 5 cm length, 
hex/CH2Cl2, 9:1) provided 10.2 mg of 20ka containing a total of 4% of 21ea and 20ea for 
spectroscopic characterization. The ratio of 21ka to 20ka was determined to be 90:10 by NMR 
spectroscopy prior to chromatography. 
Data for 21ka: 
1
H NMR: (500 MHz, CDCl3) 
δ 7.31 (d, J = 8.1 Hz, 2H, HC(aryl))), 7.14 (d, J = 7.8 Hz, 2H, HC(aryl))), 4.85 (d, J 
= 7.8 Hz, 1H, HC(6)), 4.40 (td, J = 7.7, 6.6 Hz, 1H, HC(2)), 4.01 – 3.84 (m, 2H, 
H2C(5)), 2.34 (s, 3H, H3C(11)), 1.97 – 1.84 (m, 2H, H2C(4)), 1.81 (dtd, J = 12.8, 6.8, 
5.6 Hz, 1H, HC(3)), 1.52 (ddd, J = 16.3, 12.4, 7.8 Hz, 1H, HC(3’)). 
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13
C NMR: (125 MHz, CDCl3) 
δ 138.4 (C(7/10)), 136.6 (C(7/10)), 129.3 (C(8/9)), 127.9 (C8/9)), 82.7 (C(2)), 68.7 
(C(5)), 58.2 (C(6)), 30.2 (C(3)), 26.1 (C(4)), 21.1 (C(11)). 
IR: (KBr pellet) 
2977 (m), 2866 (m), 1513 (m), 1458 (w), 1167 (w), 1102 (m), 1064 (s), 844 (w), 812 
(m), 766 (w), 725 (m), 658 (m). 
MS: (ESI) 
197 (100), 272 (20), 274 (22), 277 (52, M
79
Br+Na
+
), 279 (60, M
81
Br+Na
+
), 287 (38), 
289 (36), 309 (34), 311 (33). 
TLC: Rf 0.19 (hexanes/EtOAc, 19:1) [UV] 
SFC: (2R,6R)-21ka, tR 4.5 min (91.1%); (2S,6S)-21ka, tR 5.2 min (6.00%); (2R,3R)-20ka, 
tR 6.7 min (1.00%); (2S,3S)-20ka, tR 11.2 min (1.88%) (Chirapak OJ, 200 bar, 2.5 
mL/min, gradient from 5% MeOH in CO2 to 20% MeOH in CO2 over 10 min) 
Opt. Rot.: [α]D
24
 -118.6 (c = 1.01, EtOH) 
Analysis: C12H15OBr (255.1) 
 Calcd: C, 56.49; H, 5.93 
 Found: C, 56.62; H, 5.71 
 
Data for 20ka: 
1
H NMR: (500 MHz, CDCl3) 
δ 7.20 (d, J = 8.0 Hz, 2H, HC(aryl)), 7.16 (d, J = 8.0 Hz, 2H, HC(aryl)), 4.47 (br s, 
1H, HC(3)), 4.46 (br s, 1H, HC(2)), 4.34 – 4.20 (m, 1H, HC(6)), 3.69 (td, J = 11.8, 
2.7 Hz, 1H, HC(6’)), 2.41 – 2.35 (m, 1H, HC(4)), 2.34 (s, 3H, H3C(11), 2.32 - 2.23 
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(m, 2H, HC(4’, 5)), 1.73 – 1.39 (m, 1H, HC(5’)). 
13
C NMR: (125 MHz, CDCl3) 
δ 137.7 (C(7/10)), 137.0 (C(7/10)), 128.7 (C(8/9)), 125.2 (C(8/9)), 80.2 (C(2)), 69.1 
(C(6)), 56.5 (C(3)), 32.9 (C(4)), 21.2 (C(11)), 20.5 (C(5)). 
MS: (EI, 70 eV) 
55 (15), 65 (11), 91 (34), 105 (30), 115 (10), 119 (100), 120 (40), 131 (30), 174 (43), 
175 (42), 254 (12, M
79
Br
+
), 256 (12, M
81
Br
+
). 
HRMS: calcd for C12H15OBr: 254.03063, found: 254.03029 
TLC: Rf 0.20 (hexanes/EtOAc, 19:1) [UV] 
Opt. Rot.: [α]D
24 
19.58 (c = 0.68, EtOH) 
 
Bromocycloetherification of 19l. Preparation of (2R)-Tetrahydro-2-[(R)-bromo(4-
fluorophenyl)methyl]furan (21la) and (2S,3S)-3-Bromotetrahydro-2-(4-fluorophenyl)-2H-
pyran (20la) 
  
Following General Procedure 14, a 100-mL Schlenk flask was charged with N-
bromosuccinimide (214 mg, 1.2 mmol, 1.2 equiv), toluene (29 mL), a solution of 19l in toluene 
(180.6 mg in 4.0 mL, 1.0 equiv, 1.0 mmol), a solution of 24a in toluene (38 mg in 2.0 mL, 0.05 
mmol, 0.05 equiv), a solution of Ph3P=S in toluene (15 mg in 5.0 mL, 0.05 mmol, 0.05 equiv), 
and stirred for 12 h at 0 
o
C to yield after column chromatography (silica gel, 3 cm diam, 10 cm 
length, hexane/EtOAc, 19:1), 202.4 mg (78%) of 21la as a colorless oil. The ratio of 21la to 20la 
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was determined to be 95:5 by NMR spectroscopy prior to chromatography. 
Data for 21la:  
1
H NMR: (500 MHz, CDCl3) 
δ 7.48 – 7.37 (m, 2H, HC(8)), 7.08 – 6.96 (m, 2H, HC(9)), 4.87 (d, J = 7.1 Hz, 1H, 
HC(6)), 4.34 (dt, J = 7.4, 6.6 Hz, 1H, HC(2)), 3.99 – 3.84 (m, 2H, HC(5)), 2.37 –
1.94 – 1.79 (m, 3H, HC(4, 4’, 3), 1.61 – 1.52 (m, 1H, HC(3’)). 
13
C NMR: (125 MHz, CDCl3) 
δ 162.5 (d, J = 248.1 Hz, C(10)), 135.5 (d, J = 3.2 Hz, C(7)) 129.9 (d, J = 8.2 Hz, 
C(8)), 115.5 (d, J = 21.6 Hz, C(9)), 82.5 (C(2)), 68.9 (C(5)), 57.0 (C(6)), 30.2 (C(3)), 
26.1 (C(4)). 
19
F NMR: (470 MHz, CDCl3) 
δ -113.36 (tt, J = 8.8, 5.2 Hz, 1F, FC(10)). 
IR: (neat) 
2977 (m), 2871 (m), 1604 (m), 1509 (s), 1459 (w), 1419 (w), 1353 (w), 1297 (w), 
1228 (s), 1159 (m), 1067 (m), 1014 (w), 927 (w), 853 (m), 839 (m), 778 (w), 729 
(m), 657 (w). 
MS: (EI, 70 eV) 
107 (16), 108 (25), 109 (100), 122 (15), 133 (13), 136 (14), 178 (18), 179 (19), 187 
(12), 189 (12), 258 (2, M
79
Br
+
), 260 (2, M
81
Br
+
). 
TLC: Rf 0.12 (hexanes/EtOAc, 19:1) [UV] 
SFC: (2R,6R)-21la, tR 4.0 min (89.6%); (2S,6S)-21la, tR 4.9 min (9.69%); (2S,3S)-20la, tR 
5.4 min (0.410%); (2R,3R)-20la, tR 6.1 min (0.268%) (Chirapak OJ, 200 bar, 2.5 
mL/min, gradient from 1% MeOH in CO2 to 10% MeOH in CO2 over 10 min) 
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Opt. Rot.: [α]D
24
 -99.6 (c = 1.05, EtOH) 
Analysis: C11H12OBrF (259.15) 
 Calcd: C, 50.99; H, 4.67 
 Found: C, 51.09; H, 4.41 
Bromocycloetherification of 19m. Preparation of (2R)-Tetrahydro-2-[(R)-bromo(4-
trifluoromethoxyphenyl)methyl]furan (21ma) 
 
Following General Procedure 14, a 100-mL Schlenk flask was charged with N-
bromosuccinimide (214 mg, 1.2 mmol, 1.2 equiv), toluene (29 mL), a solution of 19m in toluene 
(180.6 mg in 4.0 mL, 1.0 equiv, 1.0 mmol), a solution of 24a in toluene (38 mg in 2.0 mL, 0.05 
mmol, 0.05 equiv), a solution of Ph3P=S in toluene (15 mg in 5.0 mL, 0.05 mmol, 0.05 equiv), 
and stirred for 12 h at 0 
o
C to yield after column chromatography (silica gel, 3 cm diam, 10 cm 
length, hexane/EtOAc, 19:1), followed by column chromatography (silica gel, 3 cm diam, 10 cm 
length, hexane/TBME, 19:1) provided 250.6 mg (77%) of a colorless oil, which was further 
purified by bulb-to-bulb distillation (50 – 60 oC, 0.0003 mmHg) to yield 216.5 mg (67%) of 
21ma as a colorless oil. The ratio of 21ma to 20ma was determined to be 98:2 by NMR 
spectroscopy prior to chromatography. 
Data for 21ma: 
bp:  50 – 60 oC (ABT, 0.0003 mmHg) 
1
H NMR: (500 MHz, CDCl3) 
δ 7.52 – 7.44 (m, 2H, HC(aryl)), 7.18 (d, J = 8.3 Hz, 2H, HC(aryl)), 4.88 (d, J = 6.7 
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Hz, 1H, HC(6)), 4.33 (dt, J = 7.4, 6.4 Hz, 1H, HC(2)), 3.99 – 3.84 (m, 2H, H2C(5)), 
1.95 – 1.81 (m, 3H, HC(4, 4’, 3)), 1.64 – 1.52 (m, 1H, HC(3’)). 
13
C NMR: (125 MHz, CDCl3) 
δ 150.0 (q, J = 1.7 Hz, C(10)), 138.2 (C(7)), 129.7 (C(8/9)), 120.9 (C(7)), 120.4 (q, J 
= 257.7 Hz, C(11)) , 82.3 (C(2)), 68.9 (C(5)), 56.6 (C(6)), 30.2 (C(3)), 26.1 (C(4)). 
19
F NMR: (470 MHz, CDCl3) 
δ -58.2 (s, 3F, F3C(11)). 
IR: (neat) 
2979 (m), 2873 (m), 1905 (w), 1779 (w), 1608 (w), 1594 (w), 1509 (s), 1460 (w), 
1421 (w), 1263 (s), 1219 (s), 1165 (s), 1068 (m), 1019 (m), 923 (w), 840 (m), 679 
(w), 658 (w), 545 (w). 
MS: (CI) 
71 (24), 159 (17), 175 (13), 229 (29), 244 (19), 245 (100), 246 (13), 273 (11), 289 
(11), 291 (10), 325 (3, M
79
Br+H
+
), 327 (3, M
81
Br+H
+
). 
TLC: Rf 0.17 (hexanes/EtOAc, 19:1) [UV] 
SFC: (2R,6R)-21ma, tR 3.51 min (81.4%); (2S,6S)-21ma, tR 3.80 min (15.6%); 
(2S/2R,3S/3R)-20ma, tR 4.00 min (1.31%); (2R/2S,3R/3S)-20ma, tR 4.18 min 
(1.71%) (Chirapak AD, 200 bar, 1.5 mL/min, 5% MeOH in CO2) 
Opt. Rot.: [α]D
24 
-83.0 (c = 1.03, EtOH) 
Analysis: C12H12O2BrF3 (325.12) 
 Calcd: C, 44.33; H, 3.72 
 Found: C, 44.72; H, 3.73 
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Bromocycloetherification of 19b in the Presence of 24a and Ph3P=S. (Table 17, Entry 2) 
Following General Procedure 13, a 10-mL Schlenk flask was charged with N-
bromosuccinimide (21 mg, 0.12 mmol, 1.2 equiv), followed by toluene (2.9 mL), a solution of 
19b (19.41 mg, 1.0 equiv, 0.1 mmol) in toluene (0.4 mL), a solution of 24b (3.8 mg, 0.05 equiv, 
0.005 mmol) in toluene (0.2 mL), and a 0.01 M solution of Ph3P=S in toluene (0.5 mL, 0.05 
equiv, 0.005 mmol). After stirring for 12 h, quenching, aqueous workup and filtration though a 
plug of SiO2 (0.2g, 25:1 hexane/EtOAc) an oil containing 21ba was obtained. 
Data for 21ba: 
SFC: (2S,6R)-21ba, tR 6.7 min (36.0%); (2R,6S)-21ba, tR 7.8 min (64%) (Chiralcel OD, 
200 bar, 1.5 mL/min, 2% MeOH in CO2) 
 
Optimization of the Bromocycloetherification of 19b in the Absence of Ph3=S. General 
Procedure 15. Bromocycloetherification of 19b in the Presence of 24a (Table 17, Entry 1) 
[MTB-XIV-61] 
A 10-mL, oven-dried Schlenk flask, fitted with a septum and a magnetic stir bar, wrapped 
in Al-foil, under Ar, was charged with N-bromosuccinimide (22 mg, 0.12 mmol, 1.2 equiv). The 
flask was then evacuated and filled with argon. Toluene (3.2 mL) was added via syringe and then 
the flask was cooled to 0 
o
C (thermostated H2O/ethylene glycol bath). A solution of 19b (16.0 
mg, 0.1 mmol, 1.0 equiv) in toluene (0.6 mL) was added via short cannula. A solution of 24a 
(7.5 mg, 0.01 mmol, 0.1 equiv) in toluene (0.2 mL) was added via syringe. The reaction mixture 
was stirred at 0 
o
C for 39 h. Chilled (ca. 0 
o
C) aq. Na2S2O3 solution (1 mL) was added, followed 
by chilled sat. aq. NaHCO3 solution (1 mL). The resulting biphasic mixture was stirred at 0 
o
C 
for 10 min, after which it was allowed to warm to room temperature while stirring vigorously. 
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The colorless biphasic mixture was transferred to a 60-mL separatory funnel where it was diluted 
with H2O (5 mL) and was extracted with Et2O (3 x 5 mL). The combined organic extracts were 
dried over MgSO4, filtered, and concentrated in vacuo (23 
o
C, 6 mmHg). The residue was 
purified by column chromatography (silica gel (4.5g), 1 cm diam., 10 cm length, hexane/EtOAc, 
19:1) to provide 23.9 mg (89%) of 21ba. 
Data for 21ba: 
SFC: (2S,6R)-21ba, tR 6.7 min (15.5%); (2R,6S)-21ba, tR 7.8 min (84.5%) (Chiralcel OD, 
200 bar, 1.5 mL/min, 2% MeOH in CO2) 
 
Optimization of the Bromocycloetherification of 19c in the Absence of Ph3=S. 
Bromocycloetherification of 19c in the Presence of 24a Table 17, Entry 3) [MTB-XIV-85] 
Following General Procedure 15, a 10-mL Schlenk flask was charged with N-
bromosuccinimide (21 mg, 0.12 mmol, 1.2 equiv), followed by toluene (3.0 mL) and a solution 
of 19c (19.3 mg, 1.0 equiv, 0.1 mmol) and  24a (3.8 mg, 0.05 equiv, 0.005 mmol) in toluene (1.0 
mL). After stirring for 40 h and quenching, column chromatography (SiO2, 1 cm diam, 10 cm 
length, hexane/EtOAc 19:1) provided 13.6 mg (50 %) of 21ca. 
Data for 21ca: 
SFC: (2S,6R)-21ca, tR 9.1 min (82.0%); (2R,6S)-21ca, tR 9.9 min (18.0%) (Chiralcel OD, 
200 bar, 1.5 mL/min, 2% MeOH in CO2) 
 
Optimization of the Bromocycloetherification of 19b in the Absence of Ph3=S. 
Bromocycloetherification of 19b in the Presence of 24g (Table 17, Entry 4) [MTB-XiV-98] 
Following General Procedure 15, a 10-mL Schlenk flask was charged with N-
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bromosuccinimide (21 mg, 0.12 mmol, 1.2 equiv), followed by toluene (3.0 mL) and a solution 
of 19b (19.2 mg, 1.0 equiv, 0.1 mmol) and  24g (5.0mg, 0.05 equiv, 0.005 mmol) in toluene (1.0 
mL). After stirring for 40 h and quenching, column chromatography (SiO2, 1 cm diam, 10 cm 
length, hexane/EtOAc 19:1) provided 22.6 mg (83 %) of 21ba. 
Data for 21ba: 
SFC: (2S,6R)-21ba, tR 6.7 min (15.4%); (2R,6S)-21ba, tR 7.8 min (84.6%) (Chiralcel OD, 
200 bar, 1.5 mL/min, 2% MeOH in CO2) 
 
Optimization of the Bromocycloetherification of 19c in the Absence of Ph3=S. 
Bromocycloetherification of 19c in the Presence of 24g (Table 17, Entry 5) [MTB-XIV-99] 
Following General Procedure 15, a 10-mL Schlenk flask was charged with N-
bromosuccinimide (21 mg, 0.12 mmol, 1.2 equiv), followed by toluene (3.0 mL) and a solution 
of 19c (19.3 mg, 1.0 equiv, 0.1 mmol) and  24g (5.0 mg, 0.05 equiv, 0.005 mmol) in toluene (1.0 
mL). After stirring for 40 h and quenching, column chromatography (SiO2, 1 cm diam, 10 cm 
length, hexane/EtOAc 19:1) provided 21.5 mg (79 %) of 21ca. 
Data for 21ca: 
SFC: (2S,6R)-21ca, tR 9.0 min (86.1%); (2R,6S)-21ca, tR 9.7 min (13.9%) (Chiralcel OD, 
200 bar, 1.5 mL/min, 2% MeOH in CO2) 
 
Optimization of the Bromocycloetherification of 19b in the Absence of Ph3=S. 
Bromocycloetherification of 19b in the Presence of 24h (Table 17, Entry 6) [MTB-XV-12] 
Following General Procedure 15, a 10-mL Schlenk flask was charged with N-
bromosuccinimide (21 mg, 0.12 mmol, 1.2 equiv), followed by toluene (3.0 mL) and a solution 
270 
 
of 19b (19.1 mg, 1.0 equiv, 0.1 mmol) and  24h (4.8 mg, 0.05 equiv, 0.005 mmol) in toluene (1.0 
mL). After stirring for 40 h and quenching, column chromatography (SiO2, 1 cm diam, 10 cm 
length, hexane/EtOAc 19:1) provided 8.1 mg (30 %) of 21ba. 
Data for 21ba: 
SFC: (2S,6R)-21ba, tR 7.1 min (52.6%); (2R,6S)-21ba, tR 7.8 min (47.3%) (Chiralcel OD, 
200 bar, 1.5 mL/min, 2% MeOH in CO2) 
 
Optimization of the Bromocycloetherification of 19c in the Absence of Ph3=S. 
Bromocycloetherification of 19c in the Presence of 24h (Table 17, Entry 7) [MTB-XV-13] 
Following General Procedure 15, a 10-mL Schlenk flask was charged with N-
bromosuccinimide (21 mg, 0.12 mmol, 1.2 equiv), followed by toluene (3.0 mL) and a solution 
of 19c (18.7 mg, 1.0 equiv, 0.1 mmol) and  24h (4.8 mg, 0.05 equiv, 0.005 mmol) in toluene (1.0 
mL). After stirring for 15 h and quenching, column chromatography (SiO2, 1 cm diam, 10 cm 
length, hexane/EtOAc 19:1) provided 20.0mg (79 %) of 21ca. 
Data for 21ca: 
SFC: (2S,6R)-21ca, tR 9.0 min (44.2%); (2R,6S)-21ca, tR 9.7 min (55.7%) (Chiralcel OD, 
200 bar, 1.5 mL/min, 2% MeOH in CO2) 
 
Optimization of the Bromocycloetherification of 19b in the Absence of Ph3=S. 
Bromocycloetherification of 19b in the Presence of 24i (Table 17, Entry 8) [MTB-XIV-83] 
Following General Procedure 15, a 10-mL Schlenk flask was charged with N-
bromosuccinimide (21 mg, 0.12 mmol, 1.2 equiv), followed by toluene (3.0 mL) and a solution 
of 19b (19.3 mg, 1.0 equiv, 0.1 mmol) and  24i (2.9 mg, 0.05 equiv, 0.005 mmol) in toluene (1.0 
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mL). After stirring for 40 h and quenching, column chromatography (SiO2, 1 cm diam, 10 cm 
length, hexane/EtOAc 19:1) provided 17.4 mg (65 %) of 21ba. 
Data for 21ba: 
SFC: (2S,6R)-21ba, tR 7.1 min (31.6%); (2R,6S)-21ba, tR 7.8 min (68.4%) (Chiralcel OD, 
200 bar, 1.5 mL/min, 2% MeOH in CO2) 
 
Optimization of the Bromocycloetherification of 19c in the Absence of Ph3=S. 
Bromocycloetherification of 19c in the Presence of 24i (Table 17, Entry 9) [MTB-XIV-84] 
Following General Procedure 15, a 10-mL Schlenk flask was charged with N-
bromosuccinimide (21 mg, 0.12 mmol, 1.2 equiv), followed by toluene (3.0 mL) and a solution 
of 19c (19.3 mg, 1.0 equiv, 0.1 mmol) and  24i (2.9 mg, 0.05 equiv, 0.005 mmol) in toluene (1.0 
mL). After stirring for 15 h and quenching, column chromatography (SiO2, 1 cm diam, 10 cm 
length, hexane/EtOAc 19:1) provided 20.5 mg (76 %) of 21ca. 
Data for 21ca: 
SFC: (2S,6R)-21ca, tR 9.0 min (79.9%); (2R,6S)-21ca, tR 9.7 min (20.0%) (Chiralcel OD, 
200 bar, 1.5 mL/min, 2% MeOH in CO2) 
 
Optimization of the Bromocycloetherification of 19b in the Absence of Ph3=S. 
Bromocycloetherification of 19b in the Presence of 24j (Table 17, Entry 10) [MTB-XIV-79] 
Following General Procedure 15, a 10-mL Schlenk flask was charged with N-
bromosuccinimide (21 mg, 0.12 mmol, 1.2 equiv), followed by toluene (3.0 mL) and a solution 
of 19b (19.2 mg, 1.0 equiv, 0.1 mmol) and  24j (3.1 mg, 0.05 equiv, 0.005 mmol) in toluene (1.0 
mL). After stirring for 40 h and quenching, column chromatography (SiO2, 1 cm diam, 10 cm 
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length, hexane/EtOAc 19:1) provided 15.8 mg (59 %) of 21ba. 
Data for 21ba: 
SFC: (2S,6R)-21ba, tR 7.1 min (39.2%); (2R,6S)-21ba, tR 7.8 min (60.8%) (Chiralcel OD, 
200 bar, 1.5 mL/min, 2% MeOH in CO2) 
 
Optimization of the Bromocycloetherification of 19c in the Absence of Ph3=S. 
Bromocycloetherification of 19c in the Presence of 24j (Table 17, Entry 11) [MTB-XIV-80] 
Following General Procedure 15, a 10-mL Schlenk flask was charged with N-
bromosuccinimide (21 mg, 0.12 mmol, 1.2 equiv), followed by toluene (3.0 mL) and a solution 
of 19c (19.3 mg, 1.0 equiv, 0.1 mmol) and  24j (3.1 mg, 0.05 equiv, 0.005 mmol) in toluene (1.0 
mL). After stirring for 40 h and quenching, column chromatography (SiO2, 1 cm diam, 10 cm 
length, hexane/EtOAc 19:1) provided 17.2 mg (64 %) of 21ca. 
Data for 21ca: 
SFC: (2S,6R)-21ca, tR 9.0 min (69.6%); (2R,6S)-21ca, tR 9.7 min (30.4%) (Chiralcel OD, 
200 bar, 1.5 mL/min, 2% MeOH in CO2) 
 
Optimization of the Bromocycloetherification of 19b in the Absence of Ph3=S. 
Bromocycloetherification of 19b in the Presence of 24k (Table 17, Entry 12) [MTB-XIV-86] 
Following General Procedure 15, a 10-mL Schlenk flask was charged with N-
bromosuccinimide (21 mg, 0.12 mmol, 1.2 equiv), followed by toluene (3.0 mL) and a solution 
of 19b (19.3 mg, 1.0 equiv, 0.1 mmol) and  24k (3.9 mg, 0.05 equiv, 0.005 mmol) in toluene (1.0 
mL). After stirring for 40 h and quenching, column chromatography (SiO2, 1 cm diam, 10 cm 
length, hexane/EtOAc 19:1) provided 22.0 mg (82 %) of 21ba. 
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Data for 21ba: 
SFC: (2S,6R)-21ba, tR 7.1 min (37.2%); (2R,6S)-21ba, tR 7.8 min (62.8%) (Chiralcel OD, 
200 bar, 1.5 mL/min, 2% MeOH in CO2) 
 
Optimization of the Bromocycloetherification of 19c in the Absence of Ph3=S. 
Bromocycloetherification of 19c in the Presence of 24k (Table 17, Entry 13) [MTB-XKV-
87] 
Following General Procedure 15, a 10-mL Schlenk flask was charged with N-
bromosuccinimide (21 mg, 0.12 mmol, 1.2 equiv), followed by toluene (3.0 mL) and a solution 
of 19c (19.3 mg, 1.0 equiv, 0.1 mmol) and  24k (3.9 mg, 0.05 equiv, 0.005 mmol) in toluene (1.0 
mL). After stirring for 40 h and quenching, column chromatography (SiO2, 1 cm diam, 10 cm 
length, hexane/EtOAc 19:1) provided 20.2 mg (75 %) of 21ca. 
Data for 21ca: 
SFC: (2S,6R)-21ca, tR 9.0 min (63.5%); (2R,6S)-21ca, tR 9.7 min (36.5%) (Chiralcel OD, 
200 bar, 1.5 mL/min, 2% MeOH in CO2) 
 
Optimization of the Bromocycloetherification of 19b in the Absence of Ph3=S. 
Bromocycloetherification of 19b in the Presence of 24l (Table 17, Entry 14) [MTB-XIV-
100] 
Following General Procedure 15, a 10-mL Schlenk flask was charged with N-
bromosuccinimide (21 mg, 0.12 mmol, 1.2 equiv), followed by toluene (3.0 mL) and a solution 
of 19b (18.9 mg, 1.0 equiv, 0.1 mmol) and  24l (3.5 mg, 0.05 equiv, 0.005 mmol) in toluene (1.0 
mL). After stirring for 12 h and quenching, column chromatography (SiO2, 1 cm diam, 10 cm 
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length, hexane/EtOAc 19:1) provided 23.4 mg (87 %) of 21ba. 
Data for 21ba: 
SFC: (2S,6R)-21ba, tR 7.1 min (28.2%); (2R,6S)-21ba, tR 7.8 min (71.8%) (Chiralcel OD, 
200 bar, 1.5 mL/min, 2% MeOH in CO2) 
 
Optimization of the Bromocycloetherification of 19c in the Absence of Ph3=S. 
Bromocycloetherification of 19c in the Presence of 24l (Table 17, Entry 15) [MTB-XV-06] 
Following General Procedure 15, a 10-mL Schlenk flask was charged with N-
bromosuccinimide (21 mg, 0.12 mmol, 1.2 equiv), followed by toluene (3.0 mL) and a solution 
of 19c (19.3 mg, 1.0 equiv, 0.1 mmol) and  24k (3.9 mg, 0.05 equiv, 0.005 mmol) in toluene (1.0 
mL). After stirring for 40 h and quenching, column chromatography (SiO2, 1 cm diam, 10 cm 
length, hexane/EtOAc 19:1) provided 20.2 mg (75 %) of 21ca. 
Data for 21ca: 
SFC: (2S,6R)-21ca, tR 9.0 min (63.5%); (2R,6S)-21ca, tR 9.7 min (36.5%) (Chiralcel OD, 
200 bar, 1.5 mL/min, 2% MeOH in CO2) 
 
Correlation of Absolute Configuration.  
Debromination of 21aa. Preparation of (R)-2-Benzyltetrahydrofuran
170
  
  
A 5-mL, oven-dried one-piece condenser flask, fitted with an Ar inlet, a septum, and a 
magnetic stir bar, was charged with AIBN (0.74 mg, 0.0045 mmol, 0.1 equiv). The flask was 
evacuated and filled with Ar, and then was charged with a solution of 21aa (10.9 mg, 0.045 
275 
 
mmol, 1.0 equiv, 93:7 er) in C6H6 (0.70 mL) via cannula. Tri-n-butyltin hydride (14.5 μL, 0.054 
mmol, 1.2 equiv) was added via syringe. The flask was heated to reflux for 4.5 h, and then a 
solution of AIBN (0.4 mg, 0.0023 mmol, 0.05 equiv) in C6H6 (0.033 mL) was added, and heating 
was continued for 4 h. The solution was allowed to cool to room temperature, and solid KF (250 
mg) was added. The resulting suspension was stirred for 36h, filtered through glass wool, and 
concentrated in vacuo (23 
o
C, 25 mmHg). Column chromatography (silica gel, 1 cm diam, 10 cm 
length, gradient from pentane/CH2Cl2 100:0 (40 mL) to 70:30 (50 mL) to 50:50 (50 mL)) 
provided 4.4 mg of (R)-2-benzyltetrahydrofuran (56%) as a colorless oil. The spectroscopic data 
were in accordance with those described in the literature.
170 
Data for (R)-2-benzyltetrahydrofuran: 
SFC: (S)-2-benzyltetrahydrofuran, tR 3.426 min (6.96%); (R)-2-benzyltetrahydrofuran, tR 
3.714 min (93.0%); (Welk-O1, 200 bar, 2.5 mL/min, gradient from 1% MeOH/CO2 
to 5% MeOH/CO2 over 10 min, 220 nm) 
Opt. Rot.: [α]D
24 
-1.9 (c = 0.36, CHCl3) 
 
Debromination of 21ga. Preparation of (R)-2-Benzyltetrahydrofuran 
  
A 5-mL, oven-dried one-piece condenser flask, fitted with an Ar inlet, a septum, and a 
magnetic stir bar, was charged with AIBN (1.9 mg, 0.01 mmol, 0.1 equiv). The flask was 
evacuated and filled with Ar, and then was charged with a solution of 21ga (26.4 mg, 0.0109 
mmol, 1.0 equiv, 91:9 er) in C6H6 (1.5 mL) via cannula. Tri-n-butyltin hydride (35 μL, 0.13 
mmol, 1.2 equiv) was added via syringe. The flask was heated to reflux for 4.5 h, and then a 
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solution of AIBN (0.8 mg, 0.005 mmol, 0.05 equiv) in C6H6 (0.065 mL) was added, and heating 
was continued for 4 h. The solution was allowed to cool to room temperature, and solid KF (500 
mg) was added. The resulting suspension was stirred for 36h, filtered through glass wool, and 
concentrated in vacuo (23 
o
C, 25 mmHg). Column chromatography (silica gel, 1 cm diam, 10 cm 
length, gradient from pentane/CH2Cl2 100:0 (40 mL) to 70:30 (50 mL) to 50:50 (50 mL)) 
provided 8.0 mg of (R)-2-benzyltetrahydrofuran (45%) as a colorless oil. The spectroscopic data 
were in accordance with those described in the literature. 
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Data for (R)-2-benzyltetrahydrofuran: 
SFC: (S)-2-benzyltetrahydrofuran, tR 3.431 min (9.26%); (R)-2-benzyltetrahydrofuran, tR 
3.707 min (90.7%); (Welk-O1, 200 bar, 2.5 mL/min, gradient from 1% MeOH/CO2 
to 5% MeOH/CO2 over 10 min, 220 nm) 
Opt. Rot.: [α]D
24 
-5.5 (c = 0.75, CHCl3) 
Preparation of Starting Materials 
General Procedure 16. Wittig Olefination of 2-Methylbenzaldehyde. Preparation of (4Z)-5-
(2-Methylphenyl)-4-pentenenitrile (66i)  
 
A 250-mL, flame-dried Schlenk flask, fitted with a septum and a magnetic stir bar, filled 
with Ar, was charged with (3-cyanopropyl)triphenylphosphonium chloride (4.774 g, 13.0 mmol, 
1.0 equiv) and toluene (10.0 mL). The flask was placed in an oil bath (45 
o
C), and the toluene 
was slowly removed under vacuum. Heating was continued under vacuum (0.1 mmHg) for 20 
min, after which the flask was allowed to cool to room temperature and was filled with Ar. 
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Tetrahydrofuran (32 mL) was added and then a thermocouple was fitted, and the white stirred 
suspension was cooled in an ice bath. A cold solution of KHMDS (2.593 g, 13.0 mmol, 1.0 
equiv) in THF (34 mL) was added over 20 min. The resulting orange suspension was stirred at 0 
o
C for 20 min. 2-Methylbenzaldehyde (1.53 mL, 13.3 mmol, 1.02 equiv) was added slowly over 
20 min, during which time the color darkened to green and then to blue and finally lightened to 
tan. The mixture was stirred at 0
o
 C for 10 min. Saturated aq. NaHCO3 solution was added, and 
the resulting biphasic mixture was transferred to a 500-mL separatory funnel where it was 
diluted with H2O (50 mL) and was extracted with TBME (3 x 50 mL). The combined organic 
extracts were washed with 1 M HCl (2 x 20 mL) and brine (30 mL). The organic extracts were 
dried over MgSO4, filtered and concentrated in vacuo (23 
o
C, 6 mmHg). Hexane (100 mL) was 
added to precipitate Ph3P=O and the resulting suspension was filtered, concentrated in vacuo, 
redissolved in hexane (50 mL), refiltered, and reconcentrated. 
1
H NMR showed a 90:10 ratio of 
(Z)-66i to (E)-66i. The residue was purified by column chromatography (silica gel (75 g), 4 cm 
diam, 12 cm long, hexane/TBME 14:1), keeping only the fractions that appeared to be a single 
isomer, and bulb-to-bulb distillation (130 - 140 
o
C, 0.35 mmHg) to provide 1.561 g (70%) of 66i 
as a colorless oil. The Z:E ratio was 99.7:0.3 by 
1
H NMR integration of HC(4) (E isomer δ 6.06 
(dt, J = 15.8, 6.5 Hz, 1H), SNR 1730).  
Data for 66i:  
bp:  130 – 140 oC (ABT, 0.35 mmHg) 
1
H NMR: (500 MHz, CDCl3) 
δ 7.24 – 7.14 (m, 3H, HC(aryl)), 7.14 – 7.08 (m, 1H, HC(aryl)), 6.65 (dt, J = 11.3, 
1.8 Hz, 1H, HC(5)), 5.73 (dt, J = 11.3, 7.2 Hz, 1H, HC(4)), 2.55 – 2.46 (m, 2H, 
H2C(3)), 2.39 (t, J = 6.9 Hz, 2H, H2C(2)), 2.26 (s, 3H, H3C(13)). 
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13
C NMR: (125 MHz, CDCl3) 
δ 136.3 (C(6/7)), 135.6 (C(6/7)), 131.6 (C(4)), 129.9 (C(aryl)), 128.6 (C(5)), 127.6 
(C(aryl)), 127.4 (C(aryl)), 125.5 (C(aryl)), 119.1 (C(1)), 24.2 (C(3)), 19.8 (C(13)), 
17.45 (C(2)). 
IR: (neat) 
3058 (w), 3016 (m), 2921 (m), 2860 (w), 2245 (m), 1601 (w), 1508 (m), 1486 (m), 
1459 (m), 1442 (m), 1426 (m), 1323 (w), 1223 (m), 844 (m), 785 (s), 753 (s), 739 
(s). 
MS: (EI, 70 eV) 
91 (18), 115 (33), 116 (28), 128 (11), 129 (13), 131 (100), 135 (11), 171 (16, M
+
). 
TLC: Rf 0.30 (hexanes/EtOAc, 9:1) [UV] 
Analysis: C12H13N (171.2) 
 Calcd: C, 84.17; H, 7.65; N, 8.18 
 Found: C, 83.95; H, 7.68; N, 8.18 
 
Wittig Olefination of 2-Naphthaldehyde. Preparation of (4Z)-5-(2-Naphthyl)-4-
pentenenitrile (66h) 
 
Following General Procedure 16, (3-cyanopropyl)triphenylphosphonium chloride (1.829 
g, 5.0 mmol, 1.0 equiv), toluene (5 mL), THF (9 mL), a solution of KHMDS in THF (0.997 g, 
1.0 equiv, 5.0 mmol, 12 mL) and a solution of 2-naphthaldehyde in THF (0.800 g, 5.1 mmol, 
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1.02 equiv, 4 mL) were combined to yield after column chromatography (silica gel (48 g), 3 cm 
diam, 13 cm length, hexane/EtOAc 9:1) and recrystallization from hot cyclohexane (ca 10 mL, 
cooled to 6 
o
C) 757 mg (73%) of 66h as colorless needles. The Z/E ratio of the crude material 
was 88:12, after purification it was 99:1 (SNR 1670).  
Data for 66h: 
mp: 52 – 54 oC 
1
H NMR: (500 MHz, CDCl3) 
δ 7.89 – 7.76 (m, 3H, HC(10, 13, 8)), 7.70 (s, 1H, HC(15)), 7.55 – 7.43 (m, 2H, 
HC(11, 12)), 7.38 (dd, J = 8.5, 1.7 Hz, 1H, HC(7)), 6.77 (dt, J = 11.5, 2.0 Hz, 1H, 
HC(5)), 5.74 (dt, J = 11.5, 7.2 Hz, 1H, HC(4)), 2.76 (qd, J = 7.2, 1.8 Hz, 2H, 
HC(3)), 2.47 (t, J = 7.2 Hz, 2H, HC(2)). 
13
C NMR: (125 MHz, CDCl3) 
δ 134.0 (C(9/6/14)), 133.2 (C(9/6/14)), 132.4 (C(9/6/14)), 132.2 (C(5)), 127.94 
(C(4/aryl)), 127.92 (C(4/aryl)), 127.91 (C(4/aryl)), 127.6 (C(aryl)), 127.4 (C(aryl)), 
126.7 (C(7)), 126.3 (C(11/12)), 126.1 (C(11/12)), 119.1 (C(1)), 24.5 (C(2)), 17.6 
(C(3)). 
IR: (neat) 
3016 (w), 2928 (w), 2242 (m), 1507 (w), 1423 (m), 1345 (w), 1314 (w), 1274 (w), 
1124 (2), 1015 (w), 969 (w), 903 (m), 866 (s), 830 (s), 818 (s), 757 (s), 720 (m), 625 
(m). 
MS: (EI, 70 eV) 
152 (19), 165 (32), 166 (14), 167 (100), 168 (13), 207 (32, M
+
). 
TLC: Rf 0.19 (hexanes/EtOAc, 9:1) [UV] 
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Analysis: C15H13N (207.3) 
 Calcd: C, 86.92; H, 6.32 ; N, 6.76 
 Found: C, 86.63; H, 6.17; N, 6.77 
Wittig Olefination of 3-Methylbenzaldehyde. Preparation of (4Z)-5-(3-Methylphenyl)-4-
pentenenitrile (66j) 
 
Following General Procedure 16, (3-cyanopropyl)triphenylphosphonium chloride (4.755 
g, 13.0 mmol, 1.0 equiv), toluene (10 mL), THF (32 mL), a solution of KHMDS in THF (2.593 
g, 1.0 equiv, 13.0 mmol, 34 mL) and 3-methylbenzaldehyde (1.60 mL, 13.65 mmol, 1.05 equiv) 
were combined to yield after column chromatography (silica gel (81 g), 4 cm diam, 13 cm 
length, hexane/EtOAc 14:1) and bulb-to-bulb distillation (100-105 
o
C, 0.095 mmHg) 1.662 g 
(75%) of 66j as a colorless oil. The Z/E ratio of the crude material was 95:5, after purification it 
was 99.5:0.5 (SNR 2047).  
Data for 66j:  
bp:  100 – 105 oC (ABT, 0.095 mmHg) 
1
H NMR: (500 MHz, CDCl3) 
δ 7.32 – 7.19 (m, 1H, HC(10)), 7.11 (d, J = 7.6 Hz, 1H, HC(11)), 7.07 (m, 
2H,HC(9,7)), 6.60 (d, J = 11.5 Hz, 1H, HC(5)), 5.65 (dt, J = 11.5, 7.2 Hz, 1H, 
HC(4)), 2.70 (qd, J = 7.2, 1.6 Hz, 2H, H2C(3)), 2.45 (t, J = 7.2 Hz, 2H, H2C(2)), 2.39 
(s, 3H, H3C(13)). 
13
C NMR: (125 MHz, CDCl3) 
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δ 137.9 (C(8)), 136.4 (C(6)), 132.1 (C(5)), 129.3 (C(9)), 128.2 (C(10)), 127.9 
(C(11)), 127.3 (C(4)), 125.6 (C(7)), 119.1 (C(1)), 24.4 (C(3)), 21.4 (C(13)), 17.5 
(C(2)). 
IR: (neat) 
3015 (m), 2921 (m), 2866 (w), 2246 (m), 1949 (w), 1877 (w), 1792 (w), 1704 (w), 
1603 (m), 1589 (m), 1487 (w), 1427 (m), 1327 (w), 1262 (w), 1218 (w), 1170 (w), 
1092 (w), 1045 (w), 992 (w), 911 (w), 799 (m), 749 (w), 693 (m).  
MS: (EI, 70 eV) 
61 (15), 91 (18), 115 (18), 116 (17), 129 (12), 131 (100), 132 (10), 171 (31, M
+
). 
TLC: Rf 0.23 (hexanes/EtOAc, 9:1) [UV] 
Analysis: C12H13N (171.2) 
 Calcd: C, 84.17; H, 7.65; N, 8.18 
 Found: C, 84.38; H, 7.65; N, 8.29 
 
Wittig Olefination of 4-Methylbenzaldehyde. Preparation of Preparation of (4Z)-5-(4-
Methylphenyl)-4-pentenenitrile (66k) 
 
Following General Procedure 16, (3-cyanopropyl)triphenylphosphonium chloride (1.829 
g, 5.0 mmol, 1.0 equiv), toluene (5 mL), THF (12 mL), a solution of KHMDS in THF (0.997 g, 
1.0 equiv, 5.0 mmol, 13 mL) and 4-methylbenzaldehyde (0.62 mL, 5.25 mmol, 1.05 equiv) were 
combined to yield after column chromatography (silica gel (48 g), 3 cm diam, 13 cm length, 
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hexane/TBME 9:1) and bulb-to-bulb distillation (110 - 115 
o
C, 0.155mmHg) 691 mg (81%) of 
66k as a colorless oil. The Z/E ratio of the crude material was 96:4, after purification it was 
99.8:0.2 (SNR 1460).  
Data for 66k:  
bp:  110 – 115 oC (ABT, 0.155 mmHg) 
1
H NMR: (500 MHz, CDCl3) 
δ 7.22 – 7.08 (m, 4H, HC(7, 8)), 6.58 (dt, J = 11.5, 1.8 Hz, 1H, HC(5)), 5.61 (dt, J = 
11.5, 7.2 Hz, 1H, HC(4)), 2.68 (qd, J = 7.3, 1.8 Hz, 2H, HC(3)), 2.44 (t, J = 7.3 Hz, 
2H, HC(2)), 2.37 (s, 3H, HC(10)). 
13
C NMR: (125 MHz, CDCl3) 
δ 136.9 (C(9)), 133.6 (C(6)), 131.9 (C(5)), 129.0 (C(7/8)), 128.5 (C(7/8)), 126.8 
(C(4)), 119.2 (C(1)), 24.4 (C(3)), 21.1 (C(10)), 17.5 (C(2)). 
IR: (neat) 
3017 (s), 2923 (w), 2246 (w) 1909 (w), 1610 (w), 1513 (m), 1428 (m), 1326 (w), 
1216 (w), 1183 (w), 1020 (w), 827 (m), 732 (w), 691 (w), 628 (w). 
 
MS: (EI, 70 eV) 
61 (11), 91 (17), 115 (20), 116 (18), 129 (12), 131 (100), 132 (11), 171 (26, M
+
). 
TLC: Rf 0.22 (hexanes/EtOAc, 9:1) [UV] 
Analysis: C12H13N (171.2) 
 Calcd: C, 84.17; H, 7.65; N, 8.18; 
 Found: C, 84.11; H, 7.72; N, 8.23;  
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Wittig Olefination of 4-Trifluoromethoxybenzaldehyde. Preparation of (4Z)-5-(4-
Trifluoromethoxyphenyl)-4-pentenenitrile (66m) 
 
Following General Procedure 16, (3-cyanopropyl)triphenylphosphonium chloride (4.775 
g, 13.0 mmol, 1.0 equiv), toluene (10 mL), THF (32 mL), a solution of KHMDS in THF (2.59 g, 
1.0 equiv, 13.0 mmol, 34 mL) and 4-trifluoromethoxybenzaldehyde (1.95 mL, 13.65 mmol, 1.05 
equiv) were combined to yield after column chromatography (silica gel, 4 cm diam, 12 cm 
length, hexane/EtOAc 9:1) and bulb-to-bulb distillation (105-110 
o
C, 0.2 mmHg) 2.442 g (78%) 
of 66m as a colorless oil. The Z/E ratio of the crude material was 92:8, after purification it was 
99:1 (SNR 1440).  
Data for 66m: 
bp:  105 – 110 oC (ABT, 0.2 mmHg) 
1
H NMR: (500 MHz, CDCl3) 
δ 7.31 – 7.23 (m, 2H, HC(aryl)), 7.23 – 7.16 (m, 2H, HC(aryl)), 6.59 (dt, J = 11.5, 
1.8 Hz, 1H, HC(5)), 5.70 (dt, J = 11.5, 7.2 Hz, 1H, HC(4)), 2.64 (qd, J = 7.2, 1.8 Hz, 
2H, H2C(3)), 2.45 (t, J = 7.1 Hz, 2H, H2C(2)). 
13
C NMR: (125 MHz, CDCl3) 
δ 148.1 ((C(9)), 135.1 (C(6)), 130.8 (C(4)), 130.0 (C(7)), 128.4 (C(5)), 120.8 (C(8), 
120.4 (q, J = 257.6, C(10)), 119.0 (C(1)), 24.3 (C(3)), 17.5 (C(2)). 
IR: (neat) 
3021 (w), 2935 (w), 2247 (m), 1707 (w), 1605 (w), 1585 (w), 1505 (m), 1428 (m), 
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1401 (w), 1258 (m), 1215 (m), 1164 (m), 1109 (m), 1018 (m), 922 (m), 858 (m), 817 
(m), 742 (w), 667 (w). 
MS: (EI, 70 eV) 
115.1 (53), 116.1 (11), 201.1 (100), 202.1 (11), 241.1 (28, M
+
) 
TLC: Rf 0.20 (hexanes/EtOAc, 9:1) [UV/I2/CAM] 
Analysis: C12H10ONF3 (241.209) 
 Calcd: C, 59.75; H, 4.18; N, 5.81 
 Found: C, 59.66; H, 4.10; N, 6.03 
 
Hydrolysis of 66h. Preparation of (4Z)-5-(2-Naphthyl)-4-penteneoic Acid (16h) 
 
A 250-mL, round-bottomed flask was charged with 66h (0.650 g, 3.14 mmol, 1.0 equiv), 
MeOH (71 mL) and aq. NaOH solution (21 mL of 25% solution). The flask was fitted with a 
magnetic stir bar and a condenser and then was heated to reflux in an oil bath for 31 h. The 
resulting solution was concentrated in vacuo (30 
o
C, 6 mmHg) to remove MeOH and then was 
transferred to a 500-mL separatory funnel where it was diluted with H2O (130 mL), extracted 
with Et2O (2 x 50 mL). The Et2O extracts were discarded, and the aqueous phase was carefully 
acidified with 6 M HCl (30 mL, pH < 2). After cooling to room temperature, the mixture was 
extracted with Et2O (3 x 50 mL). The combined Et2O extracts were dried over MgSO4, filtered 
and concentrated in vacuo (23 
o
C, 6 mmHg). The residue was purified by chromatography (silica 
gel, 2 cm diam, 10 cm long, hexane/EtOAc/AcOH, 69.5:30:0.5) and recrystallization 
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(EtOAc/Hex, ca. 0.5 mL/ca. 4 mL) to provide 646.2 mg (91%) of 16h as colorless needles. 
Data for 16h:  
mp:  88 – 89 oC  
1
H NMR: (500 MHz, CDCl3) 
δ 10.90 (br s, HO), 7.85 – 7.79 (m, 2H, HC(10, 13)), 7.81 (d, J = 8.5 Hz, 1H, 
HC(8)), 7.72 (s, 1H, HC(15)), 7.51 – 7.43 (m, 2H, HC(11, 12)), 7.41 (dd, J = 8.5, 1.7 
Hz, 1H, HC(7)), 6.64 (dt, J = 11.6, 2.0 Hz, 1H, HC(5)), 5.72 (dt, J = 11.6, 7.2 Hz, 
1H, HC(4)), 2.76 (qd, J = 7.4, 1.9 Hz, 2H, H2C(3)), 2.53 (t, J = 7.5 Hz, 2H, H2C(2)). 
13
C NMR: (125 MHz, CDCl3) 
δ 179.4 (C(1)), 134.5 (C(14/9/6)), 133.3 (C(14/9/6)), 132.2 (C(14/9/6), 130.4 
(C(5/4)), 130.3 (C(5/4)), 127.9 (C(aryl)), 127.7 (C(aryl)), 127.5 (C(aryl), 127.4 
(C(Aryl)), 126.9 (C(7)), 126.1 (C(12/11)), 125.8 (C(12/11)), 34.2 (C(2)), 23.8 
(C(3)). 
IR: (KBr pellet) 
3051 (m), 3010 (m), 2907 (m), 2060 (m), 1733 (s), 1636 (s), 1405 (s), 1316 (m), 
1405 (s), 1273 (s), 1255 (s), 1180 (s), 965 (w), 953 (w), 898 (m), 865 (s), 749 (w), 
719 (s), 646 (w). 
MS: (EI, 70 eV) 
152 (25), 165 (51), 166 (35), 167 (100). 168 (14), 178 (12), 179 (13), 226 (51, M
+
). 
TLC: Rf 0.19 (hexanes/EtOAc/HOAc, 79.5:20:0.5) [UV] 
Analysis: C15H14O2Br (226.3) 
 Calcd: C, 76.62; H, 6.24 
 Found: C, 79.58; H, 6.26 
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Hydrolysis of 66i. Preparation of (4Z)-5-(2-Methylphenyl)-4-penteneoic Acid (16i) 
 
A 500-mL, round-bottomed flask was charged with 66i (1.373 g, 8.01 mmol, 1.0 equiv), 
MeOH (180 mL) and aq. NaOH solution (54 mL of 25% solution). The flask was fitted with a 
magnetic stir bar and a condenser and then was heated to reflux in an oil bath for 24 h. The 
resulting solution was concentrated in vacuo (30 
o
C, 6 mmHg) to remove MeOH and then was 
transferred to a 500-mL separatory funnel where it was diluted with H2O (50 mL), extracted with 
TBME (2 x 50 mL). The TBME extracts were discarded, and the aqueous phase was carefully 
acidified with 6 M HCl (100 mL, pH < 2). After cooling to room temperature, the mixture was 
extracted with CH2Cl2 (3 x 50 mL). The combined CH2Cl2 extracts were dried over MgSO4, 
filtered and concentrated in vacuo (23 
o
C, 6 mmHg). The residue was purified by 
chromatography (silica gel (39 g), 3 cm diam, 10 cm long, hexane/EtOAc/AcOH gradient from 
90:10:0 to 80:20:0 to 79:20:1) and bulb-to-bulb distillation (145 – 150 oC, 0.155 mmHg) to 
provide 1.39 g (91%) of 16i as a colorless oil. 
Data for 16i: 
bp:  145 – 150 oC (ABT, 0.155 mmHg) 
1
H NMR: (500 MHz, CDCl3) 
δ 7.23 – 7.12 (m, 4H, HC(aryl)), 6.52 (dt, J = 11.4, 1.6 Hz, 1H, HC(5)), 5.71 (dt, J = 
11.4, 7.0 Hz, 1H, HC(4)), 2.53 – 2.39 (m, 4H, H2C(2, 3)), 2.26 (s, 3H, H3C(13)). 
13
C NMR: (125 MHz, CDCl3) 
δ 179.4 (C(1)), 136.21 (C(6/7)), 136.17 (C(6/7)), 129.8 (C(4/aryl)), 129.7 (2C, 
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C(4/aryl)), 128.8 (C(5)), 127.1 (C(aryl)), 125.4 (C(aryl)), 34.0 (C(2)), 23.5 (C(3)), 
19.8 (C(13)). 
IR: (neat) 
3015 (m), 1708 (s), 1487 (w), 1412 (m), 1281 (m), 1215 (m), 942 (w), 785 (m), 754 
(m), 736 (m) 
MS: (EI, 70 eV) 
91 (27), 105 (10), 115 (31), 116 (22), 117 (10), 128 (20), 129 (36), 130 (20), 131 
(100), 132 (11), 190 (48, M
+
) 
TLC: Rf 0.30 (hexanes/EtOAc/HOAc, 79.5:20:0.5) [UV] 
Analysis: C12H14O2 (190.2) 
 Calcd: C, 75.76; H, 7.42 
 Found: C, 76.04; H, 7.65 
Hydrolysis of 66j. Preparation of (4Z)-5-(3-Methylphenyl)-4-pentenoic Acid (16j) 
 
A 500-mL, round-bottomed flask was charged with 66j (1.577 g, 9.2 mmol, 1.0 equiv), 
MeOH (207 mL) and aq. NaOH solution (62 mL of 25% solution). The flask was fitted with a 
magnetic stir bar and a condenser and then was heated to reflux in an oil bath for 24 h. The 
resulting solution was concentrated in vacuo (30 
o
C, 6 mmHg) to remove MeOH and then was 
transferred to a 500-mL separatory funnel where it was diluted with H2O (100 mL), extracted 
with Et2O (3 x 50 mL). The Et2O extracts were discarded, and the aqueous phase was carefully 
acidified with 6 M HCl (pH < 2). After cooling to room temperature, the mixture was extracted 
with Et2O (3 x 75 mL). The combined Et2O extracts were dried over MgSO4, filtered and 
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concentrated in vacuo (23 
o
C, 6 mmHg). The residue was purified by chromatography (silica gel, 
3 cm diam, 10 cm long, hexane/EtOAc/AcOH, 79.5:20:0.5) and bulb-to-bulb distillation (120 – 
125 
o
C, 0.095 mmHg) to provide 1.613 g (92%) of 16j as a colorless oil. 
Data for 16j: 
bp:  120 – 125 oC (ABT, 0.095 mmHg) 
1
H NMR: (500 MHz, CDCl3) 
δ 7.24 (d, J = 7.8 Hz, 1H, HC(aryl)), 7.14 – 7.02 (m, 3H, HC(aryl)), 6.47 (dt, J = 
11.7, 1.9 Hz, 1H, HC(5)), 5.63 (dt, J = 11.6, 7.2 Hz, 1H, HC(4)), 2.68 (qd, J = 7.4, 
1.8 Hz, 2H, H2C(3)), 2.50 (t, J = 7.5 Hz, 2H, H2C(2)), 2.37 (s, 3H, H3C(12)). 
13
C NMR: (125 MHz, CDCl3) 
δ 179.4 (C(1)), 137.8 (C(6/8), 137.0 (C(6/8)), 130.5 (C(5)), 129.7 (C(4)), 129.4 
(C(aryl)), 128.1 (C(aryl)), 127.6 (C(aryl)), 125.7 (C(aryl)), 34.2 (C(2)), 23.8 (C(3)), 
21.4 (C(12)). 
IR: (neat) 
3013 (m), 2920 (m), 1710 (s), 1602 (w), 1582 (w), 1487 (w), 1412 (m), 1281 (m), 
1208 (m), 1167 (w), 1092 (w), 910 (m), 797 (m), 747 (w), 693 (m). 
MS: (EI, 70 eV) 
91 (26), 105 (12), 115 (25), 116 (17), 128 (20), 129 (33), 130 (19), 131 (100), 132.1 
(11), 190 (47, M
+
). 
TLC: Rf 0.14 (hexanes/EtOAc/HOAc, 79.5:20:0.5) [UV] 
Analysis: C12H14O2 (190.2) 
 Calcd: C, 75.76; H, 7.42 
 Found: C, 75.68; H, 7.41 
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Hydrolysis of 66k. Preparation of (4Z)-5-(4-Methylphenyl)-4-pentenoic Acid (16k) 
 
A 250-mL, round-bottomed flask was charged with 66k (0.555 g, 3.24 mmol, 1.0 equiv), 
MeOH (73 mL) and aq. NaOH solution (22 mL of 25% solution). The flask was fitted with a 
magnetic stir bar and a condenser and then was heated to reflux in an oil bath for 26 h. The 
resulting solution was concentrated in vacuo (30 
o
C, 6 mmHg) to remove MeOH and then was 
transferred to a 500-mL separatory funnel where it was diluted with H2O (30 mL), extracted with 
Et2O (3 x 30 mL). The Et2O extracts were discarded, and the aqueous phase was carefully 
acidified with 6 M HCl (40 mL, pH < 2). After cooling to room temperature, the mixture was 
extracted with Et2O (3 x 30 mL). The combined Et2O extracts were dried over MgSO4, filtered 
and concentrated in vacuo (23 
o
C, 6 mmHg). The residue was purified by chromatography (silica 
gel, 2 cm diam, 10 cm long, hexane/EtOAc/AcOH, 79.5:20:0.5) and recrystallization (hexane, 
ca. 0.5 mL) to provide 538.9 mg (87%) of 16k as colorless needles. 
Data for 16k:  
mp:  55 – 56 oC  
1
H NMR: (500 MHz, CDCl3) 
δ 11.55 (br s, 1H, HO), 7.24 – 7.10 (m, 4H, HC(aryl)), 6.47 (dt, J = 11.6, 1.9 Hz, 1H, 
HC(5)), 5.60 (dt, J = 11.7, 7.2 Hz, 1H, HC(4)), 2.69 (qd, J = 7.3, 1.8 Hz, 2H, 
H2C(3)), 2.51 (t, J = 7.6 Hz, 2H, H2C(2)), 2.37 (s, 3H, H3C(10)). 
13
C NMR: (125 MHz, CDCl3) 
δ 179.5 (C(1)), 136.52 (C(9)), 134.2 (C(6)), 130.3 (C(5)), 129.1 (C(4)), 128.9 
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(C(aryl)), 128.6 (C(aryl)), 34.2 (C(2)), 23.7 (C(3)), 21.1 (C(10)). 
IR: (KBr pellet) 
3010 (s), 2921 (s), 1710 (s), 1513 (m), 1439 (s), 1425 (s), 1411 (s), 1350 (w), 1296 
(s), 1214 (s), 1124 (w), 910 (m), 837 (s), 754 (w), 691 (m). 
MS: (EI, 70 eV) 
91 (20), 115 (22), 116 (15), 128 (15), 129 (24), 130 (11), 131 (100), 132 (11), 190 
(42, M
+
). 
TLC: Rf 0.22 (hexanes/EtOAc/HOAc, 79.5:20:0.5) [UV] 
Analysis: C12H14O2 (190.2) 
 Calcd: C, 75.76; H, 7.42 
 Found: C, 75.76; H, 7.58 
 
Hydrolysis of 66m. Preparation of (4Z)-5-(4-Trifluoromethoxyphenyl)-4-pentenoic Acid 
(16m) 
 
A 500-mL, round-bottomed flask was charged with 66m (2.161 g, 8.96 mmol, 1.0 equiv), 
MeOH (200 mL) and aq. NaOH solution (60 mL of 25% solution). The flask was fitted with a 
magnetic stir bar and a condenser and then was heated to reflux in an oil bath for 24 h. The 
resulting solution was concentrated in vacuo (30 
o
C, 6 mmHg) to remove MeOH and then was 
transferred to a 500-mL separatory funnel where it was diluted with H2O (50 mL), and Et2O (50 
mL). The resulting triphasic mixture was diluted with H2O (150 mL), MeOH (40 mL) and 
hexane (25 mL), producing a biphasic mixture. The phases were separated and the aqueous phase 
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was extracted with 2:1 Et2O/hexane (75 mL). The Et2O/hexane extracts were discarded, and the 
aqueous phase was carefully acidified with 6 M HCl (112 mL, pH < 2). Ice was added slowly 
until the mixture reached room temperature. The mixture was extracted with Et2O (3 x 50 mL). 
The combined Et2O extracts were dried over MgSO4, filtered and concentrated in vacuo (23 
o
C, 
6 mmHg). The residue was purified by chromatography (silica gel (39 g), 3 cm diam, 10 cm 
long, hexane/acetone, 70:30), followed by further column chromatography (silica gel, 3 cm 
diam, hexane/EtOAc/AcOH 69.5:30:0.5), bulb-to-bulb distillation (145 – 150 oC, 0.150 mmHg) 
and sacrificial column chromatography (silica gel, 3 cm diam, 15 cm length, CH2Cl2) to provide 
1.69 g (72%) of 16i as a colorless oil. The purity was estimated as 95% by 
19
F NMR integration. 
Data for 16m: 
bp:  145 – 150 oC (ABT, 0.150 mmHg) 
1
H NMR: (500 MHz, CDCl3) 
δ 7.32 – 7.26 (m, 2H, HC(aryl)), 7.19 (d, J = 8.2 Hz, 2H, HC(aryl)), 6.46 (dt, J = 
11.6, 1.9 Hz, 1H, ), 5.67 (dt, J = 11.6, 7.2 Hz, 1H), 2.64 (qd, J = 7.8, 7.4, 1.8 Hz, 
2H), 2.50 (t, J = 7.6 Hz, 2H). 
13
C NMR: (125 MHz, CDCl3) 
δ 179.1 (C(1)), 147.9 (C(3)), 135.8 (C(6)), 130.7 (C(4)), 130.0 (C(7)), 129.1 (C(5)), 
120.7 (C(8)), 120.5 (q, J = 256.8 Hz, F3C(10)), 34.0 (C(2)), 23.6 (C(3)). 
19
F NMR: (470 MHz, CDCl3) 
δ -58.25. 
IR: (neat) 
3020 (m), 2921 (m), 2675 (m), 1713 (s), 1506 (s), 1415 (m), 1258 (s), 1215 (s), 1164 
(s), 1018 (m), 922 (m), 857 (m), 667 (m). 
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MS: (EI, 70 eV) 
63 (11), 69 (19), 77 (13), 109 (11), 115 (75), 116 (11), 127 (11), 129 (21), 175 (19), 
201 (100), 260 (72, M
+
).  
HRMS: calcd for C12H11O3F3: 260.06604, found: 260.06704 
TLC: Rf 0.31 (hexanes/EtOAc/HOAc, 79.5:20:0.5) [UV] 
 
General Procedure 17. LiAlH4 Reduction of 16i. Preparation of (4Z)-5-(2-Methylphenyl)-4-
penten-1-ol (19i) 
 
A 100-mL, oven-dried Schlenk flask, filled with Ar, fitted with a septum and a magnetic 
stir bar, was charged with 16i (950.8 mg, 5.0 mmol, 1.0 equiv). Tetrahydrofuran (29 mL) was 
added, and the flask was cooled in an ice bath. Solid LiAlH4 (199 mg, 5.25 mmol, 1.05 equiv) 
was added in three portions over 5 min. The reaction was stirred at 0 
o
C for 2.25 h, and then H2O 
(0.2 mL), 2 M aq. NaOH sol. (0.4 mL), and H2O (0.6 mL) were added. The resulting white 
suspension was filtered through Celite (ca. 2 cm) washing with EtOAc (ca. 100 mL). The filtrate 
was concentrated in vacuo (23 
o
C, 6 mmHg). The residue was purified by column 
chromatography (silica gel (39 g), 3 cm diam, 10 cm length, hexane/EtOAc, 4:1). Further 
purification by column chromatography (silica gel (39 g), 3 cm diam, 10 cm length, CH2Cl2) 
followed by bulb-to-bulb distillation (105 – 110 oC, 0.077 mmHg) provided 786 mg (89%) of 19i 
as a colorless oil. 
Data for 19i: 
bp:  105 – 110 oC (ABT, 0.077 mmHg) 
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1
H NMR: (500 MHz, CDCl3) 
δ 7.30 – 7.07 (m, 4H, HC(Aryl)), 6.48 (dt, J = 11.4, 1.5 Hz, 1H, HC(5)), 5.73 (dt, J = 
11.4, 7.4 Hz, 1H, HC(4)), 3.61 (t, J = 6.4 Hz, 2H, H2C(1)), 2.26 (s, 3H, H3C(12)), 
2.28 – 2.21 (qd, J = 7.5, 1.7 Hz, 2H, H2C(3)), 1.67 (dq, J = 13.8, 6.8 Hz, 2H, 
H2C(2)), 1.39 (br s, 1H, OH). 
13
C NMR: (125 MHz, CDCl3) 
δ 136.5 (C(6/7)), 136.2 (C(6/7)), 131.8 (C(4)), 129.8 (C(aryl)), 128.9 (C(aryl)), 
128.6 (C(5)), 126.9 (C(aryl)), 125.3 (C(aryl)), 62.4 (C(1)), 32.6 (C(2)), 24.6 (C(3)), 
19.8 (C(12)). 
IR: (neat) 
3339 (s), 3008 (s), 2938 (s), 1601 (w), 1485 (s), 1455 (s), 1378 (m), 1159 (w), 1105 
(w), 1058 (s), 943 (w), 870 (w), 828 (w), 787 (s), 750 (s). 
MS: (EI, 70 eV) 
61 (58), 70 (34), 73 (18), 77 (10), 88 (22), 91 (33), 105 (40), 116 (27), 117 (26), 128 
(38), 129 (37), 130 (15), 131 (60), 132 (13), 143 (100), 144 (13), 158 (15), 176 (46, 
M
+
) 
TLC: Rf 0.18 (hexanes/EtOAc, 4:1) [UV] 
Analysis: C12H16O (176.2) 
 Calcd: C, 81.77; H, 9.15 
 Found: C, 81.69; H, 9.18 
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LiAlH4 Reduction of 16h. Preparation of (4Z)-5-(2-Naphthyl)-4-penten-1-ol (19h) 
 
Following General Procedure 17, 16h (1.131 g, 5.0 mmol, 1.0 equiv) was combined with 
THF (29 mL) and LiAlH4 (0.199 g, 5.25 mmol, 1.05 equiv) to yield after column 
chromatography (silica gel, 3 cm diam, 10 cm length, hexane/EtOAc 7:3) and recrystallization 
from Et2O (ca 1 mL) /hexane (ca 2 mL) 927 mg (87%) of 19h as short needles. 
Data for 19h: 
mp: 41 – 42 oC  
1
H NMR: (500 MHz, CDCl3) 
δ 7.86 – 7.76 (m, 3H, HC(8, 10, 13)), 7.73 (s, 1H, HC(15)), 7.51 – 7.43 (m, 2H, 
HC(10, 12)), 7.43 (dd, J = 8.5, 1.8 Hz, 1H, HC(7)), 6.61 (dt, J = 11.6, 1.9 Hz, 1H, 
HC(5)), 5.76 (dt, J = 11.6, 7.3 Hz, 1H, HC(4)), 3.69 (t, J = 6.5 Hz, 2H, H2C(1)), 2.52 
(qd, J = 7.4, 1.9 Hz, 2H, H2C(3)), 1.77 (dq, J = 7.8, 6.6 Hz, 2H, HC(2)), 1.26 (br s, 
1H, HO). 
13
C NMR: (125 MHz, CDCl3) 
δ 135.0 (C(6/9/14)), 133.3 (C(6/9/14)), 132.5 (C(4)), 132.1 (C(6/9/14)), 129.5 
(C(5)), 127.9 (C(aryl)), 127.6 (C(aryl)), 127.5 (C(aryl)), 127.4 (C(aryl)), 127.1 
(C(aryl)), 126.0 (C(aryl), 125.70 (C(aryl)), 62.4 (C(1)), 32.8 (C(2)), 25.0 (C(3)). 
IR: (KBr pellet) 
3324 (m, br), 3051 (w), 3010 (w), 2928 (m), 1367 (w), 1276 (w), 1062 (s), 1031 (s), 
966 (w), 950 (w), 902 (m), 865 (m), 820 (s), 746 (m), 712 (m), 630 (w). 
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MS: (EI, 70 eV) 
61 (12), 115 (14), 128 (25), 141 (45), 142 (47), 151 (10), 152 (45), 153 (19), 154 
(11), 155 (10), 165 (85), 166 (40), 167 (100), 168 (23), 178 (34), 179 (56), 180 (12), 
181 (12), 193 (17), 204 (10), 212 (80, M
+
), 213 (13). 
TLC: Rf 0.14 (hexanes/EtOAc, 4:1) [UV] 
Analysis: C15H16O (212.3) 
 Calcd: C, 84.87; H, 7.60 
 Found: C, 85.07; H, 7.76 
 
LiAlH4 Reduction of 16j. Preparation of (4Z)-5-(3-Methylphenyl)-4-penten-1-ol (19j) 
 
Following General Procedure 17, a 50-mL Schlenk flask was charged with 16j (0.985 g, 
5.18 mmol, 1.0 equiv), THF (30 mL), and LiAlH4 (206 mg, 5.43 mmol, 1.05 equiv). The reaction 
was stirred for 2 h, quenched and worked up as described. Column chromatography (silica gel, 3 
cm diam, 10 cm length, hexane/EtOAc, 4:1) followed by bulb-to-bulb distillation (85-90 
o
C, 0.08 
mmHg) provided 856.9 mg (94%) of 19j as a colorless oil.  
Data for 19j: 
bp:  85 – 90 oC (ABT, 0.08 mmHg) 
1
H NMR: (500 MHz, CDCl3) 
δ 7.23 (t, J = 7.9 Hz, 1H, HC(aryl)), 7.18 – 7.08 (m, 2H, HC(aryl)), 7.05 (d, J = 7.6 
Hz, 1H, HC(aryl)), 6.43 (dt, J = 11.6, 1.9 Hz, 1H, HC(5)), 5.65 (dt, J = 11.6, 7.3 Hz, 
1H, HC(4)), 3.67 (t, J = 6.5 Hz, 2H, H2C(1)), 2.43 (qd, J = 7.4, 1.9 Hz, 2H, H2C(3)), 
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2.36 (s, 3H, H3C(12)), 1.80 – 1.66 (m, 2H, H2C(2)), 1.43 (s, 1H, HO). 
13
C NMR: (125 MHz, CDCl3) 
δ 137.7 (C(6/8)), 137.4 (C(6/8)), 131.8 (C(4)), 129.5 (C(5/aryl)), 129.4 (C(5/aryl)) , 
128.0 (C(aryl)), 127.3 (C(aryl)), 125.7 (C(aryl)), 62.4 (C(1)), 32.8 (C(2)), 24.8 
(C(3)), 21.4 (C(12)). 
IR: (neat) 
3338 (br m), 3309 (w), 2934 (m), 1602 (w), 1582 (w), 1487 (w), 1444 (w), 1169 (w), 
1057 (m), 906 (w), 787 (m), 743 (w), 692 (w). 
MS: (EI, 70 eV) 
61 (78), 62 (20), 65 (10), 70 (39), 73 (27), 77 (14), 88 (30), 91 (40), 92 (11), 105 
(44), 106 (41), 115 (40), 116 (28), 117 (25), 118 (10), 119 (12), 127 (10), 128 (37), 
129 (29), 130 (17), 131 (68), 132 (15), 143 (100), 144 (13), 145 (13), 157 (12), 176 
(54, M
+
). 
TLC: Rf 0.22 (hexanes/EtOAc, 4:1) [UV] 
Analysis: C12H16O (176.2) 
 Calcd: C, 81.77; H, 9.15 
 Found: C, 81.49; H, 9.27 
 
LiAlH4 Reduction of 16k. Preparation of (4Z)-5-(4-Methylphenyl)-4-penten-1-ol (19k) 
 
Following General Procedure 17, a 15-mL Schlenk flask was charged with 66k (0.2283 g, 1.2 
mmol, 1.0 equiv), THF (7.0 mL), and LiAlH4 (48 mg, 1.26 mmol, 1.05 equiv). The reaction was 
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stirred for 3 h, quenched and worked up as described. Column chromatography (silica gel, 2 cm 
diam, 10 cm length, hexane/EtOAc, 4:1) followed by bulb-to-bulb distillation (80 - 85 
o
C, 0.09 
mmHg), chromatography (silica gel, 2 cm diam, 10 cm length, CH2Cl2), and bulb-to-bulb 
distillation (80-85 
o
C, 0.09 mmHg) provided 152.9 mg (72%) of 19k as a colorless oil.  
Data for 19k: 
bp:  80 – 85 oC (ABT, 0.09 mmHg) 
1
H NMR: (500 MHz, CDCl3) 
δ 7.23 – 7.13 (m, 4H, HC(aryl)), 6.43 (dt, J = 11.7, 1.9 Hz, 1H, HC(5)), 5.63 (dt, J = 
11.6, 7.3 Hz, 1H, HC(4), 3.66 (t, J = 6.5 Hz, 2H, H2C(1)), 2.43 (qd, J = 7.4, 1.9 Hz, 
2H, H2C(3)), 2.35 (s, 3H, H3C(10)), 1.72 (dq, J = 7.5, 6.5 Hz, 2H, H2C(2)), 1.48 ( br 
s, 1H, HO). 
13
C NMR: (125 MHz, CDCl3) 
δ 136.3 (C(6/9)), 134.6 (C(6/9)), 131.3 (C(4)), 129.3 (C(5)), 128.8 (C(7/8)), 128.6 
(C(7/8)), 62.4 (C(1)), 32.8 (C(2)), 24.9 (C(3)), 21.1 (C(10)). 
IR: (neat) 
3338 (m), 3009 (m), 2934 (m), 2867 (m), 1610 (w), 1512 (m), 1445 (m), 1180 (w), 
1057 (m), 835 (m), 729 (w), 686 (w), 528 (w). 
MS: (EI, 70 eV) 
61 (27), 62 (59), 65 (10), 77 (15), 91 (44), 92 (12), 105 (64), 106 (23), 115 (44), 116 
(32), 117 (26), 118 (13), 119 (11), 127 (11), 128 (39), 129 (32), 130 (17), 131 (100), 
132 (22), 143 (94), 144 (13), 145 (14), 157 (13), 176 (69, M
+
). 
TLC: Rf 0.23 (hexanes/EtOAc, 4:1) [UV] 
Analysis: C12H16O (176.2) 
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 Calcd: C, 81.77; H, 9.15 
Found: C, 81.63; H, 9.10 
 
LiAlH4 Reduction of 16l. Preparation of (4Z)-5-(4-Fluorophenyl)-4-penten-1-ol (19l) 
 
Following General Procedure 17, a 100-mL Schlenk flask was charged with 16l (0.97 g, 
5.0 mmol, 1.0 equiv), THF (23 mL), and LiAlH4 (199 mg, 5.25 mmol, 1.05 equiv). The reaction 
was stirred for 5 h, quenched and worked up as described. Column chromatography (silica gel, 3 
cm diam, 10 cm length, hexane/EtOAc, 4:1) followed by bulb-to-bulb distillation (80-85 
o
C, 0.12 
mmHg) provided 818 mg (90%) of 19l as a colorless oil.  
Data for 19l: 
bp: 80 – 85 oC (ABT, 0.12 mmHg) 
1
H NMR: (500 MHz, CDCl3) 
δ 7.24 (dd, J = 8.5, 5.6 Hz, 2H, HC(7)), 7.01 (t, J = 8.7 Hz, 2H, HC(8)), 6.40 (dt, J = 
11.6, 2.0 Hz, 1H, HC(5)), 5.65 (dt, J = 11.6, 7.3 Hz, 1H, HC(4)), 3.65 (t, J = 6.5 Hz, 
2H, H2C(1)), 2.38 (qd, J = 7.4, 1.9 Hz, 2H, H2C(3)), 1.71 (ddt, J = 8.2, 7.4, 6.5 Hz, 
2H, H2C(2)), 1.58 (s, 1H, HO). 
13
C NMR: (125 MHz, CDCl3) 
δ 161.4 (d, J = 246.1 Hz, C(9)), 133.4 (d, J = 3.7 Hz, C(6)), 131.9 (d, J = 1.4 Hz, 
C(5)), 130.2 (d, J = 7.8 Hz, C(7)), 128.3 (C(4)), 115.0 (d, J = 21.2 Hz, C(8)), 62.3 
(C(1)), 32.7 (C(3)), 24.7 (C(4)). 
19
F NMR: (470 MHz, CDCl3) 
 δ -116.01 (tt, J = 8.6, 5.4 Hz, FC(9)). 
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IR: (neat) 
3381 (m), 3012 (m), 2937 (m), 2874 (m), 1892 (w), 1647 (w), 1603 (s), 1509 (s), 
1435 (m), 1398 (m), 1224 (s), 1158 (m), 1058 (m), 904 (w), 842 (s), 732 (m), 681 
(w), 615 (m). 
MS: (EI, 70 eV) 
109 (72), 115 (19), 122 (14), 133 (40), 134 (17), 135 (73), 136 (23), 161 (33), 162 
(30), 180 (38, M
+
) 
TLC: Rf 0.19 (hexanes/EtOAc, 4:1) [UV] 
Analysis: C11H13OF (180.21) 
 Calcd: C, 73.31; H, 7.27 
 Found: C, 73.58; H, 7.53 
 
LiAlH4 Reduction of 16m. Preparation of (4Z)-5-(4-Trifluoromethoxyphenyl)-4-penten-1-ol 
(19m) 
 
Following General Procedure 17, a 100-mL Schlenk flask was charged with 16m (1.303 
g, 5.0 mmol, 1.0 equiv, contained ca. 5% inseparable impurities (see preparation for details)), 
THF (29 mL), and LiAlH4 (199 mg, 5.25 mmol, 1.05 equiv). The reaction was stirred for 1.5 h, 
quenched and worked up as described. Repeated sacrificial column chromatography (silica gel, 3 
cm diam, 10 cm length, hexane/EtOAc, 4:1; then silica gel, 3 cm diam, 10 cm length, CH2Cl2; 
then silica gel, 3 cm diam, 10 cm length, hexane/TBME, 70:30) followed by bulb-to-bulb 
distillation (100 - 105 
o
C, 0.084 mmHg) provided 786.4 mg (64%) of 19m as a colorless oil.  
Data for 19m:  
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bp: 100 – 105 oC (ABT, 0.084 mmHg) 
1
H NMR: (500 MHz, CDCl3) 
δ 7.35 – 7.22 (m, 2H, HC(aryl)), 7.22 – 7.12 (m, 2H, HC(aryl)), 6.41 (dt, J = 11.7, 
1.9 Hz, 1H, HC(5))), 5.70 (dt, J = 11.6, 7.3 Hz, 1H, HC(4))), 3.67 (dt, J = 6.9, 3.6 
Hz, 2H, H2C(1)), 2.40 (qd, J = 7.4, 1.9 Hz, 2H, H2C(3)), 1.79 – 1.67 (m, 2H, 
H2C(2)), 1.48 (br s, 1H, HO). 
13
C NMR: (125 MHz, CDCl3) 
δ 147.7 (C(9)), 136.2 (C(6)), 132.9 (C(4)), 130.0 (C(7)), 128.0 (C(5)), 120.6 (C(8)), 
120.5 (q, J = 256.8 Hz), 62.3 (C(1)), 32.7 (C(2)), 24.8 (C(3)). 
19
F NMR: (470 MHz, CDCl3) 
 δ -58.25 (F3C(10)). 
IR: (neat) 
3338 (m), 3015 (w), 2938 (m), 2873 (m), 1606 (w), 1585 (w), 1506 (s), 1401 (m), 
1264 (s), 1218 (s), 1164 (s), 1058 (m), 1017 (m), 922 (m), 855 (m), 815 (m), 666 
(m).  
MS: (EI, 70 eV) 
61 (100), 70 (54), 73 (36), 88 (42), 91 (15), 115 (44), 127 (25), 128 (18), 129 (11), 
143 (47), 175 (39), 188 (13), 201 (28), 201 (18), 213 (34), 227 (13), 228 (20), 246 
(39, M
+
).  
TLC: Rf 0.13 (hexanes/EtOAc, 4:1) [UV] 
Analysis: C12H13O2F3 (246.1) 
 Calcd: C, 58.54; H, 5.32 
 Found: C, 58.79; H, 5.31 
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Catalyst Preparation. Arylation of (1S)-2,2'-bis(methoxymethoxy)-3,3'-diiodo-1,1'-
binaphthalene. Preparation of (1S)-2,2'-Bis(methoxymethoxy)-3,3'-bis(2,4,6-
triphenylphenyl)-1,1'-binaphthalene, 66.
†††
 [MTB-XV-91] 
 
A 50-mL, flame-dried Schlenk flask, fitted with a septum and a magnetic stir bar, under 
Ar, was charged with (1S)-2,2'-bis(methoxymethoxy)-3,3'-diiodo-1,1'-binaphthalene
171‡‡‡
 (313 
mg, 0.5 mmol, 1.0 equiv) and NiCl2(PPh3)2 (32.7 mg, 0.05 mmol, 0.1 equv). Two portions of 
toluene (2 x 2.5 mL) were added via syringe and removed in vacuo (0.2 mmHg, 38
o
C) to dry the 
reagents. Tetrahydrofuran (5.0 mL) was added via syringe. A solution of 
triphenylphenylmagnesium bromide (0.5 M in THF, 4.0 mL, 4.0 equiv) was added dropwise via 
cannala. The solution immediately turned bright green and then slowly became deep red and 
homogenous. The flask was heated to 38
o
C in an oil bath and stirred for 15 h. The resulting 
solution was poured into a 60-mL separatory funnel containing sat. aq. NH4Cl solution (10 mL) 
where it was diluted with H2O (5 mL) and was extracted with CH2Cl2 (3 x 10 mL). The 
combined organic extracts were dried over MgSO4, filtered, and concentrated in vacuo (23 
o
C, 6 
mmHg). The residue was purified by column chromatography (silica gel, 3 cm diam., 10 cm 
long, hexane/CH2Cl2, 2:1 to 1:1) to provide 451 mg (92%) of 66 as a white solid. 
Data for 66:  
1
H NMR: (500 MHz, CDCl3) 
                                                 
†††
 Adapted from Toste et. al.’s synthesis of 24g156 
‡‡‡
 I highly recommend this precursor and V. Snieckus’s preparation of it.171  
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δ 7.85 – 7.69 (m, 8H), 7.60 (s, 2H), 7.57 (d, J = 8.2 Hz, 2H), 7.55 – 7.47 (m, 4H), 
7.47 – 7.40 (m, 6H), 7.40 – 7.32 (m, 6H), 7.32 – 7.21 (m, 6H), 7.21 – 7.15 (m, 4H), 
7.15 – 7.08 (m, 2H), 7.07 – 6.97 (m, 2H), 6.23 (d, J = 8.5 Hz, 2H), 4.49 (d, J = 6.5 
Hz, 2H), 3.89 (d, J = 6.5 Hz, 2H), 2.60 (s, 6H). 
13
C NMR: (125 MHz, CDCl3) 
δ 151.0, 143.6, 143.5, 142.3, 142.1, 140.3, 140.0, 134.8, 133.3, 133.3, 132.2, 129.8, 
129.7, 129.7, 128.8, 127.9, 127.8, 127.7, 127.5, 127.3, 127.0, 126.3, 126.0, 125.7, 
124.4, 123.7, 96.2, 67.9, 60.4, 55.4. 
TLC: Rf 0.30 (hexanes/CH2Cl2, 1:1) [UV] 
Deprotection of 66. Preparation of (S)-3,3'-Bis(2,4,6-triphenylphenyl)-[1,1'-binaphthalene]-
2,2'-diol. (67) [MTB-XVI-10] 
  
A 100-mL round-bottomed flask containing 66 (429.4 mg, 0.437 mmol, 1.0 equiv) was fitted 
with an Ar inlet, a septum and a magnetic stir bar. The flask was evacuated and filled with Ar, 
and was charged with dioxane (17 mL) and conc. aq. HCl (1.5 mL). The flask was heated to 70 
o
C in an oil bath and allowed to stir for 18.5 h. The resulting mixture was concentrated in vacuo 
(30 
o
C, 6 mmHg) and the residue was purified by column chromatography (silica gel, 3 cm 
diam., 10 cm long, hexane/CH2Cl2, 2:1) to provide 375.8 mg (96%) of 67 as a white solid.  
Data for 67:  
303 
 
1
H NMR: (500 MHz, CDCl3) 
δ 7.81 – 7.70 (m, 9H), 7.59 (d, J = 8.1 Hz, 2H), 7.54 – 7.45 (m, 7H), 7.45 – 7.38 (m, 
2H), 7.38 – 7.29 (m, 9H), 7.29 – 7.19 (m, 10H), 7.19 – 7.09 (m, 9H), 6.52 (d, J = 8.4 
Hz, 2H), 4.47 (s, 2H, OH). 
13
C NMR: (125 MHz, CDCl3) 
δ 151.1, 143.4, 143.2, 141.9, 141.8, 140.5, 140.4, 134.1, 133.1, 132.5, 129.6, 129.33, 
129.1, 128.8, 128.6, 128.2, 127.7, 127.6, 127.5, 127.5, 127.2, 126.9, 126.8, 126.6, 
123.71, 123.68, 110.2. 
TLC: Rf 0.40 (hexanes/CH2Cl2, 1:1) [UV] 
Phosphorylation of 67. Preparation of 4-Hydroxy-2,6-bis(2,4,6-triphenylphenyl)-(11bR)-
dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-oxide. (24h) 
 
 A 15-mL, oven-dried, round-bottomed flask was charged with a solution of 67 (359.1 
mg, 0.401 mmol, 1.0 equiv) in PhMe. The solution was concentrated in vacuo (30 
o
C, 6 mmHg), 
and then the flask was fitted with  an Ar inlet, a condenser, a septum and a magnetic stir bar. The 
flask was heated to 95 
o
C in vacuo for 15 min, after which it was allowed to cool and was filled 
with Ar. Pyridine (3.0 mL) was added, and the solution turned yellow. Phosphorus oxychloride 
(75 μL, 0.8022 mmol, 2.0 equiv) was added, and then the flask was heated to 95 oC in an oil bath 
for 3.5 h. Water (3.0 mL) was added and the flask was heated to 100 
o
C in an oil bath for 8.5 h. 
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The resulting mixture was poured into a 100-mL separatory funnel where it was diluted with 
PhMe/Et2O (1:1, 40 mL) and was washed with 6 M aq. HCl (3 x 10 mL). Each aq. layer was 
sequentially back extracted with PhMe/Et2O (10 mL). The organic back-extract was washed with 
6 M HCl (5 mL). The combined organic phases were filtered through glass wool and were 
concentrated in vacuo (30 
o
C, 6 mmHg). 
1
H NMR showed the residues contained residual 
pyridine salts. The flask was fitted with a magnetic stir bar and was charged with Et2O (75 mL), 
PhMe (10 mL), and 6 M HCl (10 mL). The biphasic mixture was stirred vigourously for 45 min 
and then was poured into a 250-mL separatory funnel. The phases were separated The organic 
phase was filtered through glass wool and was concentrated in vacuo (30 
o
C, 6 mmHg). The 
residue was dissolved in PhMe (50 mL) and was reconcentrated in vacuo (30 
o
C, 6 mmHg). The 
residue was recrystallized from MeCN (ca. 60 mL, boiled down to ca 30 mL) to provide 315.7 
mg (82%) of 24h as fine, white, powdery crystals. 
Data for 67:  
1
H NMR: (500 MHz, CDCl3) 
δ 7.49 (d, J = 1.5 Hz, 2H), 7.39 – 7.22 (m, 16H), 7.22 – 7.10 (m, 10H), 7.07 (d, J = 
7.1 Hz, 4H), 6.99 (t, J = 7.7 Hz, 2H), 6.58 – 6.47 (m, 10H). 
31
P NMR: (125 MHz, CDCl3) 
δ 3.58. 
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X-ray Crystal Structure of 21ha 
 
Figure 17. ORTEP Image of 21ha. 
 
Crystals of 21ha suitable for X-ray crystallography were obtained by dissolution in EtOAc (20 
mg in ca. 0.05 mL), dilution with hexane (ca 0.5 mL) and partial concentration in vacuo  (6 
mmHg, 23 
o
C)  until crystallization initiated. After ca. 2 h at 23 
o
C short needles were obtained 
and harvested directly from the mother liquor. The crystallographic coordinates of 21ha have 
been deposited with the Cambridge Crystallographic Data Centre; deposition no. 831569. These 
data can be obtained free of charge via from the Cambridge Crystallographic Data Centre, 12 
Union Road, Cambridge CB2 1EZ, UK; fax: (+44) 1223-336-033; via 
www.ccdc.cam.ac.uk/conts/retrieving.html or deposit@ccdc.cam.ac.uk). 
 
Identification code  bm53oas 
Empirical formula  C15 H15 Br O 
Formula weight  291.18 
Temperature  193(2) K 
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Wavelength  0.71073 ≈ 
Crystal system  Orthorhombic 
Space group  P 21 21 21  
Unit cell dimensions a = 5.858(3) ≈ a= 90°. 
 b = 14.245(7) ≈ b= 90°. 
 c = 15.198(7) ≈ g = 90°. 
Volume 1268.2(10) ≈3 
Z 4 
Density (calculated) 1.525 Mg/m3 
Absorption coefficient 3.222 mm-1 
F(000) 592 
Crystal size 0.632 x 0.231 x 0.052 mm3 
Theta range for data collection 1.96 to 25.61∞. 
Index ranges -7<=h<=7, -17<=k<=17, -18<=l<=18 
Reflections collected 12266 
Independent reflections 2380 [R(int) = 0.0511] 
Completeness to theta = 25.61∞ 99.7 %  
Absorption correction Integration 
Max. and min. transmission 0.8661 and 0.5922 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2380 / 189 / 218 
Goodness-of-fit on F2 1.013 
Final R indices [I>2sigma(I)] R1 = 0.0319, wR2 = 0.0645 
R indices (all data) R1 = 0.0478, wR2 = 0.0711 
Absolute structure parameter -0.002(13) 
Largest diff. peak and hole 0.284 and -0.274 e.≈-3 
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Table 29. Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (≈2x 
103) for bm53oas.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
______________________________________________________________________________ 
 x y z U(eq) 
______________________________________________________________________________
_ 
Br(1) 8034(2) 8626(1) 6682(1) 56(1) 
O(1) 12349(5) 7191(2) 6715(2) 63(1) 
C(1) 12432(9) 6876(4) 5822(3) 74(1) 
C(2) 10817(10) 6069(4) 5758(4) 74(2) 
C(3) 8938(7) 6342(4) 6389(3) 59(1) 
C(4) 10289(8) 6854(3) 7123(3) 50(1) 
C(5) 8986(7) 7654(3) 7548(2) 44(1) 
Br(1B) 7491(14) 9006(8) 6781(6) 61(2) 
O(1B) 11980(40) 6874(19) 6897(15) 64(3) 
C(1B) 12180(60) 6210(20) 6180(20) 72(3) 
C(2B) 10200(60) 6390(30) 5590(20) 69(3) 
C(3B) 8930(50) 7240(20) 5913(14) 63(3) 
C(4B) 9620(40) 7128(14) 6894(12) 59(2) 
C(5B) 8890(30) 7944(11) 7452(8) 53(4) 
C(6) 10186(5) 8155(2) 8281(2) 40(1) 
C(7) 9215(6) 8155(2) 9097(2) 41(1) 
C(8) 10278(5) 8596(2) 9816(2) 39(1) 
C(9) 9259(6) 8634(3) 10657(2) 46(1) 
C(10) 10303(7) 9098(3) 11331(3) 55(1) 
C(11) 12388(7) 9547(2) 11201(2) 52(1) 
C(12) 13419(6) 9527(2) 10405(2) 47(1) 
C(13) 12429(5) 9049(2) 9685(2) 39(1) 
C(14) 13412(6) 9013(2) 8845(2) 43(1) 
C(15) 12357(5) 8587(2) 8156(2) 42(1) 
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Table 30.   Bond lengths [≈] and angles [∞] for  bm53oas. 
_____________________________________________________  
Br(1)-C(5)  1.991(4) 
O(1)-C(1)  1.431(5) 
O(1)-C(4)  1.439(5) 
C(1)-C(2)  1.491(7) 
C(1)-H(1A)  0.9900 
C(1)-H(1B)  0.9900 
C(2)-C(3)  1.510(7) 
C(2)-H(2A)  0.9900 
C(2)-H(2B)  0.9900 
C(3)-C(4)  1.550(5) 
C(3)-H(3A)  0.9900 
C(3)-H(3B)  0.9900 
C(4)-C(5)  1.516(6) 
C(4)-H(4)  1.0000 
C(5)-C(6)  1.499(5) 
C(5)-H(5)  1.0000 
Br(1B)-C(5B)  1.999(10) 
O(1B)-C(4B)  1.429(11) 
O(1B)-C(1B)  1.440(11) 
C(1B)-C(2B)  1.493(12) 
C(1B)-H(1C)  0.9900 
C(1B)-H(1D)  0.9900 
C(2B)-C(3B)  1.505(12) 
C(2B)-H(2C)  0.9900 
C(2B)-H(2D)  0.9900 
C(3B)-C(4B)  1.553(11) 
C(3B)-H(3C)  0.9900 
C(3B)-H(3D)  0.9900 
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Table 30 cont. 
C(4B)-C(5B)  1.503(10) 
C(4B)-H(4B)  1.0000 
C(5B)-C(6)  1.503(9) 
C(5B)-H(5B)  1.0000 
C(6)-C(7)  1.364(4) 
C(6)-C(15)  1.425(4) 
C(7)-C(8)  1.407(4) 
C(7)-H(7)  0.9500 
C(8)-C(9)  1.411(5) 
C(8)-C(13)  1.429(4) 
C(9)-C(10)  1.364(5) 
C(9)-H(9)  0.9500 
C(10)-C(11)  1.393(5) 
C(10)-H(10)  0.9500 
C(11)-C(12)  1.353(5) 
C(11)-H(11)  0.9500 
C(12)-C(13)  1.413(4) 
C(12)-H(12)  0.9500 
C(13)-C(14)  1.402(4) 
C(14)-C(15)  1.358(4) 
C(14)-H(14)  0.9500 
C(15)-H(15)  0.9500 
 
C(1)-O(1)-C(4) 109.4(3) 
O(1)-C(1)-C(2) 106.3(4) 
O(1)-C(1)-H(1A) 110.5 
C(2)-C(1)-H(1A) 110.5 
O(1)-C(1)-H(1B) 110.5 
C(2)-C(1)-H(1B) 110.5 
H(1A)-C(1)-H(1B) 108.7 
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Table 30 cont. 
C(1)-C(2)-C(3) 102.9(4) 
C(1)-C(2)-H(2A) 111.2 
C(3)-C(2)-H(2A) 111.2 
C(1)-C(2)-H(2B) 111.2 
C(3)-C(2)-H(2B) 111.2 
H(2A)-C(2)-H(2B) 109.1 
C(2)-C(3)-C(4) 101.9(4) 
C(2)-C(3)-H(3A) 111.4 
C(4)-C(3)-H(3A) 111.4 
C(2)-C(3)-H(3B) 111.4 
C(4)-C(3)-H(3B) 111.4 
H(3A)-C(3)-H(3B) 109.3 
O(1)-C(4)-C(5) 110.8(3) 
O(1)-C(4)-C(3) 106.0(3) 
C(5)-C(4)-C(3) 113.8(4) 
O(1)-C(4)-H(4) 108.7 
C(5)-C(4)-H(4) 108.7 
C(3)-C(4)-H(4) 108.7 
C(6)-C(5)-C(4) 116.1(3) 
C(6)-C(5)-Br(1) 106.9(2) 
C(4)-C(5)-Br(1) 112.5(3) 
C(6)-C(5)-H(5) 107.0 
C(4)-C(5)-H(5) 107.0 
Br(1)-C(5)-H(5) 107.0 
C(4B)-O(1B)-C(1B) 104.0(15) 
O(1B)-C(1B)-C(2B) 106.2(14) 
O(1B)-C(1B)-H(1C) 110.5 
C(2B)-C(1B)-H(1C) 110.5 
O(1B)-C(1B)-H(1D) 110.5 
C(2B)-C(1B)-H(1D) 110.5 
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Table 30 cont. 
H(1C)-C(1B)-H(1D) 108.7 
C(1B)-C(2B)-C(3B) 109.0(14) 
C(1B)-C(2B)-H(2C) 109.9 
C(3B)-C(2B)-H(2C) 109.9 
C(1B)-C(2B)-H(2D) 109.9 
C(3B)-C(2B)-H(2D) 109.9 
H(2C)-C(2B)-H(2D) 108.3 
C(2B)-C(3B)-C(4B) 95.6(16) 
C(2B)-C(3B)-H(3C) 112.6 
C(4B)-C(3B)-H(3C) 112.6 
C(2B)-C(3B)-H(3D) 112.6 
C(4B)-C(3B)-H(3D) 112.6 
H(3C)-C(3B)-H(3D) 110.1 
O(1B)-C(4B)-C(5B) 118.1(13) 
O(1B)-C(4B)-C(3B) 106.4(13) 
C(5B)-C(4B)-C(3B) 112.7(16) 
O(1B)-C(4B)-H(4B) 106.3 
C(5B)-C(4B)-H(4B) 106.3 
C(3B)-C(4B)-H(4B) 106.3 
C(6)-C(5B)-C(4B) 118.9(10) 
C(6)-C(5B)-Br(1B) 118.9(8) 
C(4B)-C(5B)-Br(1B) 114.5(10) 
C(6)-C(5B)-H(5B) 99.3 
C(4B)-C(5B)-H(5B) 99.3 
Br(1B)-C(5B)-H(5B) 99.3 
C(7)-C(6)-C(15) 119.6(3) 
C(7)-C(6)-C(5) 118.7(3) 
C(15)-C(6)-C(5) 121.7(3) 
C(7)-C(6)-C(5B) 123.4(9) 
C(15)-C(6)-C(5B) 115.3(9) 
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Table 30 cont. 
C(5)-C(6)-C(5B) 17.0(6) 
C(6)-C(7)-C(8) 121.4(3) 
C(6)-C(7)-H(7) 119.3 
C(8)-C(7)-H(7) 119.3 
C(7)-C(8)-C(9) 122.2(3) 
C(7)-C(8)-C(13) 118.9(3) 
C(9)-C(8)-C(13) 118.8(3) 
C(10)-C(9)-C(8) 120.6(3) 
C(10)-C(9)-H(9) 119.7 
C(8)-C(9)-H(9) 119.7 
C(9)-C(10)-C(11) 120.6(4) 
C(9)-C(10)-H(10) 119.7 
C(11)-C(10)-H(10) 119.7 
C(12)-C(11)-C(10) 120.6(3) 
C(12)-C(11)-H(11) 119.7 
C(10)-C(11)-H(11) 119.7 
C(11)-C(12)-C(13) 121.3(3) 
C(11)-C(12)-H(12) 119.4 
C(13)-C(12)-H(12) 119.4 
C(14)-C(13)-C(12) 123.6(3) 
C(14)-C(13)-C(8) 118.2(3) 
C(12)-C(13)-C(8) 118.1(3) 
C(15)-C(14)-C(13) 122.1(3) 
C(15)-C(14)-H(14) 119.0 
C(13)-C(14)-H(14) 119.0 
C(14)-C(15)-C(6) 119.8(3) 
C(14)-C(15)-H(15) 120.1 
C(6)-C(15)-H(15) 120.1 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
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Table 31.   Anisotropic displacement parameters  (≈2x 103) for bm53oas.  The anisotropic 
displacement factor exponent takes the form:  -2p2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
Br(1) 52(1)  60(1) 57(1)  18(1) -12(1)  -4(1) 
O(1) 47(2)  81(2) 59(2)  -16(2) 10(2)  -18(1) 
C(1) 63(3)  96(3) 63(3)  -23(2) 14(2)  -15(2) 
C(2) 68(3)  85(4) 70(3)  -29(3) 3(3)  -7(3) 
C(3) 54(2)  63(3) 61(2)  -19(2) 1(2)  -13(2) 
C(4) 44(3)  56(2) 50(2)  -1(2) -4(2)  -10(2) 
C(5) 41(2)  43(2) 46(2)  8(2) 2(2)  -4(2) 
Br(1B) 50(3)  69(5) 63(3)  27(3) 10(2)  -4(3) 
O(1B) 52(5)  80(5) 60(5)  -14(5) 2(5)  -12(5) 
C(1B) 62(5)  86(5) 67(5)  -20(5) 4(5)  -11(5) 
C(2B) 63(5)  81(5) 63(5)  -21(5) 3(5)  -11(5) 
C(3B) 57(6)  74(6) 58(6)  -17(6) -2(6)  -7(6) 
C(4B) 51(4)  68(4) 57(4)  -11(4) 0(4)  -7(4) 
C(5B) 47(7)  58(7) 55(7)  -4(7) -3(7)  3(7) 
C(6) 35(2)  32(2) 54(2)  0(2) -3(2)  1(1) 
C(7) 30(2)  38(2) 55(2)  3(2) 1(2)  -1(2) 
C(8) 35(2)  30(2) 51(2)  4(2) -2(1)  9(2) 
C(9) 37(2)  43(2) 58(2)  7(2) 4(2)  3(2) 
C(10) 56(2)  58(2) 51(2)  -1(2) 1(2)  6(2) 
C(11) 50(3)  50(2) 55(2)  -7(2) -12(2)  3(2) 
C(12) 42(2)  37(2) 62(2)  0(2) -6(2)  -1(2) 
C(13) 32(2)  33(2) 53(2)  3(1) -4(2)  2(1) 
C(14) 34(2)  38(2) 59(2)  5(2) 0(2)  -2(2) 
C(15) 39(2)  40(2) 48(2)  0(2) 3(1)  -3(2) 
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______________________________________________________________________________  
 
Table 32.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (≈2x 10 3) 
for bm53oas. 
______________________________________________________________________________  
 x  y  z  U(eq) 
______________________________________________________________________________ 
H(1A) 13998 6675 5666 89 
H(1B) 11964 7386 5417 89 
H(2A) 11558 5476 5941 89 
H(2B) 10224 5998 5152 89 
H(3A) 8135 5783 6621 71 
H(3B) 7816 6766 6106 71 
H(4) 10705 6388 7588 60 
H(5) 7558 7380 7801 52 
H(1C) 12143 5561 6411 86 
H(1D) 13639 6307 5865 86 
H(2C) 9171 5839 5591 83 
H(2D) 10743 6496 4983 83 
H(3C) 7262 7193 5822 76 
H(3D) 9513 7833 5652 76 
H(4B) 8770 6569 7118 71 
H(5B) 7472 7670 7716 64 
H(7) 7789 7850 9181 49 
H(9) 7834 8333 10754 55 
H(10) 9601 9114 11895 66 
H(11) 13092 9870 11675 62 
H(12) 14836 9841 10328 56 
H(14) 14861 9297 8753 52 
H(15) 13064 8576 7594 51 
______________________________________________________________________________  
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C.6. Addition of Silyl Ketene Imines To Carbonyl Electrophiles 
C.6.1. Preparation of Silyl Ketene Imines 
General Procedure 18. Preparation of Silyl Ketene Imines. Preparation of 1-(1,1-
Dimethylethyl)-N-[2-(4-methoxyphenyl)-1-propenylidene]-1,1-dimethylsilanmine (46c) 
 
 n-Butyllithium (2.6 M in hexanes, 1.9 mL, 1.0 equiv) was added via syringe to a flame-
dried, 50-mL, Schlenk flask containing a –78 °C (dry ice/acetone bath, internal temp) solution of 
i-Pr2NH (0.70 mL, 5.0 mmol, 1.0 equiv) in 6 mL of THF. The reaction mixture was stirred for 10 
min at –78 °C and then a solution of  2-(4-methoxyphenyl)propanenitrile (0.801 g, 5.0 mmol) in 
2 mL of THF was added to the reaction via cannula. The resulting yellow solution was stirred for 
10 min at –78 °C and then a solution of TBSCl (0.904 g, 6.0 mmol, 1.2 equiv) in THF (4.0 mL) 
was added via cannula. The solution was allowed to warm to room temperature and the solvent 
was removed under high vacuum (0.2 mm Hg). The residue was taken up in 25 mL of anhydrous 
pentane then filtered via cannula into a flame dried, 100-mL, round bottomed flask.  Removal of 
the solvent under vacuum (0.2 mmHg) afforded 1.29g (94%) of 46c as a yellow oil. 
Data for 46c: 
1 
H NMR: (500 MHz, C6D6) 
δ 7.11-7.07 (m, 2 H, HC(4)), 6.9-6.87 (m, 2 H, HC(5)), 3.00 (3 H, H3C(7)), 1.90 (s, 
3 H, H3C(8)), 0.91 (s, 9 H, H3C(10)), 0.11 (s, 6 H, H3C(9) and H3C(9’)). 
13
C NMR: (125 MHz, C6D6)  
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δ 189.7 (C(1)), 156.3 (C(6)), 130.8 (C(3)), 124.0 (C(4)), 114.8 (C(5)), 54.8 (C(2)), 
47.6 (C(7)), 25.5 (C(10)) , 17.7 (C(11)), 12.0 (C(8)), -4.8 (C(9, 9’)). 
IR: (neat)  
2953 (s), 2930 (s), 2897 (s), 2857 (s), 2034 (s), 1680 (w), 1609 (w), 1574 (w), 1509 
(s), 1471 (m), 1374 (m), 1284 (m), 1251 (m), 1179 (m), 1112 (w), 1064 (w), 1037 
(s), 962 (m), 840 (s), 810 (s), 823 (s), 785 (s), 709 (s), 678 (w), 633 (w). 
MS: (EI, 70 eV) 
73 (77), 135 (20), 161 (18), 207 (16), 275 (100). 
HRMS Calcd for C16H25NOSi: 275.1705, found: 275.1705 
 
Preparation of 1-(1,1-Dimethylethyl)-N-[2-(2-methylphenyl)-1-propenylidene]-1,1- 
dimethylsilanmine (3d) 
  
 Following General Procedure 18, i-Pr2NH (0.39 mL, 2.8 mmol, 1.0 equiv), THF (3 mL), 
2.41 M n-BuLi in hexanes (1.15 mL, 1 equiv), 2-(2-methylphenyl)propanenitrile (0.406 g, 2.79 
mmol) in 1 mL of THF, and a solution of TBSCl (0.904 g, 1.2 equiv, 6.0 mmol) in 1 mL of THF 
were combined to afford 646 mg (89%) of 3d as a yellow liquid.  
Data for 3d: 
1
H NMR: (500 MHz, C6D6) 
δ  7.29-7.24 (m, 1 H, HC(4,5,6)), 7.19-7.16 (m, 2 H, HC(4,5,6)), 7.10-7.06 (m, 1 H 
HC(7)), 2.52 (s, 3 H, H3C(9)), 2.08 (s, 3 H, H3C(10)), 0.95 (s, 9 H, H3C(13)), 0.13 
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(s, 6 H, H3C(11) and H3C(11’)). 
13
C NMR: (125 MHz, C6D6)  
δ 185.2 (C(1)), 137.0 (C(8)), 134.1 (C(3)), 130.9 (C(4,5,6,7)), 126.6 (C(4,5,6,7)), 
124.8 (C(4,5,6,7)), 124.0 (HC(4,5,6,7), 45.9 (C(2)), 25.5 (H3C(13), 22.2 (C(9)). 
17.7 (C(12)) , 15.4 (C(10)), -5.2 (C(11, 11’)). 
MS: (EI, 70 eV) 
73 (100), 119 (30), 145 (16), 202 (37), 259 (85). 
HRMS Calcd for C16H25NSi: 259.1756, found: 259.1758 
 
Preparation of N-[2-(2-methylphenyl)-1-propenylidene]-1,1,1-tris(1-methylethyl)silanmine 
(3d)  
 
Following General Procedure 18, i-Pr2NH (1.73 mL, 12.34 mmol 1.0 equiv), THF (13.5 
mL), n-butyllithium (2.4 M in hexanes, 5.14 mL, 1.0 equiv), triisopropylchlorosilane (3.17 mL, 
14.80 mmol, 1.2 equiv) and 2-phenylpropanenitrile (1.64 mL, 12.34 mmol, 1.0 equiv) were 
combined to afford a yellow liquid, which was purified by bulb-to-bulb distillation (165-170°C, 
150 mtorr) to provide 3.20 g (90%) of 54a as a bright yellow oil. 
Data for 54a:  
1
H NMR: (500 MHz, C6D6) 
 δ 7.31 – 7.24 (m, 2H, HC(5)), 7.23 – 7.18 (m, 2H, HC(4)), 6.97 – 6.90 (m,1H, 
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HC(6)), 1.91 (s, 3H, H3C(7)), 1.05 – 0.99 (m, 24H, HC(8), H3C(9). 
 
Preparation of 1-(1,1-Dimethylethyl)-N-[2-phenyl-1-propenylidene]-1,1-dimethylsilanmine 
(54b) [MTB-IV-08] 
 
Following General Procedure 18, i-Pr2NH (1.73 mL, 12.34 mmol 1.0 equiv), THF (14 
mL), n-butyllithium (2.4 M in hexanes, 5.14 mL, 1.0 equiv), TBDPSCl (3.2 mL, 12.34 mmol, 
1.0 equiv) and 2-phenylpropanenitrile (1.64 mL, 12.34 mmol, 1.0 equiv) were combined to 
afford a 4.69 g of a yellow solid, which was recrystallized from hot hexane (3 mL) under Ar to 
provide 4.16 g (91%) of 54b as yellow plates. 
Data for 67:  
1
H NMR: (500 MHz, CDCl3) 
δ 7.88 – 7.77 (m, 4H), 7.21 (d, J = 4.1 Hz, 4H), 7.19 – 7.11 (m, 7H), 6.93 (hept, J = 
3.9 Hz, 1H, HC(6)), 1.91 (s, 3H, H3C(7)), 1.16 (s, 9H, H3C(13)). 
13
C NMR: (125 MHz, CDCl3) 
δ 188.7 (C(1)), 138.7, 135.6, 132.5, 130.5, 129.0, 123.4, 122.8, 48.2 (C(2)), 26.7 
(C(13)), 19.5 (C(12)), 11.7 (C(7)). 
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C.6.2. Addition of Silyl Ketene Imines to Aromatic Aldehydes. 
General Procedure 19. Addition of Silyl Ketene Imines to Aromatic Aldehydes. 
Preparation of (2R,3S)-3-hydroxy-2-methyl-2-phenyl-3-(4-trifluoromethylphenyl)propane-
nitrile. (47ba) (Table 18, entry 1) 
 
To a flame-dried, 10-mL, Schlenk flask equipped with a magnetic stir bar, a 
thermocouple, a gas inlet tube and a septum were added (R,R)-1 (42 mg, 0.05 mmol, 0.05 equiv), 
4-(trifluoromethyl)benzaldehyde (174 mg, 1.0 mmol) and CH2Cl2 (4.0 mL, 0.25 M in aldehyde).  
The solution was cooled to –78 °C (internal temp) in a dry ice-acetone bath and 126 L of SiCl4 
(1.1 mmol, 1.1 equiv) was added to the reaction mixture with stirring. The resulting bright-
yellow solution was allowed to stir for 5 min at –78 °C and then 0.86 mL of a 1.4 M solution of 
silyl ketene imine 3a in CH2Cl2 (1.2 mmol, 1.2 equiv) was added dropwise via syringe over 5 
min.  The resulting reaction mixture was allowed to stir at –78 °C for 2 h and was then quenched 
by pouring the cold solution into a 125 mL Erlenmeyer flask containing a rapidly stirring 
solution of sat. aq. KF (20 mL) and sat. aq. NaHCO3 (20 mL) solutions.  The biphasic mixture 
was vigorously stirred for 3 h at ambient temperature and then was filtered through a pad of 
Celite (ca. 7 g) using a 60 mL, coarse glass frit, Büchner funnel. The filtrate was transferred to a 
125-mL separatory funnel and the organic layer was isolated.  The aqueous layer was extracted 
with CH2Cl2 (3 x 25 mL) and then the organic layers were combined and dried over MgSO4 (ca. 
3 g). The solution was filtered and concentrated in vacuo (23 C, 14 mmHg) and resultant 
residue was purified by column chromatography (silica gel (30 g), 3 cm diam, hexanes/EtOAc, 
320 
 
4/1) to afford 292 mg of a white solid, which was recrystallized from hot PhMe (ca. 0.1 mL) and 
hexanes (ca. 0.5 mL) to yield 269 mg (88%) of 47ba as white needles. 
Data for 47ca:  
mp: 125-126°C 
1
H NMR: (500 MHz, CDCl3) 
δ 7.60-7.56 (m, 2 H, HC(6)), 7.47-7.37 (m, 7 H, HC(5,10,11,12)), 4.95 (s, 1 H, 
HC(3)), 1.62 (s, 3 H, H3C(13)). 
13
C NMR: (125 MHz, CDCl3)  
δ 141.6 (C(4,9)), 136.7 (C(4,9)), 130.8 (q, J = 32.2, C(7)),  128.9 (C(11)), 128.6 
(C(12)), 128.0 (C(5)), 126.7 (C(10)), 124.9 (q, J = 3.7, C(6)), 122.8 (q, J = 272.1, 
C(8)), 121.5 (C(1)), 79.0 (C(3)), 49.3 (C(2)), 22.0 (C(13)). 
IR: (KBr pellet) 
3434 (m), 3073 (w), 3030 (w), 2999 (w), 2909 (w), 2247 (w), 1623 (w), 1601 (w), 
1448 (w), 1420 (w), 1332 (m), 1163 (m), 1130 (m), 1111 (m), 1072 (m), 1050 (m), 
1019 (m), 842 (m), 763 (w), 743 (w), 711 (m), 695 (m), 636 (w). 
MS: (ESI) 
132 (66), 156 (14), 279 (18), 186 (90), 288 (22), 323 (16), 328 (M+Na, 100), 411 
(14), 419 (10).  
HRMS Calcd for C17H14F3NONa: 328.0925, found: 328.0933 
Opt. Rot.: []D
24
 12.9 (c = 0.51, CHCl3) 
TLC: Rf 0.25 (hexanes/EtOAc, 4/1) [UV (254 nm)] 
SFC: (2R,3S)-47ba, tR 7.67 min, (99.1%); (R,R)/(S,S)-47ba, tR 8.13 min, (0.22%), 
(2S,3R)-2a tR 9.26 min (0.68%) (Chiralpak AD, 125 bar, 40°C, 4% MeOH in CO2 
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2.5 mL/min) 
Analysis: C17H14F3NO (305.29) 
Calcd: C, 66.88; H, 4.62; N, 4.59% 
Found: C, 66.82; H, 4.57; N, 4.67% 
 
Preparation of (2R,3S)-3-Hydroxy-3-(4-methoxyphenyl)-2-methyl-2-phenylpropanenitrile 
(47ca) (Table 18, entry 2) 
 
Following General Procedure 19, 136.2 mg of 4-methoxybenzaldehyde (1.0 mmol, 1.0 equiv) 
was combined with 42 mg of (R,R)-34 (0.05 mmol, 0.05 equiv), 126 L of SiCl4 (1.1 mmol, 1.1 
equiv), and 0.86 mL of a 1.4 M solution of silyl ketene imine 46a (1.2 mmol, 1.2 equiv) to yield 
after column chromatography (SiO2 (27 g) 3 cm diam. EtOAc/hexanes 1/4 ) 227 mg (85%)  of 
47ca as a white solid, which was crystallized from boiling Et2O (2 mL) and hexanes (4 mL) to 
yield 210 mg (78%) of 47ca as white needles. 
Data for 47ca: 
mp: 117-120°C 
1 
H NMR: (500 MHz, CDCl3) 
δ 7.49-7.45 (m, 2 H, HC(10)), 7.43-7.34 (m, 3 H, HC(11,12)), 7.24-7.20 (m, 2 H, 
HC(5)), 6.87-6.83 (m, 2 H, 2 H, HC(6)), 4.81 (s, 1 H, HC(3)), 3.81 (s, 3 H, 
H3C(8)), 2.38 (br s, 1 H, OH), 1.58 (s, 3 H, H3C(13)). 
13
C NMR: (125 MHz, CDCl3)  
δ 159.8 (C(7)), 137.6 (C(9)), 129.9 (C(4)), 128.7 (C(5,11)), 128.7 (C(5,11)), 128.2 
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(C(12)),  126.7 (C(10)), 121.9 (C(1)), 113.4 (C(6)), 79.4 (C(3)),  55.2 (C(8)), 49.5 
(C(2)), 22.6 (C(13)). 
IR: (KBr pellet) 
3468 (s), 3060 (s), 3033 (s), 3011 (m), 3001 (m), 2973 (m), 2940 (m), 2246 (m), 
1611 (s),  1598 (m), 1513 (s), 1459 (s), 1446 (s), 1286 (s), 1244 (s), 1176 (s), 1072 
(s), 1040 (s), 1020 (s), 898 (m), 832 (s), 758 (s), 747 (s), 693 (s), 658 (m). 
MS: (ESI) 
250 (100), 251 (17), 285 (29), 290 (38). 
HRMS Calcd for C17H17NO2Na: 290.1157, found: 290.1149 
Opt. Rot.: []D
24
 36.3 (c = 0.49, CHCl3) 
TLC: Rf 0.15 (hexanes/EtOAc, 4/1)[UV (254 nm)] 
SFC: (2R,3S)-47ca tR 19.9 min (93.2%), (R,R)/(S,S)- 47ca tR 14.0 min (2.1%), (2S,3R)- 
47ca tR 15.2 min (3.2%), (R,R)/(S,S)-47ca tR 16.3min (1.4%) (Chiralcel OD, 150 
bar, 40 °C,  6% MeOH in CO2, 2.2 mL/min) 
Analysis: C17H17NO2 (267.32) 
Calcd: C, 76.38; H, 6.41;     N, 5.24% 
Found: C, 76.66; H, 6.39;     N, 5.29% 
 
Preparation of (2R,3S)-3-Hydroxy-2-methyl-3-(4-methoxycarbonylphenyl)-2-phenyl-
propanenitrile (47da) (Table 18, entry 3) 
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Following General Procedure 19, 164 mg of methyl 4-formylbenzoate (1.0 mmol, 1.0 equiv) was 
combined with 42 mg of (R,R)-34 (0.05 mmol, 0.05 equiv), 126 L of SiCl4 (1.1 mmol, 1.1 
equiv), and 0.86 mL of a 1.4 M solution of silyl ketene imine 46a (1.2 mmol, 1.2 equiv, 1.4 M in 
CH2Cl2) to yield after column chromatography (SiO2 (30 g) 3 cm diam. EtOAc/hexanes 1/4) 289 
mg (97%)  of 47da as a white solid, which was crystallized from hot EtOAc (0.5 mL) and 
hexanes (0.5 mL) to yield 277 mg (93%) of 47da as white plates. 
Data for 47da: 
mp: 112-114ºC 
1 H
 NMR: (500 MHz,CDCl3) 
δ 7.92 (d, J = 8.4, 2 H, HC(6)),  7.44 - 7.33 (m, 5 H, HC(11,12,13)), 7.28 (d, J = 8.3, 
2 H, HC(5)), 4.94 (s, 1 H, HC(3)), 3.88 (s, 3 H, H3C(9)), 2.77 (br s, 1 H, OH), 1.60 
(s, 3 H, H3C(14)). 
13
C NMR: (125 MHz,CDCl3) 
δ 166.8 (C(8)), 142.7 (C(4,10)), 136.8 (C(4,10)), 130.2 (C(7)), 129.1 (C(6)), 128.8 
(C(12)), 128.5 (C(13)), 127.6 (C(5)), 126.75 (C(11)), 121.7 (C(1)), 79.1 (C(3)), 52.2 
(C(9)), 49.2 (C(2)), 21.9 (C(14)). 
IR: (KBr pellet) 
3493 (m), 3419 (s), 3063 (m), 3036 (m), 3003 (m), 2951 (m), 2884 (m), 1718 (s), 
1698 (s), 1612 (m), 1493 (m), 1446 (s), 1436 (s), 1418 (s), 1381 (m), 1281 (s), 1189 
(m), 1115 (s), 1019 (s), 959 (m), 889 (m), 853 (m), 783 (m), 728 (s), 697 (s), 640 
(m). 
MS: (ESI) 
296 (M+H,87), 264 (9), 165(21), 133 (9), 132 (100). 
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HRMS Calcd for C18H18NO3: 296.1287, found: 296.1299 
Opt. Rot.: []D
24
 5.5 (c = 0.52, CHCl3) 
TLC: Rf 0.11 (hexanes/EtOAc, 4/1) [UV (254 nm)] 
SFC: (2S,3R)-47da, tR 5.20 min, (1.4%); (R,R)/(S,S)-47da, tR 5.80 min (0.8%); (2R,3S)-
47da, tR 7.60 min (97.8%)  (Chiralpak OB, 120 bar, 40°C, 10% MeOH in CO2, 2 
mL/min) 
Analysis: C18H17NO3 (295.33) 
Calcd: C, 73.19; H, 5.80; N, 4.74% 
Found: C, 73.25; H, 5.84; N, 4.90% 
 
Preparation of (2R,3S)-3-Hydroxy-2-methyl-3-(methylphenyl)-2-phenylpropanenitrile 
(47ea) (Table 18, entry 4) 
 
Following General Procedure 19, 120.6 mg of 2-tolualdehyde (1.0 mmol, 1.0 equiv) was 
combined with 42 mg of (R,R)-1 (0.05 mmol, 0.05 equiv), 126 L of SiCl4 (1.1 mmol, 1.1 equiv) 
and 0.86 mL of a 1.4 M solution of silyl ketene imine 46a (1.2 mmol, 1.2 equiv, 1.4 M in 
CH2Cl2) to yield after column chromatography (SiO2 (30 g) 3 cm diam. hexanes/EtOAc 4/1 ) 237 
mg (94%) of 47ea as a white solid, which was crystallized from hot EtOAc (1 mL) and hexanes 
(1 mL) to afford 213 mg (84%) of 47ea as white plates. 
Data for 47ea: 
mp: 154-155°C 
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1 
H NMR: (500 MHz, CDCl3) 
δ 7.65 (dd, J = 7.5,1.9, 1 H, HC(8)), 7.47-7.43 (m, 2 H, HC(13)),  7.41-7.34  (m,  3 
H, HC(12, 9)), 7.29-7.22 (m, 2 H, HC(14, 8)), 7.12-7.09 (m, 1 H, HC(7)),  5.22 (s, 1 
H, HC(3)), 2.35 (br. s, 1 H, OH), 2.09 (s, 3 H, H3C(10)), 1.65 (s, 3 H, H3C(15)). 
13
C NMR: (125 MHz, CDCl3)  
δ 137.6 (C(4,11,9)), 136.3 (C(4,11,9)), 136.1 (C(4,11,9)),  130.3 (C(7)), 128.8 
(C(12)), 128.5 (C(8)),  128.3 (C(9)), 127.1 (C(8)), 126.8 (C(13)), 126.2 (C(14)), 
122.1 (C(1)), 74.3 (C(3)), 45.0 (C(15)), 19.54 (C(10)). 
IR: (KBr pellet) 
3416 (s), 3061 (m), 3018 (m), 2996 (m), 2939 (m), 2245 (s), 1977 (w), 1956 (w), 
1921 (w), 1895 (w), 1876 (w), 1840 (w), 1809 (w), 1600 (m), 1499 (s), 1464 (s), 
1447 (s), 1387 (s), 1043 (s), 1027 (s), 782 (s), 735 (s), 710 (s), 695 (s), 615 (m). 
MS: (ESI) 
132 (16), 207 (13), 234 (48), 274 (48), 275 (M
+
Na, 16), 365 (78), 366 (18), 397 
(13), 444 (31), 444 (22). 
HRMS Calcd for C17H17NONa: 274.1218, found: 274.1208 
Opt. Rot.: []D
24 
44.6 (c = 0.49, CHCl3) 
TLC: Rf 0.25 (hexanes/EtOAc, 4/1)[UV (254 nm)] 
HPLC: (2R,3S)-47ea tR 32.1 min,  (98.4%), (R,R)/(S,S)-47ea tR 28.7 min (0.7%), (2S,3R)-
47ea tR 38.5 (0.8%) (Chiralpak AD-RH, gradient from 30% MeCN in H2O (0.5% 
AcOH) to 50% MeCN over 30 min, 0.5 mL/min) 
Analysis: C17H17NO (251.32) 
Calcd: C, 81.24; H, 6.82; N, 5.57% 
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Found: C, 80.94; H, 6.83; N, 5.81% 
 
Preparation of (2R,3S)-3-Hydroxy-2-methyl-3-(1-naphthyl)-2-phenylpropanenitrile (47fa) 
(Table 18, entry 5) 
 
Following General Procedure 19, 156 mg of 1-naphthaldehyde (1.0 mmol, 1.0 equiv) was 
combined with 42 mg of (R,R)-34 (0.05 mmol, 0.05 equiv), 126 L of SiCl4 (1.1 mmol, 1.1 
equiv) and 0.86 mL of a 1.4 M solution of silyl ketene imine 46a (1.2 mmol, 1.2 equiv, 1.4 M in 
CH2Cl2) to yield after column chromatography (SiO2 (25 g) 3 cm diam. hexanes/EtOAc 4/1 ) 270 
mg (94%)  of 47fa as a yellow foam, which was recrystallized twice from hot toluene (0.2 mL) to 
yield 218 mg (76%) of 47fa as white plates. 
Data for 47fa: 
mp: 87-89°C 
1
H NMR: (500 MHz, CDCl3) 
δ 8.04-8.00 (m, 1 H, HC(17)), 7.95-7.91 (m, 1 H, HC(11)), 7.90-7.87 (m, 2 H, 
HC(6,9)), 7.63-7.57 (m, 3 H, HC(16,7,8)), 7.50-7.45 (m, 2 H, HC(12,13)), 7.45-
7.40 (m, 2H, HC(15)), 7.40-7.35 (m, 1H, HC(7,8)),  5.86 (s, 1H, HC(3)), 2.31 (br. s, 
1H, OH), 1.55 (s, 3H, H3C(18)). 
13
C NMR: (125 MHz, CDCl3)  
δ 138.2 (C(14)), 134.2 (C(5,10,4)), 133.3 (C(5,10,4)), 131.4 (C(5,10,4)), 129.3 
(C(6,9)), 129.0 (C(Aryl)), 128.9 (C(15)), 128.4 (C(7,8)), 126.6 (C(16)), 126.2 
(C(12,13)), 125.6 (C(17)), 125.4 (C((Aryl))), 125.4 (C((Aryl))), 122.4 (C((Aryl))),  
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121.4 (C(1)), 73.4 (C(3)), 50.9 (C(2)), 23.1 (C(18)). 
IR: (KBr pellet) 
3445 (m), 3059 (w), 3002 (w), 2984 (w), 2939 (w), 2917 (w), 2249 (w), 1596 (w), 
1512 (2), 1495 (w), 1454 (w), 1444 (w), 1390 (w), 1376 (w), 1345 (w), 1305 (w), 
1257 (w), 1213 (w), 1166 (w), 1073 (w), 1050 (m), 1025 (m), 802 (m), 783 (s), 698 
(m). 
MS: (ESI) 
243 (35), 270 (100), 271 (40), 305 (39), 310 (M
+
+Na,33). 
HRMS Calcd for C20H17NONa: 310.1208, found: 310.1206 
Opt. Rot.: []D
24
 15.2  (c = 0.51, CHCl3) 
TLC: Rf 0.26 (hexanes/EtOAc, 4/1) [UV (254 nm)] 
SFC: (2R,3S)-47fa, tR 11.3 min, (98.3%), (R,R)/(S,S)-47fa tR 13.3 min (0.4%), (2S,3R)-
47fa tR 16.8 min (1.2%) (Chiralpak AS, 125 bar, 40°C, 8% MeOH in CO2 3.0 
mL/min) 
Analysis: C20H17NO (287.35) 
Calcd: C, 83.59; H, 5.96; N, 4.87% 
Found: C, 83.31; H, 5.88; N, 4.93% 
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Preparation of (2R,3R)-3-(2-Furyl)-3-hydroxy-2-methyl-2-phenylpropanenitrile (47ga) 
(Table 18, entry 6) 
 
Following General Procedure 19, 96.0 mg of 2-furaldehyde (1.0 mmol, 1.0 equiv) was 
combined with 42 mg of (R,R)-34 (0.05 mmol, 0.05 equiv), 126 L of SiCl4 (1.1 mmol, 1.1 
equiv) and 0.86 mL of a 1.4 M solution of silyl ketene imine 46a (1.2 mmol, 1.2 equiv, 1.4 M in 
CH2Cl2) to yield after column chromatography (SiO2 (29 g) 3 cm diam hexanes/EtOAc 4/1 ) 219 
mg (96%) of 47ga as a white solid, which was sublimed under high vacuum (75°C) to yield 209 
mg (92%) of 47ga as white needles. 
Data for  47ga: 
mp: 79-81°C 
1 
H NMR: (500 MHz, CDCl3) 
δ 7.47-7.44 (m, 2 H, HC(9)), 7.41-7.32 (m, 2 H, HC(7,10,11)), 6.41 (d, J = 3.4, 1 
H, HC(5)), 6.37 (dd, J = 1.8, 3.3, HC(6)), 4.89 (s, 1 H, HC(3)), 2.74 (br s, 1 H, 
OH), 1.64 (s, 3H, H3C(12)).  
13
C NMR: (125 MHz, CDCl3)  
δ 151.5 (C(4)), 142.3 (C(7)), 137.2 (C(8)), 128.7 (C(10)), 128.3 (C(11)), 126.3 
(C(9)), 121.5 (C(1)), 110.5 (C(6)), 108.7 (C(5)), 73.8 (C(3)), 48.9 (C(2)), 22.2 
(C(12)).  
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IR: (KBr pellet) 
3400 (s), 3147 (w), 3123 (w), 3058 (w), 3026 (w), 2994 (w), 2869 (m), 2256 (m), 
1615 (w), 1598 (m), 1584 (w), 1499 (s), 1448 (s), 1382 (s), 1296 (s), 1274 (m), 
1188 (m), 1155 (m), 1088 (s), 1077 (s), 1072 (s), 1048 (s), 1009 (s), 741 (s), 694 
(s). 
MS: (ESI) 
210 (100), 211 (13), 250 (M
+
+Na,62), 360 (2). 
HRMS Calcd for C14 H13NO2Na: 250.0844, found: 250.0845 
Opt. Rot.: []D
24 
35.3 (c = 0.50, CHCl3) 
TLC: Rf 0.14 (hexanes/EtOAc, 4/1)[UV (254 nm)]  
SFC: (2R,3S)-47ga tR 3.2 min, (93.9%),  (R,R)/(S,S)-47ga tR 2.8 min, (1.0%) (2S,3R)-
47ga tR 3.5 min, (5.08%)  (Chiralpak AD, 120 bar, 40 °C, 9% MeOH in CO2, 3.2 
mL/min) 
Analysis: C14 H13NO2 (227.25) 
Calcd: C, 73.99; H, 5.77; N, 6.16% 
Found: C, 73.80; H, 5.72; N, 6.30% 
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Preparation of  (2R,3S)-3-Hydroxy-2-methyl-3-phenyl-2-(4-trifluromethylphenyl)propane-
nitrile (47ab) (Table 19, entry 1) 
 
Following General Procedure 19, 106 mg of benzaldehyde (1.0 mmol, 1.0 equiv) was combined 
with 42 mg of (R,R)-34 (0.05 mmol, 0.05 equiv), 126 L of SiCl4 (1.1 mmol, 1.1 equiv), and 
0.86 mL of a 1.4 M solution of silyl ketene imine 46b (1.2 mmol, 1.2 equiv) to yield after 
column chromatography (SiO2 (32 g) 3 cm diam., hexanes/EtOAc 5:1) 258 mg (80%)  of 47ab 
as a white solid, and 11 mg (3%) of the diastereomer as an oil. The white solid was crystallized 
from hot i-Pr2O (2 mL) and hexanes (2 mL) to yield 234 mg (73%) of 47ab as white needles. 
Data for 47ab: 
mp: 111-116°C 
1
H NMR: (500 MHz, CDCl3) 
δ 7.67-7.62 (m, 2 H, HC(10)), 7.58-7.54 (m, 2 H, HC(9)), 7.38-7.31 (m, 3 H, 
HC(7,6)), 7.30-7.27 (m, 2 H, HC(5)), 4.93 (s, 1 H, HC(3)), 2.37 (br. s, 1 H, OH)), 
2.11 (dq, J = 7.4, 14.8, 1 H, H2C(13)),  1.89 (dq, J = 7.4, 14.8, 1 H, H2C(13`)), 0.83 
(t, J = 7.4, 3 H, H3C (14)). 
13
C NMR: (125 MHz, CDCl3)  
δ 139.5 (C(4,8)), 138.1 (C(4,8)), 130.4 (q, J = 33.0, C(11)), 129.1 (C(7)), 120.2 
(C(6)), 127.9 (C(9)), 125.5 (q, J = 3.5, C(10)), 123.8 (q, J = 272.4, F3C(12)), 120.0 
(C(1)), 79.3 (C(3)), 56.2 (C(2)), 28.8 (C(13)), 9.2 (C(14)). 
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IR: (KBr pellet) 
3563 (m), 3088 (w), 3067 (w), 3052 (w), 3037 (w), 2986 (w), 2949 (w), 2891 (w), 
2241 (w), 1952 (w), 1915 (w), 1620 (w), 1453 (m), 1413 (m), 1325 (s), 1164 (s), 
1137 (s), 1116 (s), 1067 (s), 1019 (s), 847 (m), 712 (m), 698 (m), 686 (m), 624 (m). 
MS: (ESI) 
102 (27), 214 (12), 275 (14), 302 (22), 342 (M
+
+Na,37), 512 (100), 516 (23), 658 
(31), 666 (39), 667 (15), 826 (11). 
HRMS Calcd for C18H16NOF3Na: 342.1082, found: 342.1096 
Opt. Rot.: []D
24   
58.5 (c = 0.515, CHCl3) 
TLC: Rf 0.32 (hexanes/EtOAc, 4/1)[UV (254 nm)] 
SFC: (2R,3S)-47ab tR 7.0 min (99.5%), (2S,3R)-47ab tR 6.6 min (0.5%) (Chiralpak OD, 
125 bar, 5% MeOH in CO2, 2.5 mL/min) 
Analysis: C18H16F3NO (319.32) 
Calcd: C, 67.70; H, 5.05; N, 4.39% 
Found: C, 67.98; H, 4.89; N, 4.52% 
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Preparation of (2R,3S)-3-Hydroxy-2-(4-methoxyphenyl)-2-methyl-3-phenylpropanenitrile 
(47ac) (Table 19, entry 2) 
 
 Following General Procedure 19, 106 mg of benzaldehyde (1.0 mmol, 1.0 equiv) was 
combined with 42 mg of (R,R)-34 (0.05 mmol, 0.05 equiv), 126 L of SiCl4 (1.1 mmol, 1.1 
equiv), and 0.86 mL of a 1.4 M solution of silyl ketene imine 46c (1.2 mmol, 1.2 equiv) to yield 
after column chromatography (SiO2 (30 g), 3 cm diam., gradient from CH2Cl2/hexanes 7/1 to 
neat CH2Cl2 to CH2Cl2/EtOAc 7/1) 295 mg of 47ac as a white solid, which was crystallized from 
hot isopropyl acetate (1 mL) and an equal volume of hexanes (1 mL) to yield 240 mg (90%) of 
47ac as white needles. 
Data for 47ac: 
mp: 153-154°C  
1
H NMR: (500 MHz, CDCl3) 
δ 7.40-7.36 (m, 2 H, HC(9)), 7.35-7.32 (m, 3 H, HC(7,6)), 7.31-7.28 (m, 2 H, 
HC(5)), 6.94-6.90 (m, 2 H, HC(10)), 4.82 (s, 1 H, HC(3)), 3.83 (s, 3 H, H3C(12)), 
1.58 (s, 3 H, H3C(13)). 
13
C NMR: (125 MHz, CDCl3)   
δ 159.5 (C(11)), 137.8 (C(4)), 129.3 (C(8)), 128.8 (C(7)), 128.1 (C(6)), 128.0 
(C(9)), 127.6 (C(5)), 122.0 (C(1)), 114.1 (C(10)), 79.9 (C(10)), 55.3 (C(12)), 48.7 
(C(2)). 
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IR: (KBr pellet) 
3482 (s), 3086 (w), 3068 (w), 3038 (w), 2992 (m), 2946 (m), 2847 (w), 2242 (w), 
1612 (w), 1585 (w), 1514 (s), 1453 (m), 1408 (w), 1379 (m), 1300 (m), 1248 (s), 
1189 (m), 1040 (m), 1026 (m), 885 (w), 828 (m), 800 (m), 710 (s), 643 (w), 609 
(w). 
MS: (ESI) 
290 (M
+
+Na, 100), 291 (17). 
HRMS Calcd for C17H17NO2Na: 290.1157, found: 290.1154 
Opt. Rot.: []D
24  
19.4 (c = 0.495, CHCl3) 
TLC: Rf 0.15 (hexanes/EtOAc, 4/1)[UV (254 nm)] 
SFC: (2R,3S)-47ac tR 9.4 min (97.8%), (R,R)/(S,S)-47ac tR 7.8 min (0.8%) (R,R)/(S,S)-
47ac tR 8.3 min (0.5%), (2S,3R)-47ac tR 10.5 min (0.9%) (Chiralpak AD, 125 bar, 
40 °C, 8% MeOH in CO2, 2.5 mL/min) 
Analysis: C17H17NO2 (267.32) 
Calcd: C, 76.38; H, 6.41; N, 5.24% 
Found: C, 76.58; H, 6.45; N, 5.36% 
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Preparation of (2R,3S)-3-Hydroxy-2-methyl-2-(2-methylphenyl)-3-phenylpropanenitrile 
(47ad) (Table 19, entry 3) 
 
 Following General Procedure 19, 106 mg of benzaldehyde (1.0 mmol, 1.0 equiv) was 
combined with 42 mg of (R,R)-1 (0.05 mmol, 0.05 equiv), 126 L of SiCl4 (1.1 mmol, 1.1 
equiv), and 0.86 mL of a 1.4 M solution of silyl ketene imine 46d (1.2 mmol, 1.2 equiv) to yield 
after column chromatography (SiO2 (32 g) 3 cm diam., EtOAc/hexanes 1/4 ) 222 mg (88%)  of 
47ad as a white solid. A sample (3.6 mg) was taken for derivatization and determination of er 
(see compound 47ada). The white solid was crystallized from i-Pr2O (2 mL) and 20 drops of 
hexanes to yield 187 mg (74%) of 47ad as white needles. 
Data for 47ad: 
mp: 121-122 °C 
1
H NMR: (500 MHz, CDCl3)  
δ 7.27-7.24 (m, 3 H, HC(6,12)), 7.23-7.19 (m, 2 H, HC(11,7)), 7.14-7.09 (m, 1 H, 
HC(10)), 7.03-7.00 (m, 3 H, HC(5,9)), 5.27 (s, 1 H, HC(3)), 2.70 (s, 3 H, H3C(14)), 
1.60 (s, 3 H, H3C(15)). 
13
C NMR: (125 MHz, CDCl3)  
δ 137.2 (C(8)), 135.6 (C(4,13)), 134.2 (C(4,13)), 132.7 (C(12)), 128.4 (C(11,7)), 
128.2 (C(11,7)), 127.7 (C(9)), 127.5 (C(6,5)), 127.5 (C(6,5)), 126.3 (C(10)), 122.72 
(C(1)), 76.0 (C(3)), 47.3 (C(2)), 21.8 (C(14)), 20.8 (C(15)). 
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IR: (KBr pellet) 
3484 (s), 3059 (w), 3034 (w), 3005 (w), 2986 (w), 2939 (w), 2237 (m), 1956 (w), 
1488 (m), 1453 (m), 1406 (w), 1389 (w), 1375 (m), 1329 (w), 1292 (w), 1245 (w), 
1197 (m), 1088 (w), 1059 (m), 1033 (m), 915 (m), 771 (m), 748 (m), 721 (s), 711 
(s). 
MS: (ESI) 
146 (100), 147 (12), 207 (18), 234 (97), 235 (27), 258 (13), 169 (26), 274 (M
+
+Na, 
34), 345 (12).  
HRMS Calcd for C17H17NONa: 274.1208, found: 274.1223 
Opt. Rot.: []D
24   
-59.5 (c = 0.495, CHCl3) 
TLC: Rf 0.28 (hexanes/EtOAc, 4/1) [UV (254 nm)] 
Analysis: C17H17NO (251.32) 
Calcd: C, 81.24; H, 6.82; N, 5.57% 
Found: C, 81.00; H, 6.79; N, 5.70% 
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Derivatization of Nitrile 47ad with 3,5-Dinitrobenzoyl Chloride. 
Preparation of (1S,2R)-2-Cyano-1-phenyl-2-(2-methylphenyl)propyl-3,5-dinitrobenzoate 
(47ada) 
 
 A 10-mL, round-bottomed flask equipped with a condenser, inert gas inlet, and magnetic 
stir bar was flame dried.  The flask was charged with 47ad (0.25 mmol, 62.8 mg, 1.0 equiv), dry 
1,2-dichloroethane (2.5 mL), 4-dimethylaminopyridine (61.1 mg, 0.5 mmol, 2.0 equiv), and 3,5-
dinitrobenzoylchloride (86.4 mg, 0.375 mmol, 1.5 equiv), under Ar.  The mixture was heated to 
reflux for 6.5 h, then was stirred overnight at room temperature.  The resulting mixture was 
poured into a 125-mL separatory funnel and the flask was rinsed with 5 mL of CH2Cl2 to 
dissolve the solids.  Water (15 mL), and Et2O (15 mL) were added to the separatory funnel and 
the mixture washed 3 x 15 mL Et2O.  Combined organic layers were washed with aq. CuSO4 
solution (10 mL) and brine (2x10 mL).  The organic layer was dried over MgSO4, then was 
filtered and concentrated in vacuo (23°C, 15 mmHg).  The residue was purified by column 
chromatography (SiO2 (15 g), 2 cm diameter column, gradient from CH2Cl2/hexanes 3:2, to 
CH2Cl2/hexanes 3:1) to yield 47ada 78 mg, (70%) as a white solid, which was recrystallized 
from EtOAc (0.5 mL) and hexanes (0.5 mL) to afford 47ada as white needles (70 mg, 63%). 
Data for 47ada: 
mp: 190-195°C 
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1
H NMR: (500 MHz, CDCl3) 
δ 9.28 (t, J = 2.1, 1 H, HC(20)), 9.18 (d, J = 2.1, 2 H, HC(18)), 7.35 (m, 1 H, 
HC(Aryl)), 7.33-7.29 (m, 4 H, HC(Aryl)), 7.18-7.13 (m, 4 H, HC(Aryl)), 6.70 (s, 1 
H, HC(3)), 2.81 (s, 3 H, H3C(14)), 1.90 (s, 3 H, H3C(15)). 
13
C NMR: (125 MHz, CDCl3)  
δ 161.13 (C(16)), 148.75 (C(19)), 136.40 (C(4,8,13,17)), 133.21 (C(12)), 133.02 
 (C(4,8,13,17)), 132.97 (C(4,8,13,17)), 132.79 (C(4,8,13,17)), 129.46 (HC(18)), 
129.46 (C(Aryl)), 128.29 (C(Aryl)), 127.54 (C(Aryl)), 127.52 (C(Aryl)), 126.63 
(C(Aryl)), 122.88 (C(20)), 121.24 (C(1)), 78.33 (C(3)), 46.04 (C(2)), 21.83 
(C(14,15)), 21.71 (C(14,15)). 
IR: (KBr pellet) 
3113 (m), 3091 (w), 2997 (w), 2234 (w), 1742 (s), 1629 (m), 1544 (s), 1456 (m), 
1347 (s), 1329 (m), 1269 (s), 1207 (w), 1156 (s), 1076 (w), 1032 (w), 981 (s), 920 
(m), 912 (m), 771 (m), 764 (m), 757 (m), 732 (s), 719 (s), 703 (s), 632 (m). 
MS: (ESI) 
234 (12), 468 (M
+
+Na, 100), 469 (18).  
Opt. Rot.: []D
24   
-99.9 (c = 0.485, CHCl3) 
TLC: Rf 0.33 (hexanes/EtOAc, 4/1)[UV (254 nm)] 
HPLC: (2R,3S)-47ada tR 38.2 min (85.2%), (R,R)/(S,S)-47ada tR 26.7 min (10.1%)  
(2R,3S)-47ada tR 33.5 min (5.1%)  (Rexchrom Pirkle Covalent S-N1N-
Napthylleucine, 1 mL /min from 0 to 20 min, 0.9 mL/min at 30 min, 20% i-PrOH in 
hexane from 0 to 20 min, then a gradient to 50% over 10 min.) 
Analysis: C24 H19N3O6 (445.2) 
Calcd: C, 64.72; H, 4.30;      N, 9.43% 
Found: C, 64.99; H, 4.20;      N, 9.39% 
338 
 
 
Addition of Silyl Ketene Imines to Ketones. Preparation of 3-Hydroxy-2,3-dimethyl-2-
phenyloctanenitrile (49ba) [MTB-II-56] 
 
To a flame-dried, 5-ml Schlenk flask equipped with a magnetic stir bar and a septum 
were added n-Oct3P=O (58mg, 0.15 mmol, 0.5 equiv), n-Bu4NI (111 mg, 0.3 mmol, 1.0 equiv), 
38b (42 μL, 0.3 mmol, 1.0 equiv), silyl ketene imine 46a (96.5 μL, 0.5 mmol, 2.0 equiv) and 
CH2Cl2 (1.2 ml). Silicon tetrachloride was added (38 μL, 0.33 mmol, 1.1 equiv) to the reaction 
mixture with stirring. The reaction was stirred for 10 h and was then quenched by pouring the 
solution into a 50-mL Erlenmeyer flask containing a rapidly stirring solution of sat. aq. KF (5 
mL) and sat. aq. NaHCO3  (5 mL) solutions. The mixture was stirred vigorously for 1 h and then 
transferred to a 125-mL separatory funnel. Water was added (20 mL), and the mixture was 
extracted with Et2O (3 x 10 mL). The combined organic extracts were dried over MgSO4, filtered 
and concentrated in vacuo (23° C, 14 mmHg). The resulting residue was purified by column 
chromatography (silica gel, 18 g, 10 x 2 cm diam, hexanes/EtOAc 6:1) to afford 21.1 mg (28%) 
of 49ba as a thick colorless oil. 
Data for 49ba: 
1
H NMR: (500 MHz, CDCl3) 
δ 7.54 – 7.50 (m, 2H, HC(11)), 7.42 – 7.37 (m, 2H (HC(12)), 7.37 – 7.32 (m, 1H , 
HC(13)), 1.83 (s, 3H, H3C(9,14)), 1.68 – 1.51 (m, 2H), 1.40 – 1.14 (m, 6H), 1.30 (s, 
3H, H3C(9,14)), 0.85 (t, J = 7.1, 3H, H3C(8)). 
MS: (ESI) 
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251.2 (66), 268.2 (100, M+Na), 359.0 (90). 
HRMS: Calculated: C16H23NONa (M+Na) (268.1677); Found: 268.1685. 
TLC: Rf 0.22 (hexanes/EtOAc/HOAc, 79.5:20:0.5) [UV] 
 
C.6.3. Addition of Silyl Ketene Imines to Ketones 
General Procedure 20. Addition of Silyl Ketene Imines to Ketones with In Situ NMR 
Monitoring. Addition of 46a to 38b in the Presence of 1.0 equiv of n-Bu4NI and 0.5 equiv of 
DMSO. (Table 20, entry 1) [MTB-II-58] 
 
 An oven-dried NMR tube, fitted with septum, under Ar was charged with n-Bu4NI (92 
mg, 0.25 mmol, 1.0 equiv), C6Me6 (12.4 mg), DMSO (15 μL, 0.125 mmol, 0.5 equiv), 38b (35 
μL, 0.25 mmol, 1.0 equiv) and CH2Cl2 (1.0 mL). The tube was agitated in a vortex mixer and 
then was charged with 46a (80 μL, 0.3 mmol, 1.2 equiv). Silicon tetrachloride (31 μL, 0.275 
mmol, 1.1 equiv) was added and then the tube was agitated in a vortex mixer. The septum was 
covered in Parafilm
®
, and the tube was placed in a dessicator over P2O5. After 25 h, a No-D
113
 
1
H 
NMR spectrum was taken (acquisition parameters d1=20, at=9, nt=8) and a yield of 23% was 
calculated based on the ratio of the integrals for C6Me6 (δ 2.24 (s, 18H)) and the combined 
integrals for both isomers of 49ba (δ 1.83 (s, 3H), 1.82 (s, 3H)). 
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Addition of 46a to 38b in the Presence of 1.0 equiv of n-Bu4NI and 0.5 equiv of 
(Me2N)2C=O. (Table 20, entry 2) [MTB-II-59] 
Following General Procedure 20, an NMR tube was charged with n-Bu4NI (92 mg, 0.25 
mmol, 1.0 equiv), C6Me6 (10.6 mg), (Me2N)2C=O (15 μL, 0.125 mmol, 0.5 equiv), 38b (35 μL, 
0.25 mmol, 1.0 equiv), CH2Cl2 (1.0 mL), 46a (80 μL, 0.3 mmol, 1.2 equiv) and SiCl4 (31 μL, 
0.275 mmol, 1.1 equiv). After 25 h, 54% yield was observed by 
1
H NMR spectroscopy. 
 
Addition of 46a to 38b in the Presence of 1.0 equiv of n-Bu4NI and 0.5 equiv of 
(Me2N)2C=S. (Table 20, entry 3) [MTB-II-60] 
Following General Procedure 20, an NMR tube was charged with n-Bu4NI (92 mg, 0.25 
mmol, 1.0 equiv), C6Me6 (16.5 mg), (Me2N)2C=S (16.5 mg, 0.125 mmol, 0.5 equiv), 38b (35 μL, 
0.25 mmol, 1.0 equiv), CH2Cl2 (1.0 mL), 46a (80 μL, 0.3 mmol, 1.2 equiv) and SiCl4 (31 μL, 
0.275 mmol, 1.1 equiv). After 25 h, 52% yield was observed by 
1
H NMR spectroscopy. 
 
Addition of 46a to 38b in the Presence of 1.0 equiv of n-Bu4NI and 0.5 equiv of n-Bu3P=S. 
(Table 20, entry 4) [MTB-II-61] 
Following General Procedure 20, an NMR tube was charged with n-Bu4NI (92 mg, 0.25 
mmol, 1.0 equiv), C6Me6 (12.3 mg), n-Bu3P=S (15 μL, 0.125 mmol, 0.5 equiv), 38b (35 μL, 0.25 
mmol, 1.0 equiv), CH2Cl2 (1.0 mL), 46a (80 μL, 0.3 mmol, 1.2 equiv) and SiCl4 (31 μL, 0.275 
mmol, 1.1 equiv). After 25 h, 40% yield was observed by 
1
H NMR spectroscopy. 
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Addition of 46a to 38b in the Presence of 1.0 equiv of n-Bu4NI and 0.5 equiv of n-Oct3P=O. 
(Table 20, entry 5) [MTB-II-62] 
Following General Procedure 20, an NMR tube was charged with n-Bu4NI (92 mg, 0.25 
mmol, 1.0 equiv), C6Me6 (12.3 mg), n-Oct3P=O (48 mg, 0.125 mmol, 0.5 equiv), 38b (35 μL, 
0.25 mmol, 1.0 equiv), CH2Cl2 (1.0 mL), 46a (80 μL, 0.3 mmol, 1.2 equiv) and SiCl4 (31 μL, 
0.275 mmol, 1.1 equiv). After 2 h, 20% yield was observed by 
1
H NMR spectroscopy. 
 
Addition of 46a to 38b in the Presence of 1.0 equiv of n-Bu4NI and 0.5 equiv of 50. (Table 
20, entry 6) [MTB-II-63] 
Following General Procedure 20, an NMR tube was charged with n-Bu4NI (92 mg, 0.25 
mmol, 1.0 equiv), C6Me6 (15.6 mg), 50 (27 mg, 0.125 mmol, 0.5 equiv), 38b (35 μL, 0.25 mmol, 
1.0 equiv), CH2Cl2 (1.0 mL), 46a (80 μL, 0.3 mmol, 1.2 equiv) and SiCl4 (31 μL, 0.275 mmol, 
1.1 equiv). After 2 h, 55% yield was observed by 
1
H NMR spectroscopy. After 18 h, 70% yield 
was observed by 
1
H NMR spectroscopy. 
Addition of 46a to 38b in the Presence of 1.0 equiv of n-Bu4NI and 0.5 equiv of Pyridine N-
Oxide. (Table 20, entry 7) [MTB-II-64] 
Following General Procedure 20, an NMR tube was charged with n-Bu4NI (92 mg, 0.25 
mmol, 1.0 equiv), C6Me6 (13.9 mg), Pyridine N-Oxide (12 mg, 0.125 mmol, 0.5 equiv), 38b (35 
μL, 0.25 mmol, 1.0 equiv), CH2Cl2 (1.0 mL), 46a (80 μL, 0.3 mmol, 1.2 equiv) and SiCl4 (31 μL, 
0.275 mmol, 1.1 equiv). After 2 h, 0% yield was observed by 
1
H NMR spectroscopy.  
 
Addition of 46a to 38b in the Presence of 1.0 equiv of n-Bu4NI and 0.5 equiv of (EtO)3P=O. 
(Table 20, entry 8) [MTB-II-65] 
Following General Procedure 20, an NMR tube was charged with n-Bu4NI (92 mg, 0.25 
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mmol, 1.0 equiv), C6Me6 (14.1 mg), (EtO)3P=O (21μL, 0.125 mmol, 0.5 equiv), 38b (35 μL, 
0.25 mmol, 1.0 equiv), CH2Cl2 (1.0 mL), 46a (80 μL, 0.3 mmol, 1.2 equiv) and SiCl4 (31 μL, 
0.275 mmol, 1.1 equiv). After 2 h, 8% yield was observed by 
1
H NMR spectroscopy.  
 
Addition of 46a to 38b in the Presence of 1.0 equiv of n-Bu4NI and 0.5 equiv of Ph3P=Se. 
(Table 20, entry 9) [MTB-II-66] 
Following General Procedure 20, an NMR tube was charged with n-Bu4NI (92 mg, 0.25 
mmol, 1.0 equiv), C6Me6 (14.7 mg), Ph3P=Se (43 mg, 0.125 mmol, 0.5 equiv), 38b (35 μL, 0.25 
mmol, 1.0 equiv), CH2Cl2 (1.0 mL), 46a (80 μL, 0.3 mmol, 1.2 equiv) and SiCl4 (31 μL, 0.275 
mmol, 1.1 equiv). After 2 h, 0% yield was observed by 
1
H NMR spectroscopy.  
 
Addition of 46a to 38b in the Presence of 0.5 equiv of n-Bu4NI and 0.5 equiv of 50. (Table 
21, entry 1) [MTB-II-67] 
Following General Procedure 20, an NMR tube was charged with n-Bu4NI (46 mg, 0.125 
mmol, 0.5 equiv), C6Me6 (14.3 mg), 50 (27 mg, 0.125 mmol, 0.5 equiv), 38b (35 μL, 0.25 mmol, 
1.0 equiv), CH2Cl2 (1.0 mL), 46a (80 μL, 0.3 mmol, 1.2 equiv) and SiCl4 (31 μL, 0.275 mmol, 
1.1 equiv). After 8.5 h, 80% yield was observed by 
1
H NMR spectroscopy.  
 
Addition of 46a to 38b in the Presence of 0.2 equiv of n-Bu4NI and 0.5 equiv of 50. (Table 
21, entry 2) [MTB-II-68] 
Following General Procedure 20, an NMR tube was charged with n-Bu4NI (19 mg, 0.05 
mmol, 0.2 equiv), C6Me6 (12.7 mg), 50 (27 mg, 0.125 mmol, 0.5 equiv), 38b (35 μL, 0.25 mmol, 
1.0 equiv), CH2Cl2 (1.0 mL), 46a (80 μL, 0.3 mmol, 1.2 equiv) and SiCl4 (31 μL, 0.275 mmol, 
1.1 equiv). After 8.5 h, 40% yield was observed by 
1
H NMR spectroscopy.  
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Addition of 46a to 38b in the Presence of 0.5 equiv of 50 and the Absence of n-Bu4NI. 
(Table 21, entry 3) [MTB-II-70] 
Following General Procedure 20, an NMR tube was charged with C6Me6 (14.7 mg), 50 
(27 mg, 0.125 mmol, 0.5 equiv), 38b (35 μL, 0.25 mmol, 1.0 equiv), CH2Cl2 (1.0 mL), 46a (80 
μL, 0.3 mmol, 1.2 equiv) and SiCl4 (31 μL, 0.275 mmol, 1.1 equiv). After 8.5 h, 23% yield was 
observed by 
1
H NMR spectroscopy.  
 
Addition of 46a to 38b in the Presence of 0.5 equiv of n-Bu4NI and 0.2 equiv of 50. (Table 
21, entry 4) [MTB-II-71] 
Following General Procedure 20, an NMR tube was charged with n-Bu4NI (46 mg, 0.125 
mmol, 0.5 equiv), C6Me6 (14.3 mg), 50 (11 mg, 0.05 mmol, 0.2 equiv), 38b (35 μL, 0.25 mmol, 
1.0 equiv), CH2Cl2 (1.0 mL), 46a (80 μL, 0.3 mmol, 1.2 equiv) and SiCl4 (31 μL, 0.275 mmol, 
1.1 equiv). After 1 h, 27% yield was observed by 
1
H NMR spectroscopy. After 6 h, 57% yield 
was observed by 
1
H NMR spectroscopy. After 29 h, 70% yield was observed by 
1
H NMR 
spectroscopy. 
 
Addition of 46a to 38b in the Presence of 0.5 equiv of n-Bu4NOTf and 0.2 equiv of 50. 
(Table 21, entry 5) [MTB-II-77] 
Following General Procedure 20, an NMR tube was charged with n-Bu4NOTf (49 mg, 
0.125 mmol, 0.5 equiv), C6Me6 (12.8 mg), 50 (11 mg, 0.05 mmol, 0.2 equiv), 38b (35 μL, 0.25 
mmol, 1.0 equiv), CH2Cl2 (1.0 mL), 46a (80 μL, 0.3 mmol, 1.2 equiv) and SiCl4 (31 μL, 0.275 
mmol, 1.1 equiv). After 1 h, 21% yield was observed by 
1
H NMR spectroscopy. After 17.5 h, 
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53% yield was observed by 
1
H NMR spectroscopy.  
 
Addition of 46a to 38b in the Presence of 0.5 equiv of n-Bu4NI, 2.0 equiv of 46a and 0.2 
equiv of 50. (Table 21, entry 6) [MTB-II-79] 
Following General Procedure 20, an NMR tube was charged with n-Bu4NI (46 mg, 0.125 
mmol, 0.5 equiv), C6Me6 (13 mg), 50 (11 mg, 0.05 mmol, 0.2 equiv), 38b (35 μL, 0.25 mmol, 
1.0 equiv), CH2Cl2 (1.0 mL), 46a (134 μL, 0.5 mmol, 2.0 equiv) and SiCl4 (31 μL, 0.275 mmol, 
1.1 equiv). After 1 h, 47% yield was observed by 
1
H NMR spectroscopy. After 17.5 h, 81% yield 
was observed by 
1
H NMR spectroscopy.  
 
General Procedure 21. Enantioselective Addition of Silyl Ketene Imines to Ketones with In 
Situ NMR Monitoring. Addition of 46a to 38c in the Presence of 0.05 equiv of (R,R)-34. 
Preparation of 3-Hydroxy2,3-dimethyl-2,5-diphenylpentanenitrile (49ca) (Table 22, entry 
3) [MTB-III-22] 
 
An oven-dried NMR tube, fitted with septum, under Ar was charged with n-Bu4NI (46.2 
mg, 0.125 mmol, 0.5 equiv), C6Me6 (18.3 mg), (R-R)-34 (12.5 mg, 0.0125 mmol, 0.05 equiv), 
38c (38 μL, 0.25 mmol, 1.0 equiv) and CH2Cl2 (1.0 mL). The tube was agitated in a vortex mixer 
and then was charged with 46a (134 μL, 0.5 mmol, 2.0 equiv). Silicon tetrachloride (31 μL, 
0.275 mmol, 1.1 equiv) was added and then the tube was agitated in a vortex mixer. The septum 
was covered in Parafilm
®
, and the tube was placed in a desiccator over P2O5. After 25 h, a No-
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1
H NMR spectrum was taken (acquisition parameters d1=20, at=9, nt=8) and a yield of 65% 
was calculated based on the ratio of the integrals for C6Me6 (δ 2.24 (s, 18H)) and the combined 
integrals for  both isomers of 49ca (δ 1.08 (s, 3H), 1.92 (s, 3H)). After 30 h, the reaction was 
quenched by pouring the solution into a 50-mL Erlenmeyer flask containing a rapidly stirring 
solution of sat. aq. KF (5 mL) and sat. aq. (5 mL) NaHCO3 solutions. The mixture was stirred 
vigorously for 1h and then was transferred to a 125-mL separatory funnel. Water was added (20 
mL), and the mixture was extracted with CH2Cl2 (3 x 10 mL). The combined organic layers were 
dried over Na2SO4, filtered and concentrated in vacuo (23° C, 14 mmHg). The resulting residue 
was purified by column chromatography (silica gel, 18 g, 10 x 2 cm diam, hexanes/EtOAc 5:1) 
to afford 10 mg (14%) of 49ca as a thick, colorless oil. The stereochemistry of 49ca is assumed 
to be (2R,3S) by analogy to 47 purely for the sake of clarity in presenting CSP-SFC data. The 
configuration of 49ca should be considered to be unknown. 
  
Data for 49ca:  
1
H NMR: (500 MHz, CDCl3) 
δ 7.55 – 7.49 (m, 2H), 7.47 – 7.31 (m, 3H), 7.31 – 7.23 (m, 3H), 7.19 (m, 
1H), 7.12 (m, 1H), 2.81 – 2.62 (m, 2H, H2C(5)), 1.99 – 1.88 (m, 1H, H2-
C(4)), 1.85 (s, 3H, H3C(14,15)), 1.81 – 1.72 (m, 1H, H2C(4)), 1.40 (s, 
3H, H3C(14,15)). 
TLC: Rf 0.12 (hexanes/EtOAc, 5:1) [KMnO4] 
SFC: (2S,3R)-49ca, tR 18.3 min (13%), (2S,3S)/(2R,3R)-49ca, tR 19.8 min (12%), 
(2R,3S)-49ca, tR 24.9 min (53%), (2R,3R)/(2S,3S)-49ca 26.6 min (22%) 
(Chiralpak OD, 125 bar, 40 °C, 3% iPrOH in CO2, 3 mL/min) 
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Addition of 46a to 38b in the Presence of 0.05 equiv of (R,R)-34. (Table 21, entry 1) [MTB-
III-20] 
 
A flame-dried, 5-mL Schlenk flask, fitted with septum and a magnetic stir bar, under Ar 
was charged with n-Bu4NI (46.2 mg, 0.125 mmol, 0.5 equiv), (R-R)-34 (10.5 mg, 0.0125 mmol, 
0.05 equiv), 38c (38 μL, 0.25 mmol, 1.0 equiv) and CH2Cl2 (1.0 mL). 46a (134 μL, 0.5 mmol, 
2.0 equiv) and SiCl4 (31 μL, 0.275 mmol, 1.1 equiv) was added and then the septum was 
replaced  with a ground glass stopper. The mixture was stirred for 24 h and was then quenched 
by pouring the solution into a 50-mL Erlenmeyer flask containing a rapidly stirring solution of 
sat. aq. KF (5 mL) and sat. aq. (5 mL) NaHCO3 solutions. The mixture was stirred vigorously for 
1h and then was transferred to a 125-mL separatory funnel. Water was added (20 mL), and the 
mixture was extracted with CH2Cl2 (3 x 10 mL). The combined organic layers were dried over 
Na2SO4, filtered and concentrated in vacuo (23° C, 14 mmHg). The resulting residue was 
purified by column chromatography (silica gel, 18 g, 10 x 2 cm diam, hexanes/EtOAc 6:1) to 
afford 27.7 mg (45%) of 49ba as a thick, colorless oil. The stereochemistry of 49ba is assumed 
to be (2R,3S) by analogy to 47 purely for the sake of clarity in presenting CSP-SFC data. The 
configuration of 49ba should be considered to be unknown. 
Data for 49ba:  
SFC: (2S,3R)-49ba, tR 14.9 min (9.2%), (2S,3S)/(2R,3R)-49ba tR 16.2 min (19.1%), 
(2R,3S)-49ba tR 16.9 min (62.5%), (2R,3R)/(2S,3S)-49ba tR 18.9 min (9.2%), 
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(Chiralpak AD, 125 bar, 2.5% MeOH in CO2, 1.1 mL/min, 35° C, 206 nm) 
 
Addition of 46a to 38b in the Presence of 0.15 equiv of (R,R)-34. (Table 21, entry 2) [MTB-
III-19] 
 
A flame-dried, 5-mL Schlenk flask, fitted with septum and a magnetic stir bar, under Ar 
was charged with n-Bu4NI (46.2 mg, 0.125 mmol, 0.5 equiv), (R-R)-34 (31.6 mg, 0.0375 mmol, 
0.15 equiv), 38c (38 μL, 0.25 mmol, 1.0 equiv) and CH2Cl2 (1.0 mL). 46a (134 μL, 0.5 mmol, 
2.0 equiv) and SiCl4 (31 μL, 0.275 mmol, 1.1 equiv) was added and then the septum was 
replaced  with a ground glass stopper. The mixture was stirred for 24 h and was then quenched 
by pouring the solution into a 50-mL Erlenmeyer flask containing a rapidly stirring solution of 
sat. aq. KF (5 mL) and sat. aq. (5 mL) NaHCO3 solutions. The mixture was stirred vigorously for 
1h and then was transferred to a 125-mL separatory funnel. Water was added (20 mL), and the 
mixture was extracted with CH2Cl2 (3 x 10 mL). The combined organic layers were dried over 
Na2SO4, filtered and concentrated in vacuo (23° C, 14 mmHg). The resulting residue was 
purified by column chromatography (silica gel, 18 g, 10 x 2 cm diam, hexanes/EtOAc 6:1) to 
afford 27.7 mg (45%) of 49ba as a thick, colorless oil. The stereochemistry of 49ba is assumed 
to be (2R,3S) by analogy to 47 purely for the sake of clarity in presenting CSP-SFC data. The 
configuration of 49ba should be considered to be unknown. 
Data for 49ba:  
SFC: (2S,3R)-49ba, tR 14.9 min (9.7%), (2S,3S)/(2R,3R)-49ba tR 16.2 min (19.5%), 
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(2R,3S)-49ba tR 16.9 min (61.2%), (2R,3R)/(2S,3S)-49ba tR 18.9 min (9.6%), 
(Chiralpak AD, 125 bar, 2.5% MeOH in CO2, 1.1 mL/min, 35° C, 206 nm) 
 
Addition of 46a to 38b in the Presence of 0.05 equiv of (R,R)-51a. (Table 21, entry 4) [MTB-
II-87] 
Following General Procedure 21, an NMR tube was charged with n-Bu4NI (46 mg, 0.125 
mmol, 0.5 equiv), C6Me6 14.0 mg), (R,R)-51a (10.2 mg, 0.0125 mmol, 0.05 equiv), 38b (35 μL, 
0.25 mmol, 1.0 equiv), CH2Cl2 (1.0 mL), 46a (134 μL, 0.5 mmol, 2.0 equiv) and SiCl4 (31 μL, 
0.275 mmol, 1.1 equiv). After 1 h, 6% yield was observed by 
1
H NMR spectroscopy. After 25 h, 
the reaction was quenched and subjected to aqueous workup to provide after column 
chromatography 35.1 mg (58 %) of 49ba. 
Data for 49ba:  
SFC: (2S,3R)-49ba, tR 9.1 min (17.4%), (2S,3S)/(2R,3R)-49ba tR 9.8 min (23.1%), 
(2R,3S)-49ba tR 10.3 min (48.4%), (2R,3R)/(2S,3S)-49ba tR 11.3 min (11.0%), 
(Chiralpak AD, 125 bar, 2.5% MeOH in CO2, 2.5 mL/min, 35° C, 215 nm) 
 
Addition of 46a to 38b in the Presence of 0.05 equiv of (R,R)-51b. (Table 21, entry 5) [MTB-
II-86] 
Following General Procedure 21, an NMR tube was charged with n-Bu4NI (46 mg, 0.125 
mmol, 0.5 equiv), C6Me6 13.4 mg), (R,R)-51b (10.0 mg, 0.0125 mmol, 0.05 equiv), 38b (35 μL, 
0.25 mmol, 1.0 equiv), CH2Cl2 (1.0 mL), 46a (134 μL, 0.5 mmol, 2.0 equiv) and SiCl4 (31 μL, 
0.275 mmol, 1.1 equiv). After 17 h, 87% yield was observed by 
1
H NMR spectroscopy. After 25 
h, the reaction was quenched and subjected to aqueous workup to provide after column 
chromatography 44.5 mg (73 %) of 49ba. 
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Data for 49ba:  
SFC: (2S,3R)-49ba, tR 9.1 min (19.3%), (2S,3S)/(2R,3R)-49ba tR 9.8 min (22.1%), 
(2R,3S)-49ba tR 10.3 min (46.2%), (2R,3R)/(2S,3S)-49ba tR 11.3 min (12.3%), 
(Chiralpak AD, 125 bar, 2.5% MeOH in CO2, 2.5 mL/min, 35° C, 215 nm) 
 
Addition of 46a to 38b in the Presence of 0.05 equiv of 51c. (Table 21, entry 6) [MTB-II-82] 
Following General Procedure 21, an NMR tube was charged with n-Bu4NI (46 mg, 0.125 
mmol, 0.5 equiv), C6Me6 12.7 mg), 51c (4.6 mg, 0.0125 mmol, 0.05 equiv), 38b (35 μL, 0.25 
mmol, 1.0 equiv), CH2Cl2 (1.0 mL), 46a (134 μL, 0.5 mmol, 2.0 equiv) and SiCl4 (31 μL, 0.275 
mmol, 1.1 equiv). After 19 h, 59% yield was observed by 
1
H NMR spectroscopy. After 20 h, the 
reaction was quenched and subjected to aqueous workup to provide after column 
chromatography 28 mg (46 %) of 49ba. 
Data for 49ba:  
SFC: (2S,3R)-49ba, tR 9.1 min (35.9%), (2S,3S)/(2R,3R)-49ba tR 9.8 min (17.0%), 
(2R,3S)-49ba tR 10.3 min (16.6%), (2R,3R)/(2S,3S)-49ba tR 11.3 min (30.4%), 
(Chiralpak AD, 125 bar, 2.5% MeOH in CO2, 2.5 mL/min, 35° C, 220 nm) 
 
Addition of 46a to 38b in the Presence of 0.05 equiv of 51d. (Table 21, entry 7) [MTB-II-84] 
Following General Procedure 21, an NMR tube was charged with n-Bu4NI (46 mg, 0.125 
mmol, 0.5 equiv), C6Me6 14.8 mg), 51d (6.2 mg, 0.0125 mmol, 0.05 equiv), 38b (35 μL, 0.25 
mmol, 1.0 equiv), CH2Cl2 (1.0 mL), 46a (134 μL, 0.5 mmol, 2.0 equiv) and SiCl4 (31 μL, 0.275 
mmol, 1.1 equiv). After 26 h, 45% yield was observed by 
1
H NMR spectroscopy. After 36 h, the 
reaction was quenched and subjected to aqueous workup to provide after column 
chromatography 41.6 mg (68 %) of 49ba. 
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Data for 49ba:  
SFC: (2S,3R)-49ba, tR 9.1 min (41.9%), (2S,3S)/(2R,3R)-49ba tR 9.8 min (13.2%), 
(2R,3S)-49ba tR 10.3 min (10.7%), (2R,3R)/(2S,3S)-49ba tR 11.3 min (34.1%), 
(Chiralpak AD, 125 bar, 2.0% MeOH in CO2, 2.5 mL/min, 35° C, 220 nm) 
 
Addition of 46a to 38b in the Presence of 0.05 equiv of 51e. (Table 21, entry 8) [MTB-II-85] 
Following General Procedure 21, an NMR tube was charged with n-Bu4NI (46 mg, 0.125 
mmol, 0.5 equiv), C6Me6 (14.4 mg), 51e (8.7 mg, 0.0125 mmol, 0.05 equiv), 38b (35 μL, 0.25 
mmol, 1.0 equiv), CH2Cl2 (1.0 mL), 46a (134 μL, 0.5 mmol, 2.0 equiv) and SiCl4 (31 μL, 0.275 
mmol, 1.1 equiv). After 26 h, 80% yield was observed by 
1
H NMR spectroscopy. After 36 h, the 
reaction was quenched and subjected to aqueous workup to provide after column 
chromatography 38.5 mg (63 %) of 49ba. 
Data for 49ba:  
SFC: (2S,3R)-49ba, tR 9.1 min (19.4%), (2S,3S)/(2R,3R)-49ba tR 9.8 min (31.4%), 
(2R,3S)-49ba tR 10.3 min (29.2%), (2R,3R)/(2S,3S)-49ba tR 11.3 min (20.0%), 
(Chiralpak AD, 125 bar, 2.5% MeOH in CO2, 2.5 mL/min, 35° C, 220 nm) 
 
Addition of 46a to 38c in the Presence of 0.05 equiv of 51f. (Table 21, entry 9) [MTB-III-24] 
Following General Procedure 21, an NMR tube was charged with n-Bu4NI (46 mg, 0.125 
mmol, 0.5 equiv), C6Me6 (14.4 mg), 51f (5.5 mg, 0.0125 mmol, 0.05 equiv), 38c (38 μL, 0.25 
mmol, 1.0 equiv), CH2Cl2 (1.0 mL), 46a (134 μL, 0.5 mmol, 2.0 equiv) and SiCl4 (31 μL, 0.275 
mmol, 1.1 equiv). After 23.5 h, 69% yield was observed by 
1
H NMR spectroscopy. After 23.8 h, 
the reaction was quenched and subjected to aqueous workup to provide after column 
chromatography 15.3 mg (22 %) of 49ca. 
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Data for 49ca:  
SFC: (2S,3R)-49ca, tR 18.1 min (23%), (2S,3S)/(2R,3R)-49ca, tR 19.7 min (22.5%), 
(2R,3S)-49ca, tR 24.9 min (29.2%), (2R,3R)/(2S,3S)-49ca 26.6 min (25.1%) 
(Chiralpak OD, 125 bar, 40 °C, 3% iPrOH in CO2, 10% iPrOH in CO2 after 20 min, 
3 mL/min, 215 nm) 
 
Addition of 46a to 38c in the Presence of 0.1 equiv of 51f. (Table 21, entry 10) [MTB-III-30] 
Following General Procedure 21, an NMR tube was charged with n-Bu4NI (46 mg, 0.125 
mmol, 0.5 equiv), C6Me6 (14.4 mg), 51f (11.0 mg, 0.025 mmol, 0.1 equiv), 38c (38 μL, 0.25 
mmol, 1.0 equiv), CH2Cl2 (1.0 mL), 46a (134 μL, 0.5 mmol, 2.0 equiv) and SiCl4 (31 μL, 0.275 
mmol, 1.1 equiv). After 24 h, 68% yield was observed by 
1
H NMR spectroscopy. After 25 h, the 
reaction was quenched and subjected to aqueous workup to provide after column 
chromatography 35.3 mg (51 %) of 49ca. 
Data for 49ca:  
SFC: (2S,3R)-49ca, tR 18.1 min (16.3%), (2S,3S)/(2R,3R)-49ca, tR 19.7 min (17.7%), 
(2R,3S)-49ca, tR 24.9 min (36.2%), (2R,3R)/(2S,3S)-49ca 26.6 min (29.7%) 
(Chiralpak OD, 125 bar, 40 °C, 3% iPrOH in CO2, 10% iPrOH in CO2 after 20 min, 
3 mL/min, 215 nm) 
 
Addition of 46a to 38c in the Presence of 0.05 equiv of 51g. (Table 21, entry 11) [MTB-III-
25] 
Following General Procedure 21, an NMR tube was charged with n-Bu4NI (46 mg, 0.125 
mmol, 0.5 equiv), C6Me6 (16.6 mg), (R,R)-51g (11.9 mg, 0.0125 mmol, 0.05 equiv), 38c (38 μL, 
0.25 mmol, 1.0 equiv), CH2Cl2 (1.0 mL), 46a (134 μL, 0.5 mmol, 2.0 equiv) and SiCl4 (31 μL, 
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0.275 mmol, 1.1 equiv). After 17 h, 42% yield was observed by 
1
H NMR spectroscopy. After 
23.8 h, the reaction was quenched and subjected to aqueous workup to provide after column 
chromatography 12 mg (17 %) of 49ca. 
Data for 49ca:  
SFC: (2S,3R)-49ca, tR 18.1 min (19.2%), (2S,3S)/(2R,3R)-49ca, tR 19.7 min (16.7%), 
(2R,3S)-49ca, tR 24.9 min (37.6%), (2R,3R)/(2S,3S)-49ca 26.6 min (26.4%) 
(Chiralpak OD, 125 bar, 40 °C, 3% iPrOH in CO2, 10% iPrOH in CO2 after 20 min, 
3 mL/min, 215 nm) 
Addition of 46a to 38c in the Presence of 0.05 equiv of 51h. (Table 21, entry 12) [MTB-III-
32] 
Following General Procedure 21, an NMR tube was charged with n-Bu4NI (46 mg, 0.125 
mmol, 0.5 equiv), C6Me6 (15.1 mg), (R,R)-51h (6.23 mg, 0.0125 mmol, 0.05 equiv), 38c (38 μL, 
0.25 mmol, 1.0 equiv), CH2Cl2 (1.0 mL), 46a (134 μL, 0.5 mmol, 2.0 equiv) and SiCl4 (31 μL, 
0.275 mmol, 1.1 equiv). After 1 h, 22% yield was observed by 
1
H NMR spectroscopy. After 17 
h, 44% yield and complete consumption of 46a and 38c was observed by 
1
H NMR spectroscopy 
. After 23.8 h, the reaction was quenched and subjected to aqueous workup to provide after 
column chromatography 21 mg (30 %) of 49ca. 
Data for 49ca:  
SFC: (2S,3R)-49ca, tR 18.1 min (7.8%), (2S,3S)/(2R,3R)-49ca, tR 19.7 min (14.1%), 
(2R,3S)-49ca, tR 24.9 min (37.7%), (2R,3R)/(2S,3S)-49ca 26.6 min (40.4%) 
(Chiralpak OD, 125 bar, 40 °C, 3% iPrOH in CO2, 10% iPrOH in CO2 after 20 min, 
3 mL/min, 215 nm) 
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Addition of 46a to 38c in the Presence of 0.1 equiv of 51i. (Table 21, entry 13) [MTB-III-38] 
Following General Procedure 21, an NMR tube was charged with n-Bu4NI (46 mg, 0.125 
mmol, 0.5 equiv), C6Me6 (15.1 mg), (S)-51i (11.5 mg, 0.025 mmol, 0.1 equiv), 38c (38 μL, 0.25 
mmol, 1.0 equiv), CH2Cl2 (1.0 mL), 46a (134 μL, 0.5 mmol, 2.0 equiv) and SiCl4 (31 μL, 0.275 
mmol, 1.1 equiv). After 19 h, 55% yield was observed by 
1
H NMR spectroscopy . After 26 h, the 
reaction was quenched and subjected to aqueous workup to provide after column 
chromatography 26 mg (37 %) of 49ca. 
Data for 49ca:  
SFC: (2S,3R)-49ca, tR 18.1 min (30.8%), (2S,3S)/(2R,3R)-49ca, tR 19.7 min (29.9%), 
(2R,3S)-49ca, tR 24.9 min (19.9%), (2R,3R)/(2S,3S)-49ca 26.6 min (19.3%) 
(Chiralpak OD, 125 bar, 40 °C, 3% iPrOH in CO2, 10% iPrOH in CO2 after 20 min, 
3 mL/min, 215 nm) 
 
Addition of Silyl Ketene Imines to Aliphatic Aldehydes. Attempted Addition of 46a to 30a 
at 23 
o
C in the presence of 0.5 equiv of n-Bu4NI and 0.2 equiv of 50. (Table 24, entry 1) 
[MTB-III-64] 
 
An oven-dried, 5-mm NMR tube, fitted with a septum, under Ar was charged with n-
Bu4NI (46.2 mg, 0.25 mmol, 1.0 equiv), 50 (10.8 mg, 0.05 mmol, 0.2 equiv), 30a (33 μL, 0.25 
mmol, 1.0 equiv), 46a (134 μL, 0.5 mmol, 2.0 equiv) and CH2Cl2 (1.0 mL). The tube was 
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agitated in a vortex mixer. Silicon tetrachloride (31 μL, 0.275 mmol, 1.1 equiv) was added. The 
tube was agitated in a vortex mixer. . The septum was covered in Parafilm
®
, and the tube was 
placed in a desiccator over P2O5. After 14 h, a No-D
113
 
1
H NMR spectrum was taken (acquisition 
parameters d1=20, at=9, nt=8). 53aa was not observed. After 15h, the reaction mixture was 
quenched by pouring the solution into a 50-mL Erlenmeyer flask containing a rapidly stirring 
solution of sat. aq. KF (5 mL) and sat. aq. (5 mL) NaHCO3 solutions. The mixture was stirred 
vigorously for 4 h and then was transferred to a 125-mL separatory funnel. The mixture was 
extracted with CH2Cl2 (3 x 10 mL). The combined organic layers were dried over Na2SO4, 
filtered and concentrated in vacuo (23° C, 14 mmHg). The residue contained a complex mixture 
of products by 
1
H NMR, which did not include 53aa. 
 
C.6.4. Addition of Silyl Ketene Imines to Aliphatic Aldehydes. 
Addition of 46a to 30a between 0 and 14 
o
C in the presence of 0.5 equiv of n-Bu4NI and 0.2 
equiv of 50. Preparation of (2R,3S)-3-hydroxy-2-methyl-2,5-diphenylpentanenitrile. (53aa) 
(Table 24, entry 2) [MTB-III-69] 
 
A flame-dried, 5-mL Schlenk flask, fitted with septum and a magnetic stir bar, under Ar 
was charged with n-Bu4NI (46.2 mg, 0.25 mmol, 1.0 equiv), 50 (10.8 mg, 0.05 mmol, 0.2 equiv), 
30a (33 μL, 0.25 mmol, 1.0 equiv), 46a (134 μL, 0.5 mmol, 2.0 equiv) and CH2Cl2 (1.0 mL). 
The flask was cooled to 0 
o
C (ice bath). Silicon tetrachloride (31 μL, 0.275 mmol, 1.1 equiv) was 
added. The mixture was stirred for 16 h. Between 5 and 16 h the bath temperature increased to 
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14 
o
C. After 16h, the reaction mixture was quenched by pouring the solution into a 50-mL 
Erlenmeyer flask containing a rapidly stirring solution of sat. aq. KF (5 mL) and sat. aq. (5 mL) 
NaHCO3 solutions. The mixture was stirred vigorously for 7 h and then was transferred to a 125-
mL separatory funnel. The mixture was extracted with CH2Cl2 (3 x 10 mL) and EtOAc (10 mL). 
The combined organic layers were dried over Na2SO4, filtered and concentrated in vacuo (23° C, 
14 mmHg). The resulting residue was purified by column chromatography (silica gel, 18 g, 10 
cm long,  2 cm diam, hexanes/EtOAc 4:1) to provide 22 mg (33%) of 53aa as a thick, colorless 
oil.  
Data for 53aa: 
1
H NMR: (500 MHz, CDCl3) 
δ 7.48 – 7.43 (m, 2H, HC(7,11)), 7.44 – 7.38 (m, 2H, HC(8,12)), 7.38 – 7.35 (m,1H, 
HC(13,9)), 7.31 – 7.24 (m, 2H, HC(8,12)), 7.20 – 7.23 (m, 1H, HC(13,9)), 7.18 – 
7.14 (m, 2H, HC(7,11)), 3.78 (ddd, J = 10.7, 5.4, 1.9, 1H, HC(3)), 2.92 (ddd, J = 
14.0, 9.3, 4.9, 1H, H2C(4)), 2.66 (dt, J = 13.9, 8.3, 1H, H2C(4)), 2.00 (dd, J = 22.2, 
8.4, 1H, H2C(5)), 1.87 – 1.74 (m, 1H, H2C(5)), 1.71 (s, 3H, H3C(14)). 
13
C NMR: (125 MHz, CDCl3) 
δ 141.0 (C(6/10)), 137.3 (C(6/10)), 129.0 (C(Aryl)), 128.5(C(Aryl)), 128.4(C(Aryl)), 
126.5(C(Aryl)), 126.1(C(Aryl)), 122.1 (C(1)), 76.4 (C(3)) 48.6 (C(2)), 33.6 (C(4/5)), 
32.1 (C(4/5)), 22.3 (C(14)). 
TLC: Rf 0.21 (hexanes/EtOAc, 4:1) [KMnO4] 
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Addition of Silyl Ketene Imines to Aliphatic Aldehydes. Addition of 46a to 30a at 0 
o
C in 
the presence of 0.5 equiv of n-Bu4NI and 0.05 equiv of (R,R)-34. (Table 24, entry 3) [MTB-
III-77] 
 
A flame-dried, 5-mL Schlenk flask, fitted with septum and a magnetic stir bar, under Ar 
was charged with n-Bu4NI (46.2 mg, 0.25 mmol, 1.0 equiv), (R,R)-34 (10.5 mg, 0.05 mmol, 0.2 
equiv) and CH2Cl2 (1.0 mL). The flask was fitted with an internal temperature probe and was 
cooled to 0 
o
C (thermostated IPA bath).  30a (33 μL, 0.25 mmol, 1.0 equiv), 46a (134 μL, 0.5 
mmol, 2.0 equiv) and SiCl4 (31 μL, 0.275 mmol, 1.1 equiv) were added via syringe. The mixture 
was stirred for 24 h, and then the reaction mixture was quenched by pouring the solution into a 
50-mL Erlenmeyer flask containing a rapidly stirring solution of sat. aq. KF (5 mL) and sat. aq. 
(5 mL) NaHCO3 solutions. The mixture was stirred vigorously for 1.5 h and then was transferred 
to a 125-mL separatory funnel. The mixture was extracted with CH2Cl2 (3 x 10 mL). The 
combined organic layers were dried over Na2SO4, filtered and concentrated in vacuo (23° C, 14 
mmHg). The resulting residue was purified by column chromatography (silica gel, 18 g, 10 cm 
long,  2 cm diam, hexanes/EtOAc 4:1) to provide 43.9mg (66%) of 53aa as a thick, colorless oil.  
Data for 53aa:  
SFC: (2S,3S)/(2R,3R)-53aa, tR 11.5 min (5.4%), (2R,3S)-53aa, tR 12.2 min (78.8%), 
(2R,3R)/(2S,3S)-53aa tR 14.0 min (5.2%), (2S,3R)-53aa, tR 19.8 min (10.4%) 
(Chiralpak AS, 135 bar, 40 °C, 8% MeOH in CO2, 1 mL/min). 
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General Procedure 22. Addition of Silyl Ketene Imines to Aliphatic Aldehydes. In-Situ IR 
Monitoring of the Addition of 46a to 30a at -10 
o
C in the presence of 0.5 equiv of n-Bu4NI 
and 0.05 equiv of (R,R)-34. (Table 24, entry 4) [MTB-III-81] 
 
A oven-dried, 3-necked React-IR cell, fitted with a magnetic stir bar, an internal 
temperature probe, a septum and a stopper, was charged with (R,R)-34 (10.5 mg, 0.0125 mmol, 
0.05 equiv) and n-Bu4NI (46.2 mg, 0.125 mmol, 0.5 equiv). The cell was fitted to the React-IR 
probe (ZrComp), and purged with argon through an oil  bubbler. Dichloromethane (1.0  mL)  
was  added  via  syringe,  and the cell was cooled to -10 
o
C (thermostated iPrOH bath). A 
background spectrum  was acquired (4 cm
-1
 resolution, 4400 – 1500 cm-1, 1024 scans). Data 
acquisition was begun (4 cm
-1
 resolution, 256 scans, 3 min/spectrum). The cell was charged with 
30a (33 μL, 0.25 mmol, 1.0 equiv), 46a (134 μL, 0.5 mmol, 2.0 equiv) and SiCl4 (31 μL, 0.275 
mmol, 1.1 equiv) via syringe. The mixture was stirred for 18 h at -10 
o
C and was then quenched 
by pouring the solution into a 50-mL Erlenmeyer flask containing a rapidly stirring solution of 
sat. aq. KF (5 mL) and sat. aq. (5 mL) NaHCO3 solutions. The mixture was stirred vigorously for 
2h and then was transferred to a 125-mL separatory funnel. Water was added (20 mL), and the 
mixture was extracted with CH2Cl2 (3 x 10 mL) and EtOAc (10 mL). The combined organic 
layers were dried over Na2SO4, filtered and concentrated in vacuo (23° C, 14 mmHg). The 
resulting residue was purified by column chromatography (silica gel, 18 g, 10 x 2 cm diam, 
hexanes/EtOAc 4:1) to provide 49.4 mg (74%) of 53aa as a thick, colorless oil.  
358 
 
Data for 53aa:  
SFC: (2S,3S)/(2R,3R)-53aa, tR 11.5 min (5.0%), (2R,3S)-53aa, tR 12.2 min (81.8%), 
(2R,3R)/(2S,3S)-53aa tR 14.0 min (4.4%), (2S,3R)-53aa, tR 19.8 min (8.8%) 
(Chiralpak AS, 135 bar, 40 °C, 8% MeOH in CO2, 1 mL/min). 
 
Addition of Silyl Ketene Imines to Aliphatic Aldehydes. In-Situ IR Monitoring of the 
Addition of 46a to 30a at -20 
o
C in the presence of 0.5 equiv of n-Bu4NI and 0.05 equiv of 
(R,R)-34. (Table 24, entry 5) [MTB-III-97] 
Following General Procedure 22, a React-IR cell was charged with (R,R)-34 (10.5 mg, 
0.0125 mmol, 0.05 equiv), n-Bu4NI (46.2 mg, 0.125 mmol, 0.5 equiv), CH2Cl2 (1.0 mL) 30a (33 
μL, 0.25 mmol, 1.0 equiv), 46a (134 μL, 0.5 mmol, 2.0 equiv) and SiCl4 (31 μL, 0.275 mmol, 1.1 
equiv) at -20 
o
C for 17 h to provide after chromatography 44 mg (66%) of 53aa. 
Data for 53aa:  
SFC: (2S,3S)/(2R,3R)-53aa, tR 11.5 min (6.0%), (2R,3S)-53aa, tR 12.2 min (84.4%), 
(2R,3R)/(2S,3S)-53aa tR 14.0 min (3.1%), (2S,3R)-53aa, tR 19.8 min (6.3%) 
(Chiralpak AS, 135 bar, 40 °C, 8% MeOH in CO2, 1 mL/min). 
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Addition of Silyl Ketene Imines to Aliphatic Aldehydes. In-Situ IR Monitoring of the 
Addition of 46a to 30a at 0 
o
C in the presence of 0.5 equiv of n-Bu4NCl and 0.05 equiv of 
(R,R)-34. (Table 24, entry 6) [MTB-III-87] 
Following General Procedure 22, a React-IR cell was charged with (R,R)-34 (10.5 mg, 
0.0125 mmol, 0.05 equiv), n-Bu4NCl (34.7 mg, 0.125 mmol, 0.5 equiv), CH2Cl2 (1.0 mL) 30a 
(33 μL, 0.25 mmol, 1.0 equiv), 46a (134 μL, 0.5 mmol, 2.0 equiv) and SiCl4 (31 μL, 0.275 
mmol, 1.1 equiv) at 0 
o
C for 1 h to provide only trace 53aa. Rapid decay of the ketene imine 
stretch was observed by IR. 
 
Addition of Silyl Ketene Imines to Aliphatic Aldehydes. In-Situ IR Monitoring of the 
Addition of 46a to 30a at -20 
o
C in the presence of 0.5 equiv of n-Bu4NBr and 0.05 equiv of 
(R,R)-34. (Table 24, entry 7) [MTB-III-89] 
Following General Procedure 22, a React-IR cell was charged with (R,R)-34 (10.5 mg, 
0.0125 mmol, 0.05 equiv), n-Bu4NBr (40.3 mg, 0.125 mmol, 0.5 equiv), CH2Cl2 (1.0 mL) 30a 
(33 μL, 0.25 mmol, 1.0 equiv), 46a (134 μL, 0.5 mmol, 2.0 equiv) and SiCl4 (31 μL, 0.275 
mmol, 1.1 equiv) at 0 
o
C for 17 h to provide after chromatography 37 mg (56%) of 53aa. 
Data for 53aa:  
SFC: (2S,3S)/(2R,3R)-53aa, tR 11.5 min (10.2%), (2R,3S)-53aa, tR 12.2 min (71.3%), 
(2R,3R)/(2S,3S)-53aa tR 14.0 min (8.2%), (2S,3R)-53aa, tR 19.8 min (10.3%) 
(Chiralpak AS, 135 bar, 40 °C, 8% MeOH in CO2, 1 mL/min). 
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Addition of Silyl Ketene Imines to Aliphatic Aldehydes. In-Situ IR Monitoring of the 
Addition of 46a to 30a at -20 
o
C in the presence of 0.5 equiv of n-Bu4NOTf and 0.05 equiv 
of (R,R)-34. (Table 24, entry 8) [MTB-III-91] 
Following General Procedure 22, a React-IR cell was charged with (R,R)-34 (10.5 mg, 
0.0125 mmol, 0.05 equiv), n-Bu4NOTf (48.9 mg, 0.125 mmol, 0.5 equiv), CH2Cl2 (1.0 mL) 30a 
(33 μL, 0.25 mmol, 1.0 equiv), 46a (134 μL, 0.5 mmol, 2.0 equiv) and SiCl4 (31 μL, 0.275 
mmol, 1.1 equiv) at 0 
o
C for 17 h to provide only a trace of 53aa by 
1
H NMR. 
 
Addition of Silyl Ketene Imines to Aliphatic Aldehydes. In-Situ IR Monitoring of the 
Addition of 54a to 30a at 0 
o
C in the presence of 0.5 equiv of n-Bu4NI and 0.05 equiv of 
(R,R)-34. (Table 24, entry 9) [MTB-III-100] 
Following General Procedure 22, a React-IR cell was charged with (R,R)-34 (10.5 mg, 
0.0125 mmol, 0.05 equiv), n-Bu4NI (46.2 mg, 0.125 mmol, 0.5 equiv), CH2Cl2 (1.0 mL) 30a (33 
μL, 0.25 mmol, 1.0 equiv), 54a (144 mg, 0.5 mmol, 2.0 equiv) and SiCl4 (31 μL, 0.275 mmol, 
1.1 equiv) at 0 
o
C for 17 h to provide after chromatography 42 mg (63%) of 53aa. 
Data for 53aa:  
SFC: (2S,3S)/(2R,3R)-53aa, tR 11.5 min (3.8%), (2R,3S)-53aa, tR 12.2 min (85.7%), 
(2R,3R)/(2S,3S)-53aa tR 14.0 min (2.9%), (2S,3R)-53aa, tR 19.8 min (7.4%) 
(Chiralpak AS, 135 bar, 40 °C, 8% MeOH in CO2, 1 mL/min). 
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Addition of Silyl Ketene Imines to Aliphatic Aldehydes. In-Situ IR Monitoring of the 
Addition of 54b to 30a at 0 
o
C in the presence of 0.5 equiv of n-Bu4NI and 0.05 equiv of 
(R,R)-34. (Table 24, entry 10) [MTB-III-IV-11] 
Following General Procedure 22, a React-IR cell was charged with (R,R)-34 (10.5 mg, 
0.0125 mmol, 0.05 equiv), n-Bu4NI (46.2 mg, 0.125 mmol, 0.5 equiv), CH2Cl2 (0.8 mL) 30a (33 
μL, 0.25 mmol, 1.0 equiv), 54b (0.46 ml of a 1.2 M solution in CH2Cl2, 0.5 mmol, 2.0 equiv) and 
SiCl4 (31 μL, 0.275 mmol, 1.1 equiv) at 0 
o
C for 17 h to provide after chromatography 13 mg 
(20%) of 53aa. 
Data for 53aa:  
SFC: (2S,3S)/(2R,3R)-53aa, tR 11.5 min (2.9%), (2R,3S)-53aa, tR 12.2 min (71.0%), 
(2R,3R)/(2S,3S)-53aa tR 14.0 min (6.7%), (2S,3R)-53aa, tR 19.8 min (19.4%) 
(Chiralpak AS, 135 bar, 40 °C, 8% MeOH in CO2, 1 mL/min). 
 
Addition of Silyl Ketene Imines to Aliphatic Aldehydes. In-Situ IR Monitoring of the 
Addition of 46a to 30a at 0 
o
C in the presence of 0.05 equiv of (R,R)-34. (Table 24, entry 11) 
[MTB-III-IV-13] 
Following General Procedure 22, a React-IR cell was charged with (R,R)-34 (10.5 mg, 
0.0125 mmol, 0.05 equiv), CH2Cl2 (0.8 mL) 30a (33 μL, 0.25 mmol, 1.0 equiv), 54b (0.46 ml of 
a 1.2 M solution in CH2Cl2, 0.5 mmol, 2.0 equiv) and SiCl4 (31 μL, 0.275 mmol, 1.1 equiv) at 0 
o
C for 17 h to provide after chromatography 22.9 mg (34%) of 53aa. 
Data for 53aa:  
SFC: (2S,3S)/(2R,3R)-53aa, tR 11.5 min (10.1%), (2R,3S)-53aa, tR 12.2 min (57.2%), 
(2R,3R)/(2S,3S)-53aa tR 14.0 min (9.6%), (2S,3R)-53aa, tR 19.8 min (23.0%) 
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(Chiralpak AS, 135 bar, 40 °C, 8% MeOH in CO2, 1 mL/min). 
 
Addition of Silyl Ketene Imines to Aliphatic Aldehydes. In-Situ IR Monitoring of the 
Addition of 46a to 30a at -20 
o
C in the presence of 1.0 equiv of n-Bu4NI and 0.05 equiv of 
(R,R)-34. (Table 24, entry 12) [MTB-IV-06] 
Following General Procedure 22, a React-IR cell was charged with (R,R)-34 (10.5 mg, 
0.0125 mmol, 0.05 equiv), n-Bu4NI (94.2 mg, 0.125 mmol, 1.0 equiv), CH2Cl2 (1.0 mL), 30a (33 
μL, 0.25 mmol, 1.0 equiv), 46a (134 μL, 0.5 mmol, 2.0 equiv) and SiCl4 (31 μL, 0.275 mmol, 1.1 
equiv) at 0 
o
C for 17 h to provide after chromatography 44.6 mg (67%) of 53aa. 
Data for 53aa:  
SFC: (2S,3S)/(2R,3R)-53aa, tR 11.5 min (5.8%), (2R,3S)-53aa, tR 12.2 min (85.8%), 
(2R,3R)/(2S,3S)-53aa tR 14.0 min (5.1%), (2S,3R)-53aa, tR 19.8 min (9.0%) 
(Chiralpak AS, 135 bar, 40 °C, 8% MeOH in CO2, 1 mL/min). 
 
Addition of Silyl Ketene Imines to Aliphatic Aldehydes. In-Situ IR Monitoring of the 
Addition of 46a to 30a at -20 
o
C in the presence of 1.0 equiv of n-Bu4NI and 0.05 equiv of 
(R,R)-34. (Table 24, entry 12) [MTB-IV-06] 
Following General Procedure 22, a React-IR cell was charged with (R,R)-34 (10.5 mg, 
0.0125 mmol, 0.05 equiv), n-Bu4NI (94.2 mg, 0.125 mmol, 1.0 equiv), CH2Cl2 (1.0 mL), 30a (33 
μL, 0.25 mmol, 1.0 equiv), 46a (134 μL, 0.5 mmol, 2.0 equiv) and SiCl4 (31 μL, 0.275 mmol, 1.1 
equiv) at 0 
o
C for 17 h to provide after chromatography 44.6 mg (67%) of 53aa. 
Data for 53aa:  
SFC: (2S,3S)/(2R,3R)-53aa, tR 11.5 min (5.8%), (2R,3S)-53aa, tR 12.2 min (85.8%), 
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(2R,3R)/(2S,3S)-53aa tR 14.0 min (5.1%), (2S,3R)-53aa, tR 19.8 min (9.0%) 
(Chiralpak AS, 135 bar, 40 °C, 8% MeOH in CO2, 1 mL/min). 
 
Addition of Silyl Ketene Imines to Aliphatic Aldehydes. Addition of 56a to 30a at -20 
o
C in 
the presence of 1.0 equiv of n-Bu4NI and 0.05 equiv of (R,R)-34. Preparation of (2R,3S)-3-
hydroxy-2-methyl-2,5-diphenylpentanenitrile (53aa) (Table 24, entry 13) [MTB-IV-18] 
 
A flame-dried, 5-mL Schlenk flask, fitted with septum and a magnetic stir bar, under Ar 
was charged with n-Bu4NI (92.5 mg, 0.25 mmol, 1.0 equiv), (R,R)-34 (10.5 mg, 0.0125 mmol, 
0.05 equiv), 30a (33 μL, 0.25 mmol, 1.0 equiv), 54a (144 mg, 0.5 mmol, 2.0 equiv) and CH2Cl2 
(0.6 mL). The flask was fitted with an internal temperature probe and was cooled to -20 
o
C. 
Silicon tetrachloride (31 μL, 0.275 mmol, 1.1 equiv) was added. The mixture was stirred for 24 h 
at -20 
o
C and was then quenched by pouring the solution into a 50-mL Erlenmeyer flask 
containing a rapidly stirring solution of sat. aq. KF (5 mL) and sat. aq. (5 mL) NaHCO3 
solutions. The mixture was stirred vigorously for 1h and then was transferred to a 125-mL 
separatory funnel. Water was added (20 mL), and the mixture was extracted with CH2Cl2 (3 x 10 
mL). The combined organic layers were dried over Na2SO4, filtered and concentrated in vacuo 
(23° C, 14 mmHg). The resulting residue was purified by column chromatography (silica gel, 25 
g, 12 x 2 cm diam, hexanes/EtOAc 4:1) to provide 56 mg (84%) of 53aa as a thick, colorless oil.  
Data for 53aa:  
SFC: (2S,3S)/(2R,3R)-53aa, tR 11.5 min (0.4%), (2R,3S)-53aa, tR 12.2 min (93.3%), 
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(2R,3R)/(2S,3S)-53aa tR 14.0 min (1.0%), (2S,3R)-53aa, tR 19.8 min (5.2%) 
(Chiralpak AS, 135 bar, 40 °C, 8% MeOH in CO2, 1 mL/min). 
 
Addition of Silyl Ketene Imines to Aliphatic Aldehydes. Addition of 56a to 30a at -20 
o
C in 
the presence of 1.0 equiv of n-Bu4NI and 0.05 equiv of (S,S)-55a. Preparation of (2R,3S)-3-
hydroxy-2-methyl-2,5-diphenylpentanenitrile (53aa) (Table 24, entry 14) [MTB-IV-49] 
 
A flame-dried, 5-mL Schlenk flask, fitted with septum and a magnetic stir bar, under Ar 
was charged with n-Bu4NI (92.5 mg, 0.25 mmol, 1.0 equiv), (S,S)-55a (8.7 mg, 0.0125 mmol, 
0.05 equiv), 30a (33 μL, 0.25 mmol, 1.0 equiv), 54a (144 mg, 0.5 mmol, 2.0 equiv) and CH2Cl2 
(0.6 mL). The flask was fitted with an internal temperature probe and was cooled to -20 
o
C. 
Silicon tetrachloride (31 μL, 0.275 mmol, 1.1 equiv) was added. The mixture was stirred for 24 h 
at -20 
o
C and was then quenched by pouring the solution into a 50-mL Erlenmeyer flask 
containing a rapidly stirring solution of sat. aq. KF (5 mL) and sat. aq. (5 mL) NaHCO3 
solutions. The mixture was stirred vigorously for 1h and then was transferred to a 125-mL 
separatory funnel. Water was added (20 mL), and the mixture was extracted with CH2Cl2 (3 x 10 
mL). The combined organic layers were dried over Na2SO4, filtered and concentrated in vacuo 
(23° C, 14 mmHg). The resulting residue was purified by column chromatography (silica gel, 25 
g, 12 x 2 cm diam, hexanes/EtOAc 64:1) to provide 45.6 mg (69%) of 53aa as a thick, colorless 
oil.  
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Data for 53aa:  
SFC: (2S,3S)/(2R,3R)-53aa, tR 11.5 min (0.9%), (2R,3S)-53aa, tR  12.2 min (23.5%), 
(2R,3R)/(2S,3S)-53aa tR 14.0 min (0.6%), (2S,3R)-53aa, tR 19.8 min (75.0%) 
(Chiralpak AS, 135 bar, 40 °C, 8% MeOH in CO2, 1 mL/min). 
 
Addition of Silyl Ketene Imines to Aliphatic Aldehydes. Addition of 56a to 30a at -20 
o
C in 
the presence of 1.0 equiv of n-Bu4NI and 0.05 equiv of (R,R)-55b. (Table 24, entry 15) 
[MTB-IV-50] 
 
A flame-dried, 5-mL Schlenk flask, fitted with septum and a magnetic stir bar, under Ar 
was charged with n-Bu4NI (92.5 mg, 0.25 mmol, 1.0 equiv), (R,R)-55b (13.9 mg, 0.0125 mmol, 
0.15 equiv), 30a (33 μL, 0.25 mmol, 1.0 equiv), 54a (144 mg, 0.5 mmol, 2.0 equiv) and CH2Cl2 
(0.6 mL). The flask was fitted with an internal temperature probe and was cooled to -20 
o
C. 
Silicon tetrachloride (31 μL, 0.275 mmol, 1.1 equiv) was added. The mixture was stirred for 24 h 
at -20 
o
C and was then quenched by pouring the solution into a 50-mL Erlenmeyer flask 
containing a rapidly stirring solution of sat. aq. KF (5 mL) and sat. aq. (5 mL) NaHCO3 
solutions. The mixture was stirred vigorously for 1h and then was transferred to a 125-mL 
separatory funnel. Water was added (20 mL), and the mixture was extracted with CH2Cl2 (3 x 10 
mL). The combined organic layers were dried over Na2SO4, filtered and concentrated in vacuo 
(23° C, 14 mmHg). The resulting residue was purified by column chromatography (silica gel, 25 
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g, 12 x 2 cm diam, hexanes/EtOAc 64:1) to provide 65.4 mg (98%) of 53aa as a thick, colorless 
oil.  
Data for 53aa:  
SFC: (2S,3S)/(2R,3R)-53aa, tR 11.5 min (0.9%), (2R,3S)-53aa, tR  12.2 min (23.5%), 
(2R,3R)/(2S,3S)-53aa tR 14.0 min (0.6%), (2S,3R)-53aa, tR 19.8 min (75.0%) 
(Chiralpak AS, 135 bar, 40 °C, 8% MeOH in CO2, 1 mL/min). 
 
Addition of Silyl Ketene Imines to Aliphatic Aldehydes. Addition of 56a to 30a at -20 
o
C in 
the presence of 1.0 equiv of n-Bu4NI and 0.05 equiv of (R,R)-55c. (Table 24, entry 15) 
[MTB-VI-69] 
 
A flame-dried, 5-mL Schlenk flask, fitted with septum and a magnetic stir bar, under Ar 
was charged with (R,R)-55c (13.2 mg, 0.0125 mmol, 0.15 equiv) as a solution in CH2Cl2 (0.5 
mL). The solvent was removed in vacuo (0.1 mmHg), and the residue was dissolved in dry PhMe 
(2.0 mL). The solution was concentrated in vacuo (0.1 mmHg, 50 
o
C) to dry the catalyst.  n-
Bu4NI (92.5 mg, 0.25 mmol, 1.0 equiv), 30a (33 μL, 0.25 mmol, 1.0 equiv), 54a (134 μL, 0.5 
mmol, 2.0 equiv) and CH2Cl2 (0.6 mL) were added. The flask was fitted with an internal 
temperature probe and was cooled to -20 
o
C. Silicon tetrachloride (31 μL, 0.275 mmol, 1.1 
equiv) was added. The mixture was stirred for 24 h at -20 
o
C and was then quenched by pouring 
the solution into a 50-mL Erlenmeyer flask containing a rapidly stirring solution of sat. aq. KF (5 
mL) and sat. aq. (5 mL) NaHCO3 solutions. The mixture was stirred vigorously for 2h and then 
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was transferred to a 125-mL separatory funnel. Water was added (20 mL), and the mixture was 
extracted with CH2Cl2 (3 x 10 mL). The combined organic layers were dried over Na2SO4, 
filtered and concentrated in vacuo (23° C, 14 mmHg). The resulting residue was purified by 
column chromatography (silica gel, 25 g, 12 x 2 cm diam, hexanes/EtOAc 64:1) to provide 63 
mg (84%) of 53aa as a thick, colorless oil.  
Data for 53aa:  
SFC: (2S,3S)/(2R,3R)-53aa, tR 12.0 min (14.7%), (2R,3S)-53aa, tR  12.7 min (34.5%), 
(2R,3R)/(2S,3S)-53aa tR 14.0 min (10.7%), (2S,3R)-53aa, tR 19.8 min (40.1%) 
(Chiralpak AS, 135 bar, 40 °C, 8% MeOH in CO2, 1 mL/min). 
 
Addition of Silyl Ketene Imines to Aliphatic Aldehydes. Addition of 54a to 30b. 
Preparation of (2R,3S)-3-Hydroxy-2-methyl-2-phenyloctanenitrile (53ba) (Table 25, entry 
1) [MTB-IV-21] 
 
A flame-dried, 5-mL Schlenk flask, fitted with septum and a magnetic stir bar, under Ar 
was charged with n-Bu4NI (92.5 mg, 0.25 mmol, 1.0 equiv), (R,R)-34 (10.5 mg, 0.0125 mmol, 
0.05 equiv), 30b (31 μL, 0.25 mmol, 1.0 equiv), 54a (144 mg, 0.5 mmol, 2.0 equiv) and CH2Cl2 
(0.6 mL). The flask was fitted with an internal temperature probe and was cooled to -20 
o
C. 
Silicon tetrachloride (31 μL, 0.275 mmol, 1.1 equiv) was added. The mixture was stirred for 24 h 
at -20 
o
C and was then quenched by pouring the solution into a 50-mL Erlenmeyer flask 
containing a rapidly stirring solution of sat. aq. KF (5 mL) and sat. aq. (5 mL) NaHCO3 
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solutions. The mixture was stirred vigorously for 1h and then was transferred to a 125-mL 
separatory funnel. Water was added (20 mL), and the mixture was extracted with CH2Cl2 (3 x 10 
mL). The combined organic layers were dried over Na2SO4, filtered and concentrated in vacuo 
(23° C, 14 mmHg). The resulting residue was purified by column chromatography (silica gel, 25 
g, 12 x 2 cm diam, hexanes/EtOAc 64:1) to provide 54 mg (94%) of 53ba as a thick, colorless 
oil.  
Data for 53ba: 
1
H NMR: (500 MHz, CDCl3) 
δ 7.52 – 7.47 (m, 2H, HC(9)), 7.45 – 7.39 (m, 2H, HC(10)), 7.38 – 7.33 (m, 1H, 
HC(11)), 3.78 (ddd, J = 10.5, 5.6, 2.0, 1H, HC(3)), 1.74 (s, 3H, HC(12)), 1.46 – 1.37 
(m, 2H), 1.37 – 1.17 (m, 6H), 0.88 (t, J = 6.9, 3H, H3C(8)). 
TLC: Rf 0.32 (hexanes/EtOAc, 4:1) [KMnO4] 
SFC: (2S,3S)/(2R,3R)-53ba tR 7.5 min  (5%), (2R,3S)-53ba tR 7.9 min (86%), 
(2R,3R)/(2S,3S)-53ba tR 9.1 min (obscured), (2S,3R)-53ba tR 13.0 min (8%) 
(Chiralpak AS, 125 bar, 40 °C, 3% MeOH in CO2, 1.5 mL/min). 
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Addition of Silyl Ketene Imines to Aliphatic Aldehydes. Addition of 54a to 30c. Preparation 
of (2R,3S)-8-(Benzyloxy)-3-hydroxy-2-methyl-2-phenyloctanenitrile (53aa) (Table 25, entry 
2) [MTB-IV-26] 
 
A flame-dried, 5-mL Schlenk flask, fitted with septum and a magnetic stir bar, under Ar 
was charged with n-Bu4NI (92.5 mg, 0.25 mmol, 1.0 equiv), (R,R)-34 (10.5 mg, 0.0125 mmol, 
0.05 equiv), 30c (51 mg, 0.25 mmol, 1.0 equiv), 54a (144 mg, 0.5 mmol, 2.0 equiv) and CH2Cl2 
(0.6 mL). The flask was fitted with an internal temperature probe and was cooled to -20 
o
C. 
Silicon tetrachloride (31 μL, 0.275 mmol, 1.1 equiv) was added. The mixture was stirred for 24 h 
at -20 
o
C and was then quenched by pouring the solution into a 50-mL Erlenmeyer flask 
containing a rapidly stirring solution of sat. aq. KF (5 mL) and sat. aq. (5 mL) NaHCO3 
solutions. The mixture was stirred vigorously for 1h and then was transferred to a 125-mL 
separatory funnel. Water was added (20 mL), and the mixture was extracted with CH2Cl2 (3 x 10 
mL). The combined organic layers were dried over Na2SO4, filtered and concentrated in vacuo 
(23° C, 14 mmHg). The resulting residue was purified by column chromatography (silica gel, 25 
g, 12 x 2 cm diam, hexanes/EtOAc 64:1) to provide 70 mg (83%) of 53ca as a thick, colorless 
oil.  
Data for 53ca: 
1
H NMR: (500 MHz, CDCl3) 
δ 7.50 – 7.46 (m, 2H), 7.44 – 7.39 (m, 2H), 7.38 – 7.31 (m, 5H), 7.30 – 7.26 (m, 
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1H), 4.48 (s, 2H, H2C(9)), 3.77 (ddd, J = 10.5, 5.5, 1.9, 1H, HC(3)), 3.45 (t, J = 6.5, 
2H, H2C(8)), 1.73 (s, 3H, H3C(14)), 1.63 – 1.57 (m, 4H), 1.48 – 1.30 (m, 6H). 
TLC: Rf 0.17 (hexanes/EtOAc, 4:1) [KMnO4] 
SFC: (2S,3S)/(2R,3R)-53ca tR 7.7 min (0.7%), (2R,3S)-53ca tR 10.1 min (88.9%), 
(2R,3R)/(2S,3S)-53ca tR 12.2 min (0.8%), (2S,3R)-53ca tR 13.2 min (9.4%) 
(Chiralpak OD, 125 bar, 40 °C, 8% MeOH in CO2, 3 mL/min) 
 
Addition of Silyl Ketene Imines to Aliphatic Aldehydes. Addition of 54a to 30d. 
Preparation of (2R,3S)-3-Hydroxy-2,5-dimethyl-2-phenylhexaenitrile (53da) (Table 25, 
entry 3) [MTB-IV-20] 
 
A flame-dried, 5-mL Schlenk flask, fitted with septum and a magnetic stir bar, under Ar 
was charged with n-Bu4NI (92.5 mg, 0.25 mmol, 1.0 equiv), (R,R)-34 (10.5 mg, 0.0125 mmol, 
0.05 equiv), 30d (27 μL, 0.25 mmol, 1.0 equiv), 54a (144 mg, 0.5 mmol, 2.0 equiv) and CH2Cl2 
(0.6 mL). The flask was fitted with an internal temperature probe and was cooled to -20 
o
C. 
Silicon tetrachloride (31 μL, 0.275 mmol, 1.1 equiv) was added. The mixture was stirred for 24 h 
at -20 
o
C and was then quenched by pouring the solution into a 50-mL Erlenmeyer flask 
containing a rapidly stirring solution of sat. aq. KF (5 mL) and sat. aq. (5 mL) NaHCO3 
solutions. The mixture was stirred vigorously for 1h and then was transferred to a 125-mL 
separatory funnel. Water was added (20 mL), and the mixture was extracted with CH2Cl2 (3 x 10 
mL). The combined organic layers were dried over Na2SO4, filtered and concentrated in vacuo 
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(23° C, 14 mmHg). The resulting residue was purified by column chromatography (silica gel, 25 
g, 12 x 2 cm diam, hexanes/EtOAc 64:1) to provide 70 mg (83%) of 53da as a thick, colorless 
oil.  
Data for 53da: 
1
H NMR: (500 MHz, CDCl3) 
δ 7.52 – 7.47 (m, 2H, HC(8)), 7.45 – 7.40 (m, 2H, HC(9)), 7.38 – 7.33 (m,1H, 
HC(10)), 3.85 (ddd, J = 10.4, 5.6, 2.2, 1H, HC(3)), 1.88-1.80 (m, 1H, HC(5)), 1.73 
(s, 3H, H3C(11)), 1.45 (dd, J=10.34, 3.93, 1H, H2C(2)), 1.42-1.35 (m, 1H), 0.94 (d, J 
= 6.7, 3H, H3C(6,7)), 0.89 (d, J = 6.5, 3H, H3C(6,7)). 
TLC: Rf 0.17 (hexanes/EtOAc, 4:1) [KMnO4] 
SFC: (2R,3S)-53da + (2S,3S)/(2R,3R)-53da tR 3.7 min (83%), (2R,3R)/(2S,3S)- -53da tR 
4.3 min (2%), (2S,3R)- -53da tR 6.2 min (15%) (Chiralpak AS, 125 bar, 40 °C, 3% 
MeOH in CO2, 2.5 mL/min) 
  
Synthesis of 55c. Preparation of (S)- N,N'-(5,5'-dibromo-6,6'-dimethyl[1,1'-biphenyl]-2,2'-
diyl)bis-carbamic acid, C,C'-ethyl ester (68) 
 
 To a flame dried, 50-ml Schlenk flask equipped with a magnetic stir bar and a septum 
was added 5,5'-dibromo-6,6'-dimethyl-[1,1'-biphenyl]-2,2'-diamine (1.13 g, 3.07 mmol, 1.0 
equiv), PhMe (20 mL) and pyridine (0.99 mL, 12.28 mmol, 4.0 equiv). Ethyl chloroformate 
(0.88 mL, 0.921 mmol, 3.0 equiv) was added dropwise, with stirring. The reaction was stirred 
overnight, and then quenched by the addition of H2O (ca. 1 mL). The resulting mixture was 
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poured into a 125-mL separatory funnel, where it was diluted with H2O (10 ml) and was 
extracted with EtOAc (3x 10 mL).  The combined organic extracts were dried over Na2SO4, 
filtered and concentrated in vacuo (23° C, 14 mmHg). The residue was purified by automated 
chromatography (silica gel, 40g cartridge, gradient 0:100 – 20:100 EtOAc/ hexanes)  to yield 
1.42 g (89 %) of 68 as a white foam. A sample was recrystallized from hot hexanes for analysis, 
as white needles.  
Data for 68: 
mp: 105-106 °C 
1
H NMR: (500 MHz, CDCl3) 
δ 8.03 (d, J = 8.8, 2H, HC(3)), 7.63 (d, J = 9.0, 2H, HC(4)), 5.96 (s, 1H NH), 4.11 
(q, J = 7.1, 4H, H2C(9)), 1.97 (s, 6H, H), 1.22 (t, J = 7.1, 6H). 
13
C NMR: (125 MHz, CDCl3) 
δ 153.16 (C(8)), 136.84 (C(6), 135.52 (C(2)), 133.68 (C(4)), 125.19 (C(5)), 119.67 
(C(1)), 118.61 (C(3), 61.56 (C(9)), 20.08 (C(7)) , 14.33 (C(10)). 
IR: (neat) 
3413 (s), 3308 (m), 2980 (m), 1738 (vs), 1571 (s), 1505 (vs), 1420 (s), 1380 (s), 
1293 (s), 1211 (vs), 1140 (m), 1095 (s), 1033 (s), 892 (w), 821 (m). 
TLC: Rf 0.30 (hexanes/EtOAc, 4:1) [UV] 
Opt. Rot.: [α]D
24
 -20.08 (c=0.535, EtOH) 
Analysis: C20H22Br2N2O4 (514.21) 
 Calcd: C, 46.72 H, 4.31 N, 5.43 % 
 Found: C, 46.64 H, 4.32 N, 5.47 % 
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Synthesis of 55c. Preparation of (S)- N,N'-(5,5',6,6'-tetramethyl[1,1'-biphenyl]-2,2'-diyl)bis-
carbamic acid, C,C'-ethyl ester (69) 
 
 To a 100-mL round bottom flask, equipped with a magnetic stir bar, a condenser, an inert 
gas inlet, and a septum were added CH3BF3K ( 0.893 g, 7.32 mmol, 4 equiv), 68 (0.941 g, 1.83 
mmol, 1 equiv), Cs2CO3 (3.58 g, 10.98 mmol, 6.0 equiv) and Pd(dppf)2Cl2 (0.269 g, 0.329 mmol, 
0.18 equiv). The flask was evacuated and filled with A. Tetrahydrofuran (18 mL) and H2O (3.6 
mL) were then added. Resulting red solution was refluxed for 36 h, and then was filtered through 
fluted filter paper into a 250-mL separatory funnel. The mixture was diluted with H2O (70 mL) 
and was extracted with 6:1 Et2O/hexanes (1x70 ml) and Et2O (2x30 mL).  The combined organic 
layers were washed with 1 M HCl (2 x 30 mL), dried over MgSO4 (ca. 3 g), filtered and 
concentrated in vacuo (23° C, 14 mmHg). The resulting residue was then purified by column 
chromatography (silica gel (30 g), 500 mL 65:35 CH2Cl2:hexanes, 150 mL CH2Cl2, 200 ml 
20:80 EtOAc:hexanes) to afford 574 mg (81%) of 69 as an extremely thick colorless oil.  A 
portion was further purified by bulb to bulb distillation (0.12 mmHg, 200° C) for analysis, 
providing an extremely thick colorless oil. 
Data for 69: 
1
H NMR: (500 MHz, CDCl3) 
δ  7.97 (d, J = 7.6, 2H,HC(3) ), 7.22 (d, J = 8.4, 2H, HC(4)), 5.98 (s, 2H, NH), 4.09 
(q, J = 7.1, 4H, H2C(9)), 2.29 (s, 6H, H3C(7)), 1.79 (s, 6H, H3C(11)), 1.20 (t, J = 7.1, 
6H, H3C(10)). 
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13
C NMR: (125 MHz, CDCl3) 
δ 153.5 (C(8)), 135.6 (C(5)), 133.9 (C(1)), 132.1 (C(6)), 130.5 (HC(4)), 124.7 
(C(2)), 116.6 (HC(3)), 61.0 (H2C(9)), 20.0 (H3C(7)), 16.1 (H3C(11)), 14.4 (H3-
C(10)). 
TLC: Rf 0.33 (CH2Cl2) [UV] 
Opt. Rot.: [α]D
24
 -28.53 (c=0.5, EtOH) 
Analysis:    C22H28N2O4 (384.46) 
 Calcd: C,68.73 H,7.34  N,7.29 % 
 Found: C,7.54  H,7.38  N,7.54 % 
 
Synthesis of 55c. Preparation of (S)-5,6,5',6',N2,N2'-Hexamethyl[1,1’-biphenyl]-2,2'-
diamine (70)  
 
 To a flame-dried 50-mL 3-necked flask, equipped with a condenser, a magnetic stir bar, a 
septum, and an inert gas inlet were added LiAlH4 (220 mg, 8.5 equiv, 5.8 mmol), THF (4 mL), 
and the mixture cooled in an ice bath. To this mixture 69 (262 mg, 0.682 mmol, 1.0 equiv) was 
added slowly via cannula as a solution in 3 mL of THF. The septum was replaced with a ground 
glass stopper, and the reaction brought to reflux. After 3.5 h, THF (5 mL) was added to replace 
evaporative losses, and the mixture allowed to reflux for another 3 h. After a total of 6.5 h, the 
reaction was quenched with H2O (0.2 mL), 10% aq. NaOH solution (0.4 mL) then H2O (0.6 mL) 
and was filtered through a plug of packed Celite. The Celite was washed with EtOAc (ca. 50 
mL). The resulting solution was concentrated in vacuo (23° C, 14 mmHg) and the residue 
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purified by column chromatography (silica gel (20 g), 10 long, 2 cm diam), hexane/CH2Cl2, 8:2) 
to provide 148 mg (81%) of 70 as a white solid. 
Data for 70:  
1
H NMR: (500 MHz, CDCl3) 
δ   7.09 (d, J = 8.2, 2H, HC(4)), 6.51 (br d, J = 8.0, 2H, HC(3)), 3.26 (br s, 2H, NH), 
2.71 (s, 6H, H3C(8)), 2.23 (s, 6H), 1.80 (s, 6H). 
TLC: Rf 0.125 (CH2Cl2/hexanes 8/2) [UV] 
 
Synthesis of 55c. Preparation of 3,3'-Dibromo-(S)-5,6,5',6',N2,N2'-hexamethyl[1,1’-
biphenyl]-2,2'-diamine (71) 
 
 
 To a flame dried 25-mL round bottom flask, equipped with a magnetic stir bar, an inert 
gas inlet, and a septum, was added 70 (216 mg, 0.806 mmol, 1.0 equiv), and THF(5 mL).  The 
mixture was cooled in an ice bath, and N-bromosuccinimide (301 mg, 1.69 mmol, 2.1 equiv) was 
added. The reaction was stirred for 1 min and then was quenched by adding sat. aqueous 
NaHCO3 solution (5 mL) followed by sat. aqueous Na2S2O4 solution.  The resulting mixture was 
poured into  a 125 ml separatory funnel, diluted with H2O (15 mL) and extracted with EtOAc 
(3x15 mL).  The combined organic extracts were dried over Na2SO4, filtered, and concentrated 
in vacuo (23° C, 14 mmHg). The resulting residue was purified by automated chromatography 
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(silica gel (4 g), gradient 0:100 to 3:97 hexanes/EtOAc) to provide 311.2 mg (90%) of 71 as a 
beige solid. 
Data for 71:  
1
H NMR: (500 MHz, CDCl3) 
δ   7.35 (s, 2H, HC(4)), 3.32 (s, 2H, NH), 2.54 (s, 6H, H3C(8)), 2.21 (s, 6H), 1.78 (s, 
6H). 
13
C NMR: (125 MHz, CDCl3) 
δ 143.9, 135.7, 133.8, 130.7, 130.0, 111.8 (C(3)), 34.7 (C(8)), 19.7, 16.6. 
TLC: Rf 0.22 (EtOAc/hexanes 5/95) [UV] 
 
Synthesis of 55c. Preparation of 3,3'-Diphenyl-(S)-5,6,5',6',N2,N2'-hexamethyl[1,1’-
biphenyl]-2,2'-diamine (32) 
 
 To a 100-mL pear shaped flask equipped with a magnetic stir bar, was added 71 ( 311 
mg, 0.730 mmol, 1.0 equiv), Pd(OAc)2 (16 mg, 0.073 mg, 0.1 equiv), PPh3 (38.3 mg, 0.146 
mmol, 0.2 equiv), PhB(OH)2 (267 mg, 2.19 mmol, 3 equiv) and Ba(OH)2·8H2O (918 mg, 2.92 
mmol, 4 equiv). The flask was fitted with a condenser, a septum, and an inert gas inlet and then 
evacuated and filled with Ar (4x).  Dimethoxyethane (3.2 mL) and degassed H2O (0.32 mL) 
were added, and the reaction was heated to reflux for 24 h.  After cooling to room temperature, 
the mixture was poured into a 125 ml separatory funnel, where it was diluted with H2O (20 ml) 
and extracted with EtOAc (3x 20 ml).  The combined organic extracts were dried over Na2SO4, 
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filtered and concentrated in vacuo (23° C, 14 mmHg). The resulting residue was purified twice 
by automated chromatography (silica gel (4g), hexane/EtOAc, gradient from 2:98 to 4:96) to 
provide 169 mg (55%) of 72 as a beige solid. 
Data for 72:  
1
H NMR: (500 MHz, CDCl3) 
δ   7.57 (d, J = 7.1, 8H, HC(11)), 7.40 (t, J = 7.6, 8H, HC(12)), 7.32 – 7.24 (m, 2H, 
HC(13)), 7.06 (s, 2H, HC(4)), 3.11 (s, 2H, NH), 2.29 (s, 6H), 2.20 (s, 6H), 1.93 (s, 
6H). 
13
C NMR: (125 MHz, CDCl3) 
δ 144.6, 142.03, 135.1, 132.6, 128.7, 128.2, 126.2, 35.3 (C(8)), 19.9, 16.6. 
 
Synthesis of 55c. Preparation of 55c. 
 
 A flame-dried 50-mL Schlenk flask, equipped with a magnetic stir bar, a condenser, and 
an inert gas inlet, was charged with 32 (156 mg, 0.371 mmol, 1.0 eqiv) in dry PhMe (10 mL), 
and the solution was concentrated in vacuo (0.2 mmHg) and heated in vacuo (0.2 mmHg, 50 
o
C) 
for 1.5 h. Dry THF (3.7 mL) was added, and the mixture was cooled in an ice bath.  Et3N ( 0.341 
mL, 2.45 mmol, 6.6 equiv) and PCl3 (0.0975 mL, 1.11 mmol, 3.0 equiv) were  added, and the 
reaction allowed to stir for 15 min, resulting in a white precipitate. The reaction was then 
refluxed for 5 h, and an aliquot taken (50 μL). The mixture was concentrated in vacuo (0.2 
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mmHg). The resulting white residue was stirred with dry Et2O (25 mL) and was cannula filtered 
into a tared, flame-dried 50-mL Schlenk flask. The solution was concentrated in vacuo (0.2 
mmHg). The residue was dissolved in dry Et2O (25 mL), and the solution was concentrated in 
vacuo (0.2 mmHg) again. The resulting residue was then dried in vacuo (0.2 mmHg) overnight. 
The flask was filled with Ar, weighed and taken into an Ar-filled glove-box without exposing the 
contents to air.  This provided 183.8 mg (102%)  of crude 77.  From the impurities visible in the 
1
H and 
31
P
 
NMR spectra, the purity was estimated to be 88% (corrected yield 90%). 
A flame-dried, 10-mL Schlenk flask, equipped with a magnetic stir bar, and a septum, 
was charged with N-N`dimethyl-1,5-pentanediamine (9.8 mg, 0.075 mmol, 1.0 equiv) , dioxane 
(0.75 mL) and Et2O (0.5 mL). The mixture was cooled to 0 °C and n-butyllithium (2.53 M in 
hexanes, 59.2 μL, 0.15 mmol, 2.0 equiv) was added via syringe. The mixture was allowed to stir 
for 1 h.  A solution of 33 ( 82.7 mg, 0.15 mmol, 2.0 equiv) in Et2O (2.5 mL) was added, resulting 
in a bright yellow solution, which was stirred for 1 h at 0 °C and then was allowed to warm to 
23°C where it was stirred for 17 h. The Et2O was removed in vacuo (0.2 mmHg), leaving a 
solution in dioxane, which was heated to 60 °C for 7 h.  The reaction was allowed to cool to 
room temperature, and then MCPBA ( 28 mg, 0.165 mmol, 2.2 equiv) was added as a solution in 
THF (1 mL). The reaction was allowed to stir for 16 h overnight. The reaction was then 
quenched by addition of sat. aq. NaHCO3 solution (ca. 1 mL), followed by sat. aq. Na2S2O3 
solution (ca. 1 mL). The resulting mixture was then poured into a 125-mL separatory funnel 
where it was diluted with H2O (10 ml) and was washed with EtOAc (3x10 mL). The combined 
organic layers were dried over Na2SO4, filtered, and concentrated in vacuo (23° C, 14 mmHg). 
The residue was purified by automated chromatography (silica gel (4g), gradient 0:100 
EtOAc:hexanes – 100:0 ) to provide 25 mg (31%) of 55c as a white solid. 
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Data for 55c:  
1
H NMR: (500 MHz, CDCl3) 
δ   7.95 (d, J = 7.6, 4H), 7.61 (d, J = 7.7, 4H), 7.38 (dd, J = 16.3, 8.1, 8H), 7.35 – 
7.22 (m, 6H), 7.13 (s, 2H), 2.96 – 2.77 (m, 2H), 2.52 (d, J = 8.6, 6H), 2.36 (s, 6H), 
2.31 (s, 6H), 2.19 (d, J = 8.9, 6H), 2.05 (d, J = 2.7, 6H), 1.92 (s, 6H), 1.88 (d, J = 
8.8, 6H), 1.24 – 1.04 (m, J = 31.9, 4H), 0.98 – 0.80 (m, 2H, H2C(16)). 
31
P NMR: (200 MHz, CDCl3) 
δ 24.24. 
MS: (ESI) 
1050.9 (M+H).  
TLC: Rf 0.22 (EtOAc/hexanes 5/95) [UV] 
 
C.7. Supporting Information for Appendix A 
In Situ 
1
H NMR Observation of Phosphine Catalysis in The Generation of a Ge(IV) 
Enolate. Reaction in the Presence of Ph3P. [MTB-V-92] 
 
An oven-dried, 5-mm NMR tube, fitted with a septum, under Ar, was charged with 
GeCl2·dioxane (49 mg, 0.21 mmol, 1.0 equiv), PPh3 (2.8 mg, 0.01 mmol, 0.05 equiv), C6Me6 
(10.6 mg) and dioxane (0.7 mL). The tube was agitated in a vortex mixer and was then inserted 
in to the NMR spectrometer. The spectrometer was shimmed, and the tube was ejected from the 
instrument. 59a (31 μL, 0.21 mmol, 1.0 equiv) was added. The tube was inverted and reinserted 
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into the spectrometer. An arrayed acquisition was begun (at=4.1, d1=15, nt=2, 30 second delay 
between acquisitions). 
Time 
(min) 
integral of 
59a (9.38 
ppm) 
 Normalized 
to C5Me6 
59a 
remaining 
3 0.0747 41.0% 
4 0.0503 27.6% 
5 0.0405 22.2% 
6 0.0349 19.2% 
7 0.0303 16.6% 
8 0.0306 16.8% 
9 0.029 15.9% 
10 0.0294 16.2% 
11 0.0292 16.0% 
12 0.0284 15.6% 
13 0.028 15.4% 
14 0.0272 14.9% 
15 0.0273 15.0% 
16 0.0282 15.5% 
17 0.027 14.8% 
18 0.0271 14.9% 
19 0.0269 14.8% 
 
In Situ 
1
H NMR Observation of Phosphine Catalysis in The Generation of a Ge(IV) 
Enolate. Reaction in the Absence of Ph3P. [MTB-V-91] 
 
An oven-dried, 5-mm NMR tube, fitted with a septum, under Ar, was charged with 
GeCl2·dioxane (49 mg, 0.21 mmol, 1.0 equiv), PPh3 (2.8 mg, 0.01 mmol, 0.05 equiv), C6Me6 
(10.6 mg) and dioxane (0.7 mL). The tube was agitated in a vortex mixer and was then inserted 
in to the NMR spectrometer. The spectrometer was shimmed, and the tube was ejected from the 
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instrument. 59a (31 μL, 0.21 mmol, 1.0 equiv) was added. The tube was inverted and reinserted 
into the spectrometer. An arrayed acquisition was begun (at=4.1, d1=15, nt=2, 30 second delay 
between acquisitions). 
Time 
(min) 
integral of 
59a (9.38 
ppm) 
Normalized 
to C5Me6 
59a 
remaining 
3 0.1744 95.8% 
4 0.1736 95.4% 
5 0.1736 95.4% 
6 0.1732 95.1% 
7 0.1725 94.8% 
8 0.1723 94.7% 
9 0.1726 94.8% 
10 0.1718 94.4% 
11 0.1719 94.4% 
12 0.1718 94.4% 
13 0.1719 94.4% 
14 0.172 94.5% 
15 0.1717 94.3% 
16 0.1722 94.6% 
17 0.1723 94.7% 
18 0.1723 94.7% 
19 0.1728 94.9% 
20 0.1726 94.8% 
 
Preparation of trichloro[(2-methyl-1-propen-1-yl)oxy]-germane. (58e) [MTB-VI-86] 
 
A flame-dried, 5-mL Schlenk flask, equipped with a septum and a magnetic stir bar, was charged 
with PhMe (1.5 mL), GeCl4 (0.171 mL, 1.5 mmol, 1.0 equiv) and Et3N (0.228 mL, 1.53 mmol, 
1.02 equiv). The flask was cooled in an ice bath. 30e (0.137 mL, 1.5 mmol, 1.0 equiv) was added 
dropwise over 5 min. The mixture was allowed to stir for 30 min, and then was allowed to warm 
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to room temperature for 30 min. The white suspension was cooled in an ice bath, and then was 
cannula filtered into a flame-dried 5-mL Schlenk flask. The filter and solids were rinsed with dry 
PhMe ( 0.5 mL) and the resulting clear, colorless solution was  maintained in the ice bath under 
Ar. A tared, oven dried NMR tube, fitted with a septum was charged with dry anisole (15 μL) 
and the mass recorded. The tube was then charged with the solution of 58e (0.1 mL) and dry 
PhMe (0.5 mL), and vortexed briefly. No-D 
1
H NMR was taken, integrating the vinylic signals at 
δ 6.07 and 6.21 ppm (1 H total, ~1.7:1 ratio) and the signal at 3.28 ppm (3H, anisole CH3).  From 
the ratio of these signals, and the recorded mass of anisole, a titer of 0.59 M was calculated (79% 
of theoretical concentration). Note that final concentration is variable. This solution was used 
immediately without further purification.   
Data for 58e:  
1
H NMR: (500 MHz, C6H5CH3) 
δ  6.21 (m, 1H, HC(1)), 6.07 (m, 1H HC(1)), 1.58 (d, J = 0.8, 3H, H3C(3,4)), 1.51 (d, 
J = 0.9, 3H, H3C(3,4)), 1.32 (d, J = 1.1, 3H, H3C(3,4)), 1.27 (m, 3H, H3C(3,4)). 
 
General Procedure 23. Catalyst Survey for the Reaction of 58e with Aldehydes. Reaction of 
58e with 30a in the Absence of a Catalyst. (Table 26, entry 1) [MTB-VI-89]  
 
 An oven-dried 5-mm NMR tube was taken into the glove box and was fitted with a sealed 
capillary tube containing PhMe-d8. The tube was removed from the glove box. The tube was 
tared, and then was charged with anisole (15 μL, 14.9 mg). 59e (174 μL, 0.59 M in PhMe, 1.03 
mmol, 1.0 equiv) and PhMe (0.526 mL). The tube was inserted into the spectrometer and 
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shimmed. The tube was ejected from the spectrometer, and 30a (12.8 μL, 1.03 mmol, 1.0 equiv) 
was added. The tube was inverted and was reinserted into the spectrometer. An arrayed 
acquisition was begun (nt=1, d1=32, at=8, pad=array of zeros).  The signal for 60be at 9.0 ppm 
was monitored. The yield after 5 min was 14%. 
 
Catalyst Survey for the Reaction of 58e with Aldehydes. Reaction of 58e with 30a in the 
Presence of Ph3P. (Table 26, entry 2) [MTB-VI-90] 
 Following General Procedure 23, an NMR tube was charged with anisole (15 μL, 
14.7 mg), PPh3 (1.4 mg, 0.05 mmol, 0.05 equiv), 59e (174 μL, 0.59 M in PhMe, 1.03 mmol, 1.0 
equiv) and PhMe (0.526 mL) After 5 min, 23% yield was observed by 
1
H NMR spectroscopy.  
 
Catalyst Survey for the Reaction of 58e with Aldehydes. Reaction of 58e with 30a in the 
Presence of n-Bu3P=O. (Table 26, entry 3) [MTB-VI-87] 
 Following General Procedure 23, an NMR tube was charged with anisole (15 μL, 
15.6 mg), n-Bu3P=O (1.1 mg, 0.05 mmol, 0.05 equiv), 59e (174 μL, 0.59 M in PhMe, 1.03 
mmol, 1.0 equiv), PhMe (0.526 mL) and 30a (12.8 μL, 1.03 mmol, 1.0 equiv). After 5 min, 50% 
yield was observed by 
1
H NMR spectroscopy. 
 
Catalyst Survey for the Reaction of 58e with Aldehydes. Reaction of 58e with 30a in the 
Presence of 50. (Table 26, entry 4) [MTB-VI-79] 
 Following General Procedure 23, an NMR tube was charged with anisole (15 μL, 
14.7 mg), 50 (1.1 mg, 0.05 mmol, 0.05 equiv), 59e (154 μL, 0.67 M in PhMe, 1.03 mmol, 1.0 
equiv), PhMe (0.545 mL) and 30a (12.8 μL, 1.03 mmol, 1.0 equiv). After 5 min, 44% yield was 
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observed by 
1
H NMR spectroscopy. 
 
Catalyst Survey for the Reaction of 58e with Aldehydes. Reaction of 58e with 30a in the 
Presence of H2O. (Table 26, entry 5) [MTB-VI-88] 
 Following General Procedure 23, an NMR tube was charged with anisole (15 μL, 
15.6 mg), n-Bu3P=O (1.1 mg, 0.05 mmol, 0.05 equiv), 59e (174 μL, 0.59 M in PhMe, 1.03 
mmol, 1.0 equiv) H2O saturated PhMe (0.272 mL, 0.05 equiv), PhMe (0.254mL) and 30a (12.8 
μL, 1.03 mmol, 1.0 equiv). After 5 min, 18% yield was observed by 1H NMR spectroscopy. 
 
Catalyst Survey for the Reaction of 58e with Aldehydes. Reaction of 58e with 33a in 
PhMe/CH2Cl2. (Table 26, entry 6) [MTB-VII-63] 
 Following General Procedure 23, an NMR tube was charged with anisole (15 μL, 
15.2 mg), 59e (204 μL, 0.50 M in PhMe, 1.03 mmol, 1.0 equiv), CH2Cl2 (0.526 mL) and 33a 
(10.5 μL, 1.03 mmol, 1.0 equiv). After 5 min, 21% yield was observed by 1H NMR 
spectroscopy. Fitting to the second order integrated rate law provided kobs = 0.0048 L mol
-1
 sec
-1
.  
 
Catalyst Survey for the Reaction of 58e with Aldehydes. Reaction of 58e with 33a in the 
presence of n-Bu3P=O in PhMe/CH2Cl2. (Table 26, entry 7) [MTB-VII-64] 
 Following General Procedure 23, an NMR tube was charged with anisole (15 μL, 
13.9 mg), 59e (204 μL, 0.50 M in PhMe, 1.03 mmol, 1.0 equiv), n-Bu3P=O (2.2 mg, 0.005 
mmol, 0.01 equiv),  CH2Cl2 (0.526 mL) and 33a (10.5 μL, 1.03 mmol, 1.0 equiv). After 5 min, 
71% yield was observed by 
1
H NMR spectroscopy. Fitting to the second order integrated rate 
law provided kobs = 0.23 L mol
-1
 sec
-1
.  
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Catalyst Survey for the Reaction of 58e with Aldehydes. Reaction of 58e with 33a in the 
Presence of 64 in PhMe/CH2Cl2. Preparation of (2,2-dimethoxy-1,1-
dimethylethyl)benzenemethanol
172
 (Scheme 63.)[MTB-VII-64] 
 Following General Procedure 23, an NMR tube was charged with 64 (3.4 mg, 0.1 
equiv, 0.01 mmol), anisole (15 μL, 13.9 mg), 59e (204 μL, 0.50 M in PhMe, 1.03 mmol, 1.0 
equiv), CH2Cl2 (0.526 mL) and 33a (10.5 μL, 1.03 mmol, 1.0 equiv). Fitting to the second order 
integrated rate law provided kobs = 1.2  L mol
-1
 sec
-1
. The reaction was quenched with MeOH 
(1.0 mL) and was poured into stirred sat. aq. NaHCO3 solution (10 mL). The resulting mixture 
was transferred into a 125-mL separatory funnel, where it was extracted with 4:1 TBME/hexane 
(3 x 5 mL). The combined organic extracts were dried over Na2SO4, filtered, and concentrated in 
vacuo (23° C, 14 mmHg). The residue was purified by column chromatography (silica gel (4 g), 
1 cm diam, hexane/EtOAc, 4:1), to provide 19.7 mg (85%) of 61ae. 
Data for 61ae:  
GC: (S)/(R)-61ae, tR 61.9 min (25.5%); (R)/(S)- 61ae, tR 63.1 min (74.5%); (BP-A, 13 psi, 
135 
o
C). 
 
Attempts to Develop an Enantioselective Aldol Reaction Under Reductive Conditions. 
Reaction in the Presence of 64 (0.1 equiv) in dioxane.(Table 28, entry 1) [MTB-VIII-11] 
 
 A 5-mL, flame-dried Schlenk flask, fitted with a septum and a magnetic stir bar was 
charged with 64 (3.4 mg, 0.01 mmol, 0.1 equiv) and GeCl2·dioxane (23 mg, 1.0 equiv, 0.1 
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mmol) in an Ar-filled glove box. The flask was removed from the glove box and was charged 
with dioxane (0.7 mL) and 33a (10 μL, 0.1 mmol, 1.0 equiv) via syringe. 59e (16μL, 0.15 mmol, 
1.5 equiv) was added dropwise via syringe over 5 min. The solution was allowed to stir for 13 h 
overnight. The reaction was quenched by addition of MeOH (0.7 mL) and was then poured into 
stirred sat. aq. NaHCO3 solution (10 mL). The resulting mixture was transferred into a 125-mL 
separatory funnel, where it was extracted with 4:1 TBME/hexane (3 x 5 mL). The combined 
organic extracts were dried over Na2SO4, filtered, and concentrated in vacuo (23° C, 14 mmHg). 
The residue was purified by column chromatography (silica gel (4 g), 1 cm diam, hexane/EtOAc, 
4:1), to provide 12.2 mg (54%) of 61ae. 
Data for 61ae:  
SFC: (S)/(R)-61ae, tR 4.0 min (51%); (R)/(S)- 61ae, tR 4.4 min (49%); (Chiralpak OD, 150 
bar, 40 °C, 5% MeOH in CO2, 3 mL/min). 
 
Attempts to Develop an Enantioselective Aldol Reaction Under Reductive Conditions. 
Reaction in the Presence of 64 (1.0 equiv) in dioxane.(Table 28, entry 2) [MTB-VIII-25] 
 
 A 0.5-mL, flame-dried Schlenk flask, fitted with a septum and a magnetic stir bar, was 
charged with 64 (6.7 mg, 0.02 mmol, 1.0  equiv) and GeCl2·dioxane (4.6 mg, 1.0 equiv, 0.02 
mmol) in an Ar-filled glove box. The flask was removed from the glove box and was charged 
with dioxane (0.09 mL) and 33a (20 μL of a 10 vol% solution in dioxane, 0.02 mmol, 1.0 equiv) 
via syringe. A white precipitate formed. 59e (31 μL of a 0.632 M solution in dioxane, 0.03 
mmol, 1.5 equiv) was added dropwise via syringe over 5 min. The solution was allowed to stir 
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for 18 h overnight. The reaction was quenched by addition of MeOH (0.14 mL) and was then 
poured into stirred sat. aq. NaHCO3 solution (2 mL) in a test tube. The organic layer was 
decanted via pipet. The aqueous phase was extracted with 4:1 TBME/hexane (3 x 1 mL). The 
combined organic extracts were dried over Na2SO4, filtered, and concentrated in vacuo (23° C, 
14 mmHg). The residue was purified by preparative TLC (silica gel, analytical plate, 16 cm 
wide, 10 cm long, hexane/EtOAc, 85:15), to provide <1 mg (<20%) of 61ae. 
Data for 61ae:  
GC: (S)/(R)-61ae, tR 67.2 min (35.7%); (R)/(S)- 61ae, tR 68.6 min (64.3%); (BP-A, 13 psi, 
135 
o
C). 
 
Attempts to Develop an Enantioselective Aldol Reaction Under Reductive Conditions. 
Reaction in the Presence of 64 (0.1 equiv) and PPh3 (0.1 equiv) in CH2Cl2. (Table 28, entry 
3) [MTB-VIII-47] 
 
 A 5-mm, oven-dried NMR tube, fitted with a septum, containing C6Me6 (10.6 mg) was 
charged with 64 (3.4 mg, 0.01 mmol, 0.1  equiv), PPh3 (2.2 mg, 0.01 mmol, 0.1 equiv)  and 
GeCl2·dioxane (23.8 mg, 1.0 equiv, 0.1 mmol) in an Ar-filled glove box. The flask was removed 
from the glove box and was charged with CH2Cl2 (0.48 mL) and 33a (10 μL, 0.1 mmol, 1.0 
equiv) via syringe. 59e (219 μL of a 0.47 M solution in dioxane, 0.15 mmol, 1.5 equiv) was 
added via syringe. The septum was covered in a layer of Parafilm, and the tube was placed in a 
dessicator over P2O5. After 2.5 h, 66% of 33a had been consumed by 
1
H NMR. The reaction was 
quenched by addition of MeOH (0.7 mL) and was then poured into stirred sat. aq. NaHCO3 
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solution (10 mL). The resulting mixture was transferred into a 125-mL separatory funnel, where 
it was extracted with 4 TBME (3 x 5 mL). The combined organic extracts were dried over 
Na2SO4, filtered, and concentrated in vacuo (23° C, 14 mmHg). The residue was purified by 
column chromatography (silica gel (4 g), 1 cm diam, hexane/EtOAc, 85:15, deactivated w/ 8 
drops of Et3N), to provide 9.7 mg (42%) of 61ae. 
Data for 61ae:  
GC: (S)/(R)-61ae, tR 53.9 min (49.9%); (R)/(S)- 61ae, tR 54.9 min (51.1%); (BP-A, 13 psi, 
135 
o
C). 
Attempts to Develop an Enantioselective Aldol Reaction Under Reductive Conditions. 
Reaction in the Presence of 64 (0.1 equiv) and PPh3 (1.0 equiv) in CH2Cl2. (Table 28, entry 
4) [MTB-VIII-46] 
 
 A 5-mm, oven-dried NMR tube, fitted with a septum, containing C6Me6 (10.0 mg) was 
charged with 64 (3.4 mg, 0.01 mmol, 0.1  equiv), PPh3 (22 mg, 0.1 mmol, 1.0 equiv)  and 
GeCl2·dioxane (23.8 mg, 1.0 equiv, 0.1 mmol) in an Ar-filled glove box. The flask was removed 
from the glove box and was charged with CH2Cl2 (0.48 mL) and 33a (10 μL, 0.1 mmol, 1.0 
equiv) via syringe. 59e (219 μL of a 0.47 M solution in dioxane, 0.15 mmol, 1.5 equiv) was 
added via syringe. The septum was covered in a layer of Parafilm, and the tube was placed in a 
dessicator over P2O5. After 3.5 h, 70% of 33a had been consumed by 
1
H NMR. The reaction was 
quenched by addition of MeOH (0.7 mL) and was then poured into stirred sat. aq. NaHCO3 
solution (10 mL). The resulting mixture was transferred into a 125-mL separatory funnel, where 
it was extracted with TBME (3 x 5 mL). The combined organic extracts were dried over Na2SO4, 
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filtered, and concentrated in vacuo (23° C, 14 mmHg). The residue was purified by column 
chromatography (silica gel (4 g), 1 cm diam, hexane/EtOAc, 85:15, deactivated w/ 8 drops of 
Et3N), to provide 13.2 mg (57%) of 61ae. 
Data for 61ae:  
GC: (S)/(R)-61ae, tR 54.5 min (45.8%); (R)/(S)- 61ae, tR 55.5 min (54.2%); (BP-A, 13 psi, 
135 
o
C). 
Attempts to Develop an Enantioselective Aldol Reaction Under Reductive Conditions. 
Reaction in the Presence of 64 (0.1 equiv) and PPh3 (1.5 equiv) in CH2Cl2. (Table 28, entry 
5) [MTB-VIII-49] 
 
 A 5-mm, oven-dried NMR tube, fitted with a septum, containing C6Me6 (11.8 mg) was 
charged with 64 (3.4 mg, 0.01 mmol, 0.1  equiv), PPh3 (40 mg, 0.15 mmol, 1.5 equiv)  and 
GeCl2·dioxane (23.8 mg, 1.0 equiv, 0.1 mmol) in an Ar-filled glove box. The flask was removed 
from the glove box and was charged with CH2Cl2 (0.48 mL) and 33a (10 μL, 0.1 mmol, 1.0 
equiv) via syringe. 59e (219 μL of a 0.47 M solution in dioxane, 0.15 mmol, 1.5 equiv) was 
added via syringe. The septum was covered in a layer of Parafilm, and the tube was placed in a 
dessicator over P2O5. After 1.5 h, 71% of 33a had been consumed by 
1
H NMR. The reaction was 
quenched by addition of MeOH (0.7 mL) and was then poured into stirred sat. aq. NaHCO3 
solution (10 mL). The resulting mixture was transferred into a 125-mL separatory funnel, where 
it was extracted withTBME (3 x 5 mL). The combined organic extracts were dried over Na2SO4, 
filtered, and concentrated in vacuo (23° C, 14 mmHg). The residue was purified by column 
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chromatography (silica gel (4 g), 1 cm diam, hexane/EtOAc, 85:15, deactivated w/ 8 drops of 
Et3N), to provide 14 mg (60%) of 61ae. 
Data for 61ae:  
GC: (S)/(R)-61ae, tR 54.5 min (44.0%); (R)/(S)- 61ae, tR 55.5 min (56.0%); (BP-A, 13 psi, 
135 
o
C). 
Preparation of Materials 
Preparation of 50e as a Solution in Dioxane. [MTB-VIII-12] 
 
An oven-dried, 100-mL, 3-necked flask, fitted with a thermometer, a magnetic stirbar, an Ar 
inlet and wrapped in foil, was charged with Et2O (45 mL) and 30e (1.26 mL, 13.9 mmol, 1.0 
equiv). The solution was cooled to 2 
o
C and Br2 (0.708 mL, 13.9 mmol, 1.0 equiv) was added 
dropwise over 10 min. After 0.45 mL of Br2 was added, the solution became abruptly cloudy and 
the addition was paused until it clarified. The solution was allowed to stir for 21 h, after which it 
was  transferred to a 125 mL separatory funnel, where it was washed with brine (3 x 5 mL) and 
sat. aq. Na2CO3 solution (4 x 5 mL). The clear, colorless organic phase was dried over MgSO4 
and K2CO3. The solution was filtered through a plug of silica gel (3 cm thick, 5 cm wide). 
Dioxane (10 mL) was added and the solution was concentrated in vacuo (0 
o
C, 10 mmHg) to a 
total mass of ca. 11 g. The solution was transferred to a storage flask containing K2CO3 (ca 50 
mg), using dioxane (2 mL) to rinse the original flask. The total mass of the solution was 12.36 g 
and the concentration was 0.632 M based on 
1
H NMR integration vs. C6Me6 internal standard. 
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C.8.  Supporting Information for Appendix B 
General Procedure 23. Determination of the Partial Order in 19l of Bromocylization of 19l 
by 
19
F NMR. (0.025 M, replicate 1) [MTB-XVI-56] 
The following stock solutions were prepared and used for all runs to determine the partial 
order in 19l (except for additional replicates run at a later date as indicated.): 
Solution A: An oven-dried 2-mL volumetric flask, equipped with a septum was charged with 19l 
(84.15 mg, 0.4332 mmol). The flask was evacuated and filled with Ar via a needle. 
Fluorobenzene (39.5 μL, 1 equiv with respect to 19l) was added via syringe, and then the flask 
was filled to the mark with dry PhMe. 
 
Solution B: An oven-dried conical vial, equipped with a PTFE/silicone septum and cap was 
charged with 24a (5.41 mg, 0.00719 mmol). The vial was evacuated and filled with Ar via a 
needle and then was charged with Solution C (825 μL). 
 
Solution C: An oven-dried 10-mL volumetric flask, equipped with a septum was charged with 
Ph3P=S (25.66 mg, 0.08717 mmol). The flask was evacuated and filled with Ar via a needle, and 
then the flask was filled to the mark with dry PhMe. 
 
 An oven-dried, 5-mm NMR tube, fitted with a septum, wrapped in Al foil, was charged 
with NBS (3.72 mg, 0.021 mmol). The septum was removed and tube was then brought in to an 
Ar filled glove box, where the septum was replaced. The tube removed from the glove box and 
was charged with PhMe-d8 (0.1 mL), Solution A (81 μL) and PhMe (494 μL). The tube was 
agitated in a vortex mixer until homogenous by visual inspection. The tube was inserted into the 
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NMR spectrometer and shimmed. An initial time point was acquired (64 scans, at=1, pw=8.25, 
d1=2.77) to determine response factors and correct for any evaporation of the PhF standard. The 
tube was ejected from the spectrometer. Solution B (25 μL) was added. The tube was rapidly 
inverted three times and was reinserted into the spectrometer. An arrayed acquisition was begun 
(nt=8, d1=2.77, at=1, pad=array of zeroes). 
 
Table 33. NMR Data for MTB-XVI-56. 
 std Integral 19l integral  
 20597.1 24844.6 1.206218 
Time   [olefin] 
26.3 2695.25 3243.45 0.024941 
55.01 2550.25 3033.93 0.024657 
83.72 2545.87 2984.85 0.0243 
112.43 2538.01 2953.7 0.024121 
141.14 2531.87 2911.5 0.023834 
169.85 2522.67 2875.43 0.023624 
198.56 2548.35 2844.24 0.023132 
227.27 2528.63 2802.35 0.022969 
255.98 2526.74 2773.45 0.02275 
284.69 2539.3 2749.99 0.022446 
313.4 2534.17 2724.48 0.022282 
342.11 2529.42 2695.38 0.022086 
370.82 2526.35 2666.79 0.021878 
399.53 2532.92 2645.77 0.021649 
428.24 2543.17 2633.28 0.02146 
456.95 2531.51 2598.88 0.021278 
485.66 2537.25 2581.57 0.021088 
514.37 2527.82 2559.37 0.020985 
543.08 2526.68 2541.1 0.020844 
571.79 2540.28 2527.35 0.02062 
600.5 2551.63 2495.99 0.020274 
629.21 2550.7 2497.09 0.02029 
y = -9.58E-06x + 2.52E-02 
R² = 9.93E-01 
0.022 
0.0225 
0.023 
0.0235 
0.024 
0.0245 
0.025 
0 50 100 150 200 250 300 
[o
le
fi
n
] 
T (sec) 
Initial Rate 
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Table 33 cont. 
657.92 2542.75 2496.66 0.02035 
686.63 2536.97 2476.91 0.020235 
715.34 2542.04 2469.4 0.020134 
744.05 2549.99 2453.6 0.019942 
772.76 2544.57 2432.23 0.019811 
801.47 2549.57 2427.63 0.019735 
830.18 2538.99 2417.36 0.019733 
858.89 2534.13 2431.16 0.019884 
887.6 2554.67 2401.22 0.019481 
916.31 2551.1 2384.08 0.019369 
945.02 2543.16 2381.46 0.019408 
973.73 2543.46 2380.18 0.019395 
1002.44 2552.2 2378.86 0.019318 
1031.15 2554.07 2370.94 0.01924 
1059.86 2545.62 2349.05 0.019125 
1088.57 2548.74 2349.58 0.019106 
1117.28 2548.66 2334.79 0.018987 
1145.99 2550.72 2326.17 0.018901 
1174.7 2544.03 2325.14 0.018943 
1203.41 2555 2336.25 0.018951 
1232.12 2532.15 2324.72 0.019028 
1260.83 2544.79 2316.21 0.018864 
1289.54 2541.63 2312.11 0.018854 
1318.25 2550.28 2310 0.018773 
1346.96 2538.67 2306.86 0.018833 
1375.67 2555.04 2306.46 0.01871 
1404.38 2563.94 2291.98 0.018528 
1433.09 2556.24 2276.92 0.018461 
1461.8 2536.08 2298.36 0.018783 
1490.51 2553.89 2273.47 0.01845 
1519.22 2546.37 2262.49 0.018415 
1547.93 2561.35 2272.15 0.018386 
1576.64 2550.65 2275.26 0.018488 
1605.35 2537.05 2265.95 0.018511 
1634.06 2554.13 2271.94 0.018436 
1662.77 2558.57 2270.57 0.018393 
1691.48 2550.04 2268.83 0.01844 
1720.19 2552.1 2263.78 0.018384 
 
Determination of the Partial Order in 19l of Bromocylization of 19l by 
19
F NMR. (0.025 M, 
replicate 2) [MTB-XVI-57] 
Following General Procedure 23, NBS (3.72 mg, 0.021 mmol), PhMe-d8 (0.1 mL), 
Solution A (81 μL), PhMe (494 μL) and Solution B (25 μL) were combined. 
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Table 34. NMR data for MTB-XVI-57. 
 std Integral 19l integral  
 21317.3 25591.9 1.200523 
Time   [olefin] 
23.12 2651.38 3204.25 0.025167 
53.28 2548.29 3027.65 0.024742 
83.44 2537.61 2968.76 0.024362 
113.6 2523.3 2912.1 0.024033 
143.76 2540.67 2878.42 0.023593 
173.92 2537.05 2838.92 0.023302 
204.08 2539.52 2791.12 0.022887 
234.24 2542.03 2771.49 0.022704 
264.4 2535.71 2730.97 0.022428 
294.56 2548.19 2695.4 0.022027 
324.72 2534.33 2671.25 0.021949 
354.88 2537.6 2636.68 0.021637 
385.04 2536.2 2626.19 0.021563 
415.2 2532.75 2605.42 0.021422 
445.36 2537 2580.3 0.02118 
475.52 2536.4 2566.68 0.021073 
505.68 2549.79 2544.73 0.020783 
535.84 2533.44 2527.24 0.020773 
566 2531.14 2493.48 0.020514 
596.16 2546.78 2495.39 0.020404 
626.32 2534.39 2483.54 0.020406 
656.48 2544.05 2468.52 0.020206 
686.64 2547.23 2460.17 0.020113 
716.8 2537.2 2426.2 0.019913 
746.96 2538.76 2427.03 0.019908 
777.12 2544.86 2414.84 0.01976 
807.28 2549.61 2396.52 0.019574 
837.44 2541.88 2385.42 0.019542 
867.6 2544.35 2389.15 0.019554 
897.76 2541.41 2374.18 0.019454 
927.92 2532.48 2373.07 0.019513 
958.08 2540.92 2347.19 0.019237 
988.24 2549.76 2355.71 0.019239 
1018.4 2558.48 2352.77 0.01915 
1048.56 2546.77 2358.42 0.019284 
1078.72 2542.83 2345.79 0.019211 
1108.88 2539.26 2336.48 0.019161 
y = -1.11E-05x + 2.53E-02 
R² = 9.92E-01 0.022 
0.0225 
0.023 
0.0235 
0.024 
0.0245 
0.025 
0 50 100 150 200 250 300 
Initial Rate 
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Table 34 cont. 
1139.04 2535.32 2316.65 0.019028 
1169.2 2535.92 2314.16 0.019003 
1199.36 2531.48 2318.84 0.019075 
1229.52 2538.59 2320.93 0.019039 
1259.68 2539.6 2313.57 0.018971 
1289.84 2547.92 2303.94 0.01883 
1320 2541.26 2289.37 0.01876 
1350.16 2552.35 2297.04 0.018741 
1380.32 2550.89 2283.63 0.018642 
1410.48 2538.45 2283.14 0.01873 
1440.64 2547.05 2284.05 0.018674 
1470.8 2547.88 2276.47 0.018606 
1500.96 2546.66 2270.4 0.018565 
1531.12 2546.22 2266.49 0.018536 
1561.28 2547.97 2262.33 0.01849 
1591.44 1589.08 1420.56 0.018616 
 
Determination of the Partial Order in 19l of Bromocylization of 19l by 
19
F NMR. (0.025 M, 
replicate 3) [MTB-XVI-70] 
Following General Procedure 23, NBS (3.72 mg, 0.021 mmol), PhMe-d8 (0.1 mL), 
Solution A (81 μL), PhMe (494 μL) and Solution B (25 μL) were combined. 
 
Table 35. NMR Data for MTB-XVI-70. 
 std Integral 19l integral  
    
 14463.4 17260.2 1.193371 
Time   [olefin] 
31.41 1835.44 2170.08 0.024769 
61.57 1780.74 2073.4 0.024392 
91.73 1787.79 2053.85 0.024067 
121.89 1779.44 2029.86 0.023897 
y = -8.42E-06x + 2.49E-02 
R² = 9.90E-01 
0.0224 
0.0226 
0.0228 
0.023 
0.0232 
0.0234 
0.0236 
0.0238 
0.024 
0.0242 
0.0244 
0.0246 
0 50 100 150 200 250 300 
[o
le
fi
n
] 
T (sec) 
Initial Rate 
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Table 35 cont. 
152.05 1782.71 2006.25 0.023576 
182.21 1781.92 1979.55 0.023272 
212.37 1783.06 1955.74 0.022978 
242.53 1779.18 1945.79 0.022911 
272.69 1777.81 1918.59 0.022608 
302.85 1786.31 1901.89 0.022305 
333.01 1784.1 1889.22 0.022183 
363.17 1791.05 1864.64 0.02181 
393.33 1786.67 1848.42 0.021673 
423.49 1779.13 1826.96 0.021512 
453.65 1794.22 1816.97 0.021215 
483.81 1788.59 1814.1 0.021248 
513.97 1794.64 1792.98 0.02093 
544.13 1793.59 1779.99 0.02079 
574.29 1795.88 1772.04 0.020671 
604.45 1794.22 1765.75 0.020617 
634.61 1797.37 1749.29 0.020389 
664.77 1792.24 1735.89 0.02029 
694.93 1789.8 1738.47 0.020348 
725.09 1792.21 1729.38 0.020215 
755.25 1800.04 1713.72 0.019944 
785.41 1798.31 1707.38 0.01989 
815.57 1798.5 1704.79 0.019858 
845.73 1345.88 1273.89 0.019829 
 
Determination of the Partial Order in 19l of Bromocylization of 19l by 
19
F NMR. (0.00791 
M, replicate 1) [MTB-XVI-58] 
Following General Procedure 23, NBS (3.71 mg, 0.021 mmol), PhMe-d8 (0.1 mL), 
Solution A (26 μL), PhMe (549 μL) and Solution B (25 μL) were combined. 
 
y = -2.69E-06x + 7.86E-03 
R² = 9.10E-01 
0.007 
0.0071 
0.0072 
0.0073 
0.0074 
0.0075 
0.0076 
0.0077 
0.0078 
0 50 100 150 200 250 300 350 
[o
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rf
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] 
T (sec) 
Initial Rate 
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Table 36. NMR Data for MTB-XVI-58. 
 std Integral 19l integral  
 6794.25 8149.76 1.199508 
Time   [olefin] 
28.32 852.969 995.645 0.007693 
58.48 814.002 942.512 0.007631 
88.64 797.913 936.753 0.007737 
118.8 802.4 927.785 0.00762 
148.96 812.52 910.561 0.007385 
179.12 807.073 897.973 0.007332 
209.28 809.285 896.035 0.007297 
239.44 804.349 876.072 0.007178 
269.6 797.518 872.2 0.007207 
299.76 806.246 863.056 0.007055 
329.92 804.034 856.306 0.007019 
360.08 812.173 837.424 0.006795 
390.24 814.44 822.521 0.006656 
420.4 807.291 828.485 0.006763 
450.56 804.078 822.587 0.006742 
480.72 800.906 824.411 0.006784 
510.88 802.109 811.056 0.006664 
541.04 803.484 805.904 0.00661 
571.2 809.463 780.337 0.006353 
601.36 798.126 793.135 0.006549 
631.52 799.238 779.325 0.006426 
661.68 820.63 767.821 0.006166 
691.84 821.792 761 0.006103 
722 805.198 761.902 0.006236 
752.16 809.143 752.085 0.006125 
782.32 799.856 740.999 0.006105 
812.48 830.09 736.42 0.005847 
842.64 816.438 742.332 0.005992 
872.8 803.424 742.803 0.006093 
902.96 804.033 734.777 0.006023 
933.12 816.632 731.095 0.0059 
963.28 796.625 717.131 0.005933 
993.44 815.914 714.415 0.00577 
1023.6 805.967 718.091 0.005872 
1053.76 810.401 714.592 0.005811 
1083.92 814.054 698.459 0.005654 
1114.08 820.507 693.094 0.005567 
1144.24 807.59 706.157 0.005762 
1174.4 827.28 693.442 0.005524 
1204.56 812.8 695.925 0.005643 
1234.72 817.683 682.872 0.005504 
1264.88 802.791 687.359 0.005643 
1295.04 812.166 683.571 0.005547 
1325.2 827.206 688.584 0.005486 
1355.36 811.184 666.031 0.005411 
1385.52 803.22 668.157 0.005482 
1415.68 817.786 673.639 0.005429 
1445.84 810.976 666.444 0.005416 
1476 819.741 658.747 0.005296 
1506.16 809.051 653.777 0.005325 
1536.32 816.995 652.539 0.005264 
1566.48 812.217 656.34 0.005325 
1596.64 814.363 645.277 0.005222 
1626.8 816.406 657.837 0.00531 
1656.96 813.052 644.229 0.005222 
1687.12 806.784 634.355 0.005182 
1717.28 813.345 636.682 0.005159 
1747.44 815.705 641.654 0.005184 
1777.6 830.269 630.155 0.005002 
1807.76 824.658 627.794 0.005017 
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Determination of the Partial Order in 19l of Bromocylization of 19l by 
19
F NMR. (0.00791 
M, replicate 2) [MTB-XVI-65] 
Following General Procedure 23, NBS (3.67 mg, 0.021 mmol), PhMe-d8 (0.1 mL), 
Solution A (26 μL), PhMe (549 μL) and Solution B (25 μL) were combined. 
 
Table 37. NMR Data for MTB-XVI-65. 
 4310.98 5230.46 1.213288 
Time   [olefin] 
29.85 551.221 651.211 0.007697 
60.01 524.427 625.417 0.00777 
90.17 520.698 611.738 0.007655 
120.33 508.607 603.334 0.007729 
150.49 515.793 597.242 0.007544 
180.65 522.408 586.282 0.007312 
210.81 516.735 571.122 0.007201 
240.97 514.003 563.235 0.007139 
271.13 517.496 553.528 0.006969 
301.29 517.063 549.643 0.006926 
331.45 517.713 535.391 0.006738 
361.61 525.446 531.533 0.006591 
391.77 523.743 521.724 0.00649 
421.93 515.637 512.898 0.006481 
452.09 523.187 515.718 0.006422 
482.25 518.954 508.854 0.006389 
512.41 520.296 499.238 0.006252 
542.57 524.292 498.755 0.006198 
572.73 533.096 493.835 0.006036 
602.89 519.982 488.778 0.006124 
633.05 264.709 235.927 0.005807 
 
y = -3.81E-06x + 8.05E-03 
R² = 9.17E-01 
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0.0071 
0.0072 
0.0073 
0.0074 
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Determination of the Partial Order in 19l of Bromocylization of 19l by 
19
F NMR. (0.00791 
M, replicate 3) [MTB-XVI-66] 
Following General Procedure 23, NBS (3.70 mg, 0.021 mmol), PhMe-d8 (0.1 mL), 
Solution A (26 μL), PhMe (549 μL) and Solution B (25 μL) were combined. 
 
Table 38. NMR Data for MTB-XVI-66. 
 4048.39 4909.38 1.212675 
Time   [olefin] 
31.12 531.18 635.536 0.007799 
61.28 495.936 599.86 0.007885 
91.44 491.027 581.88 0.007725 
121.6 500.422 583.631 0.007603 
151.76 495.489 564.902 0.007432 
181.92 488.91 559.575 0.007461 
212.08 487.899 550.719 0.007358 
242.24 494.39 538 0.007094 
272.4 496.131 532.601 0.006998 
302.56 493.325 519.69 0.006867 
332.72 497.094 518.437 0.006799 
362.88 496.664 510.02 0.006694 
393.04 496.157 502.541 0.006603 
423.2 489.153 501.246 0.00668 
453.36 491.953 487.767 0.006463 
483.52 495.821 487.529 0.00641 
513.68 495.12 473.507 0.006234 
543.84 504.645 475.637 0.006144 
574 496.005 468.36 0.006155 
604.16 484.341 466.725 0.006282 
634.32 251.643 228.854 0.005928 
 
y = -3.85E-06x + 8.09E-03 
R² = 9.42E-01 
0.007 
0.0071 
0.0072 
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0.0074 
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Determination of the Partial Order in 19l of Bromocylization of 19l by 
19
F NMR. (0.0141M, 
replicate 1) [MTB-XVI-59] 
Following General Procedure 23, NBS (3.75 mg, 0.021 mmol), PhMe-d8 (0.1 mL), 
Solution A (45.5 μL), PhMe (529 μL) and Solution B (25 μL) were combined. 
 
Table 39. NMR Data for MTB-XVI-59. 
 11246.4 13513.8 1.201611 
Time   [olefin] 
28.63 1413.02 1708.01 0.014141 
58.79 1347.14 1618.21 0.014053 
88.95 1334.68 1579.9 0.013848 
119.11 1329.32 1567.39 0.013794 
149.27 1345.97 1547.78 0.013453 
179.43 1328.37 1528.68 0.013463 
209.59 1340.63 1512.51 0.013199 
239.75 1336.55 1489.81 0.01304 
269.91 1329.81 1467.62 0.012911 
300.07 1327.55 1461.82 0.012882 
330.23 1331.82 1438.32 0.012634 
360.39 1349.61 1424.46 0.012348 
390.55 1334.61 1416.07 0.012413 
420.71 1333.93 1406.67 0.012337 
450.87 1333.36 1387.23 0.012172 
481.03 1337.86 1392 0.012172 
511.19 1329.11 1381.81 0.012163 
541.35 1346.75 1363.2 0.011842 
571.51 1346.19 1331.44 0.011571 
601.67 1341.39 1322.79 0.011537 
631.83 1344.33 1320.43 0.011491 
661.99 1344.08 1322.84 0.011514 
692.15 1345.1 1291.28 0.011231 
722.31 1334.51 1306.61 0.011454 
752.47 1322.26 1301.97 0.011519 
782.63 1327.35 1287.88 0.011351 
y = -5.11E-06x + 1.43E-02 
R² = 9.81E-01 
0.0124 
0.0126 
0.0128 
0.013 
0.0132 
0.0134 
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Table 39 cont. 
812.79 1340.31 1297.96 0.011329 
842.95 1338.75 1274.63 0.011139 
873.11 1346.16 1273.63 0.011069 
903.27 1359.92 1265.47 0.010886 
933.43 1328.18 1270.55 0.011191 
963.59 1341.42 1252.57 0.010924 
993.75 1357.83 1257.53 0.010835 
1023.91 1335.31 1234.86 0.010819 
1054.07 1347.65 1245.3 0.01081 
1084.23 1350.8 1232.76 0.010677 
1114.39 349.597 306.267 0.010249 
 
Determination of the Partial Order in 19l of Bromocylization of 19l by 
19
F NMR. (0.0141M, 
replicate 2) [MTB-XVI-64] 
Following General Procedure 23, NBS (3.75 mg, 0.021 mmol), PhMe-d8 (0.1 mL), 
Solution A (45.5 μL), PhMe (529 μL) and Solution B (25 μL) were combined. 
 
Table 40. NMR Data for MTB-XVI-64. 
 7805.54 9304.52 1.192041 
Time   [olefin] 
28.62 996.746 1184.99 0.01402 
58.78 950.228 1120.27 0.013903 
88.94 950.133 1114.37 0.013831 
119.1 943.365 1107.42 0.013844 
149.26 942.662 1091.48 0.013655 
179.42 939.383 1079.81 0.013556 
209.58 943.801 1057 0.013207 
239.74 950.278 1059.3 0.013146 
269.9 942.466 1048.79 0.013123 
300.06 942.53 1039.09 0.013001 
330.22 942.185 1034.01 0.012942 
y = -4.11E-06x + 1.42E-02 
R² = 9.70E-01 
0.0124 
0.0126 
0.0128 
0.013 
0.0132 
0.0134 
0.0136 
0.0138 
0.014 
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Table 40 cont. 
360.38 945.096 1015.64 0.012673 
390.54 946.719 1013.44 0.012624 
420.7 945.204 998.437 0.012457 
450.86 937.395 993.772 0.012502 
481.02 943.813 992.287 0.012398 
511.18 955.914 983.042 0.012127 
541.34 955.35 979.89 0.012096 
571.5 948.954 954.643 0.011864 
601.66 943.718 962.409 0.012026 
631.82 941.417 964.378 0.01208 
661.98 948.077 949.808 0.011814 
692.14 945.211 946.621 0.01181 
722.3 952.016 936.128 0.011596 
752.46 946.12 932.852 0.011627 
782.62 955.447 930.689 0.011487 
812.78 959.674 930.371 0.011433 
842.94 949.983 916.812 0.011381 
873.1 953.301 921.168 0.011395 
903.26 943.824 916.935 0.011457 
933.42 946.635 905.307 0.011278 
963.58 949.616 905.476 0.011245 
993.74 952.508 901.776 0.011165 
1023.9 949.682 891.893 0.011075 
1054.06 951.127 898.781 0.011144 
1084.22 942.623 891.25 0.01115 
1114.38 952.091 889.487 0.011017 
1144.54 951.451 886.101 0.010983 
1174.7 949.758 884.325 0.01098 
1204.86 955.584 885.681 0.01093 
1235.02 962.673 877.873 0.010754 
1265.18 961.11 873.996 0.010724 
1295.34 950.444 876.117 0.010871 
1325.5 949.374 874.761 0.010866 
1355.66 964.114 874.273 0.010694 
1385.82 948.947 867.895 0.010786 
1415.98 958.412 863.166 0.010621 
1446.14 951.972 859.648 0.010649 
1476.3 954.441 853.042 0.01054 
1506.46 952.017 860.005 0.010653 
1536.62 957.537 846.024 0.010419 
1566.78 949.757 854.409 0.010609 
1596.94 951.41 847.086 0.0105 
1627.1 946.491 850.786 0.0106 
1657.26 956.008 838.02 0.010337 
1687.42 959.848 842.904 0.010356 
1717.58 954.24 838.859 0.010367 
1747.74 956.06 839.719 0.010358 
1777.9 950.299 832.618 0.010332 
1808.06 954.112 838.704 0.010366 
 
Determination of the Partial Order in 19l of Bromocylization of 19l by 
19
F NMR. (0.0141M, 
replicate 3) [MTB-XVI-67] 
Following General Procedure 23, NBS (3.76 mg, 0.021 mmol), PhMe-d8 (0.1 mL), 
Solution A (45.5 μL), PhMe (529 μL) and Solution B (25 μL) were combined. 
403 
 
 
Table 41. NMR Data for MTB-XVI-67. 
 7454.57 9049.16 1.213908 
Time   [olefin] 
32.44 975.032 1166.84 0.013858 
62.6 907.831 1093.73 0.013952 
92.76 915.23 1078.12 0.013641 
122.92 908.33 1047.99 0.013361 
153.08 911.021 1026.41 0.013047 
183.24 914.155 1014.81 0.012855 
213.4 917.48 997.094 0.012585 
243.56 916.798 992.877 0.012541 
273.72 916.395 976.697 0.012342 
303.88 912.894 962.096 0.012205 
334.04 914.708 950.89 0.012038 
364.2 911.28 940.337 0.01195 
394.36 913.324 927.149 0.011756 
424.52 908.942 913.682 0.011641 
454.68 920.938 906.617 0.0114 
484.84 917.187 901.63 0.011384 
515 925.868 892.393 0.011162 
545.16 923.804 892.035 0.011182 
575.32 921.609 870.571 0.010939 
605.48 914.472 865.708 0.010963 
635.64 922.477 860.756 0.010806 
665.8 919.953 850.352 0.010704 
695.96 918.018 846.627 0.01068 
726.12 921.988 839.066 0.010539 
756.28 932.355 829.832 0.010307 
786.44 921.048 831.884 0.010459 
816.6 910.949 826.093 0.010502 
846.76 934.36 825.814 0.010235 
876.92 913.712 810.081 0.010267 
907.08 927.901 802.948 0.010021 
937.24 918.283 819.225 0.010331 
967.4 932.602 799.042 0.009922 
997.56 914.659 805.137 0.010194 
1027.72 925.763 801.29 0.010023 
1057.88 920.348 790.923 0.009952 
1088.04 811.947 686.857 0.009796 
 
y = -9.00E-06x + 1.45E-02 
R² = 9.96E-01 
0.0124 
0.0126 
0.0128 
0.013 
0.0132 
0.0134 
0.0136 
0.0138 
0.014 
0.0142 
0 50 100 150 200 250 
[o
le
fi
n
] 
T (sec) 
Initial Rate 
404 
 
Determination of the Partial Order in 19l of Bromocylization of 19l by 
19
F NMR. (0.0141M, 
replicate 4) [MTB-XVII-18] 
Replicates 4-5 (MTB-XVII-18, MTB-XVII-21) were run later and used the following 
stock solutions: 
Solution A: An oven-dried 2-mL volumetric flask, equipped with a septum was charged with 19l 
(121.72 mg, 0.6266 mmol). The flask was evacuated and filled with Ar via a needle. 
Fluorobenzene (59 μL, 1 equiv with respect to 19l) was added via syringe, and then the flask was 
filled to the mark with dry PhMe. 
 
Solution B: An oven-dried conical vial, equipped with a PTFE/silicone septum and cap was 
charged with 24a (5.40 mg, 0.00717 mmol). The vial was evacuated and filled with Ar via a 
needle and then was charged with Solution C (825 μL). 
 
Solution C: An oven-dried 10-mL volumetric flask, equipped with a septum was charged with 
Ph3P=S (25.86 mg, 0.08785 mmol). The flask was evacuated and filled with Ar via a needle, and 
then the flask was filled to the mark with dry PhMe. 
 
Following General Procedure 23, NBS (3.70 mg, 0.021 mmol), PhMe-d8 (0.1 mL), 
Solution A (31.5 μL), PhMe (543 μL) and Solution B (25 μL) were combined. 
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Table 42. NMR Data for MTB-XVII-18. 
 13175 12685.5 0.962846 
Time   [Olefin] 
26.94 1629.67 1591.49 0.014258 
57.1 1593.45 1539.14 0.014103 
87.26 1598.78 1501.68 0.013714 
117.42 1611.08 1486.32 0.01347 
147.58 1588.36 1466.39 0.013479 
177.74 1582.14 1436.81 0.013259 
207.9 1605.82 1422.72 0.012936 
238.06 1602.95 1407.56 0.012821 
268.22 1594.53 1380.62 0.012642 
298.38 1617.19 1366.46 0.012337 
328.54 1595.58 1344.71 0.012305 
358.7 1602.72 1319.54 0.012021 
388.86 1596.66 1333.64 0.012195 
419.02 1597.17 1292.74 0.011818 
449.18 1596.61 1286.26 0.011762 
479.34 1610.04 1288.48 0.011684 
509.5 1609.13 1264.89 0.011477 
539.66 1601.58 1250.24 0.011398 
569.82 1614.4 1258.94 0.011386 
599.98 1594.73 1239.35 0.011347 
630.14 1601.5 1232.65 0.011238 
660.3 1605.98 1206.32 0.010967 
690.46 1601.41 1212.69 0.011056 
720.62 1609.2 1203.28 0.010918 
750.78 1600.02 1189.81 0.010857 
780.94 1604.64 1195.86 0.010881 
811.1 1608.73 1179.41 0.010704 
841.26 1603.88 1173.7 0.010684 
871.42 1624.45 1181.39 0.010618 
901.58 1613.4 1147.77 0.010387 
931.74 1607.23 1149.09 0.010439 
961.9 1615.1 1146.2 0.010362 
992.06 200.417 145.289 0.010584 
 
y = -6.65E-06x + 1.44E-02 
R² = 9.58E-01 
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Determination of the Partial Order in 19l of Bromocylization of 19l by 
19
F NMR. 
(0.00141M, replicate 5) [MTB-XVII-21] 
Replicates 4-5 (MTB-XVII-18, MTB-XVII-21) were run later and used the following 
stock solutions: 
Solution A: An oven-dried 2-mL volumetric flask, equipped with a septum was charged with 19l 
(121.72 mg, 0.6266 mmol). The flask was evacuated and filled with Ar via a needle. 
Fluorobenzene (59 μL, 1 equiv with respect to 19l) was added via syringe, and then the flask was 
filled to the mark with dry PhMe. 
 
Solution B: An oven-dried conical vial, equipped with a PTFE/silicone septum and cap was 
charged with 24a (5.40 mg, 0.00717 mmol). The vial was evacuated and filled with Ar via a 
needle and then was charged with Solution C (825 μL). 
 
Solution C: An oven-dried 10-mL volumetric flask, equipped with a septum was charged with 
Ph3P=S (25.86 mg, 0.08785 mmol). The flask was evacuated and filled with Ar via a needle, and 
then the flask was filled to the mark with dry PhMe. 
 
Following General Procedure 23, NBS (3.79 mg, 0.021 mmol), PhMe-d8 (0.1 mL), 
Solution A (31.5 μL), PhMe (543 μL) and Solution B (25 μL) were combined. 
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Table 43. NMR Data for MTB-XVII-21. 
 13365.3 12998 0.972518 
Time   [Olefin] 
26.6 1649.96 1616.22 0.01416 
56.76 1599.21 1562.03 0.014119 
86.92 1613.67 1542.85 0.013821 
117.08 1603.58 1517.49 0.013679 
147.24 1606.31 1493.68 0.013442 
177.4 1615.86 1468.8 0.01314 
207.56 1606.53 1463.3 0.013166 
237.72 1622.01 1446.8 0.012894 
267.88 1609.96 1418.08 0.012732 
298.04 1606.6 1391.82 0.012523 
328.2 1622.49 1380.07 0.012295 
358.36 1600.7 1366.84 0.012343 
388.52 1621.5 1349.4 0.01203 
418.68 1615.99 1335.79 0.011949 
448.84 1620.08 1313.38 0.011719 
479 1623.93 1317.39 0.011727 
509.16 1621.97 1291.68 0.011512 
539.32 1611.75 1287.15 0.011544 
569.48 1604.33 1284.01 0.011569 
599.64 1619.37 1264.44 0.011287 
629.8 1620.46 1257.71 0.011219 
659.96 1618.18 1250.95 0.011175 
690.12 1613.55 1244.68 0.011151 
720.28 1615.11 1220.86 0.010927 
750.44 1629.95 1218 0.010802 
780.6 1625.02 1216.88 0.010825 
810.76 1616.04 1208.94 0.010814 
840.92 1624.92 1206.21 0.01073 
871.08 1632.73 1208.31 0.010698 
901.24 1624.16 1190.32 0.010594 
931.4 1632.3 1195.74 0.010589 
961.56 1619.5 1178.54 0.010519 
991.72 1621.25 1185.16 0.010567 
1021.88 1635.08 1175.96 0.010396 
1052.04 1625.71 1169.83 0.010402 
1082.2 1630.88 1176.39 0.010427 
1112.36 1619.43 1159.09 0.010346 
1142.52 1613 1143.3 0.010246 
y = -6.39E-06x + 1.44E-02 
R² = 9.79E-01 
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Table 43 cont. 
1172.68 1621.55 1156.93 0.010313 
1202.84 1635.43 1140.96 0.010085 
1233 1627.86 1148.47 0.010198 
1263.16 1623.6 1143.3 0.010179 
1293.32 1628.7 1127.54 0.010007 
1323.48 1632.23 1131.24 0.010018 
1353.64 1616.62 1133.78 0.010138 
1383.8 1626.59 1117.32 0.009929 
1413.96 1620.59 1117.93 0.009972 
1444.12 1624.09 1118.12 0.009952 
1474.28 1634.97 1115.77 0.009865 
1504.44 1629.04 1112.56 0.009872 
1534.6 1610.6 1118.66 0.01004 
1564.76 1625.15 1102.17 0.009803 
1594.92 1625.77 1111.25 0.00988 
1625.08 1630.28 1098.99 0.009744 
1655.24 1625.7 1094.65 0.009733 
1685.4 1622.98 1095.52 0.009757 
1715.56 1631.5 1102.4 0.009767 
1745.72 1638.74 1090.7 0.009621 
1775.88 1635 1085.19 0.009594 
1806.04 1621.14 1097.87 0.009789 
1836.2 1633.51 1080.39 0.009561 
1866.36 1639.36 1076.64 0.009493 
1896.52 1628.78 1085.03 0.00963 
1926.68 1624.6 1072.91 0.009546 
1956.84 1622.3 1073.69 0.009567 
1987 1628.31 1080.86 0.009595 
2017.16 1631.94 1062.03 0.009407 
2047.32 1641.51 1059.59 0.009331 
2077.48 1630.88 1069.66 0.009481 
2107.64 1632.77 1061.42 0.009397 
2137.8 1637.24 1066.5 0.009416 
2167.96 1624.67 1057.24 0.009407 
2198.12 1624 1058.73 0.009424 
2228.28 1633.93 1060.7 0.009384 
2258.44 1636.46 1058.11 0.009347 
2288.6 1644.86 1055.62 0.009277 
2318.76 1629.06 1054.98 0.009361 
2348.92 1626.76 1046.61 0.0093 
2379.08 1634.06 1051.86 0.009305 
2409.24 1628.62 1027.23 0.009117 
2439.4 1634.03 1064.38 0.009416 
2469.56 1634.67 1037.18 0.009172 
2499.72 1634.89 1036.33 0.009163 
2529.88 1630.64 1038.75 0.009208 
2560.04 1636.59 1035.19 0.009143 
2590.2 1645.22 1043.32 0.009167 
2620.36 1627.32 1043.61 0.00927 
2650.52 1628.56 1029.92 0.009142 
2680.68 1623.15 1025.42 0.009132 
2710.84 1641.03 1033.18 0.009101 
2741 1637.94 1027.88 0.009071 
2771.16 1637.86 1022.18 0.009021 
2801.32 1625.81 1025.8 0.00912 
2831.48 1630.1 1029.2 0.009127 
2861.64 1640.3 1006.96 0.008874 
2891.8 1633.23 1016.97 0.009001 
2921.96 1637.76 1022.09 0.009021 
2952.12 1636.23 1010.95 0.008931 
2982.28 1635.43 1007.32 0.008904 
3012.44 1627.08 1015.7 0.009024 
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Determination of the Partial Order in 19l of Bromocylization of 19l by 
19
F NMR. (0.04446 
M, replicate 1) [MTB-XVI-60] 
Following General Procedure 23, NBS (3.73 mg, 0.021 mmol), PhMe-d8 (0.1 mL), 
Solution A (144 μL), PhMe (431 μL) and Solution B (25 μL) were combined. 
 
Table 44. NMR Data  for MTB-XVI-60. 
 38246.8 46310.6 1.210836 
Time   [olefin] 
29.81 4869.52 5900.56 0.04449 
59.97 4616.23 5514.21 0.043859 
90.13 4585.56 5431.6 0.043491 
120.29 4580.85 5352.4 0.0429 
150.45 4588.81 5282.37 0.042266 
180.61 4584.09 5227.19 0.041867 
210.77 4591.81 5186.81 0.041474 
240.93 4572.43 5126.71 0.041167 
271.09 4587.45 5086.1 0.040707 
301.25 4589.92 5026.47 0.040208 
331.41 4596.15 4989.41 0.039858 
361.57 4571.67 4944.04 0.039707 
391.73 4600.94 4924.17 0.039296 
421.89 4572.99 4893.69 0.039291 
452.05 4594.06 4847.76 0.038744 
482.21 4596.38 4829.91 0.038582 
512.37 4602.84 4813.07 0.038393 
542.53 4592.55 4790.96 0.038303 
572.69 4584.01 4764.66 0.038163 
602.85 4591.09 4752.29 0.038006 
633.01 4576.08 4723.16 0.037896 
663.17 4586.1 4724.66 0.037826 
693.33 4576.22 4712.44 0.037809 
723.49 4586.36 4691.51 0.037558 
753.65 4583.49 4673 0.037433 
783.81 4593.72 4662.42 0.037265 
y = -1.65E-05x + 4.49E-02 
R² = 9.92E-01 
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Table 44 cont. 
813.97 4583.51 4654.65 0.037286 
844.13 4597.8 4646.77 0.037107 
874.29 4578.84 4644.39 0.037242 
904.45 4585.64 4641.81 0.037166 
934.61 4586.53 4623.82 0.037015 
964.77 4570.41 4627.16 0.037172 
994.93 4562.52 4610.15 0.0371 
1025.09 4582.84 4613.19 0.03696 
1055.25 4594.58 4616.02 0.036888 
1085.41 4572.62 4591.89 0.036871 
1115.57 4584.72 4596.75 0.036813 
1145.73 4579.88 4588.68 0.036787 
1175.89 4573.81 4600.9 0.036934 
1206.05 4580.75 4591.21 0.0368 
1236.21 4580.73 4597.96 0.036854 
1266.37 4581.65 4574.19 0.036657 
1296.53 4584.82 4579.52 0.036674 
1326.69 4568.15 4581.38 0.036823 
1356.85 4589.66 4578.54 0.036627 
1387.01 4577.57 4574.1 0.036689 
1417.17 4573.62 4562.16 0.036624 
1447.33 4580.19 4572.9 0.036658 
1477.49 4569 4566.71 0.036698 
1507.65 4568.55 4574.62 0.036765 
1537.81 4567.2 4562.97 0.036682 
1567.97 4568.89 4550.78 0.036571 
1598.13 4577.1 4570.71 0.036665 
1628.29 4572.2 4565.95 0.036666 
1658.45 4586.65 4566.76 0.036557 
1688.61 4576.99 4569.06 0.036653 
1718.77 4579.25 4565.25 0.036604 
1748.93 4576.37 4540.69 0.03643 
1779.09 4568.95 4543.64 0.036513 
1809.25 4595.02 4550.21 0.036358 
1839.41 4558.07 4542.55 0.036591 
1869.57 4564.7 4542.11 0.036535 
1899.73 4578.29 4555.41 0.036533 
1929.89 4566.1 4551.17 0.036596 
1960.05 4573.56 4543.39 0.036474 
1990.21 4557.52 4562.66 0.036758 
2020.37 4569.04 4535.64 0.036448 
2050.53 4593.58 4544.72 0.036326 
2080.69 4568.68 4544.8 0.036524 
2110.85 4589.01 4540.06 0.036325 
2141.01 4582.69 4529.75 0.036292 
2171.17 4573.9 4542.21 0.036462 
2201.33 4562.39 4523.07 0.0364 
2231.49 4569.63 4532.73 0.03642 
2261.65 4579.36 4545.24 0.036443 
2291.81 4559.84 4531.75 0.03649 
2321.97 4571.4 4536.4 0.036435 
2352.13 4569.35 4533.66 0.03643 
2382.29 4576.73 4540.29 0.036424 
2412.45 4555.95 4530.3 0.03651 
2442.61 4569.47 4524.08 0.036352 
2472.77 4570.53 4530.74 0.036397 
2502.93 4565.19 4536.43 0.036485 
2533.09 4562.62 4535.29 0.036496 
2563.25 4577.08 4528.12 0.036324 
2593.41 4573.15 4518.99 0.036282 
2623.57 4576.38 4526.28 0.036314 
2653.73 4563.54 4520.4 0.036369 
2683.89 4569.46 4509.31 0.036233 
2714.05 4561.97 4528.36 0.036446 
2744.21 4551.84 4510.48 0.036383 
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2774.37 4562.65 4512.7 0.036314 
2804.53 4577.77 4523.65 0.036282 
2834.69 4555.54 4515.41 0.036393 
2864.85 4568.45 4522.88 0.03635 
2895.01 4564.38 4512.31 0.036298 
2925.17 4570.38 4530.39 0.036395 
2955.33 4573.15 4508.06 0.036194 
2985.49 4558.34 4511.37 0.036338 
3015.65 4572.68 4498.58 0.036121 
3045.81 4572.14 4513.51 0.036246 
3075.97 4576.11 4507.49 0.036166 
3106.13 4565.98 4505.58 0.036231 
3136.29 4574.4 4497.53 0.036099 
3166.45 4569.33 4508.25 0.036226 
3196.61 4567.52 4489.11 0.036086 
3226.77 4567.57 4514.06 0.036286 
3256.93 4561.66 4506.25 0.03627 
3287.09 4540.23 4494.57 0.036347 
3317.25 4576.16 4508.61 0.036174 
3347.41 4556.42 4493.82 0.036212 
3377.57 4561.39 4497.85 0.036205 
3407.73 4565.43 4498.27 0.036176 
3437.89 4562.23 4498.81 0.036206 
3468.05 4568.98 4495.05 0.036122 
3498.21 4575.39 4510.19 0.036193 
3528.37 4554.99 4501.67 0.036287 
3558.53 4553.94 4515.46 0.036406 
3588.69 4556.43 4500.2 0.036263 
3618.85 4557.52 4506.16 0.036303 
 
Determination of the Partial Order in 19l of Bromocylization of 19l by 
19
F NMR. (0.04446 
M, replicate 2) [MTB-XVI-63] 
Following General Procedure 23, NBS (3.70 mg, 0.021 mmol), PhMe-d8 (0.1 mL), 
Solution A (144 μL), PhMe (431 μL) and Solution B (25 μL) were combined. 
 
y = -1.31E-05x + 4.48E-02 
R² = 9.95E-01 
0.0415 
0.042 
0.0425 
0.043 
0.0435 
0.044 
0.0445 
0 50 100 150 200 250 
[o
le
fi
n
] 
T (sec) 
Initial Rate 
412 
 
Table 45. NMR Data for MTB-XVI-63. 
 26806.9 31511.5 1.1755 
Time   [olefin] 
29.81 3399.27 3951.26 0.043961 
59.97 3248.53 3778.39 0.043989 
90.13 3252.16 3749.13 0.043599 
120.29 3256.5 3709.79 0.043084 
150.45 3257.52 3687.21 0.042809 
180.61 3256.48 3653.51 0.042431 
210.77 3260.98 3620.16 0.041986 
240.93 3262.39 3573.25 0.041424 
271.09 3256.33 3546.71 0.041193 
301.25 3258.24 3523.87 0.040903 
331.41 3253.49 3493.47 0.04061 
361.57 3262.45 3482.21 0.040368 
391.73 3271.57 3458.18 0.039977 
421.89 3270.21 3437.46 0.039754 
452.05 3257.18 3405.72 0.039545 
482.21 3259.07 3397.61 0.039428 
512.37 3268.03 3377.38 0.039086 
542.53 3267.61 3354.93 0.038831 
572.69 3272.61 3347.06 0.03868 
602.85 3269.68 3334.8 0.038573 
633.01 3271.57 3325.14 0.038439 
663.17 3263.92 3303.85 0.038283 
693.33 3263.99 3302.79 0.03827 
723.49 3275.07 3295.81 0.03806 
753.65 2442.78 2462.57 0.038126 
 
Determination of the Partial Order in 19l of Bromocylization of 19l by 
19
F NMR. (0.04446 
M, replicate 3) [MTB-XVI-68] 
Following General Procedure 23, NBS (3.70 mg, 0.021 mmol), PhMe-d8 (0.1 mL), 
Solution A (144 μL), PhMe (431 μL) and Solution B (25 μL) were combined. 
 
y = -1.69E-05x + 4.47E-02 
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Table 46. NMR data for MTB-XVI-68. 
 24048.7 29339.1 1.219987 
Time   [olefin] 
27 3065.22 3737.14 0.04443 
57.16 2935.43 3517.44 0.043667 
87.32 2920.97 3460 0.043166 
117.48 2912.28 3428 0.042895 
147.64 2921.28 3377.05 0.042127 
177.8 2919.15 3335.34 0.041637 
207.96 2921.78 3301.54 0.041178 
238.12 2922.02 3265.3 0.040723 
268.28 2921.48 3222.07 0.040191 
298.44 2934.03 3199.16 0.039734 
328.6 2920.3 3173.91 0.039606 
358.76 2920.47 3136.18 0.039133 
388.92 2931.3 3125.29 0.038853 
419.08 2928.26 3102.07 0.038604 
449.24 2920.74 3081.1 0.038442 
479.4 2930.26 3070.86 0.03819 
509.56 2933.39 3048.41 0.03787 
539.72 2929.91 3041.66 0.037831 
569.88 2929.6 3020.81 0.037576 
600.04 2931.2 3015.95 0.037495 
630.2 2923.05 2997 0.037363 
660.36 2927.92 2986.01 0.037164 
690.52 2929.58 2982.22 0.037096 
720.68 2932.24 2981.84 0.037058 
750.84 2931.29 2962.49 0.036829 
781 2934.79 2951.69 0.036651 
811.16 741.384 739.98 0.036372 
 
 
Determination of the Partial Order in 19l of Bromocylization of 19l by 
19
F NMR. (0.07906 
M, replicate 1) [MTB-XVI-61] 
Following General Procedure 23, NBS (3.72 mg, 0.021 mmol), PhMe-d8 (0.1 mL), 
Solution A (256 μL), PhMe (319 μL) and Solution B (25 μL) were combined. 
414 
 
 
Table 47. NMR data for MTB-XVI-61. 
 44295.8 52778.7 1.191506 
Time   [olefin] 
29.15 5674.02 6665.38 0.077944 
59.31 5409.89 6314.64 0.077447 
89.47 5395.76 6243.66 0.076777 
119.63 5388.71 6181.72 0.076115 
149.79 5404.21 6116.18 0.075092 
179.95 5393.47 6067.26 0.07464 
210.11 5406.76 6018.57 0.073859 
240.27 5414.4 5978.33 0.073262 
270.43 5402.79 5937.89 0.072922 
300.59 5397.44 5889.67 0.072402 
330.75 5401.67 5868.87 0.07209 
360.91 5398.65 5844.36 0.071829 
391.07 5400.83 5815.34 0.071443 
421.23 5409.7 5805.12 0.071201 
451.39 5398.4 5771.12 0.070932 
481.55 5419.06 5769.47 0.070641 
511.71 5400.5 5753.1 0.070683 
541.87 5397.14 5735 0.070504 
572.03 5413.72 5721.51 0.070123 
602.19 5394.82 5706.77 0.070188 
632.35 5398.64 5708.81 0.070163 
662.51 5407 5699.65 0.069942 
692.67 5397.14 5688.09 0.069928 
722.83 5400.56 5674.97 0.069722 
752.99 5403.02 5681.53 0.069771 
783.15 5397.62 5668.18 0.069677 
813.31 5396.43 5672.5 0.069745 
843.47 5392.99 5668.66 0.069743 
873.63 5402.23 5653.26 0.069434 
903.79 5398.32 5656.19 0.06952 
933.95 5381.13 5651.73 0.069687 
964.11 5384.84 5648.87 0.069604 
994.27 5377.83 5644.78 0.069645 
1024.43 5387.62 5638.92 0.069446 
1054.59 5382.06 5639.93 0.06953 
1084.75 5387.99 5636.18 0.069407 
1114.91 5374.34 5630.74 0.069516 
1145.07 5381.26 5631.97 0.069442 
y = -2.56E-05x + 7.90E-02 
R² = 9.87E-01 
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Table 47 cont. 
1175.23 5374.7 5624.98 0.069441 
1205.39 5375.03 5636.76 0.069582 
1235.55 5377.09 5627.08 0.069436 
1265.71 5385.67 5628.45 0.069342 
1295.87 678.259 700.702 0.068546 
 
Determination of the Partial Order in 19l of Bromocylization of 19l by 
19
F NMR. (0.07906 
M, replicate2) [MTB-XVI-62] 
Following General Procedure 23, NBS (3.71 mg, 0.021 mmol), PhMe-d8 (0.1 mL), 
Solution A (256 μL), PhMe (319 μL) and Solution B (25 μL) were combined. 
 
Table 48. NMR data for MTB-XVI-62. 
 42576.7 51381.8 1.206806 
Time   [olefin] 
29.88 5450.4 6519.46 0.078359 
60.04 5098.26 6072.47 0.078028 
90.2 5080.52 5998.67 0.077349 
120.36 5071.56 5922.79 0.076505 
150.52 5073.77 5884.73 0.07598 
180.68 5072.61 5827.53 0.075259 
210.84 5076.93 5785.52 0.074653 
241 5073.86 5744.1 0.074163 
271.16 5077.04 5712.91 0.073714 
301.32 5071.83 5671.57 0.073256 
331.48 5080.04 5637.79 0.072702 
361.64 5072.03 5606.54 0.072413 
391.8 5076.14 5596.97 0.072231 
421.96 5067.35 5568.92 0.071994 
452.12 5068.43 5561.74 0.071886 
482.28 5057.67 5533.65 0.071675 
512.44 5066.16 5521.38 0.071396 
542.6 5068.71 5511.68 0.071235 
y = -2.29E-05x + 7.94E-02 
R² = 9.96E-01 
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Table 48 cont. 
572.76 5055.6 5506.47 0.071352 
602.92 5063.5 5501.83 0.071181 
633.08 5069.75 5478.64 0.070793 
663.24 5059.21 5473.98 0.07088 
693.4 5061.24 5473.55 0.070846 
723.56 5053.99 5461.3 0.070789 
753.72 5057.17 5454.89 0.070662 
783.88 5057.83 5446.51 0.070544 
814.04 5040.56 5444.09 0.070754 
844.2 5053.62 5443.79 0.070567 
874.36 5042.12 5443.05 0.070719 
904.52 5043.87 5435.41 0.070595 
934.68 5046.54 5423.93 0.070409 
964.84 5036.59 5422.71 0.070532 
995 5052.9 5426.91 0.070359 
1025.16 5046.94 5426.62 0.070438 
1055.32 5041.22 5426.06 0.070511 
1085.48 5042.04 5425.94 0.070498 
1115.64 5039.7 5414.75 0.070385 
1145.8 5041.85 5413.31 0.070336 
1175.96 5040.81 5424.47 0.070496 
1206.12 5036.9 5403.85 0.070282 
1236.28 5037.81 5412.31 0.07038 
1266.44 5035.39 5412.35 0.070414 
1296.6 5035.81 5410.95 0.07039 
1326.76 5033.23 5402.59 0.070317 
1356.92 5037.97 5404.02 0.07027 
1387.08 5020.58 5395.2 0.070398 
1417.24 5029.97 5402.73 0.070365 
1447.4 5038.85 5398.01 0.070179 
1477.56 5035.16 5393.13 0.070167 
1507.72 5035.2 5396.83 0.070215 
1537.88 5029.47 5390.64 0.070214 
1568.04 5030.23 5389.06 0.070183 
1598.2 5025.47 5383.21 0.070173 
1628.36 5030.81 5387.26 0.070151 
1658.52 2523.26 2691.22 0.06987 
Determination of the Partial Order in 19l of Bromocylization of 19l by 
19
F NMR. (0.07906 
M, replicate 3) [MTB-XVI-69] 
Following General Procedure 23, NBS (3.74 mg, 0.021 mmol), PhMe-d8 (0.1 mL), 
Solution A (256 μL), PhMe (319 μL) and Solution B (25 μL) were combined. 
417 
 
 
Table 49. NMR Data for MTB-XVI-69. 
 46880.1 56501.4 1.205232 
Time   [olefin] 
37.12 5977.25 7046.16 0.077328 
67.28 5549.13 6613.73 0.078182 
97.44 5533.31 6559.72 0.077765 
127.6 5541.58 6499.04 0.076931 
157.76 5543.65 6439.02 0.076192 
187.92 5548.62 6389.69 0.075541 
218.08 5541.79 6334.83 0.074984 
248.24 5547.39 6277.54 0.074231 
278.4 5552.38 6247.67 0.073812 
308.56 5549.78 6212.14 0.073426 
338.72 5546.31 6174.69 0.073029 
368.88 5541.28 6145.68 0.072752 
399.04 5555.81 6120.71 0.072267 
429.2 5550.33 6099.62 0.072089 
459.36 5541.47 6073.93 0.0719 
489.52 5556.99 6056.91 0.071499 
519.68 5551.21 6039.07 0.071362 
549.84 5559.76 6030.47 0.071151 
580 5546.64 6018.05 0.071172 
610.16 5540.75 5996.97 0.070999 
640.32 3466.19 3755.04 0.071064 
y = -2.26E-05x + 7.98E-02 
R² = 9.83E-01 
0.076 
0.0765 
0.077 
0.0775 
0.078 
0.0785 
0 50 100 150 200 
[o
le
fi
n
] 
T (sec) 
Initial Rate 
418 
 
 
General Procedure 24. Determination of the Partial Order in 24a of Bromocylization of 19l 
by 
19
F NMR. (0.0988 mM, replicate 1) [MTB-XVI-71] 
The following stock solutions were prepared and used for all runs to determine the partial 
order in 24a: 
Solution A: An oven-dried 2-mL volumetric flask, equipped with a septum was charged with 19l 
(44.82 mg, 0.2307 mmol). The flask was evacuated and filled with Ar via a needle. 
Fluorobenzene (22 μL, 1 equiv with respect to 19l) was added via syringe, and then the flask was 
filled to the mark with dry PhMe. 
 
Solution B: An oven-dried conical vial, equipped with a PTFE/silicone septum and cap was 
charged with 24a (5.41 mg, 0.00719 mmol). The vial was evacuated and filled with Ar via a 
needle and then was charged with dry PhMe (825 μL). 
 
Solution C: An oven-dried 10-mL volumetric flask, equipped with a septum was charged with 
Ph3P=S (25.75 mg, 0.08748 mmol). The flask was evacuated and filled with Ar via a needle, and 
then the flask was filled to the mark with dry PhMe. 
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An oven-dried, 5-mm NMR tube, fitted with a septum, wrapped in Al foil, was charged 
with NBS (3.72 mg, 0.021 mmol). The septum was removed and tube was then brought in to an 
Ar filled glove box, where the septum was replaced. The tube removed from the glove box and 
was charged with PhMe-d8 (0.1 mL), Solution A (151 μL) and PhMe (416 μL). The tube was 
agitated in a vortex mixer until homogenous by visual inspection. The tube was inserted into the 
NMR spectrometer and shimmed. An initial time point was acquired (64 scans, at=1, pw=8.25, 
d1=2.77) to determine response factors and correct for any evaporation of the PhF standard. The 
tube was ejected from the spectrometer. Solution B (8 μL) and Solution C  (25 μL) were added . 
The tube was rapidly inverted three times and was reinserted into the spectrometer. An arrayed 
acquisition was begun (nt=8, d1=2.77, at=1, pad=array of zeroes). 
 
Table 50.  NMR Data for MTB-XVI-71. 
 11985.7 15965.7 1.332062 
Time   [olefin] 
29.15 1546.64 2070.52 0.025125 
58.75 1468.39 1926.74 0.024626 
88.35 1445.96 1923.85 0.024971 
117.95 1453.85 1921.61 0.024806 
147.55 1457.77 1900.63 0.024469 
177.15 1445.7 1902.45 0.024697 
206.75 1455.84 1899.18 0.024483 
236.35 1449.89 1880.9 0.024347 
265.95 1453.65 1881.4 0.024291 
y = -3.94E-06x + 2.53E-02 
R² = 9.81E-01 
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Table 50 cont. 
295.55 1453.55 1867.14 0.024108 
325.15 1452.17 1870.27 0.024171 
354.75 1452.4 1855.1 0.023972 
384.35 1457.31 1844.56 0.023755 
413.95 1456.19 1833.91 0.023636 
443.55 1454.91 1822.61 0.023511 
473.15 1456.99 1823.17 0.023485 
502.75 1452.82 1800.64 0.023261 
532.35 1461.66 1797.02 0.023074 
561.95 1453.73 1788.21 0.023086 
591.55 1464.33 1777.48 0.022781 
621.15 1462.38 1771.68 0.022737 
650.75 1461.62 1766.26 0.02268 
680.35 1444.32 1754.07 0.022793 
709.95 1454.27 1745.74 0.022529 
739.55 1453.87 1748.53 0.022572 
769.15 1457.73 1739.24 0.022392 
798.75 1452.04 1732.61 0.022394 
828.35 1460.27 1736.03 0.022312 
857.95 1448.35 1721.81 0.022311 
887.55 1454.75 1719.96 0.022189 
917.15 1446.91 1718.61 0.022292 
946.75 1454.07 1718.02 0.022175 
976.35 1447.95 1724.76 0.022356 
1005.95 1455.66 1726.24 0.022256 
1035.55 1451.29 1719 0.02223 
1065.15 1461.78 1720.82 0.022094 
1094.75 1451.88 1716.13 0.022184 
1124.35 1450.28 1723.27 0.022301 
1153.95 1461.72 1719.01 0.022071 
1183.55 1453.79 1708.45 0.022055 
1213.15 1460.67 1707.64 0.021941 
1242.75 1450.63 1710.89 0.022135 
1272.35 1457.04 1710.24 0.022029 
1301.95 1452.42 1709.19 0.022086 
1331.55 1453.15 1708.87 0.022071 
1361.15 1451.12 1711.62 0.022137 
1390.75 1454.19 1704.27 0.021995 
1420.35 1442.08 1706.02 0.022203 
1449.95 1445.61 1708.98 0.022187 
1479.55 1461.55 1700.18 0.021832 
1509.15 1456.01 1700.1 0.021914 
1538.75 1451.04 1703.04 0.022027 
1568.35 1450.5 1703.9 0.022047 
1597.95 1451.93 1711.59 0.022124 
1627.55 1449.18 1702.1 0.022043 
1657.15 1461.87 1703.04 0.021864 
1686.75 1450.39 1699.99 0.021998 
1716.35 1453.92 1698.96 0.021931 
1745.95 1452.8 1701.5 0.021981 
1775.55 1452.17 1693.68 0.021889 
1805.15 1454.8 1693.37 0.021846 
1834.75 1459.3 1698.79 0.021848 
1864.35 1447.35 1701.46 0.022063 
1893.95 1452.81 1697.11 0.021924 
1923.55 1457.46 1699.09 0.021879 
1953.15 1451.66 1690.36 0.021854 
1982.75 1455.74 1692.98 0.021826 
2012.35 1445.8 1693.83 0.021988 
2041.95 1446.94 1688.08 0.021896 
2071.55 1452.87 1691.64 0.021852 
2101.15 1451.01 1693.33 0.021902 
2130.75 1454.08 1694.38 0.021869 
2160.35 1455.75 1691.36 0.021805 
2189.95 1457.69 1688.42 0.021739 
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Table 50 cont. 
2219.55 1448.49 1696.82 0.021985 
2249.15 1454.33 1696.52 0.021893 
2278.75 1454.21 1688.01 0.021785 
2308.35 1455.23 1690.05 0.021796 
2337.95 1447.7 1698.04 0.022013 
2367.55 1449.75 1690.75 0.021888 
2397.15 1451.58 1698.37 0.021959 
2426.75 1449.13 1693.79 0.021937 
2456.35 1448.57 1698.74 0.022009 
2485.95 1452.49 1692.54 0.02187 
2515.55 1459.58 1685.68 0.021675 
2545.15 1451.04 1692.63 0.021893 
2574.75 1453.51 1679.13 0.021681 
2604.35 1447.3 1685.32 0.021854 
2633.95 1450.6 1686.61 0.021821 
2663.55 1444.99 1685.19 0.021888 
2693.15 1453.39 1683.34 0.021737 
2722.75 1451.58 1679.9 0.02172 
2752.35 1454.5 1687.57 0.021775 
2781.95 1450.99 1690.88 0.021871 
2811.55 1445.96 1685.41 0.021876 
2841.15 1452.82 1691.99 0.021858 
2870.75 1449.99 1692.58 0.021908 
2900.35 1448.28 1686.31 0.021852 
2929.95 1448.05 1679.84 0.021772 
2959.55 1455.74 1695.9 0.021864 
2989.15 1446.63 1673.62 0.021713 
3018.75 1449.11 1688.97 0.021874 
3048.35 1448.07 1692.32 0.021934 
3077.95 1448.3 1684.61 0.02183 
3107.55 1449.66 1685.07 0.021816 
3137.15 1450.16 1679.84 0.02174 
3166.75 1447.9 1677.26 0.021741 
3196.35 1449.44 1683.48 0.021798 
3225.95 1452.39 1680.46 0.021715 
3255.55 1446.9 1686.81 0.02188 
3285.15 1447.98 1685.93 0.021852 
3314.75 1454.11 1676.72 0.021641 
3344.35 1450.78 1683.14 0.021774 
3373.95 1446.19 1679.16 0.021791 
3403.55 1444.77 1681.32 0.021841 
3433.15 1455.74 1682.99 0.021698 
3462.75 1450.44 1682.13 0.021766 
3492.35 1446.58 1676.71 0.021754 
3521.95 1442.35 1679.04 0.021848 
3551.55 1445.74 1684.77 0.021871 
 
Determination of the Partial Order in 24a of Bromocylization of 19l by 
19
F NMR. (0.0988 
mM, replicate 2) [MTB-XVI-78] 
Following General Procedure 24, NBS (3.67 mg, 0.021 mmol), PhMe-d8 (0.1 mL), 
Solution A (151 μL), PhMe (416 μL), Solution B (8 μL) and Solution C  (25 μL)  were 
combined. 
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Table 51. NMR Data for MTB-XVI-78. 
 12953.9 17056.4 1.3167 
Time   [olefin] 
42.34 1637.12 2131.32 0.024718 
72.5 1524 2010.36 0.025046 
102.66 1526.93 1998.97 0.024857 
132.82 1531.42 2003.22 0.024836 
162.98 1534.94 1994.67 0.024674 
193.14 1521.4 1989.45 0.024828 
223.3 1517.97 1985.65 0.024837 
253.46 1518.77 1979.11 0.024742 
283.62 1524.8 1974.44 0.024586 
313.78 1519.13 1964.81 0.024557 
343.94 1529.7 1948.85 0.024189 
374.1 1532.42 1950.6 0.024168 
404.26 1521.64 1942.73 0.024241 
434.42 1528.45 1932.48 0.024006 
464.58 1516.84 1929.25 0.024149 
494.74 1531.59 1915.05 0.023741 
524.9 1522.12 1905.9 0.023774 
555.06 1521.82 1899.05 0.023693 
585.22 1523.41 1891.33 0.023572 
615.38 1522.43 1893.34 0.023613 
645.54 1525.81 1877.06 0.023358 
675.7 1525.38 1874.5 0.023332 
705.86 1531.04 1867.02 0.023153 
736.02 1538.64 1858.33 0.022932 
766.18 1520.45 1845.83 0.02305 
796.34 1532.46 1839.57 0.022792 
826.5 1527.34 1834.28 0.022803 
856.66 1526.98 1837.48 0.022848 
886.82 1523.9 1827.96 0.022775 
916.98 1528.92 1827.63 0.022696 
947.14 1527.83 1821.07 0.022631 
977.3 1528.12 1814.44 0.022544 
1007.46 1525.43 1820.19 0.022656 
1037.62 1532.33 1812.11 0.022454 
1067.78 1525.51 1809.83 0.022526 
1097.94 1531.42 1812.55 0.022472 
1128.1 1522.35 1804.25 0.022503 
y = -3.03E-06x + 2.54E-02 
R² = 9.74E-01 
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Table 51 cont. 
1158.26 1528.32 1799.86 0.02236 
1188.42 1533.57 1797.16 0.02225 
1218.58 1526.83 1790.28 0.022263 
1248.74 1530.49 1800.43 0.022336 
1278.9 1531.77 1800.46 0.022317 
1309.06 1519.13 1796.81 0.022457 
1339.22 1519.6 1795.41 0.022433 
1369.38 1529.13 1792.8 0.022261 
1399.54 1527.43 1793.68 0.022297 
1429.7 1526.99 1791.16 0.022272 
1459.86 1528.07 1791.39 0.022259 
1490.02 1529.72 1789.49 0.022211 
1520.18 1532.16 1784.15 0.02211 
1550.34 1532.81 1788.54 0.022155 
1580.5 1528.67 1782.06 0.022134 
1610.66 1518.9 1787.54 0.022345 
1640.82 1529.12 1780.83 0.022112 
1670.98 1525.23 1773.21 0.022074 
1701.14 1527.66 1785.84 0.022196 
1731.3 1527.59 1778.14 0.022101 
1761.46 1529.27 1775.89 0.022049 
1791.62 1531.65 1774.12 0.021993 
1821.78 1527.47 1774.18 0.022054 
1851.94 1526.76 1774.32 0.022066 
1882.1 1527.93 1776.89 0.022081 
1912.26 1519.51 1775.14 0.022181 
1942.42 1520.63 1770.58 0.022108 
1972.58 1526.56 1774.62 0.022072 
2002.74 1525.55 1765.48 0.021973 
2032.9 1531.06 1762.81 0.021861 
2063.06 1525.67 1765.68 0.021974 
2093.22 1530.26 1758.89 0.021824 
2123.38 1525.75 1780 0.022151 
2153.54 1521.12 1762.74 0.022003 
2183.7 1523.46 1773.96 0.022109 
2213.86 1529.59 1761.77 0.021869 
2244.02 1541.45 1758.52 0.021661 
2274.18 1527.95 1762.69 0.021904 
2304.34 1527.06 1752.28 0.021787 
2334.5 1525.11 1759.19 0.021901 
2364.66 1531.3 1759.09 0.021811 
2394.82 1534.6 1766.8 0.02186 
2424.98 1533.98 1760.41 0.02179 
2455.14 1518.17 1757.3 0.021978 
2485.3 1531.05 1767.29 0.021917 
2515.46 1515.45 1753.85 0.021974 
2545.62 1525.37 1761.78 0.02193 
2575.78 1523.5 1748.96 0.021797 
2605.94 1522.74 1758.7 0.021929 
2636.1 1520.34 1754.94 0.021917 
2666.26 1524.47 1756.99 0.021883 
2696.42 1522.18 1761.67 0.021974 
2726.58 1523.17 1747.91 0.021788 
2756.74 1521.97 1757.88 0.02193 
2786.9 1520.71 1745.98 0.021799 
2817.06 1526.3 1750.39 0.021774 
2847.22 1524.08 1748.44 0.021782 
2877.38 573.751 657.899 0.021772 
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Determination of the Partial Order in 24a of Bromocylization of 19l by 
19
F NMR. (0.0988 
mM, replicate 3) [MTB-XVI-79] 
Following General Procedure 24, NBS (3.76 mg, 0.021 mmol), PhMe-d8 (0.1 mL), 
Solution A (151 μL), PhMe (416 μL), Solution B (8 μL) and Solution C  (25 μL)  were 
combined. 
 
Table 52. NMR Data for MTB-XVI-79. 
 12000.3 16213.9 1.351125 
Time   [olefin] 
43.72 1564.4 2086.88 0.024683 
73.88 1421.41 1925.9 0.02507 
104.04 1413.79 1914.07 0.025051 
134.2 1404.37 1904.17 0.025088 
164.36 1406.97 1910.02 0.025119 
194.52 1401.8 1904.34 0.025136 
224.68 1404.69 1906.1 0.025108 
254.84 1412.4 1897.4 0.024857 
285 1409.25 1894.48 0.024874 
315.16 1405.37 1888.09 0.024859 
345.32 1413.74 1896.55 0.024822 
375.48 1415.19 1880.09 0.024582 
405.64 1403.71 1886.74 0.02487 
435.8 1416.32 1878.44 0.02454 
465.96 1402.66 1878.96 0.024786 
496.12 1416.99 1863.66 0.024336 
526.28 1410.38 1871.89 0.024558 
556.44 1401.66 1861.91 0.024579 
586.6 1404.49 1851.55 0.024393 
616.76 1402.27 1858.31 0.024521 
646.92 1407.58 1847.25 0.024283 
677.08 1404.65 1843.81 0.024288 
707.24 1404.86 1828.9 0.024088 
y = -2.28E-06x + 2.57E-02 
R² = 9.18E-01 
0.0232 
0.0234 
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0.0242 
0.0244 
0.0246 
0.0248 
0.025 
0 200 400 600 800 1000 1200 
[o
le
fi
n
] 
T (sec) 
Initial Rate 
425 
 
Table 52 cont. 
737.4 1411.4 1826.51 0.023945 
767.56 1398.94 1817.2 0.024035 
797.72 1403.46 1808.62 0.023845 
827.88 1401.38 1813.14 0.02394 
858.04 1407.99 1799.48 0.023648 
888.2 1412.72 1798.33 0.023554 
918.36 1414.91 1790.55 0.023415 
948.52 1403.26 1784.67 0.023532 
978.68 1406.71 1788.44 0.023524 
1008.84 1405.47 1776.78 0.023391 
1039 1403.2 1779.38 0.023464 
1069.16 1404.7 1785.09 0.023514 
1099.32 1408.96 1774.71 0.023306 
1129.48 1409.41 1774.42 0.023295 
1159.64 1405.79 1768.25 0.023274 
1189.8 1410.08 1766.1 0.023175 
1219.96 1406.5 1767.73 0.023255 
1250.12 1398.28 1755.05 0.023224 
1280.28 1395.75 1771.29 0.023482 
1310.44 1407.5 1760.93 0.023149 
1340.6 1399.08 1759.03 0.023264 
1370.76 1401.16 1761.78 0.023265 
1400.92 1405.73 1757.77 0.023137 
1431.08 1400.05 1754.1 0.023182 
1461.24 1400.11 1750.85 0.023138 
1491.4 1393.63 1753.8 0.023285 
1521.56 1402.11 1750.86 0.023105 
1551.72 1405.55 1747.43 0.023004 
1581.88 1404.36 1756.99 0.023149 
1612.04 1400.81 1746.34 0.023067 
1642.2 1395.76 1746.48 0.023152 
1672.36 1386.03 1750.44 0.023368 
1702.52 1404.23 1750.08 0.02306 
1732.68 1401.37 1741.32 0.022992 
1762.84 1394.65 1739.29 0.023076 
1793 1408.05 1738.51 0.022846 
1823.16 1408.85 1743.21 0.022894 
1853.32 1390.58 1745.27 0.023223 
1883.48 1397.36 1741.13 0.023055 
1913.64 1397.91 1734.1 0.022953 
1943.8 1403.12 1734.13 0.022868 
1973.96 1404.57 1734.87 0.022854 
2004.12 1395.11 1735.62 0.023019 
2034.28 1391.7 1726.44 0.022954 
2064.44 1395.34 1735.54 0.023014 
2094.6 1393.44 1732.96 0.023011 
2124.76 1395.07 1726.67 0.022901 
2154.92 1403.16 1736.18 0.022895 
2185.08 1391.44 1728.81 0.022989 
2215.24 1403.02 1728.45 0.022795 
2245.4 1398.52 1728.58 0.02287 
2275.56 1401.01 1734.82 0.022912 
2305.72 1398.88 1726.84 0.022841 
2335.88 1393.25 1727.58 0.022943 
2366.04 1395.3 1730.37 0.022946 
2396.2 1400.96 1728.78 0.022833 
2426.36 1393.48 1729.98 0.022971 
2456.52 1402.42 1727.88 0.022797 
2486.68 1408.23 1716.5 0.022554 
2516.84 1395.76 1721.37 0.02282 
2547 1401.07 1722.48 0.022748 
2577.16 1398.16 1713.32 0.022674 
2607.32 1393.68 1730.5 0.022975 
2637.48 1407.81 1713.99 0.022527 
2667.64 1396.95 1711.86 0.022674 
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2697.8 1393.18 1725.84 0.022921 
2727.96 1391.58 1721.07 0.022884 
2758.12 1389.51 1722.5 0.022937 
2788.28 1396.16 1705.54 0.022603 
2818.44 1393.12 1722.33 0.022876 
2848.6 1397.04 1719.6 0.022775 
2878.76 1396.95 1715.09 0.022717 
2908.92 1049.93 1290.41 0.022741 
 
Determination of the Partial Order in 24a of Bromocylization of 19l by 
19
F NMR. (0.1757 
mM, replicate 1) [MTB-XVI-72] 
Following General Procedure 24, NBS (3.75 mg, 0.021 mmol), PhMe-d8 (0.1 mL), 
Solution A (151 μL), PhMe (409 μL), Solution B (14 μL) and Solution C  (25 μL)  were 
combined. 
 
Table 53. NMR Data for MTB-XVI-72. 
 12438.5 16432.1 1.321068 
Time   [olefin] 
31.56 1572.32 2080.86 0.025045 
61.16 1500.79 1972.9 0.024877 
90.76 1491.86 1958.04 0.024838 
120.36 1493.32 1952.5 0.024743 
149.96 1493.61 1935.09 0.024518 
179.56 1494.44 1925.46 0.024382 
209.16 1502.69 1900.62 0.023935 
238.76 1499.78 1875.96 0.023671 
268.36 1503.84 1870.33 0.023536 
297.96 1497.62 1860.83 0.023514 
327.56 1493.44 1847.07 0.023405 
357.16 1503.83 1821.84 0.022926 
y = -6.08E-06x + 2.53E-02 
R² = 9.48E-01 
0.0225 
0.023 
0.0235 
0.024 
0.0245 
0.025 
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386.76 1488.06 1823.28 0.023187 
416.36 1490.46 1802.76 0.022889 
445.96 1492.84 1790.14 0.022693 
475.56 1503.81 1779.51 0.022394 
505.16 1499.16 1765.07 0.022281 
534.76 1498.07 1758.02 0.022208 
564.36 1505.86 1744.12 0.021918 
593.96 1500.06 1736.76 0.02191 
623.56 1505.35 1722.54 0.021654 
653.16 1500.18 1712.04 0.021597 
682.76 1496.64 1707.51 0.02159 
712.36 1511.54 1702.88 0.02132 
741.96 1504.27 1702.5 0.021418 
771.56 1503.77 1689.58 0.021262 
801.16 1504.74 1686.98 0.021216 
830.76 1495.37 1681.83 0.021284 
860.36 1507.83 1676.75 0.021044 
889.96 1508.35 1664.76 0.020886 
919.56 1506.21 1665.9 0.02093 
949.16 1502.69 1656.91 0.020866 
978.76 1505.97 1648.53 0.020716 
1008.36 1510.6 1651.35 0.020687 
1037.96 1506.62 1643.4 0.020642 
1067.56 1503.29 1641.61 0.020665 
1097.16 1514.02 1636.47 0.020455 
1126.76 1504.14 1629.92 0.020507 
1156.36 1507.96 1625.44 0.020398 
1185.96 1510.58 1622.12 0.020321 
1215.56 1506.24 1626.1 0.02043 
1245.16 1503.57 1610.9 0.020275 
1274.76 1504.33 1619.75 0.020376 
1304.36 1509.58 1625.8 0.020381 
1333.96 1510.97 1617.56 0.020259 
1363.56 1504.35 1612.32 0.020282 
1393.16 1506.23 1612.12 0.020254 
1422.76 1505.1 1605.77 0.02019 
1452.36 1516.88 1609.81 0.020083 
1481.96 1508.65 1601.73 0.020092 
1511.56 1512.62 1600.99 0.02003 
1541.16 1503.78 1598.21 0.020112 
1570.76 1504.02 1597.24 0.020097 
1600.36 1508.85 1598.26 0.020045 
1629.96 1506.41 1594.1 0.020026 
1659.56 1503.3 1603.02 0.020179 
1689.16 1505.36 1598.38 0.020093 
1718.76 1500.83 1586.64 0.020006 
1748.36 1493.55 1579.62 0.020015 
1777.96 1506.02 1586.29 0.019933 
1807.56 1500.68 1584.72 0.019984 
1837.16 1499.76 1585.57 0.020007 
1866.76 1501.63 1579.42 0.019904 
1896.36 1513.73 1580.76 0.019762 
1925.96 1501.79 1576.3 0.019863 
1955.56 1496.9 1586.54 0.020057 
1985.16 1314.34 1375.75 0.019808 
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Determination of the Partial Order in 24a of Bromocylization of 19l by 
19
F NMR. (0.1757 
mM, replicate 2) [MTB-XVI-77] 
Following General Procedure 24, NBS (3.78 mg, 0.021 mmol), PhMe-d8 (0.1 mL), 
Solution A (151 μL), PhMe (409 μL), Solution B (14 μL) and Solution C  (25 μL)  were 
combined. 
 
Table 54. NMR data for MTB-XVI-77. 
 12173.3 16266.7 1.336261 
Time   [olefin] 
30.34 1520.86 2031.73 0.024993 
60.5 1475.32 1961.43 0.024873 
90.66 1471.92 1938.43 0.024639 
120.82 1468.52 1934.06 0.02464 
150.98 1467.45 1928.78 0.024591 
181.14 1467.53 1904.27 0.024277 
211.3 1463.97 1898.26 0.024259 
241.46 1464.4 1885.8 0.024093 
271.62 1468.78 1873.32 0.023862 
301.78 1473.36 1860.95 0.023631 
331.94 1472.67 1832.77 0.023284 
362.1 1463.31 1827.08 0.02336 
392.26 1470.87 1807.08 0.022985 
422.42 1465.22 1792.01 0.022882 
452.58 1475.27 1786.94 0.022661 
482.74 1469.09 1783.01 0.022707 
512.9 1468.66 1761.37 0.022438 
543.06 1462.49 1742.31 0.022289 
573.22 1467.53 1732.85 0.022091 
603.38 1475.79 1735.38 0.022 
633.54 1465.45 1719.28 0.021949 
663.7 1469.99 1706.94 0.021725 
693.86 1470.46 1701.68 0.021651 
y = -5.72E-06x + 2.53E-02 
R² = 9.77E-01 
0.022 
0.0225 
0.023 
0.0235 
0.024 
0.0245 
0.025 
0 100 200 300 400 500 600 
[o
le
fi
n
] 
T (sec) 
Initial Rate 
429 
 
Table 54 cont. 
724.02 1466.41 1692.37 0.021592 
754.18 1481.48 1687.33 0.021309 
784.34 1476.21 1678.31 0.02127 
814.5 1482.69 1668.01 0.021047 
844.66 1473.82 1664.2 0.021126 
874.82 1469.25 1654.95 0.021074 
904.98 1475.92 1647.94 0.020889 
935.14 1482.24 1648.54 0.020808 
965.3 1477.46 1650.92 0.020905 
995.46 1473.98 1642.43 0.020847 
1025.62 1481.69 1643.33 0.02075 
1055.78 1474.45 1636.26 0.020762 
1085.94 1477.61 1634.6 0.020697 
1116.1 1480.11 1626.01 0.020553 
1146.26 1478.6 1614.2 0.020425 
1176.42 1479.03 1625.29 0.020559 
1206.58 1472.88 1615.53 0.020521 
1236.74 1470.37 1617.96 0.020587 
1266.9 1483.6 1611.18 0.020318 
1297.06 1483.82 1619.41 0.020419 
1327.22 1474.59 1612.15 0.020454 
1357.38 1471.09 1615.27 0.020543 
1387.54 1476.22 1608.56 0.020386 
1417.7 1479.79 1611.78 0.020378 
1447.86 1477.34 1604.5 0.020319 
1478.02 1476.04 1600.17 0.020282 
1508.18 1484.39 1605 0.020229 
1538.34 1480.59 1594.79 0.020152 
1568.5 1478.99 1597.63 0.02021 
1598.66 1483.54 1599.68 0.020174 
1628.82 1480.94 1601.09 0.020227 
1658.98 1481.29 1594.56 0.02014 
1689.14 1482.38 1590.91 0.020079 
1719.3 1475.13 1594.94 0.020228 
1749.46 1466.43 1590.69 0.020294 
1779.62 1480.83 1587.17 0.020052 
1809.78 182.14 199.583 0.020501 
 
Determination of the Partial Order in 24a of Bromocylization of 19l by 
19
F NMR. (0.1757 
mM, replicate 3) [MTB-XVI-82] 
Following General Procedure 24, NBS (3.76 mg, 0.021 mmol), PhMe-d8 (0.1 mL), 
Solution A (151 μL), PhMe (409 μL), Solution B (14 μL) and Solution C (25 μL) were 
combined. 
430 
 
 
 
Table 55. NMR Data for MTB-XVI-82. 
 12799.4 17042 1.331469 
Time   [olefin] 
35.72 1659.29 2178.19 0.024648 
65.88 1593.39 2096.85 0.024709 
96.04 1589.35 2071.66 0.024474 
126.2 1588.66 2074.75 0.024521 
156.36 1588.3 2056.51 0.024311 
186.52 1594.12 2052.06 0.02417 
216.68 1586.82 2040.88 0.024149 
246.84 1591.91 2026.41 0.023901 
277 1598.13 2009.42 0.023608 
307.16 1590.8 2006.68 0.023685 
337.32 1584.4 1984.66 0.02352 
367.48 1593.5 1979.94 0.02333 
397.64 1588.14 1967.94 0.023267 
427.8 1584.84 1953.06 0.023139 
457.96 1587.09 1944.15 0.023 
488.12 1602.86 1934.41 0.02266 
518.28 1590.73 1921 0.022675 
548.44 1592.63 1906.17 0.022473 
578.6 1595.4 1903.65 0.022404 
608.76 1589.36 1888.9 0.022315 
638.92 1591.3 1872.48 0.022094 
669.08 1599.24 1872.38 0.021983 
699.24 1586.95 1875.96 0.022196 
729.4 1593.76 1858.73 0.021898 
759.56 1591.69 1852 0.021847 
789.72 1590.44 1834.35 0.021656 
819.88 1602.88 1827.05 0.021402 
850.04 1595.81 1825.99 0.021485 
880.2 1606.99 1814.4 0.0212 
910.36 1600.92 1815.21 0.02129 
940.52 1592.3 1820.88 0.021472 
970.68 1605.82 1806.67 0.021125 
1000.84 1597.73 1803.06 0.021189 
1031 1599.75 1796.88 0.02109 
1061.16 1598.94 1787.28 0.020988 
y = -4.53E-06x + 2.50E-02 
R² = 9.86E-01 
0.0225 
0.023 
0.0235 
0.024 
0.0245 
0.025 
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Table 55 cont. 
1091.32 1598.51 1773.14 0.020827 
1121.48 1604.5 1779.2 0.020821 
1151.64 1605.87 1779.78 0.02081 
1181.8 1603.12 1762.49 0.020643 
1211.96 400.499 439.084 0.020585 
 
Determination of the Partial Order in 24a of Bromocylization of 19l by 
19
F NMR. (0.556 
mM, replicate 1) [MTB-XVI-73] 
Following General Procedure 24, NBS (3.75 mg, 0.021 mmol), PhMe-d8 (0.1 mL), 
Solution A (151 μL), PhMe (379 μL), Solution B (45 μL) and Solution C (25 μL) were 
combined. 
 
Table 56. NMR Data for MTB-XVI-73. 
 13341.8 17573.6 1.317184 
Time   [olefin] 
31.56 1651.28 2129.68 0.024479 
61.72 1607.08 2014.56 0.023792 
91.88 1596.78 1959.83 0.023295 
122.04 1608.17 1909.88 0.022541 
152.2 1590.27 1875.42 0.022383 
182.36 1601.47 1829.99 0.021688 
212.52 1589.76 1806.4 0.021566 
242.68 1607.03 1772.03 0.020929 
272.84 1595.56 1735.89 0.020649 
303 1608.78 1719.93 0.020291 
333.16 1606.5 1698.7 0.020069 
363.32 1610.36 1681.43 0.019818 
393.48 1608.99 1659.88 0.01958 
423.64 603.408 620.337 0.019512 
y = -2.09E-05x + 2.51E-02 
R² = 9.94E-01 
0.022 
0.0225 
0.023 
0.0235 
0.024 
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Determination of the Partial Order in 24a of Bromocylization of 19l by 
19
F NMR. (0.556 
mM, replicate 2) [MTB-XVI-76] 
Following General Procedure 24, NBS (3.75 mg, 0.021 mmol), PhMe-d8 (0.1 mL), 
Solution A (151 μL), PhMe (379 μL), Solution B (45 μL) and Solution C (25 μL) were 
combined. 
 
Table 57. NMR Data for MTB-XVI-76. 
 12381.8 16642.7 1.344126 
Time   [olefin] 
40.59 1451.88 1974.18 0.02529 
70.75 1394.11 1822.13 0.02431 
100.91 1367.83 1768.8 0.024052 
131.07 1378.93 1711.67 0.023088 
161.23 1365.77 1680.22 0.022882 
191.39 1373.61 1629.07 0.022059 
221.55 1375.57 1603.72 0.021684 
251.71 1369.23 1570.72 0.021336 
281.87 1377.71 1552.97 0.020966 
312.03 1384.52 1533.17 0.020596 
342.19 1384.11 1515.95 0.020371 
372.35 1374.65 1492.98 0.0202 
402.51 1389.09 1477.38 0.019782 
432.67 1383.13 1466.39 0.019719 
462.83 1391.84 1444.5 0.019303 
492.99 1375.65 1436.43 0.019421 
523.15 1377.33 1430.14 0.019313 
553.31 1385.59 1428.53 0.019176 
583.47 1379.73 1413.44 0.019054 
613.63 347.877 353.539 0.018902 
y = -1.74E-05x + 2.56E-02 
R² = 9.27E-01 
0.0226 
0.0228 
0.023 
0.0232 
0.0234 
0.0236 
0.0238 
0.024 
0.0242 
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Determination of the Partial Order in 24a of Bromocylization of 19l by 
19
F NMR. (0.556 
mM, replicate 3) [MTB-XVI-81] 
Following General Procedure 24, NBS (3.69 mg, 0.021 mmol), PhMe-d8 (0.1 mL), 
Solution A (151 μL), PhMe (379 μL), Solution B (45 μL) and Solution C (25 μL) were 
combined. 
 
Table 58.  NMR Data for MTB-XVI-81. 
 13169.2 17576.5 1.334667 
Time   [olefin] 
35.72 1565.22 2099.34 0.025123 
65.88 1537.35 2001.95 0.024392 
96.04 1527.7 1947.17 0.023874 
126.2 1534.96 1912.48 0.023338 
156.36 1534.14 1875.1 0.022894 
186.52 1531.76 1843.22 0.02254 
216.68 1532.82 1810.29 0.022122 
246.84 1537.32 1779.64 0.021684 
277 1532.5 1748.86 0.021376 
307.16 1535.41 1717.18 0.020949 
337.32 1529.25 1698.85 0.020809 
367.48 1541.32 1686.43 0.020495 
397.64 1538.07 1672.57 0.020369 
427.8 1534.55 1656.28 0.020217 
457.96 1531.41 1635.11 0.02 
488.12 1538.02 1632.46 0.019881 
518.28 1542.6 1624.47 0.019725 
548.44 1547.73 1609.69 0.019481 
578.6 1541.03 1591.23 0.019341 
608.76 1543.05 1581.23 0.019195 
638.92 1548.19 1577.36 0.019084 
669.08 1349.52 1369.69 0.019011 
 
y = -1.55E-05x + 2.54E-02 
R² = 9.94E-01 
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Determination of the Partial Order in 24a of Bromocylization of 19l by 
19
F NMR. (0.988 
mM, replicate 1) [MTB-XVI-74] 
Following General Procedure 24, NBS (3.71 mg, 0.021 mmol), PhMe-d8 (0.1 mL), 
Solution A (151 μL), PhMe (344 μL), Solution B (79 μL) and Solution C (25 μL) were 
combined. 
 
Table 59. NMR Data for MTB-XVI-74. 
 15261.8 19667 1.288642 
Time   [olefin] 
34.97 1668.8 2111.29 0.024544 
65.13 1624.57 1948.3 0.023266 
95.29 1630.61 1864.84 0.022187 
125.45 1622.74 1799.53 0.021514 
155.61 1620.14 1746.52 0.020914 
185.77 1629.54 1713.69 0.020402 
215.93 1626.91 1672.38 0.019942 
246.09 1625.09 1635.21 0.019521 
276.25 1624.09 1603.22 0.019151 
306.41 1636.69 1586.16 0.018801 
336.57 1627.12 1572.99 0.018755 
366.73 1638.13 1550.48 0.018362 
396.89 1636.4 1527.69 0.018111 
427.05 1630.75 1515.62 0.018031 
457.21 1634.2 1504.1 0.017856 
487.37 1621.04 1479.71 0.017709 
517.53 1639.41 1470.4 0.0174 
547.69 1633.28 1460.06 0.017343 
577.85 1631.52 1446.51 0.0172 
608.01 1637.29 1437.81 0.017037 
638.17 1624.11 1418.76 0.016947 
668.33 1643.79 1410.68 0.016649 
698.49 1636.85 1409.39 0.016704 
728.65 1637.76 1395.56 0.016531 
y = -4.24E-05x + 2.60E-02 
R² = 1.00E+00 
0.0232 
0.0234 
0.0236 
0.0238 
0.024 
0.0242 
0.0244 
0.0246 
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Table 59 cont. 
758.81 1636.01 1389.01 0.016471 
788.97 1636.89 1388.27 0.016454 
819.13 1633.82 1372.97 0.016303 
849.29 1641.1 1366.22 0.016151 
879.45 1639.64 1358.08 0.016069 
909.61 1634.53 1356.37 0.016099 
939.77 1636.6 1355.47 0.016068 
969.93 1636.42 1348.11 0.015982 
1000.09 1639.1 1343.39 0.0159 
1030.25 1636.6 1329.61 0.015761 
1060.41 1641.87 1337.13 0.015799 
1090.57 1636.66 1326.28 0.015721 
1120.73 1638.36 1313.96 0.015559 
1150.89 1644.15 1316.26 0.015531 
1181.05 1643.26 1322.84 0.015617 
1211.21 1636.51 1306.44 0.015487 
1241.37 1639.51 1308.2 0.01548 
1271.53 1646.67 1302.62 0.015347 
1301.69 1639.61 1294.94 0.015322 
1331.85 1634.33 1295.19 0.015375 
1362.01 1648.92 1284.94 0.015118 
1392.17 1638.58 1287.89 0.015248 
1422.33 1645.35 1281.96 0.015116 
1452.49 1629.01 1277.39 0.015213 
1482.65 1639.53 1277.53 0.015117 
1512.81 1640.46 1275.71 0.015087 
1542.97 1648.47 1273.58 0.014988 
1573.13 1643 1257.15 0.014844 
1603.29 1641.65 1264.73 0.014946 
1633.45 1647.21 1252.07 0.014746 
1663.61 1656 1247.36 0.014613 
1693.77 1646.17 1255.71 0.014799 
1723.93 1649.36 1253.25 0.014741 
1754.09 1643.01 1256.18 0.014833 
1784.25 1638.92 1239.13 0.014668 
1814.41 1634.05 1239.95 0.014721 
1844.57 1654.23 1242.83 0.014576 
1874.73 1638.57 1234.37 0.014615 
1904.89 1647.76 1238.37 0.01458 
1935.05 1643.27 1235.19 0.014583 
1965.21 1640.17 1230.86 0.014559 
1995.37 1648.75 1230.95 0.014484 
2025.53 1648.23 1228.1 0.014455 
2055.69 1650.88 1222.34 0.014364 
2085.85 1648.15 1218.04 0.014337 
2116.01 1644.39 1221.03 0.014406 
2146.17 1640.7 1214.89 0.014365 
2176.33 1641.36 1213.27 0.01434 
2206.49 1643.98 1207.94 0.014255 
2236.65 1641.24 1207.48 0.014273 
2266.81 1641.56 1209.15 0.01429 
2296.97 1639.97 1200.96 0.014207 
2327.13 1646.28 1203.36 0.014181 
2357.29 1644.79 1210.48 0.014278 
2387.45 1652.67 1199.08 0.014076 
2417.61 1643.11 1190.09 0.014051 
2447.77 1650.14 1188.47 0.013973 
2477.93 1650.39 1192.37 0.014016 
2508.09 1643.92 1187.95 0.014019 
2538.25 1641.2 1185.34 0.014012 
2568.41 1651.33 1185.56 0.013928 
2598.57 1638.79 1184.65 0.014024 
2628.73 1643.03 1182.39 0.013961 
2658.89 1642.55 1174.17 0.013868 
2689.05 1633.01 1174.43 0.013952 
436 
 
Table 59 cont. 
2719.21 1644.04 1172.86 0.01384 
2749.37 1642.95 1186.21 0.014007 
2779.53 1647.66 1170.14 0.013778 
2809.69 1644.98 1178.56 0.013899 
2839.85 1639.39 1174.37 0.013897 
2870.01 1634.92 1171.5 0.013901 
2900.17 1637.83 1170.63 0.013866 
2930.33 1641.78 1171.03 0.013838 
2960.49 1644.87 1152.16 0.013589 
2990.65 1636.02 1158.88 0.013742 
3020.81 1648.19 1165.81 0.013722 
3050.97 1642.36 1159.21 0.013693 
3081.13 1653.29 1158.36 0.013593 
3111.29 1642.87 1158.26 0.013678 
3141.45 1640.33 1155.15 0.013662 
3171.61 1645.87 1165.56 0.013739 
3201.77 1642.32 1148.82 0.013571 
3231.93 1635.66 1150.79 0.013649 
3262.09 1642.64 1152.06 0.013606 
3292.25 207.019 144.626 0.013553 
 
Determination of the Partial Order in 24a of Bromocylization of 19l by 
19
F NMR. (0.988 
mM, replicate 2) [MTB-XVI-75] 
Following General Procedure 24, NBS (3.72 mg, 0.021 mmol), PhMe-d8 (0.1 mL), 
Solution A (151 μL), PhMe (344 μL), Solution B (79 μL) and Solution C (25 μL) were 
combined. 
 
Table 60. NMR Data for MTB-XVI-75. 
 13114.9 17590.6 1.341268 
Time   [olefin] 
y = -3.26E-05x + 2.49E-02 
R² = 1.00E+00 
0.0224 
0.0226 
0.0228 
0.023 
0.0232 
0.0234 
0.0236 
0.0238 
0 10 20 30 40 50 60 70 80 
[o
le
fi
n
] 
T (sec) 
Initial Rate 
437 
 
Table 60 cont. 
40.94 1584.1 2004.73 0.023588 
71.1 1443.58 1750.69 0.022604 
101.26 1446.92 1685.62 0.021714 
131.42 1445.37 1621.04 0.020904 
161.58 1443.14 1576.84 0.020366 
191.74 1444.49 1540.81 0.019882 
221.9 1446.01 1504.4 0.019392 
252.06 1437.38 1483.55 0.019238 
282.22 1443.94 1456.66 0.018803 
312.38 1444.88 1427.69 0.018417 
342.54 1461.63 1406.09 0.017931 
372.7 1448.6 1400.78 0.018024 
402.86 1449.7 1383.16 0.017784 
433.02 1441.67 1364.13 0.017637 
463.18 1089.59 1006.24 0.017213 
 
Determination of the Partial Order in 24a of Bromocylization of 19l by 
19
F NMR. (0.988 
mM, replicate 3) [MTB-XVI-80] 
Following General Procedure 24, NBS (3.75 mg, 0.021 mmol), PhMe-d8 (0.1 mL), 
Solution A (151 μL), PhMe (344 μL), Solution B (79 μL) and Solution C (25 μL) were 
combined. 
 
Table 61. NMR Data for MTB-XVI-80. 
 14393.4 19081.1 1.325684 
Time   [olefin] 
30.55 1560.37 2080.86 0.025149 
60.71 1545.97 1941.64 0.023685 
90.87 1534.4 1856.43 0.022816 
121.03 1533.93 1792.78 0.022041 
151.19 1535.58 1748.26 0.02147 
y = -2.88E-05x + 2.54E-02 
R² = 1.00E+00 
0.0227 
0.0228 
0.0229 
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0.0232 
0.0233 
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Table 61 cont. 
181.35 1530.52 1713.9 0.021118 
211.51 1532.63 1674.01 0.020598 
241.67 1537.35 1649.57 0.020235 
271.83 1532.05 1616.23 0.019894 
301.99 1544.72 1587.62 0.019382 
332.15 1543.72 1577.04 0.019265 
362.31 1539.37 1555.23 0.019052 
392.47 1544.1 1533.18 0.018725 
422.63 771.875 765.36 0.018699 
 
Determination of the Partial Order in Ph3P=S of Bromocylization of 19l by 
19
F NMR. 
(0.0988 mM, replicate 1) [MTB-XVI-83] 
The following stock solutions were prepared and used for all runs to determine the partial 
order in Ph3P=S (except replicates run at a later date as indicated): 
Solution A: An oven-dried 2-mL volumetric flask, equipped with a septum was charged with 19l 
(48.61 mg, 0.2503 mmol). The flask was evacuated and filled with Ar via a needle. 
Fluorobenzene (23 μL, 1 equiv with respect to 19l) was added via syringe, and then the flask was 
filled to the mark with dry PhMe. 
 
Solution B: An oven-dried conical vial, equipped with a PTFE/silicone septum and cap was 
charged with 24a (5.41 mg, 0.00719 mmol). The vial was evacuated and filled with Ar via a 
needle and then was charged with dry PhMe (825 μL). 
 
Solution C: An oven-dried 10-mL volumetric flask, equipped with a septum was charged with 
Ph3P=S (25.75 mg, 0.08748 mmol). The flask was evacuated and filled with Ar via a needle, and 
then the flask was filled to the mark with dry PhMe. A portion was deposited in an oven-dried 
conical vial, equipped with a PTFE/silicone septum and cap for convenience. 
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Following General Procedure 24, NBS (3.74 mg, 0.021 mmol), PhMe-d8 (0.1 mL), 
Solution A (140 μL), PhMe (427 μL), Solution B (25 μL) and Solution C (8 μL) were combined. 
 
Table 62. NMR Data for MTB-XVI-83. 
 13979.6 15803.3 1.130454 
Time   [olefin] 
33.68 1766.05 2009.56 0.025164 
63.84 1699.33 1921.51 0.025006 
94 1701.83 1907.69 0.02479 
124.16 1699.24 1909.98 0.024858 
154.32 1703.32 1907.47 0.024766 
184.48 1694.76 1890.17 0.024665 
214.64 1703.73 1890.83 0.024544 
244.8 1705.88 1874.36 0.024299 
274.96 1707.38 1874.11 0.024275 
305.12 1711.66 1871.17 0.024176 
335.28 1705.39 1862.99 0.024159 
365.44 1697.65 1865.17 0.024297 
395.6 1702.63 1853.72 0.024077 
425.76 1703.82 1856.35 0.024095 
455.92 1698.4 1858.41 0.024199 
486.08 1695.69 1849.73 0.024124 
516.24 1700.68 1848.86 0.024042 
546.4 1704.88 1834.82 0.023801 
576.56 1697.97 1826.71 0.023792 
606.72 1695.17 1828.92 0.02386 
636.88 1700.13 1824.02 0.023727 
667.04 1713.69 1826.07 0.023565 
697.2 1703.22 1811.52 0.023521 
727.36 1698.99 1813.16 0.023601 
757.52 1704.1 1812.26 0.023519 
787.68 1691.25 1804.62 0.023597 
817.84 1696.69 1794.71 0.023393 
848 1703.97 1791.19 0.023247 
878.16 1709.59 1786.52 0.02311 
908.32 1700.03 1798.02 0.02339 
938.48 1704.75 1797.53 0.023319 
968.64 1706.32 1794.52 0.023258 
y = -1.80E-06x + 2.49E-02 
R² = 9.19E-01 
0.0232 
0.0234 
0.0236 
0.0238 
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0.0242 
0.0244 
0.0246 
0.0248 
0.025 
0 200 400 600 800 1000 
[o
le
fi
n
] 
T (sec) 
Initial Rate 
440 
 
Table 62 cont. 
998.8 1695.29 1781.74 0.023243 
1028.96 1714 1790.57 0.023103 
1059.12 1702.82 1791.53 0.023267 
1089.28 1702.73 1785.74 0.023193 
1119.44 1706.35 1780.23 0.023073 
1149.6 1699.83 1781.05 0.023172 
1179.76 1701.55 1777.85 0.023107 
1209.92 1700.67 1778.87 0.023132 
1240.08 1704.34 1769.9 0.022966 
1270.24 1706.44 1779.7 0.023064 
1300.4 1699.94 1773.42 0.023071 
1330.56 1703.01 1779.26 0.023105 
1360.72 1699.26 1769.63 0.023031 
1390.88 1705.93 1773.12 0.022986 
1421.04 1700.51 1765.6 0.022961 
1451.2 1695.02 1764.96 0.023028 
1481.36 1699.16 1763.21 0.022949 
1511.52 1699.83 1759.85 0.022896 
1541.68 1705.63 1767.61 0.022919 
1571.84 1705.22 1757.42 0.022792 
1602 1698.55 1758.06 0.02289 
1632.16 1707.01 1751.95 0.022697 
1662.32 1708.57 1760.77 0.022791 
1692.48 1699.31 1760.59 0.022913 
1722.64 1694.18 1754.51 0.022903 
1752.8 1698.22 1756.64 0.022876 
1782.96 1695.79 1748.09 0.022797 
1813.12 1693.82 1751.13 0.022863 
1843.28 1701.85 1742.86 0.022648 
1873.44 1705.26 1757.74 0.022796 
1903.6 1697.66 1753.06 0.022837 
1933.76 1688.92 1745.7 0.022858 
1963.92 1702.18 1746.39 0.022689 
1994.08 1703.79 1742.07 0.022612 
2024.24 1706.14 1748.95 0.02267 
2054.4 1699.23 1743.29 0.022688 
2084.56 1709.33 1753.66 0.022689 
2114.72 1697.99 1737.6 0.022631 
2144.88 1710.02 1751.36 0.02265 
2175.04 1702.13 1743.24 0.022649 
2205.2 1697.76 1738.68 0.022648 
2235.36 1695.57 1734.82 0.022627 
2265.52 1705.57 1738.41 0.022541 
2295.68 1697.49 1738.58 0.02265 
2325.84 1703.33 1726.16 0.022411 
2356 1698.18 1740.1 0.022661 
2386.16 1695.36 1731.04 0.02258 
2416.32 1708.28 1736.21 0.022477 
2446.48 1703.1 1743.08 0.022634 
2476.64 1709.65 1740.63 0.022516 
2506.8 1696.88 1735.29 0.022616 
2536.96 1699.15 1728.51 0.022497 
2567.12 1706.98 1741.35 0.02256 
2597.28 852.05 860.154 0.022325 
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Determination of the Partial Order in Ph3P=S of Bromocylization of 19l by 
19
F NMR. 
(0.0988 mM, replicate 2) [MTB-XVI-90] 
Following General Procedure 24, NBS (3.70 mg, 0.021 mmol), PhMe-d8 (0.1 mL), 
Solution A (140 μL), PhMe (427 μL), Solution B (25 μL) and Solution C (8 μL) were combined. 
 
 
Table 63. NMR Data for MTB-XVI-90. 
 15609.1 17241.3 1.104567 
Time   [olefin] 
33.12 1882.47 2115.46 0.025435 
63.28 1858.23 2059.55 0.025085 
93.44 1844.86 2054.91 0.02521 
123.6 1842.45 2045.96 0.025133 
153.76 1849.85 2038.06 0.024936 
183.92 1842.96 2036.23 0.025007 
214.08 1852.84 2041.25 0.024935 
244.24 1848.16 2027.28 0.024827 
274.4 1845.93 2030.63 0.024898 
304.56 1850.5 2027.31 0.024796 
334.72 1836.37 2025.76 0.024968 
364.88 1852.22 2026.92 0.024768 
395.04 1850.28 2017.18 0.024675 
425.2 1847.2 2010.01 0.024628 
455.36 1845.44 2011.2 0.024666 
485.52 1847.35 2013.42 0.024668 
515.68 1849.37 2003.05 0.024514 
545.84 1837.42 1995.75 0.024584 
576 1851.36 1991.58 0.024348 
606.16 1843.54 1991.27 0.024447 
636.32 1848.72 1992.5 0.024394 
666.48 1846.11 1992.36 0.024426 
696.64 1851.15 1990.75 0.02434 
726.8 1846.03 1978.49 0.024257 
y = -1.04E-06x + 2.51E-02 
R² = 9.48E-01 
0.0236 
0.0238 
0.024 
0.0242 
0.0244 
0.0246 
0.0248 
0.025 
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Table 63 cont. 
756.96 1851.07 1979.1 0.024199 
787.12 1836.36 1967.74 0.024253 
817.28 1845.75 1968.34 0.024137 
847.44 1842.4 1970.68 0.024209 
877.6 1848.49 1975.03 0.024183 
907.76 1847.03 1964.48 0.024073 
937.92 1842.32 1960.37 0.024084 
968.08 1850.99 1966.75 0.024049 
998.24 1850.58 1958.11 0.023948 
1028.4 1856.31 1961.7 0.023918 
1058.56 1845.7 1941.99 0.023814 
1088.72 1853.88 1960.35 0.023933 
1118.88 1846.92 1953.53 0.02394 
1149.04 1837.03 1949 0.024013 
1179.2 1849.61 1945.77 0.02381 
1209.36 1854.91 1945.86 0.023743 
1239.52 1847.17 1950.29 0.023897 
1269.68 1851.48 1947.41 0.023806 
1299.84 1848.81 1943.68 0.023795 
1330 1842.84 1935.52 0.023772 
1360.16 1847.99 1938.3 0.023739 
1390.32 1846.66 1933.07 0.023692 
1420.48 1847.88 1928.92 0.023626 
1450.64 1844.89 1933.82 0.023724 
1480.8 1849.74 1928.89 0.023602 
1510.96 1837.73 1928.43 0.02375 
1541.12 1847.21 1923.34 0.023566 
1571.28 1848.18 1935.19 0.023699 
1601.44 1846.66 1922.19 0.023559 
1631.6 1847.89 1933.88 0.023687 
1661.76 1846.74 1925.76 0.023602 
1691.92 1847.5 1925.1 0.023584 
1722.08 1851.99 1924.96 0.023525 
1752.24 1837.89 1918.95 0.023632 
1782.4 1848.58 1926.24 0.023584 
1812.56 1850.38 1919.1 0.023474 
1842.72 1841.04 1914.71 0.023539 
1872.88 1848.45 1917.52 0.023479 
1903.04 1843.64 1917.02 0.023534 
1933.2 1842.15 1915.92 0.02354 
1963.36 1848.99 1916.61 0.023461 
1993.52 1849.7 1911.26 0.023387 
2023.68 1839.96 1913.65 0.02354 
2053.84 1847.57 1904.86 0.023335 
2084 1856.3 1909.33 0.02328 
2114.16 1843.91 1909.62 0.02344 
2144.32 1843.15 1912.7 0.023487 
2174.48 1856.73 1912.46 0.023313 
2204.64 1849.07 1908.87 0.023365 
2234.8 1846.97 1906.69 0.023365 
2264.96 1843.28 1898.94 0.023317 
2295.12 1849.9 1904.81 0.023305 
2325.28 1838.41 1913.85 0.023562 
2355.44 1848.15 1912.5 0.023421 
2385.6 1847.09 1902.16 0.023308 
2415.76 1841.99 1918.39 0.023572 
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Determination of the Partial Order in Ph3P=S of Bromocylization of 19l by 
19
F NMR. 
(0.0988 mM, replicate 3) [MTB-XVI-91] 
Following General Procedure 24, NBS (3.69 mg, 0.021 mmol), PhMe-d8 (0.1 mL), 
Solution A (140 μL), PhMe (427 μL), Solution B (25 μL) and Solution C (8 μL) were combined. 
 
 
 
Table 64. NMR Data for MTB-XVI-91. 
 15816.2 17467.9 1.104431 
Time   [olefin] 
38.91 1934.62 2152.27 0.025183 
69.07 1896.12 2096.22 0.025025 
99.23 1896.66 2090.1 0.024945 
129.39 1883.22 2092.04 0.025146 
159.55 1887.66 2078.21 0.024921 
189.71 1891.57 2080.7 0.024899 
219.87 1891.02 2070.1 0.02478 
250.03 1886.41 2069.9 0.024838 
280.19 1881.44 2068.21 0.024883 
310.35 1897.75 2060.37 0.024576 
340.51 1884.16 2061.31 0.024764 
370.67 1890.1 2045.14 0.024493 
400.83 1886.5 2038.37 0.024458 
430.99 1893.51 2046.3 0.024463 
461.15 1882.02 2046.46 0.024614 
491.31 1890.18 2026.67 0.024271 
521.47 1892.31 2032.68 0.024315 
551.63 1884.87 2033.19 0.024417 
581.79 1891.11 2018.86 0.024165 
611.95 1894.88 2021.19 0.024145 
642.11 1891.9 2018.86 0.024155 
y = -1.51E-06x + 2.51E-02 
R² = 9.25E-01 
0.0236 
0.0238 
0.024 
0.0242 
0.0244 
0.0246 
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0.025 
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Table 64 cont. 
672.27 1886.43 2005.49 0.024065 
702.43 1891.48 2009.52 0.024049 
732.59 1888.59 2008.82 0.024077 
762.75 1894.56 1998.43 0.023877 
792.91 1892.08 2004.2 0.023977 
823.07 1890.64 1994.35 0.023878 
853.23 1887.82 1996.54 0.02394 
883.39 1881.43 1989.15 0.023932 
913.55 1893.34 1988.16 0.02377 
943.71 1883.16 1989.43 0.023913 
973.87 1895.2 1978.36 0.023629 
1004.03 1886.08 1980.68 0.023771 
1034.19 1893.97 1976.82 0.023626 
1064.35 1894.27 1980.4 0.023665 
1094.51 1893.97 1972.2 0.023571 
1124.67 1890.99 1975.55 0.023648 
1154.83 1884.25 1976.62 0.023746 
1184.99 1895.71 1968.24 0.023502 
1215.15 1884.87 1964.66 0.023594 
1245.31 1892.97 1963.93 0.023485 
1275.47 1884.76 1968.23 0.023639 
1305.63 1884.59 1960.53 0.023548 
1335.79 1894.78 1955.89 0.023366 
1365.95 1895.19 1959.4 0.023403 
1396.11 1885.67 1961.14 0.023542 
1426.27 1888.49 1954.85 0.023432 
1456.43 1881.29 1954.39 0.023516 
1486.59 1881.57 1957.94 0.023555 
1516.75 1895.19 1941.24 0.023186 
1546.91 1892.43 1950.93 0.023336 
1577.07 1882.25 1945.82 0.023401 
1607.23 1892.73 1945.98 0.023273 
1637.39 1889.73 1955.16 0.02342 
1667.55 1885.53 1941.01 0.023302 
1697.71 1889.03 1944.43 0.0233 
1727.87 1885.57 1944.25 0.023341 
1758.03 1885.93 1953.01 0.023441 
1788.19 1898.79 1944.23 0.023178 
1818.35 1889.98 1935.1 0.023176 
1848.51 1890.98 1935.88 0.023174 
1878.67 1898.12 1936.45 0.023093 
1908.83 1883.68 1942.85 0.023347 
1938.99 1897.11 1940.56 0.023155 
1969.15 1897.97 1934.3 0.023069 
1999.31 1880.1 1936.41 0.023314 
2029.47 1886.38 1942.04 0.023304 
2059.63 1890.64 1935.11 0.023169 
2089.79 1892.21 1934.46 0.023142 
2119.95 1889.62 1939.63 0.023235 
2150.11 1884.9 1917.88 0.023032 
2180.27 1897.19 1928.79 0.023013 
2210.43 1895.89 1930.61 0.023051 
2240.59 1887.55 1935.41 0.02321 
2270.75 1889.9 1926.5 0.023074 
2300.91 1886.84 1920.27 0.023037 
2331.07 1885.67 1930.56 0.023175 
2361.23 1892.07 1925.06 0.023031 
2391.39 1894.5 1924.76 0.022998 
2421.55 1891.81 1916.75 0.022935 
2451.71 1895.77 1930.61 0.023052 
2481.87 1892.29 1921.19 0.022982 
2512.03 1894.81 1923.23 0.022976 
2542.19 1893.16 1924.81 0.023015 
2572.35 1894.03 1914.37 0.022879 
2602.51 1888.18 1917.87 0.022992 
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Table 64 cont. 
2632.67 1889.47 1916.39 0.022959 
2662.83 1892.95 1922.41 0.022988 
2692.99 1889.5 1913.73 0.022926 
2723.15 1891.98 1917.87 0.022946 
2753.31 1884.8 1916.08 0.023012 
2783.47 1898.66 1916.7 0.022851 
2813.63 1892.51 1912.29 0.022873 
2843.79 1893.28 1915.97 0.022907 
2873.95 1893.71 1916.4 0.022907 
2904.11 1891.43 1909.09 0.022847 
2934.27 1891.82 1907.71 0.022826 
2964.43 1888.52 1904.35 0.022826 
2994.59 1880.2 1916.71 0.023076 
3024.75 1885.42 1907.97 0.022907 
3054.91 1896.28 1906.04 0.022753 
3085.07 1878.95 1896.35 0.022846 
3115.23 1652.85 1666.26 0.02282 
 
Determination of the Partial Order in Ph3P=S of Bromocylization of 19l by 
19
F NMR. 
(0.176 mM, replicate 1) [MTB-XVI-84] 
Following General Procedure 24, NBS (3.76 mg, 0.021 mmol), PhMe-d8 (0.1 mL), 
Solution A (140 μL), PhMe (421 μL), Solution B (25 μL) and Solution C (14 μL) were 
combined. 
 
Table 65. NMR Data for MTB-XVI-84. 
 14589.2 16474.8 1.129246 
Time   [olefin] 
32.47 1763.4 2023.9 0.025409 
62.63 1714.46 1943.24 0.025093 
92.79 1709.78 1908.43 0.024711 
y = -4.10E-06x + 2.52E-02 
R² = 9.82E-01 
0.022 
0.0225 
0.023 
0.0235 
0.024 
0.0245 
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Table 65 cont. 
122.95 1701.32 1905.44 0.024795 
153.11 1698.76 1895.9 0.024708 
183.27 1700.17 1880.8 0.024491 
213.43 1688.35 1872.29 0.024551 
243.59 1697.91 1856.55 0.024207 
273.75 1699.35 1846.75 0.024059 
303.91 1698.37 1836.03 0.023933 
334.07 1694.22 1818.46 0.023762 
364.23 1688.76 1812.2 0.023757 
394.39 1700.03 1811.52 0.023591 
424.55 1699.56 1790.65 0.023325 
454.71 1699.99 1783.75 0.023229 
484.87 1690.3 1765.62 0.023125 
515.03 1695.14 1771.32 0.023134 
545.19 1692.71 1763.05 0.023059 
575.35 1695.94 1744.41 0.022771 
605.51 1702.83 1748.01 0.022726 
635.67 1700.34 1744.44 0.022713 
665.83 1693.18 1732.11 0.022648 
695.99 1700.43 1720.97 0.022406 
726.15 1704.18 1719.14 0.022333 
756.31 1705.44 1722.61 0.022362 
786.47 1701.61 1706.4 0.022201 
816.63 1707.79 1704.77 0.0221 
846.79 1701.98 1697.26 0.022077 
876.95 1698.11 1696.77 0.022121 
907.11 1699.43 1698.95 0.022132 
937.27 1702.73 1692.47 0.022005 
967.43 1705.25 1683.61 0.021858 
997.59 1689.46 1676.17 0.021965 
1027.75 1692.03 1667.63 0.021819 
1057.91 850.384 837.887 0.021813 
 
Determination of the Partial Order in Ph3P=S of Bromocylization of 19l by 
19
F NMR. 
(0.176 mM, replicate 2) [MTB-XVI-89] 
Following General Procedure 24, NBS (3.76 mg, 0.021 mmol), PhMe-d8 (0.1 mL), 
Solution A (140 μL), PhMe (421 μL), Solution B (25 μL) and Solution C (14 μL) were 
combined. 
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Table 66. NMR Data for MTB-XVI-89. 
 14939.4 16789.7 1.123854 
Time   [olefin] 
35.35 1821.33 2061.46 0.025178 
65.51 1789.73 2001.48 0.024877 
95.67 1783.67 1983.28 0.024734 
125.83 1777.81 1971.83 0.024673 
155.99 1775.9 1957.47 0.024519 
186.15 1779.92 1943.33 0.024287 
216.31 1779.34 1928.95 0.024115 
246.47 1775.76 1914.27 0.02398 
276.63 1772.41 1910.2 0.023974 
306.79 1771.94 1894.04 0.023778 
336.95 1782.08 1885.98 0.023542 
367.11 1785.01 1878.82 0.023414 
397.27 1787.3 1862.01 0.023175 
427.43 1780.73 1855.12 0.023174 
457.59 1787.76 1836.6 0.022853 
487.75 1779.79 1831.05 0.022886 
517.91 1773.66 1833.2 0.022992 
548.07 1784.27 1828.01 0.02279 
578.23 1776.63 1808.44 0.022643 
608.39 1778.12 1804.15 0.022571 
638.55 1783.97 1805.79 0.022517 
668.71 1778.3 1791.84 0.022414 
698.87 1782.12 1785.18 0.022283 
729.03 1789.77 1784.22 0.022176 
759.19 1770.14 1771.9 0.022267 
789.35 1780.26 1772.74 0.022151 
819.51 1781.82 1762.53 0.022004 
849.67 1776.67 1756.5 0.021992 
879.83 1773.81 1757.11 0.022035 
909.99 1781.14 1751.76 0.021878 
940.15 1783.27 1749.76 0.021827 
970.31 1778.69 1738.19 0.021738 
1000.47 1788.87 1735.57 0.021582 
1030.63 1779.93 1730.39 0.021626 
1060.79 1780.8 1733.18 0.02165 
1090.95 1777.13 1728.25 0.021633 
1121.11 1784.6 1720.91 0.021451 
y = -4.29E-06x + 2.51E-02 
R² = 9.74E-01 
0.022 
0.0225 
0.023 
0.0235 
0.024 
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Table 66 cont. 
1151.27 1780.88 1715.28 0.021425 
1181.43 1777.59 1722.22 0.021552 
1211.59 1781.68 1705.63 0.021295 
1241.75 1787.61 1720.25 0.021407 
1271.91 1785.71 1711.23 0.021317 
1302.07 1781.36 1712.16 0.021381 
1332.23 1785.98 1708.69 0.021282 
1362.39 1779.72 1700.52 0.021255 
1392.55 1783.75 1698.24 0.021179 
1422.71 1774.87 1698.83 0.021292 
1452.87 1782.41 1693.44 0.021135 
1483.03 1772.62 1696.31 0.021287 
1513.19 1785.19 1702.91 0.02122 
1543.35 1788.02 1691.53 0.021044 
1573.51 1789.02 1689.22 0.021004 
1603.67 1775.44 1684.04 0.0211 
1633.83 1775.6 1686.63 0.02113 
1663.99 1786.07 1685.71 0.020995 
1694.15 1776.98 1683.59 0.021076 
1724.31 1787.63 1673.12 0.02082 
1754.47 1777.53 1669.45 0.020892 
1784.63 1779.4 1670.4 0.020882 
1814.79 1778.67 1682.44 0.021041 
1844.95 1783.81 1679.73 0.020947 
1875.11 1774.08 1678.76 0.02105 
1905.27 1776.25 1672.66 0.020948 
1935.43 1779.03 1672.5 0.020913 
1965.59 1779.8 1671.96 0.020897 
1995.75 1784.19 1672.35 0.02085 
2025.91 1116.15 1037.85 0.020684 
 
Determination of the Partial Order in Ph3P=S of Bromocylization of 19l by 
19
F NMR. 
(0.176 mM, replicate 3) [MTB-XVI-94] 
Following General Procedure 24, NBS (3.67 mg, 0.021 mmol), PhMe-d8 (0.1 mL), 
Solution A (140 μL), PhMe (421 μL), Solution B (25 μL) and Solution C (14 μL) were 
combined. 
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Table 67. NMR Data for MTB-XVI-94. 
 14530.9 16464.4 1.133061 
Time   [olefin] 
37.4 1799.86 2060.67 0.025261 
67.56 1749.09 1973.78 0.024899 
97.72 1751.96 1956.2 0.024636 
127.88 1743.43 1952.34 0.024708 
158.04 1733.86 1955.68 0.024887 
188.2 1747.95 1943.52 0.024533 
218.36 1746.6 1939.78 0.024504 
248.52 1746.72 1925.48 0.024322 
278.68 1741.06 1918.76 0.024316 
308.84 1736.63 1915.55 0.024337 
339 1741.45 1902.6 0.024106 
369.16 1750.21 1895.68 0.023898 
399.32 1747.29 1884.69 0.023799 
429.48 1743.57 1890.1 0.023918 
459.64 1755.48 1874.55 0.023561 
489.8 1738.97 1862.51 0.023632 
519.96 1741.9 1854.87 0.023495 
550.12 1746.99 1851.14 0.02338 
580.28 1742.64 1845.19 0.023363 
610.44 1738.69 1851.43 0.023495 
640.6 1741.16 1834.28 0.023244 
670.76 1752.43 1832.46 0.023072 
700.92 1745.87 1823.54 0.023046 
731.08 1741.46 1822.61 0.023092 
761.24 1743.15 1808.4 0.02289 
791.4 1744.95 1802.45 0.022791 
821.56 1745.8 1798.02 0.022724 
851.72 1749.02 1793.55 0.022626 
881.88 1740.86 1787.74 0.022658 
912.04 1743.31 1781.26 0.022544 
942.2 1738.53 1782.28 0.022619 
972.36 1746.74 1774.03 0.022409 
1002.52 1740.21 1776.03 0.022518 
1032.68 1746.66 1770.97 0.022371 
1062.84 1748.19 1763.52 0.022258 
1093 1745.06 1771.22 0.022395 
1123.16 1745.72 1760.77 0.022254 
y = -2.72E-06x + 2.50E-02 
R² = 9.76E-01 
0.022 
0.0225 
0.023 
0.0235 
0.024 
0.0245 
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Table 67 cont. 
1153.32 1738.9 1759.83 0.02233 
1183.48 1748.42 1761.14 0.022225 
1213.64 1747.54 1756.12 0.022172 
1243.8 1739.98 1757.32 0.022284 
1273.96 1746.64 1754.73 0.022166 
1304.12 1741.92 1743.94 0.02209 
1334.28 1744.13 1737.89 0.021985 
1364.44 1740.64 1741.23 0.022072 
1394.6 1747.49 1737.46 0.021937 
1424.76 1744.18 1737.54 0.02198 
1454.92 1749.27 1737.04 0.02191 
1485.08 1744.92 1732.43 0.021906 
1515.24 439.545 429.856 0.021578 
 
Determination of the Partial Order in Ph3P=S of Bromocylization of 19l by 
19
F NMR. 
(0.556 mM, replicate 1) [MTB-XVI-85] 
Following General Procedure 24, NBS (3.74 mg, 0.021 mmol), PhMe-d8 (0.1 mL), 
Solution A (140 μL), PhMe (390 μL), Solution B (25 μL) and Solution C (45 μL) were 
combined. 
 
 
Table 68. NMR Data for MTB-XVI-85. 
 14675.4 16587.2 1.130272 
Time   [olefin] 
38.5 1791.12 1990.39 0.024579 
68.66 1672.04 1802.89 0.02385 
98.82 1663.8 1758.88 0.023383 
128.98 1672.12 1697.85 0.022459 
y = -2.26E-05x + 2.55E-02 
R² = 9.85E-01 
0.022 
0.0225 
0.023 
0.0235 
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Table 68 cont. 
159.14 1668.34 1657 0.021968 
189.3 1675.29 1619.15 0.021377 
219.46 1673.99 1587.41 0.020975 
249.62 1665.88 1547.26 0.020544 
279.78 1671.46 1532.6 0.020281 
309.94 1678.66 1501.16 0.01978 
340.1 1689 1481.32 0.019399 
370.26 1682.6 1456.74 0.01915 
400.42 1681.85 1435.09 0.018873 
430.58 1676.7 1423.1 0.018773 
460.74 1680.27 1398.23 0.018406 
490.9 1686.8 1394.15 0.018281 
521.06 1674.81 1374.23 0.018149 
551.22 1687.82 1360.42 0.017828 
581.38 1677 1362.6 0.017972 
611.54 1695.4 1344.2 0.017537 
641.7 1686.34 1335.37 0.017515 
671.86 1695.99 1325.32 0.017284 
702.02 845.442 662.819 0.017341 
 
Determination of the Partial Order in Ph3P=S of Bromocylization of 19l by 
19
F NMR. 
(0.556 mM, replicate 2) [MTB-XVI-88] 
Following General Procedure 24, NBS (3.69 mg, 0.021 mmol), PhMe-d8 (0.1 mL), 
Solution A (140 μL), PhMe (390 μL), Solution B (25 μL) and Solution C (45 μL) were 
combined. 
 
Table 69. NMR Data for MTB-XVI-88. 
 16330.5 18005.5 1.102569 
Time   [olefin] 
33.25 1868.64 2069 0.025106 
y = -2.23E-05x + 2.57E-02 
R² = 9.90E-01 
0.0228 
0.023 
0.0232 
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Table 69 cont. 
63.41 1832.51 1968.66 0.024359 
93.57 1840.75 1913.21 0.023567 
123.73 1838.99 1866.54 0.023014 
153.89 1840.25 1818.86 0.022411 
184.05 1837.06 1795.74 0.022164 
214.21 1834.64 1761.34 0.021768 
244.37 1846.03 1726.37 0.021205 
274.53 1843.31 1688.51 0.02077 
304.69 1855.9 1665.69 0.02035 
334.85 1847.73 1631.86 0.020025 
365.01 1853.18 1613.98 0.019748 
395.17 1855.02 1583.33 0.019353 
425.33 1853.09 1568.37 0.019191 
455.49 1862.42 1554.82 0.018929 
485.65 1857.87 1532.47 0.018703 
515.81 1872.69 1512.15 0.018309 
545.97 1852.45 1503.14 0.018399 
576.13 1856.8 1485.89 0.018145 
606.29 695.311 547.071 0.01784 
 
Determination of the Partial Order in Ph3P=S of Bromocylization of 19l by 
19
F NMR. 
(0.556 mM, replicate 3) [MTB-XVI-93] 
Following General Procedure 24, NBS (3.68 mg, 0.021 mmol), PhMe-d8 (0.1 mL), 
Solution A (140 μL), PhMe (390 μL), Solution B (25 μL) and Solution C (45 μL) were 
combined. 
 
Table 70. NMR Data for MTB-XVI-93. 
 14967.6 17046.9 1.13892 
Time   [olefin] 
36 1721.25 1984.85 0.025312 
y = -1.41E-05x + 2.53E-02 
R² = 9.96E-01 
0.0224 
0.0226 
0.0228 
0.023 
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0.0238 
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Table 70 cont. 
66.16 1695.12 1881.85 0.024369 
96.32 1685.75 1836.74 0.023917 
126.48 1677.54 1799.86 0.023551 
156.64 1680.7 1772.88 0.023155 
186.8 1674.18 1725.25 0.02262 
216.96 1676.58 1699.81 0.022255 
247.12 1680.02 1668.08 0.021795 
277.28 1681.5 1655.67 0.021613 
307.44 1682.81 1620.19 0.021134 
337.6 1689.29 1603.43 0.020835 
367.76 1684.82 1583.67 0.020633 
397.92 1690.71 1562.02 0.02028 
428.08 1684.25 1549.24 0.020191 
458.24 1690.75 1534.11 0.019917 
488.4 1686.19 1514.61 0.019717 
518.56 1696.91 1500.4 0.019409 
548.72 1697.14 1482.77 0.019178 
578.88 852.108 738.335 0.01902 
 
Determination of the Partial Order in Ph3P=S of Bromocylization of 19l by 
19
F NMR. 
(0.988 mM, replicate 1) [MTB-XVI-86] 
Following General Procedure 24, NBS (3.75 mg, 0.021 mmol), PhMe-d8 (0.1 mL), 
Solution A (140 μL), PhMe (356 μL), Solution B (25 μL) and Solution C (79 μL) were 
combined. 
 
Table 71. NMR Data for MTB-XVI-86. 
 16376.5 18320.3 1.118694 
Time   [olefin] 
32.81 1805.97 1982.57 0.024533 
62.97 1754.08 1820.66 0.023196 
y = -4.43E-05x + 2.60E-02 
R² = 1.00E+00 
0.023 
0.0232 
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Table 71 cont. 
93.13 1756.04 1751.5 0.02229 
123.29 1754.58 1672.36 0.0213 
153.45 1760.41 1622.86 0.020601 
183.61 1762.47 1579.5 0.020027 
213.77 1775 1537.34 0.019355 
243.93 1769.29 1496.51 0.018902 
274.09 1784.46 1468.97 0.018396 
304.25 1791.57 1440.75 0.017971 
334.41 1788.5 1417.01 0.017706 
364.57 1787.8 1387.92 0.017349 
394.73 1785.84 1360.62 0.017026 
424.89 1788.09 1349.48 0.016866 
455.05 1790.6 1326.41 0.016554 
485.21 1799.26 1314.38 0.016325 
515.37 1792.96 1290.78 0.016088 
545.53 1791.57 1297.91 0.01619 
575.69 1801.26 1284.29 0.015934 
605.85 1804.23 1273.03 0.015768 
636.01 1813.94 1271.1 0.01566 
666.17 1813.26 1261.42 0.015546 
696.33 1803.2 1249.19 0.015482 
726.49 1803.84 1244.99 0.015424 
756.65 1810.55 1242.3 0.015334 
786.81 1814.86 1241.25 0.015284 
816.97 1804.83 1245.19 0.015418 
847.13 1817.51 1238.21 0.015225 
877.29 1809.47 1228.98 0.015178 
907.45 1819.39 1234.28 0.015161 
937.61 1812.62 1233.68 0.01521 
967.77 1813.59 1224.51 0.015089 
997.93 1811.7 1226.14 0.015125 
1028.09 1810.95 1221.88 0.015078 
1058.25 1818.55 1212.77 0.014903 
1088.41 1820.34 1214.91 0.014915 
1118.57 1814.82 1220.18 0.015025 
1148.73 1818.85 1218.77 0.014975 
1178.89 1821.59 1212.62 0.014877 
1209.05 1816.85 1213.55 0.014927 
1239.21 1817.2 1212.58 0.014912 
1269.37 1811.63 1211.23 0.014941 
1299.53 1809.26 1208.82 0.014931 
1329.69 1817.66 1213.26 0.014917 
1359.85 1811.71 1201.34 0.014819 
1390.01 1816.72 1205.47 0.014828 
1420.17 1814.6 1203.75 0.014825 
1450.33 1807.88 1200.12 0.014835 
1480.49 1820.89 1196.93 0.01469 
1510.65 1825.16 1205.65 0.014762 
1540.81 1367.69 900.079 0.014707 
 
Determination of the Partial Order in Ph3P=S of Bromocylization of 19l by 
19
F NMR. 
(0.988 mM, replicate 2) [MTB-XVI-87] 
Following General Procedure 24, NBS (3.70 mg, 0.021 mmol), PhMe-d8 (0.1 mL), 
Solution A (140 μL), PhMe (356 μL), Solution B (25 μL) and Solution C (79 μL) were 
combined. 
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Table 72. NMR Data for MTB-XVI-87. 
 15715.2 17776.9 1.131191 
Time   [olefin] 
28.84 1715.19 1928.47 0.024849 
59 1687.12 1771.66 0.023208 
89.16 1668.34 1681.07 0.022269 
119.32 1661.95 1618.59 0.021524 
149.48 1663.97 1566.92 0.020812 
179.64 1672.61 1511.39 0.01997 
209.8 1679.88 1465.3 0.019278 
239.96 1681.42 1426.72 0.018753 
270.12 420.111 354.107 0.018628 
 
Determination of the Partial Order in Ph3P=S of Bromocylization of 19l by 
19
F NMR. 
(0.988 mM, replicate 3) [MTB-XVI-92] 
Following General Procedure 24, NBS (3.75 mg, 0.021 mmol), PhMe-d8 (0.1 mL), 
Solution A (140 μL), PhMe (356 μL), Solution B (25 μL) and Solution C (79 μL) were 
combined. 
y = -5.44E-05x + 2.64E-02 
R² = 1.00E+00 
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Table 73. NMR Data for MTB-XVI-92. 
 17325.9 19176.2 1.106794 
Time   [olefin] 
38.91 1929 2093.86 0.024518 
69.07 1909.78 1967.82 0.023274 
99.23 1903.61 1903.21 0.022583 
129.39 1914.48 1841.81 0.02173 
159.55 1916.23 1789.65 0.021096 
189.71 1916.08 1733.81 0.020439 
219.87 1929.41 1689.2 0.019776 
250.03 1932.02 1650.39 0.019295 
280.19 1940.84 1613.81 0.018782 
310.35 1944.96 1575.52 0.018297 
340.51 1939.28 1536.19 0.017893 
370.67 1950.4 1513.48 0.017528 
400.83 1959.41 1478.41 0.017043 
430.99 1952.28 1456.69 0.016854 
461.15 1958.04 1435 0.016554 
 
General Procedure 25. Determination of the Partial Order in NBS of Bromocylization of 
19l by 
19
F NMR. (3.00 mM, replicate 1) [MTB-XVI-95] 
The following stock solutions were prepared and used for all runs to determine the partial 
order in NBS (except for additional replicates run at a later date as indicated): 
Solution A: An oven-dried 2-mL volumetric flask, equipped with a septum was charged with 19l 
(44.96 mg, 0.2314 mmol). The flask was evacuated and filled with Ar via a needle. 
y = -3.21E-05x + 2.57E-02 
R² = 9.74E-01 
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Fluorobenzene (22 μL, 1 equiv with respect to 19l) was added via syringe, and then the flask was 
filled to the mark with dry PhMe. 
 
Solution B: An oven-dried conical vial, equipped with a PTFE/silicone septum and cap was 
charged with 24a (5.39 mg, 0.00716 mmol). The vial was evacuated and filled with Ar via a 
needle and then was charged with Solution C (825 μL). 
 
Solution C: An oven-dried 10-mL volumetric flask, equipped with a septum was charged with 
Ph3P=S (25.73 mg, 0.08741 mmol). The flask was evacuated and filled with Ar via a needle, and 
then the flask was filled to the mark with dry PhMe. 
Stock solutions of NBS in PhMe were reprepared periodically to ensure freshness. 
 
 An oven-dried, 5-mm NMR tube, fitted with a septum, wrapped in Al foil, was charged 
with NBS (3.72 mg, 0.021 mmol). The septum was removed and tube was then brought in to an 
Ar filled glove box, where the septum was replaced. The tube removed from the glove box and 
was charged with PhMe-d8 (0.1 mL), Solution A (152 μL), a solution of NBS in PhMe (70 μL, 
29.97 mM), and PhMe (354 μL). The tube was agitated in a vortex mixer. The tube was inserted 
into the NMR spectrometer and shimmed. An initial time point was acquired (64 scans, at=1, 
pw=8.25, d1=2.77) to determine response factors and correct for any evaporation of the PhF 
standard. The tube was ejected from the spectrometer. Solution B (25 μL) was added. The tube 
was rapidly inverted three times and was reinserted into the spectrometer. An arrayed acquisition 
was begun (nt=8, d1=2.77, at=1, pad=array of zeroes). Note: the poor data quality is due to the 
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limited concentration range plotted. 10% conversion of limiting reagent (NBS) is only 1.2% of 
the signal intensity.  
 
Table 74. NMR Data for MTB-XVI-95. 
 23625.2 25133.7 1.063851 
Time   [Olefin] 
24.63 2859.92 3135.87 0.025767 
54.79 2819.95 2990.4 0.02492 
84.95 2784.95 2990.53 0.025234 
115.11 2768.75 2985.58 0.02534 
145.27 2784.38 2976.49 0.025121 
175.43 2786.64 2966.58 0.025017 
205.59 2792.89 2976.92 0.025048 
235.75 2780.3 2967.7 0.025083 
265.91 2777 2965.43 0.025094 
296.07 2781.09 2970.18 0.025097 
326.23 2780.37 2969.42 0.025097 
356.39 2766.27 2958.7 0.025134 
386.55 2778.39 2959.12 0.025028 
416.71 2766.5 2964.79 0.025184 
446.87 2773.26 2949.76 0.024995 
477.03 2777.05 2940.35 0.024881 
507.19 2795.26 2948.21 0.024785 
537.35 2780.91 2932.59 0.024781 
567.51 2786.65 2936.69 0.024765 
597.67 2771.96 2925.59 0.024802 
627.83 2779.17 2932.83 0.024799 
657.99 2782.78 2926.83 0.024716 
688.15 2773.82 2914.76 0.024694 
718.31 2787.46 2914.81 0.024573 
748.47 2780.66 2922.84 0.024701 
778.63 2773.7 2905.25 0.024614 
808.79 2776.96 2889.63 0.024453 
838.95 2771.78 2896.49 0.024557 
869.11 2779.28 2896.34 0.024489 
899.27 2774.63 2897.78 0.024543 
929.43 2768.95 2879.15 0.024435 
959.59 2761.74 2875.04 0.024464 
y = -9.27E-07x + 2.53E-02 
R² = 7.31E-01 
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Table 74 cont. 
989.75 2778.89 2868.69 0.024259 
1019.91 2784.35 2884.93 0.024348 
1050.07 2779.04 2869.11 0.024261 
1080.23 2776.39 2875.04 0.024335 
1110.39 2782.16 2878.35 0.024312 
1140.55 2775.96 2863 0.024236 
1170.71 2774.04 2856.38 0.024197 
1200.87 2774.96 2852.61 0.024157 
1231.03 2790 2853.86 0.024037 
1261.19 2781.83 2846.15 0.024043 
1291.35 2781.59 2851.99 0.024094 
1321.51 2772.3 2829.41 0.023984 
1351.67 2787.21 2836.62 0.023916 
1381.83 2779.14 2835.41 0.023975 
1411.99 2436.29 2476.41 0.023887 
 
Determination of the Partial Order in NBS of Bromocylization of 19l by 
19
F NMR. (3.00 
mM, replicate 2) [MTB-XVII-07] 
Following General Procedure 24, PhMe-d8 (0.1 mL), Solution A (152 μL), a solution of 
NBS in PhMe (70 μL, 29.94 mM), PhMe (354 μL) and Solution B (25 μL) were combined. 
 
 
Table 75. NMR Data for MTB-XVII-07. 
 26349.1 28514.7 1.082189 
Time   [Olefin] 
27.22 2818.18 3094.22 0.025364 
57.38 2732.98 2959.56 0.025017 
87.54 2723.05 2938.38 0.024928 
117.7 2718.91 2942.45 0.025001 
147.86 2711.71 2950.3 0.025134 
y = -1.14E-06x + 2.53E-02 
R² = 5.64E-01 
0.0245 
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0.0247 
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178.02 2702.46 2943.11 0.025158 
208.18 2716.77 2927.71 0.024895 
238.34 2722.04 2941.01 0.02496 
268.5 2714.32 2939.83 0.025021 
298.66 2702.95 2934.25 0.025078 
328.82 2710.56 2923.95 0.02492 
358.98 2705.97 2916.79 0.024901 
389.14 2724.55 2916.9 0.024732 
419.3 2714.89 2910.5 0.024766 
449.46 2704.46 2918.02 0.024926 
479.62 2723.91 2922.56 0.024786 
509.78 2719.82 2896.5 0.024602 
539.94 2714.74 2887.93 0.024575 
570.1 2708.79 2893.04 0.024673 
600.26 2714.19 2909.43 0.024763 
630.42 2718.07 2900.13 0.024649 
660.58 2720.69 2886.08 0.024506 
690.74 2707.14 2887.71 0.024642 
720.9 2713.74 2884.32 0.024553 
751.06 2719.08 2874.31 0.02442 
781.22 2718.32 2873.13 0.024417 
811.38 2714.24 2869.19 0.02442 
841.54 2718.76 2861.08 0.024311 
871.7 2707.49 2858.42 0.024389 
901.86 2720.8 2858.18 0.024268 
932.02 2711.53 2838.61 0.024184 
962.18 2731.04 2837.38 0.024001 
992.34 2715.02 2852.23 0.024269 
1022.5 2376.87 2475.85 0.024063 
 
Determination of the Partial Order in NBS of Bromocylization of 19l by 
19
F NMR. (3.00 
mM, replicate 3) [MTB-XVII-08] 
Following General Procedure 24, PhMe-d8 (0.1 mL), Solution A (152 μL), a solution of 
NBS in PhMe (70 μL, 29.94 mM), PhMe (354 μL) and Solution B (25 μL) were combined.  
 
y = -8.34E-07x + 2.52E-02 
R² = 3.92E-01 
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Table 76. NMR Data for MTB-XVII-08. 
 25266.4 27488 1.087927 
Time   [Olefin] 
28 2978.94 3237.78 0.024976 
58.16 2802.3 3046.8 0.024984 
88.32 2797.3 3017.64 0.02479 
118.48 2794.9 3028.21 0.024898 
148.64 2785.4 3013.04 0.024858 
178.8 2789.13 3024.63 0.02492 
208.96 2787.52 3012.39 0.024833 
239.12 2792.89 3025.07 0.02489 
269.28 2780.55 3028.85 0.025032 
299.44 2791.39 3020.7 0.024867 
329.6 2795.93 3008.79 0.024729 
359.76 2789.69 3003.43 0.02474 
389.92 2798.66 3004.88 0.024673 
420.08 2787.86 2982.91 0.024587 
450.24 2794.4 2994.08 0.024622 
480.4 2793.03 2992.98 0.024625 
510.56 2792.5 2994.96 0.024646 
540.72 2788.66 2986.47 0.02461 
570.88 2798.46 2983.21 0.024497 
601.04 2802.37 2980.93 0.024444 
631.2 2789.87 2978.85 0.024536 
661.36 2787.67 2974.4 0.024519 
691.52 2804.96 2969.96 0.024331 
721.68 2803 2959.28 0.024261 
751.84 2790.4 2958.59 0.024365 
782 2788.9 2945.81 0.024272 
812.16 2789.36 2942.52 0.024241 
842.32 2793.74 2942.92 0.024207 
872.48 2790.74 2937.85 0.024191 
902.64 2780.4 2931.82 0.024231 
932.8 2785.76 2932.41 0.024189 
962.96 2790.35 2912.35 0.023984 
993.12 2787.62 2901.12 0.023915 
1023.28 2790.88 2921.17 0.024052 
1053.44 2783.6 2911.22 0.024033 
1083.6 2784.27 2917.18 0.024076 
1113.76 2783.99 2924.78 0.024142 
1143.92 2780.07 2906.78 0.024027 
1174.08 2780.74 2902.6 0.023987 
1204.24 2793.87 2898.5 0.02384 
1234.4 2779.57 2872.82 0.02375 
1264.56 2786.56 2902.18 0.023933 
1294.72 2786.06 2888.47 0.023824 
1324.88 2808.16 2872.87 0.023509 
1355.04 2789.48 2868.18 0.023628 
1385.2 2780.92 2862.34 0.023652 
1415.36 2774.96 2867.52 0.023746 
1445.52 2791.6 2866.44 0.023596 
1475.68 2777.04 2857.03 0.023641 
1505.84 2777.14 2868.04 0.023732 
1536 1738.29 1795.22 0.023732 
Determination of the Partial Order in NBS of Bromocylization of 19l by 
19
F NMR. (5.33 
mM, replicate 1) [MTB-XVI-96] 
Following General Procedure 24, PhMe-d8 (0.1 mL), Solution A (152 μL), a solution of 
NBS in PhMe (125 μL, 29.97 mM), PhMe (299 μL) and Solution B (25 μL) were combined.  
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Table 77. NMR Data for MTB-XVI-96. 
 23395.8 24943.9 1.06617 
Time   [Olefin] 
23.3 3000.82 3231.36 0.02525 
53.46 2944.29 3128.79 0.024918 
83.62 2932.23 3100.13 0.024791 
113.78 2939.36 3101.94 0.024745 
143.94 2921.96 3090.82 0.024804 
174.1 2931.81 3086.02 0.024682 
204.26 2942.95 3070.65 0.024466 
234.42 2942.54 3078.3 0.02453 
264.58 2935.2 3074.96 0.024565 
294.74 2926.39 3059.69 0.024517 
324.9 2946.81 3042.03 0.024206 
355.06 2938.43 3034.1 0.024212 
385.22 2950.12 3023.59 0.024032 
415.38 2941.63 3005.62 0.023958 
445.54 2944.34 3008.67 0.023961 
475.7 2940.45 2975 0.023724 
505.86 2941.84 2963.3 0.023619 
536.02 2931.87 2957.83 0.023656 
566.18 2939.72 2944 0.023483 
596.34 2943.57 2931.96 0.023356 
626.5 2939.78 2908.78 0.023201 
656.66 2954.22 2903.68 0.023047 
686.82 2933.73 2889.44 0.023094 
716.98 2941.85 2881.99 0.022971 
747.14 2935.85 2872.5 0.022942 
777.3 2939.08 2859.18 0.022811 
807.46 2939.16 2854.46 0.022773 
837.62 2945.13 2829.87 0.022531 
867.78 2946.74 2831.33 0.02253 
897.94 2937.91 2823.05 0.022532 
928.1 2945.32 2807.51 0.022351 
958.26 2937.23 2808.1 0.022418 
988.42 2948.67 2812.07 0.022362 
1018.58 2928.73 2788.71 0.022327 
1048.74 2941.44 2784.91 0.022201 
1078.9 2941.1 2775.43 0.022128 
1109.06 2937.9 2765.09 0.022069 
y = -2.40E-06x + 2.50E-02 
R² = 7.84E-01 
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0.02445 
0.0245 
0.02455 
0.0246 
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0.0247 
0.02475 
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1139.22 2938.12 2748.8 0.021938 
1169.38 2939.08 2753.61 0.021969 
1199.54 2925.54 2753.74 0.022071 
1229.7 2946.29 2754.72 0.021924 
1259.86 2953.39 2745.65 0.021799 
1290.02 2937.09 2736.89 0.02185 
1320.18 2944.71 2743.23 0.021844 
1350.34 2950.7 2726.45 0.021666 
1380.5 2938.92 2731.64 0.021795 
1410.66 2947.73 2723.66 0.021666 
1440.82 2930.1 2728.11 0.021832 
1470.98 2938.5 2715.89 0.021672 
1501.14 2938.49 2707.1 0.021602 
1531.3 2944.76 2704.3 0.021534 
1561.46 2941.37 2705.37 0.021567 
1591.62 2939.77 2685.42 0.02142 
1621.78 2931.67 2696.29 0.021566 
1651.94 2940.88 2686.03 0.021416 
1682.1 2948.29 2700.2 0.021475 
1712.26 2953.41 2679.8 0.021276 
1742.42 2929.73 2673.19 0.021395 
1772.58 2937.55 2683.47 0.02142 
1802.74 2947.81 2672.54 0.021259 
1832.9 2946.57 2660.4 0.021171 
1863.06 2936.31 2666.91 0.021297 
1893.22 2938.11 2637.27 0.021047 
1923.38 2937.66 2664.75 0.02127 
1953.54 2954.74 2667.91 0.021172 
1983.7 2933.87 2649.75 0.021178 
2013.86 2956.58 2640.3 0.02094 
2044.02 2938.35 2655.28 0.021189 
2074.18 2948.69 2658.06 0.021137 
2104.34 2943.89 2644.35 0.021063 
2134.5 2947.44 2640.55 0.021007 
2164.66 2215.45 1984.35 0.021002 
 
Determination of the Partial Order in NBS of Bromocylization of 19l by 
19
F NMR. (5.33 
mM, replicate 2) [MTB-XVII-06] 
Following General Procedure 24, PhMe-d8 (0.1 mL), Solution A (152 μL), a solution of 
NBS in PhMe (125 μL, 29.94 mM), PhMe (299 μL) and Solution B (25 μL) were combined.  
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Table 78. NMR Data for MTB-XVII-06. 
 22465.2 24216.5 1.077956 
Time   [Olefin] 
30 2908.41 3184.91 0.025397 
60.16 2674.23 2928.13 0.025394 
90.32 2663.17 2910.45 0.025345 
120.48 2645.59 2912.76 0.025534 
150.64 2647.65 2897.02 0.025376 
180.8 2661.02 2905.93 0.025327 
210.96 2657 2883.99 0.025173 
241.12 2661.69 2887.49 0.025159 
271.28 2663.11 2888.83 0.025158 
301.44 2655.44 2864.47 0.025018 
331.6 2657.12 2861.25 0.024974 
361.76 2649.1 2860.3 0.025041 
391.92 2666.49 2844.57 0.024741 
422.08 2653.67 2843.6 0.024852 
452.24 2651.89 2812.29 0.024595 
482.4 2664.28 2829.7 0.024632 
512.56 2663.93 2819.81 0.024549 
542.72 2651.58 2796.5 0.02446 
572.88 2645.22 2784.11 0.02441 
603.04 2653.48 2773 0.024237 
633.2 2653.15 2774.97 0.024257 
663.36 2648.79 2760.65 0.024171 
693.52 2650.71 2749.85 0.024059 
723.68 2661.96 2764.4 0.024085 
753.84 2666.27 2745.71 0.023883 
784 2647.07 2723.51 0.023862 
814.16 2654.14 2741.52 0.023956 
844.32 2658.42 2728.81 0.023806 
874.48 2654.58 2719.45 0.023759 
904.64 2655.76 2714.83 0.023708 
934.8 338.324 340.657 0.023352 
 
y = -2.62E-06x + 2.51E-02 
R² = 8.61E-01 
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Determination of the Partial Order in NBS of Bromocylization of 19l by 
19
F NMR. (5.33 
mM, replicate 3) [MTB-XVII-25] 
Replicates 3-4 (MTB-XVII-25, MTB-XVII-26) were run later and used the following 
stock solutions: 
Solution A: An oven-dried 2-mL volumetric flask, equipped with a septum was charged with 19l 
(121.72 mg, 0.6266 mmol). The flask was evacuated and filled with Ar via a needle. 
Fluorobenzene (59 μL, 1 equiv with respect to 19l) was added via syringe, and then the flask was 
filled to the mark with dry PhMe. 
 
Solution B: An oven-dried conical vial, equipped with a PTFE/silicone septum and cap was 
charged with 24a (5.40 mg, 0.00717 mmol). The vial was evacuated and filled with Ar via a 
needle and then was charged with Solution C (825 μL). 
 
Solution C: An oven-dried 10-mL volumetric flask, equipped with a septum was charged with 
Ph3P=S (25.86 mg, 0.08785 mmol). The flask was evacuated and filled with Ar via a needle, and 
then the flask was filled to the mark with dry PhMe. 
 
Following General Procedure 24, PhMe-d8 (0.1 mL), Solution A (56 μL), a solution of 
NBS in PhMe (125 μL, 30.09 mM), PhMe (394 μL) and Solution B (25 μL) were combined.  
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Table 79. NMR Data for MTB-XVII-25. 
 15633.1 15428.4 0.986906 
Time   [Olefin] 
30 1969.37 1906.07 0.024517 
60.16 1838.41 1813.02 0.024982 
90.32 1846.88 1814.14 0.024883 
120.48 1849.19 1814.69 0.024859 
150.64 1847.17 1804.65 0.024749 
180.8 1850.47 1805.86 0.024721 
210.96 1856.08 1809.03 0.02469 
241.12 1844.05 1800.75 0.024737 
271.28 1844.26 1806.42 0.024812 
301.44 1849.83 1798.86 0.024634 
331.6 1833.93 1788.99 0.024711 
361.76 1848.64 1786.61 0.024482 
391.92 1843.7 1779.08 0.024444 
422.08 1844.96 1792.2 0.024607 
452.24 1841.85 1783.23 0.024525 
482.4 1844.06 1776.77 0.024407 
512.56 1842.17 1779.26 0.024467 
542.72 1844.56 1771.71 0.024331 
572.88 1849.36 1768.29 0.024221 
603.04 1841.17 1764.05 0.024271 
633.2 1845.98 1756.31 0.024101 
663.36 1842.52 1756.74 0.024152 
693.52 1842.05 1756.5 0.024155 
723.68 1846.18 1745.76 0.023954 
753.84 1837.96 1739.93 0.023981 
784 1846.65 1736.06 0.023815 
814.16 1844.11 1736.65 0.023856 
844.32 1847.81 1727.64 0.023684 
874.48 1842.6 1722.69 0.023683 
904.64 1841.18 1717.96 0.023636 
934.8 1841.62 1722.53 0.023694 
964.96 1850.28 1719.01 0.023535 
995.12 1845.85 1712.97 0.023508 
1025.28 1382.68 1283.57 0.023516 
 
y = -1.08E-06x + 2.50E-02 
R² = 8.21E-01 
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Determination of the Partial Order in NBS of Bromocylization of 19l by 
19
F NMR. (5.33 
mM, replicate 3) [MTB-XVII-26] 
Following General Procedure 24, PhMe-d8 (0.1 mL), Solution A (56 μL), a solution of 
NBS in PhMe (125 μL, 30.09 mM), PhMe (395 μL) and Solution B (25 μL) were combined.  
 
Table 80. NMR Data for MTB-XVII-26. 
 16016.8 15611.3 0.974683 
Time   [Olefin] 
30 1998.97 1963.88 0.025199 
60.16 1978.88 1913.97 0.024808 
90.32 1978.23 1922.63 0.024928 
120.48 1979.3 1918.95 0.024867 
150.64 1971.79 1917.21 0.024939 
180.8 1976.27 1912.35 0.02482 
210.96 1981.99 1920.38 0.024852 
241.12 1975.56 1907.92 0.024771 
271.28 1981.94 1898.11 0.024564 
301.44 1973.28 1915.76 0.024902 
331.6 1980.27 1896.53 0.024565 
361.76 1981.83 1905.8 0.024665 
391.92 1975.65 1887.16 0.024501 
422.08 1977.9 1879.11 0.024368 
452.24 1980.35 1882.97 0.024388 
482.4 1981.46 1880.84 0.024347 
512.56 1975.17 1872.88 0.024321 
542.72 1978.5 1875 0.024308 
572.88 1973.72 1871.16 0.024317 
603.04 1983.02 1861.1 0.024072 
633.2 1974.11 1858.74 0.02415 
663.36 1982.47 1858.8 0.024049 
693.52 1972.05 1851.19 0.024077 
723.68 1985.31 1840.06 0.023773 
753.84 1977.63 1835.56 0.023807 
784 1975.22 1832.7 0.023799 
y = -1.47E-06x + 2.51E-02 
R² = 5.64E-01 
0.02445 
0.0245 
0.02455 
0.0246 
0.02465 
0.0247 
0.02475 
0.0248 
0.02485 
0.0249 
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Table 80 cont. 
814.16 1980.66 1833.26 0.023741 
844.32 1976.48 1831.99 0.023774 
874.48 1977.82 1826.77 0.02369 
904.64 1978.09 1814.42 0.023527 
934.8 1976.99 1807.53 0.023451 
964.96 1981.46 1808.43 0.02341 
995.12 1979.85 1805.03 0.023385 
1025.28 1977.33 1801.22 0.023365 
1055.44 1961.84 1800.46 0.023539 
1085.6 1988 1795.21 0.023162 
1115.76 1972.85 1789.79 0.023269 
1145.92 1981.44 1785.11 0.023108 
1176.08 1975.07 1784.24 0.023171 
1206.24 1982.54 1773.25 0.022942 
1236.4 1980.71 1770.22 0.022924 
1266.56 1984.05 1774.76 0.022944 
1296.72 1983.49 1767.53 0.022857 
1326.88 1980.68 1766.69 0.022878 
1357.04 1985.1 1757.88 0.022713 
1387.2 1985.92 1762.29 0.022761 
1417.36 1986.22 1751.71 0.022621 
1447.52 1980.03 1752.44 0.022701 
1477.68 1981.84 1756.11 0.022728 
1507.84 1976.03 1746.9 0.022675 
1538 1979.89 1740.03 0.022542 
1568.16 1977.2 1738.6 0.022554 
1598.32 1982.36 1744.9 0.022577 
1628.48 1980.57 1737.79 0.022505 
1658.64 1985.52 1733.42 0.022393 
1688.8 1981.01 1734.92 0.022463 
1718.96 1987.74 1728.2 0.0223 
1749.12 1979.21 1725.67 0.022364 
1779.28 1984.36 1720.58 0.02224 
1809.44 1984.04 1720.62 0.022244 
1839.6 1985.77 1715.05 0.022153 
1869.76 1988.42 1718.66 0.02217 
1899.92 1975.28 1717.19 0.022298 
1930.08 1987.81 1721.96 0.022219 
1960.24 1983.01 1709.28 0.022109 
1990.4 1978.37 1701.35 0.022058 
2020.56 1984.8 1712.45 0.02213 
2050.72 1979.87 1707.93 0.022126 
2080.88 1986.24 1700.44 0.021959 
2111.04 1984.53 1695.53 0.021914 
2141.2 1981.94 1695.65 0.021944 
2171.36 1988.19 1693.41 0.021846 
2201.52 1980.17 1696.06 0.021969 
2231.68 1976.12 1686.7 0.021893 
2261.84 1985.26 1682.23 0.021734 
2292 1980.95 1680.01 0.021753 
2322.16 1985.89 1686.08 0.021777 
2352.32 1986.67 1681.49 0.021709 
2382.48 1979.83 1677.64 0.021734 
2412.64 1988.17 1683.22 0.021715 
2442.8 1990.51 1680.49 0.021655 
2472.96 1981.82 1679.36 0.021735 
2503.12 1989.5 1675.89 0.021606 
2533.28 1988.63 1672.18 0.021568 
2563.44 1994.45 1671.22 0.021493 
2593.6 1977.91 1675.25 0.021725 
2623.76 1983.8 1669.21 0.021582 
2653.92 1986.09 1666.74 0.021525 
2684.08 1990 1666.32 0.021477 
2714.24 1977.67 1664.2 0.021584 
2744.4 1978.53 1667.8 0.021621 
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2774.56 1983.01 1660.78 0.021481 
2804.72 1990.23 1665.01 0.021458 
2834.88 1988.23 1661.39 0.021433 
2865.04 1982.23 1659.69 0.021476 
2895.2 1983.41 1656.09 0.021416 
2925.36 1981.91 1662.71 0.021518 
2955.52 1986.57 1652.74 0.021339 
2985.68 1984.13 1651.04 0.021343 
3015.84 1986.42 1652.57 0.021339 
 
Determination of the Partial Order in NBS of Bromocylization of 19l by 
19
F NMR. (9.49 
mM, replicate 1) [MTB-XVI-97] 
Following General Procedure 24, PhMe-d8 (0.1 mL), Solution A (152 μL), a solution of 
NBS in PhMe (221 μL, 29.97 mM), PhMe (202 μL) and Solution B (25 μL) were combined.  
 
Table 81. NMR Data for MTB-XVI-97. 
 24160.4 25842.4 1.069618 
Time   [Olefin] 
30 2907.25 3161.97 0.025421 
60.16 2846.88 3023.99 0.024827 
90.32 2832.59 3010.52 0.024841 
120.48 2825.95 2982.51 0.024668 
150.64 2818.26 2991.97 0.024813 
180.8 2817.23 2967.73 0.024621 
210.96 2816.84 2962.26 0.024579 
241.12 2814.49 2943.45 0.024444 
271.28 2814.76 2927.63 0.02431 
301.44 2830.67 2900.61 0.02395 
331.6 2819.06 2890.41 0.023964 
361.76 2815.88 2867.6 0.023802 
391.92 2821.84 2843.51 0.023552 
y = -2.39E-06x + 2.50E-02 
R² = 8.49E-01 
0.0242 
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Table 81 cont. 
422.08 2836.81 2829.04 0.023309 
452.24 2820.84 2806.76 0.023256 
482.4 2822.02 2782.14 0.023043 
512.56 2825.88 2760.53 0.022832 
542.72 2816.43 2728.25 0.022641 
572.88 2821.04 2727.67 0.022599 
603.04 2831.34 2712.74 0.022394 
633.2 2826.04 2690.62 0.022253 
663.36 2825.89 2675.77 0.022131 
693.52 2832.27 2671.41 0.022045 
723.68 2823.37 2644.24 0.02189 
753.84 2829.16 2627.77 0.021709 
784 2828.7 2624.5 0.021686 
814.16 2827.96 2607.27 0.021549 
844.32 2819.62 2591.46 0.021482 
874.48 2833.22 2592.79 0.021389 
904.64 2836.02 2577.78 0.021245 
934.8 2833.89 2547.23 0.021009 
964.96 2830.17 2565.79 0.021189 
995.12 2834.53 2538.57 0.020932 
1025.28 2820.02 2532.47 0.02099 
1055.44 2828.55 2522.07 0.02084 
1085.6 2827.02 2505.73 0.020717 
1115.76 2822.76 2509.99 0.020783 
1145.92 2820.3 2503.24 0.020745 
1176.08 2817.2 2466.85 0.020466 
1206.24 2814.78 2485.25 0.020637 
1236.4 2824.04 2475.9 0.020491 
1266.56 2831.47 2467.36 0.020367 
1296.72 2831.35 2472 0.020406 
1326.88 2817.86 2460.55 0.020409 
1357.04 2838 2460.65 0.020265 
1387.2 2828.01 2449.15 0.020242 
1417.36 2829.58 2445.02 0.020196 
1447.52 2833.89 2436.54 0.020096 
1477.68 2825.87 2439.84 0.02018 
1507.84 2841.8 2411.79 0.019836 
1538 2818.79 2422.4 0.020086 
1568.16 2826.4 2419.69 0.02001 
1598.32 2834.51 2410.38 0.019876 
1628.48 2841.73 2419.79 0.019902 
1658.64 2822.1 2399.48 0.019873 
1688.8 2828.07 2395.54 0.019798 
1718.96 2815.42 2385.8 0.019806 
1749.12 2823.98 2388.27 0.019767 
1779.28 2823.88 2374.3 0.019652 
1809.44 2839.73 2385.3 0.019633 
1839.6 2834.8 2384.62 0.019661 
1869.76 2833.81 2383.7 0.01966 
1899.92 2838.97 2384.65 0.019632 
1930.08 2832.74 2384.94 0.019678 
1960.24 2828.79 2376.38 0.019635 
1990.4 2837.22 2371.64 0.019537 
2020.56 2819.57 2368.05 0.01963 
2050.72 2836.62 2354.06 0.019397 
2080.88 2836.5 2356.65 0.019419 
2111.04 2835.99 2355.78 0.019415 
2141.2 2832.21 2343.86 0.019343 
2171.36 2837.28 2360.47 0.019445 
2201.52 2831.4 2358.73 0.019471 
2231.68 2835.18 2350.63 0.019378 
2261.84 2842.53 2348.57 0.019311 
2292 2854.04 2351.14 0.019254 
2322.16 2839.71 2331.68 0.019191 
2352.32 2841.76 2332.12 0.019181 
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2382.48 2848.13 2335.07 0.019162 
2412.64 2838.64 2338.07 0.019251 
2442.8 2828.02 2335.71 0.019304 
2472.96 2837.54 2340.26 0.019277 
2503.12 2833.54 2321.83 0.019152 
2533.28 2825.91 2329.3 0.019265 
2563.44 2842.25 2329.89 0.01916 
2593.6 2831.64 2333.87 0.019264 
2623.76 2847.96 2337.98 0.019187 
2653.92 2843.99 2310.48 0.018988 
2684.08 2834.3 2315.36 0.019093 
2714.24 2846.67 2310.44 0.01897 
 
Determination of the Partial Order in NBS of Bromocylization of 19l by 
19
F NMR. (9.49 
mM, replicate 2) [MTB-XVI-100] 
Following General Procedure 24, PhMe-d8 (0.1 mL), Solution A (152 μL), a solution of 
NBS in PhMe (221 μL, 30.08 mM), PhMe (202 μL) and Solution B (25 μL) were combined.  
 
Table 82. NMR Data for MTB-XVI-100. 
 24165.9 25986.5 1.075338 
Time   [Olefin] 
28.62 2953.36 3174.23 0.024987 
58.78 2886.87 3061.19 0.024652 
88.94 2871.37 3045.62 0.024659 
119.1 2863.65 3042.84 0.024703 
149.26 2858.81 3026.79 0.024615 
179.42 2873.56 3011.12 0.024361 
209.58 2868.34 3011.32 0.024407 
239.74 2869.31 2989.63 0.024223 
269.9 2877.72 2987.8 0.024138 
300.06 2869.89 2969.99 0.024059 
y = -2.82E-06x + 2.49E-02 
R² = 9.02E-01 
0.024 
0.0241 
0.0242 
0.0243 
0.0244 
0.0245 
0.0246 
0.0247 
0.0248 
0 50 100 150 200 250 300 350 
[o
le
fi
n
] 
T (sec) 
Initial Rate 
472 
 
Table 82 cont. 
330.22 2867.61 2933.72 0.023784 
360.38 2866.2 2922.47 0.023705 
390.54 2858.67 2918.41 0.023734 
420.7 2868.99 2895.35 0.023462 
450.86 2877.9 2880.91 0.023273 
481.02 2863.45 2869.81 0.0233 
511.18 2871.36 2857.75 0.023138 
541.34 2867.3 2828.95 0.022938 
571.5 2859.9 2830.43 0.023009 
601.66 2857.66 2798.75 0.022769 
631.82 2870.73 2782.11 0.022531 
661.98 2874.09 2776.44 0.022459 
692.14 2869.02 2757.57 0.022345 
722.3 2881.71 2737.41 0.022084 
752.46 2876.17 2743.62 0.022177 
782.62 2868 2732 0.022146 
812.78 2881.03 2693.05 0.021732 
842.94 2881.25 2696.49 0.021758 
873.1 2864.88 2678.99 0.02174 
903.26 2862.75 2677.95 0.021748 
933.42 2876.46 2664.57 0.021536 
963.58 2879.85 2653.26 0.021419 
993.74 2861.87 2637.49 0.021426 
1023.9 2870.46 2632.42 0.021321 
1054.06 2856.88 2624.33 0.021356 
1084.22 2874.13 2611.78 0.021126 
1114.38 2885.41 2585.21 0.02083 
1144.54 2892.23 2610.16 0.020981 
1174.7 2873.21 2566.55 0.020767 
1204.86 2881.93 2588.63 0.020882 
1235.02 2879.84 2576.37 0.020799 
1265.18 2873.64 2566.36 0.020763 
1295.34 2885.82 2563.51 0.020652 
1325.5 2879.67 2563.18 0.020693 
1355.66 2874.46 2532.54 0.020483 
1385.82 2891.36 2532.94 0.020367 
1415.98 2878.92 2538.07 0.020496 
1446.14 2889.86 2531.42 0.020365 
1476.3 2880.24 2523.08 0.020366 
1506.46 2869 2523.35 0.020448 
1536.62 2874.16 2522.39 0.020403 
1566.78 2890.87 2511.16 0.020195 
1596.94 2882.9 2507.31 0.02022 
1627.1 2875.45 2511.55 0.020306 
1657.26 2883.16 2495.59 0.020123 
1687.42 2887.43 2485.96 0.020016 
1717.58 2878.99 2481.1 0.020035 
1747.74 2887.38 2487.55 0.020029 
1777.9 2874.95 2484.3 0.020089 
1808.06 2883.02 2465 0.019878 
1838.22 2877.91 2481.29 0.020045 
1868.38 2879.64 2479.04 0.020014 
1898.54 2888.57 2463.96 0.019831 
1928.7 2881.79 2466.1 0.019895 
1958.86 2880.29 2460.8 0.019863 
1989.02 2885.45 2448.77 0.01973 
2019.18 2892.8 2451.52 0.019702 
2049.34 2882.18 2452.5 0.019783 
2079.5 2891.41 2446.36 0.01967 
2109.66 2880.39 2436.08 0.019662 
2139.82 2881.53 2442.14 0.019703 
2169.98 2880.38 2434.21 0.019647 
2200.14 2880.23 2431.7 0.019628 
2230.3 2876.83 2451.24 0.019809 
2260.46 2887.06 2443.11 0.019674 
473 
 
Table 82 cont. 
2290.62 2886.52 2434.25 0.019606 
2320.78 2898.01 2418.8 0.019404 
2350.94 2886.09 2430.74 0.019581 
2381.1 2891.73 2417.34 0.019435 
2411.26 2883.36 2425.08 0.019553 
2441.42 2887.5 2422.14 0.019502 
2471.58 2889.15 2408.19 0.019378 
2501.74 2879.25 2420.64 0.019545 
2531.9 2890.96 2404.67 0.019338 
2562.06 2889.24 2409.64 0.019389 
2592.22 2887.4 2405.42 0.019368 
2622.38 2884.94 2412.03 0.019438 
2652.54 2882.16 2405.55 0.019404 
2682.7 2883.11 2410.79 0.01944 
2712.86 2896.36 2395.94 0.019232 
 
Determination of the Partial Order in NBS of Bromocylization of 19l by 
19
F NMR. (9.49 
mM, replicate 3) [MTB-XVII-24] 
Following General Procedure 24, PhMe-d8 (0.1 mL), Solution A (56 μL), a solution of 
NBS in PhMe (221 μL, 30.09 mM), PhMe (297 μL) and Solution B (25 μL) were combined.  
 
 
Table 83. NMR Data for MTB-XVII-24. 
 25514.7 25011.3 0.98027 
Time   [Olefin] 
30 3188.89 3052.75 0.024414 
60.16 2978.32 2909.7 0.024916 
90.32 2977.17 2908.2 0.024912 
120.48 2987.33 2892.49 0.024694 
150.64 2994.64 2880.49 0.024531 
y = -3.66E-06x + 2.52E-02 
R² = 9.35E-01 
0.0238 
0.024 
0.0242 
0.0244 
0.0246 
0.0248 
0.025 
0 50 100 150 200 250 300 350 
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le
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] 
T (sec) 
Initial Rate 
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Table 83 cont. 
180.8 2976.53 2864.07 0.02454 
210.96 2970.07 2847.09 0.024447 
241.12 2988.63 2832.9 0.024174 
271.28 2996.79 2833.27 0.024112 
301.44 3001.23 2817.29 0.02394 
331.6 2966.38 2803.05 0.024099 
361.76 2990.41 2768.8 0.023613 
391.92 2994.51 2754.99 0.023463 
422.08 2981.16 2738.44 0.023427 
452.24 2979.28 2727.76 0.02335 
482.4 2980.14 2703.82 0.023139 
512.56 2985.1 2698.45 0.023054 
542.72 2983.9 2687.38 0.022969 
572.88 2981.33 2671.89 0.022856 
603.04 2978.7 2663.15 0.022801 
633.2 2988 2657.42 0.022682 
663.36 2992.93 2634.61 0.02245 
693.52 2997.9 2629.93 0.022373 
723.68 2997.05 2608.08 0.022193 
753.84 751.015 651.183 0.022113 
 
Determination of the Partial Order in NBS of Bromocylization of 19l by 
19
F NMR. (9.49 
mM, replicate 4) [MTB-XVII-27] 
Following General Procedure 24, PhMe-d8 (0.1 mL), Solution A (56 μL), a solution of 
NBS in PhMe (221 μL, 29.97 mM), PhMe (297 μL) and Solution B (25 μL) were combined.  
 
Table 84. NMR Data for MTB-XVII-27. 
 17202.1 16897.9 0.982316 
Time   [Olefin] 
30 2032.97 2008.44 0.025143 
60.16 2014.83 1969.81 0.024881 
y = -2.70E-06x + 2.50E-02 
R² = 9.18E-01 
0.0241 
0.0242 
0.0243 
0.0244 
0.0245 
0.0246 
0.0247 
0.0248 
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Table 84 cont. 
90.32 2010.73 1958.29 0.024786 
120.48 2016.71 1969.8 0.024858 
150.64 2011.7 1961.88 0.02482 
180.8 2019.94 1952.92 0.024606 
210.96 2014.01 1946.46 0.024596 
241.12 2014.97 1929.93 0.024376 
271.28 2014.05 1933.76 0.024435 
301.44 2014.86 1917.51 0.02422 
331.6 2012.18 1914.12 0.02421 
361.76 2010.77 1895.8 0.023995 
391.92 2011.46 1889.36 0.023905 
422.08 2006.4 1877.27 0.023812 
452.24 2016.98 1872.39 0.023626 
482.4 2005.57 1853.18 0.023516 
512.56 2004.3 1841.24 0.02338 
542.72 2012.63 1831.01 0.023153 
572.88 2008.21 1832.09 0.023218 
603.04 2014.24 1811.65 0.02289 
633.2 2009.44 1807.88 0.022897 
663.36 2006.96 1799.93 0.022825 
693.52 1504.89 1346.04 0.022764 
 
Determination of the Partial Order in NBS of Bromocylization of 19l by 
19
F NMR. (16.8 
mM, replicate 1) [MTB-XVI-98] 
Following General Procedure 24, PhMe-d8 (0.1 mL), Solution A (152 μL), a solution of 
NBS in PhMe (394 μL, 30.08 mM), PhMe (30 μL) and Solution B (25 μL) were combined.  
 
Table 85. NMR Data for MTB-XVI-98. 
 23421.6 25173.5 1.074798 
Time   [Olefin] 
25.41 2876.06 3141.24 0.025405 
y = -7.34E-06x + 2.48E-02 
R² = 9.88E-01 
0.0232 
0.0234 
0.0236 
0.0238 
0.024 
0.0242 
0.0244 
0.0246 
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Table 85 cont. 
55.57 2794.7 2995.48 0.024931 
85.73 2773.89 2968.41 0.024891 
115.89 2776.34 2934.16 0.024582 
146.05 2766.91 2913.95 0.024496 
176.21 2766.18 2884.36 0.024254 
206.37 2770.64 2853.19 0.023953 
236.53 2767.35 2819.66 0.0237 
266.69 2766.8 2803.93 0.023572 
296.85 2768.96 2775.69 0.023317 
327.01 2767.78 2749.22 0.023104 
357.17 2768.5 2726.58 0.022908 
387.33 2767.55 2689.18 0.022602 
417.49 2768.59 2659.48 0.022343 
447.65 2782.04 2639.69 0.02207 
477.81 2768.25 2609.02 0.021922 
507.97 2764.75 2598.58 0.021862 
538.13 2776.82 2544.36 0.021313 
568.29 2773.49 2561.05 0.021479 
598.45 2773.47 2528.51 0.021206 
628.61 2768.57 2529.78 0.021254 
658.77 2781.04 2499.81 0.020908 
688.93 2794.29 2500.74 0.020817 
719.09 2765.9 2482.39 0.020876 
749.25 2790.3 2467.57 0.02057 
779.41 2778.59 2441.74 0.02044 
809.57 2779.36 2419.25 0.020246 
839.73 2768.76 2413.32 0.020274 
869.89 2782.89 2408.01 0.020127 
900.05 2786.79 2384.4 0.019902 
930.21 2781.14 2388.54 0.019977 
960.37 2076.34 1785.97 0.020007 
 
Determination of the Partial Order in NBS of Bromocylization of 19l by 
19
F NMR. (16.8 
mM, replicate 2) [MTB-XVI-99] 
Following General Procedure 24, PhMe-d8 (0.1 mL), Solution A (152 μL), a solution of 
NBS in PhMe (394 μL, 30.08 mM), PhMe (30 μL) and Solution B (25 μL) were combined.  
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Table 86. NMR Data for MTB-XVI-99. 
 24022.6 25783.2 1.073289 
Time   [Olefin] 
29.12 3013.16 3223.08 0.024916 
59.28 2937.98 3103.88 0.024608 
89.44 2917.38 3080.84 0.024598 
119.6 2933.3 3047.49 0.0242 
149.76 2921.5 3025.72 0.024124 
179.92 2921.33 3003.07 0.023945 
210.08 2921.72 2972.92 0.023701 
240.24 2928.98 2929.87 0.0233 
270.4 2914.75 2904.52 0.023211 
300.56 2914.19 2879.52 0.023016 
330.72 2914.31 2846.92 0.022754 
360.88 2920.92 2814.16 0.022442 
391.04 2930.38 2777.38 0.022077 
421.2 2924.68 2771.88 0.022076 
451.36 2918.59 2746.84 0.021922 
481.52 2919.67 2718.2 0.021686 
511.68 2914.79 2682.08 0.021433 
541.84 2924.32 2667.56 0.021248 
572 2914.37 2654.43 0.021215 
602.16 2937.05 2629.36 0.020853 
632.32 2925.18 2615.99 0.020831 
662.48 2929.37 2595.01 0.020634 
692.64 2928.26 2578.68 0.020512 
722.8 2913.58 2573.17 0.020571 
 
Determination of the Partial Order in NBS of Bromocylization of 19l by 
19
F NMR. (16.8 
mM, replicate 3) [MTB-XVII-09] 
Following General Procedure 24, PhMe-d8 (0.1 mL), Solution A (152 μL), a solution of 
NBS in PhMe (394 μL, 29.94 mM), PhMe (30 μL) and Solution B (25 μL) were combined.  
y = -7.07E-06x + 2.49E-02 
R² = 9.56E-01 
0.0232 
0.0234 
0.0236 
0.0238 
0.024 
0.0242 
0.0244 
0.0246 
0.0248 
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Table 87. NMR Data for MTB-XVII-09. 
 22637.2 24552.5 1.084609 
Time   [Olefin] 
30 2788.92 3100.83 0.025628 
60.16 2714.8 2945.45 0.025008 
90.32 2680.19 2904.81 0.024982 
120.48 2699.85 2897.61 0.024738 
150.64 2695.71 2866.87 0.024513 
180.8 2702.88 2834.35 0.024171 
210.96 2695.52 2811.26 0.02404 
241.12 2687.61 2786.45 0.023897 
271.28 2685.3 2753.62 0.023636 
301.44 2692.05 2709.53 0.023199 
331.6 2693.58 2685.87 0.022984 
361.76 2687.56 2657.5 0.022792 
391.92 2683.19 2663.31 0.022879 
422.08 2691.46 2616.05 0.022404 
452.24 2688.95 2598.65 0.022276 
482.4 2690.24 2581.11 0.022115 
512.56 2692.62 2551.76 0.021844 
542.72 2690.26 2528.68 0.021665 
572.88 2690.43 2501.76 0.021433 
603.04 2688.23 2503.75 0.021468 
633.2 2685.58 2481.73 0.0213 
663.36 2685.31 2464.64 0.021156 
693.52 2693.39 2455.73 0.021016 
723.68 2697.57 2443.55 0.020879 
753.84 2679.36 2427.3 0.020881 
784 2682.53 2424.27 0.020831 
814.16 2703.12 2412.16 0.020569 
844.32 2701.76 2397.64 0.020455 
874.48 2695.68 2381.56 0.020364 
904.64 2703.79 2369.18 0.020197 
934.8 2683.03 2361.44 0.020287 
964.96 2687.28 2351.1 0.020166 
995.12 2346.92 2058.34 0.020216 
 
y = -7.09E-06x + 2.49E-02 
R² = 9.81E-01 
0.0234 
0.0236 
0.0238 
0.024 
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Determination of the Partial Order in NBS of Bromocylization of 19l by 
19
F NMR. (16.8 
mM, replicate 4) [MTB-XVII-28] 
Following General Procedure 24, PhMe-d8 (0.1 mL), Solution A (56 μL), a solution of 
NBS in PhMe (394 μL, 29.94 mM), PhMe (125 μL) and Solution B (25 μL) were combined.  
 
Table 88. NMR Data for MTB-XVII-28. 
 15601.4 16068.1 1.029914 
Time   [Olefin] 
30 1807.01 1871.59 0.02514139 
60.16 1798.04 1816.97 0.02452943 
90.32 1788.97 1810.89 0.02457130 
120.48 1783.04 1787.8 0.02433867 
150.64 1783.07 1777.65 0.02420009 
180.8 1792.04 1750.77 0.02371485 
210.96 1794.44 1740.95 0.02355030 
241.12 1785.75 1715.54 0.02331950 
271.28 1783.19 1704.83 0.02320719 
301.44 1786.78 1683.91 0.02287636 
331.6 1786.19 1661.43 0.02257841 
361.76 1787.87 1645.98 0.02234743 
391.92 1798.17 1627.29 0.02196713 
422.08 1778.11 1615.07 0.02204813 
452.24 1803.1 1607.7 0.02164334 
482.4 1792.2 1592.89 0.02157438 
y = -7.46E-06x + 2.49E-02 
R² = 9.43E-01 
0.0232 
0.0234 
0.0236 
0.0238 
0.0240 
0.0242 
0.0244 
0.0246 
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